Citrus Sinensis ID: 003489
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 816 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SXB8 | 842 | G-type lectin S-receptor- | yes | no | 0.960 | 0.931 | 0.528 | 0.0 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.970 | 0.965 | 0.503 | 0.0 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.975 | 0.970 | 0.484 | 0.0 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.960 | 0.944 | 0.493 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.966 | 0.929 | 0.458 | 0.0 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.966 | 0.937 | 0.451 | 0.0 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.973 | 0.975 | 0.434 | 0.0 | |
| Q9SYA0 | 804 | G-type lectin S-receptor- | no | no | 0.966 | 0.981 | 0.438 | 0.0 | |
| O64781 | 831 | G-type lectin S-receptor- | no | no | 0.957 | 0.939 | 0.428 | 0.0 | |
| O64770 | 804 | G-type lectin S-receptor- | no | no | 0.936 | 0.950 | 0.440 | 0.0 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/820 (52%), Positives = 563/820 (68%), Gaps = 36/820 (4%)
Query: 25 DTITSSQFIRDPES--IISSGSKFKLGFFSPDGNFTN-RYIGIWYNKGGSANKTVVWVAN 81
D IT S I+D ES ++ F+ GFF+P + T RY+GIWY K +TVVWVAN
Sbjct: 31 DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEK--IPIQTVVWVAN 88
Query: 82 RNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNI 141
++ P+ D+SG+ +I +DGNL V +G+ ++ WS+NVS + T QL+DSGNL+L DN
Sbjct: 89 KDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNR 148
Query: 142 SQVSI-WDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPE 200
+ I W+SF+ P D+F M + TD RTG ++LTSW S +PS G+++AG+ FT PE
Sbjct: 149 NNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPE 208
Query: 201 VFIWINGTRPYWRSGPWNGRYFIGIPDMNSV-YLDGFNLGEDHQKGTRYLTFAFADNDVF 259
+ IW N P WRSGPWNG+ FIG+P+M+S+ +LDGFNL D+Q GT +++A ND F
Sbjct: 209 LLIWKNNV-PTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQ-GTISMSYA---NDSF 263
Query: 260 ---FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLG 316
F L P+G + ++ W +I +P DCD YG+CG FGSC++ + P C C+ G
Sbjct: 264 MYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKG 323
Query: 317 FEPKNAEDWNRGNWSGGEVE------------------GKQDGFFKLETMKVPYFAERSS 358
F PKN +WN GNWS G + GK DGF KL+ MKVP AERS
Sbjct: 324 FVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERSE 383
Query: 359 ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKD 418
A+E C C +NCSC AYAY+ G+GCM+W+ +L+D++ G +L+IRVAH EL
Sbjct: 384 ASEQVCPKVCLDNCSCTAYAYDRGIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSELKTHS 443
Query: 419 MKLVIILSVIVGIIAIA-ICTFFAWRWFAKRKA-MKENSKVQRLDLGEAYANFSTEKVNP 476
V+I + ++G++ IA +C A R + KR A K+ S EA + + N
Sbjct: 444 NLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQ 503
Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE 536
+L++L +F F+ LA +T++F L NKLGQGGFGPVYKGKL +GQEIAVKRLS+ SGQG E
Sbjct: 504 IKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLE 563
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR 596
E MNEV+VIS LQHRNLV+LLGCC+E EE ML+YEYMP KSLD++LFDP +Q +LDW R
Sbjct: 564 ELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTR 623
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
FNI++GI RGLLYLHRDSRL+IIHRDLKASNILLD++LNPKISDFGLARIF N+D+A T
Sbjct: 624 FNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANT 683
Query: 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK 716
+R+VGTYGYMSPEYAMEG FSEKSDVFS GV+ LEI+SGR+N+S + EE L LL YAWK
Sbjct: 684 RRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWK 743
Query: 717 LWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
LWND L DP + + F+ EI +CV++GLLCVQE DRPN+ V+ ML +E L
Sbjct: 744 LWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLA 803
Query: 777 AAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
KQPAF VRRGA + A SS+Q+ Q SINDV++T + GR
Sbjct: 804 DPKQPAFIVRRGASE-AESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/829 (50%), Positives = 564/829 (68%), Gaps = 37/829 (4%)
Query: 6 IVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIW 65
+ +L+ SCF+ + A + S + D E+I+SS F+ GFFSP N T+RY GIW
Sbjct: 11 VCILVLSCFF--LSVSLAQERAFFSGKLNDSETIVSSFRTFRFGFFSPV-NSTSRYAGIW 67
Query: 66 YNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNT 125
YN + +TV+WVAN++KP+ DSSG+ ++S+DGNLVV +G+++V WS+NVS+ A+ ++T
Sbjct: 68 YNS--VSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANST 125
Query: 126 RAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK-KVQLTSWRSLSNP 184
A+LLDSGNLVL + S +W+SF+ PTD++ M V T+ R G V +TSW+S S+P
Sbjct: 126 VAELLDSGNLVLKEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDP 185
Query: 185 SIGSFSAGLDSFTIPEVFIWINGT--RPYWRSGPWNGRYFIGIPDMNS-VYLDGFNLGED 241
S GS++A L PE+FI N WRSGPWNG+ F G+PD+ + V+L F + +D
Sbjct: 186 SPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDD 245
Query: 242 HQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
G+ +++A +F + +G++ R W + + + + P +CD Y +CG F
Sbjct: 246 -TNGSVTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFA 304
Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE------------GKQDGFFKLETMK 349
+CN +K P+CSC+ GF P+N +WN GNWSGG G DGF +L MK
Sbjct: 305 TCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMK 364
Query: 350 VPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRV 409
+P FA RS A+E +C C CSC A A+ +G GCMIW +L+D ++L + G +LYIR+
Sbjct: 365 LPDFARRSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNGSLVDSQELSASGLDLYIRL 424
Query: 410 AHEELDRKDMKLVIILSVIVG-IIAIAICTFFAWRWFAKRKAMKENSKVQRL-DLGEAYA 467
AH E+ KD + ++I +++ G I +A C A R K++A K+ +++ + EA A
Sbjct: 425 AHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALA 484
Query: 468 NFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL 527
N +L++L +F F+ LA ATNNF L NKLGQGGFGPVYKGKLQ+GQEIAVKRL
Sbjct: 485 GG-----NKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRL 539
Query: 528 SKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR 587
S+ASGQG EE +NEV+VIS LQHRNLV+LLGCC+ EE ML+YE+MP KSLD +LFD +R
Sbjct: 540 SRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRR 599
Query: 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
LLDW RFNII GI RGLLYLHRDSRLRIIHRDLKASNILLD++L PKISDFGLARIF
Sbjct: 600 AKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIF 659
Query: 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFE 707
GN+D+A T+R+VGTYGYM+PEYAM G FSEKSDVFS GV+LLEI+SGR+N++
Sbjct: 660 PGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNSNS------ 713
Query: 708 LTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767
TLL Y W +WN+ + LVDP I + F+ EI +C+++GLLCVQE DRP++ TV SM
Sbjct: 714 -TLLAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSM 772
Query: 768 LNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
L+SEI D+P KQPAF R ++ SS N + + SIN+VT+T + GR
Sbjct: 773 LSSEIADIPEPKQPAFISRNNVPEAESSENSDLKD-SINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/833 (48%), Positives = 550/833 (66%), Gaps = 37/833 (4%)
Query: 2 ISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRY 61
+S + VL SCF+ + A + S + D E+I+SS F+ GFFSP N TNRY
Sbjct: 7 LSPIVHVLSLSCFF--LSVSLAHERALFSGTLNDSETIVSSFRTFRFGFFSPV-NSTNRY 63
Query: 62 IGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLAN 121
GIWYN +TV+WVAN++ P+ DSSG+ +ISEDGNLVV +G+++V WS+NVS+ A+
Sbjct: 64 AGIWYNS--IPVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRAS 121
Query: 122 NSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK-KVQLTSWRS 180
++T A+LL+SGNLVL D + +W+SF+ PTD++ M V T+ RTG + +TSW +
Sbjct: 122 ANSTVAELLESGNLVLKDANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTN 181
Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWING--TRPYWRSGPWNGRYFIGIPDM-NSVYLDGFN 237
S+PS GS++A L PE+FI+ N WRSGPWNG F G+PD+ ++L F
Sbjct: 182 PSDPSPGSYTAALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFK 241
Query: 238 LGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKC 297
+ +D G+ +++A L +G R W + + + + P +CD+Y +C
Sbjct: 242 VNDD-TNGSATMSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRC 300
Query: 298 GAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV------------EGKQDGFFKL 345
G + +CN +K P CSC+ GF P+N +WN GNWSGG + +G D F KL
Sbjct: 301 GQYTTCNPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNKGSADRFLKL 360
Query: 346 ETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNL 405
+ MK+P FA RS A+E +C C +CSC A+A+ +G GCMIW +L+D + L + G +L
Sbjct: 361 QRMKMPDFARRSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNRSLVDSQVLSASGMDL 420
Query: 406 YIRVAHEELDRKDMKLVII-LSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRL-DLG 463
IR+AH E +D + ++I S+ GI +A C A R K++A K+ + +++
Sbjct: 421 SIRLAHSEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAKKKGTDAEQIFKRV 480
Query: 464 EAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIA 523
EA A S EK L++L +F F+ LA AT+NF L+NKLGQGGFGPVYKG L +GQEIA
Sbjct: 481 EALAGGSREK-----LKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIA 535
Query: 524 VKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF 583
VKRLS+ASGQG EE + EV+VIS LQHRNLV+L GCC+ EE ML+YE+MP KSLD ++F
Sbjct: 536 VKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIF 595
Query: 584 DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
DP+ LLDW RF II GI RGLLYLHRDSRLRIIHRDLKASNILLD++L PKISDFGL
Sbjct: 596 DPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGL 655
Query: 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703
ARIF GN+D+A T+R+VGTYGYM+PEYAM G FSEKSDVFS GV+LLEI+SGR+N+
Sbjct: 656 ARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNS---- 711
Query: 704 EEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPT 763
TLL + W +WN+ + +VDP I + F+ EI +CV++ LLCVQ+ DRP++ T
Sbjct: 712 ---HSTLLAHVWSIWNEGEINGMVDPEIFDQLFEKEIRKCVHIALLCVQDAANDRPSVST 768
Query: 764 VVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
V ML+SE+ D+P KQPAF R ++ S + + SIN+VT+T + GR
Sbjct: 769 VCMMLSSEVADIPEPKQPAFMPRNVGLEAEFSESIALK-ASINNVTITDVSGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/820 (49%), Positives = 541/820 (65%), Gaps = 36/820 (4%)
Query: 23 ATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANR 82
ATD IT S RD E+++S+ S F+ GFFSP N T RY GIW+N +TVVWVAN
Sbjct: 21 ATDVITFSSEFRDSETVVSNHSTFRFGFFSPV-NSTGRYAGIWFNN--IPVQTVVWVANS 77
Query: 83 NKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVL--HDN 140
N P+ DSSG+ +IS++GNLVV++G+ QVHWS+NV + A+LL++GNLVL N
Sbjct: 78 NSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTN 137
Query: 141 ISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPE 200
+W+SF+ P + + M ++TD +TG+ ++L SW+S +PS G +SAGL PE
Sbjct: 138 TGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPE 197
Query: 201 VFIWINGTRPYWRSGPWNGRYFIGIPDMN-SVYLDGFNLGEDHQKGTRYLTFAFADNDVF 259
+ +W + WRSGPWNG+YFIG+P+M+ + L L D+ +G+ +++A
Sbjct: 198 LVVWKDDLL-MWRSGPWNGQYFIGLPNMDYRINLFELTLSSDN-RGSVSMSYAGNTLLYH 255
Query: 260 FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSC--NSQKIPICSCLLGF 317
F L +G++ +R W K + P+ CD Y CG F SC N P C C+ GF
Sbjct: 256 FLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGF 315
Query: 318 EPKNAEDWNRGNWSGGEVEG---------------KQDGFFKLETMKVPYFAERSSANED 362
+P++ +WN GNW+ G V K DGF +++ MKVP+ +RS ANE
Sbjct: 316 KPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANEQ 375
Query: 363 KCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELD-RKDMKL 421
C + C NCSC AY+++ G+GC++W+ NL+D+++ G YIR+A E R + +
Sbjct: 376 DCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNRSI 435
Query: 422 VIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKV-----NP 476
VI ++++VG A A AK + N+++ L E S+ V N
Sbjct: 436 VITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRL----LNERMEALSSNDVGAILVNQ 491
Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE 536
+L++L +F F+ LA ATNNF + NKLGQGGFG VYKG+LQ+G +IAVKRLS+ SGQG E
Sbjct: 492 YKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVE 551
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR 596
EF+NEV+VIS LQHRNLVRLLG C+E EE ML+YE+MP LD++LFDP +Q LLDW R
Sbjct: 552 EFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTR 611
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
FNII GI RGL+YLHRDSRL+IIHRDLKASNILLD++LNPKISDFGLARIF GN+D+ +T
Sbjct: 612 FNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVST 671
Query: 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK 716
R+VGTYGYM+PEYAM G FSEKSDVFS GV+LLEIVSGR+N+SFY++ L YAWK
Sbjct: 672 VRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWK 731
Query: 717 LWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
LWN I LVDP+I E F+ EI RCV+VGLLCVQ+ DRP++ TV+ ML+SE +LP
Sbjct: 732 LWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLP 791
Query: 777 AAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
KQPAF RRG + SS Q+ SIN+V++T + GR
Sbjct: 792 EPKQPAFIPRRGTSE-VESSGQSDPRASINNVSLTKITGR 830
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/840 (45%), Positives = 533/840 (63%), Gaps = 51/840 (6%)
Query: 18 FGTATATDTITSSQFIRD---PESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANK 74
+ ++ A +TI + +RD + ++S F+LGFFSP G+ T+R++GIWY G +K
Sbjct: 20 YESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSP-GSSTHRFLGIWY--GNIEDK 76
Query: 75 TVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNV-SSLANNSNTRAQLLDSG 133
VVWVANR P+ D SG+ IS DGNLV+L+GK WSSN+ SS NN+N + D+G
Sbjct: 77 AVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTG 136
Query: 134 NLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGL 193
N VL + + IW+SF PTDTF +M+V + +TG SWRS ++PS G++S G+
Sbjct: 137 NFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGV 196
Query: 194 DSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSV--YLDGFNLGED-HQKGTRYLT 250
D PE+ +W WRSG WN F GIP+M+ + YL GF L + G+ Y T
Sbjct: 197 DPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFT 256
Query: 251 FAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQ-K 307
+ +D V F + G EE W + + P ++CD Y +CG FG C+ +
Sbjct: 257 YVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGS 316
Query: 308 IPICSCLLGFEPKNAEDWNRG-----------NWSGGEVEGKQDGFFKLETMKVPYF--A 354
ICSC+ G+E + +W+RG N S GE D F L+++K+P F
Sbjct: 317 NGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGE-----DEFLTLKSVKLPDFEIP 371
Query: 355 ERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEEL 414
E + + + C+++C NCSC AY+ G+GCMIW +L+D+++ +GG++L+IR+A E+
Sbjct: 372 EHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEV 431
Query: 415 -DRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEK 473
+ + K+ +I++V+VG+I I I WR F ++K + + D A+ + K
Sbjct: 432 GENRKTKIAVIVAVLVGVILIGIFALLLWR-FKRKKDVSGAYCGKNTDTSVVVADLTKSK 490
Query: 474 VNPARLQ---------------DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD 518
+ +L VF+ +A ATN+F N+LG+GGFGPVYKG L+D
Sbjct: 491 ETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLED 550
Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578
G+EIAVKRLS SGQG +EF NE+++I+ LQHRNLVRLLGCC E EE ML+YEYMPNKSL
Sbjct: 551 GREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSL 610
Query: 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
D FLFD +Q+L+DW RF+II+GI+RGLLYLHRDSRLRIIHRDLK SN+LLD ++NPKI
Sbjct: 611 DFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKI 670
Query: 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 698
SDFG+ARIFGGNQ++A T R+VGTYGYMSPEYAMEG FS KSDV+SFGVLLLEIVSG++N
Sbjct: 671 SDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRN 730
Query: 699 TSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDR 758
TS E +L+GYAW L+ +LVDP I + K E +RC++V +LCVQ+ +R
Sbjct: 731 TSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAER 789
Query: 759 PNMPTVVSMLNSEIKDLPAAKQPAFT-VRRGAYDSASSSNQNQQ-ICSINDVTVTLMEGR 816
PNM +V+ ML S+ L A +QP FT RR + D + + +QQ I S N++T T++ GR
Sbjct: 790 PNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 691 bits (1783), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/826 (45%), Positives = 517/826 (62%), Gaps = 37/826 (4%)
Query: 20 TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWV 79
+ + +++ T + IR+ +S+IS F+LGFF+P N T RY+GIWY +TVVWV
Sbjct: 25 SCSTSNSFTRNHTIREGDSLISEDESFELGFFTPK-NSTLRYVGIWYKN--IEPQTVVWV 81
Query: 80 ANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVL-H 138
ANR KPL+D G I++DGNLV++NG+ + WS+NV +NN T A L +G+LVL
Sbjct: 82 ANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNN--TVAVLFKTGDLVLCS 139
Query: 139 DNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTI 198
D+ + W+SF PTDTF M+V + G+ W+S S+PS G +S G+D
Sbjct: 140 DSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGA 199
Query: 199 PEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSV--YLDGFNLGEDHQK-GTRYLTFAFAD 255
E+ IW G + WRSGPWN F GIPDM Y+ GF L + G+ Y T+ +D
Sbjct: 200 LEIVIW-EGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASD 258
Query: 256 NDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQK---IPI 310
+ F F + P G E+ W + + + P+ +C+ Y +CG + C+ K
Sbjct: 259 SSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGK 318
Query: 311 CSCLLGFEPKNAEDWNRGNWSGG------------EVEGKQDGFFKLETMKVPYFAERS- 357
CSC+ GFEP + + WN ++SGG V G++DGF L+ +KVP F
Sbjct: 319 CSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVL 378
Query: 358 SANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELD-- 415
N + CKD C+ +CSCKAYA +G+GCMIWT +LID+ GG ++ IR+A +L
Sbjct: 379 HNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGG 438
Query: 416 RKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAM---KENSKVQRLDLGEAYANFSTE 472
+++ L II+ ++G + +C + W++ KA K++ V + Y++ +
Sbjct: 439 KENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIK 498
Query: 473 KV--NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA 530
+ + DL +F+F+ +A+AT +F NKLGQGGFG VYKG +G+EIAVKRLS
Sbjct: 499 VLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGK 558
Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
S QG EEF NE+++I+ LQHRNLVRLLGCC+E E ML+YEYMPNKSLD FLFD +Q
Sbjct: 559 SKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGS 618
Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
LDW KR+ +I GI+RGLLYLHRDSRL+IIHRDLKASNILLD ++NPKISDFG+ARIF
Sbjct: 619 LDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYR 678
Query: 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTL 710
QD A T R+VGTYGYM+PEYAMEG FSEKSDV+SFGVL+LEIVSGRKN SF + +L
Sbjct: 679 QDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SL 737
Query: 711 LGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770
+GYAW LW+ +++DP++ ++ E +RC++VG+LC Q+ V RPNM +V+ ML S
Sbjct: 738 IGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLES 797
Query: 771 EIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
+ LP +QP F + D + + + S+NDVT T + GR
Sbjct: 798 QTSQLPPPRQPTFHSFLNSGDIELNFD-GHDVASVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/836 (43%), Positives = 521/836 (62%), Gaps = 42/836 (5%)
Query: 1 MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNR 60
M + IV S F + A IT + + +++ S ++LGFFSP+ N N+
Sbjct: 1 MGKIGIVFFASLLFLLIIFPSCAFAAITRASPLSIGQTLSSPNGTYELGFFSPN-NSRNQ 59
Query: 61 YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLA 120
Y+GIW+ + VVWVANR+KP+ +++ TI+ +G+L+++ ++ V WS +
Sbjct: 60 YVGIWFKN--ITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWS--IGETF 115
Query: 121 NNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRS 180
+++ RA+LL++GNLVL D +S+ ++W+SF+ DT E V D+ KK L+SW++
Sbjct: 116 SSNELRAELLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKN 175
Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGE 240
++PS G F A L + P+ FI + G+RPYWR GPW F GIP+M+ ++ F++ +
Sbjct: 176 PTDPSPGEFVAELTTQVPPQGFI-MRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQ 234
Query: 241 DHQKGTRYLTFAFA---DNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKC 297
D GT LT++ N + LT G+L+ W +G + P + CDVY C
Sbjct: 235 DVAAGTGSLTYSLERRNSNLSYTTLTSAGSLK-IIWNNGSGWVT-DLEAPVSSCDVYNTC 292
Query: 298 GAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE----------------GKQDG 341
G FG C P C CL GF PK+ E+WN+ NW+GG + D
Sbjct: 293 GPFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDI 352
Query: 342 FFKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
F + +K P F E S NE+ C+ +C NCSC A++Y +GC++W L+D+ + +
Sbjct: 353 FDIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELVDVMQFVA 412
Query: 401 GGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRL 460
GG L IR+A EL + +I+ S++ I++ + FA W+ + KA + +S L
Sbjct: 413 GGETLSIRLASSELAGSNRVKIIVASIVS--ISVFMILVFASYWYWRYKAKQNDSNPIPL 470
Query: 461 DLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQ 520
E + E++ P QD+ F+ + + TNNF + NKLGQGGFGPVYKG LQDG+
Sbjct: 471 ---ETSQDAWREQLKP---QDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGK 524
Query: 521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
EIA+KRLS SGQG EEFMNE+++IS LQHRNLVRLLGCC+E EE +LIYE+M NKSL++
Sbjct: 525 EIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNT 584
Query: 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
F+FD ++ LDWPKRF II+GI+ GLLYLHRDS LR++HRD+K SNILLD+++NPKISD
Sbjct: 585 FIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISD 644
Query: 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS 700
FGLAR+F G Q QA T+R+VGT GYMSPEYA G FSEKSD+++FGVLLLEI++G++ +S
Sbjct: 645 FGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISS 704
Query: 701 FYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN 760
F E TLL +AW W ++ DL+D IS SG + E+ RCV +GLLC+Q+ DRPN
Sbjct: 705 FTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPN 764
Query: 761 MPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
+ V+SML + + DLP KQP F ++ DS S + + S+N++T T + GR
Sbjct: 765 IAQVMSMLTTTM-DLPKPKQPVFAMQVQESDSESKT-----MYSVNNITQTAIVGR 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/831 (43%), Positives = 519/831 (62%), Gaps = 42/831 (5%)
Query: 1 MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNR 60
M++ + L + F + +++ IT+ + +++ S+ ++LGFFSP+ N ++
Sbjct: 1 MMTRFACLHLFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPN-NTQDQ 59
Query: 61 YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLA 120
Y+GIW+ + + VVWVANR KP+ DS+ IS G+L++LNGK WSS V+
Sbjct: 60 YVGIWFKD--TIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVT--F 115
Query: 121 NNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRS 180
++S RA+L DSGNL + DN+S+ ++W SF DT ++ +L T +K LTSW+S
Sbjct: 116 SSSGCRAELSDSGNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKS 175
Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGE 240
++PS G F G + +P + G+ PYWRSGPW F GIP M+ Y F L +
Sbjct: 176 YTDPSPGDF-LGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQ 234
Query: 241 DHQKGTRYLTFAFADNDVF-FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGA 299
D G+ YLT+ D + LT +G++ + + D ++Y+ P CD YG CG
Sbjct: 235 D-VNGSGYLTYFQRDYKLSRITLTSEGSI--KMFRDNGMGWELYYEAPKKLCDFYGACGP 291
Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQ------------DGFFKLET 347
FG C P+C C GF PK+ E+W RGNW+GG V + D F ++
Sbjct: 292 FGLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIAN 351
Query: 348 MKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
+K P F E SS N ++C +C +NCSC A+AY G+GC++W +L+D + + G L
Sbjct: 352 IKPPDFYEFASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQDLMDAVQFSATGELLS 411
Query: 407 IRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWR-WFAKRKAMKENSKVQRLDLGEA 465
IR+A ELD K I+ S IV + I F A+ W + + + SK +A
Sbjct: 412 IRLARSELDGNKRKKTIVAS-IVSLTLFMILGFTAFGVWRCRVEHIAHISK-------DA 463
Query: 466 YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK 525
+ N + P + L F+ + NATNNF L+NKLGQGGFG VYKGKLQDG+EIAVK
Sbjct: 464 WKN----DLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 519
Query: 526 RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP 585
RLS +SGQG+EEFMNE+++IS LQHRNLVR+LGCC+E EE +LIYE+M NKSLD+FLFD
Sbjct: 520 RLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDS 579
Query: 586 QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
+++ +DWPKRF+II+GI+RGLLYLH DSRLR+IHRDLK SNILLD+ +NPKISDFGLAR
Sbjct: 580 RKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLAR 639
Query: 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE 705
++ G + Q T+R+VGT GYMSPEYA G FSEKSD++SFGVL+LEI+SG K + F +
Sbjct: 640 MYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGV 699
Query: 706 FELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVV 765
TL+ YAW+ W++ IDL+D +++S +E+ RC+ +GLLCVQ DRPN ++
Sbjct: 700 EGKTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELL 759
Query: 766 SMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
+ML + DLP+ KQP F A+ + + + + ++N +T +++ GR
Sbjct: 760 AMLTT-TSDLPSPKQPTF-----AFHTRDDESLSNDLITVNGMTQSVILGR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/830 (42%), Positives = 517/830 (62%), Gaps = 49/830 (5%)
Query: 6 IVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIW 65
++++ + Y+D T++ ++ Q + P+ + ++LGFFSP+ N +Y+GIW
Sbjct: 32 LLIIFPTFGYADINTSSP---LSIGQTLSSPDGV------YELGFFSPN-NSRKQYVGIW 81
Query: 66 YNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNT 125
+ A + VVWVANR+KP+ ++ TIS +G+L++L+G + V WS+ + +N +
Sbjct: 82 FKN--IAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNKCH- 138
Query: 126 RAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS 185
A+LLD+GNLV+ D++S ++W SF+ +T + V D+ GK LTSWRS S+PS
Sbjct: 139 -AELLDTGNLVVIDDVSGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPS 197
Query: 186 IGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKG 245
G F+ P+ I G+ PYWRSGPW F GIP +++ Y+ F + +D KG
Sbjct: 198 PGEFTLEFTPQVPPQGLI-RRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKG 256
Query: 246 TRYLTFAFADND--VFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSC 303
T +++ N + LT +G ++ W DGK+ K++F PT+ CD+Y CG FG C
Sbjct: 257 TASFSYSMLRNYKLSYVTLTSEGKMK-ILWNDGKS-WKLHFEAPTSSCDLYRACGPFGLC 314
Query: 304 NSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------------EVEGKQ-DGFFKLET 347
+ P C CL GF PK+ ++W +GNW+ G + +GK+ D F+ +
Sbjct: 315 VRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTR 374
Query: 348 MKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
+K P + + N ++C C NCSC A+AY G+GC++W L+D + S G +L
Sbjct: 375 VKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNRELVDTVQFLSDGESLS 434
Query: 407 IRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAY 466
+R+A EL + + IIL V + I F A++ + R E + + +A+
Sbjct: 435 LRLASSELAGSN-RTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAW 493
Query: 467 ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR 526
A + + P + + +F+ + ATNNF +NKLGQGGFGPVYKGKL DG+EIAVKR
Sbjct: 494 A----KDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKR 549
Query: 527 LSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ 586
LS +SGQG +EFMNE+ +IS LQH+NLVRLLGCC++ EE +LIYEY+ NKSLD FLFD
Sbjct: 550 LSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDST 609
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
+ +DW KRFNII+G++RGLLYLHRDSRLR+IHRDLK SNILLD+ + PKISDFGLAR+
Sbjct: 610 LKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARM 669
Query: 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706
G Q Q T+R+VGT GYM+PEYA G FSEKSD++SFGVLLLEI+ G K + F E
Sbjct: 670 SQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSEE-- 727
Query: 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766
TLL YAW+ W + +DL+D +++S E+ RCV +GLLCVQ DRPN ++S
Sbjct: 728 GKTLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMS 787
Query: 767 MLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
ML + I +LP+ KQP FTV + D S+SN + ++N++T ++++GR
Sbjct: 788 MLTT-ISELPSPKQPTFTVH--SRDDDSTSN---DLITVNEITQSVIQGR 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/805 (44%), Positives = 499/805 (61%), Gaps = 41/805 (5%)
Query: 27 ITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPL 86
IT+ + +++ SS ++LGFFSP+ N N Y+GIW+ G + VVWVANR P
Sbjct: 26 ITTESPLSVEQTLSSSNGIYELGFFSPN-NSQNLYVGIWFK--GIIPRVVVWVANRETPT 82
Query: 87 IDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSI 146
D+S IS +G+L++ NGK V WS + +N S RA+L D+GNLV+ DN S ++
Sbjct: 83 TDTSANLAISSNGSLLLFNGKHGVVWSIGENFASNGS--RAELTDNGNLVVIDNASGRTL 140
Query: 147 WDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWIN 206
W+SF+ DT + +L TG+K LTSW++ ++PS G F G + +P + +
Sbjct: 141 WESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVF-VGQITPQVPSQVLIMR 199
Query: 207 GTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQG 266
G+ Y+R+GPW F GIP M+ Y F+L +D + F + ++ +G
Sbjct: 200 GSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQQDANGSGFFTYFDRSFKLSRIIISSEG 259
Query: 267 NLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWN 326
++ + + ++ + P N CD+YG CG FG C C CL GF P + E+W
Sbjct: 260 SM--KRFRHNGTDWELSYMAPANSCDIYGVCGPFGLCIVSVPLKCKCLKGFVPHSTEEWK 317
Query: 327 RGNWSGG-------EVEGKQDG-----FFKLETMKVPYFAE-RSSANEDKCKDQCSNNCS 373
RGNW+GG +G G F + +K+P F E SS + ++C C +NCS
Sbjct: 318 RGNWTGGCARLTELHCQGNSTGKDVNIFHPVTNVKLPDFYEYESSVDAEECHQSCLHNCS 377
Query: 374 CKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELD-RKDMKLVIILSVIVGII 432
C A+AY G+GC+IW NL+D + +GG L IR+AH EL K K+++ +V + +
Sbjct: 378 CLAFAYIHGIGCLIWNQNLMDAVQFSAGGEILSIRLAHSELGGNKRNKIIVASTVSLSLF 437
Query: 433 AIAICTFFA-WRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELA 491
I F WR+ K KA L +A+ N K P L F +
Sbjct: 438 VILTSAAFGFWRYRVKHKAYT---------LKDAWRNDLKSKEVPG----LEFFEMNTIQ 484
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR 551
ATNNF L+NKLGQGGFG VYKGKLQDG+EIAVK+LS +SGQG+EEFMNE+++IS LQHR
Sbjct: 485 TATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHR 544
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
NLVR+LGCC+E EE +LIYE+M NKSLD+F+FD +++ +DWPKRF+I++GI+RGLLYLH
Sbjct: 545 NLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLH 604
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
RDSRL++IHRDLK SNILLD+ +NPKISDFGLAR++ G Q Q T+R+VGT GYMSPEYA
Sbjct: 605 RDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYA 664
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731
G FSEKSD++SFGVLLLEI+ G K + F + E TLL YAW+ W + IDL+D +
Sbjct: 665 WTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDL 724
Query: 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYD 791
++S +E+ RCV +GLLCVQ DRPN +++ML + DLP+ KQP F V +
Sbjct: 725 ADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTT-TSDLPSPKQPTFVV----HS 779
Query: 792 SASSSNQNQQICSINDVTVTLMEGR 816
S+ ++ + ++N++T +++ GR
Sbjct: 780 RDDESSLSKDLFTVNEMTQSMILGR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 816 | ||||||
| 224114125 | 832 | predicted protein [Populus trichocarpa] | 0.985 | 0.966 | 0.613 | 0.0 | |
| 359496521 | 844 | PREDICTED: G-type lectin S-receptor-like | 0.980 | 0.947 | 0.574 | 0.0 | |
| 224114137 | 827 | predicted protein [Populus trichocarpa] | 0.974 | 0.961 | 0.589 | 0.0 | |
| 224078778 | 831 | predicted protein [Populus trichocarpa] | 0.985 | 0.967 | 0.576 | 0.0 | |
| 296084622 | 817 | unnamed protein product [Vitis vinifera] | 0.965 | 0.964 | 0.590 | 0.0 | |
| 359496538 | 887 | PREDICTED: G-type lectin S-receptor-like | 0.950 | 0.874 | 0.597 | 0.0 | |
| 224112032 | 824 | predicted protein [Populus trichocarpa] | 0.977 | 0.968 | 0.570 | 0.0 | |
| 224114141 | 824 | predicted protein [Populus trichocarpa] | 0.977 | 0.968 | 0.569 | 0.0 | |
| 359496519 | 854 | PREDICTED: G-type lectin S-receptor-like | 0.977 | 0.934 | 0.558 | 0.0 | |
| 147840284 | 827 | hypothetical protein VITISV_016155 [Viti | 0.948 | 0.935 | 0.575 | 0.0 |
| >gi|224114125|ref|XP_002316674.1| predicted protein [Populus trichocarpa] gi|222859739|gb|EEE97286.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 995 bits (2573), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/835 (61%), Positives = 620/835 (74%), Gaps = 31/835 (3%)
Query: 3 SVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYI 62
S+ + L+ CF +FG + DTI+ SQFIRDPE+I+S+G KF+LGFFSP N TNRY+
Sbjct: 8 SIIALHLILYCFCLEFGASI--DTISLSQFIRDPETIVSAGKKFELGFFSPV-NSTNRYV 64
Query: 63 GIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANN 122
IWY+ + T VWVANRNKPL DSSGI TISEDGNLVVLNG+K+ WSSNVS+ N+
Sbjct: 65 AIWYSN--ISITTPVWVANRNKPLNDSSGIMTISEDGNLVVLNGQKETLWSSNVSTGMND 122
Query: 123 SNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLS 182
S RAQL+D GNLVL + + S+W SFQEP+DT+ +M+++ + RTGKK LTSW+S S
Sbjct: 123 S--RAQLMDDGNLVLGGSENGNSLWQSFQEPSDTYIPKMRLTANPRTGKKTPLTSWKSPS 180
Query: 183 NPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDH 242
+PSIGSFS G+D +IPEV +W N +RP WR+GPWNG+ FIG+P+MNSVYLDGFNL +D
Sbjct: 181 DPSIGSFSLGIDPSSIPEVVLW-NDSRPIWRTGPWNGQVFIGVPEMNSVYLDGFNLADDG 239
Query: 243 QKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTND-CDVYGKCGA 299
G L+ FAD F L+ +G + W D Y + D CDVYGKCG+
Sbjct: 240 NGGFT-LSVGFADESYITNFVLSSEGKFGQVFWDDMNEGSWRYQWESVQDECDVYGKCGS 298
Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFK 344
F SC+++ PICSCL GFEPKNA++WN NW+ G V GK+DGF K
Sbjct: 299 FASCDAKNTPICSCLKGFEPKNADEWNSRNWTHGCVRRKAMRCERIQNGGELGKEDGFSK 358
Query: 345 LETMKVPYFAERSSA-NEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGT 403
LE +KVP FAE SS+ E KC+D C NNCSC AYAY G+ CM+W NL DI+K SGG
Sbjct: 359 LERVKVPGFAEWSSSITEQKCRDDCWNNCSCIAYAYYTGIYCMLWKGNLTDIKKFSSGGA 418
Query: 404 NLYIRVAHEELDRK--DMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLD 461
+LYIR+A+ ELD K +MK++I L+V+VG IAIAIC F++WRW +++ K+ +R
Sbjct: 419 DLYIRLAYTELDNKKINMKVIISLTVVVGAIAIAICVFYSWRWIERKRTSKKVLLPKRKH 478
Query: 462 LGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQE 521
N + +N +LQ+L +F+ + L AT+NF ANKLGQGGFGPVYKGK DGQE
Sbjct: 479 PILLDENVIQDNLNHVKLQELPLFSLQMLIVATDNFNTANKLGQGGFGPVYKGKFPDGQE 538
Query: 522 IAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF 581
IA+KRLS+ASGQGQEEFM EV+VIS LQH NLVRLLGCCVE EE ML+YEYMPN+SLD+F
Sbjct: 539 IALKRLSRASGQGQEEFMTEVVVISKLQHMNLVRLLGCCVEGEEKMLVYEYMPNRSLDAF 598
Query: 582 LFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641
LFDP R+ LLDW KRFNI++GI RGLLYLHRDSRLRIIHRDLKASNILLD +LNPKISDF
Sbjct: 599 LFDPSRKQLLDWKKRFNIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDF 658
Query: 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 701
G+ARIFG N+DQA T R+VGT+GYMSPEYAMEGRFSEKSDVFSFGVLLLEI+SGRKNTSF
Sbjct: 659 GMARIFGRNEDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIISGRKNTSF 718
Query: 702 YHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNM 761
Y E L+LLGYAWKLWN+ N+ LVDP IS F EI RCV+VGLLCVQEF KDRP +
Sbjct: 719 YGNEEALSLLGYAWKLWNEGNIAALVDPGISYPSFHEEIFRCVHVGLLCVQEFAKDRPAI 778
Query: 762 PTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
TV+SMLNSEI DLP KQPAF+ RR D+A S +Q+ SIN+VTVTL+ GR
Sbjct: 779 FTVISMLNSEIVDLPTPKQPAFSERRSELDTA-SLQHDQRPESINNVTVTLLSGR 832
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496521|ref|XP_002262970.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/848 (57%), Positives = 636/848 (75%), Gaps = 48/848 (5%)
Query: 4 VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
+A+++LLS FG TA DT+TS++FI DPE+++S+GS FKLGFFS + TNRY+G
Sbjct: 10 IALLLLLSVIC---FGFCTAIDTMTSTRFIEDPETLVSNGSAFKLGFFSL-ADSTNRYVG 65
Query: 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
IWY+ + TV+WVANR+KPL DSSGI TISEDGNL+V+NG+K++ WSSNVS+ + NS
Sbjct: 66 IWYST--PSLSTVIWVANRDKPLNDSSGIVTISEDGNLLVMNGQKEIVWSSNVSNASANS 123
Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
+ AQLLDSGNLVL DN ++ W+S Q P+ + MK+STD TG+KV LTSW+S S+
Sbjct: 124 S--AQLLDSGNLVLQDNSGSIT-WESIQHPSHSLLPNMKISTDTNTGEKVVLTSWKSPSD 180
Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQ 243
PSIGSFS G++ IP++FIW NG+ PYWRSGPW+ + FIGIPDM+SVY GF + +D +
Sbjct: 181 PSIGSFSLGMNPLNIPQIFIW-NGSHPYWRSGPWSSQIFIGIPDMDSVYRSGFQVVDD-K 238
Query: 244 KGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
+GT Y TF A++ +F + LT QG+L + GK + + ++CDVYG CGAFG
Sbjct: 239 EGTVYATFTEANSSIFLYYVLTSQGSLVQTDREYGKEEWGVTWRSNKSECDVYGTCGAFG 298
Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV---------------EGKQDGFFKLE 346
CNS PICSCL G+EPK E+W+RGNW+ G V +GK DGFF+L
Sbjct: 299 ICNSGTSPICSCLRGYEPKYTEEWSRGNWTSGCVRKTTLQCERTNSSGQQGKIDGFFRLT 358
Query: 347 TMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
T+KVP +A+ S A+ED+C+++C NCSC AY+Y G+GCM+W+ +LID++K G +LY
Sbjct: 359 TVKVPDYADWSLAHEDECREECLKNCSCIAYSYYSGIGCMLWSGSLIDLQKFTKRGADLY 418
Query: 407 IRVAHEEL--DRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSK-VQRLDLG 463
IR+AH EL +++DMK++I +++++G IAIAICT+F WRW R+A+KE SK + D G
Sbjct: 419 IRLAHSELGKNKRDMKVIISVTIVIGTIAIAICTYFLWRWIG-RQAVKEKSKEILPSDRG 477
Query: 464 EAYANFST----EKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
AY N+ + VN +L++L + +FE+LA ATNNF ANKLGQGGFGPVY+G L G
Sbjct: 478 HAYQNYDMNMLGDNVNRVKLEELPLLDFEKLAAATNNFHEANKLGQGGFGPVYRGNLPGG 537
Query: 520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG-C----------CVEREENML 568
Q+IAVKRLS+AS QGQEEFMNE++VIS +QHRNLVRLLG C C+E +E +L
Sbjct: 538 QKIAVKRLSRASAQGQEEFMNEMIVISKIQHRNLVRLLGFCIEGDVRLLGFCIEGDEKLL 597
Query: 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
IYEYMPNKSLD+FLFDP ++ LDW +RF+II+GI RGLLYLHRDSRL+IIHRDLKASNI
Sbjct: 598 IYEYMPNKSLDAFLFDPLKRESLDWRRRFSIIEGIGRGLLYLHRDSRLKIIHRDLKASNI 657
Query: 629 LLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVL 688
LLD+DLN KISDFG+ARIFG NQDQA T R+VGTYGYMSPEYAM G+FSEKSDVFSFGVL
Sbjct: 658 LLDEDLNAKISDFGMARIFGSNQDQANTMRVVGTYGYMSPEYAMGGQFSEKSDVFSFGVL 717
Query: 689 LLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGL 748
LLEIVSGR+NTSF +++ ++LLGYAW LW +N+ +L+D I+E+ F+ EI RC++VGL
Sbjct: 718 LLEIVSGRRNTSFQYDDQHMSLLGYAWTLWCQHNIQELIDETIAEACFQEEISRCIHVGL 777
Query: 749 LCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDV 808
LCVQE KDRP++ TV+SML+SEI LP+ KQP F ++ A D+ SS + + CS N V
Sbjct: 778 LCVQESAKDRPSISTVLSMLSSEIAHLPSPKQPPFLEKQTAIDTESSQPRENK-CSSNQV 836
Query: 809 TVTLMEGR 816
TVT+++GR
Sbjct: 837 TVTIIQGR 844
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114137|ref|XP_002316677.1| predicted protein [Populus trichocarpa] gi|222859742|gb|EEE97289.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2474), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/839 (58%), Positives = 611/839 (72%), Gaps = 44/839 (5%)
Query: 3 SVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYI 62
S +L+ CF +FG + DTITSSQ+I+DPE I+S+G+KFKLGFFSP N TNRY
Sbjct: 8 STIAFLLILYCFCWEFGASV--DTITSSQYIKDPEDIVSAGNKFKLGFFSPV-NSTNRYA 64
Query: 63 GIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANN 122
IWY+ + T VWVANRN PL DSSGI TISEDGNLVVLNG+K++ WSSNVS+ N+
Sbjct: 65 AIWYSN--ISITTPVWVANRNMPLNDSSGIMTISEDGNLVVLNGQKEILWSSNVSTGMND 122
Query: 123 SNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLS 182
S RAQL+D GNLVL + + S+W SFQEP+DT+ +M+++ + RTGKK L SW S+S
Sbjct: 123 S--RAQLMDDGNLVLGGSENGNSLWQSFQEPSDTYMPKMRLTANSRTGKKTLLKSWTSVS 180
Query: 183 NPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDH 242
+PSIGS S G+D IP+ +IW NG+RP WR+GPWNG+ FIGIP+M SVYLDGFN+ D
Sbjct: 181 DPSIGSISGGIDPSRIPQFYIW-NGSRPIWRTGPWNGQVFIGIPEMVSVYLDGFNIA-DE 238
Query: 243 QKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAF 300
GT L+ FA+ + + L+ +G + W D + + + +P ++CDVYGKCG+F
Sbjct: 239 GNGTFTLSVGFANESLISNYILSSEGKFGKVLWDDTEGSWRYEWKFPKDECDVYGKCGSF 298
Query: 301 GSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFKL 345
GSCN + PICSCL GFEPKNA++WN GNW+ G V GK+DGF KL
Sbjct: 299 GSCNPKDSPICSCLKGFEPKNADEWNNGNWTNGCVRRRELQCERTQNGGQVGKEDGFLKL 358
Query: 346 ETMKVPYFAE-RSSANEDKCKDQCSN-NCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGT 403
E MKVP F+E SS +E CK++C N NCSC AY+Y G GCM+W NL D++K P
Sbjct: 359 ERMKVPDFSEWLSSTSEHTCKNECLNINCSCIAYSYYPGFGCMLWRGNLTDLKKFPIKAA 418
Query: 404 NLYIRVAHEELDRK--DMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKE----NSKV 457
+LYIR+A ELD K ++K++I L+V+VG IAIAIC F++WR +++ K+ KV
Sbjct: 419 DLYIRLADSELDNKKINLKVIISLTVVVGAIAIAICVFYSWRRIDRKRKSKKVFLSKRKV 478
Query: 458 QRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ 517
L + N + +N +LQ+L +F+ + L AT+NF ANKLGQGGFGPVYKG L
Sbjct: 479 GYPILSDE--NMIQDNLNHVKLQELPLFSLQTLIAATDNFNTANKLGQGGFGPVYKGNLS 536
Query: 518 DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577
DGQEIAVKRLS++SGQG EEFMNEV+VIS LQHRNLVR+LGCCVE EE MLIYEYMPNKS
Sbjct: 537 DGQEIAVKRLSRSSGQGLEEFMNEVVVISKLQHRNLVRILGCCVEGEEKMLIYEYMPNKS 596
Query: 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637
LD+FLFD R+ LLDW RF I++GI RGLLYLHRDSRLRIIHRDLKASNILLD +LNPK
Sbjct: 597 LDAFLFDSLRKQLLDWKNRFKIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPK 656
Query: 638 ISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697
ISDFG+ARIFG ++DQA T+R+VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLE +SGRK
Sbjct: 657 ISDFGMARIFGNHEDQANTRRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLETISGRK 716
Query: 698 NTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKD 757
NT+++ L AWKLWN+ N+ LVDP IS F EI RCV+VGLLCVQEF KD
Sbjct: 717 NTTYF-------LTSQAWKLWNEGNIAALVDPGISYPSFHEEIFRCVHVGLLCVQEFAKD 769
Query: 758 RPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
RP + TV+SMLNSEI DLP KQPAF+ RR D+ S +Q+ SIN+VTVTL+ GR
Sbjct: 770 RPAIFTVISMLNSEIADLPTPKQPAFSERRSELDT-KSLQHDQRPESINNVTVTLLSGR 827
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078778|ref|XP_002305625.1| predicted protein [Populus trichocarpa] gi|222848589|gb|EEE86136.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/835 (57%), Positives = 609/835 (72%), Gaps = 31/835 (3%)
Query: 2 ISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRY 61
ISVA++ LL+S F + TA DTITS+QF++DPE+I+S+G+ + LGFFSP N T+RY
Sbjct: 8 ISVALL-LLTSSFCVEI--ITAIDTITSTQFLKDPEAIVSNGNIYTLGFFSP-VNSTDRY 63
Query: 62 IGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLAN 121
+GIW+N+ T +WVANRN PL DSSGI IS+DG LVVLNG++++ WS+NVS+ +
Sbjct: 64 VGIWFNEVPVV--TAIWVANRNNPLNDSSGILAISKDGALVVLNGQQEILWSTNVSNFVS 121
Query: 122 NSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSL 181
NS+ AQL D+GNLVL DN ++ +W+SFQ P+DTF+S MK+S + RTG K +TSW+S
Sbjct: 122 NSS--AQLSDTGNLVLRDNNNEEIMWESFQYPSDTFFSNMKLSANKRTGGKTLITSWKSA 179
Query: 182 SNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGED 241
++PSIGSFSAGL+ IPE+FIW + PY+RSGPWN FIG+P MNS +DG NL +D
Sbjct: 180 TDPSIGSFSAGLNHLDIPEIFIWKD-NYPYFRSGPWNRLVFIGVPYMNSAAVDGLNLVDD 238
Query: 242 HQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGA 299
+ GT LTF++A+ + F LT QG LE+ W G + + P DC+ YG+CG
Sbjct: 239 GE-GTIDLTFSYANQSIMSSFVLTSQGQLEQTRWEHGMEDRIVLWSVPMFDCEFYGRCGL 297
Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG----------------EVEGKQDGFF 343
FGSCN+Q PICSCL GFEP N E+W GNW+GG E GK D F
Sbjct: 298 FGSCNAQASPICSCLRGFEPNNPEEWYVGNWTGGCIRRKSLQCERVKSESEAAGKNDVFL 357
Query: 344 KLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGT 403
KL MKVP A+ S E +CKD+C NCSC AYAY+ G+GCM W +LID+++ P+GG
Sbjct: 358 KLGNMKVPDLAQWSRLTEIECKDKCLTNCSCIAYAYDSGIGCMSWIGDLIDVQEFPTGGA 417
Query: 404 NLYIRVAHEELD-RKDMKLVIILSVIVGIIAIA-ICTFFAWRWFAKRKAMKENSKVQRLD 461
+LYIR+A+ ELD K+++I+S ++G I A IC WR+ +K + K +S
Sbjct: 418 DLYIRMAYSELDGNHRKKVIVIVSAVIGTITSAMICALLTWRFMSKHRGEKLHSDTNEKH 477
Query: 462 LGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQE 521
+ + + ++ +LQ+L +F+ E L AT+ F L+NKLGQGGFGPVYKGKL DG+E
Sbjct: 478 PSFLDRDMAGDSMDHVKLQELPLFSLESLTAATDGFDLSNKLGQGGFGPVYKGKLSDGKE 537
Query: 522 IAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF 581
IAVKRLS+ASGQG +EFMNEV VIS LQHRNLVRLLGCCVE EE +L+YEYMPNKSLD+F
Sbjct: 538 IAVKRLSRASGQGLKEFMNEVEVISKLQHRNLVRLLGCCVEGEEKLLVYEYMPNKSLDAF 597
Query: 582 LFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641
L+DP R+ LLDW KRFNII+GI RGLLYLHRDSRLRIIHRDLKASNILLD +L PKISDF
Sbjct: 598 LYDPLRKQLLDWKKRFNIIEGICRGLLYLHRDSRLRIIHRDLKASNILLDPELKPKISDF 657
Query: 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 701
G ARIFGG++DQA T R+VGTYGY+SPEYAMEGRFSEKSDV+SFGVLLLEIVSGR+NTSF
Sbjct: 658 GAARIFGGDEDQANTIRVVGTYGYISPEYAMEGRFSEKSDVYSFGVLLLEIVSGRRNTSF 717
Query: 702 YHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNM 761
Y E L+LLG+AWKLWN+ N+ LVDP IS+ ++EI RC++VGLLCVQEF +DRP
Sbjct: 718 YGNEQALSLLGFAWKLWNEGNISALVDPAISDPSSQVEIFRCIHVGLLCVQEFPEDRPTA 777
Query: 762 PTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
TVVSMLNSEI L KQP F R+ ++ +QN++ CSIN VTVT+++ R
Sbjct: 778 STVVSMLNSEISYLATPKQPPFAERKYHFNE-ERPHQNEEKCSINYVTVTVVDAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084622|emb|CBI25710.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/831 (59%), Positives = 626/831 (75%), Gaps = 43/831 (5%)
Query: 7 VVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWY 66
V LL +CF+ FG +A DTITS+ FI+DPE+I+SSG FKLGFFS DG+ +NRY+GIWY
Sbjct: 9 VSLLLTCFWFVFG-CSAIDTITSTHFIKDPETIVSSGRVFKLGFFSLDGS-SNRYVGIWY 66
Query: 67 NKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTR 126
N ++ T++WVAN+++PL DSSG+ TISEDGN+ VLNG+K++ WSSNVS+ A N+
Sbjct: 67 NT--TSLLTIIWVANKDRPLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAA-VNSS 123
Query: 127 AQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSI 186
AQL DSGNLVL D + VS+W+S Q P+ +F +MK+ST+ RT + LTSW+S S+PS+
Sbjct: 124 AQLQDSGNLVLRDK-NGVSVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSM 182
Query: 187 GSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGT 246
GSF+AG++ IP+VFIW NG+RPYWRSGPW+G+ G+ D+ + LDG N+ +D ++GT
Sbjct: 183 GSFTAGVEPLNIPQVFIW-NGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDD-KEGT 239
Query: 247 RYLTFAFADNDVFFA--LTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCN 304
Y+TFA ++ F+A LTP+G L E + + + N+C++YGKCG FG CN
Sbjct: 240 VYVTFAHPESGFFYAYVLTPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCN 299
Query: 305 SQKIPICSCLLGFEPKNAEDWNRGNWSGGEV---------------EGKQDGFFKLETMK 349
S+ PICSCL G+EPK+ ++WNRGNW+GG V E K DGF KL MK
Sbjct: 300 SRDSPICSCLKGYEPKHTQEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMK 359
Query: 350 VPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRV 409
VP FAE+S A ED C+ QC NCSC AY+Y G+GCM W+ +LIDI+KL S G NL+IRV
Sbjct: 360 VPDFAEQSYALEDDCRQQCLRNCSCIAYSYYTGIGCMWWSGDLIDIQKLSSTGANLFIRV 419
Query: 410 AHEEL--DRK-DMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGE-A 465
AH EL DRK D ++++I++VI+G IAIA+CT+F RW A+++ L +G+ +
Sbjct: 420 AHSELKQDRKRDARVIVIVTVIIGTIAIALCTYFLRRWIARQRG--------NLLIGKFS 471
Query: 466 YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK 525
+ + VN +L++L + +F +LA ATNNF ANKLGQGGFGPVY+GKL +GQ+IAVK
Sbjct: 472 DPSVPGDGVNQVKLEELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVK 531
Query: 526 RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP 585
RLS+AS QG EEFMNEV+VIS LQHRNLVRL+GCC+E +E MLIYE+MPNKSLD+ LFDP
Sbjct: 532 RLSRASTQGLEEFMNEVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDP 591
Query: 586 QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
++ +LDW RF II+GI RGLLYLHRDSRLRIIHRDLKASNILLD+DLNPKISDFG+AR
Sbjct: 592 VKRQILDWRTRFKIIEGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMAR 651
Query: 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE 705
IFG NQDQA TKR+VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN+SFYHEE
Sbjct: 652 IFGSNQDQANTKRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNSSFYHEE 711
Query: 706 FELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVV 765
+ TLLGYAWKLW ++N+ L+D I E+ F+ EI+RC++VGLLCVQE KDRP++ TVV
Sbjct: 712 Y-FTLLGYAWKLWKEDNMKTLIDGSILEACFQEEILRCIHVGLLCVQELAKDRPSVSTVV 770
Query: 766 SMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
M+ SEI LP KQPAFT R D SS + CS+N V++T++EGR
Sbjct: 771 GMICSEIAHLPPPKQPAFTEMRSGIDIESSDKK----CSLNKVSITMIEGR 817
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496538|ref|XP_002270222.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2440), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/817 (59%), Positives = 618/817 (75%), Gaps = 41/817 (5%)
Query: 25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
DTITS+ FI+DPE+I+SSG FKLGFFS DG+ +NRY+GIWYN ++ T++WVAN+++
Sbjct: 87 DTITSTHFIKDPETIVSSGRVFKLGFFSLDGS-SNRYVGIWYNT--TSLLTIIWVANKDR 143
Query: 85 PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
PL DSSG+ TISEDGN+ VLNG+K++ WSSNVS+ A N+ AQL DSGNLVL D + V
Sbjct: 144 PLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAA-VNSSAQLQDSGNLVLRDK-NGV 201
Query: 145 SIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIW 204
S+W+S Q P+ +F +MK+ST+ RT + LTSW+S S+PS+GSF+AG++ IP+VFIW
Sbjct: 202 SVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGVEPLNIPQVFIW 261
Query: 205 INGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFA--L 262
NG+RPYWRSGPW+G+ G+ D+ + LDG N+ +D ++GT Y+TFA ++ F+A L
Sbjct: 262 -NGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDD-KEGTVYVTFAHPESGFFYAYVL 318
Query: 263 TPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNA 322
TP+G L E + + + N+C++YGKCG FG CNS+ PICSCL G+EPK+
Sbjct: 319 TPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSCLKGYEPKHT 378
Query: 323 EDWNRGNWSGGEV---------------EGKQDGFFKLETMKVPYFAERSSANEDKCKDQ 367
++WNRGNW+GG V E K DGF KL MKVP FAE+S A ED C+ Q
Sbjct: 379 QEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAEQSYALEDDCRQQ 438
Query: 368 CSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEEL--DRK-DMKLVII 424
C NCSC AY+Y G+GCM W+ +LIDI+KL S G NL+IRVAH EL DRK D ++++I
Sbjct: 439 CLRNCSCIAYSYYTGIGCMWWSGDLIDIQKLSSTGANLFIRVAHSELKQDRKRDARVIVI 498
Query: 425 LSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFST-----EKVNPARL 479
++VI+G IAIA+CT+F RW A+++A K K++ L L FS + VN +L
Sbjct: 499 VTVIIGTIAIALCTYFLRRWIARQRAKK--GKIEEL-LSFNRGKFSDPSVPGDGVNQVKL 555
Query: 480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM 539
++L + +F +LA ATNNF ANKLGQGGFGPVY+GKL +GQ+IAVKRLS+AS QG EEFM
Sbjct: 556 EELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFM 615
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
NEV+VIS LQHRNLVRL+GCC+E +E MLIYE+MPNKSLD+ LFDP ++ +LDW RF I
Sbjct: 616 NEVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKI 675
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659
I+GI RGLLYLHRDSRLRIIHRDLKASNILLD+DLNPKISDFG+ARIFG NQDQA TKR+
Sbjct: 676 IEGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRV 735
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN 719
VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN+SFYHEE+ TLLGYAWKLW
Sbjct: 736 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNSSFYHEEY-FTLLGYAWKLWK 794
Query: 720 DNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAK 779
++N+ L+D I E+ F+ EI+RC++VGLLCVQE KDRP++ TVV M+ SEI LP K
Sbjct: 795 EDNMKTLIDGSILEACFQEEILRCIHVGLLCVQELAKDRPSVSTVVGMICSEIAHLPPPK 854
Query: 780 QPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
QPAFT R D SS + CS+N V++T++EGR
Sbjct: 855 QPAFTEMRSGIDIESSDKK----CSLNKVSITMIEGR 887
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112032|ref|XP_002332843.1| predicted protein [Populus trichocarpa] gi|222833304|gb|EEE71781.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/839 (57%), Positives = 599/839 (71%), Gaps = 41/839 (4%)
Query: 4 VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
+A + LL CF G A DTITSSQ+I+DPE+++S+G+KFKLGFFSP GN TNRY+G
Sbjct: 1 MAALRLLLCCFCWQLGAAV--DTITSSQYIKDPEAVVSAGNKFKLGFFSP-GNSTNRYVG 57
Query: 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
IWY+ + T VW+ANRNKPL DSSGI TISEDGN+VVL+G+K++ WSSNVS+ +NS
Sbjct: 58 IWYSN--ISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS 115
Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
+ AQL D GN++L S+W SFQEP+DTF +M+++ + RTGKK Q+TSW+S S+
Sbjct: 116 S--AQLTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSD 173
Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQ 243
PS+GSFS+G++ +IPEVF+W N +RP+WRSGPWNG+ FIGIP+MNSVYL+G+NL +D
Sbjct: 174 PSVGSFSSGIEPSSIPEVFVW-NDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGD 232
Query: 244 KGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
GT L+ A+ FAL+ +G E W + YP +DCD+YGKCG FG
Sbjct: 233 -GTFSLSVGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFG 291
Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFKLE 346
CN+Q IC CL GFEPKN+++WNR NW+ G V K+D F KL+
Sbjct: 292 FCNTQNSLICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLD 351
Query: 347 TMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNL 405
+KVP F+E SSA+E CKD+C NNCSC AY+Y G+GCM+W L DIRK SGG NL
Sbjct: 352 KVKVPDFSEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRGKLTDIRKFSSGGANL 411
Query: 406 YIRVAHEELDR-KDMKLVIILSVIVGIIAIAICTFFAWRWFAK-RKAMKENSKVQRLDLG 463
Y+R+A E + +DMK VI ++V+ G I +A+ FF WR AK R+ +E+ ++
Sbjct: 412 YVRLADLEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRK 471
Query: 464 EAY-----ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD 518
+ Y N E +N + Q+L +F + L AT+ F ANKLG+GGFGPVY+G L D
Sbjct: 472 KGYPIFFNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPD 531
Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578
GQEIAVKRLS+ASGQGQEEFMNEV+VIS LQHRNLVRLLGCCVE +E ML+YEYMPNKSL
Sbjct: 532 GQEIAVKRLSRASGQGQEEFMNEVVVISELQHRNLVRLLGCCVEGDEKMLVYEYMPNKSL 591
Query: 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
D+ LFDP R+ +LDW KRFNI+ GI RGLLYLHRDSRLRIIHRDLK SNILLD +LNPKI
Sbjct: 592 DASLFDPVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKI 651
Query: 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 698
SDFG+ARIFGGN+D T+R+VGTYGYMSPEYAM GRFSEKSDVFSFGVLLLEIVSGR++
Sbjct: 652 SDFGMARIFGGNEDHVKTRRVVGTYGYMSPEYAMHGRFSEKSDVFSFGVLLLEIVSGRRS 711
Query: 699 TSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF-KMEIIRCVNVGLLCVQEFVKD 757
T E L LL +AWKLWN+ N LVDP ++ + K+EI RC++VGLLCVQEF KD
Sbjct: 712 TKIDGNEQGLNLLEFAWKLWNEGNAPALVDPALTLDQYSKVEIFRCIHVGLLCVQEFAKD 771
Query: 758 RPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
RP + T++SMLNSEI DLP PA+T R + + SIN V+ TL GR
Sbjct: 772 RPAISTIISMLNSEIVDLPLPNNPAYTERLIGLHTERRGD------SINFVSTTLFTGR 824
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114141|ref|XP_002316678.1| predicted protein [Populus trichocarpa] gi|222859743|gb|EEE97290.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2409), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/839 (56%), Positives = 599/839 (71%), Gaps = 41/839 (4%)
Query: 4 VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
+A + LL CF G A DTITSSQ+I+DPE+++S+G+KFKLGFFSP GN TNRY+G
Sbjct: 1 MAALRLLLCCFCWQLGAAV--DTITSSQYIKDPEAVVSAGNKFKLGFFSP-GNSTNRYVG 57
Query: 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
IWY+ + T VW+ANRNKPL DSSGI TISEDGN+VVL+G+K++ WSSNVS+ +NS
Sbjct: 58 IWYSN--ISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS 115
Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
+ AQL D GN++L S+W SFQEP+DTF +M+++ + RTGKK Q+TSW+S S+
Sbjct: 116 S--AQLTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSD 173
Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQ 243
PS+GSFS+G++ +IPEVF+W N +RP+WRSGPWNG+ FIGIP+MNSVYL+G+NL +D
Sbjct: 174 PSVGSFSSGIEPSSIPEVFVW-NDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGD 232
Query: 244 KGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
GT L+ A+ FAL+ +G E W + YP +DCD+YGKCG FG
Sbjct: 233 -GTFSLSVGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFG 291
Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFKLE 346
CN+Q IC CL GFEPKN+++WNR NW+ G V K+D F KL+
Sbjct: 292 FCNTQNSLICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLD 351
Query: 347 TMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNL 405
+KVP F+E SSA+E CKD+C NNCSC AY+Y G+GCM+W L DIRK SGG NL
Sbjct: 352 KVKVPDFSEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRGKLTDIRKFSSGGANL 411
Query: 406 YIRVAHEELDR-KDMKLVIILSVIVGIIAIAICTFFAWRWFAK-RKAMKENSKVQRLDLG 463
Y+R+A E + +DMK VI ++V+ G I +A+ FF WR AK R+ +E+ ++
Sbjct: 412 YVRLADLEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRK 471
Query: 464 EAY-----ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD 518
+ Y N E +N + Q+L +F + L AT+ F ANKLG+GGFGPVY+G L D
Sbjct: 472 KGYPIFFNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPD 531
Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578
GQEIAVKRLS+ASGQGQEEFMNEV+VIS LQH+NLVRLLGCCVE +E ML+YEYMPNKSL
Sbjct: 532 GQEIAVKRLSRASGQGQEEFMNEVVVISELQHKNLVRLLGCCVEGDEKMLVYEYMPNKSL 591
Query: 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
D+ LFDP R+ +LDW KRFNI+ GI RGLLYLHRDSRLRIIHRDLK SNILLD +LNPKI
Sbjct: 592 DASLFDPVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKI 651
Query: 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 698
SDFG+ARIFGGN+D T+R+VGTYGYMSPEYAM GRFSEKSDVFSFGVLLLEIVSGR++
Sbjct: 652 SDFGMARIFGGNEDHVKTRRVVGTYGYMSPEYAMHGRFSEKSDVFSFGVLLLEIVSGRRS 711
Query: 699 TSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF-KMEIIRCVNVGLLCVQEFVKD 757
T E L LL +AWKLWN+ N LVDP ++ + K+EI RC++VGLLCVQEF KD
Sbjct: 712 TKIDGNEQGLNLLEFAWKLWNEGNAPALVDPALTLDQYSKVEIFRCIHVGLLCVQEFAKD 771
Query: 758 RPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
RP + T++SMLNSEI DLP PA+T R + + SIN V+ TL GR
Sbjct: 772 RPAISTIISMLNSEIVDLPLPNNPAYTERLIGLHTERRGD------SINFVSTTLFTGR 824
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496519|ref|XP_002263029.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2399), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/860 (55%), Positives = 619/860 (71%), Gaps = 62/860 (7%)
Query: 4 VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
+A+++LLS FG TA DT+TS++FI DPE+++S GS FKLGFFS + TNRY+G
Sbjct: 10 IALLLLLSVIC---FGFCTAIDTMTSTRFIEDPETLVSDGSAFKLGFFSL-ADSTNRYVG 65
Query: 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
IWY+ + T++WVANR+KPL DSSG+ TISEDGNL+V+NG+K++ WS+NVS+ A NS
Sbjct: 66 IWYST--PSLSTIIWVANRDKPLNDSSGLVTISEDGNLLVMNGQKEIFWSTNVSNAAANS 123
Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
+ AQLLDSGNLVL DN +++ W+S Q P+ +F +MK+S D +G+KV LTSW+S S+
Sbjct: 124 S--AQLLDSGNLVLRDNSGRIT-WESIQHPSHSFLPKMKISADTDSGEKVVLTSWKSPSD 180
Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYF-----IGIPDMNSVYLDGFNL 238
PSIGSFS G++ IP+ F+W NG+ PYWRSGPWNG+ F IG+P MNSV+L+GF
Sbjct: 181 PSIGSFSLGMNPLNIPQAFVW-NGSHPYWRSGPWNGQIFIGQIYIGVPKMNSVFLNGFGF 239
Query: 239 G-EDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYG 295
D + GT Y TF A++ +F + LTPQG + E DGK ++ + ++CDVYG
Sbjct: 240 QVVDDKAGTVYETFTLANSSIFLYYVLTPQGTVVETYREDGKEEWEVTWRSNNSECDVYG 299
Query: 296 KCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV---------------EGKQD 340
CGAFG CNS PICSCL G+EPK E+W+RGNW+ G V +GK D
Sbjct: 300 TCGAFGICNSGNSPICSCLRGYEPKYIEEWSRGNWTSGCVRKTPLQCERTNSSGQQGKLD 359
Query: 341 GFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
GFF+L T+KVP FA+ S A ED+C++QC NCSC AY+Y G+GCM W+ NLID+ K
Sbjct: 360 GFFRLTTVKVPDFADWSLALEDECREQCLKNCSCMAYSYYSGIGCMSWSGNLIDLGKFTQ 419
Query: 401 GGTNLYIRVAHEELD-----------------RKDMKLVIILSVIVGIIAIAICTFFAWR 443
GG +LYIR+A+ EL+ ++DMK +I +++++G IAI I T+F+WR
Sbjct: 420 GGADLYIRLANSELEWNMRTPKLIKHLMATYKKRDMKAIISVTIVIGTIAIGIYTYFSWR 479
Query: 444 WFAKRKAMKENSKVQRLDLGEAYANFSTEKV----NPARLQDLLVFNFEELANATNNFQL 499
W K+ ++ ++ D G+AY + ++ N +L++L + E+L ATNNF
Sbjct: 480 WRRKQTVKDKSKEILLSDRGDAYQIYDMNRLGDNANQFKLEELPLLALEKLETATNNFHE 539
Query: 500 ANKLGQGGFGPVYK---GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
ANKLGQGGFGPVY+ GKL GQEIAVKRLS+AS QG EEF NEV+VIS +QHRNLVRL
Sbjct: 540 ANKLGQGGFGPVYRVMLGKLPGGQEIAVKRLSRASAQGLEEFGNEVVVISKIQHRNLVRL 599
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
LG C+E +E +LIYEYMPNKSLDSFLFDP ++ LDW +RFNII+GI RGLLYLHRDSR
Sbjct: 600 LGYCIEGDEKLLIYEYMPNKSLDSFLFDPLKRDFLDWRRRFNIIEGIGRGLLYLHRDSRF 659
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
RIIHRDLKASNILLD+DL KISDFG+ARI GGNQDQA T R+VGTYGYMSPEYAMEGRF
Sbjct: 660 RIIHRDLKASNILLDEDLTAKISDFGIARIVGGNQDQANTMRVVGTYGYMSPEYAMEGRF 719
Query: 677 SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF 736
SEKSDVFSFGVLLLEIVSGR+NTSF +++ ++LLGYAW LW ++N+ +L+D +I+E GF
Sbjct: 720 SEKSDVFSFGVLLLEIVSGRRNTSFQYDDQYMSLLGYAWTLWCEHNIEELIDEIIAEEGF 779
Query: 737 KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDSASSS 796
+ EI RC++VGLL VQE KDRP++ TVVSML+SEI LP KQP F ++ SS
Sbjct: 780 QEEISRCIHVGLLAVQELAKDRPSISTVVSMLSSEIAHLPPPKQPPFLEKQ-----IESS 834
Query: 797 NQNQQICSINDVTVTLMEGR 816
Q S N VTVT+++GR
Sbjct: 835 QPRQNKYSSNQVTVTVIQGR 854
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147840284|emb|CAN63987.1| hypothetical protein VITISV_016155 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2399), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/832 (57%), Positives = 604/832 (72%), Gaps = 58/832 (6%)
Query: 18 FGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVV 77
F TATDTITS+QFI+DPE+++S+GS FK+GFFSP GN T RY GIWYN ++ TV+
Sbjct: 21 FQFCTATDTITSTQFIKDPETMVSNGSLFKMGFFSP-GNSTKRYFGIWYNS--TSLFTVI 77
Query: 78 WVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVL 137
W+ANR PL DSSGI +SEDGNL+VLN +K++ WSSNVS+ A NS RAQLLDSGNLVL
Sbjct: 78 WIANRENPLNDSSGIVMVSEDGNLLVLNDQKEIFWSSNVSNAALNS--RAQLLDSGNLVL 135
Query: 138 HDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFT 197
D S W SFQ P+ F +M++S +++TG+K LTSW+S S+PS+GSFS G+D
Sbjct: 136 QDKNSGRITWQSFQHPSHAFLQKMELSENMKTGEKQGLTSWKSPSDPSVGSFSTGIDPSD 195
Query: 198 IPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTF--AFAD 255
IPE+F+W NG+RP+WRSGPWNG+ IG+PDMN YL+GF++ D ++G +TF A+A
Sbjct: 196 IPEIFVW-NGSRPFWRSGPWNGQTLIGVPDMN--YLNGFHIVND-KEGNVSVTFEHAYAS 251
Query: 256 NDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLL 315
++ L+PQG + E DG + +I + +CDVYGKCGAFG CN++ PICSCL
Sbjct: 252 ILWYYVLSPQGTIVEIYSDDGMKNWEITWQSRKTECDVYGKCGAFGICNAKNSPICSCLR 311
Query: 316 GFEPKNAEDWNRGNWSGGEV---------------EGKQDGFFKLETMKVPYFAERSSAN 360
G+EP+N E+W+RGNW+GG V EG+ DGF +L T+KVP FAE S A
Sbjct: 312 GYEPRNIEEWSRGNWTGGCVRKTPFQCEKINGSMEEGEADGFIRLTTVKVPDFAEWSLAL 371
Query: 361 EDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMK 420
ED CK+ C NCSC AYAY G+GCM W+ NL D++K S G +LYIRV + EL
Sbjct: 372 EDDCKEFCLKNCSCIAYAYYTGIGCMSWSRNLTDVQKFSSNGADLYIRVPYSEL------ 425
Query: 421 LVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENS-KVQRLDLGEAYANFST-----EKV 474
G I +A+ +F+ RW KR+A + ++ D G+ + N S +++
Sbjct: 426 ---------GTIFVAVFIYFSRRWITKRRAKNKKRKEMLSSDRGDVHLNVSDANILGDRM 476
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYK----------GKLQDGQEIAV 524
N +L++L + +F +L ATNNF ANKLGQGGFG VY+ G+L +GQEIAV
Sbjct: 477 NQVKLEELPLVDFGKLVTATNNFDEANKLGQGGFGSVYRVMLAHLELHGGRLPEGQEIAV 536
Query: 525 KRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD 584
KRLS+AS QG EEFMNEV+VIS LQHRNLVRLLGCC+E +E MLIYEYMP KSLD+ LFD
Sbjct: 537 KRLSRASAQGLEEFMNEVVVISKLQHRNLVRLLGCCIEGDEKMLIYEYMPKKSLDALLFD 596
Query: 585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
P RQ LDW KRF+II+GI RGLLYLHRDSRLRIIHRDLKASNILLD +LNPKISDFG+A
Sbjct: 597 PLRQETLDWKKRFSIIEGIGRGLLYLHRDSRLRIIHRDLKASNILLDXNLNPKISDFGMA 656
Query: 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
RIFGGNQDQA T R+VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR+N SFYH+
Sbjct: 657 RIFGGNQDQANTIRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRRNNSFYHD 716
Query: 705 EFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTV 764
E L+LLGYAWKLWN++N+ L+D ISE+ F EI+RC++VGLLCVQE KDRP++ TV
Sbjct: 717 EQSLSLLGYAWKLWNEHNIETLIDGSISEACFPDEILRCIHVGLLCVQELAKDRPSISTV 776
Query: 765 VSMLNSEIKDLPAAKQPAFTVRRGAYDSASSSNQNQQICSINDVTVTLMEGR 816
VSM+ SEI LP K+PAFT R+ + D+ S Q+Q CS++ ++T+++ R
Sbjct: 777 VSMICSEIAXLPTPKKPAFTERQISKDT-ESXGQSQNNCSVDRASITIIQAR 827
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 816 | ||||||
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.587 | 0.568 | 0.498 | 4.1e-173 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.590 | 0.568 | 0.456 | 9.8e-172 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.866 | 0.879 | 0.457 | 6.6e-168 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.876 | 0.878 | 0.446 | 9.7e-167 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.936 | 0.930 | 0.433 | 5.4e-166 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.370 | 0.385 | 0.611 | 2.5e-164 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.863 | 0.876 | 0.452 | 3.4e-164 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.875 | 0.884 | 0.445 | 1.9e-163 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.925 | 0.908 | 0.421 | 3.1e-163 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.875 | 0.882 | 0.445 | 3.5e-162 |
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 4.1e-173, Sum P(2) = 4.1e-173
Identities = 245/491 (49%), Positives = 320/491 (65%)
Query: 335 VEGKQDGFFKLETMKVPYFAERS-SANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLI 393
V G++DGF L+ +KVP F N + CKD C+ +CSCKAYA +G+GCMIWT +LI
Sbjct: 355 VAGQEDGFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLI 414
Query: 394 DIRKLPSGGTNLYIRVAHEELD--RKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAM 451
D+ GG ++ IR+A +L +++ C + W++ KA
Sbjct: 415 DMEHFERGGNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAF 474
Query: 452 ---KENSKVQRLDLGEAYANFSTEKV---NPARLQDLLVFNFEELANATNNFQLANKLGQ 505
K++ V + Y++ S KV + DL +F+F+ +A+AT +F NKLGQ
Sbjct: 475 LWKKKDITVSDIIENRDYSS-SPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQ 533
Query: 506 GGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565
GGFG VYKG +G+EIAVKRLS S QG EEF NE+++I+ LQHRNLVRLLGCC+E E
Sbjct: 534 GGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNE 593
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
ML+YEYMPNKSLD FLFD +Q LDW KR+ +I GI+RGLLYLHRDSRL+IIHRDLKA
Sbjct: 594 KMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKA 653
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSF 685
SNILLD ++NPKISDFG+ARIF QD A T R+VGTYGYM+PEYAMEG FSEKSDV+SF
Sbjct: 654 SNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSF 713
Query: 686 GVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVN 745
GVL+LEIVSGRKN SF + +L+GYAW LW+ +++DP++ ++ E +RC++
Sbjct: 714 GVLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIH 772
Query: 746 VGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDXXXXXXXXXXXXXX 805
VG+LC Q+ V RPNM +V+ ML S+ LP +QP F + D
Sbjct: 773 VGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVN 832
Query: 806 XDVTVTLMEGR 816
DVT T + GR
Sbjct: 833 -DVTFTTIVGR 842
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1166 (415.5 bits), Expect = 9.8e-172, Sum P(2) = 9.8e-172
Identities = 228/500 (45%), Positives = 317/500 (63%)
Query: 332 GGEVEGKQDGFFKLETMKVPYFAERSSA--NEDKCKDQCSNNCSCKAYAYEIGVGCMIWT 389
G E DGF + +K P F+ S +E C+ C NNCSC AY Y GC+ W
Sbjct: 352 GCETNQSGDGFLPMGNIKWPDFSYWVSTVGDEPGCRTVCLNNCSCGAYVYTATTGCLAWG 411
Query: 390 HNLIDIRKLPSGGTNLYIRVAHEEL-DRKDMKXXXXXXXXXXXXXXXXCTFFAWR----- 443
+ LID+ +L +G L +++ EL + C W+
Sbjct: 412 NELIDMHELQTGAYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGRNI 471
Query: 444 -------WFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNN 496
W ++ + + LD+ ++ F + V + +L V++ + + AT+N
Sbjct: 472 KDAVHGSWRSRHSSTQSQQNSAMLDISQSI-RFDDD-VEDGKSHELKVYSLDRIRTATSN 529
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
F +NKLG+GGFGPVY G L G+E+AVKRL + SGQG EEF NEV++I+ LQHRNLVRL
Sbjct: 530 FSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRL 589
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
LGCC+ REE +L+YEYMPNKSLD+FLF+P++Q LLDW KRF+II+GI+RGLLYLHRDSRL
Sbjct: 590 LGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRL 649
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
R++HRDLKASNILLD D+ PKISDFG+AR+FGG+Q+Q T R+VGT+GYMSPEYAMEG F
Sbjct: 650 RVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIF 709
Query: 677 SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF 736
S KSDV+ FGVL+LEI++G++ SF+ E L + GYAW+ WN++N +L+DP+I S
Sbjct: 710 SVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCS 769
Query: 737 KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYDXXXXX 796
+++RC+++ LLCVQ+ +RP++PTV+ ML+++ LP + P +R G
Sbjct: 770 VRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLR-GREIESSKS 828
Query: 797 XXXXXXXXXXDVTVTLMEGR 816
VT+T + GR
Sbjct: 829 SEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1633 (579.9 bits), Expect = 6.6e-168, P = 6.6e-168
Identities = 340/743 (45%), Positives = 463/743 (62%)
Query: 56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
N ++Y+GIW+ + + VVWVANR KP+ DS+ IS G+L++LNGK W
Sbjct: 55 NTQDQYVGIWFKD--TIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSG 112
Query: 116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
RA+L DSGNL + DN+S+ ++W SF DT ++ +L T +K L
Sbjct: 113 VTFSSSG--CRAELSDSGNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVL 170
Query: 176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
TSW+S ++PS G F G + +P + G+ PYWRSGPW F GIP M+ Y
Sbjct: 171 TSWKSYTDPSPGDF-LGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGP 229
Query: 236 FNLGEDHQKGTRYLTFAFADNDVF-FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVY 294
F L +D G+ YLT+ D + LT +G++ + + D ++Y+ P CD Y
Sbjct: 230 FTLHQD-VNGSGYLTYFQRDYKLSRITLTSEGSI--KMFRDNGMGWELYYEAPKKLCDFY 286
Query: 295 GKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG-----EVE------GKQ-DGF 342
G CG FG C P+C C GF PK+ E+W RGNW+GG E++ G+ D F
Sbjct: 287 GACGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDF 346
Query: 343 FKLETMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSG 401
++ +K P F E SS N ++C +C +NCSC A+AY G+GC++W +L+D + +
Sbjct: 347 HQIANIKPPDFYEFASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQDLMDAVQFSAT 406
Query: 402 GTNLYIRVAHEELD-RKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSKVQRL 460
G L IR+A ELD K K T F W + + + SK
Sbjct: 407 GELLSIRLARSELDGNKRKKTIVASIVSLTLFMILGFTAFGV-WRCRVEHIAHISK---- 461
Query: 461 DLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQ 520
+A+ N + P + L F+ + NATNNF L+NKLGQGGFG VYKGKLQDG+
Sbjct: 462 ---DAWKN----DLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGK 514
Query: 521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
EIAVKRLS +SGQG+EEFMNE+++IS LQHRNLVR+LGCC+E EE +LIYE+M NKSLD+
Sbjct: 515 EIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDT 574
Query: 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
FLFD +++ +DWPKRF+II+GI+RGLLYLH DSRLR+IHRDLK SNILLD+ +NPKISD
Sbjct: 575 FLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISD 634
Query: 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS 700
FGLAR++ G + Q T+R+VGT GYMSPEYA G FSEKSD++SFGVL+LEI+SG K +
Sbjct: 635 FGLARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISR 694
Query: 701 FYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN 760
F + TL+ YAW+ W++ IDL+D +++S +E+ RC+ +GLLCVQ DRPN
Sbjct: 695 FSYGVEGKTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPN 754
Query: 761 MPTVVSMLNSEIKDLPAAKQPAF 783
+++ML + DLP+ KQP F
Sbjct: 755 TLELLAMLTTT-SDLPSPKQPTF 776
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1622 (576.0 bits), Expect = 9.7e-167, P = 9.7e-167
Identities = 335/751 (44%), Positives = 468/751 (62%)
Query: 56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
N N+Y+GIW+ + VVWVANR+KP+ +++ TI+ +G+L+++ ++ V W
Sbjct: 55 NSRNQYVGIWFKN--ITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIG 112
Query: 116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
RA+LL++GNLVL D +S+ ++W+SF+ DT E V D+ KK L
Sbjct: 113 ETFSSNEL--RAELLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVL 170
Query: 176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
+SW++ ++PS G F A L + P+ FI + G+RPYWR GPW F GIP+M+ ++
Sbjct: 171 SSWKNPTDPSPGEFVAELTTQVPPQGFI-MRGSRPYWRGGPWARVRFTGIPEMDGSHVSK 229
Query: 236 FNLGEDHQKGTRYLTFAFA---DNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCD 292
F++ +D GT LT++ N + LT G+L+ W +G + P + CD
Sbjct: 230 FDISQDVAAGTGSLTYSLERRNSNLSYTTLTSAGSLKI-IWNNGSGWVTD-LEAPVSSCD 287
Query: 293 VYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------EVEGKQ---- 339
VY CG FG C P C CL GF PK+ E+WN+ NW+GG +V
Sbjct: 288 VYNTCGPFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQA 347
Query: 340 ---DGFFKLETMKVPYFAERSSA-NEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDI 395
D F + +K P F E S NE+ C+ +C NCSC A++Y +GC++W L+D+
Sbjct: 348 NNGDIFDIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELVDV 407
Query: 396 RKLPSGGTNLYIRVAHEELDRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENS 455
+ +GG L IR+A EL + FA W+ + KA + +S
Sbjct: 408 MQFVAGGETLSIRLASSELAGSNR--VKIIVASIVSISVFMILVFASYWYWRYKAKQNDS 465
Query: 456 KVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK 515
L+ + + E++ P QD+ F+ + + TNNF + NKLGQGGFGPVYKG
Sbjct: 466 NPIPLETSQ---DAWREQLKP---QDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGN 519
Query: 516 LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575
LQDG+EIA+KRLS SGQG EEFMNE+++IS LQHRNLVRLLGCC+E EE +LIYE+M N
Sbjct: 520 LQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMAN 579
Query: 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635
KSL++F+FD ++ LDWPKRF II+GI+ GLLYLHRDS LR++HRD+K SNILLD+++N
Sbjct: 580 KSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMN 639
Query: 636 PKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
PKISDFGLAR+F G Q QA T+R+VGT GYMSPEYA G FSEKSD+++FGVLLLEI++G
Sbjct: 640 PKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITG 699
Query: 696 RKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFV 755
++ +SF E TLL +AW W ++ DL+D IS SG + E+ RCV +GLLC+Q+
Sbjct: 700 KRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQA 759
Query: 756 KDRPNMPTVVSMLNSEIKDLPAAKQPAFTVR 786
DRPN+ V+SML + + DLP KQP F ++
Sbjct: 760 GDRPNIAQVMSMLTTTM-DLPKPKQPVFAMQ 789
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 353/814 (43%), Positives = 483/814 (59%)
Query: 4 VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESI---IXXXXXXXXXXXXPDGNFTNR 60
VA ++L+++ F S +G A T TSS P SI + N N+
Sbjct: 4 VACLLLITALF-SSYGYAAIT---TSS-----PLSIGVTLSSPGGSYELGFFSSNNSGNQ 54
Query: 61 YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXXXXXXX 120
Y+GIW+ K + +VWVANR KP+ + TIS +G+L++L+ KK + W
Sbjct: 55 YVGIWFKK--VTPRVIVWVANREKPVSSTMANLTISSNGSLILLDSKKDLVWSSGGDPTS 112
Query: 121 XXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRS 180
RA+LLD+GNLV+ DN++ +W SF+ DT + D+ KK LTSW+S
Sbjct: 113 NK--CRAELLDTGNLVVVDNVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKS 170
Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGE 240
++PS G F A + +P + G+ PYWRSGPW G F GIP+M++ Y++ + +
Sbjct: 171 ETDPSPGEFVAEITP-QVPSQGLIRKGSSPYWRSGPWAGTRFTGIPEMDASYVNPLGMVQ 229
Query: 241 DHQKGTRYLTFAFADND--VFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCG 298
D GT F N + LTP+G+L +G +K +F P CD+YG+CG
Sbjct: 230 DEVNGTGVFAFCVLRNFNLSYIKLTPEGSLRITR-NNGTDWIK-HFEGPLTSCDLYGRCG 287
Query: 299 AFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------------EVEGK-QDGF 342
FG C P+C CL GFEPK+ E+W GNWS G E +GK +D F
Sbjct: 288 PFGLCVRSGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVF 347
Query: 343 FKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSG 401
+ + +K P E +S +NE++C C NCSC A++Y G+GC++W L+D K G
Sbjct: 348 YHVSNIKPPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQELLDTVKFIGG 407
Query: 402 GTNLYIRVAHEELD-RKDMKXXXXXXXXXXXXXXXXCTFFA-WRWFAKRKAMKENSKVQR 459
G L +R+AH EL RK +K WR+ K+ SK
Sbjct: 408 GETLSLRLAHSELTGRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQNGSSLVSK-DN 466
Query: 460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
++ G ++ ++ V+ L F +L ATNNF + NKLGQGGFG VYKGKLQDG
Sbjct: 467 VE-GAWKSDLQSQDVS-----GLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDG 520
Query: 520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579
+EIAVKRL+ +S QG EEFMNE+ +IS LQHRNL+RLLGCC++ EE +L+YEYM NKSLD
Sbjct: 521 KEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLD 580
Query: 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639
F+FD +++ +DW RFNII+GI+RGLLYLHRDS LR++HRDLK SNILLD+ +NPKIS
Sbjct: 581 IFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKIS 640
Query: 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699
DFGLAR+F GNQ Q +T +VGT GYMSPEYA G FSEKSD++SFGVL+LEI++G++ +
Sbjct: 641 DFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEIS 700
Query: 700 SFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI--SESGFKMEIIRCVNVGLLCVQEFVKD 757
SF + + LL YAW W++N ++L+D + S+S +E RCV++GLLCVQ D
Sbjct: 701 SFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAID 760
Query: 758 RPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGAYD 791
RPN+ V+SML S DLP QP F + D
Sbjct: 761 RPNIKQVMSMLTSTT-DLPKPTQPMFVLETSDED 793
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.5e-164, Sum P(2) = 2.5e-164
Identities = 186/304 (61%), Positives = 237/304 (77%)
Query: 481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMN 540
+L + + ++ AT+ F NKLGQGGFGPVYKG L GQE+AVKRLS+ S QG EEF N
Sbjct: 449 ELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKN 508
Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
E+ +I+ LQHRNLV++LG CV+ EE MLIYEY PNKSLDSF+FD +R+ LDWPKR II
Sbjct: 509 EIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEII 568
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
KGI+RG+LYLH DSRLRIIHRDLKASN+LLD D+N KISDFGLAR GG++ +A T R+V
Sbjct: 569 KGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVV 628
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720
GTYGYMSPEY ++G FS KSDVFSFGVL+LEIVSGR+N F +EE +L LLG+AW+ + +
Sbjct: 629 GTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLE 688
Query: 721 NNVIDLVDPLISESGFKM-EIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAK 779
+ +++D ++ES + E++R +++GLLCVQ+ KDRPNM VV ML+SE+ L +
Sbjct: 689 DKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDP-R 747
Query: 780 QPAF 783
QP F
Sbjct: 748 QPGF 751
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 339/749 (45%), Positives = 467/749 (62%)
Query: 56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
N N Y+GIW+ G + VVWVANR P D+S IS +G+L++ NGK V W
Sbjct: 54 NSQNLYVGIWFK--GIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIG 111
Query: 116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
+RA+L D+GNLV+ DN S ++W+SF+ DT + +L TG+K L
Sbjct: 112 ENFASNG--SRAELTDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVL 169
Query: 176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
TSW++ ++PS G F G + +P + + G+ Y+R+GPW F GIP M+ Y
Sbjct: 170 TSWKTDTDPSPGVF-VGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASP 228
Query: 236 FNLGEDHQKGTRYLTF---AFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCD 292
F+L +D G+ + T+ +F + + ++ +G+++ R +G ++ + P N CD
Sbjct: 229 FSLQQD-ANGSGFFTYFDRSFKLSRII--ISSEGSMK-RFRHNG-TDWELSYMAPANSCD 283
Query: 293 VYGKCGAFGSCNSQKIPI-CSCLLGFEPKNAEDWNRGNWSGG-----EV--EGKQDG--- 341
+YG CG FG C +P+ C CL GF P + E+W RGNW+GG E+ +G G
Sbjct: 284 IYGVCGPFGLC-IVSVPLKCKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQGNSTGKDV 342
Query: 342 --FFKLETMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKL 398
F + +K+P F E SS + ++C C +NCSC A+AY G+GC+IW NL+D +
Sbjct: 343 NIFHPVTNVKLPDFYEYESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQNLMDAVQF 402
Query: 399 PSGGTNLYIRVAHEEL--DRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSK 456
+GG L IR+AH EL ++++ F WR+ K KA
Sbjct: 403 SAGGEILSIRLAHSELGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYT---- 458
Query: 457 VQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKL 516
L +A+ N K P L F + ATNNF L+NKLGQGGFG VYKGKL
Sbjct: 459 -----LKDAWRNDLKSKEVPG----LEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKL 509
Query: 517 QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576
QDG+EIAVK+LS +SGQG+EEFMNE+++IS LQHRNLVR+LGCC+E EE +LIYE+M NK
Sbjct: 510 QDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNK 569
Query: 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636
SLD+F+FD +++ +DWPKRF+I++GI+RGLLYLHRDSRL++IHRDLK SNILLD+ +NP
Sbjct: 570 SLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNP 629
Query: 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
KISDFGLAR++ G Q Q T+R+VGT GYMSPEYA G FSEKSD++SFGVLLLEI+ G
Sbjct: 630 KISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGE 689
Query: 697 KNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVK 756
K + F + E TLL YAW+ W + IDL+D +++S +E+ RCV +GLLCVQ
Sbjct: 690 KISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPA 749
Query: 757 DRPNMPTVVSMLNSEIKDLPAAKQPAFTV 785
DRPN +++ML + DLP+ KQP F V
Sbjct: 750 DRPNTLELLAMLTTT-SDLPSPKQPTFVV 777
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1591 (565.1 bits), Expect = 1.9e-163, P = 1.9e-163
Identities = 333/748 (44%), Positives = 460/748 (61%)
Query: 56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
N N+Y+GIW+ G + VVWVANR KP+ DS+ IS +G+L++ NGK V W
Sbjct: 54 NSQNQYVGIWFK--GIIPRVVVWVANREKPVTDSTANLAISNNGSLLLFNGKHGVAWSSG 111
Query: 116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
+RA+L D+GNL++ DN S ++W SF DT + +L TG+K L
Sbjct: 112 EALVSNG--SRAELSDTGNLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVL 169
Query: 176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
+SW+S ++PS+G F + +P + G+ PY+RSGPW F GIP M+ +
Sbjct: 170 SSWKSYTDPSVGDFVLQITP-QVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGP 228
Query: 236 FNLGEDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDV 293
++ +D G+ LT+ ND LT +G +E +W +G + + F P + CD
Sbjct: 229 VSVQQD-TNGSGSLTY-LNRNDRLQRTMLTSKGT-QELSWHNGTDWV-LNFVAPEHSCDY 284
Query: 294 YGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV-------EGKQDG----- 341
YG CG FG C P C+C GF PK E+W RGNW+GG V +G G
Sbjct: 285 YGVCGPFGLCVKSVPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTELYCQGNSTGKYANV 344
Query: 342 FFKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
F + +K P F E +S N ++C+ C +NCSC A+AY G+GC++W +L+D +
Sbjct: 345 FHPVARIKPPDFYEFASFVNVEECQKSCLHNCSCLAFAYIDGIGCLMWNQDLMDAVQFSE 404
Query: 401 GGTNLYIRVAHEELD-RKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSKVQR 459
GG L IR+A EL K K F + W R +K N+ +
Sbjct: 405 GGELLSIRLARSELGGNKRKKAITASIVSLSLVVIIAFVAFCF-W---RYRVKHNADITT 460
Query: 460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
D + ++ + + P + L F+ + ATNNF ++NKLGQGGFGPVYKGKLQDG
Sbjct: 461 -DASQV--SWRND-LKPQDVPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDG 516
Query: 520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579
+EIAVKRLS +SGQG+EEFMNE+++IS LQH+NLVR+LGCC+E EE +LIYE+M N SLD
Sbjct: 517 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLD 576
Query: 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639
+FLFD +++ +DWPKR +II+GI+RG+ YLHRDS L++IHRDLK SNILLD+ +NPKIS
Sbjct: 577 TFLFDSRKRLEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKIS 636
Query: 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699
DFGLAR++ G + Q T+R+VGT GYM+PEYA G FSEKSD++SFGVL+LEI+SG K +
Sbjct: 637 DFGLARMYQGTEYQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKIS 696
Query: 700 SFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP 759
F + + E TL+ YAW+ W D IDL+D +++S +E+ RCV +GLLCVQ DRP
Sbjct: 697 RFSYGKEEKTLIAYAWESWCDTGGIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRP 756
Query: 760 NMPTVVSMLNSEIKDLPAAKQPAFTVRR 787
N ++SML + DLP +QP F V R
Sbjct: 757 NTLELLSMLTTT-SDLPPPEQPTFVVHR 783
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1589 (564.4 bits), Expect = 3.1e-163, P = 3.1e-163
Identities = 337/799 (42%), Positives = 481/799 (60%)
Query: 6 IVVLLSSCFYSDFGTATATDTITSSQFIRDPESIIXXXXXXXXXXXXPDGNFTNRYIGIW 65
++++ + Y+D T++ ++ Q + P+ + P+ N +Y+GIW
Sbjct: 32 LLIIFPTFGYADINTSSP---LSIGQTLSSPDGVYELGFFS------PN-NSRKQYVGIW 81
Query: 66 YNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXXXXXXXXXXXT 125
+ A + VVWVANR+KP+ ++ TIS +G+L++L+G + V W
Sbjct: 82 FKN--IAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNK--C 137
Query: 126 RAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS 185
A+LLD+GNLV+ D++S ++W SF+ +T + V D+ GK LTSWRS S+PS
Sbjct: 138 HAELLDTGNLVVIDDVSGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPS 197
Query: 186 IGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKG 245
G F+ P+ I G+ PYWRSGPW F GIP +++ Y+ F + +D KG
Sbjct: 198 PGEFTLEFTPQVPPQGLIR-RGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKG 256
Query: 246 TRYLTFAFADNDV--FFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSC 303
T +++ N + LT +G ++ W DGK+ K++F PT+ CD+Y CG FG C
Sbjct: 257 TASFSYSMLRNYKLSYVTLTSEGKMKI-LWNDGKSW-KLHFEAPTSSCDLYRACGPFGLC 314
Query: 304 NSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------------EVEGKQ-DGFFKLET 347
+ P C CL GF PK+ ++W +GNW+ G + +GK+ D F+ +
Sbjct: 315 VRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTR 374
Query: 348 MKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
+K P + + N ++C C NCSC A+AY G+GC++W L+D + S G +L
Sbjct: 375 VKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNRELVDTVQFLSDGESLS 434
Query: 407 IRVAHEELDRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSKVQRLDLGEAY 466
+R+A EL + + F A++ + R E + + +A+
Sbjct: 435 LRLASSELAGSN-RTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAW 493
Query: 467 ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR 526
A + + P + + +F+ + ATNNF +NKLGQGGFGPVYKGKL DG+EIAVKR
Sbjct: 494 A----KDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKR 549
Query: 527 LSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ 586
LS +SGQG +EFMNE+ +IS LQH+NLVRLLGCC++ EE +LIYEY+ NKSLD FLFD
Sbjct: 550 LSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDST 609
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
+ +DW KRFNII+G++RGLLYLHRDSRLR+IHRDLK SNILLD+ + PKISDFGLAR+
Sbjct: 610 LKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARM 669
Query: 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706
G Q Q T+R+VGT GYM+PEYA G FSEKSD++SFGVLLLEI+ G K + F EE
Sbjct: 670 SQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRF-SEEG 728
Query: 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766
+ TLL YAW+ W + +DL+D +++S E+ RCV +GLLCVQ DRPN ++S
Sbjct: 729 K-TLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMS 787
Query: 767 MLNSEIKDLPAAKQPAFTV 785
ML + I +LP+ KQP FTV
Sbjct: 788 MLTT-ISELPSPKQPTFTV 805
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1579 (560.9 bits), Expect = 3.5e-162, P = 3.5e-162
Identities = 332/746 (44%), Positives = 458/746 (61%)
Query: 56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
N N+Y+GIW+ G + VVWVANR KP+ DS+ TIS +G+L++ N V W
Sbjct: 54 NSQNQYVGIWFK--GIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIG 111
Query: 116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
+RA+L D+GNLV+ DN S ++W+SF+ DT + +L TG+K L
Sbjct: 112 ETFASNG--SRAELTDNGNLVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVL 169
Query: 176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
TSW+S ++PS G F+ + +P + G++ YWRSGPW F GIP M+ Y
Sbjct: 170 TSWKSHTDPSPGDFTVQITP-QVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSP 228
Query: 236 FNLGEDHQKGTRYLTFAFADNDV--FFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDV 293
F+L +D G+ T+ F N + +T +G+L + + ++ F P N CD+
Sbjct: 229 FSLQQD-TNGSGSFTY-FERNFKLSYIMITSEGSL--KIFQHNGMDWELNFEAPENSCDI 284
Query: 294 YGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE-----------GKQ-DG 341
YG CG FG C P C C GF PK+ E+W RGNW+ G V GK +G
Sbjct: 285 YGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTELHCQGNTNGKTVNG 344
Query: 342 FFKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
F+ + +K P F E +S + + C C +NCSC A+AY G+GC++W +L+D + +
Sbjct: 345 FYHVANIKPPDFYEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSA 404
Query: 401 GGTNLYIRVAHEELDRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKE-NSKVQR 459
GG L IR+A EL K FA F + K ++K+ +
Sbjct: 405 GGEILSIRLASSELGGN--KRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISK 462
Query: 460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
+ EA+ N + P + L F + AT+NF L+NKLGQGGFG VYKGKLQDG
Sbjct: 463 IASKEAWNN----DLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDG 518
Query: 520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579
+EIAVKRLS +SGQG+EEFMNE+++IS LQH+NLVR+LGCC+E EE +L+YE++ NKSLD
Sbjct: 519 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLD 578
Query: 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639
+FLFD +++ +DWPKRFNII+GI+RGL YLHRDS LR+IHRDLK SNILLD+ +NPKIS
Sbjct: 579 TFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKIS 638
Query: 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699
DFGLAR++ G + Q T+R+ GT GYM+PEYA G FSEKSD++SFGV+LLEI++G K +
Sbjct: 639 DFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKIS 698
Query: 700 SFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP 759
F + TLL YAW+ W ++ IDL+D +++S +E+ RCV +GLLCVQ DRP
Sbjct: 699 RFSYGRQGKTLLAYAWESWCESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRP 758
Query: 760 NMPTVVSMLNSEIKDLPAAKQPAFTV 785
N ++SML + DL + KQP F V
Sbjct: 759 NTMELLSMLTTT-SDLTSPKQPTFVV 783
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SXB8 | Y1133_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5280 | 0.9607 | 0.9311 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 816 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-58 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-58 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-58 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-46 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-40 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-39 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-33 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-31 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-31 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-31 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-30 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-30 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-30 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-30 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-28 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-18 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 9e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 3e-58
Identities = 97/285 (34%), Positives = 141/285 (49%), Gaps = 44/285 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDG-----QEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
L KLG+G FG VYKG L+ E+AVK L + AS Q EEF+ E ++ L H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+LLG C E E M++ EYMP L +L + + L + I+RG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE- 120
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYGYMSPEYA 671
IHRDL A N L+ ++L KISDFGL+R ++ + + +L +M+PE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG---YAWKLWNDNNVIDLVD 728
EG+F+ KSDV+SFGVLL EI + LG Y + V++ +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT----------------LGEEPYPGMSNAE--VLEYL- 217
Query: 729 PLISESGFKMEII-RC----VNVGLLCVQEFVKDRPNMPTVVSML 768
+ G+++ C + L C E +DRP +V +L
Sbjct: 218 ----KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 5e-58
Identities = 93/286 (32%), Positives = 138/286 (48%), Gaps = 43/286 (15%)
Query: 501 NKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVR 555
KLG+G FG VYKGKL+ E+AVK L + AS + +++F+ E V+ L H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGLLY 609
LLG C E E L+ EYM L +L F +S L + I++G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYGYMSP 668
L + +HRDL A N L+ +DL KISDFGL+R ++ + + T + +M+P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727
E +G F+ KSDV+SFGVLL EI + G Y ++ V++ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPG-------------LSNEEVLEYL 220
Query: 728 DPLISESGFKMEIIRCV-----NVGLLCVQEFVKDRPNMPTVVSML 768
G+++ + L C Q +DRP +V L
Sbjct: 221 -----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 5e-58
Identities = 97/285 (34%), Positives = 140/285 (49%), Gaps = 43/285 (15%)
Query: 498 QLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
L KLG+G FG VYKGKL+ E+AVK L + AS Q EEF+ E ++ L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+V+LLG C E E ++ EYM L S+L + + L + I+RG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
IHRDL A N L+ ++L KISDFGL+R + D + +M+PE
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG---YAWKLWNDNNVIDLVD 728
EG+F+ KSDV+SFGVLL EI + LG Y + V++ +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT----------------LGEQPYPGMSNEE--VLEYL- 216
Query: 729 PLISESGFKMEII-RC----VNVGLLCVQEFVKDRPNMPTVVSML 768
++G+++ C ++ L C E +DRP +V +L
Sbjct: 217 ----KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 77/201 (38%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 502 KLGQGGFGPVYKGKL-----QDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVR 555
KLG+G FG VYKG L ++AVK L AS + +EEF+ E ++ L H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
LLG C + E ++ EYMP L FL + L + I++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
+HRDL A N L+ ++L KISDFGL+R I+ + + + +M+PE +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179
Query: 675 RFSEKSDVFSFGVLLLEIVSG 695
+F+ KSDV+SFGVLL EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 73/194 (37%), Positives = 110/194 (56%), Gaps = 11/194 (5%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
LG+GGFG VY + + G+++A+K + K S EE + E+ ++ L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ L+ EY SL L + + + L + I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 621 RDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE-YAMEGRFSE 678
RDLK NILLD D+ K++DFGL+++ ++ K +VGT YM+PE +G +SE
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 679 KSDVFSFGVLLLEI 692
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 70/217 (32%), Positives = 114/217 (52%), Gaps = 13/217 (5%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNLV 554
+++ KLG+G FG VY + + G+ +A+K + K + E + E+ ++ L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
RL + ++ L+ EY L L +R L + RF ++ I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
I+HRDLK NILLD+D + K++DFGLAR + VGT YM+PE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
+ + D++S GV+L E+++G+ F ++ L L
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 78/213 (36%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNL 553
++L KLG G FG VYK K + G+ +AVK L K + + E+ ++ L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
VRL+ +++ L+ EY L +L R L + I I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS- 116
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
IIHRDLK NILLD++ KI+DFGLA+ + T VGT YM+PE +
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172
Query: 674 GR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEE 705
G + K DV+S GV+L E+++G+ F E
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK--PPFSGEN 203
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 29/215 (13%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
+ LG+G FG VY +D G+ +AVK LS S + E E+ ++S+LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 553 LVRLLGCCVEREENML-IY-EYMPNKSLDSFLFDPQRQSLLDWPKRF-----NIIKGISR 605
+VR G + E+N L I+ EY+ SL S L K+F +I+ +R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 606 ----GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
GL YLH I+HRD+K +NIL+D D K++DFG A+ G + T + G
Sbjct: 109 QILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
T +M+PE + +D++S G ++E+ +G+
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 78/224 (34%), Positives = 117/224 (52%), Gaps = 17/224 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
F L KLG G FG V++G ++ +A+K L Q++F EV + L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
C E +I E M SL +FL P+ Q L ++ ++ G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
IHRDL A NIL+ +DL K++DFGLAR+ + ++ K++ Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 677 SEKSDVFSFGVLLLEIVS-------GRKNTSFYHEEFELTLLGY 713
S KSDV+SFG+LL E+ + G N HE ++ GY
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQITAGY 221
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
F++ K+G+GGFG VYK + + G+E+A+K + S + +E+ +NE+ ++ +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLY 609
G ++++E ++ E+ SL + L + + K + +GL Y
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LH IIHRD+KA+NILL D K+ DFGL+ D A +VGT +M+PE
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPE 167
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ K+D++S G+ +E+ G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 77/220 (35%), Positives = 118/220 (53%), Gaps = 25/220 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNL 548
+ +LG+G FG VYKG+L +A+K L + A + Q+EF E ++S+L
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF-------------DPQRQSLLDWPK 595
QH N+V LLG C + + +++EY+ + L FL D +S LD
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQA 654
+I I+ G+ YL S +HRDL A N L+ + L KISDFGL+R I+ + +
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+K L+ +M PE + G+F+ +SD++SFGV+L EI S
Sbjct: 183 QSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 78/205 (38%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +L KLG G FG V+ G ++AVK L K E F+ E ++ L+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L C E E ++ EYM SL FL + + L P+ ++ I+ G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLES-- 121
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA--ATKRLVGTYGYMSPEYAM 672
IHRDL A NIL+ ++L KI+DFGLAR+ ++ A K + + +PE A
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAAN 177
Query: 673 EGRFSEKSDVFSFGVLLLEIVS-GR 696
GRF+ KSDV+SFG+LL EIV+ GR
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 72/208 (34%), Positives = 118/208 (56%), Gaps = 19/208 (9%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQHRN 552
N+QL + +G+G FG VYKG L+ G +A+K++S K + + M E+ ++ NL+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 553 LVRLLGCCVEREENMLIY-EYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLY 609
+V+ +G +E +++ I EY N SL + F P +SL+ + + + +GL Y
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVY--VYQVLQGLAY 114
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LH +IHRD+KA+NIL D K++DFG+A A+ +VGT +M+PE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPE 169
Query: 670 -YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
M G S SD++S G ++E+++G
Sbjct: 170 VIEMSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 54/113 (47%), Positives = 67/113 (59%), Gaps = 4/113 (3%)
Query: 73 NKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDS 132
N+TVVWVANR PL DSS + DGNLV+ +G +V WSSN S S A L D
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSG--KGSGCVAVLQDD 58
Query: 133 GNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS 185
GNLVL+DN S +W SF PTDT K ++ G +LTSW+S ++PS
Sbjct: 59 GNLVLYDN-SGKVLWQSFDHPTDTLLPGQKD-GNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQDGQ--EIAVKRLSKASG-QGQEEFMNEVMVISNLQ 549
+ + +LG+G FG V + L D ++AVK L+ + Q + +F E+ ++ L
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
H N+V+ G C + LI EY+P+ SL +L + + ++ + I +G+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGM 122
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAATKRLVGTYGY 665
YL R IHRDL A NIL++ + KISDFGLA++ ++D + Y
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTS 700
+PE +FS SDV+SFGV L E+ + G + S
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 77/204 (37%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +G+G FG V G + GQ++AVK L S Q F+ E V++ L+H NLV
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLV 63
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRD 613
+LLG ++ ++ EYM SL +L R + L F + + G+ YL
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK 121
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
+HRDL A N+L+ +DL K+SDFGLA+ +Q Q + K V + +PE E
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPV---KWTAPEALRE 173
Query: 674 GRFSEKSDVFSFGVLLLEIVS-GR 696
+FS KSDV+SFG+LL EI S GR
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRN 552
++ + LGQG G VYK + + G+ A+K++ + +++ + E+ + + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR----GLL 608
+V+ G + E ++ EYM SL L + + P+ ++ I+R GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPE--PVLAYIARQILKGLD 113
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLH IIHRD+K SN+L++ KI+DFG++++ DQ T VGT YMSP
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSP 169
Query: 669 EYAMEGRF-----SEKSDVFSFGVLLLEIVSGR 696
E R S +D++S G+ LLE G+
Sbjct: 170 E-----RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 63/206 (30%), Positives = 115/206 (55%), Gaps = 21/206 (10%)
Query: 503 LGQGGFGPVYKGK-LQDGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
LG G FG VYKG + +G+ +A+K L + + + +E ++E V++++ H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
LG C+ + LI + MP L ++ + + Q LL+W + I++G+ YL
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
R++HRDL A N+L+ + KI+DFGLA++ ++ + + +M+ E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 673 EGRFSEKSDVFSFGVLLLEIVS-GRK 697
++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 23/228 (10%)
Query: 499 LANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
L +LG+G FG V+ G+ D + +AVK L + AS +++F E +++N QH
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR---------FNII 600
N+V+ G C E + ++++EYM + L+ FL P L I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
I+ G++YL + +HRDL N L+ DL KI DFG++R ++ + + +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFE 707
+ +M PE M +F+ +SDV+SFGV+L EI + K + E
Sbjct: 186 LPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
+++ ++G+G FG VY + DG+ +K LS S + +E+ +NEV ++ L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK---GISRGLLY 609
+++ E+ + ++ EY L + +++ I+ + L Y
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LH SR +I+HRD+K NI L + K+ DFG++++ D A T +VGT Y+SPE
Sbjct: 119 LH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGRK 697
++ KSD++S G +L E+ + +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 5e-33
Identities = 78/205 (38%), Positives = 112/205 (54%), Gaps = 12/205 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L KLG G FG V+ G ++A+K L + S E F+ E ++ LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
RL V +E +I EYM N SL FL P+ L K ++ I+ G+ ++ R +
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ--DQAATKRLVGTYGYMSPEYAM 672
IHRDL+A+NIL+ + L KI+DFGLAR+ N+ + K + + +PE
Sbjct: 123 ---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAIN 176
Query: 673 EGRFSEKSDVFSFGVLLLEIVS-GR 696
G F+ KSDV+SFG+LL EIV+ GR
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 72/203 (35%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 501 NKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVR 555
+LG G FG V KG G+E+ AVK L + G++EF+ E V++ L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
L+G C E ML+ E P L +L + + D + ++ G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESK-- 114
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAAT--KRLVGTYGYMSPEYA 671
+HRDL A N+LL + KISDFG++R G D +A T + + Y +PE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APECI 170
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
G+FS KSDV+S+GV L E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ QL KLG G FG V++G + +AVK L K ++F+ E ++ L+H L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L C E ++ E M SL +L L P+ ++ ++ G+ YL +
Sbjct: 65 QLYAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYA 671
IHRDL A N+L+ ++ K++DFGLAR+ + +A G + +PE A
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAA 176
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS-GR 696
+ RFS KSDV+SFG+LL EIV+ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 6e-33
Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQH-R 551
++++ KLG+G FG VY + D + +A+K L+K + E F+ E+ ++++L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+V+L + L+ EY+ SL+ L R+ L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 612 RDSRLRIIHRDLKASNILLDDDLN-PKISDFGLARIFGGNQ----DQAATKRLVGTYGYM 666
IIHRD+K NILLD D K+ DFGLA++ A VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 667 SPEYAM---EGRFSEKSDVFSFGVLLLEIVSGR 696
+PE + S SD++S G+ L E+++G
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 77/210 (36%), Positives = 117/210 (55%), Gaps = 22/210 (10%)
Query: 503 LGQGGFGPVYKGKLQD-------GQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLV 554
LG G FG VY+G D +AVK L K A+ Q ++EF+ E ++SN H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS----LLDWPKRFNIIKGISRGLLYL 610
+LLG C+ E +I E M L S+L D + + LL + +I +++G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 611 HRDSRLRIIHRDLKASNILL-----DDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYG 664
++ IHRDL A N L+ D D KI DFGLAR I+ + + + L+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE ++G+F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 68/204 (33%), Positives = 115/204 (56%), Gaps = 9/204 (4%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
+F++ NK+G+G FG V+K + D + A+K+ LSK + + +EE ++E V++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
++R +++ + ++ EY N L L QR L + + I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
+I+HRD+K+ N+ LD N KI D G+A++ N + A T +VGT Y+SPE
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174
Query: 673 EGRFSEKSDVFSFGVLLLEIVSGR 696
+ ++EKSDV++ GV+L E +G+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-31
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 29/214 (13%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQHR 551
++ ++G+G +G VYK + + G+ +A+K++ +E F + E+ ++ L+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58
Query: 552 NLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI--IKGISR-- 605
N+VRL + + +++EYM + L L P+ +F IK +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--------VKFTESQIKCYMKQL 109
Query: 606 --GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
GL YLH + I+HRD+K SNIL+++D K++DFGLAR + T R++ T
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
Query: 664 GYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
Y PE + R+ + D++S G +L E+ G+
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 78/207 (37%), Positives = 115/207 (55%), Gaps = 12/207 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
+ QL KLG G FG V+ G ++AVK L K E F+ E ++ L+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
LV+L V E ++ EYM SL FL D + ++L P ++ ++ G+ Y+ R
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIER 120
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEY 670
+ IHRDL+++NIL+ D L KI+DFGLAR+ +D T R + + +PE
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEA 174
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVS-GR 696
A+ GRF+ KSDV+SFG+LL E+V+ GR
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ----DGQEIAVK---RLSKASGQGQEEFMNEVMVISNL 548
+ L LG G FG VY+G + D E+ V S Q + +F+ E +++S
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGIS 604
H+N+VRL+G ER ++ E M L SFL + P+R S L + ++
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLAR-IFGGNQDQAATKRLV 660
+G YL + IHRD+ A N LL KI+DFG+AR I+ + + + ++
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M PE ++G F+ K+DV+SFGVLL EI S
Sbjct: 184 -PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 62/232 (26%), Positives = 115/232 (49%), Gaps = 28/232 (12%)
Query: 472 EKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA 530
E+ A L+D++ + ++ K+G+G G VYK G+E+A+K++ +
Sbjct: 1 EEELKAALKDIV-----SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RL 54
Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
Q +E +NE++++ + +H N+V + +E ++ EYM SL +
Sbjct: 55 RKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDI 105
Query: 591 LDW-PKRFN------IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
+ R N + + + +GL YLH +IHRD+K+ NILL D + K++DFG
Sbjct: 106 ITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGF 162
Query: 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
A + + + +VGT +M+PE + K D++S G++ +E+ G
Sbjct: 163 AAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE 562
LG G FG V+ GK + ++A+K + + + +++F+ E V+ L H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRD 622
+ ++ EYM N L ++L +R+ L ++ + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 623 LKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYAMEGRFSEK 679
L A N L+ +D K+SDFGLAR +Q ++ GT + PE RFS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 680 SDVFSFGVLLLEIVSGRK 697
SDV+SFGVL+ E+ S K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 6/195 (3%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
K+G+G FG VYKG L+ E+AVK +F+ E ++ H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
V+++ ++ E +P SL +FL + + L K + + G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKS 680
RDL A N L+ ++ KISDFG++R G + + +PE GR++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 681 DVFSFGVLLLEIVSG 695
DV+S+G+LL E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 66/197 (33%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 503 LGQGGFGPVYKGKLQ--DGQEI--AVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
+G G FG V +G+L+ +EI A+K L + +S + + +F+ E ++ H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G + M+I EYM N SLD FL + + +++GI+ G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
+HRDL A NIL++ +L K+SDFGL+R ++ TK + +PE +F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 678 EKSDVFSFGVLLLEIVS 694
SDV+SFG+++ E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 503 LGQGGFGPVYK-GKLQDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG+G FG V K G+ A+K L K + E + E ++S + H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 559 CCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRL 616
+ EE + L+ EY P L S L ++ + RF I L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF-YAAEIVLALEYLHS---L 112
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
II+RDLK NILLD D + K++DFGLA+ + + T GT Y++PE + +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 677 SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT 709
+ D +S GVLL E+++G+ FY E+ +
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK--PPFYAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM--NEVMVISNLQHRNL 553
+++ +G+G FG V K + DG+ + K + + +E+ +EV ++ L+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 554 VRLLGCCVEREENMLIY---EYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLL 608
VR ++R N +Y EY L + +R+ + + F I + +++ LL
Sbjct: 62 VRYYDRIIDRS-NQTLYIVMEYCEGGDLAQLIQKCKKERKYI---EEEF-IWRILTQLLL 116
Query: 609 YLHR-----DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
L+ D ++HRDLK +NI LD + N K+ DFGLA+I G + A T VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTP 174
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
YMSPE + EKSD++S G L+ E+ +
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 75/204 (36%), Positives = 113/204 (55%), Gaps = 12/204 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+ +L KLGQG FG V+ G +A+K L K E F+ E V+ L+H LV+
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
L V E ++ EYM SL FL + L P+ ++ I+ G+ Y+ R
Sbjct: 66 LYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER--- 120
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEYAME 673
+ +HRDL+A+NIL+ ++L K++DFGLAR+ +D T R + + +PE A+
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 674 GRFSEKSDVFSFGVLLLEIVS-GR 696
GRF+ KSDV+SFG+LL E+ + GR
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 51/124 (41%), Positives = 67/124 (54%), Gaps = 8/124 (6%)
Query: 30 SQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDS 89
S + ++++SSGS F+LGFF Y I Y ++TVVWVANR+ P S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGS---SRTVVWVANRDNPS-GS 55
Query: 90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149
S T+ DGNLV+ +G V WSSN + N N LLD GNLVL+D+ +W S
Sbjct: 56 SCTLTLQSDGNLVIYDGSGTVVWSSNTTR--VNGNYVLVLLDDGNLVLYDSDGNF-LWQS 112
Query: 150 FQEP 153
F P
Sbjct: 113 FDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 74/202 (36%), Positives = 107/202 (52%), Gaps = 10/202 (4%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +L KLG G FG V+ G + ++AVK L K + F+ E ++ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
RL + E +I EYM SL FL + PK + I+ G+ Y+ R +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEYAM 672
IHRDL+A+N+L+ + L KI+DFGLAR+ +D T R + + +PE
Sbjct: 124 ---YIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAIN 177
Query: 673 EGRFSEKSDVFSFGVLLLEIVS 694
G F+ KSDV+SFG+LL EIV+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 47/121 (38%), Positives = 67/121 (55%), Gaps = 9/121 (7%)
Query: 30 SQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDS 89
S + ++++S S F+LGFF+ N Y I Y ++TVVWVANR+ P+
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTL--IMQNDYNLILYKSS---SRTVVWVANRDNPV-SD 54
Query: 90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149
S T+ DGNLV+ +G +V WSSN + N N LLD GNLV++D+ +W S
Sbjct: 55 SCTLTLQSDGNLVLYDGDGRVVWSSNTTG--ANGNYVLVLLDDGNLVIYDS-DGNFLWQS 111
Query: 150 F 150
F
Sbjct: 112 F 112
|
Length = 114 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 42/114 (36%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 212 WRSGPWNGRYFIGIPDM--NSVYLDGFNLGEDHQKGTRYLTFAFADNDVF--FALTPQGN 267
WRSGPWNG F GIP+M S Y+ F Y T+ +N ++ L+ +G+
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTE----NNEEVYYTYRMTNNSIYSRLTLSSEGS 56
Query: 268 LEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKN 321
LE W+ +++ P + CDVYG+CG +G C+ P C+C+ GF PKN
Sbjct: 57 LERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISN 547
L +LGQG FG VY+G K + +A+K +++ + + EF+NE V+
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF----DPQRQSLLDWPKRFNIIK-- 601
++VRLLG + +++ E M L S+L + + L P I+
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 602 -GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
I+ G+ YL + +HRDL A N ++ +DL KI DFG+ R I+ + + K L
Sbjct: 126 AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +M+PE +G F+ KSDV+SFGV+L E+ +
Sbjct: 183 LPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 69/199 (34%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 499 LANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
+ +KLG G +G VY+G + +AVK L K EEF+ E V+ ++H NLV+LL
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G C +I E+M +L +L + RQ ++ + IS + YL + +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGN--QDQAATKRLVGTYGYMSPEYAMEGR 675
IHRDL A N L+ ++ K++DFGL+R+ G+ A K + + +PE +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNK 181
Query: 676 FSEKSDVFSFGVLLLEIVS 694
FS KSDV++FGVLL EI +
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
F + KLG+G +G VYK + GQ +A+K + + +E + E+ ++ +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
G + + ++ EY S+ + L + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
+ IHRD+KA NILL+++ K++DFG++ + T ++GT +M+PE E
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 175
Query: 676 FSEKSDVFSFGVLLLEIVSGR 696
++ K+D++S G+ +E+ G+
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 41/232 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKGK---LQDGQE---IAVKRLSK-ASGQGQEEFMNEVMVISN 547
NN + +GQG FG V++ + L + +AVK L + AS Q +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-------------------PQRQ 588
H N+V+LLG C + L++EYM L+ FL
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 589 SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR--- 645
L ++ I K ++ G+ YL S + +HRDL N L+ +++ KI+DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 646 ---IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +++ A R +M PE R++ +SDV+++GV+L EI S
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 77/204 (37%), Positives = 115/204 (56%), Gaps = 12/204 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+ +L KLGQG FG V+ G ++A+K L K E F+ E ++ L+H LV
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
L V E ++ E+M SL FL + + L P+ ++ I+ G+ Y+ R
Sbjct: 66 LYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIER--- 120
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEYAME 673
+ IHRDL+A+NIL+ D+L KI+DFGLAR+ +D T R + + +PE A+
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 674 GRFSEKSDVFSFGVLLLEIVS-GR 696
GRF+ KSDV+SFG+LL E+V+ GR
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 75/214 (35%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 502 KLGQGGFGPVYKGKL------QDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRNLV 554
+LG+ FG VYKG L + Q +A+K L KA G +EEF +E M+ S LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLF-------------DPQRQSLLDWPKRFNIIK 601
LLG + + +I+ Y + L FL D +S L+ +I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLV 660
I+ G+ +L S ++H+DL N+L+ D LN KISD GL R ++ + + L+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+MSPE M G+FS SD++S+GV+L E+ S
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 68/200 (34%), Positives = 107/200 (53%), Gaps = 21/200 (10%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
+LG G FG V GK + ++A+K + + S ++EF+ E V+ L H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 562 EREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
++ ++ EYM N L ++L + Q LL+ + K + G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCEGMAYLESK---Q 120
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYAMEG 674
IHRDL A N L+DD K+SDFGL+R ++ ++ VG+ + PE +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYS 176
Query: 675 RFSEKSDVFSFGVLLLEIVS 694
+FS KSDV++FGVL+ E+ S
Sbjct: 177 KFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 498 QLANKLGQGGFGPVYKG-KLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLV 554
Q NK+G G FG VY L G+ +AVK R+ + +E +E+ V+ L+H NLV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP--KRFNIIKGISRGLLYLHR 612
+ G V RE+ + EY +L+ L + +LD + + + GL YLH
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVY--TLQLLEGLAYLHS 117
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT--KRLVGTYGYMSPEY 670
I+HRD+K +NI LD + K+ DFG A N + L GT YM+PE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 671 AMEGRFSEK---SDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
G+ +D++S G ++LE+ +G++ S EF++
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 75/204 (36%), Positives = 109/204 (53%), Gaps = 16/204 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +G+G FG V G + G ++AVK + + A+ Q F+ E V++ L+H NLV
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLV 62
Query: 555 RLLGCCVEREENMLIY-EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+LLG VE + + I EYM SL +L R S+L + + YL +
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
+ +HRDL A N+L+ +D K+SDFGL + QD T +L + +PE E
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--PVKWTAPEALRE 173
Query: 674 GRFSEKSDVFSFGVLLLEIVS-GR 696
+FS KSDV+SFG+LL EI S GR
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 14/199 (7%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
L +G+G FG V +G+ GQ++AVK + K Q F+ E V++ L H+NLVRLLG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQA-FLEETAVMTKLHHKNLVRLLG 66
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
+ ++ E M +L +FL R +L+ + ++ G+ YL ++
Sbjct: 67 VILHNGLY-IVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
+HRDL A NIL+ +D K+SDFGLAR+ +L + +PE +FS
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSS 176
Query: 679 KSDVFSFGVLLLEIVS-GR 696
KSDV+S+GVLL E+ S GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
L ++G G FG V+ G + +++A+K + + + +E+F+ E V+ L H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
C ER L++E+M + L +L ++ + + G+ YL + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYAMEGR 675
IHRDL A N L+ ++ K+SDFG+ R +Q ++T GT + SPE +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSK 177
Query: 676 FSEKSDVFSFGVLLLEIVS 694
+S KSDV+SFGVL+ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 503 LGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
LG+G FG V + LQD G+ +AVK+L ++ + +F E+ ++ +LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 558 GCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
G C R L+ EY+P SL +L + + LD K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT--YGYMSPEYAME 673
R +HRDL NIL++ + KI DFGL ++ +++ + + + Y +PE E
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 674 GRFSEKSDVFSFGVLLLEIVS 694
+FS SDV+SFGV+L E+ +
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-Q 549
++F+ +G+G F V K + +E A+K L K + + E V++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 550 HRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
H +++L + EEN+ + EY PN L ++ ++ LD I L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ----------------- 651
YLH IIHRDLK NILLD D++ KI+DFG A++ N
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 652 -DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
++ VGT Y+SPE E + SD+++ G ++ ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKAS--GQGQE---EFMNEVMVISNLQHRNLVRL 556
LG G FG VY+G L DG AVK +S A GQE + E+ ++S LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 557 LGCCVEREENMLIY-EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
LG E E+N+ I+ E +P SL L ++ P + I GL YLH R
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLH--DR 121
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM-EG 674
+HRD+K +NIL+D + K++DFG+A+ + + K G+ +M+PE +G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 675 RFSEKSDVFSFGVLLLEIVSGR 696
+ +D++S G +LE+ +G+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKR--LSKASGQGQEEFMNEVMVISNLQHR 551
++++L +G G VY E +A+KR L K +E EV +S H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+V+ V +E L+ Y+ SL + + LD ++K + +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQA-ATKRLVGTYGYMSPE 669
+ + IHRD+KA NILL +D + KI+DFG+ A + G K VGT +M+PE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 670 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
+ + K+D++SFG+ +E+ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 502 KLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+LG+G FG V+ + QD +AVK L +AS +++F E +++ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSL----------LDWPKRFNIIKGI 603
G C E ++++EYM + L+ FL P + L L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
+ G++YL + L +HRDL N L+ L KI DFG++R R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M PE + +F+ +SD++SFGV+L EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 76/206 (36%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+ +L KLG G FG V+ ++AVK + K E F+ E V+ LQH LV+
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRD 613
L V +E +I E+M SL FL + +Q L PK + I+ G+ ++ +
Sbjct: 66 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQR 121
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEYA 671
+ IHRDL+A+NIL+ L KI+DFGLAR+ +D T R + + +PE
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAI 175
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS-GR 696
G F+ KSDV+SFG+LL+EIV+ GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 502 KLGQGGFGPVYKGK-LQDGQE---IAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRL 556
KLG G FG V +G+ G + +AVK L ++F+ E ++ +L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS-----LLDWPKRFNIIKGISRGLLYLH 611
G V M++ E P SL L L D+ + I+ G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD---QAATKRLVGTYGYMSP 668
R IHRDL A NILL D KI DFGL R N+D ++ + + +P
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAP 169
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVS 694
E FS SDV+ FGV L E+ +
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRLSKASGQG-QEEFMNEVMVISNL 548
N Q LG+G FG V+ K + +E + VK L K + Q EF E+ + L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKG 602
H+N+VRLLG C E E + +I EY L FL + + L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
I+ G+ +L S R +HRDL A N L+ K+S L++ N + + +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY-NSEYYKLRNALIP 181
Query: 663 YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+++PE E FS KSDV+SFGVL+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 15/211 (7%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLV 554
F L +G+G FG VYK + Q +A+K + + + E + E+ +S + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+ G ++ + +I EY S L + LD I++ + GL YLH +
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSPEYAM 672
IHRD+KA+NILL ++ + K++DFG++ G +KR VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 673 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703
+ + EK+D++S G+ +E+ G S H
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)
Query: 503 LGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
+G G FG V++G L+ G++ +A+K L + Q ++F++E ++ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G + + M+I EYM N +LD +L D + + +++GI+ G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG---TYGYMSPEYAMEG 674
+HRDL A NIL++ +L K+SDFGL+R+ D T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 675 RFSEKSDVFSFGVLLLEIVS 694
+F+ SDV+SFG+++ E++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 21/217 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
+N L +LG+G FG V+ + QD +AVK L AS +++F E +++NL
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----------FDPQRQSLLDWPKRFN 598
QH ++V+ G CVE + ++++EYM + L+ FL + R + L + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATK 657
I + I+ G++YL + +HRDL N L+ ++L KI DFG++R ++ + +
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
++ +M PE M +F+ +SDV+S GV+L EI +
Sbjct: 182 TMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 19/199 (9%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
+LG G FG V+ GK + ++A+K +++ + +E+F+ E V+ L H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
+++ ++ E+M N L ++L QRQ L ++ + + G+ YL R+S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 622 DLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG------YMSPEYAMEGR 675
DL A N L+ K+SDFG+ R ++ + G + PE +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEVFNFSK 177
Query: 676 FSEKSDVFSFGVLLLEIVS 694
+S KSDV+SFGVL+ E+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 84/286 (29%), Positives = 140/286 (48%), Gaps = 46/286 (16%)
Query: 503 LGQGGFGPVYKG--KLQDGQEI--AVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
+G G FG V G KL +EI A+K L + Q +F++E ++ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G + + M++ EYM N SLD+FL Q + + +++GI+ G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMG 126
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG------YMSPEYA 671
+HRDL A NIL++ +L K+SDFGL+R+ + + A T R G + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731
+F+ SDV+S+G+++ E++S Y E W++ N +VI +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS-------YGER-------PYWEMSN-QDVIKAI---- 222
Query: 732 SESGFKMEIIRCVNVGLL-----CVQEFVKDRPNMPTVVSMLNSEI 772
E G+++ L C Q+ +RP +VS+L+ I
Sbjct: 223 -EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 34/221 (15%)
Query: 497 FQLANKLGQGGFGPVYKGKL--QDG--QEIAVKRLSKASGQGQ---EEFMNEVMVISNLQ 549
+L LG+G FG V +G+L DG ++AVK + K EEF++E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 550 HRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK-- 601
H N+++L+G C E M+I +M + L SFL L P++ +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLL 116
Query: 602 ----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN---QDQ 653
I+ G+ YL S IHRDL A N +L +D+ ++DFGL++ I+ G+ Q +
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
A K V +++ E + ++ KSDV++FGV + EI +
Sbjct: 174 IA-KMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 9e-25
Identities = 70/229 (30%), Positives = 112/229 (48%), Gaps = 35/229 (15%)
Query: 496 NFQLANKLGQGGFGPVYKGK------LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNL 548
N L LG+G FG V K +AVK L + + + + ++E ++ +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPK 595
H ++++L G C + +LI EY SL SFL + ++ S LD P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 596 RFNIIKG--------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
+ G ISRG+ YL + ++++HRDL A N+L+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 648 GGNQDQAATKRLVG--TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
++ + KR G +M+ E + ++ +SDV+SFGVLL EIV+
Sbjct: 178 --YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 503 LGQGGFGPVYKGKL-QDGQE---IAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
+G G FG V +G+L G+ +A+K L + Q +F++E ++ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G + M+I E+M N +LDSFL Q + +++GI+ G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGN-QDQAATKRLVGTYG--YMSPEYAMEG 674
+HRDL A NIL++ +L K+SDFGL+R + D T L G + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 675 RFSEKSDVFSFGVLLLEIVS 694
+F+ SDV+S+G+++ E++S
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 24/205 (11%)
Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQHRNLVRL 556
KLG+G +G VYK + + G+ +A+K++ +E + E+ ++ L+H N+V+L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS----RGLLYLHR 612
L + L++EY + L +L N+IK I RGL Y H
Sbjct: 64 LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSP------NLIKSIMYQLLRGLAYCHS 116
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
RI+HRDLK NIL++ D K++DFGLAR F G + T +V T Y +PE +
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171
Query: 673 EGRFSEKS-DVFSFGVLLLEIVSGR 696
+ + D++S G + E+++G+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 42/272 (15%)
Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLG 558
+LG G G V K + G+ +AVK + Q++ + E+ ++ +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDSRL 616
+ + EYM SLD L ++ P+R I + +GL YLH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
+IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 677 SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND--NNVIDLVD------ 728
S KSD++S G+ L+E+ +GR + + ND + + +L+
Sbjct: 177 SVKSDIWSLGLSLIELATGR----------------FPYPPENDPPDGIFELLQYIVNEP 220
Query: 729 -PLISESGFKMEIIRCVNVGLLCVQEFVKDRP 759
P + F + VN LC+ + ++RP
Sbjct: 221 PPRLPSGKFSPDFQDFVN---LCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/210 (30%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEE---------FMNEVMVISNLQHRN 552
+G G FG VY G G+ +AVK++ S + E+ ++ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+V+ LG ++ + + EY+P S+ + L + ++L+ N ++ I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR----LVGTYGYM 666
H +R IIHRD+K +NIL+D+ KISDFG+++ N T L G+ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+PE + ++ K+D++S G L++E+++G+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
+++ ++G+G G V+K K + G+ +A+K+ L + G + + E+ + QH
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL---- 608
+V+LL +L+ EYMP+ L L D +R P +K R LL
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEER------PLPEAQVKSYMRMLLKGVA 113
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
Y+H I+HRDLK +N+L+ D KI+DFGLAR+F + + + + V T Y +P
Sbjct: 114 YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP 169
Query: 669 EYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
E R + D+++ G + E+++G
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/214 (34%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 502 KLGQGGFGPVYKGKL-----QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVR 555
+LG+ FG +YKG L Q +A+K L + Q EF E +++ L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLF--------------DPQRQSLLDWPKRFNIIK 601
LLG + + +++EY+ L FL D +S LD +I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLV 660
I+ G+ YL S +H+DL A NIL+ + L+ KISD GL+R I+ + + K L+
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M PE M G+FS SD++SFGV+L EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 25/212 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
+F++ KLG+G +G VYK K L D Q A+K L S + +E+ +NE+ +++++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 553 LVR-----LLGC--CVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGIS 604
++ L G C+ + EY P L + +++ L+ + + I +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
RGL LH +I+HRDLK++NILL + KI D G++++ N K +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPH 166
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
YM+PE +S KSD++S G LL E+ +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG+GGFG V +++ G+ A K+L K +G++ +NE ++ + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
+++ L+ M L +++ + + I GL +LH + RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
++RDLK N+LLDD N +ISD GLA + K GT GYM+PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 679 KSDVFSFGVLLLEIVSGR 696
D F+ G L E+++GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 65/202 (32%), Positives = 117/202 (57%), Gaps = 20/202 (9%)
Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
LG G FG VYKG + +G+ + A+K L++ +G + EFM+E ++++++ H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
LG C+ L+ + MP+ L ++ + + Q LL+W + I++G++YL
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
R++HRDL A N+L+ + KI+DFGLAR+ G++ + +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 673 EGRFSEKSDVFSFGVLLLEIVS 694
+F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKR-----LSKASGQGQEEFMNEVMVISNL 548
N++ LGQG FG VY D G+E+AVK+ S + + E+ ++ NL
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
QH +V+ GC + E + EYMP S+ L +L + R + I G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVE 118
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYMS 667
YLH + I+HRD+K +NIL D N K+ DFG + R+ K + GT +MS
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVS 694
PE + K+DV+S G ++E+++
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 63/220 (28%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISNLQ 549
NF++ K+G+G F VYK L DG+ +A+K++ + +++ + E+ ++ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLL 608
H N+++ L +E E ++ E L + ++Q L+ + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
++H S+ RI+HRD+K +N+ + K+ D GL R F + A LVGT YMSP
Sbjct: 121 HMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
E E ++ KSD++S G LL E+ + + + FY ++ L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
N + +++ +LG G FG VYK + + G A K + S + E+FM E+ ++S +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V L + ++ E+ +LDS + + +R L P+ + + + L +L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSP 668
H ++IHRDLKA NILL D + K++DFG++ + Q KR +GT +M+P
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAP 172
Query: 669 EYAMEGRFSE-----KSDVFSFGVLLLEIVSGR 696
E F + K+D++S G+ L+E+
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 66/223 (29%), Positives = 114/223 (51%), Gaps = 24/223 (10%)
Query: 499 LANKLGQGGFGPVYKGK------LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
L +LG+G FG V+ + +D +AVK L + +++F E +++NLQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR-----------FNI 599
+V+ G C + + ++++EYM + L+ FL P L+D R +I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKR 658
I+ G++YL + +HRDL N L+ +L KI DFG++R ++ + +
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 701
++ +M PE M +F+ +SDV+SFGV+L EI + K F
Sbjct: 186 MLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCV 561
LG+G FG V+KG L+D +AVK + Q + +F++E ++ H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
+R+ ++ E +P SFL + + +F + + G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKN---CIHR 117
Query: 622 DLKASNILLDDDLNPKISDFGLARIF-GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKS 680
DL A N L+ ++ KISDFG++R G + K++ + +PE GR+S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 681 DVFSFGVLLLEIVS 694
DV+S+G+LL E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 32/227 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE---------------IAVKRL-SKASGQGQEEF 538
+L KLG+G FG V+ + + E +AVK L + + + +F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 539 MNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
+ E+ ++S L++ N++RLLG CV + +I EYM N L+ FL QR+ + N
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANN 122
Query: 599 I-----------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
I I+ G+ YL + L +HRDL N L+ + KI+DFG++R
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
R V +M+ E + G+F+ SDV++FGV L E+ +
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
+G+G FG VY G L DGQ+I AVK L++ + + E+F+ E +++ + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 558 GCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
G C+ E + +++ YM + L +F+ + F + +++G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN----QDQAATKRLVGTYGYMSPEYA 671
+ +HRDL A N +LD+ K++DFGLAR I+ + K V +M+ E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESL 174
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
+F+ KSDV+SFGVLL E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG-QEEFMNEVMVISNLQHRN 552
++LG+G G V K +L++ I A+K ++ Q++ + E+ + + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 553 LVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRF-NIIKGISRGLLY 609
+V+ G ++ + + EY SLDS +++ K I + + +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LH SR +IIHRD+K SNILL K+ DFG++ A T GT YM+PE
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPE 173
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+S SDV+S G+ LLE+ R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQHRNL 553
+Q K+G+G +G VYK + G+ +A+K++ E+ ++ L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
++LL + + L++E+M + L + D RQ L + + + +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE +
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLG 172
Query: 674 GRF-SEKSDVFSFGVLLLEIVSGR 696
+ S D++S G + E++S R
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 62/207 (29%), Positives = 113/207 (54%), Gaps = 19/207 (9%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEFM-NEVMVISNLQ---H 550
++ ++G+G +G VYK + L G+ +A+K++ S +G E+ ++ L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 551 RNLVRLLGCC----VEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
N+VRLL C +RE + L++E++ ++ L ++L + L ++++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
G+ +LH RI+HRDLK NIL+ D KI+DFGLARI+ + A +V T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWY 172
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEI 692
+PE ++ ++ D++S G + E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 71/217 (32%), Positives = 116/217 (53%), Gaps = 19/217 (8%)
Query: 493 ATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSK-ASGQGQEEFMNEVMVI 545
A ++ +LGQG FG VY KG ++D E +A+K +++ AS + + EF+NE V+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF----DPQRQSLLDWP---KRFN 598
++VRLLG + + ++I E M L S+L + + + P K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATK 657
+ I+ G+ YL+ + + +HRDL A N ++ +D KI DFG+ R I+ + + K
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
L+ +MSPE +G F+ SDV+SFGV+L EI +
Sbjct: 181 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 70/201 (34%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 503 LGQGGFGPV----YKGKLQD-GQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNLVRL 556
LG+G FG V Y G+ +AVK L + GQ + E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 557 LGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
GCC E+ LI EY+P SL +L P+ + L+ + + I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYGYMSPEYAME 673
IHRDL A N+LLD+D KI DFGLA+ + G++ + + + E E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 674 GRFSEKSDVFSFGVLLLEIVS 694
+FS SDV+SFGV L E+++
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-22
Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 37/227 (16%)
Query: 502 KLGQGGFGPVYKGKLQDGQE-----------------IAVKRL-SKASGQGQEEFMNEVM 543
KLG+G FG V+ ++ + Q+ +AVK L A+ + +F+ EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------------FDPQRQS 589
++S L+ N++RLLG CV+ + +I EYM N L+ FL P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 590 LL--DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
L + ++ I+ G+ YL S L +HRDL N L+ ++L KI+DFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
R V +M+ E + G+F+ SDV++FGV L EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKR--LSKASGQGQEEFM--------NEVMVISNLQHR 551
+G+G +G VY + G+ +AVK+ L + +E+ + +L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 552 NLVRLLGCCVEREENML-IY-EYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIKGIS 604
N+V+ LG E E L I+ EY+P S+ S L F+ Q + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--------TEQVL 118
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
GL YLH I+HRDLKA N+L+D D KISDFG+++ D + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 665 YMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRK 697
+M+PE +S K D++S G ++LE+ +GR+
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQHRN 552
++ +G+G FG V+ + + Q++ + + ++E NE V+ L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
++ +E + M++ EY P +L ++ + SLLD I+ + LL LH
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLD---EDTILHFFVQILLALHH 116
Query: 613 DSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
I+HRDLK NILLD KI DFG+++I ++ +A T +VGT Y+SPE
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELC 173
Query: 672 MEGR-FSEKSDVFSFGVLLLEIVS 694
EG+ +++KSD+++ G +L E+ S
Sbjct: 174 -EGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 59/195 (30%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+GQG G VY + GQE+A+K+++ +E +NE++V+ +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ +E ++ EY+ SL D ++ +D + + + + L +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKS 680
RD+K+ NILL D + K++DFG Q + +T +VGT +M+PE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 681 DVFSFGVLLLEIVSG 695
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-22
Identities = 33/77 (42%), Positives = 49/77 (63%), Gaps = 2/77 (2%)
Query: 336 EGKQDGFFKLETMKVPYFAERSSA-NEDKCKDQCSNNCSCKAYAY-EIGVGCMIWTHNLI 393
+G DGF KL +K+P A +A + ++C++ C +NCSC AYAY GC++W L
Sbjct: 8 DGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLN 67
Query: 394 DIRKLPSGGTNLYIRVA 410
++R L SGG LY+R+A
Sbjct: 68 NLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 495 NNFQLANKLGQGGFGPVYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
NN LG G FG V + K ++AVK L A +E M+E+ ++S+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
L H N+V LLG C ++I EY L +FL +R+S L + +++G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYG 664
+ +L + IHRDL A N+LL KI DFGLAR + N RL
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVK 208
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE ++ +SDV+S+G+LL EI S
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
LG+G +G VY + Q IA+K + + + + E+ + S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 562 EREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
E + E +P SL + L Q+++ + K+ I GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEGLKYLH---D 126
Query: 616 LRIIHRDLKASNILLDDDLNP-KISDFGLA-RIFGGNQDQAATKRLVGTYGYMSPEYAME 673
+I+HRD+K N+L++ KISDFG + R+ G N T+ GT YM+PE +
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEVIDK 183
Query: 674 GR--FSEKSDVFSFGVLLLEIVSGR 696
G + +D++S G ++E+ +G+
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 64/227 (28%), Positives = 113/227 (49%), Gaps = 31/227 (13%)
Query: 493 ATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEF----MNEVMVISN 547
++++ KLG+G FG VYK +++ G+ +A+K++ + + + F + E+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 548 LQHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
L+H N+V L+ VER + ++ YM + L L +P + L +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK--LTESQIKCY 120
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ-----A 654
+ + G+ YLH + I+HRD+KA+NIL+D+ KI+DFGLAR + G
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 655 ATKR----LVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
R LV T Y PE + E R++ D++ G + E+ + R
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 59/218 (27%), Positives = 112/218 (51%), Gaps = 30/218 (13%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS----KASGQGQ--EEFMNEVMVISNL 548
+ +LG G F Y+ + ++ G +AVK+++ +S Q + E E+ +++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRG 606
H +++R+LG E L E+M S+ L + +++++ N + + RG
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLA-----RIFGGNQDQAATKR 658
L YLH + +IIHRD+K +N+L+D L +I+DFG A + G + Q +
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---Q 167
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
L+GT +M+PE ++ DV+S G +++E+ + +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 28/220 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL-QDG--QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
N+ + + +G+G FG V K ++ +DG + A+KR+ + AS +F E+ V+ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDP------QRQSLLDWPKR 596
H N++ LLG C R L EY P+ +L FL DP S L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
+ ++RG+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R +
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178
Query: 657 KRLVGTYG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
K+ +G +M+ E ++ SDV+S+GVLL EIVS
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 54/197 (27%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 501 NKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
K+G+G G V G+++AVK++ Q +E NEV+++ + QH N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
+ +E ++ E++ +L D + ++ + + + + L +LH +I
Sbjct: 85 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 620 HRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
HRD+K+ +ILL D K+SDFG A++ +++ K LVGT +M+PE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 679 KSDVFSFGVLLLEIVSG 695
+ D++S G++++E+V G
Sbjct: 195 EVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 499 LANKLGQGGFGPVYKGKLQD---GQ---EIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
L +LGQG FG VY+G +D G+ +AVK +++ AS + + EF+NE V+
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLF-------DPQRQSLLDWPKRFNIIKGIS 604
++VRLLG + + +++ E M + L S+L + + + + I+
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTY 663
G+ YL+ + +HRDL A N ++ D KI DFG+ R I+ + + K L+
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
M+PE +G F+ SD++SFGV+L EI S
Sbjct: 187 W-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 33/219 (15%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDG-----QEIAVKRLSKASGQGQ-EEFMNEVMVISNLQH 550
L++ L +G FG ++ G L D +E+ VK + + + Q + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 551 RNLVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK------GI 603
+N++ +L C+E E ++Y YM +L FL R + P+ + + I
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALSTQQLVHMAIQI 126
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IF-------GGNQDQAA 655
+ G+ YLH+ +IH+D+ A N ++D++L KI+D L+R +F G N+++
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+ E + +S SDV+SFGVLL E+++
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 499 LANKLGQGGFGPVYKG--KLQDGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQHRNL 553
L +G+G FG VY+G + ++I AVK S +E+F+ E ++ H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
V+L+G E ++ E P L S+L + LD +S L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEYA 671
R +HRD+ A N+L+ K+ DFGL+R +D++ K G +M+PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPESI 180
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
RF+ SDV+ FGV + EI+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 502 KLGQGGFGPVYKGKLQDGQE-----------------IAVKRL-SKASGQGQEEFMNEVM 543
KLG+G FG V+ + + ++ +AVK L A+ + +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSL------LDWPK 595
++S L+ N++RLL C+ + +I EYM N L+ FL +PQ + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ I+ G+ YL S L +HRDL N L+ + KI+DFG++R
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
R V +MS E + G+F+ SDV++FGV L EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 22/205 (10%)
Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-----FMNEVMVISNLQHRNLVR 555
K+G+G +G VYKG+ + GQ +A+K++ S +EE + E+ ++ LQH N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVC 63
Query: 556 LLGCCVEREENMLIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
L ++ LI+E++ K LDS + L + I++GI L+ H
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCHS 119
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
R++HRDLK N+L+D+ K++DFGLAR F G + T +V T Y +PE +
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 673 EG-RFSEKSDVFSFGVLLLEIVSGR 696
R+S D++S G + E+ + +
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 57/205 (27%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQH---R 551
+Q +G+G +G VY+GK + G+ +A+K ++ + + EV ++S L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+ + G ++ +I EY S+ + + + + II+ + L Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+ +IHRD+KA+NIL+ + N K+ DFG+A + N + +T VGT +M+PE
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVI 173
Query: 672 MEGR-FSEKSDVFSFGVLLLEIVSG 695
EG+ + K+D++S G+ + E+ +G
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 502 KLGQGGFGPVYKGKLQDGQEI-----------------AVKRLSK-ASGQGQEEFMNEVM 543
KLG+G FG V+ + Q+ AVK L AS +E+F+ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLLDWPK 595
++S L N+ RLLG C +I EYM N L+ FL L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ I+ G+ YL L +HRDL N L+ + KI+DFG++R +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
R +M+ E + G+F+ KSDV++FGV L EI++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLS------KASGQGQEEFMNEVMVISNLQH 550
+ LG+G +G VY G GQ IAVK++ A+ + E+ EV ++ +L+H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V+ LG C++ + E++P S+ S L R L P K I G+ YL
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR---IFGGNQDQAAT-KRLVGTYGYM 666
H + ++HRD+K +N++L + K+ DFG AR G + + K + GT +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+PE E + KSD++S G + E+ +G+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 61/204 (29%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+++ +LG G FG VYK K ++ G A K + S + E++M E+ +++ H +V+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
LLG + ++ E+ P ++D+ + + R L P+ I + + L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS--- 128
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSPEYAM- 672
++IIHRDLKA N+LL D + K++DFG++ + +R +GT +M+PE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 673 ----EGRFSEKSDVFSFGVLLLEI 692
+ + K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 503 LGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRL 556
LG+G FG V + G+++AVK L SG + E+ ++ NL H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 557 LGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
G C E N LI E++P+ SL +L P+ ++ ++ ++ I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK-RLVGTYGYMSPEYAME 673
R + +HRDL A N+L++ + KI DFGL + +++ K L + +PE ++
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 674 GRFSEKSDVFSFGVLLLEIVS 694
+F SDV+SFGV L E+++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 41/214 (19%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
++L ++G G +G VYK + + G+ +A+K + G E E+ ++ +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSF-------LFDPQ-----RQSLLDWPKRFNIIKGI 603
G + R++ ++ EY SL L + Q R++L
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL------------- 111
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKR--LV 660
+GL YLH IHRD+K +NILL +D + K++DFG+ A++ KR +
Sbjct: 112 -KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFI 162
Query: 661 GTYGYMSPEYA---MEGRFSEKSDVFSFGVLLLE 691
GT +M+PE A +G + K D+++ G+ +E
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.3 bits (231), Expect = 1e-20
Identities = 57/195 (29%), Positives = 107/195 (54%), Gaps = 10/195 (5%)
Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+GQG G V+ + GQE+A+K+++ +E +NE++V+ L++ N+V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ +E ++ EY+ SL D ++ +D + + + + L +LH + ++IH
Sbjct: 86 LVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKS 680
RD+K+ N+LL D + K++DFG Q + +T +VGT +M+PE + K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 681 DVFSFGVLLLEIVSG 695
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 1e-20
Identities = 58/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+GQG G VY + GQE+A+K+++ +E +NE++V+ ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ +E ++ EY+ SL D ++ +D + + + + L +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKS 680
RD+K+ NILL D + K++DFG Q + +T +VGT +M+PE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 681 DVFSFGVLLLEIVSG 695
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 489 ELANATNNFQLANKLGQGGFGPVYKG--KLQDGQE--IAVKRL-SKASGQGQEEFMNEVM 543
EL N + ++ LG G FG + +G KL +E +A+ L + S + + F+ E +
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
+ H N+VRL G M++ EYM N +LDSFL + Q L + ++ G+
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGL 116
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
+ G+ YL S + +H+ L A +L++ DL KIS F +D++ + T
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEA--IYTTM 166
Query: 664 G------YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +PE FS SDV+SFG+++ E++S
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 55/199 (27%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 503 LGQGGFGP--VYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG+G FG +Y+ + +D + K L++ S + + + +NE++++S LQH N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
++ ++ EY +L + Q+ L + + I + Y+H+ I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
+HRD+K NI L K+ DFG+++I G A T +VGT YMSPE +++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNF 180
Query: 679 KSDVFSFGVLLLEIVSGRK 697
KSD+++ G +L E+++ ++
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 62/208 (29%), Positives = 116/208 (55%), Gaps = 20/208 (9%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNLQH 550
F+ LG G FG VYKG + +G+++ A+K L +A S + +E ++E V++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR----QSLLDWPKRFNIIKGISRG 606
++ RLLG C+ LI + MP L ++ + + Q LL+W + I++G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
+ YL R++HRDL A N+L+ + KI+DFGLA++ G ++ + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ E + ++ +SDV+S+GV + E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 41/219 (18%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEE-----FMNEVMVISNL 548
+Q K+G+G +G VYK + G+ +A+K RL + ++E + E+ ++ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKEL 55
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMP---NKSLDS---FLFDPQRQSLLDWPKRFNIIKG 602
H N+VRLL + L++E++ K +DS DP +IK
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP------------LIKS 103
Query: 603 ----ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
+ +G+ Y H S R++HRDLK N+L+D + K++DFGLAR FG + T
Sbjct: 104 YLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHE 159
Query: 659 LVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
+V T Y +PE + R +S D++S G + E+V+ R
Sbjct: 160 VV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 59/196 (30%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+G+G G V + + G+++AVK + Q +E NEV+++ + QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ EE ++ E++ +L + Q+ L+ + + + + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEK 679
RD+K+ +ILL D K+SDFG A+I ++D K LVGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 680 SDVFSFGVLLLEIVSG 695
D++S G++++E+V G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 32/221 (14%)
Query: 499 LANKLGQGGFGPVYKGKLQD------GQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QH 550
L LG+G FG V K + +AVK L A+ + + ++E+ ++ + +H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQ---SLLDWPKRFNIIK---- 601
+N++ LLG C + ++ EY + +L FL P + P + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 602 ----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD---QA 654
++RG+ +L S+ + IHRDL A N+L+ +D KI+DFGLAR + D +
Sbjct: 136 SFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI-HHIDYYRKT 191
Query: 655 ATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVS 694
RL +M+PE A+ R ++ +SDV+SFGVLL EI +
Sbjct: 192 TNGRL--PVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 24/204 (11%)
Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
LG G FG V+KG + +G I A+K + SG Q +E + ++ + +L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGLLYL 610
LG C L+ + P SL + DPQR LL+W + I++G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR--LLNWCVQ------IAKGMYYL 125
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
R++HR+L A NILL D +I+DFG+A + + + +M+ E
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVS 694
+ GR++ +SDV+S+GV + E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 502 KLGQGGFGPVYKG--KLQDGQ-EIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLL 557
+LG G FG V KG K++ Q ++A+K L + + ++E M E ++ L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK---GISRGLLYLHRDS 614
G C E E ML+ E L+ FL + + + N+++ +S G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMSPEYAM 672
+HRDL A N+LL + KISDFGL++ G + D R G + + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECIN 171
Query: 673 EGRFSEKSDVFSFGVLLLEIVS-GRK 697
+FS +SDV+S+G+ + E S G+K
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVRLLG 558
+ +G +G V+ K G A+K + KA ++ + E ++S Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 559 CCVEREENM-LIYEYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+ ++N+ L+ EY+P L S L D D + I I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLA------RIFGGNQDQAATKRLVGTYGYM 666
IIHRDLK NIL+D + + K++DFGL+ R N D+ KR+VGT Y+
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
+PE + S+ D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+GQG G VY + GQE+A+++++ +E +NE++V+ ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ +E ++ EY+ SL D ++ +D + + + + L +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEK 679
RD+K+ NILL D + K++DFG A+I +Q+ +VGT +M+PE + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 680 SDVFSFGVLLLEIVSG 695
D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 63/221 (28%), Positives = 113/221 (51%), Gaps = 18/221 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISNLQHR 551
NFQ+ K+G+G F VY+ L D + +A+K++ + +++ + E+ ++ L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR--FNIIKGISRGL 607
N+++ L +E E ++ E L + F Q++ + P+R + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI---PERTVWKYFVQLCSAV 119
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
++H SR R++HRD+K +N+ + K+ D GL R F + A LVGT YMS
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 174
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
PE E ++ KSD++S G LL E+ + + FY ++ L
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 62/205 (30%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
NFQ K+G+G +G VYK + G+ +A+K RL + + E+ ++ L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+LL + L++E++ ++ L F+ D S + P + + + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
R++HRDLK N+L++ + K++DFGLAR FG + T +V T Y +PE +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEILL 173
Query: 673 EGRF-SEKSDVFSFGVLLLEIVSGR 696
++ S D++S G + E+V+ R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
F ++G+G FG VYKG +E+ A+K + + + E+ E+ V+S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
R G ++ + +I EY+ S LD P ++ + I++ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
R IHRD+KA+N+LL + + K++DFG+A Q + T VGT +M+PE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 674 GRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703
+ K+D++S G+ +E+ G S H
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 31/206 (15%)
Query: 501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVISNLQHRNLV 554
KLG+G + VYK + + G+ +A+K++ + ++ +N E+ ++ L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 555 RLLGCCVEREENMLIYEYMP--------NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
LL + L++E+M +KS+ L +S + RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKS---------YMLMTLRG 114
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L YLH + I+HRDLK +N+L+ D K++DFGLAR F G+ ++ T ++V T Y
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYR 169
Query: 667 SPEYAMEGR-FSEKSDVFSFGVLLLE 691
+PE R + D++S G + E
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG GGFG V K++ + A+K + K QE +E ++ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
+++ ++ EY L + L D R ++ RF I + YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHN---RGI 114
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
I+RDLK N+LLD + K+ DFG A+ Q T GT Y++PE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF 171
Query: 679 KSDVFSFGVLLLEIVSGR 696
D +S G+LL E+++GR
Sbjct: 172 SVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
F ++G G FG VY + ++ + +A+K++S + Q E++ + EV + L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+ GC + L+ EY + D + + ++ L + + I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE--Y 670
R IHRD+KA NILL + K++DFG A + + VGT +M+PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVIL 184
Query: 671 AM-EGRFSEKSDVFSFGVLLLEI 692
AM EG++ K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 69/230 (30%), Positives = 119/230 (51%), Gaps = 34/230 (14%)
Query: 499 LANKLGQGGFGPVYKGKL-QDGQ--EIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
L LG+G FG V +G+L QD ++AVK + A + E+F++E + + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 554 VRLLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF------NIIK 601
+RL+G C++ E+ ++I +M + L SFL L D P+ +
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMT 119
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGN-QDQAATKRL 659
I+ G+ YL S IHRDL A N +L++++N ++DFGL+ +I+ G+ Q ++
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-------GRKNTSFY 702
+++ E + ++ KSDV+SFGV + EI + G +N+ Y
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 73/281 (25%), Positives = 133/281 (47%), Gaps = 31/281 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISNLQHR 551
NF++ K+G+G F VY+ L DG +A+K++ + + + + E+ ++ L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR--FNIIKGISRGL 607
N+++ +E E ++ E L + F Q++ + P++ + + L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI---PEKTVWKYFVQLCSAL 119
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
++H SR R++HRD+K +N+ + K+ D GL R F + A LVGT YMS
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 174
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727
PE E ++ KSD++S G LL E+ + + FY ++ L L I+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNLYSLC---------KKIEQC 223
Query: 728 D-PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767
D P + + E+ + VN +C+ + RP++ V +
Sbjct: 224 DYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 70/214 (32%), Positives = 115/214 (53%), Gaps = 26/214 (12%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHR 551
+++ KLG+G +G V+K + + +A+K++ A + Q F E+M + L H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHP 67
Query: 552 NLVRLLGCCVEREENM----LIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRG 606
N+V+LL V + EN L++EYM ++ L R ++L D KR+ I+ + +
Sbjct: 68 NIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF---GGNQDQAATKRLVGTY 663
L Y+H S +IHRDLK SNILL+ D K++DFGLAR N + V T
Sbjct: 120 LKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 664 GYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
Y +PE + R+++ D++S G +L E++ G+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 62/204 (30%), Positives = 111/204 (54%), Gaps = 9/204 (4%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNL 553
NF+ KLG+G + VYKG+ + EI A+K + + +G + E+ ++ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
VRL + ML++EYM +K L ++ + LD + + +G+ + H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
R++HRDLK N+L++ K++DFGLAR FG + + + V T Y +P+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE--VVTLWYRAPDVLLG 174
Query: 674 GR-FSEKSDVFSFGVLLLEIVSGR 696
R +S D++S G ++ E+++GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 499 LANKLGQGGFGPVY---KGKLQDGQEIAV-KRLSKASGQGQEEFMN--EVMVISNLQHRN 552
L +LG+G FG VY K + + V K + E E ++S L H
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLH 611
+V+ +ER+ +I EY + LD L + L + + + + LL +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ---VCEWFIQLLLGVH 120
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+ RI+HRDLKA NI L ++L KI DFG++R+ G+ D A T GT YMSPE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177
Query: 672 MEGRFSEKSDVFSFGVLLLEI 692
+ KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 71/212 (33%), Positives = 107/212 (50%), Gaps = 28/212 (13%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNL-QHRNLVRLL 557
+G+G FG V + ++ DG ++ A+K L + AS +F E+ V+ L H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 558 GCCVEREENMLIYEYMPNKSLDSFL-------FDPQ------RQSLLDWPKRFNIIKGIS 604
G C R + EY P +L FL DP S L + ++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
G+ YL S + IHRDL A N+L+ ++L KI+DFGL+R ++ K+ +G
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181
Query: 665 --YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+ E ++ KSDV+SFGVLL EIVS
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 34/217 (15%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
F+ N++G+G +G VY+ + EI A+K R+ + E+ ++ NL+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDS-FL-FDPQRQ---SLLD-WPKRFNI--IKGIS 604
+V L E + K LDS FL + Q SLLD P F+ +K +
Sbjct: 68 IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 605 ----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
RGL YLH + IIHRDLK SN+LL D KI+DFGLAR + G + T ++V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV 170
Query: 661 GTYGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 696
T Y +PE + + D+++ G +L E+++ +
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 62/202 (30%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRL 556
LG G FG VYKG + DG+ + A+K L + S + +E ++E V++ + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
LG C+ L+ + MP L ++ + + Q LL+W + I++G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
+R++HRDL A N+L+ + KI+DFGLAR+ ++ + +M+ E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 673 EGRFSEKSDVFSFGVLLLEIVS 694
RF+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
F ++G+G FG V+KG Q++ A+K + + + E+ E+ V+S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+ G ++ + +I EY+ S D R D + ++K I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
+ IHRD+KA+N+LL + + K++DFG+A Q + T VGT +M+PE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703
+ K+D++S G+ +E+ G S H
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 19/198 (9%)
Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLL 557
++G G FG VY + +++ + +A+K++S + Q E++ + EV + L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
GC + L+ EY + D L + ++ L + + + G +GL YLH +
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEV-EIAAVTHGALQGLAYLHSHN--- 135
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM---EG 674
+IHRD+KA NILL + K+ DFG A I A VGT +M+PE + EG
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189
Query: 675 RFSEKSDVFSFGVLLLEI 692
++ K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDG-------QEIAVKRLS-----KASGQGQEEFMNEVM 543
+ + LG G FG VYK + ++ +EI V + + + + ++EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 544 VI-SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL-DSFLFDPQRQSLLDWPKRFNIIK 601
+I L+H N+VR +E + ++ + + L + F +++ + +NI
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+ L YLH++ R I+HRDL +NI+L +D I+DFGLA+ Q ++ +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
T Y PE + EK+DV++FG +L ++ +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 8e-19
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
F K+G+G FG V+KG Q++ A+K + + + E+ E+ V+S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+ G ++ + +I EY+ S LD L +P LD + I++ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSPEYA 671
+ IHRD+KA+N+LL + K++DFG+A G KR VGT +M+PE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703
+ + K+D++S G+ +E+ G S H
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 503 LGQGGFGPVY------KGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
LG+GGFG V GKL +++ KRL K +G E M E +++ + R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSR 615
+ + L+ M L +++ ++ P+ I GL +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
RII+RDLK N+LLD+D N +ISD GLA Q + TK GT G+M+PE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 676 FSEKSDVFSFGVLLLEIVSGR 696
+ D F+ GV L E+++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 502 KLGQGGFGPVYKG--KLQDGQE-IAVKRLSKASGQG--QEEFMNEVMVISNLQHRNLVRL 556
+LG G FG V KG K++ ++ +AVK L + ++E + E V+ L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
+G C E E ML+ E L+ FL Q+ + ++ +S G+ YL +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG-----YMSPEYA 671
+HRDL A N+LL KISDFGL++ G +++ K T+G + +PE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECM 170
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
+FS KSDV+SFGVL+ E S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 60/209 (28%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAV-KRLSKASGQGQEEFMNEVMVISNLQH 550
N +++ +LG G FG VYK + ++ +A K + S + E++M E+ ++++ H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V+LL ++ E+ ++D+ + + +R L P+ + K L YL
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYL 119
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSP 668
H + +IIHRDLKA NIL D + K++DFG++ + +R +GT +M+P
Sbjct: 120 HEN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAP 172
Query: 669 EYAM-----EGRFSEKSDVFSFGVLLLEI 692
E M + + K+DV+S G+ L+E+
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 502 KLGQGGFGPVYKGKLQDGQE-IAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
K+G+G +G VYK + + E IA+K RL + + E+ ++ +QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG----ISRGLLYLHRDS 614
+ L++EY+ LD S D+ K +IK I RG+ Y H S
Sbjct: 69 VVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--S 120
Query: 615 RLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
R++HRDLK N+L+D N K++DFGLAR F G + T +V T Y +PE +
Sbjct: 121 H-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 674 GR-FSEKSDVFSFGVLLLEIVSGR 696
R +S D++S G + E+V+ +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQ-HRN 552
+++ +LG G FG VY + + G+ +A+K++ K EE MN EV + L H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+L E +E ++EYM +L + D ++ +II I +GL ++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
HRDLK N+L+ KI+DFGLAR + + V T Y +PE +
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILL 171
Query: 673 EGRF-SEKSDVFSFGVLLLEIVSGR 696
S D+++ G ++ E+ + R
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL- 548
L + T F+L +G+G +G VYK + + ++ ++ +EE E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 549 QHRNLVRLLGC------CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN---- 598
H N+ G ++ L+ E S+ + + L KR
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWI 115
Query: 599 --IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
I++ RGL YLH + ++IHRD+K NILL + K+ DFG++ D
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLG 168
Query: 657 KR--LVGTYGYMSPE-----YAMEGRFSEKSDVFSFGVLLLEIVSG 695
+R +GT +M+PE + + +SDV+S G+ +E+ G
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 70/223 (31%), Positives = 114/223 (51%), Gaps = 38/223 (17%)
Query: 497 FQLANKLGQGGFGPVYKG--KLQDG--QEIAVKRLSKA---SGQGQEEFMNEVMVISNLQ 549
F L LG+G FG V + K +DG Q++AVK L KA S EEF+ E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 550 HRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFL---------FDPQRQSLLDWP 594
H N+++L+G + M+I +M + L +FL F Q+L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV--- 116
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN--Q 651
RF I I+ G+ YL S IHRDL A N +L++++ ++DFGL++ I+ G+ +
Sbjct: 117 -RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170
Query: 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
A+K V +++ E + ++ SDV++FGV + EI++
Sbjct: 171 QGCASKLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 51/286 (17%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRL-SKASGQGQEEFMNEVMVISNLQH-RNLVRLLGC 559
+G+G FG V K + G +AVKR+ S + Q+ + ++ V+ +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 560 CVEREENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDS 614
+ + E M + SLD F +++ + + P+ I + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLKEE- 126
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE-YAME 673
L+IIHRD+K SNILLD + N K+ DFG I G D A R G YM+PE
Sbjct: 127 -LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPS 182
Query: 674 GR--FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV---- 727
R + +SDV+S G+ L E+ +G+ + + W N+V D +
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGK----------------FPYPKW--NSVFDQLTQVV 224
Query: 728 --DPLI----SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767
DP I E F + +N LC+ + RP ++
Sbjct: 225 KGDPPILSNSEEREFSPSFVNFIN---LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 82/314 (26%), Positives = 135/314 (42%), Gaps = 62/314 (19%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
++ ++ +LG+G +G V K + + G +AVKR+ +A+ QE Q R L
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQE------------QKRLL 47
Query: 554 VRL-----LGCCVE---------REENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKR 596
+ L C RE ++ I + + SLD F ++D P+
Sbjct: 48 MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTI----PED 103
Query: 597 F--NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
I I + L YLH S+L +IHRD+K SN+L++ + K+ DFG I G D
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSV 158
Query: 655 ATKRLVGTYGYMSPEY---AMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFE-LT 709
A G YM+PE + + + KSDV+S G+ ++E+ +GR + F+ L
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK 218
Query: 710 LLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769
V++ P + F E VN C+++ K+RPN P ++
Sbjct: 219 ------------QVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQHPF 263
Query: 770 SEIKDLPAAKQPAF 783
E+ +F
Sbjct: 264 FELHLSKNTDVASF 277
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 71/212 (33%), Positives = 109/212 (51%), Gaps = 28/212 (13%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNL-QHRNLVRLL 557
+G+G FG V K +++ DG + A+KR+ + AS +F E+ V+ L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI-----SRGLLYLHR 612
G C R L EY P+ +L FL ++ +L+ F I S+ LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 613 D--------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
D S+ + IHRDL A NIL+ ++ KI+DFGL+R + K+ +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174
Query: 665 --YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+ E ++ SDV+S+GVLL EIVS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 75/254 (29%), Positives = 119/254 (46%), Gaps = 38/254 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEE-FMNEVMVISNLQH 550
++F+ LG G FG V + + + A+K LSKA Q E +NE ++ +++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR----- 605
LV L G + L+ EY+P L S L R+S RF ++R
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKS-----GRFPE--PVARFYAAQ 109
Query: 606 ---GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
L YLH L I++RDLK N+LLD D KI+DFG A+ G T L GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGT 161
Query: 663 YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLLG-YAWKL 717
Y++PE + + + D ++ G+L+ E+++G F+ + +E L G +
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY--PPFFDDNPIQIYEKILEGKVRFPS 219
Query: 718 WNDNNVIDLVDPLI 731
+ + DL+ L+
Sbjct: 220 FFSPDAKDLIRNLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
+++ K+G+G FG +Y K + D + +K L+K + +E EV++++ ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V E ++ EY L + + QR L + + IS GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 613 DSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+I+HRD+K+ NI L + + K+ DFG+AR + + A T VGT Y+SPE
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEIC 174
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
++ K+D++S G +L E+ +
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 68/225 (30%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 495 NNFQLANKLGQGGFGPVYK----GKLQDGQE----IAVKRLS-KASGQGQEEFMNEVMVI 545
+ L LG+G FG V + G + + +AVK L A+ + + ++E+ ++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
+ +H+N++ LLG C + +I EY +L FL FD + + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
+ + ++RG+ YL +SR R IHRDL A N+L+ +D KI+DFGLAR G +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHD 186
Query: 652 DQAATKRLVGTY--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
K G +M+PE + ++ +SDV+SFG+L+ EI +
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 39/213 (18%)
Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMN----EVMVISNLQHRNLVR 555
N++G G G VYK + G+ A+K + G ++ E+ ++ ++ H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 556 LLGCCVEREENMLIYEYMPNKSLDS-------FLFDPQRQSLLDWPKRFNIIKGISRGLL 608
E ++ E+M SL+ FL D RQ L G+
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--------------SGIA 182
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLHR I+HRD+K SN+L++ N KI+DFG++RI Q VGT YMSP
Sbjct: 183 YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSP 237
Query: 669 EYA----MEGRFSEKS-DVFSFGVLLLEIVSGR 696
E G + + D++S GV +LE GR
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
++G+G FG V+ G+L+ D +AVK + + +F+ E ++ H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
C +++ ++ E + +FL L + +++ + G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 620 HRDLKASNILLDDDLNPKISDFGLAR-------IFGGNQDQAATKRLVGTYGYMSPEYAM 672
HRDL A N L+ + KISDFG++R G Q K + +PE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-------WTAPEALN 169
Query: 673 EGRFSEKSDVFSFGVLLLEIVS 694
GR+S +SDV+SFG+LL E S
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 4e-18
Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 55/229 (24%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVMVIS 546
++L +G G +G V + G+++A+K++S F + E+ ++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLR 54
Query: 547 NLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDP-------QRQSLL 591
+L+H N++ LL + + S + F L + Q L
Sbjct: 55 HLRHENIIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT 101
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
D ++ + I RGL YLH + +IHRDLK SNIL++ + + KI DFGLAR G +
Sbjct: 102 DDHIQY-FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR--GVDP 155
Query: 652 DQAATKRL---VGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
D+ L V T Y +PE + R+++ D++S G + E+++ +
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 62/218 (28%), Positives = 114/218 (52%), Gaps = 29/218 (13%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF----MNEVMVISNLQHR 551
F + ++G+G +G VYK + +D G+ +A+K++ + + E F + E+ ++ L HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 552 NLVRLLGCCVEREENM----------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN--I 599
N+V L ++++ + L++EYM D L L+ + +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659
+K + GL Y H+ + L HRD+K SNILL++ K++DFGLAR++ + + T ++
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 660 VGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
+ T Y PE + E R+ DV+S G +L E+ + +
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
F ++G G FG VY + ++ + +A+K++S + Q E++ + EV + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+ GC + L+ EY + D L + ++ L + + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHS 143
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
+ +IHRD+KA NILL + K++DFG A I + VGT +M+PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 673 ---EGRFSEKSDVFSFGVLLLEI 692
EG++ K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 497 FQLANKLGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
F+ LG+GGFG V GK+ +++ KR+ K G+ +NE ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
R +V L ++ L+ M L ++ ++ + + I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H++ RI++RDLK NILLDD + +ISD GLA Q K VGT GYM+PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEV 172
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
R++ D ++ G LL E+++G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 501 NKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRL 556
+++G G FG VY E+ AVK++S + Q E++ + EV + L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
GC ++ L+ EY + D L + ++ L + + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHSHN-- 141
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM---E 673
+IHRD+KA NILL + K++DFG A + VGT +M+PE + E
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDE 194
Query: 674 GRFSEKSDVFSFGVLLLEI 692
G++ K DV+S G+ +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
+FQ+ ++GQGG+G V+ K +D EI A+KR+ K+ E + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
LV+LL + E L EY+P + L + L + RF + + + L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFE-AVDAL 117
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H L IHRDLK N L+D + K++DFGL++ +VG+ YM+PE
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAPEV 169
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSG 695
+ D +S G +L E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRL---SKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG G G V K K + G +A K + +K+S + Q + E+ ++ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ--ILRELQIMHECRSPYIVSFYG 70
Query: 559 CCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
+ + E+M SLD P +L I + GL YL+ +
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVH 123
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
RI+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE G++
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 677 SEKSDVFSFGVLLLEIVSGR 696
+ KSDV+S G+ ++E+ G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
+F+L +G+G FG V + +D +++ A+K ++K +NE ++ L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGIS 604
LV L + EENM L+ + + L L ++ +F+ I I
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL---SQK------VKFSEEQVKFWICEIV 110
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
L YLH IIHRD+K NILLD+ + I+DF +A + +T GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGTPG 164
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697
YM+PE +S D +S GV E + G++
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
N ++++L ++G G +G VYK L G+ AVK + G E+ ++ +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSF--LFDPQRQSLLDWPKRFNIIKGISRGLL 608
N+V G + RE+ + EY SL + P + + + R + +GL
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLA 120
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLH ++ HRD+K +NILL D+ + K++DFG+A A K +GT +M+P
Sbjct: 121 YLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAP 175
Query: 669 EYAM---EGRFSEKSDVFSFGVLLLEI 692
E A G +++ D+++ G+ +E+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQ 549
N++L LGQG FG VY D G+E+AVK++ S + + E+ ++ NL
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 550 HRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
H +V+ GC + E L E+MP S+ L +L + R + I G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGV 119
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYM 666
YLH + I+HRD+K +NIL D N K+ DFG + R+ K + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
SPE + K+D++S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-18
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQ 549
N++ LGQG FG VY + G+E+A K++ S + + E+ ++ NLQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 550 HRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
H +V+ GC +R E L EYMP S+ L +L + R + I G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGM 119
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYM 666
YLH + I+HRD+K +NIL D N K+ DFG + R+ + + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
SPE + K+DV+S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 55/207 (26%), Positives = 107/207 (51%), Gaps = 16/207 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
N +F+L ++G G +G VYK + + G+ A+K + G+ E++++ + +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSF--LFDPQRQSLLDWPKRFNIIKGISRGLL 608
N+V G + R++ + E+ SL + P +S + + R + +GL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLY 120
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLH + +HRD+K +NILL D+ + K++DFG++ A K +GT +M+P
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAP 175
Query: 669 EYAM---EGRFSEKSDVFSFGVLLLEI 692
E A +G +++ D+++ G+ +E+
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-18
Identities = 27/65 (41%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 337 GKQDGFFKLETMKVPYFAERS---SANEDKCKDQCSNNCSCKAYAY---EIGVGCMIWTH 390
G DGF +L MK+P S +C+ +C +NCSC AYAY G GC+IWT
Sbjct: 2 GGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTG 61
Query: 391 NLIDI 395
L+D+
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQ 549
N++L LG+G FG VY D G+E+AVK++ S+ + + E+ ++ NL+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 550 HRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
H +V+ GC + EE L EYMP S+ L +L + R + I +G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGV 119
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYM 666
YLH + I+HRD+K +NIL D N K+ DFG + RI K + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
SPE + K+DV+S ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 54/196 (27%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 502 KLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+G+G G V + G+++AVK++ Q +E NEV+++ + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ +E ++ E++ +L D + ++ + + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEK 679
RD+K+ +ILL D K+SDFG A++ +++ K LVGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 680 SDVFSFGVLLLEIVSG 695
D++S G++++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 26/215 (12%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQE-IAVKRLSKASGQGQEEFM-----NEVMVISNLQ 549
++ ++G+G +G V+K + L++G +A+KR+ Q EE M EV V+ +L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLE 59
Query: 550 ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
H N+VRL C +RE + L++E++ ++ L ++L D + + +++
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMF 117
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+ RGL +LH R++HRDLK NIL+ K++DFGLARI+ Q A +V
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 171
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
T Y +PE ++ ++ D++S G + E+ +
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 69/276 (25%), Positives = 129/276 (46%), Gaps = 21/276 (7%)
Query: 501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
N + +G G YKGK +++G + VK ++ + E + + LQH N+V+L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGL 751
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
C + LI+EY+ K+L L + L W +R I GI++ L +LH ++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 620 HRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEK 679
+L I++D P + L + + + Y++PE +EK
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPETRETKDITEK 858
Query: 680 SDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE--SGFK 737
SD++ FG++L+E+++G K+ + +++ +A ++D ++ +DP I S +
Sbjct: 859 SDIYGFGLILIELLTG-KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 738 MEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773
EI+ +N+ L C RP V+ L S +
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN----EVMVISNLQ 549
N +++ +G+G +G V K + + G+ +A+K+ K S + E+ EV V+ L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKR--FNIIKGISRG 606
H N+V L + L++EY+ L+ L + L D + + +++ I+
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIA-- 114
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
Y H IIHRD+K NIL+ + K+ DFG AR T V T Y
Sbjct: 115 --YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYR 168
Query: 667 SPE----YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+PE G+ DV++ G ++ E++ G
Sbjct: 169 APELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 54/196 (27%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
K+G+G G V ++ G+ +AVK++ Q +E NEV+++ + QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
+ +E ++ E++ +L D + ++ + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEK 679
RD+K+ +ILL D K+SDFG A++ +++ K LVGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 680 SDVFSFGVLLLEIVSG 695
D++S G++++E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 501 NKLGQGGFGPVYKGKLQDGQEIA---VKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRL 556
+++G G FG V G+ G A VK L + A+ Q F+ EV L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLLDWPKRFNIIKGISRGLL 608
LG C+E +L+ E+ P L ++L Q+ L + ++ GLL
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLL 114
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK-RLVGTYGYMS 667
+LH + IH DL N L DL+ KI D+GLA + +D TK +++
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLA 170
Query: 668 PEYAMEGRFS--------EKSDVFSFGVLLLEI 692
PE +E R +KS+++S GV + E+
Sbjct: 171 PE-LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 502 KLGQGGFG-PVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
K+G+G FG + +DG++ +K + SK S + +EE EV V+SN++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 559 CCVEREENMLIYEYMPNKSL-------DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
E ++ +Y L LF P+ Q +LDW I L ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLF-PEDQ-ILDW------FVQICLALKHVH 118
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+I+HRD+K+ NI L D K+ DFG+AR+ + A T +GT Y+SPE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEIC 173
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
++ KSD+++ G +L E+ +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 19/202 (9%)
Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF--MNEVMVISNLQ---HRNLVR 555
++G G +G VYK + G +A+K + + + + EV ++ L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 556 LLGCC----VEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
L+ C +RE + L++E++ ++ L ++L D L ++++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H + I+HRDLK NIL+ K++DFGLARI+ Q A +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEV 178
Query: 671 AMEGRFSEKSDVFSFGVLLLEI 692
++ ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 65/253 (25%), Positives = 115/253 (45%), Gaps = 47/253 (18%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQH 550
+++ +G+G +G VYK K + DG+E A+K+ Q + E+ ++ L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 551 RNLVRLLGCCVEREENM--LIYEYMPNKSLD--SFLFDPQRQSLLDWPKRF--NIIKGIS 604
N+V L+ +E + L+++Y + F +R S+ P +++ I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSMVKSLLWQIL 118
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFGGNQDQAATKRL- 659
G+ YLH + ++HRDLK +NIL+ + KI D GLAR+F A K L
Sbjct: 119 NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-----NAPLKPLA 170
Query: 660 -----VGTYGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR-----------KNTSFY 702
V T Y +PE + R K+ D+++ G + E+++ K+ F
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230
Query: 703 HEEFE--LTLLGY 713
++ E +LG
Sbjct: 231 RDQLERIFEVLGT 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 57/191 (29%), Positives = 100/191 (52%), Gaps = 25/191 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
+ ++ K+GQG FG V+K + + Q +A+K++ +E F + E+ ++ L+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69
Query: 550 HRNLVRLLGCCVE--------REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
H N+V L+ C + L++E+ + L L + + L K+ ++K
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMK 126
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA---TKR 658
+ GL Y+HR+ +I+HRD+KA+NIL+ D K++DFGLAR F +++ T R
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 659 LVGTYGYMSPE 669
+V T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+ + L G G V+ + GQ V + K GQ + E M++ N+ H +++R
Sbjct: 67 GYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLKI-GQKGTTLI-EAMLLQNVNHPSVIR 121
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
+ V ++ +P+ S D + + +R L + I K I GL YLH
Sbjct: 122 MKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA--- 175
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
RIIHRD+K NI ++D I D G A+ A L GT +PE +
Sbjct: 176 QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARDK 232
Query: 676 FSEKSDVFSFGVLLLEIVS 694
++ K+D++S G++L E+++
Sbjct: 233 YNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQ-HRN 552
+++ K+G+G F V K + + G+ A+K + K + E+ N E+ + L H N
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 553 LVRLLGCCVEREEN----------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
++RL+ +R+ M +YE + R+ L + + +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-----------RKRPLPEKRVKSYMYQ 108
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+ + L ++HR+ I HRD+K NIL+ DD+ K++DFG R G T+ + T
Sbjct: 109 LLKSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTE-YIST 161
Query: 663 YGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVS 694
Y +PE + +G + K D+++ G + EI+S
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 40/220 (18%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL---SKASGQGQEEF----MNEVMVISN 547
++ N++ +G +G VY+ + + G+ +A+K+L + G F + E+ ++
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLK 60
Query: 548 LQHRNLVRLLGCCVERE----ENM----LIYEYMPN--KSLDSFLFDPQRQSLLDWPKRF 597
LQH N+V + +E N+ ++ EY+ + KSL + P QS +
Sbjct: 61 LQHPNIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQS-----EVK 109
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
++ + G+ +LH + I+HRDLK SN+LL++ KI DFGLAR +G
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-- 164
Query: 658 RLVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
+LV T Y +PE + +S D++S G + E+++ +
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 26/219 (11%)
Query: 499 LANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL- 548
L LG+G FG V K K ++AVK L S A+ + + ++E+ ++ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLLDWPK 595
+H+N++ LLG C + +I EY +L +L ++P + + L +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ ++RG+ YL + + IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
T +M+PE + ++ +SDV+SFGVLL EI +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEV-MVISNLQHRNLVR 555
F+L +G G +G VYKG+ ++A ++ +G +EE E+ M+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 556 LLGCCVER------EENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLL 608
G +++ ++ L+ E+ S+ + + + +L +W I + I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYM 666
+LH+ ++IHRD+K N+LL ++ K+ DFG++ D+ +R +GT +M
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYWM 178
Query: 667 SPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 695
+PE + + KSD++S G+ +E+ G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNL-QHRNLVRLL 557
LG+G FG V +L+ E+ AVK L K ++ M E V++ +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 558 GCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSR 615
C + ++ + + EY+ L +F QR D P+ RF + I GL +LH
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYGYMSPEYAME 673
II+RDLK N+LLD + + KI+DFG+ + I GG T GT Y++PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILSY 170
Query: 674 GRFSEKSDVFSFGVLLLEIVSGR 696
+ D ++ GVLL E+++G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHR 551
++ +G+G +G V K K ++ GQ +A+K+ S+ ++ M E+ ++ L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
NLV L+ ++ L++E++ + LD P LD + + I RG+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+ IIHRD+K NIL+ K+ DFG AR + V T Y +PE
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELL 172
Query: 672 M-EGRFSEKSDVFSFGVLLLEIVSG 695
+ + ++ D+++ G L+ E+++G
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG+G FG V+ +L+ Q A+K L K E M E V+S + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
C + +EN+ + EY+ L +F Q D P+ I GL +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
I++RDLK NILLD D + KI+DFG+ + + G A T GT Y++PE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQK 172
Query: 676 FSEKSDVFSFGVLLLEIVSGRKNTSFY-HEEFEL 708
++ D +SFGVLL E++ G+ + F+ H+E EL
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 499 LANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNL- 548
L LG+G FG V K K +AVK L A+ + + ++E+ ++ +
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FD----PQRQSLLDW 593
+H+N++ LLG C + ++ EY +L +L FD P+ Q L +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ--LTF 133
Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
+ ++RG+ YL + + IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
T +M+PE + ++ +SDV+SFGVLL EI +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLS-KASGQGQEEFMNEVMVI 545
+ L LG+G FG V K K ++ +AVK L A+ + + ++E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDW 593
+ +H+N++ LLG C + +I EY +L +L +D R D
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP--DE 132
Query: 594 PKRFNIIKG----ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
F + ++RG+ YL + + IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 133 QMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189
Query: 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
T +M+PE + ++ +SDV+SFGVL+ EI +
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 497 FQLANKLGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
F+ LG+GGFG V GK+ +++ KR+ K G+ +NE ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIKGI 603
R +V L ++ L+ M L + FD +R I
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY--------AAEI 111
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
+ GL LHR+ RI++RDLK NILLDD + +ISD GLA + + VGT
Sbjct: 112 TCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTV 165
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
GYM+PE R++ D + G L+ E++ G+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 503 LGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
LG+GGFG V GK+ +++ KRL K SG+ E++ N +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF--IVNL 58
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
+ L+ M L +++ + L + + + I+ G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
I++RD+K N+LLDD N ++SD GLA + G + T+R GT GYM+PE E
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPEILKEEP 170
Query: 676 FSEKSDVFSFGVLLLEIVSGR 696
+S D F+ G + E+V+GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 502 KLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEF-MNEVMVISNLQHRNLVRLLG 558
K+G+G +G V+K K ++ EI A+KR+ +G + E+ ++ L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 559 CCVEREENMLIYEYMPN---KSLDSFLFDPQR---QSLLDWPKRFNIIKGISRGLLYLHR 612
++ L++EY K DS D +S + F ++KG++ + H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----FQLLKGLA----FCHS 117
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
++HRDLK N+L++ + K++DFGLAR FG + + V T Y P+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPDVLF 172
Query: 673 EGRFSEKS-DVFSFGVLLLEIVSG 695
+ S D++S G + E+ +
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQH 550
TN + +G G FG V + Q GQ +A+K++ K ++ + E+ ++ +L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 551 RNLVRLLGCCVE-REENMLIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
N++ L + E+ + E + ++ L S + Q + + F + I RG
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQ------FIQYF--LYQILRG 120
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L Y+H ++HRDLK SNIL++++ + KI DFGLARI QD T V T Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVSTRYYR 172
Query: 667 SPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
+PE + ++ + D++S G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 502 KLGQGGFGPVYKGKLQDG---QEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
++G G FG V G++ G ++ VK L AS Q Q +F+ E +LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK---GISRGLLYLHRDS 614
G C E +L+ E+ P L +L R++ L P + + I+ GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME- 673
IH DL N LL DL KI D+GL+ +L +++PE E
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 674 -GRF-----SEKSDVFSFGVLLLEI 692
G +++S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 496 NFQLANKLGQGGFGPVY----KGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISN 547
NF+L LG G +G V+ G G+ A+K L KA+ + E E V+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
++ + L + + + LI +Y+ L + L+ QR+ + R I I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRV-YIAEIVLA 117
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF-GGNQDQAATKRLVGTYGY 665
L +LH+ L II+RD+K NILLD + + ++DFGL++ F +++A + GT Y
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEY 172
Query: 666 MSPEYAM--EGRFSEKSDVFSFGVLLLEIVSG 695
M+PE G + D +S GVL E+++G
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 498 QLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMN------------EV 542
Q LG+G +G V K G+ +A+K+ + + S ++ E+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPN---KSLDS--FLFDPQRQSLLDWPKRF 597
+++ ++H N++ L+ VE + L+ + M + K +D L + Q +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC-------- 123
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG--------G 649
I+ I GL LH+ +HRDL +NI ++ KI+DFGLAR +G
Sbjct: 124 -ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 650 NQDQAATKRL----VGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
+ + V T Y +PE M ++ D++S G + E+++G+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEV-MVISNLQHRNLV 554
F+L +G G +G VYKG+ ++ GQ A+K + + +EE E+ M+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 555 RLLGCCVER------EENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGL 607
G +++ ++ L+ E+ S+ + + + +L DW I + I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGY 665
+LH ++IHRD+K N+LL ++ K+ DFG++ D+ +R +GT +
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYW 187
Query: 666 MSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 695
M+PE + + +SD++S G+ +E+ G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRN 552
F+ LG+GGFG V +++ G+ A KRL K +G+ +NE ++ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V L ++ L+ M L +++ + F + I GL LHR
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHR 120
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYMSPEYA 671
++ ++RDLK NILLDD + +ISD GLA +I G + + VGT GYM+PE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVL 173
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
R++ D + G L+ E++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-15
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 503 LGQGGFGPVYKGKL-QDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG+G FG V +L + G+ AVK L K E M E ++S ++ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
CC + + + + E++ L +F Q+ D + I+ L++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG--- 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
II+RDLK N+LLD + + K++DFG+ + G + T GT Y++PE E +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 678 EKSDVFSFGVLLLEIVSGRKNTSFYHEEFE 707
D ++ GVLL E++ G H FE
Sbjct: 175 PSVDWWAMGVLLYEMLCG-------HAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 47/128 (36%), Positives = 68/128 (53%), Gaps = 13/128 (10%)
Query: 571 EYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
E+M SLD L R P+ I + RGL YL R+ + +I+HRD+K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGR-----IPENILGKISIAVLRGLTYL-RE-KHKIMHRDVKPSNI 131
Query: 629 LLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVL 688
L++ K+ DFG++ G D A VGT YMSPE ++ +SD++S G+
Sbjct: 132 LVNSRGEIKLCDFGVS---GQLIDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 689 LLEIVSGR 696
L+E+ GR
Sbjct: 188 LVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 501 NKLGQGGFGPVYKG--KLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
+KLG+G + VYKG KL D +A+K + +G + EV ++ +L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
+ L++EY+ +K L +L D + K F + + RGL Y HR +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---K 124
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL---VGTYGYMSPEYAM-E 673
++HRDLK N+L+++ K++DFGLAR TK V T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 674 GRFSEKSDVFSFGVLLLEIVSGR 696
+S + D++ G + E+ +GR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVMVIS 546
+ +G G FG V+ +DG+ +A+K++ F N E+ ++
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKMLC 54
Query: 547 NLQHRNLVRLL--------GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
+H N++ L EE ++ E M L + PQ S D K F
Sbjct: 55 FFKHDNVLSALDILQPPHIDPF---EEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVF- 108
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
+ I RGL YLH I+HRD+K N+L++ + KI DFGLAR+ ++ + T+
Sbjct: 109 -LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 659 LVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
+V Y Y +PE M R ++ D++S G + E++ R
Sbjct: 165 VVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 57/248 (22%)
Query: 495 NNFQLANKLGQGGFGPVY--KGKLQDGQEIAVKRLSKAS--GQGQEE-FMNE--VMVISN 547
++F++ +G+G FG V+ + K GQ A+K L K+ + Q E ++ ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIK 601
+V+L + EE++ L+ EYMP L + L F + + +
Sbjct: 60 --SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY---- 106
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA--------RIFGGNQDQ 653
I+ +L L +L IHRD+K NIL+D D + K++DFGL R + N
Sbjct: 107 -IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 654 AATKRL-------------------VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
R VGT Y++PE + + D +S GV+L E++
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 695 GRKNTSFY 702
G FY
Sbjct: 226 GF--PPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQH 550
+Q + +G+G +G V G ++A+K++S Q F + E+ ++ +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62
Query: 551 RNLVRLLGC-CVEREENM----LIYEYMPN---KSLDSFLFDPQRQSLL-DWPKRFNIIK 601
N++ +L E+ ++ E M K + + Q L D + F +
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-------QHLSNDHIQYF--LY 113
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT-KRLV 660
I RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLARI D V
Sbjct: 114 QILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 661 GTYGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 696
T Y +PE + + K+ D++S G +L E++S R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 57/221 (25%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN---------EVMVISNLQHRN 552
+G G +G V G+++A+K+LS F + E+ ++ ++ H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSF----LFDP----------QRQSLLDWPKRFN 598
++ LL + P SL+ F L + Q L D +F
Sbjct: 76 VIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF- 122
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
++ I RGL Y+H IIHRDLK SNI +++D KI DFGLAR +
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEM 172
Query: 659 --LVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + +++ D++S G ++ E+++G+
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRNL 553
+ Q LG G G VYK L + +AVK + + + Q++ M+E+ ++ +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+ G + E+M SLD + P+ I + +GL YL
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVYRKIPE-------HVLGRIAVAVVKGLTYLWS- 113
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
L+I+HRD+K SN+L++ K+ DFG++ + K VGT YM+PE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISG 167
Query: 674 GRFSEKSDVFSFGVLLLEIVSGR 696
++ SDV+S G+ +E+ GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
LG+G FG V +L+ E+ A+K L K ++ M E +++ + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
CC + ++ + + EY+ L +F QR D P+ ++ L++LHR
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
+I+RDLK NILLD + + K++DFG+ + G + T GT Y++PE E +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 678 EKSDVFSFGVLLLEIVSGR 696
D ++ GVL+ E+++G+
Sbjct: 175 PSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-----FMNEVMVISNL 548
+ ++ K+G+G +G VYK + G+ +A+K K + EE + E+ ++ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQML 57
Query: 549 QHRN-LVRLLGCCVEREEN-------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
+VRLL VE E L++EY+ + L F+ R P I
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPA--KTI 112
Query: 601 KG----ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQDQAA 655
K + +G+ + H+ ++HRDLK N+L+D KI+D GL R F ++
Sbjct: 113 KSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSY 168
Query: 656 TKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSF 701
T +V T Y +PE + +S D++S G + E+ RK F
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
++F+ ++LG G G V K + + I ++L + + + + E+ V+
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYL 610
+V G E + E+M SLD L + +R + +L + + RGL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
+ +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+S +SD++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
LG+G FG V + + G+ A+K L K ++E + E V+ N +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
++ + EY+ L F R+ + + I L YLH +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
++RDLK N++LD D + KI+DFGL + G D A K GT Y++PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 679 KSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLL 711
D + GV++ E++ GR FY+++ FEL L+
Sbjct: 175 AVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 501 NKLGQGGFGPVYKG--KLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
KLG+G + V+KG KL + +A+K + +G + EV ++ +L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
+ L++EY+ +K L ++ D + K F + I RGL Y HR +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR---K 124
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL---VGTYGYMSPEYAM-E 673
++HRDLK N+L+++ K++DFGLAR TK V T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 674 GRFSEKSDVFSFGVLLLEIVSGR 696
+S + D++ G + E+ SGR
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 50/284 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE----FMN-EVMVISNL 548
N+ + ++G G G VYK + + G +AVK++ + + EE M+ +V++ S+
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSH- 71
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRG 606
+V+ G + + + E M + LD L ++ P+ + I +
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM-STCLDKLL----KRIQGPIPEDILGKMTVAIVKA 126
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L YL + +IHRD+K SNILLD N K+ DFG++ G D A R G YM
Sbjct: 127 LHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAYM 181
Query: 667 SPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE---EFE-LTLLGYAWKLW 718
+PE ++ ++DV+S G+ L+E+ +G+ Y EFE LT K+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ---FPYKNCKTEFEVLT------KIL 232
Query: 719 NDNNVIDLVDP--LISESGFKMEIIRCVNVGLLCVQEFVKDRPN 760
+ +P L GF + V+ LC+ + + RP
Sbjct: 233 QE-------EPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRPK 266
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
+G+G +G V + DG++ +K+L+ AS + ++ E ++S L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62
Query: 560 CVERE----ENMLIY----------EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
RE E+ L+Y Y K L P+ Q +++W I+
Sbjct: 63 -AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL-PENQ-VVEW------FVQIAM 113
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
L YLH I+HRDLK N+ L K+ D G+AR+ D A+T L+GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
MSPE ++ KSDV++ G + E+ +
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRL--SKASGQGQEEFMNEVMVISNLQHR 551
N F++ +G+G +G V K + ++ +EI A+K+ S+ + + +E + E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR--FNIIKGISRGLLY 609
N+V L R + L++EY+ K++ L + + + + +IK I +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH----W 115
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
H++ I+HRD+K N+L+ + K+ DFG AR + T+ V T Y SPE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE-YVATRWYRSPE 171
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ + + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 46/199 (23%)
Query: 519 GQEIAVKRLSKASGQGQEEFMN---------EVMVISNLQHRNLVRLLGCCVEREENMLI 569
GQ +A+K+LS+ F N E++++ + H+N++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 570 YEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
+ P KSL+ F L D Q LD + ++ + G+ +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
IIHRDLK SNI++ D KI DFGLAR G T +V Y Y +PE + +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYK 195
Query: 678 EKSDVFSFGVLLLEIVSGR 696
E D++S G ++ E++ G
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 503 LGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
LG+GGFG V GK+ +++ KR+ K G+ +NE ++ + R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIKGISRGLLY 609
++ L+ M L + FD QR + GL
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY--------AAELCCGLED 117
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGNQDQAATKRLVGTYGYMSP 668
L R+ RI++RDLK NILLDD + +ISD GLA +I G + VGT GYM+P
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET----VRGRVGTVGYMAP 170
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E +++ D + G L+ E++ G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 70/233 (30%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEV 542
+ E L + T+ +++ +G+G +G VYK +DG AVK L S EE E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEY 69
Query: 543 MVISNL-QHRNLVRLLGCCVEREENM-----LIYEYMPNKS----LDSFLFDPQRQSLLD 592
++ +L H N+V+ G + ++ + L+ E S + L QR LD
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR---LD 126
Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
I+ G GL +LH + RIIHRD+K +NILL + K+ DFG++
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA------- 176
Query: 653 QAATKRL-----VGTYGYMSPEY-AMEGR----FSEKSDVFSFGVLLLEIVSG 695
Q + RL VGT +M+PE A E + + + DV+S G+ +E+ G
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 75/230 (32%), Positives = 111/230 (48%), Gaps = 31/230 (13%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVIS-NLQHRNLVRLL 557
LG+G FG V +L+ E A+K L K E M E V++ +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 558 GCCVEREENML-IYEYMPNKSL-----DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
C + +E++ + EY+ L S FD R RF + I GL +LH
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEIIC-GLQFLH 113
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+ II+RDLK N+LLD D + KI+DFG+ + + +A+T GT Y++PE
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEIL 168
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721
+++E D +SFGVLL E++ G+ S +H E E L + ND
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ---SPFHGEDEDELF---DSILNDR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
+G+GGFG VY + D G+ A+K L K QG+ +NE +++S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 559 C----CVER-----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
C C+ ++ I + M L L Q + RF + I GL +
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEH 112
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
+H +R +++RDLK +NILLD+ + +ISD GLA F + A+ VGT+GYM+PE
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 670 YAMEGR-FSEKSDVFSFGVLLLEIVSG-----RKNTSFYHEEFELTL 710
+G + +D FS G +L +++ G + T HE +TL
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVISNLQHR 551
+F LG+G FG V + + E+ A+K L K E M E V++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+ L C + + + + EY+ L ++ Q+ P I+ GL +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYGYMSP 668
H II+RDLK N++LD + + KI+DFG+ + IFGG T+ GT Y++P
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAP 170
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E + + D ++FGVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
+G+GGFG VY + D G+ A+K L K QG+ +NE +++S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 559 C----CVER-----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
C C+ ++ I + M L L Q + RF + I GL +
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAE-IILGLEH 112
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
+H +R +++RDLK +NILLD+ + +ISD GLA F + A+ VGT+GYM+PE
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 670 YAMEG-RFSEKSDVFSFGVLLLEIVSG 695
+G + +D FS G +L +++ G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
LG+G FG V K + G+ A+K L K ++E + E V+ N +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
+ + EY L F R+ + + I L YLH S +
Sbjct: 63 SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
++RDLK N++LD D + KI+DFGL + G +D A K GT Y++PE + +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 679 KSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLL 711
D + GV++ E++ GR FY+++ FEL L+
Sbjct: 176 AVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNL 553
+Q + +G G +G V + G +AVK+LS+ S + E+ ++ +++H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 554 VRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
+ LL +E ++ + ++ L++ + + Q L D +F +I I RGL
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 134
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
Y+H IIHRDLK SN+ +++D KI DFGLAR + D T V T Y +P
Sbjct: 135 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTG-YVATRWYRAP 186
Query: 669 EYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
E + +++ D++S G ++ E+++GR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
LG+G FG V + + + A+K L K ++E + E V+ N +H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLR 617
+ + EY L F R+ + + RF + +S L YLH
Sbjct: 63 SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSCD--- 115
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
+++RDLK N++LD D + KI+DFGL + G D A K GT Y++PE + +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 678 EKSDVFSFGVLLLEIVSGRKNTSFY---HEE-FELTLLG 712
D + GV++ E++ GR FY HE+ FEL L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS--KASGQGQEEFM-NEVMVISNLQHR 551
+ + +G G FG V+ + + + A+K ++ + QE+ + NE V+ + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 552 NLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG------I 603
++RL E ++ L + EY+P L S+L R S RF+ G I
Sbjct: 62 FIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL----RNS-----GRFSNSTGLFYASEI 110
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
L YLH I++RDLK NILLD + + K++DFG A+ +D+ T L GT
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWT--LCGTP 162
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
Y++PE ++ D ++ G+L+ E++ G
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
K+G+G +G V+K + ++ GQ +A+K+ S+ ++ + E+ ++ L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
+ + L++EY + L+ +P+ + II + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM-EGRFS 677
IHRD+K NIL+ K+ DFG ARI G T V T Y +PE + + ++
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTD-YVATRWYRAPELLVGDTQYG 179
Query: 678 EKSDVFSFGVLLLEIVSG 695
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMV-ISNLQHRNLVRLL 557
+G+G FG V K DG+ AVK L K + ++E M E V + N++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRL 616
++ + +Y+ L F QR+ P+ RF + I+ L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
II+RDLK NILLD + ++DFGL + G + T GT Y++PE + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 677 SEKSDVFSFGVLLLEIVSG 695
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 505 QGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR----NLVRLLGC 559
+G FG VY K G A+K L K+ + + N + + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSL----LDWPKRFNIIKGISRGLLYLHRDSR 615
++ L+ EY+ S + ++L DW K++ I + G+ LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
IIHRD+K N+L+D + K++DFGL+R N K+ VGT Y++PE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDYLAPETILGVG 169
Query: 676 FSEKSDVFSFGVLLLEIVSG 695
+ SD +S G ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVI-SNLQHRNLVRLL 557
+G+G FG V K + DG AVK L K + + Q M E V+ NL+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
E+ + +Y+ L F QR+ P+ ++ + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
II+RDLK NILLD + ++DFGL + G + + T GT Y++PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 678 EKSDVFSFGVLLLEIVSG 695
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 38/233 (16%)
Query: 503 LGQGGFGPVYKGKLQD----GQ----EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
LGQG F ++KG ++ G+ E+ +K L K+ E F ++S L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
G CV +E++++ EY+ SLD++L + ++L++ + + K ++ L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 615 RLRIIHRDLKASNILL-----DDDLNP---KISDFGLARIFGGNQDQAATKRLVGTYGYM 666
+ H ++ A N+LL NP K+SD G++ + L+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------LPKEILLERIPWV 171
Query: 667 SPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFYHEEFEL 708
PE + S +D +SFG L EI SG +K FY + +L
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 503 LGQGGFGPVY---KGKLQD-GQEIAVKRLSKASGQGQEEF--MNEVMVISNLQHRNLVRL 556
LGQG FG V+ K D GQ A+K L KA+ + ++ E +++ + H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
+ LI +++ + D F + + +F + + ++ L +LH L
Sbjct: 64 HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 117
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
II+RDLK NILLD++ + K++DFGL++ + GT YM+PE
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 677 SEKSDVFSFGVLLLEIVSG 695
++ +D +SFGVL+ E+++G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLG 558
+KLG+G + V+KG+ + +A+K + +G + EV ++ NL+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
L++EY+ + L +L + + K F + + RGL Y H+ +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIF--MFQLLRGLSYCHKR---KI 124
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL---VGTYGYMSPEYAM-EG 674
+HRDLK N+L+++ K++DFGLAR TK V T Y P+ +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 675 RFSEKSDVFSFGVLLLEIVSGR 696
+S D++ G +L E+ +GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
LG+G FG V + + G+ A+K L K ++E + E V+ N +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLR 617
+ + EY L F R+ + + RF + +S L YLH
Sbjct: 63 AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVS-ALEYLHSRD--- 115
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
+++RD+K N++LD D + KI+DFGL + G D A K GT Y++PE + +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 678 EKSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLL 711
D + GV++ E++ GR FY+++ FEL L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL----- 556
LG G G V+ D + +AVK++ Q + + E+ +I L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 557 ---------LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL--DWPKRFNIIKGISR 605
+G E ++ EYM ++ L + Q L + + F + + R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF--MYQLLR 125
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAA--TKRLVGT 662
GL Y+H + ++HRDLK +N+ ++ +DL KI DFGLARI + ++ LV
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 663 YGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
+ Y SP + +++ D+++ G + E+++G+
Sbjct: 183 W-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE-EFMNEVMVISN 547
AT+ L KLG+G + VYKG + +GQ +A+K +S + +G + E ++
Sbjct: 1 FGAATSYLNL-EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG 59
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
L+H N+V L +E ++EYM + P L + R + + + RGL
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGL 116
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
Y+H I+HRDLK N+L+ K++DFGLAR Q + +V T Y
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRP 171
Query: 668 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
P+ + +S D++ G + +E++ G+
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 41/94 (43%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAATKRLV 660
++RG+ +L SR + IHRDL A NILL ++ KI DFGLAR + D + RL
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE + ++ +SDV+SFGVLL EI S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 497 FQLANKLGQGGFGPV----YKGKLQDGQEIAVKRLSKASGQGQEE---FMNE--VMVISN 547
F+ LG+G FG V YK G+ A+K L K ++E M E + +N
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 548 -LQHRNLVRLLGCCVEREENMLIYEYMPNKSL------DSFLFDPQRQSLLDWPKRFNII 600
+H LV L C + + EY L D F + ++ F
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRA------VF-YA 107
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
+ GL YLH + +I++RDLK N+LLD + KI+DFGL + G D+ +T
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FC 162
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
GT +++PE E ++ D + GVL+ E++ G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
LG+G FG V +L+ G+ AVK L K E M E V++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
C + +E++ + E++ L +F Q + D + I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675
II+RDLK N++LD D + KI+DFG+ + +FG N +A+T GT Y++PE +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST--FCGTPDYIAPEILQGLK 172
Query: 676 FSEKSDVFSFGVLLLEIVSGR 696
++ D +SFGVLL E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
++F+ ++LG G G V+K + I ++L + + + + E+ V+
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
+V G E + E+M SLD L R P++ + + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 119
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
+ +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+S +SD++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-12
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 24/195 (12%)
Query: 517 QDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQHRNLVRLL--GCCVEREENML--I 569
G E+A+K L + + + + F E + + L H N+V LL G +L +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAV 57
Query: 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL 629
+EY+P ++L L L + ++ + L H I+HRDLK NI+
Sbjct: 58 FEYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 630 L---DDDLNPKISDFGLARIFGGNQDQAATK-----RLVGTYGYMSPEYAMEGRFSEKSD 681
+ + K+ DFG+ + G +D ++GT Y +PE + SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 682 VFSFGVLLLEIVSGR 696
++++G++ LE ++G+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSKAS----GQGQEEFMNEVMVISN 547
NF+L LG G +G V+ + G + A+K L KA+ + E E V+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG-ISR 605
++ + L + + + LI +Y+ L + L +R + I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
L +LH+ L II+RD+K NILLD + + ++DFGL++ F ++ + A GT Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172
Query: 666 MSPEYAM--EGRFSEKSDVFSFGVLLLEIVSG 695
M+P+ +G + D +S GVL+ E+++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHR 551
+Q +G G +G V Y +L+ Q++AVK+LS+ S E+ ++ +++H
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 552 NLVRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
N++ LL +E + + + L++ + + Q L D +F +I + RG
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRG 130
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L Y+H IIHRDLK SN+ +++D +I DFGLAR Q V T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182
Query: 667 SPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
+PE + +++ D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSKAS----GQGQEEFMNEVMVISN 547
NF+L LG G +G V+ + G + A+K L KA+ + E E V+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
++ + L + E + LI +Y+ + + L+ QR + + RF I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRF-YSGEIILA 117
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L +LH+ L I++RD+K NILLD + + ++DFGL++ F ++++ T GT YM
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173
Query: 667 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 695
+PE +G + D +S G+L+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 503 LGQGGFGPVYKGKLQD---------GQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQH 550
LGQG F +YKG L+ GQE++V K G F ++S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL--KVLGSDHRDSLAFFETASLMSQLSH 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
++LV+L G CV R+EN+++ EY+ LD FL + L W + ++ K ++ L YL
Sbjct: 61 KHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 611 HRDSRLRIIHRDLKASNILL---DDDLNP----KISDFGLARIFGGNQDQAATKRLVGTY 663
+++H ++ NIL+ + K+SD G+ ++ V
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE------RVERI 168
Query: 664 GYMSPEYAMEGRFSEKS--DVFSFGVLLLEIVSG 695
+++PE G+ S D +SFG LLEI S
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVISNLQHR 551
+F LG+G FG V + + E+ A+K L K E M E V++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+ L C + + + + EY+ L ++ Q+ P+ IS GL +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
HR II+RDLK N++LD + + KI+DFG+ + D T+ GT Y++PE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI 172
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ + D +++GVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRN 552
++++ KLG+G + VYKGK + +G+ +A+K + +G + E ++ L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRG 606
+V L +E L++EY+ + L ++ P+ L F +++G+S
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF----LFQLLRGLS-- 117
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
Y+H+ I+HRDLK N+L+ D K++DFGLAR + V T Y
Sbjct: 118 --YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYR 170
Query: 667 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 695
P+ + +S D++ G + +E++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 519 GQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575
G +AVK+LS+ Q Q + E++++ + H+N++ LL + P
Sbjct: 46 GINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQ 92
Query: 576 KSLDSF--------LFDPQRQSL----LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL 623
KSL+ F L D + LD + ++ + G+ +LH IIHRDL
Sbjct: 93 KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149
Query: 624 KASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVF 683
K SNI++ D KI DFGLAR N T +V Y Y +PE + + E D++
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRY-YRAPEVILGMGYKENVDIW 206
Query: 684 SFGVLLLEIVSG 695
S G ++ E+V G
Sbjct: 207 SVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR----NL 553
++LG+G +G VYK + G +A+K RL E N++++ ++ H+ +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-----DESKFNQIIMELDILHKAVSPYI 61
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
V G + EYM SLD + I + +GL +L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY--- 670
IIHRD+K +N+L++ + K+ DFG++ GN + K +G YM+PE
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 671 -AMEGR--FSEKSDVFSFGVLLLEIVSGR 696
++ +SDV+S G+ +LE+ GR
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 22/233 (9%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ- 549
++L +LGQG +G V + + + +A+K+++ + + + E+ ++ + +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 550 HRNLVRLLGCCVEREEN---MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
H+N+ L + N + +YE + L + Q L D + I + I G
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP--LTDAHFQSFIYQ-ILCG 117
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA--TKRLVGTYG 664
L Y+H + ++HRDLK N+L++ D KI DFGLAR F N + A V T
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 665 YMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR---KNTSFYHEEFE-LTLLG 712
Y +PE + + K+ DV+S G +L E++ + K + + + L +LG
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 60/248 (24%), Positives = 119/248 (47%), Gaps = 33/248 (13%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCC 560
K+G+G +G VYK K +DG++ L + G G E+ ++ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 561 VEREENM--LIYEYMPNKSLDSFLF---DPQRQSLLDWPKRF--NIIKGISRGLLYLHRD 613
+ + L+++Y + F + + P+ +++ I G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 614 SRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIFGGN-QDQAATKRLVGTYGYMS 667
++HRDLK +NIL+ + P KI+D G AR+F + A +V T+ Y +
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 668 PEYAMEGR-FSEKSDVFSFGVLLLEIVSG-----------RKNTSFYHEEFE--LTLLGY 713
PE + R +++ D+++ G + E+++ + + F+H++ + +++G+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 714 -AWKLWND 720
A K W D
Sbjct: 244 PADKDWED 251
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 32/158 (20%)
Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEE-----FMNEVMVISNLQHRNL 553
KLG+G + VYKG+ + GQ +A+K RL EE + E ++ +L+H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLE------HEEGAPFTAIREASLLKDLKHANI 65
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGL 607
V L ++ L++EY+ + L ++ L F ++ RGL
Sbjct: 66 VTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLF----LFQLL----RGL 116
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
Y H+ R++HRDLK N+L+ + K++DFGLAR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVI-SNLQHRNLVRLL 557
+G+G FG V K + DG+ AVK L K + + Q+ M E V+ N++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
E+ + +++ L F QR+ P+ I+ L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
I++RDLK NILLD + ++DFGL + G T GT Y++PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 678 EKSDVFSFGVLLLEIVSG 695
D + G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQ--EIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
+F LG G FG V ++ +A+KR K+ Q++ +E +++ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
V L G + L+ E++ +FL +R +P L++
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIFE 145
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
+ S L I++RDLK N+LLD D K++DFG A++ T L GT Y++PE
Sbjct: 146 YLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEI 199
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSG 695
+ + +D ++ G+ + EI+ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 30/250 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHR 551
+F++ LG G FG V K + G+ A+K L K + + E ++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL--- 608
+V ++ + + E++ L + L R +P ++ K L+
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----FPN--DVAKFYHAELVLAF 131
Query: 609 -YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
YLH II+RDLK N+LLD+ + K++DFG A+ + T L GT Y++
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLA 183
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLLG-YAWKLWNDNN 722
PE + D ++ GVLL E ++G F+ + +E L G + W D
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYP--PFFDDTPFRIYEKILAGRLKFPNWFDGR 241
Query: 723 VIDLVDPLIS 732
DLV L+
Sbjct: 242 ARDLVKGLLQ 251
|
Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 41/94 (43%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAATKRLV 660
++RG+ +L SR + IHRDL A NILL ++ KI DFGLAR + D + + RL
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE + ++ +SDV+SFGVLL EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 503 LGQGGFGPVYKGKLQDGQE----IAVKRLSKAS-GQGQEEFMN---EVMVISNLQHRNLV 554
LG+GG+G V++ + G + A+K L KA+ + Q++ + E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
L+ + LI EY+ L L +R+ + + IS L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYGYMSPEYAM 672
II+RDLK NILLD + K++DFGL + I G T GT YM+PE M
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILM 173
Query: 673 EGRFSEKSDVFSFGVLLLEIVSG 695
+ D +S G L+ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 61/248 (24%), Positives = 118/248 (47%), Gaps = 33/248 (13%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCC 560
K+G+G +G VYK K +DG++ L + G G E+ ++ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 561 VEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY-----LHRD 613
+ + L+++Y + F R S + K + +G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKF--HRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 614 SRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIFGGN-QDQAATKRLVGTYGYMS 667
++HRDLK +NIL+ + P KI+D G AR+F + A +V T+ Y +
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 668 PEYAMEGR-FSEKSDVFSFGVLLLEIVSG-----------RKNTSFYHEEFE--LTLLGY 713
PE + R +++ D+++ G + E+++ + + ++H++ + ++G+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 714 -AWKLWND 720
A K W D
Sbjct: 244 PADKDWED 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--- 552
+F LG+G FG V + + E+ ++ K Q++ + MV + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 553 --LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
L +L C + + EY+ L ++ Q+ P I+ GL +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H II+RDLK N++LD + + KI+DFG+ + D TK GT Y++PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEI 172
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ + D ++FGVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-11
Identities = 31/91 (34%), Positives = 54/91 (59%)
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
LL +H +IHRD+K++NILL + K+ DFG ++++ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697
+PE +S+K+D+FS GVLL E+++ ++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 37/213 (17%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVMVISNLQHRN 552
+G+G +G V K + +++A+K+++ A F N E+ ++ +L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 553 LVRLLGCC--VERE---ENMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISR 605
++ + RE + ++YE M D+ L R Q+L D ++ + + + R
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLR 119
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR D V T Y
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRWY 174
Query: 666 MSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRK 697
+PE + ++ DV+S G + E++ GRK
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 503 LGQGGFGP--VYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
+G+G FG + + D Q+ A+K RL K+S E+ E ++++ ++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
++ EY L + QR L + G+ ++H R+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RV 121
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
+HRD+K+ NI L + K+ DFG AR+ A T VGT Y+ PE ++
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNN 179
Query: 679 KSDVFSFGVLLLEIVS 694
KSD++S G +L E+ +
Sbjct: 180 KSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQG---QEEFMNEVMVISNLQH 550
+ + +G+GG G VY D + +A+K++ + + ++ F+ E + ++L H
Sbjct: 4 YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 551 RNLVRLLGCCVEREENMLIYEYMP---NKSLDSFLFDPQRQSLLDWP-------KRF-NI 599
+V + C + + +Y MP +L S L ++ L F +I
Sbjct: 62 PGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA---- 655
I + Y+H S+ ++HRDLK NILL I D+G A ++
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 656 ----------TK--RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
T ++VGT YM+PE + SE +D+++ GV+L ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 524 VKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE---YMPNKSLD- 579
+ + KA + + NE++ + L H N++++ E +L E YM + D
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247
Query: 580 ---SFLFDPQRQ---SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD 633
SF++D L R I+K + + Y+H ++IHRD+K NI L+ D
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303
Query: 634 LNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 693
+ DFG A F + +A VGT SPE + E +D++S G++LL+++
Sbjct: 304 GKIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
Query: 694 S 694
S
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 43/234 (18%)
Query: 485 FNFEELANAT----NNFQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKASGQGQ-- 535
F E+ ++T +Q +G G G V Y L+ + +A+K+LS+ Q Q
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPF-QNQTH 66
Query: 536 -EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQ 586
+ E++++ + H+N++ LL + P KSL+ F L D
Sbjct: 67 AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 587 R----QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
Q LD + ++ + G+ +LH IIHRDLK SNI++ D KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
LAR G T +V Y Y +PE + + E D++S G ++ E++ G
Sbjct: 172 LARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-10
Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 5/76 (6%)
Query: 339 QDGFFKLETMKVPYFAE--RSSANEDKCKDQCSN-NCSCKAYAY-EIGVGCMIWTHN-LI 393
D F +L K+P F+ S A+ ++C +C N NCSC+++ Y GC++W+ + L
Sbjct: 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLG 62
Query: 394 DIRKLPSGGTNLYIRV 409
D R PSGG +LY ++
Sbjct: 63 DARLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 36/210 (17%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFM-----NEVMVISNLQHRNLVRL 556
+G G +G V + G+++A+K+LS+ Q E E+ ++ ++QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 557 LGCCV------EREENMLIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
L E ++ L+ YM K + L + + Q L+ + ++ GL
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV-----YQMLC----GL 130
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
Y+H IIHRDLK N+ +++D KI DFGLAR + D T +V T Y +
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRA 182
Query: 668 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
PE + +++ D++S G ++ E+++G+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 503 LGQGGFGPV-YKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
+G G +G V + G ++A+K+L + S + E+ ++ +++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 560 CVEREENMLIYEYMPNKSLDSF----LFDP---------QRQSLLDWPKRFNIIKGISRG 606
+ P+ SLD F L P + L + ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L Y+H IIHRDLK N+ +++D KI DFGLAR D T +V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV-TRWYR 182
Query: 667 SPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
+PE + +++ D++S G ++ E+++G+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+++G+ +L SR + IHRDL A NILL ++ KI DFGLAR + D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 663 YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE + ++ +SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT--KRLV 660
+ RGL Y+H + +IHRDLK SN+L+++D +I DFG+AR + + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 661 GTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRK 697
T Y +PE + ++ D++S G + E++ GR+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 39/215 (18%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQH 550
+Q +G G G V Y L + +A+K+LS+ Q Q + E++++ + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNH 75
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFN 598
+N++ LL + P KSL+ F L D Q LD +
Sbjct: 76 KNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
++ + G+ +LH IIHRDLK SNI++ D KI DFGLAR G T
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 178
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 693
+V Y Y +PE + + E D++S G ++ E+V
Sbjct: 179 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----QHRNLVRLL 557
+G+G + V +L+ + I ++ K +E ++ V ++ H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSRL 616
C + EY+ L +F QRQ L + RF + IS L YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG-- 116
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
II+RDLK N+LLD + + K++D+G+ + G + T GT Y++PE +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 677 SEKSDVFSFGVLLLEIVSGR 696
D ++ GVL+ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 34/254 (13%)
Query: 483 LVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEFM 539
+V +L ++ + +G+G FG V + + Q++ A+K LSK + F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD---PQRQSLLDWPK 595
E I + V L C + ++ + ++ EYMP L + + + P++ W K
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAK 145
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ + +L L + +IHRD+K N+LLD + K++DFG D+
Sbjct: 146 FYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM----KMDETG 196
Query: 656 TKRL---VGTYGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
R VGT Y+SPE +G + + D +S GV L E++ G +T FY +
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYAD---- 250
Query: 709 TLLGYAWKLWNDNN 722
+L+G K+ + N
Sbjct: 251 SLVGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEFMN-----EVMVISNLQHRNLVRL 556
+G+G FG VY+ + +D + I A+K LSK ++E + ++V + L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 557 LGCCVEREENM-LIYEYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIKGISRGLLYL 610
L + + ++ L+ +YM L L F R +F I + + L +L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR-------AKFYIAELV-LALEHL 112
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H+ I++RDLK NILLD + + DFGL++ D T GT Y++PE
Sbjct: 113 HKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 671 AMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEE 705
++ + +++ D +S GVL+ E+ G + FY E+
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
++F++ +G+G FG V K++ + I A+K L+K + E F E V+ N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+ + L + L+ +Y L + L + + D + + I+ +L +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAI 115
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL-VGTYGYMSPE 669
H +L +HRD+K N+LLD + + +++DFG NQD + VGT Y+SPE
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 670 Y--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706
AME G++ + D +S GV + E++ G T FY E
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIA---VKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
++G G FG V ++ +A VK L + AS + Q EF+ + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDS 614
G CVE +L++EY L S+L Q R S L +R I+ G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMH--- 116
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGL 643
+ +H DL N L DL K+ D+G+
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 54/310 (17%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQHR 551
+F + +G+G FG V + + +++ A+K LSK + + F E ++++
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 552 NLVRLLGCCVEREENML--IYEYMPNKSLDSFLFD---PQRQSLLDWPKRFNIIKGISRG 606
+V+L +++ L + EYMP L + + + P+ W RF + +
Sbjct: 104 WIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-----KW-ARFYTAE-VVLA 154
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L +H + IHRD+K N+LLD + K++DFG N VGT Y+
Sbjct: 155 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYI 210
Query: 667 SPEYAM----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722
SPE +G + + D +S GV L E++ G +T FY + +L+G K+ + N
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD----SLVGTYSKIMDHKN 264
Query: 723 VIDL-VDPLISESGFKMEII------RCVNVGLLCVQE------FVKD-------RPNMP 762
+ D IS+ ++I R V +G V E F D R +
Sbjct: 265 SLTFPDDIEISKQA--KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVA 322
Query: 763 TVVSMLNSEI 772
VV L+S+I
Sbjct: 323 PVVPELSSDI 332
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-----LVRLL 557
+G+G + V +L+ +I ++ K +E ++ V ++ + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSRL 616
C L+ EY+ L +F QRQ L + RF + I L +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG-- 116
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
II+RDLK N+LLD D + K++D+G+ + G D +T GT Y++PE +
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGTPNYIAPEILRGEEY 173
Query: 677 SEKSDVFSFGVLLLEIVSGR 696
D ++ GVL+ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 24/207 (11%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
+ K K +AVK+ L S + + E++ LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 561 VEREENMLIYEYMPNKS----LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
+ E ++ M S L + + + + I+K + L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIH---SK 120
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAA----TKRLVGTYGYMSPEY- 670
IHR +KAS+ILL D +S + + + Q K V ++SPE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 671 --AMEGRFSEKSDVFSFGVLLLEIVSG 695
++G ++EKSD++S G+ E+ +G
Sbjct: 181 QQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVI---SNLQHRNLVR 555
+G+G + V +L+ + I A+K + K E+ E V SN H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLVG 60
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLLYLHRDS 614
L C + E++ L +F QRQ L + RF + IS L +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG 116
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
II+RDLK N+LLD + + K++D+G+ + G + T GT Y++PE
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 675 RFSEKSDVFSFGVLLLEIVSGR 696
+ D ++ GVL+ E+++GR
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVI 545
F+ + ++ +++ +G+G +G V+K ++G + AVK L EE E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNIL 68
Query: 546 SNLQ-HRNLVRLLGCCVEREEN-----MLIYEYMPNKSL----DSFLFDPQRQSLLDWPK 595
L H N+V+ G +++ L+ E S+ FL +R ++ P
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPI 125
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
I+ GL +LH + + IHRD+K +NILL + K+ DFG++ + +
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 656 TKRLVGTYGYMSPEY-----AMEGRFSEKSDVFSFGVLLLEIVSG 695
T VGT +M+PE ++ + + DV+S G+ +E+ G
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 503 LGQGGFGPVYKGKLQD---------GQEIAVKRLSKASGQGQEE----FMNEVMVISNLQ 549
LG+G +Y G L E +K + K + F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS-LLDWPKRFNIIKGISRGLL 608
H+++V L G CV EN+++ E++ LD F+ R+S +L P +F + K ++ L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM---HRKSDVLTTPWKFKVAKQLASALS 119
Query: 609 YLHRDSRLRIIHRDLKASNILL-----DDDLNP--KISDFGLARIFGGNQDQAATKRLVG 661
YL D L +H ++ NILL D + P K+SD G+ Q+ V
Sbjct: 120 YL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VE 170
Query: 662 TYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 692
+++PE + + S +D +SFG L EI
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-09
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQHR 551
N +++ K+G G FG V+ K + QE + G + E + EV V+ L+H+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL--- 608
N+VR + + + N +Y M + Q+ + + I I+R LL
Sbjct: 73 NIVRYIDRFLNKA-NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 609 -YLHR----DSRLRIIHRDLKASNILLD-------------DDLN----PKISDFGLARI 646
Y H + R++HRDLK NI L ++LN KI DFGL++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 647 FGGNQDQAATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGR 696
G ++ VGT Y SPE + + +KSD+++ G ++ E+ SG+
Sbjct: 192 IG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKAS---GQGQEEFMNEVMVI-SNLQHRNLVRLL 557
+G+G FG V + + ++ AVK L K + + ++ M+E V+ N++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
++ + +Y+ L + QR+ P+ I+ L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
I++RDLK NILLD + ++DFGL + + T GT Y++PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 678 EKSDVFSFGVLLLEIVSG 695
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-09
Identities = 19/48 (39%), Positives = 31/48 (64%), Gaps = 1/48 (2%)
Query: 770 SEIKDLPAAKQPAFTVRRGAYDS-ASSSNQNQQICSINDVTVTLMEGR 816
SE ++P KQP F V R Y++ +SSS Q + ++N VTV++++ R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
+G+G FG V + + +D Q I A+K + KA + E + E V++ + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLR 617
E+ L+ ++ L L QR+ D + RF + L L +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYT----AELLCALENLHKFN 113
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
+I+RDLK NILLD + + DFGL ++ + D+ T GT Y++PE + ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYT 171
Query: 678 EKSDVFSFGVLLLEIVSGRKNTSFYHEE 705
+ D ++ GVLL E+++G FY E
Sbjct: 172 KAVDWWTLGVLLYEMLTGLP--PFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 47/147 (31%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFG-LARIFGGNQDQAATKRLVGTYGYMSPEY--A 671
+L +HRD+K N+LLD + + +++DFG R+ Q+ VGT Y+SPE A
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEILQA 177
Query: 672 ME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL-- 726
ME GR+ + D +S GV + E++ G T FY E T Y K+ N
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET---YG-KIMNHKEHFQFPP 231
Query: 727 VDPLISESGFKMEIIRCVNVGLLCVQE 753
+SE ++IR L+C E
Sbjct: 232 DVTDVSEEA--KDLIR----RLICSPE 252
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 9/162 (5%)
Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
E+ ++ + HR ++ L+ R ++ + MP D F + R L + I
Sbjct: 136 EIDILKTISHRAIINLIH--AYRWKS-TVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
+ + L YLH IIHRD+K NI LD+ N + DFG A + D
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFY 702
GT SPE + K+D++S G++L E+ KN + +
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTLF 288
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 35/222 (15%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFMNEVMVISNLQH 550
+ +++L N +G G FG VY+ D E +A+K++ Q + E++++ NL H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNH 118
Query: 551 RNLVRL-----LGCCVEREENM---LIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNI 599
N++ L C + E+N+ ++ E++P +K + + + L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-------L 171
Query: 600 IKGIS----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQDQA 654
+K S R L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ Q
Sbjct: 172 VKLYSYQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 655 ATKRLVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 695
+ + + Y +PE + ++ D++S G ++ E++ G
Sbjct: 229 S---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 495 NNFQLANKLGQGGFGPVY--KGKLQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQ 549
+F + + +G+G FG V + K G A+K + K+ QE F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---FDPQRQSLLDWPKRFNIIKGISRG 606
+ +L +++ L+ EY P L S L D + + +F + + +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAELV--- 112
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L +H ++ +HRD+K N+L+D + K++DFG A N+ +K VGT Y+
Sbjct: 113 -LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYI 170
Query: 667 SPEY--AMEG----RFSEKSDVFSFGVLLLEIVSGR 696
+PE M G + + D +S GV+ E++ GR
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 31/76 (40%), Positives = 41/76 (53%)
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
IHRDL A NILL KI DFGLAR + + +M+PE ++
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 679 KSDVFSFGVLLLEIVS 694
+SDV+S+G+LL EI S
Sbjct: 296 ESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI-FGGNQDQAATKRLVGTY 663
R L Y+H + + HRDLK NIL + D KI DFGLAR+ F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 664 GYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y +PE + +++ D++S G + E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD--SFLFDPQRQSLLDWPKRFN 598
E ++ + H ++++L G + LI +P D +L + ++ D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
I + + R + YLH + RIIHRD+KA NI ++ + + DFG A F + +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYG 242
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
GT +PE + D++S G++L E+ +
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQHR 551
+F++ +G+G FG V KL++ ++ A+K L+K + E F E V+ N ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
+ L + L+ +Y L + L + + D + + ++ ++ +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAID 116
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFG-LARIFGGNQDQAATKRLVGTYGYMSPEY 670
+L +HRD+K NIL+D + + +++DFG ++ Q++ VGT Y+SPE
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEI 174
Query: 671 --AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706
AME G++ + D +S GV + E++ G T FY E
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
IHRD+ A N+LL D KI DFGLAR + + +M+PE + ++
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 679 KSDVFSFGVLLLEIVS-GRK-------NTSFY 702
+SDV+S+G+LL EI S G+ N+ FY
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
++RG+ +L + +HRDL A N+LL KI DFGLAR + + +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 663 YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE + ++ SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 26/78 (33%), Positives = 47/78 (60%)
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF 676
+++HRDLK++NI L K+ DFG ++ + + GT Y++PE R+
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 677 SEKSDVFSFGVLLLEIVS 694
S+K+D++S GV+L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN---EVMVISNLQH 550
++F+ +G+G FG V + +D G A+K L KA +E+ + E ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+V++ ++ LI E++P + + L ++ +L + +F I + +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGL--------------------------- 643
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 644 -------ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
A + N+ Q A VGT Y++PE M+ +++ D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYST-VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 45/238 (18%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN---EVMVISNLQHR 551
+F+ +G+G FG V + +D G A+K L KA +E+ + E ++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
+V++ ++ LI E++P + + L ++ +L + +F I + + L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETV----LAID 115
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGL---------------------------- 643
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 644 ------ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
A + N+ Q A VGT Y++PE M+ +++ D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFST-VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 63/249 (25%), Positives = 114/249 (45%), Gaps = 24/249 (9%)
Query: 489 ELANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMV 544
+L ++++ +G+G FG V + + +++ A+K LSK + + F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
++ +V+L + ++ EYMP L + + S D P+++ +
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM------SNYDVPEKWARFY-TA 149
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD-QAATKRLVGTY 663
+L L + IHRD+K N+LLD + K++DFG N++ VGT
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAVGTP 207
Query: 664 GYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN 719
Y+SPE +G + + D +S GV L E++ G +T FY + +L+G K+ N
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD----SLVGTYSKIMN 261
Query: 720 DNNVIDLVD 728
N + D
Sbjct: 262 HKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 495 NNFQLANKLGQGGFGPVYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
+N Q LG G FG V + GK + +AVK L + A +E M+E+ ++S+
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNII 600
L QH+N+V LLG C ++I EY L +FL F +L + + +
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 601 KGISRGLLYLHRDS 614
K I+ Y+ DS
Sbjct: 158 KNITLEKKYIRSDS 171
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEFMNEVMVISNLQHR 551
++F+ +G+G FG V + +D I A+K+L K+ + Q + I
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
V L + E + LI EY+P + + L ++ + + RF I + +L +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYI----AETILAI 114
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGL------------ARIFGGN-------- 650
+L IHRD+K N+LLD + K+SDFGL RI
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 651 -------QDQAAT-KR--------LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +A T KR VGT Y++PE ++ ++++ D +S GV++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 695 G 695
G
Sbjct: 235 G 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
F + + +G FG VY G K + + AVK + KA + +N+ MV R+ +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDALA 59
Query: 556 L--------LGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
L L ++ N+ L+ EY+ + S L D I ++
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL---HIYGYFDEEMAVKYISEVALA 116
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
L YLHR IIHRDLK N+L+ ++ + K++DFGL+++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 28/76 (36%), Positives = 42/76 (55%)
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE 678
+HRDL A N+L+ + KI DFGLAR + + + +M+PE ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 679 KSDVFSFGVLLLEIVS 694
SDV+SFG+LL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 503 LGQGGFGPVYKGKL--------QDGQEIAVKRLSKASGQGQE-----------------E 537
LGQG +Y G+L ++ + L + + G+E
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 538 FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
F ++S + H +L + G CV EN+++ E++ + LD L + + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNIL-----LDDDLNP--KISDFGLARIFGGN 650
+ + ++ L YL + ++H ++ A NIL L + +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 651 QDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEI 692
+ +R+ +++PE G S +D +SFG LLEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 63/240 (26%), Positives = 97/240 (40%), Gaps = 45/240 (18%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
F+ LG+G G V+ +L+ G+ A+K L K + + + E +++ L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 553 LVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQS---LLDWPKRFNIIKGISRGLL 608
L L + E + L+ +Y P L L QRQ L + RF + + L
Sbjct: 63 LPTLY-ASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAE-VLLALE 117
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL-------------ARIFGGNQDQAA 655
YLH L I++RDLK NILL + + +SDF L A G +
Sbjct: 118 YLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 656 --------------TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 701
+ VGT Y++PE D ++ G+LL E++ G T F
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT--TPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 58/247 (23%), Positives = 104/247 (42%), Gaps = 63/247 (25%)
Query: 503 LGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQHRNLVRLLG 558
LG G FG V K+ A+K L K + + + E +++ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+++ + +Y+P + S L P+ + RF I + ++ + +H+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA------RFYIAE-LTLAIESVHK-- 119
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIF----------GGNQ------------- 651
+ IHRD+K NIL+D D + K++DFGL F G+
Sbjct: 120 -MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 652 --------------DQAATKR--------LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
+Q ATK+ LVGT Y++PE + +++ D +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 690 LEIVSGR 696
E++ G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 59/250 (23%), Positives = 106/250 (42%), Gaps = 55/250 (22%)
Query: 495 NNFQLANKLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQH 550
+F +G+G FG V K G+ A+K L K+ +++ + E V++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+V L + + LI E++P L + L + + + RF + + + L +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECV----LAI 114
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-------------RIFGG-------- 649
+L IHRD+K NIL+D + K+SDFGL+ ++ G
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 650 ---------------NQDQAAT----KRL-----VGTYGYMSPEYAMEGRFSEKSDVFSF 685
++DQ AT +RL VGT Y++PE ++ + ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 686 GVLLLEIVSG 695
G ++ E + G
Sbjct: 235 GAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 488 EELANATNNFQLANKLG--QGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMN--EVM 543
EL N ++ KL G FG V K + Q++ V+++ KA + F N E M
Sbjct: 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKA-----KNF-NAIEPM 60
Query: 544 VISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIK 601
V ++ + N ++L + ++LI +Y+ D LFD +++ L + II+
Sbjct: 61 VHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFG--GNQDQAATKR 658
+ L LH+ IIH D+K N+L D + + D+GL +I G D
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------ 167
Query: 659 LVGTYGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSG 695
GT Y SPE ++G + S D ++ GVL E+++G
Sbjct: 168 --GTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 16/102 (15%)
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI---------FGGNQD----Q 653
L YLH I+HRDLK N+L+ + K++DFGL++I + G+ + +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
K++ GT Y++PE + + + D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 41/123 (33%)
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGL---------ARIFGGNQ-------------- 651
++ IHRD+K NIL+D D + K++DFGL ++ +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 652 --DQAATK----------------RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 693
D+ K LVGT Y++PE + +++ D +S GV+L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 694 SGR 696
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 46/210 (21%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEE-FMNEVM------VIS 546
+F L KLG+G FG VYK L + Q + L KA+ G E +MNE + +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192
Query: 547 NLQHRNLVRLLGCCVEREENMLIYEY---------MPNK----SLDSFLFDPQRQSLLDW 593
+ + L + + +E L++ Y M +K +++ +L + Q L
Sbjct: 193 DFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLG-KVQDLPKG 249
Query: 594 PKRFN-IIKGISRGLLY----LHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIF 647
+R N II+ I R +L+ LH I+HRD+K NI+ + KI D G
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG----- 301
Query: 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFS 677
AA VG Y+ E+ ++ R++
Sbjct: 302 ------AAADLRVG-INYIPKEFLLDPRYA 324
|
Length = 566 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-05
Identities = 30/123 (24%), Positives = 55/123 (44%), Gaps = 11/123 (8%)
Query: 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL----YLHRDSRLRIIHRDLKASNI 628
+P D + + R L + + ++R LL Y+H + IIHRD+K N+
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENV 291
Query: 629 LLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVL 688
L++ + + DFG A G+ + GT +PE ++ D++S G++
Sbjct: 292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 689 LLE 691
+ E
Sbjct: 352 IFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 55/249 (22%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEFMN---EVMVISNLQHRN 552
F LG G FG V + D + + A+K L K + + + E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+VRL +++ + +Y+P + S L R + I ++ + +H+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHK 119
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD-------------------- 652
+ IHRD+K NIL+D D + K++DFGL F D
Sbjct: 120 ---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 653 ------------------QAATKR-------LVGTYGYMSPEYAMEGRFSEKSDVFSFGV 687
+AA + LVGT Y++PE + +++ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 688 LLLEIVSGR 696
+L E++ G+
Sbjct: 237 ILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 40/196 (20%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 511 VYKGKLQDGQEIAVKRL---SKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567
+YKG + +E+ ++ K + NE+ + + N++++ G ++ +++
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 568 ----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRD 622
LI EY L L D ++ L + + ++ +GL L++ ++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148
Query: 623 LKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME--GRFSEKS 680
L + + L+ ++ KI GL +I K V Y S + + ++ K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILS----SPPFKN-VNFMVYFSYKMLNDIFSEYTIKD 203
Query: 681 DVFSFGVLLLEIVSGR 696
D++S GV+L EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 32/147 (21%), Positives = 53/147 (36%), Gaps = 15/147 (10%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV--RLLGC 559
L G VY +D + +K E EV ++ L + L ++L
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
+ L+ E++ ++LD S + + + L LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111
Query: 620 HRDLKASNILLDDDLNPKISDFGLARI 646
H DL NIL+DD I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 595 KRFNIIKGISRGLLY-LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
+ N+IKG+ R +L L + R+ I+HRD+K N+L+ D KI DFG A D
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA------VDM 359
Query: 654 AATKRLVGTYGYMSPEYA 671
YG + P Y+
Sbjct: 360 CTGINFNPLYGMLDPRYS 377
|
Length = 507 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 52/241 (21%)
Query: 488 EELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIA----VKRLSKASGQGQEE--FMNE 541
E++ +T F++ + LG+G FG V + + +E V+ + K + + E FM +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKR---F 597
V +R M I Y N++ + P+ LLDW + F
Sbjct: 182 VR-------------QADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF 228
Query: 598 N------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNP------------ 636
+ II L Y H + L ++H DLK NIL+ D ++P
Sbjct: 229 SHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286
Query: 637 -KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
+I D G G ++ + +V T Y SPE + + +D++S G ++ E+ +G
Sbjct: 287 VRICDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 696 R 696
+
Sbjct: 342 K 342
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 14/108 (12%)
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF----GGNQDQ 653
NI+ G RGL YLH++ IHR++KAS+IL+ D +S GL+ ++ G + +
Sbjct: 105 NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159
Query: 654 AA---TKRLVGTYGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 696
+ ++SPE + ++ KSD++S G+ E+ +GR
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 32/96 (33%), Positives = 42/96 (43%), Gaps = 8/96 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
N LG G FG V + K +AVK L A +E M+E+ V+S
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL 582
L H N+V LLG C ++I EY L +FL
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
+N L LG G FG V + Q ++AVK L S A ++ M+E+ ++S+
Sbjct: 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH 96
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEY 572
L H N+V LLG C + +I EY
Sbjct: 97 LGPHLNIVNLLGACTKGGPIYIITEY 122
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LHR+ I+ RDL +NILLDD + +++ F + D A + + Y +PE
Sbjct: 101 LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPE 152
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+E D +S G +L E+++G+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 816 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.22 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.06 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.89 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.88 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.78 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.77 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.6 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.4 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.38 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.12 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.84 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.73 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.45 | |
| PLN02236 | 344 | choline kinase | 96.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.85 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.36 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.19 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=464.28 Aligned_cols=289 Identities=46% Similarity=0.797 Sum_probs=257.3
Q ss_pred cccccCHHHHHHHhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEE
Q 003489 481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560 (816)
Q Consensus 481 ~~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 560 (816)
....|++.++..+|++|...+.||+|+||.||+|.+++++.||||++.....+..++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443155699999999999999999999999
Q ss_pred EecCc-ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceee
Q 003489 561 VEREE-NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639 (816)
Q Consensus 561 ~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 639 (816)
.+.+. .+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||....++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99994 99999999999999999875544 89999999999999999999999988899999999999999999999999
Q ss_pred ccccceecCCCCcccccccc-cccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh
Q 003489 640 DFGLARIFGGNQDQAATKRL-VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 640 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
|||+|+..... ....... .||.+|+|||+...+..+.|+||||||++|+||+||+++.+...+..+..+..|+++.+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999654321 1111112 89999999999999999999999999999999999999888766556667999999999
Q ss_pred ccCCcccccccccc-ccccH-HHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 719 NDNNVIDLVDPLIS-ESGFK-MEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 719 ~~~~~~~l~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
..+++.+++|+.+. ..... +++.++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999987 45444 68999999999999999999999999999996653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=387.79 Aligned_cols=261 Identities=33% Similarity=0.479 Sum_probs=211.7
Q ss_pred cccccccCCCCceeEEEeEecCCcEEEEEEecccCch--hHHHHHHHHHHHhhcCCCceeeeeeEEEecC-cceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQHRNLVRLLGCCVERE-ENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~ 573 (816)
+.+.+.||+|+||+||+|.+.....||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445669999999999999984444999999764322 2569999999999999999999999999988 789999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-CceeeccccceecCCCCc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQD 652 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 652 (816)
++|+|.++++.. ....+++..+++++.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999764 45679999999999999999999999874 99999999999999997 99999999998764322
Q ss_pred ccccccccccccccChhccc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAM--EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.......||+.|||||++. ...++.|+||||||++||||+||+.||........ +...........
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~~Rp~----- 266 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGGLRPP----- 266 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCCCCC-----
Confidence 2233368999999999999 66899999999999999999999999986554211 111111111111
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCCC
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPA 777 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~~ 777 (816)
+. ......+..++.+||+.||+.||++.|++.+|+.+......
T Consensus 267 ~p----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 267 IP----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CC----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11 11445677778889999999999999999999988665554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=379.00 Aligned_cols=255 Identities=35% Similarity=0.562 Sum_probs=213.8
Q ss_pred CcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
.+++.+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..+++.+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34567899999999999999997789999999765 35567899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|.+||+. ..+..+...+.+.++.|||+||+||++++ +|||||..+||||+++..+||+|||||+...++. ...
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTA 360 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-eee
Confidence 999999976 34567899999999999999999999998 9999999999999999999999999999544333 233
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 734 (816)
.....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++.....+....+....++ .
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl----------------p 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL----------------P 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC----------------C
Confidence 334566889999999999999999999999999999999 77777655554333333222211 2
Q ss_pred ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 735 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
.+......+.+|+..||+.+|++|||++.+...|+...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 22334566778889999999999999999999998763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=372.04 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=210.4
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
.+|...+.||+|+|+.||.++. ..|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999996 88999999999763 3455678899999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
|+|++++|..+++ +++++++.+++.++.||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 5678999999999999999999999998 999999999999999999999999999987543
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.......+|||.|+|||++.....+..+||||+||+||-||.|++||+...-.+....+.... ..+
T Consensus 172 --~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~---------Y~~--- 237 (592)
T KOG0575|consen 172 --GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE---------YSM--- 237 (592)
T ss_pred --ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC---------ccc---
Confidence 344556899999999999999999999999999999999999999997543322222111110 000
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+........+++..++++||++|||+.+|+.
T Consensus 238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122345567788999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=391.71 Aligned_cols=263 Identities=30% Similarity=0.461 Sum_probs=219.1
Q ss_pred HhcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
...+.+..+.||+|+||+||+|+.. +...||||.++..... .+++|++|++++..++|||||+++|+|.++++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3466777899999999999999753 3567999999876655 78899999999999999999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCC----------C-CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQ----------R-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL 634 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~----------~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 634 (816)
.++|+|||..|+|.+||.... . ..+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996321 1 334899999999999999999999988 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHH
Q 003489 635 NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGY 713 (816)
Q Consensus 635 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~ 713 (816)
.+||+||||++.....+.........-+.+|||||.+..++||.+||||||||+|||+++ |+.|+.....++....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~--- 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC--- 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH---
Confidence 999999999997655444433333455789999999999999999999999999999999 7788776555433222
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccC
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 774 (816)
...+++. ..+......+..|++.||+.+|.+||+++||-..|....+.
T Consensus 718 ----i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 ----IRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----HHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2223222 23344567888999999999999999999999999776443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=353.11 Aligned_cols=250 Identities=29% Similarity=0.384 Sum_probs=206.0
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc-ceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-NMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~e~ 572 (816)
+++..+.||+|..|+||+++++ +++.+|+|.+... ....++++.+|++++.+.+||+||.++|.|..... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455789999999999999976 5778999998543 44567889999999999999999999999999985 9999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++|+|++++... +.+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|.+||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999533 568999999999999999999996 55 999999999999999999999999999877433
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCch--hhhhhHHHHHHHhhccCCccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE--EFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+ ....+++.++... ..|
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---------ppP 300 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---------PPP 300 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---------CCC
Confidence 34557999999999999999999999999999999999999999876411 2222333332211 112
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+... ...+++..++..|++.||.+||++.|+++.
T Consensus 301 ~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22221 234567788889999999999999999753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=354.47 Aligned_cols=202 Identities=31% Similarity=0.570 Sum_probs=181.1
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
..+|.+.++||.|+||+||+|+++ ++.+||||.+.+. ....++.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367888899999999999999965 5789999999765 5667788899999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC------CCceeeccccc
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD------LNPKISDFGLA 644 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~DfGla 644 (816)
|||.||+|.+||+. .+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999953 447999999999999999999999999 9999999999999765 45899999999
Q ss_pred eecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCch
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~ 704 (816)
+.+.. .......+|++-|||||+++.++|+.|+|+||+|++||||++|+.||.....
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 98753 3334457999999999999999999999999999999999999999875443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=352.39 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=200.5
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCc-------hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG-------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
.+.|.+.+.||+|+||.|-+|. .++++.||||++++... .......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4677888999999999999997 45799999999975311 123345799999999999999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC---CCceeeccc
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFG 642 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DfG 642 (816)
.|+||||++||.|.+++- ..+.+.+....-++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999984 3455777777889999999999999999 9999999999999765 689999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCC---CchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhc
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF---SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN 719 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 719 (816)
+|+..+ ........+||+.|.|||++..... ..+.|+||+||+||-+|+|.+||+...... .+.+.+ .
T Consensus 325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI----~ 395 (475)
T KOG0615|consen 325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQI----L 395 (475)
T ss_pred hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHH----h
Confidence 999864 3445667899999999999987653 347899999999999999999987433221 111111 0
Q ss_pred cCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 720 DNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 720 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.++... ......+..++.++++.+|++.||++||++.|+++
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111100 00112334567788889999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=338.31 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=209.8
Q ss_pred cCcccccccCCCCceeEEEeE-ecCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCceeeeee-EEEecCc-ceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLG-CCVEREE-NMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 569 (816)
.+|+++++||+|.||+||++. +.+|..||.|.+.- .+.+..+....|+.+|++|+|||||++++ .+.+.+. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999997 66899999998863 34455678899999999999999999999 5556665 7899
Q ss_pred EeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCC-CcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 570 YEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSR-LRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
||++..|+|..+|+.. +..+.+++..+++++.|++.||.++|..-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999653 345679999999999999999999998421 13999999999999999999999999999988
Q ss_pred CCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.... ......+|||.||+||.+.+.+|+.|+||||+||++|||+.-.+||... ++.. ..+....++...+.
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPPLP 249 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCCCc
Confidence 5433 3344589999999999999999999999999999999999999998643 1211 12222333222121
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.......+.+|+..|+..||+.||+...++..+...
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 133456777888899999999999976666666554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=368.65 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=217.5
Q ss_pred cCcccccccCCCCceeEEEeEecC----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
....+.+.||.|.||.|++|+++- ...||||.++... +....+|+.|+.||.+++||||++|.|+....+..++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999999762 3469999998754 44567899999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
.|||++|+|+.||+... +.+.+.+..-++++||.||+||.+.+ +|||||..+|||++.+..+|++||||++.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997654 45999999999999999999999988 99999999999999999999999999998865
Q ss_pred CCcc-cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 650 NQDQ-AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 650 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
..+. ..+...+-+.+|.|||.+...+++.++||||||+++||.++ |.+|+=.....+ +...+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIkaI 847 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKAI 847 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHHH
Confidence 5422 22333445789999999999999999999999999999887 888864333322 22222
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccC
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 774 (816)
..-.+-..+++....|.+|++.|||.|..+||.+.+|+.+|++.++.
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22233334556778899999999999999999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.85 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=199.8
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
.++|++.+.||+|+||+||+++. ++++.+|+|.+++. .....+..++|..+|.+++||.||+++..|++.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999985 45888999999764 234567889999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
+||+.||.|..+| +++..+++..+.-++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 45567899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
....+...+||+.|||||++....|+..+|.||+|+++|||++|.+||........ .... ..++. ...
T Consensus 178 --~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I-~~~k~-~~~-- 245 (357)
T KOG0598|consen 178 --DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKI-LKGKL-PLP-- 245 (357)
T ss_pred --CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHH-hcCcC-CCC--
Confidence 33345558999999999999999999999999999999999999999875332211 1111 11110 000
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRP 759 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 759 (816)
..-......+++...++.||++|-
T Consensus 246 ------p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 ------PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CccCCHHHHHHHHHHhccCHHHhc
Confidence 011234556777789999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.74 Aligned_cols=269 Identities=27% Similarity=0.407 Sum_probs=206.6
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhh--cCCCceeeeeeEEEecC----cceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISN--LQHRNLVRLLGCCVERE----ENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 568 (816)
...++.+.||+|.||.||||+++ ++.||||++.. +..+.|++|-++.+. ++|+||++++++-..+. +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556789999999999999997 69999999954 566788888888775 58999999999987766 7799
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc------CCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD------SRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
|+||.+.|+|.+|| +...++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 456799999999999999999999976 34579999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCC-CC-----chhhhHHHHHHHHHHHhCCCCCC-CCchhhhhhHH----
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR-FS-----EKSDVFSFGVLLLEIVSGRKNTS-FYHEEFELTLL---- 711 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDV~SlG~vl~elltG~~p~~-~~~~~~~~~l~---- 711 (816)
||..+............+||.+|||||++.+.- +. .+.||||+|.|||||++...-.. ...++...-..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999988776666666689999999999997643 22 36899999999999999765332 11111111110
Q ss_pred -----HHHHHhh-ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCC
Q 003489 712 -----GYAWKLW-NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775 (816)
Q Consensus 712 -----~~~~~~~-~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l 775 (816)
+..+... .+.....+.|..... ..+..+.+.+..||..||+.|-|+.=|-+++.++...-
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111 111111122211211 34567778888999999999999999999998774433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.64 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=208.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
+.|+.+.++|+|+||.||+++.+ +|+.||||++.+.. ..-.+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999976 58999999996543 2334567899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++..-|+++=+. ..-++...+.+++.|+++|+.|+|+++ ++||||||+||||+.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 9987666654422 234788889999999999999999998 99999999999999999999999999998854
Q ss_pred cccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH--------HHhhccCC
Q 003489 652 DQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA--------WKLWNDNN 722 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 722 (816)
.....+..+.|..|.|||.+.+ .+|....|||++||++.||++|.+-|+..++-+...++... ...+....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2233445788999999999987 68999999999999999999999998887776555444322 12222222
Q ss_pred cc-ccccccccc-----cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VI-DLVDPLISE-----SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~-~l~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.. .+.-|.... ...+....-+++++..|++.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 21 111111111 111223456789999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=352.21 Aligned_cols=263 Identities=29% Similarity=0.430 Sum_probs=205.0
Q ss_pred HhcCcccccccCCCCceeEEEeEe------cCCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecC
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 564 (816)
..++|++.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999974 235679999987543 23456789999999999 8999999999887654
Q ss_pred -cceEEEeeCCCCCccccccCCCC--------------------------------------------------------
Q 003489 565 -ENMLIYEYMPNKSLDSFLFDPQR-------------------------------------------------------- 587 (816)
Q Consensus 565 -~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 587 (816)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 56899999999999998864211
Q ss_pred ---CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccccccccc
Q 003489 588 ---QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664 (816)
Q Consensus 588 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 664 (816)
..++++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 234788889999999999999999998 99999999999999999999999999986543322222233456788
Q ss_pred ccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHH
Q 003489 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRC 743 (816)
Q Consensus 665 y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l 743 (816)
|+|||++....++.++||||||++||||++ |..||+....... +.. ....+..... .......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~~~~~~---------~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKDGTRMRA---------PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhcCCCCCC---------CCCCCHHH
Confidence 999999999999999999999999999997 9999865432211 111 1111111100 11123467
Q ss_pred HHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 744 VNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 744 ~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.+++.+|++.+|++|||+.||+++|++++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=347.67 Aligned_cols=270 Identities=28% Similarity=0.439 Sum_probs=212.9
Q ss_pred HHHHHHhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 488 EELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 488 ~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
+++....+.+.+.+.||+|.||+||+|++. ..||||.+.... ....+.|++|+.++++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344444566778899999999999999986 469999997653 3456789999999999999999999999998887
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.||..+|+|.+|+.+||..+ ..++..+.+.|++|||+||.|||.++ |||||||+.||+|.+++.+||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997643 45899999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccChhcccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
.-..-..........|...|||||+++. .+|+.++||||||+|+|||++|..|+.....+.- . |.-++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------i--fmVGr 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------I--FMVGR 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------E--EEecc
Confidence 6433322333344567889999999864 4689999999999999999999999872211110 0 11111
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCCC
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPA 777 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~~ 777 (816)
-.-..|.... ......++.+|...||..++++||.+.+|+.+|+.++..+|.
T Consensus 608 G~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 608 GYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred cccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 1111111111 112345677888899999999999999999999888766543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.07 Aligned_cols=265 Identities=24% Similarity=0.317 Sum_probs=209.9
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhH-HHHHHHHHHHhhcC-CCceeeeeeEEEecC-cceEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQ-HRNLVRLLGCCVERE-ENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 569 (816)
.++|.+.++||.|+||.||+|+ ..+++.||||++++.....+ ..=++|+..|++|. ||||+++..++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4689999999999999999998 45789999999976543322 23468999999998 999999999999988 88999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||| ..+|.+++++. +.++++.+++.|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||||+.+..
T Consensus 89 fE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 9999 67999999764 678999999999999999999999999 99999999999999999999999999997643
Q ss_pred CCcccccccccccccccChhccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc---
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID--- 725 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 725 (816)
. ...+..+.|..|+|||++. .+-|+.+.|+|++||+++|+.+-++-|+...+.++..-+-.+.....+....+
T Consensus 163 k---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 K---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred C---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 2 3344578899999999875 56789999999999999999999998887666544333222211111111111
Q ss_pred ---c---cccccccc----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 726 ---L---VDPLISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 726 ---l---~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
. .=|...+. -.+....++++++.+|+++||.+|||+.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0 00111111 112245678889999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=309.34 Aligned_cols=284 Identities=23% Similarity=0.349 Sum_probs=222.9
Q ss_pred cCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|...++||+|.||.||+|+ .++|+.||||+++.... .-.....+|+..|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778999999999999998 56799999999865422 224567899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|| ..+|...|++ +...+...++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 4689988865 3467899999999999999999999998 9999999999999999999999999999986544
Q ss_pred cccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc---cc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID---LV 727 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---l~ 727 (816)
.... ..+.|..|.|||.+.+. .|+...|+||.||++.||+-|.+-++...+-+....+-.+.....++.+.+ +.
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 3322 23789999999998865 589999999999999999999987776655544433332222222222211 11
Q ss_pred c---------ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCCCCCCCceecccCc
Q 003489 728 D---------PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRRGA 789 (816)
Q Consensus 728 d---------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~~~~~p~~~~~~~~ 789 (816)
| +.+. ..........++++..++..||.+|++++|++++= .. +++|.|..|..+..+..
T Consensus 234 dY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf-~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YF-KSLPLPTPPSKLPIPST 301 (318)
T ss_pred cHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcch-hh-hcCCCCCChhhCcCCcc
Confidence 1 1111 12233455668999999999999999999998853 33 67788888877765444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.38 Aligned_cols=262 Identities=25% Similarity=0.362 Sum_probs=207.6
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.+.|++.+.||.|..++||+|+ ...++.||||++.-.. ....+.+++|+..|+.++||||++++..|..+...++||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999998 5578999999997543 2335889999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
||.+|++.++++..-.. -+++..+..|++++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999654333 3899999999999999999999999 9999999999999999999999999876654433
Q ss_pred cccc-c-ccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 652 DQAA-T-KRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 652 ~~~~-~-~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.... . ...+||+.|||||+++. ..|+.|+||||||++..||.+|..||..+.+-.. |.. +..+......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~---tLqn~pp~~~-- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLL---TLQNDPPTLL-- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHH---HhcCCCCCcc--
Confidence 2221 1 56799999999999654 4689999999999999999999999987665321 110 1111111000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
-..+..+........+.+++..|++.||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111111222346778888999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.45 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=200.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC--cceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--ENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 571 (816)
.++...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|.+++|||||+.+|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677899999999999999865 48999999886654333677899999999999999999999855554 5789999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCceeeccccceecCC-
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG- 649 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~- 649 (816)
|+++|+|.+++..... .+++..+.++++||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965332 6999999999999999999999998 999999999999999 79999999999987653
Q ss_pred CCcccccccccccccccChhccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
...........||+.|||||++..+. ...++|||||||++.||+||++||..... ...+............+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~ig~~~~~P~ip- 245 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLIGREDSLPEIP- 245 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHHhccCCCCCCC-
Confidence 11222344578999999999998643 33599999999999999999999875311 111111111111111111
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
........+++..|++.+|++|||+.|+++..
T Consensus 246 --------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 246 --------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --------cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11234556777899999999999999998865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=374.34 Aligned_cols=264 Identities=31% Similarity=0.469 Sum_probs=215.7
Q ss_pred hcCcccccccCCCCceeEEEeEecC--Cc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD--GQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 566 (816)
..+.+..+.||+|.||.||.|...+ +. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3566778899999999999998653 33 3899999775 456678999999999999999999999999999999
Q ss_pred eEEEeeCCCCCccccccCCC----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 567 MLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
++++|||++|+|..||++.+ ....|...+.+.++.|||+|+.|||+++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997652 2456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
+|+.+.+...........-+.+|||||.+..+.++.|+|||||||+|||++| |..||+..+..+... . ..+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---~---~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---D---VLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH---H---HHhCC
Confidence 9996554444433333355689999999999999999999999999999999 667776544432211 0 11222
Q ss_pred CccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCC
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~ 776 (816)
+| +........+.+++.+||+.+|++||++..+++.+..++....
T Consensus 922 --------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 --------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred --------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11 1223345677799999999999999999999999988765543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.38 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=209.1
Q ss_pred cCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
..|....+||+|+.|.||.++ ..+++.||||++........+.+.+|+.+|+..+|+|||+++..+..++..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777899999999999997 5678999999997776667788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999983 345899999999999999999999999 99999999999999999999999999988754443
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.....+||+.|||||+.....|.+|.||||||++++||+-|.+||-...+-... +.....+ .|.++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng------~P~lk- 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPKLK- 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcC------CCCcC-
Confidence 455689999999999999999999999999999999999999998653331111 1111111 11111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
........+.++..+||+.|+++||++.|+++
T Consensus 491 -~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 -NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12223456778888999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.88 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=205.5
Q ss_pred HhcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcce
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 567 (816)
..++|.+.+.||+|+|++|++++ ...++++|||++.+.. ....+.+..|-++|.+| .||.|++|+..|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999998 4568999999997642 23345577899999999 8999999999999999999
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+|+||+++|+|.++|++ -+.+++...+.++.+|+.||+|||++| ||||||||+|||||++++++|+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999954 466999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCcc---------ccc--ccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHH
Q 003489 648 GGNQDQ---------AAT--KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK 716 (816)
Q Consensus 648 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 716 (816)
...... ... ...+||..|.+||++.....++.+|+|+|||+||+|+.|++||....+-.. ...+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---FqkI-- 299 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---FQKI-- 299 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---HHHH--
Confidence 643222 111 458999999999999999999999999999999999999999864433211 1111
Q ss_pred hhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 717 LWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 717 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.++ +-.+.+ .. .+...+|+...+..||.+|+|.+||.+.
T Consensus 300 -------~~l-~y~fp~-~f---p~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 -------QAL-DYEFPE-GF---PEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------HHh-cccCCC-CC---CHHHHHHHHHHHccCccccccHHHHhhC
Confidence 110 000111 11 2445567778999999999999999774
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.29 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=202.3
Q ss_pred cCcccccccCCCCceeEEEeEecC-----------------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-----------------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRL 556 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 556 (816)
++|++.++||+|+||.||++.+++ +..||+|.+.... ......|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 3369999987643 3345679999999999999999999
Q ss_pred eeEEEecCcceEEEeeCCCCCccccccCCC----------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEE
Q 003489 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620 (816)
Q Consensus 557 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 620 (816)
++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885321 1134788899999999999999999998 999
Q ss_pred eeeCCCcEEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCC--CC
Q 003489 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR--KN 698 (816)
Q Consensus 621 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~--~p 698 (816)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998664333222233345678999999998889999999999999999999754 45
Q ss_pred CCCCchhhhhhHHHHHHHhhccCCc-cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 699 TSFYHEEFELTLLGYAWKLWNDNNV-IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 699 ~~~~~~~~~~~l~~~~~~~~~~~~~-~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
+....... .............. .... ........+.+++.+||+.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQVYLF-------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccccccc-------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54332221 11111111111100 0000 011223567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.53 Aligned_cols=265 Identities=24% Similarity=0.366 Sum_probs=205.3
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 568 (816)
.+.|+.+++||+|+||.||+++ ..+|+.||+|+++-.. ........+||.+|++|.||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567778999999999999998 5679999999987554 34456678999999999999999999998877 67899
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
|+|||++ +|.-++.. ....++..++..++.||+.||+|||.++ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999954 67777743 2345899999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc---
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI--- 724 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--- 724 (816)
...... .+..+.|..|.|||++.+. .|+.+.|+||.||||.||+.|++.+....+-+....+-....-..+..+.
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 555443 3446789999999999875 69999999999999999999999887665544433322211111111111
Q ss_pred ----ccccc------cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 ----DLVDP------LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 ----~l~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+.+ .+.+. ........++++..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 11111 1112345667888899999999999998875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.38 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=215.7
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchh-HHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.+...+.++||+|-||.|.++....+..||||+++...... ..+|..|+++|.+|+||||++++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 45677889999999999999999878999999998765444 48999999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
|++|+|.+||..+.... +.-....+|+.|||.||+||.+.+ +|||||.++|+|++.++++||+|||+++-+.....
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999996543322 455667789999999999999988 99999999999999999999999999997766666
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh--CCCCCCCCchhhhhhHHHHHHHhhccCCccc-cccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFYHEEFELTLLGYAWKLWNDNNVID-LVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-l~d~ 729 (816)
.......+.+.+|||||.+..++++.++|||+||+++||+++ ..+|++...++.. ++-+..++..+.... +..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l~~- 768 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVLSR- 768 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceeccC-
Confidence 655556778899999999999999999999999999999866 5567665444322 222222222222111 111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+......+.++++.||..+.++||+++++...|.+.
T Consensus 769 ------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 ------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122345677999999999999999999999988654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=345.80 Aligned_cols=261 Identities=32% Similarity=0.388 Sum_probs=207.3
Q ss_pred hcCcccccccCCCCceeEEEeEecCC----cE-EEEEEecc---cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDG----QE-IAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~----~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
.++..+.++||+|+||.||+|++... .. ||||..+. .......+|++|+++|++++|||||+++|++....+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 45666779999999999999986532 23 89998874 345677899999999999999999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.++|||++.||+|.++|.+.. ..++..++++++.+.|.||+|||+.+ ++||||..+|+|++.++.+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999996533 25899999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
.-. ..........-+.+|+|||.+....++.++|||||||++||+++ |..|++....... ..++. ..+-.
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI~---~~~~r- 381 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKIV---KNGYR- 381 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHHH---hcCcc-
Confidence 532 11111112346789999999999999999999999999999999 7778765444311 11110 00100
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCC
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~ 776 (816)
...+......+..+..+||+.+|++||+|.++.+.|+.+.+...
T Consensus 382 --------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 382 --------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 01111223455566669999999999999999999988865544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.05 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=203.7
Q ss_pred hcCcccccccCCCCceeEEEeEe------cCCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 565 (816)
.++|++.+.||+|+||.||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999963 235689999986432 33456788999999999 89999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCCC----------------------------------------------------------
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQR---------------------------------------------------------- 587 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 587 (816)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854211
Q ss_pred --------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 588 --------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 588 --------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125788999999999999999999988 999999999999999999999999999876433222
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||.+....++.++||||||+++|||++ |..|+....... ...... ..+... ..+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~~--~~~--- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEGYRM--LSP--- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhCccC--CCC---
Confidence 22222345678999999999999999999999999999998 777875433221 111111 111100 000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
......+.+++.+|++.||++||++.||+++|++.
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01124577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.33 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=203.9
Q ss_pred hcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 565 (816)
.++|++.+.||+|+||.||+++.. ++..||+|+++... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357899999999999999998742 23579999997543 33456788999999999 89999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCC-----------------------------------------------------------
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQ----------------------------------------------------------- 586 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 586 (816)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred --------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 587 --------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 587 --------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
....+++.++++++.||++||+|||+.+ |+||||||+|||+++++.++|+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1134788899999999999999999998 99999999999999999999999999986543322222222
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFK 737 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 737 (816)
..++..|+|||++....++.++||||||+++|||++ |+.||+....... ..... ... . ....+ .
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~----~~~-~-~~~~~-------~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMV----KRG-Y-QMSRP-------D 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHH----Hcc-c-CccCC-------C
Confidence 345678999999998899999999999999999997 9999865433211 11111 110 0 00000 0
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 738 MEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 738 ~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
.....+.+++.+|++.+|++||++.+|+++|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11356778888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.59 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=203.9
Q ss_pred HhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc----Cc-hhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA----SG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREE 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 565 (816)
..++|.+.+.||+|+||+|+.|.. .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999974 46899999977653 12 33556778999999999 9999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-CCceeeccccc
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLA 644 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfGla 644 (816)
.++||||+.+|+|.+++.+ .+.+.+..+.+++.||+.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 456888999999999999999999999 9999999999999999 99999999999
Q ss_pred eecCCCCcccccccccccccccChhccccCC-CC-chhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGR-FS-EKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
.... .........+|++.|+|||++.... |+ .++||||+|++||.|++|+.||+..... .+... ...+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~k----i~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRK----IRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHH----HhcCC
Confidence 8764 2334455679999999999999877 86 7899999999999999999998752221 11111 01110
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHH
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVV 765 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl 765 (816)
. .+...+. ...+..++.+|++.||.+|+++.+|+
T Consensus 240 ~--~~p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 F--KIPSYLL-------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c--cCCCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 0000010 45677888899999999999999998
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=326.85 Aligned_cols=244 Identities=19% Similarity=0.284 Sum_probs=195.9
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCchh---HHHHHHHHHHHhhcCCCceeeeeeEEEe----cCcceEEEeeC
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVRLLGCCVE----REENMLIYEYM 573 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~ 573 (816)
..||+|++|.||+|++ +|+.||||.++...... .+.|.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 58999999997653333 4678899999999999999999999977 34568999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
++|+|.+++.. ...+++..+++++.+++.||+|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999954 34688999999999999999999985 5 7799999999999999999999999998653221
Q ss_pred ccccccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||....... +..... ..... +.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~---~~~~~-----~~ 242 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLII---NKNNS-----LK 242 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---hcCCC-----CC
Confidence 12467889999999976 679999999999999999999999987543221 111111 01100 00
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+. ......+.+++.+||+.||++|||+.||++.|+..
T Consensus 243 ~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 LP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 11234577888899999999999999999999765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=327.25 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=207.6
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..|+..+.||+|.||.||+|.. ..++.||+|++.-. .....+.+++|+.+|..++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566678999999999999985 46889999999754 445568899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+.+|++.+.|. ....+++....-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999993 3445588888889999999999999998 99999999999999999999999999987754332
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.....+||+-|||||++....|+.|+||||||++.+||++|.+|+...++.....+ +.+-..|.+.
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~ 232 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD 232 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc
Confidence 23568999999999999988999999999999999999999999887666322111 1122233444
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+ ...+.+.+++..|++.||+.||++.++++
T Consensus 233 ~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 G----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3 23345778888999999999999999865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=333.92 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=202.8
Q ss_pred ccccCHHHHHHHhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEE
Q 003489 482 LLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561 (816)
Q Consensus 482 ~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 561 (816)
+-.+.|++|. .++-||.|+.|.||+|+++ ++.||||+++... ..+++.|++|+|+||+.+.|+|.
T Consensus 118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 3445566654 3578999999999999997 8899999885432 24788999999999999999999
Q ss_pred ecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecc
Q 003489 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641 (816)
Q Consensus 562 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 641 (816)
...-.+||||||+.|-|...|+. +..+.......+..+||.||.|||.+. |||||||+-||||..+..+||+||
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred CCceeEEeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccc
Confidence 99999999999999999999953 455777788899999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC
Q 003489 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 642 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
|-++..... .....+.||..|||||++...+.++|.|||||||||||||||..|+...+... .+|. ...
T Consensus 257 GTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwG--VGs 325 (904)
T KOG4721|consen 257 GTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWG--VGS 325 (904)
T ss_pred cchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEe--ccC
Confidence 999875332 23345799999999999999999999999999999999999999986433310 0111 011
Q ss_pred CccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+...+.- ......-+.-++.+||+..|.+||++++++..|+=.
T Consensus 326 NsL~Lpv-------PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 326 NSLHLPV-------PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccccC-------cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2222221 222344566677899999999999999999999544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=373.98 Aligned_cols=261 Identities=26% Similarity=0.466 Sum_probs=212.4
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
..++..+.||+|+||.||+|+. .++..||||++...... ..+|++.+++++|||||++++++.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999986 57899999998653322 235688999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++|+|.++++ .++|.++.+++.||++||+|||.....+|+||||||+||+++.++.+++. |+.......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999993 27999999999999999999997655569999999999999999888875 665543211
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.....+++.|+|||++....++.++|||||||++|||+||+.|+..... ....+..|+............+|+.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 1123678999999999999999999999999999999999999853222 2334556665555555555666776643
Q ss_pred c--ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 734 S--GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 734 ~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
. ...++..++.+++.+|++.+|++||+|.||+++|+++.+
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2 345667788999999999999999999999999988754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.01 Aligned_cols=251 Identities=33% Similarity=0.558 Sum_probs=194.2
Q ss_pred ccccccCCCCceeEEEeEec-----CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 498 QLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 498 ~~~~~LG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++.+.||.|.||.||+|.++ .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 34679999999999999977 35679999996543 3347889999999999999999999999998888999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++|+|.++|... ....+++..+++++.||++||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999654 2356899999999999999999999988 9999999999999999999999999998763332
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.............|+|||.+....++.++||||||+++|||++ |+.|+....... +.... .+......
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~----~~~~~~~~---- 226 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL----KQGQRLPI---- 226 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH----HTTEETTS----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----ccccccee----
Confidence 2233333556789999999999999999999999999999999 677865443321 11111 11111111
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.......+.+++.+||+.+|++||++.++++.|
T Consensus 227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234567888899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.51 Aligned_cols=257 Identities=31% Similarity=0.517 Sum_probs=205.3
Q ss_pred cCcccccccCCCCceeEEEeEecC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
++|++.+.||+|+||.||+|.... ...||+|.+.... ....+.|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998643 2579999886543 234567899999999999999999999999999999
Q ss_pred EEEeeCCCCCccccccCCCC-------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC
Q 003489 568 LIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL 634 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 634 (816)
++|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854221 145888999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHH
Q 003489 635 NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGY 713 (816)
Q Consensus 635 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~ 713 (816)
.++|+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..|+....... +...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986543332222333456788999999988899999999999999999998 998876443321 1111
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
. ..+.... ........+.+++.+||+.+|++||++.||+++|++
T Consensus 239 i----~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 I----RSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1111111 112234567788899999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.08 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=202.7
Q ss_pred hcCcccccccCCCCceeEEEeEec----CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ....+.|.+|+..+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357889999999999999999753 35689999987643 2345678999999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 246899999999999999999999998 9999999999999999999999999876432
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
... ........++..|+|||.+....++.++||||||+++||+++ |+.|+....... ..... ......
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~~~--- 227 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDGFRL--- 227 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCCC---
Confidence 111 111112345678999999999999999999999999999775 999986543321 11111 111000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+ . .......+.+++..||+.+|++||++.||.+.|++.
T Consensus 228 -~-~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -P-A----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -C-C----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 0 111234577888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.09 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=204.2
Q ss_pred HhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
..++|+++..||+|+||.||+++- .+|..+|+|++++.. ....+.++.|-.+|....+++||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457999999999999999999984 469999999998754 3345678899999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
||||++||++..+| .+...|++..+..++.+++.|++-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 45577999999999999999999999999 9999999999999999999999999986432
Q ss_pred CC---------------------Ccccc------------------------cccccccccccChhccccCCCCchhhhH
Q 003489 649 GN---------------------QDQAA------------------------TKRLVGTYGYMSPEYAMEGRFSEKSDVF 683 (816)
Q Consensus 649 ~~---------------------~~~~~------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDV~ 683 (816)
.. .+... ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 00000 0124799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCchhhhh-hHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCC---
Q 003489 684 SFGVLLLEIVSGRKNTSFYHEEFEL-TLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP--- 759 (816)
Q Consensus 684 SlG~vl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP--- 759 (816)
|||||+||||.|.+||....+.... .++.|-.....+. ......+..+++.+|+. ||++|-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999877665443 3333332111111 11112455677778888 999995
Q ss_pred ChHHHHH
Q 003489 760 NMPTVVS 766 (816)
Q Consensus 760 t~~evl~ 766 (816)
.++||.+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 4666654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.21 Aligned_cols=255 Identities=30% Similarity=0.452 Sum_probs=205.8
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.++|++.+.||+|++|.||+|..++++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45788999999999999999998778899999986543 34677999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.... ...+++..+.+++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999998 999999999999999999999999999876522111
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......+..|+|||++....++.++||||||++++||++ |+.|+....... +.... ..... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~--~------ 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQV----DQGYR--M------ 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCC--C------
Confidence 1111233468999999998899999999999999999999 888876433221 11111 01000 0
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.22 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=209.3
Q ss_pred cCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 345689999876666666789999999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCC-------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCC
Q 003489 569 IYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 635 (816)
||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1234889999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHH
Q 003489 636 PKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYA 714 (816)
Q Consensus 636 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~ 714 (816)
++|+|||++................++..|+|||.+....++.++||||||+++|||++ |+.|+....... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999976543322222233456788999999998999999999999999999999 998876543322 1111
Q ss_pred HHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 715 WKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 715 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
...+...... ......+.+++.+|++.+|++||++.+|+++|+++.+
T Consensus 238 ---~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111111110 1123467789999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=326.29 Aligned_cols=264 Identities=26% Similarity=0.374 Sum_probs=212.2
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. ....+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888899999999999999865 57889999997643 3445678999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+.| +|..+|. ....+++..+..++.+++.||.|||+.+ |+|||+||+|||+++++.+|++|||+|+.+..+
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9976 9999994 4456899999999999999999999998 999999999999999999999999999987542
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
....+...||+-|||||+..++.|+..+|.||+||+|||+.+|++||... .+...+.....++ +.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~-v~------- 218 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP-VK------- 218 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC-CC-------
Confidence 23445689999999999999999999999999999999999999997521 1111111111111 11
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH--HHhccccCCCCCCCCcee
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS--MLNSEIKDLPAAKQPAFT 784 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~l~~~~~p~~~ 784 (816)
........+..+....++.||..|-+-.+++. ..++.+.....+.+|++.
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 11233456677777899999999999999864 344444444555555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=304.07 Aligned_cols=199 Identities=31% Similarity=0.439 Sum_probs=179.6
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||.++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888999999999999999965 578899999976532 33456788999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||++||.|.++|+ +.+.+++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999995 4456899999999999999999999998 9999999999999999999999999999763
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCch
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~ 704 (816)
..+-..+||+.|+|||++....+..++|.|+|||++|||+.|.+||....+
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 235568999999999999999999999999999999999999999875444
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.57 Aligned_cols=255 Identities=31% Similarity=0.488 Sum_probs=206.3
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998888899999886532 34678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998543 2345788999999999999999999988 999999999999999999999999999876432211
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......++..|+|||++....++.++||||||+++|||++ |+.|+....... ......... .. +..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~----~~----~~~- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGY----RM----PRM- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCC----CC----CCC-
Confidence 1222345678999999988889999999999999999998 888886433321 111111110 00 000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
......+.+++.+|++.+|++||++.++.++|++
T Consensus 227 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122457788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.95 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=205.8
Q ss_pred hcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 565 (816)
.++|++.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568999999999999999999753 134699999975433 34567999999999996 9999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCC-----------------------------------------------------------
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQ----------------------------------------------------------- 586 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 586 (816)
.++||||+++|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998875321
Q ss_pred ----------------------------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC
Q 003489 587 ----------------------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD 632 (816)
Q Consensus 587 ----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~ 632 (816)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788889999999999999999988 999999999999999
Q ss_pred CCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHH
Q 003489 633 DLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLL 711 (816)
Q Consensus 633 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~ 711 (816)
++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999987643332222233456788999999998899999999999999999997 8888764332211 11
Q ss_pred HHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 712 GYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 712 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.. ...+.... ........+.+++.+||+.+|++||++.+|+++|+++++
T Consensus 351 ~~----~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NK----IKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH----HhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11 11110000 011223567789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.13 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=208.8
Q ss_pred hcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 34568999987766566778999999999999999999999999999999
Q ss_pred EEEeeCCCCCccccccCCC----------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCce
Q 003489 568 LIYEYMPNKSLDSFLFDPQ----------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 637 (816)
+||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ ++||||||+|||+++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985321 2235899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHH
Q 003489 638 ISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWK 716 (816)
Q Consensus 638 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 716 (816)
|+|||+++...............++..|+|||.+....++.++||||||++++||++ |+.|+....... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i-- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI-- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--
Confidence 999999986533222222223445778999999998899999999999999999999 888875443321 11111
Q ss_pred hhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccC
Q 003489 717 LWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 717 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 774 (816)
..+..... .. .....+.+++.+|++.+|.+|||+.||++.|+++.+.
T Consensus 236 --~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 --TQGRVLQR-----PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --HcCCcCCC-----CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111110 01 1224578899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.39 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=205.7
Q ss_pred cCcccccccCCCCceeEEEeEecC------CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568888999999999999998643 478999999765444 4578999999999999999999999999999999
Q ss_pred EEEeeCCCCCccccccCCC-----------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCc
Q 003489 568 LIYEYMPNKSLDSFLFDPQ-----------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
+||||+++++|.+++.... ....+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986421 2345788999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHH
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 637 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 715 (816)
+|+|||+++...............+++.|+|||++....++.++||||||+++|||++ |+.|+.....+. ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 9999999986533222222223345788999999999999999999999999999998 999876443322 111111
Q ss_pred HhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.+..... .......+.+++.+||+.+|++||++.||+++|++
T Consensus 239 ----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111100 01123467788899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.54 Aligned_cols=265 Identities=25% Similarity=0.291 Sum_probs=213.7
Q ss_pred HhcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc-----c
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-----N 566 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 566 (816)
..++|++.++||+|+|+-||+++ ..+++.+|+|++.-...++.+..++|++..++++||||++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45799999999999999999998 66789999999977777788899999999999999999999998765443 7
Q ss_pred eEEEeeCCCCCccccccCCCC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 567 MLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
||+++|...|+|.+.+...+. +..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999875443 447999999999999999999999986 579999999999999999999999999987
Q ss_pred ecCCCCc---cc----ccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH
Q 003489 646 IFGGNQD---QA----ATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 646 ~~~~~~~---~~----~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~ 715 (816)
...-.-. +. .......|..|.|||.+. +..+++++|||||||+||+|+.|..||+...+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------- 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------- 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence 5421110 00 011235688999999885 445789999999999999999999998743221
Q ss_pred HhhccCCcc-ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 716 KLWNDNNVI-DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 716 ~~~~~~~~~-~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
.+.+. .+..+.+.-.......+.+.+++.+|++.||.+||++.+++..++.++
T Consensus 248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 222223333333346778899999999999999999999999997763
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.41 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=203.1
Q ss_pred HhcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
.+++|++.+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.+++.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998753 24679999886432 2345678999999999999999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCCC-------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCcee
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQR-------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678889999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHh
Q 003489 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKL 717 (816)
Q Consensus 639 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 717 (816)
+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..|+.....+.. ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---
Confidence 99999876543222222222345778999999998899999999999999999999 6778754433211 1111
Q ss_pred hccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
........ .......+.+++.+|++.+|++||++.|++++|++
T Consensus 235 -~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111110 01123467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.78 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=210.2
Q ss_pred HhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
...+|++.++||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34678899999999999999999888999999999776655677899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.+.. ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996542 346899999999999999999999998 99999999999999999999999999976533221
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
. .....++..|+|||.+....++.++||||||+++++|++ |+.|+........ ..... ....
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~~~-------- 222 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----AGYR-------- 222 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----hCCc--------
Confidence 1 123345778999999988899999999999999999998 7888865432211 11111 0000
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
..........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112233567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.52 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=202.4
Q ss_pred cCcccccccCCCCceeEEEeEec-CCc----EEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
.+|++.+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999854 333 38999986543 34567899999999999999999999999764 5679
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998643 235788999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.............+..|+|||.+....++.++||||||+++|||++ |+.|+........ .. .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~~~-- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGERLP-- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHhCCCCCC--
Confidence 3332222222344678999999999999999999999999999998 9988764332211 11 111111000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
. .......+.+++..|++.+|++||++.+++..|....+
T Consensus 232 ~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 01122456788899999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.47 Aligned_cols=257 Identities=30% Similarity=0.467 Sum_probs=202.7
Q ss_pred cCcccccccCCCCceeEEEeEe-----cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
++|++.+.||+|+||.||+|.. ..+..||+|.+.... ......+.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 245789999987533 3344678999999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCC--------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC
Q 003489 569 IYEYMPNKSLDSFLFDPQ--------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL 634 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 634 (816)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999984221 1235788999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHH
Q 003489 635 NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGY 713 (816)
Q Consensus 635 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~ 713 (816)
.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..|+...... .+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999987643332222333455778999999988889999999999999999998 88887543321 11111
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
. ....... . .......+.+++.+|++.+|++||++.+|+++|..
T Consensus 239 ~----~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1111110 0 01123456778889999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.47 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=202.6
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
++|++.+.||+|+||.||++.++++..+|+|.+... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999985432 35889999999999999999999998 999999999999999999999999998765322211
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|||++ |+.|+...... ........ +. ....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~----~~--~~~~~~~-- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISR----GF--RLYRPKL-- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHC----CC--CCCCCCC--
Confidence 1122345678999999988889999999999999999999 88887643322 11111111 10 0111111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 226 -----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.34 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=198.7
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999985 578999999986432 2334567899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887543 2235889999999999999999999998 9999999999999999999999999998753221
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. ....... .
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~------- 222 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKEDQ-E------- 222 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhccc-c-------
Confidence 1233578999999999999999999999999999999999999987543321111111 0000000 0
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~ 766 (816)
.........+.+++.+|++.||++||+ +.++++
T Consensus 223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011112345677888999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=327.99 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=203.7
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999865 57889999886542 2345679999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 345889999999999999999999853 3999999999999999999999999999765322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc--------
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV-------- 723 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------- 723 (816)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+.....................+..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 223357899999999999989999999999999999999999998654332111110000000000000
Q ss_pred -------------------ccccccccc----ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 724 -------------------IDLVDPLIS----ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 724 -------------------~~l~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.++.+.... ..........+.+++.+||+.||++|||+.|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000 000111235678899999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.04 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=205.4
Q ss_pred cCcccccccCCCCceeEEEeEecC----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
++|++.+.||+|+||.||+|.+.. ...||||.++... ......|.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998742 3579999886543 33456789999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|.+++.... ..+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999985432 36899999999999999999999988 99999999999999999999999999987752
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
...........++..|+|||.+....++.++||||||+++|||++ |..|+....... +..... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVE----DGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCCC----
Confidence 222222223345678999999998899999999999999999998 988875433221 111111 11000
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+. .......+.+++.+|++.+|++||++.||+++|+++
T Consensus 228 ~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 011234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.31 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=203.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999975 58899999986542 234467889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999943 346889999999999999999999998 99999999999999999999999999976532
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+........ .+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------RPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------CCC
Confidence 22345789999999999999999999999999999999999999875443322111110000000 000
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.. .........+.+++.+|++.+|.+||++.|+++.
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0001223456778889999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.32 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=203.8
Q ss_pred hcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEec-C
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER-E 564 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 564 (816)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999632 24789999986543 23345688899999999 799999999988654 4
Q ss_pred cceEEEeeCCCCCccccccCCCC---------------------------------------------------------
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQR--------------------------------------------------------- 587 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 587 (816)
..++++||+++++|.++|.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 56799999999999998853211
Q ss_pred -CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccccccccccc
Q 003489 588 -QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666 (816)
Q Consensus 588 -~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 666 (816)
...+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999988 9999999999999999999999999998764332222233345677899
Q ss_pred ChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHH
Q 003489 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVN 745 (816)
Q Consensus 667 aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~ 745 (816)
|||++....++.++|||||||+||||++ |..|+........ +. ......... .. .......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~~-~~--------~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTRM-RA--------PEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCCC-CC--------CccCCHHHHH
Confidence 9999999999999999999999999998 9888764322111 11 111111100 00 1112356788
Q ss_pred HHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 746 VGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 746 l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
++.+|++.+|++||++.||+++|+.++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=320.85 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=204.2
Q ss_pred CcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
+|++.+.||+|+||.||+|... ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 23568999886543 2345678999999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCC---------------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCc
Q 003489 569 IYEYMPNKSLDSFLFDPQ---------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN 627 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 627 (816)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhh
Q 003489 628 ILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEF 706 (816)
Q Consensus 628 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~ 706 (816)
||+++++.++|+|||+++...............++..|+|||.+....++.++||||||++++||++ |+.|++...++.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322222233455678999999988889999999999999999998 988886443321
Q ss_pred hhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 707 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
+.... ...... .........+.+++.+|++.+|++||++.|++++|++++.
T Consensus 238 ---~~~~~----~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LFNLL----KTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHH----hCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 111000 0011123467788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=315.06 Aligned_cols=255 Identities=28% Similarity=0.406 Sum_probs=203.9
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.+|++.+.||+|+||.||+|..+ .++.||+|.+... ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999865 5888999998653 344678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 999999998543 2345899999999999999999999988 99999999999999999999999999986543211
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
........+..|+|||.+....++.++||||||+++|||++ |..|++....+.. .. ...... .+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~----~~~~~~-----~~~~- 226 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE----LLEKGY-----RMER- 226 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHCCC-----CCCC-
Confidence 11112234568999999998999999999999999999998 8888764433211 11 111110 0000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111234677888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=327.18 Aligned_cols=265 Identities=28% Similarity=0.410 Sum_probs=217.0
Q ss_pred HHHHHHhcCcccccccCCCCceeEEEeEecC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc
Q 003489 488 EELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 488 ~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 566 (816)
++++-...++.+.++||-|-||.||.|.|+. .-.||||.+++. ....++|+.|+.+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3344445677888999999999999999874 567999999654 46688999999999999999999999999999999
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
|||.|||.+|+|.+||++..+ ..++-...+.++.||+.||+||...+ +|||||..+|+|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999976543 34677778899999999999999988 99999999999999999999999999998
Q ss_pred cCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
+.... ...+....-++.|.|||-+....++.|+|||+|||+||||.| |..|++..+-.....|++..
T Consensus 415 MtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg----------- 482 (1157)
T KOG4278|consen 415 MTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG----------- 482 (1157)
T ss_pred hcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-----------
Confidence 85433 223333455789999999999999999999999999999998 66677654443333332221
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccC
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 774 (816)
.+.+...-+.+.+.++++.||+++|.+||++.|+-+.||..+.+
T Consensus 483 -----yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 483 -----YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred -----ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 12222333567788899999999999999999998888766533
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=313.76 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=202.8
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999998777789999886433 345779999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.... ..+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999985432 35899999999999999999999998 999999999999999999999999999865433211
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ...... ....... +
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~~~--~---- 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS----QGLRLYR--P---- 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh----cCCCCCC--C----
Confidence 1122345678999999988889999999999999999999 888876443321 111111 1100000 0
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
......+.+++.+||+.+|++||++.+|++.|+
T Consensus 224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 012356788899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.22 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=206.9
Q ss_pred HHHhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhh--cCCCceeeeeeEEEecC----
Q 003489 491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISN--LQHRNLVRLLGCCVERE---- 564 (816)
Q Consensus 491 ~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 564 (816)
+...+.+++.+.||+|.||.||+|.++ |+.||||++.. .+++.+.+|.++.+. |+|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 345578999999999999999999998 99999999943 456678889988875 59999999999877654
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-----CCCcEEEeeeCCCcEEEcCCCCceee
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-----SRLRIIHRDLKASNILLDDDLNPKIS 639 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kl~ 639 (816)
+.+||.+|.++|||.||| .+..++....++++..+|.||+|||-. |++.|.|||||++|||+.+++...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 458999999999999999 446799999999999999999999954 77889999999999999999999999
Q ss_pred ccccceecCCCC--cccccccccccccccChhccccCC----C--CchhhhHHHHHHHHHHHhCC----------CCCCC
Q 003489 640 DFGLARIFGGNQ--DQAATKRLVGTYGYMSPEYAMEGR----F--SEKSDVFSFGVLLLEIVSGR----------KNTSF 701 (816)
Q Consensus 640 DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--s~ksDV~SlG~vl~elltG~----------~p~~~ 701 (816)
|+|||....... -....+..+||.+|||||++...- + -..+||||||.|+||+.... .||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999998765432 223445679999999999986532 2 13689999999999997632 24332
Q ss_pred CchhhhhhHHHHHHHhhccCCccccccccccc-cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 702 YHEEFELTLLGYAWKLWNDNNVIDLVDPLISE-SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 702 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
..+.+.. . +..++.. ..+.+.|.+.. -.+.+.+..+.+++..||..||..|-|+-.+.+.|.++.
T Consensus 439 ~Vp~DPs-~-eeMrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 439 VVPSDPS-F-EEMRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCC-H-HHHhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 2221110 0 0001111 11112222221 235667888999999999999999999999999998774
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.31 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=200.5
Q ss_pred cCcccccccCCCCceeEEEeEec-CCc----EEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
++|++.+.||+|+||.||+|++. +++ .+++|.+..... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999864 344 477787754322 23467788888999999999999999875 455789
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999542 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
............++..|+|||.+....++.++||||||+++|||++ |+.|+..........+ ...+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~--~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGERL--A 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCcC--C
Confidence 3332222334567789999999998899999999999999999998 9988865433221111 1111111 0
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.+.. ....+.+++.+|++.+|++||++.|+++.|....+
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 12345678889999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.33 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=198.4
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999865 68899999986432 234466889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999865321
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.....|++.|+|||++....++.++||||||+++|||++|+.|+........ .... ..... .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i----~~~~~------~ 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKI----LAGKL------E 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCc------C
Confidence 2235689999999999988899999999999999999999999865433211 1111 01100 0
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~~ 767 (816)
+ .......+.+++.+|++.||.+||+ +.|+++.
T Consensus 217 ~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 F----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 0111235678888999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=319.40 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=199.1
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.++||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57889999999999999999865 68899999986433 23345778999999999999999999999998889999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 974 888887432 235788999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC---------C
Q 003489 653 QAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN---------N 722 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~ 722 (816)
.......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||.....................+ .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 12233467899999998865 568999999999999999999999987554433222211111000000 0
Q ss_pred cccccccccccccc----HHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VIDLVDPLISESGF----KMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
......+....... ......+++++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 01111111100000 011245678899999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.17 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=206.7
Q ss_pred HhcCcccccccCCCCceeEEEeEecC------CcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecC
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 564 (816)
..++|++.+.||+|+||.||++.... ...+|+|.+... .......+.+|++++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44678899999999999999998642 367999988753 233446788999999999 7999999999999999
Q ss_pred cceEEEeeCCCCCccccccCC-------------CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDP-------------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD 631 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 631 (816)
..+++|||+++++|.+++... .....+++..+++++.||+.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 22356899999999999999999999988 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhH
Q 003489 632 DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTL 710 (816)
Q Consensus 632 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l 710 (816)
+++.+||+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |..|+.....+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~- 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK- 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-
Confidence 999999999999987644322222222345678999999988899999999999999999998 888876433321111
Q ss_pred HHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 711 LGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 711 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
........ .........+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 246 ------~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 ------LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111000 011122356778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.85 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=201.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 57889999986532 2345678899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 2345889999999999999999999998 9999999999999999999999999998753222
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH--------Hhh-ccCC
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW--------KLW-NDNN 722 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~-~~~~ 722 (816)
. .......+++.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +.+ ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12233568999999999998889999999999999999999999987644332221111110 000 0000
Q ss_pred cccccccccccc------ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VIDLVDPLISES------GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
......+..... ........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001111111000 01112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.03 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=208.0
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
..+|++.+.||+|.||.|-++. ...|+.||||.+++.. .++.-.+++|+++|..|+||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3678899999999999999997 4679999999997653 44455688999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||..+|.|.+|+. ....|++.+++.+++||..|+.|+|.++ ++|||||.+|||||.++++||+||||+..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999994 4566999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccChhccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
......++|++-|.+||++.+.+| .+..|-||||++||-|+.|..||+..+-. .++..+ ..+...
T Consensus 206 ---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQI----s~GaYr---- 271 (668)
T KOG0611|consen 206 ---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQI----SRGAYR---- 271 (668)
T ss_pred ---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHh----hccccc----
Confidence 334556899999999999999988 57899999999999999999998754332 111111 111111
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.++......-++.+|+..||++|-|+.+|....
T Consensus 272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 -------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122334456778899999999999999998764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=317.78 Aligned_cols=262 Identities=25% Similarity=0.361 Sum_probs=207.3
Q ss_pred HhcCcccccccCCCCceeEEEeEecC-----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEe-cCc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REE 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 565 (816)
..++|++.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999999765 6789999886542 3445678899999999999999999998876 467
Q ss_pred ceEEEeeCCCCCccccccCCCCC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeec
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQ-----SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 640 (816)
.++++||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 78999999999999998643322 56899999999999999999999988 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhc
Q 003489 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWN 719 (816)
Q Consensus 641 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 719 (816)
||+++.+.............++..|+|||.+....++.++||||||+++||+++ |+.|+....+. .+..+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----
Confidence 999986543322222222345678999999988889999999999999999999 99887643322 1222111
Q ss_pred cCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 720 DNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 720 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.+.. . .. .......+.+++.+|++.+|++|||+.||+++|+.+.+
T Consensus 234 ~~~~--~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYR--L---AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCC--C---CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1100 0 00 01122457788999999999999999999999987744
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=341.30 Aligned_cols=253 Identities=18% Similarity=0.220 Sum_probs=203.2
Q ss_pred cCcccccccCCCCceeEEEeEec-C-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-D-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..|.+.+.||+|++|.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999754 3 577888877555555556788999999999999999999999999999999999
Q ss_pred CCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++|+|.++|++. ....++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988542 23456889999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
.........||+.|+|||++....++.++|||||||++|||++|+.|+....... +..... . +.. ++.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~---~-~~~----~~~- 291 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVL---Y-GKY----DPF- 291 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---h-CCC----CCC-
Confidence 3233344679999999999999999999999999999999999999986433221 111110 0 110 000
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++..|++.+|++||++.+++.
T Consensus 292 ----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0112245778888999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.66 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=204.2
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
+-|++.+.||.|+-|.|-+|++ .+|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++....+.|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999985 579999999997642 233456789999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|-|.++|. +.+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--- 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--- 162 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---
Confidence 9999999999994 5577999999999999999999999998 999999999999999999999999999763
Q ss_pred CcccccccccccccccChhccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.........+|.++|.|||++.+.+|. .++||||.|||||.||||+.||+. +.-..|+..+. .+ ..++.
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~----~G-~f~MP-- 232 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQ----RG-VFEMP-- 232 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHH----cC-cccCC--
Confidence 223344557999999999999999984 689999999999999999999872 21222222211 11 11111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.....++.+++.+|+..||++|-|++||++.
T Consensus 233 -------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 -------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1123566778889999999999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=318.47 Aligned_cols=257 Identities=31% Similarity=0.470 Sum_probs=201.8
Q ss_pred cCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
.+|++.++||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35777899999999999999863 2467999999754332 3467889999999999999999999999999999
Q ss_pred EEEeeCCCCCccccccCC-------------CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC
Q 003489 568 LIYEYMPNKSLDSFLFDP-------------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL 634 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 634 (816)
+++||+++++|.+++... .....+++..+.+++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998421 11235788899999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHH
Q 003489 635 NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGY 713 (816)
Q Consensus 635 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~ 713 (816)
.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..|+...... .....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999886543332222233456789999999988889999999999999999998 77776543322 11111
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
. ........ .......+.+++..|++.+|++||++.||++.|+.
T Consensus 239 i----~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 I----RNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----HcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11111110 11123456788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=326.61 Aligned_cols=243 Identities=27% Similarity=0.393 Sum_probs=202.1
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcce
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 567 (816)
.-++|.+.+.||+|+||+|+++..+ +++.+|||.+++. ...+.+..+.|..++... +||.++.++.+|+..++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4478999999999999999999865 5788999999875 345667788898888877 5999999999999999999
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
.||||+.||++..+. ....+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999965554 4456899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.. ....+...+||+.|||||++.+..|+...|.|||||+|||||.|..||+..++++.-+ .+ ..+ +..
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---sI---~~d----~~~ 586 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---SI---VND----EVR 586 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HH---hcC----CCC
Confidence 32 3346777999999999999999999999999999999999999999998665543211 11 000 111
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
++.-...+.+.|+.+.+..+|++|--+
T Consensus 587 -------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 -------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 122234566778889999999999866
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.94 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=201.5
Q ss_pred hcCcccccccCCCCceeEEEeEecC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 566 (816)
.++|++.+.||+|++|.||+|.+.. +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998753 5678999886443 33456799999999999999999999999999999
Q ss_pred eEEEeeCCCCCccccccCCCC----CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC---Cceee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQR----QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKIS 639 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~ 639 (816)
++||||+++++|.+++..... ...+++..+++++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999864321 235899999999999999999999998 99999999999998765 58999
Q ss_pred ccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhh
Q 003489 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 640 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||+....+. +.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~--- 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFVT--- 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH---
Confidence 9999986632222111122233568999999998999999999999999999997 888876443322 111111
Q ss_pred ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 719 NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 719 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
..... .........+.+++.+|++.+|++||++.+|++.|.
T Consensus 236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 001112346778889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.21 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=195.3
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999864 68899999876543 34456799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998532 345889999999999999999999998 99999999999999999999999999875432211111111
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFK 737 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 737 (816)
...+..|+|||.+....++.++||||||+++|||++ |..|+........... .. .. .. .....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---~~----~~-~~--------~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---IE----QG-VR--------LPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---HH----cC-CC--------CCCcc
Confidence 223467999999998899999999999999999998 8777754333211111 10 00 00 00111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 738 MEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 738 ~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.....+.+++.+|++.+|++||++.||.++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12346778888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.02 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=200.8
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
.+|++.+.||+|+||.||++..+++..+|+|.+.+.. .....+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998777789999986432 345678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999985432 36899999999999999999999998 999999999999999999999999999865322111
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....+... ..... ... ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~~-----~~~--- 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVS----AGY-----RLY--- 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHH----cCC-----cCC---
Confidence 1111234567999999998899999999999999999999 7888764433211 11111 110 000
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
........+.+++.+|++.+|++|||+.|++++|
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111244678899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.63 Aligned_cols=266 Identities=29% Similarity=0.409 Sum_probs=200.9
Q ss_pred ccccccCCCCceeEEEeEe-----cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC--cceEE
Q 003489 498 QLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--ENMLI 569 (816)
Q Consensus 498 ~~~~~LG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 569 (816)
++.+.||+|+||+||++.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7889999999999988653 357789999987543 234567889999999999999999999987643 46899
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|.+++.. ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999843 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccc-ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQA-ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
..... ......++..|+|||.+....++.++||||||++++||++|+.|+........ ................+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence 22211 11223456679999999888899999999999999999999998754332211 11111110001111111111
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
..............+.+++.+|++.+|++||++.+|+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111122345778889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.61 Aligned_cols=264 Identities=26% Similarity=0.428 Sum_probs=200.7
Q ss_pred cCcccccccCCCCceeEEEeEec-----CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccce
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 567 (816)
++|++.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 5788999999776666677899999999999999999999987543 4568
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+|+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 245899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccc-cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc---
Q 003489 648 GGNQDQAA-TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV--- 723 (816)
Q Consensus 648 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 723 (816)
........ .....++..|+|||.+.+..++.++||||||++++||++|..+......... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM--------RMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh--------hhccccccccc
Confidence 43322111 1112334569999999888899999999999999999998766432211100 00000000
Q ss_pred -----cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 724 -----IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 724 -----~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.+.+...............+.+++.+|++.+|++|||+.||+++|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000000111234678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.49 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=200.6
Q ss_pred cccccccCCCCceeEEEeEecC----CcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc-----
Q 003489 497 FQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----- 565 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 565 (816)
|++.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999986532 2345678999999999999999999999876554
Q ss_pred -ceEEEeeCCCCCccccccCCC---CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecc
Q 003489 566 -NMLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641 (816)
Q Consensus 566 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 641 (816)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999885432 2346889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 642 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
|+++................+..|+|||.+....++.++||||||+++|||++ |..|+...... .+..... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence 99987643332222222345678999999988889999999999999999999 88887543322 1111111 1
Q ss_pred CCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 721 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+..... .......+.+++.+|++.||.+||++.||++.|+++
T Consensus 231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 112234678888899999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.29 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=203.8
Q ss_pred cCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
++|++.++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999642 356799999877666667889999999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCC------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCc
Q 003489 569 IYEYMPNKSLDSFLFDPQR------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
++||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHH
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 637 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 715 (816)
+|+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.|+........ .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHHHH
Confidence 9999999976543222222222345678999999998999999999999999999998 8888754333211 11110
Q ss_pred HhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
....... .......+.+++.+||+.+|++||++.||++.|+
T Consensus 239 ----~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000000 0112345678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.61 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=200.7
Q ss_pred hcCcccccccCCCCceeEEEeEecC---------------CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD---------------GQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLL 557 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 557 (816)
.++|++.+.||+|+||.||++.... ...||+|.++.. .....+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 234899998754 233456799999999999999999999
Q ss_pred eEEEecCcceEEEeeCCCCCccccccCCC---------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcE
Q 003489 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQ---------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628 (816)
Q Consensus 558 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NI 628 (816)
+++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985421 1124688899999999999999999998 99999999999
Q ss_pred EEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhC--CCCCCCCchhh
Q 003489 629 LLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG--RKNTSFYHEEF 706 (816)
Q Consensus 629 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG--~~p~~~~~~~~ 706 (816)
++++++.+||+|||++..+.............++..|+|||++....++.++||||||++++||+++ ..|+.....+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765432222222233457789999999988999999999999999999984 44554332221
Q ss_pred hhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 707 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
........+......... .........+.+++.+|++.+|++||+|.+|+++|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111000000 001112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.23 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=197.6
Q ss_pred cccccccCCCCceeEEEeEecCCc---EEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEec------Cc
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQ---EIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------EE 565 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 565 (816)
|.+.+.||+|+||.||+|+..+.. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346789999999999999875432 5899988653 234457789999999999999999999987543 24
Q ss_pred ceEEEeeCCCCCccccccCC---CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 566 NMLIYEYMPNKSLDSFLFDP---QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
.++++||+++|+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 58999999999999887422 22345889999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
+++.+.............+++.|+|||.+....++.++||||||+++|||++ |+.|+...... .+.... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~----~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL----RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HcC
Confidence 9987643322111222345778999999999999999999999999999999 78887643322 111111 111
Q ss_pred CccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
..... .......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110 011234567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=322.45 Aligned_cols=201 Identities=27% Similarity=0.392 Sum_probs=174.2
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.++|++.++||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999865 57889999886542 3345678999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345888999999999999999999752 2999999999999999999999999998755321
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~ 703 (816)
......++..|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1223568899999999998889999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.95 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=200.1
Q ss_pred HHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC--------------chhHHHHHHHHHHHhhcCCCceeee
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--------------GQGQEEFMNEVMVISNLQHRNLVRL 556 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l 556 (816)
..-+.|++.+.||+|.||.|-+++. .+++.||||++.+.. ....+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3447899999999999999999984 478999999996531 1124678999999999999999999
Q ss_pred eeEEEec--CcceEEEeeCCCCCccccccCCCCCCC-CChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC
Q 003489 557 LGCCVER--EENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD 633 (816)
Q Consensus 557 ~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~ 633 (816)
+.+..+. +..|||+||+..|.+...= ..++ ++..++++++++++.||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998754 5679999999988875432 2334 899999999999999999999999 9999999999999999
Q ss_pred CCceeeccccceecCCCC---cccccccccccccccChhccccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCchhh
Q 003489 634 LNPKISDFGLARIFGGNQ---DQAATKRLVGTYGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706 (816)
Q Consensus 634 ~~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SlG~vl~elltG~~p~~~~~~~~ 706 (816)
|++||+|||.+..+.... ........+||+.|+|||....+. .+.+.||||+||+||.|+.|+.||-.. .
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---~ 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---F 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---h
Confidence 999999999998763321 122234479999999999987643 346789999999999999999997422 1
Q ss_pred hhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 707 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
+..+.+. ++...+.-...+++-+.+.+++.++|+.||+.|-+..+|....
T Consensus 324 ~~~l~~K------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ELELFDK------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHHHH------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 2222111 1111122222334566778899999999999999999997765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.41 Aligned_cols=241 Identities=23% Similarity=0.270 Sum_probs=193.9
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68899999987532 233456788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccc
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 656 (816)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99998843 346899999999999999999999998 999999999999999999999999998753221 1222
Q ss_pred ccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccccc
Q 003489 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF 736 (816)
Q Consensus 657 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 736 (816)
....||+.|+|||++....++.++|||||||++|||++|+.||.....+.. ..... .+.. .+ .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~----~~~~------~~----p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELIL----MEEI------RF----P 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHHH----cCCC------CC----C
Confidence 345789999999999999999999999999999999999999864332211 11110 0000 00 0
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 737 KMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 737 ~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
......+.+++.+|++.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11234567788899999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.91 Aligned_cols=265 Identities=20% Similarity=0.320 Sum_probs=195.6
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----cce
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENM 567 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 567 (816)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999854 6899999998643 2234457889999999999999999999886443 368
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888843 345899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCc-ccccccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH--------H
Q 003489 648 GGNQD-QAATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW--------K 716 (816)
Q Consensus 648 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~ 716 (816)
..... ........+++.|+|||++.. ..++.++|||||||++|||++|+.||...........+.... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 112234578999999999865 678999999999999999999999986543321111110000 0
Q ss_pred hhccCCccccccccccc------cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 717 LWNDNNVIDLVDPLISE------SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 717 ~~~~~~~~~l~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
..........+...... .........+.+++.+|++.+|++||++.|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000000000 0000112456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=325.79 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=198.1
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.+ +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999865 58899999986532 234467889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999853 345788889999999999999999998 999999999999999999999999999865322
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.....|++.|+|||++....++.++|||||||++|||++|+.||....... ..... ..+.. . + +
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i----~~~~~-~-~-p- 235 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKI----LAGRL-K-F-P- 235 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHHH----hcCCc-C-C-C-
Confidence 123578999999999999999999999999999999999999986433221 11111 11110 0 0 0
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~ 766 (816)
. .....+.+++.+||+.||++||+ +.++++
T Consensus 236 --~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 --N----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --C----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 01235668888999999999997 577764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=340.45 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=205.1
Q ss_pred HHHHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC--
Q 003489 490 LANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-- 564 (816)
Q Consensus 490 l~~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 564 (816)
.....++|++.+.||+|+||+||+++. .+++.||||++... .......+.+|+..+..++|+||+++...+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557999999999999999999985 46899999998643 3344567889999999999999999988775433
Q ss_pred ------cceEEEeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCce
Q 003489 565 ------ENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637 (816)
Q Consensus 565 ------~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 637 (816)
..++||||+++|+|.++|+.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 247999999999999998643 23456889999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh
Q 003489 638 ISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL 717 (816)
Q Consensus 638 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 717 (816)
|+|||+++.+.............||+.|+|||++....++.++||||||+++|||++|+.||....... +.. ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~---~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMH---KT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HH
Confidence 999999987654333333345679999999999999999999999999999999999999986433211 111 11
Q ss_pred hccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
. .+.. ++ + .......+.+++..|++.+|++||++.++++.
T Consensus 258 ~-~~~~----~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L-AGRY----DP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h-cCCC----CC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111 11 0 11123467788889999999999999999764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=309.85 Aligned_cols=255 Identities=30% Similarity=0.466 Sum_probs=202.9
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.++|++.++||+|+||.||+|+.+++..||+|++.... ...+.+.+|++++++++|+||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35789999999999999999998777789999997533 34567899999999999999999999874 45678999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+++.+.....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 999999999543 2345789999999999999999999988 99999999999999999999999999987643321
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||+.....++.++||||||+++|||++ |+.|+....... ..... ......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~----~~~~~~-------- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQV----ERGYRM-------- 222 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHH----hcCCCC--------
Confidence 11222346678999999988899999999999999999999 777775433221 11111 000000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
....+....+.+++.+|++.+|++||++.+++++|+..
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01122345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.32 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=193.5
Q ss_pred cCcccccccCCCCceeEEEeEec--CCcEEEEEEecccC--chhHHHHHHHHHHHhhc---CCCceeeeeeEEEe-----
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNL---QHRNLVRLLGCCVE----- 562 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 562 (816)
++|++.+.||+|+||.||+++.. +++.||+|.++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46789999886432 22234566777777665 69999999999863
Q ss_pred cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 563 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
....++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 68988885432 335789999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
+++..... .......+++.|+|||.+....++.++||||||+++|||++|++||....+......+........+..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99875432 223345789999999999888999999999999999999999999875443222111110000000000
Q ss_pred cc-------ccccccccc---cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VI-------DLVDPLISE---SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~-------~l~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.. ....+.... .........+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000 000112245668899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.91 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=204.0
Q ss_pred hcCcccccccCCCCceeEEEeEec--------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEec
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER 563 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 563 (816)
.++|.+.+.||+|+||.||+++.. ....+|+|.+.... ....+++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999752 23469999987542 34456788999999999 799999999999999
Q ss_pred CcceEEEeeCCCCCccccccCCCC-------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEE
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL 630 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 630 (816)
+..++||||+++++|.+++..... ...+++.++++++.||+.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999964321 235889999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhh
Q 003489 631 DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELT 709 (816)
Q Consensus 631 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~ 709 (816)
++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 9999999999999876532221111222234568999999998889999999999999999998 778875433221
Q ss_pred HHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 710 LLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 710 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
+... .......+ ........+.+++.+|++.+|++||+|.||++.|++++.
T Consensus 251 ~~~~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 LFKL----LKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHH----HHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111 11111100 011123466778889999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.38 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=203.9
Q ss_pred HhcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcC-CCceeeeeeEEEecC
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 564 (816)
..++|.+.++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4457888899999999999999863 246799999975432 33457889999999997 999999999999999
Q ss_pred cceEEEeeCCCCCccccccCCC----------------------------------------------------------
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQ---------------------------------------------------------- 586 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 586 (816)
..++|+||+++|+|.++|+...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986421
Q ss_pred -------------------------------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEE
Q 003489 587 -------------------------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL 629 (816)
Q Consensus 587 -------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 629 (816)
....+++..+++++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124677888999999999999999987 999999999999
Q ss_pred EcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhh
Q 003489 630 LDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFEL 708 (816)
Q Consensus 630 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~ 708 (816)
+++++.++|+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |+.|+........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986533222122222456788999999998889999999999999999998 8888754322111
Q ss_pred hHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 709 TLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 709 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
+.... ..+. .... .......+.+++..||+.+|++||++.||++.|++++
T Consensus 351 -~~~~~----~~~~--~~~~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FYNAI----KRGY--RMAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHH----HcCC--CCCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111 1110 0000 0112346778888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.26 Aligned_cols=253 Identities=33% Similarity=0.497 Sum_probs=202.0
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
++|++.++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 57888999999999999999988888999999865433 4567999999999999999999999875 456789999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999998643 2345789999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|||++ |+.|+...... ....... .... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~---------~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE----RGYR---------M 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cCCC---------C
Confidence 1122345678999999988889999999999999999999 88887643321 1111111 0000 0
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.87 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=204.7
Q ss_pred hcCcccccccCCCCceeEEEeEecC-----------------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD-----------------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVR 555 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 555 (816)
.++|++.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3678999999999999999987542 2458999987543 334678899999999999999999
Q ss_pred eeeEEEecCcceEEEeeCCCCCccccccCCC--------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCc
Q 003489 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN 627 (816)
Q Consensus 556 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 627 (816)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 1236899999999999999999999988 9999999999
Q ss_pred EEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh--CCCCCCCCchh
Q 003489 628 ILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFYHEE 705 (816)
Q Consensus 628 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt--G~~p~~~~~~~ 705 (816)
|+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543332222334456788999999988889999999999999999998 55555432221
Q ss_pred hhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 706 FELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 706 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.........+.......... ........+.+++.+|++.+|++||++.||++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222222211111111110 01112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=323.96 Aligned_cols=248 Identities=26% Similarity=0.350 Sum_probs=192.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45666789999999999999865 68999999986543 23456789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986543 3456778899999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccChhcccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
......|+..|+|||.+.. ...+.++|||||||++|||++|+.||..........+..... ...
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~~------ 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQ------ 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---ccC------
Confidence 1233578999999998743 224568999999999999999999987332221111111110 000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+.. .......+.+++.+||+.||++||++.|+++.
T Consensus 293 ~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 11123457788889999999999999999874
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.43 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=204.7
Q ss_pred hcCcccccccCCCCceeEEEeEec--------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEec
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER 563 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 563 (816)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888999999999999999741 24579999886542 34457789999999999 899999999999999
Q ss_pred CcceEEEeeCCCCCccccccCCCC-------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEE
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL 630 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 630 (816)
...++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999864321 235788899999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhh
Q 003489 631 DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELT 709 (816)
Q Consensus 631 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~ 709 (816)
++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 9999999999999987643332222333455678999999988889999999999999999998 777765332221
Q ss_pred HHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 710 LLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 710 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
+.... ........ .......+.+++.+|++.+|.+||++.||++.|++++
T Consensus 248 ~~~~~----~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 248 LFKLL----KEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHH----HcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 11111 11110000 1112345677888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.05 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=205.1
Q ss_pred hcCcccccccCCCCceeEEEeEecC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 566 (816)
.++|++.+.||+|+||.||+|..+. +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678899999999999999998642 3679999986543 23456788999999999999999999999999999
Q ss_pred eEEEeeCCCCCccccccCCC-------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQ-------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 639 (816)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 1234788999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhh
Q 003489 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 640 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |+.|+........ ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH----
Confidence 9999986543322222233456788999999988889999999999999999998 8888764433221 1111
Q ss_pred ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 719 NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 719 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
..+...... ......+.+++.+|++.+|++|||+.++++.|++
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 1113567788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=310.14 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=203.0
Q ss_pred cCcccccccCCCCceeEEEeEecC-C---cEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 578888999999999999998752 3 368999886543 34456789999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998542 245899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcccc-cccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 650 NQDQAA-TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 650 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
...... ......+..|+|||++....++.++||||||+++|||++ |+.|+....... ...... ... .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~----~~~----~ 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAIN----DGF----R 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHh----cCC----C
Confidence 222111 111223567999999988889999999999999999998 999985433221 111111 110 0
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.+ ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 ~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0111235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.29 Aligned_cols=246 Identities=29% Similarity=0.431 Sum_probs=194.1
Q ss_pred ccCCCCceeEEEeEec---CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 502 KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999653 57889999986443 234567899999999999999999999875 45678999999999
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc-c
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA-A 655 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~ 655 (816)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+....... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 345889999999999999999999998 9999999999999999999999999998764332211 1
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 734 (816)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+....... +.... ..+.... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i----~~~~~~~-----~~-- 220 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMI----ESGERME-----CP-- 220 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCCCC-----CC--
Confidence 122334678999999988889999999999999999998 898886543321 11111 1111111 11
Q ss_pred ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 735 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
......+.+++.+|++.+|++||++.+|+++|++
T Consensus 221 --~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 --QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1123456788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.27 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=203.0
Q ss_pred HhcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++|+||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999754 24579999886443 2334568899999999999999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCC-------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCcee
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQ-------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
.++||||+++|+|.+++.... ....+++..+++++.||+.||+|||+.+ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 1234567788999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHh
Q 003489 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKL 717 (816)
Q Consensus 639 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 717 (816)
+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..|+.....+. ......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVM-- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH--
Confidence 99999986533222222222345678999999998899999999999999999999 677765433221 111111
Q ss_pred hccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.+..... .......+.+++.+|++.+|++||++.++++.|.+.
T Consensus 236 --~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 --DGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --cCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1110000 011235678889999999999999999999999776
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.31 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=201.7
Q ss_pred cCcccccccCCCCceeEEEeEecC-Cc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQ--EIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 569 (816)
++|++.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998753 33 4788888643 334456789999999999 799999999999999999999
Q ss_pred EeeCCCCCccccccCCC-------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCc
Q 003489 570 YEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHH
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 637 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 715 (816)
||+|||++..... .........+..|+|||++....++.++||||||+++|||++ |..||........ ....
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~~~- 231 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YEKL- 231 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH-
Confidence 9999999864211 111111233567999999988889999999999999999998 9888864433211 1111
Q ss_pred HhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCC
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l 775 (816)
..+.. ... .......+.+++.+|++.+|.+||++.+++++|++++...
T Consensus 232 ---~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 ---PQGYR-----MEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---hcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 01000 000 0112345678899999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.69 Aligned_cols=259 Identities=23% Similarity=0.386 Sum_probs=205.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999864 6899999987542 2334457889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCC-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
||+++++|.+++.... ....++...+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345788999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.. .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..+.... .... .+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~----~~~~-----~~ 226 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI----EQCD-----YP 226 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH----hcCC-----CC
Confidence 22 11223567889999999988889999999999999999999999975322211 1111111 1100 00
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.. ........+.+++.+||+.+|++||++.||++.|++.
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00 0112235677888899999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.43 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=198.4
Q ss_pred cCcccccccCCCCceeEEEeEecC--CcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD--GQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
++|++.+.||+|+||.||+|+.+. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578999999999999999998543 368999998643 223456788999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999953 345889999999999999999999998 99999999999999999999999999986532
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+... .... ..... .+.+
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~i----~~~~~--~~p~ 249 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQKI----LEGII--YFPK 249 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHHH----hcCCC--CCCC
Confidence 1 2235789999999999988899999999999999999999999875433211 1111 11100 0111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVSM 767 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~~ 767 (816)
.....+.+++.+|++.+|++|+ +++|+++.
T Consensus 250 --------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 --------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1123456788899999999995 88888764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.70 Aligned_cols=241 Identities=21% Similarity=0.249 Sum_probs=191.2
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 5788999998653 234456788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999853 345899999999999999999999998 9999999999999999999999999997542221 22334
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ . .+ ...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~---~~~~~~~~-~------~~----~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---M---YRKILQEP-L------RF----PDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---H---HHHHHcCC-C------CC----CCc
Confidence 578999999999999999999999999999999999999986433221 1 11111110 0 00 011
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
....+.+++.+|++.||++||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 224566788899999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.61 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=200.9
Q ss_pred cCcccccccCCCCceeEEEeEec-----------------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-----------------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRL 556 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 556 (816)
++|++.++||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 23468999987543 3345689999999999999999999
Q ss_pred eeEEEecCcceEEEeeCCCCCccccccCCC--------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcE
Q 003489 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ--------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628 (816)
Q Consensus 557 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NI 628 (816)
++++...+..++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986432 1234778899999999999999999998 99999999999
Q ss_pred EEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh--CCCCCCCCchhh
Q 003489 629 LLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFYHEEF 706 (816)
Q Consensus 629 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt--G~~p~~~~~~~~ 706 (816)
|+++++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222222344678999999888889999999999999999998 556664333221
Q ss_pred hhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 707 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
. .......+.... .....+. .......+.+++.+|++.+|++||++.||++.|+
T Consensus 242 ~---~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111111111110 0000000 1112356778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=316.11 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=204.5
Q ss_pred HhcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecC
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 564 (816)
..++|++.+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999742 34579999887543 33456789999999999 7999999999999999
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..++||||+++++|.++++... ...+++.++..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999985432 234899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCc
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
+.+.............++..|+|||.+....++.++||||||+++|||++ |+.|+........ ..... ..+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~----~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI----KEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH----HcCCc
Confidence 86543322222222345778999999999999999999999999999998 8888754332111 11111 11100
Q ss_pred cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.. ........+.+++.+|++.+|++||++.||++.|++.
T Consensus 263 ~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 0011234677888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.34 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=201.1
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
.++|++.++||+|+||.||+|++. +++ .||+|.++.. .....+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888999999999999999853 444 4899998654 33445678899999999999999999999875 4568
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+++||+++|+|.++++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
.............++..|+|||......++.++||||||+++|||++ |..|+....... +..... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCcCCC
Confidence 43322212222344678999999998899999999999999999998 888876433321 111111 1110000
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.......+.+++..|++.||++||++.++++.|+.+
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 011234567888899999999999999999999776
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=296.38 Aligned_cols=281 Identities=22% Similarity=0.253 Sum_probs=210.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCch--hHHHHHHHHHHHhhcCCCceeeeeeEEEe--cCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 569 (816)
+.|+.+++|++|+||.||+|+.+ +++.||+|+++..... -.-..++|+.+|.+++|||||.+..+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57888999999999999999964 6888999999754221 12346799999999999999999888764 3568999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||++ .+|..++.... .++...++.-+..|+++|++|||.+. |+|||||++|+|+...|.+||+|||||+.++.
T Consensus 156 Me~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99995 57888885543 56888899999999999999999998 99999999999999999999999999998864
Q ss_pred CCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccc--
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL-- 726 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l-- 726 (816)
. ....+..+.|..|.|||.+.+. .|+...|+||+|||+.||+++++-|+...+.+..+.+-.......+..+...
T Consensus 230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 4 2234457889999999999875 5899999999999999999999988876665443332211111111111100
Q ss_pred ---c---------cccccccccHH-HHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCCCCCCCceec
Q 003489 727 ---V---------DPLISESGFKM-EIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTV 785 (816)
Q Consensus 727 ---~---------d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~~~~~p~~~~ 785 (816)
+ ...++..+... ....-.++....+..||.+|-|+.|.++. +-..+.|.|..|.+.+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFP 377 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcC
Confidence 0 00111111110 12344566678899999999999998763 3347777777776653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.48 Aligned_cols=242 Identities=23% Similarity=0.283 Sum_probs=194.1
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.||+|+||.||+++.+ +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 6889999999753 2334567889999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccc
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 656 (816)
+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 99988843 346899999999999999999999998 999999999999999999999999998753221 1222
Q ss_pred ccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccccc
Q 003489 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF 736 (816)
Q Consensus 657 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 736 (816)
....||+.|+|||++....++.++|||||||++|||++|+.||........ .... .. ... .+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~~~---~~-~~~------~~p---- 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI---LM-EDI------KFP---- 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HHHh---cc-CCc------cCC----
Confidence 345789999999999988999999999999999999999999864333211 1110 00 000 000
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHHH
Q 003489 737 KMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVSM 767 (816)
Q Consensus 737 ~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~~ 767 (816)
......+.+++.+|++.||++|| ++.|+++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11234567788899999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=333.83 Aligned_cols=268 Identities=25% Similarity=0.293 Sum_probs=212.0
Q ss_pred HhcCcccccccCCCCceeEEEeEecCC-cEEEEEEecccCchhHHHHHHHHHHHhhcC-CCceeeeeeE-EEec------
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQDG-QEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGC-CVER------ 563 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~------ 563 (816)
...++++.+.|.+|||+.||.+....+ ..+|+|++-..+....+.+++|+++|++|+ |+|||.+++. ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 346788899999999999999997665 999999987777888899999999999997 9999999993 3221
Q ss_pred CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
-+.+|+||||++|.|-+++...... .|++.++++|+.|+++|+++||... +||||||||-+||||..++..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2457999999999999999654333 3999999999999999999999985 7899999999999999999999999999
Q ss_pred ceecCCCCccc-cc------ccccccccccChhcc---ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 003489 644 ARIFGGNQDQA-AT------KRLVGTYGYMSPEYA---MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGY 713 (816)
Q Consensus 644 a~~~~~~~~~~-~~------~~~~gt~~y~aPE~~---~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~ 713 (816)
+.-........ .. -...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 86432222110 00 012358899999987 466799999999999999999999999873221
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc-cCCCCCCCC
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI-KDLPAAKQP 781 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~-~~l~~~~~p 781 (816)
..+++..-.-...+.....+.+||..||++||++||++-+|+..+-++. +.++.+..+
T Consensus 264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 1222222222223557788899999999999999999999999886663 334444444
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=309.97 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=201.7
Q ss_pred cCcccccccCCCCceeEEEeEecC-C---cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
.+|++.+.||+|+||.||+|.... + ..||||.+... .....++|..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998653 3 35999998754 344567899999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998543 345899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcccccc-cc--cccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 650 NQDQAATK-RL--VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 650 ~~~~~~~~-~~--~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
........ .. ..+..|+|||.+....++.++||||||+++|||++ |..|+....... ........ . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~---~---~ 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQD---Y---R 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcC---C---c
Confidence 22211111 11 12457999999998999999999999999999886 998876433321 11111110 0 0
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
. + ...+....+.+++.+|++.+|++||++.+|+.+|+++
T Consensus 230 ~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 L--P-----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C--C-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 0111234567888999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.55 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=192.7
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999854 68899999986532 234456788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccc
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 656 (816)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcc
Confidence 99888843 346899999999999999999999998 999999999999999999999999998753221 1122
Q ss_pred ccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccccc
Q 003489 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGF 736 (816)
Q Consensus 657 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 736 (816)
....|++.|+|||++....++.++|||||||++|||++|+.|+.....+.. ..... . ... .+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~~---~-~~~------~~p---- 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELIL---M-EEI------RFP---- 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHh---c-CCC------CCC----
Confidence 335789999999999999999999999999999999999999864433211 11110 0 000 000
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 737 KMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 737 ~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
......+.+++.+|++.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11234566788899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.52 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=205.6
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|++|.||++.. .+++.+|||.+.... ....+++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 478999999876432 234467889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
||+++++|.+++... .....+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 23456899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
... ......++..|+|||++....++.++||||||+++|||++|..|+.....+. ....... .....+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---------~~~~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI---------EQCDYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhh---------hcCCCC
Confidence 221 1223468889999999988889999999999999999999999975332211 1111100 011111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.+.. ......+.+++.+|++.+|++||||.+|++++++.
T Consensus 227 ~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111 12334677888899999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.51 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=203.2
Q ss_pred hcCcccccccCCCCceeEEEeEec------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 566 (816)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 46789999987543 33456799999999999999999999999999999
Q ss_pred eEEEeeCCCCCccccccCCC-------------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCc
Q 003489 567 MLIYEYMPNKSLDSFLFDPQ-------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN 627 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 627 (816)
++|+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788899999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhh
Q 003489 628 ILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEF 706 (816)
Q Consensus 628 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~ 706 (816)
|++++++.++|+|||++..+..............+..|+|||.+....++.++||||||+++|||++ |..|+.....+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876533222222222344678999999988899999999999999999998 777765333221
Q ss_pred hhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 707 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
... .......... .......+.+++.+|++.+|++||++.|+++.|++
T Consensus 241 ---~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ---VIY----YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHH----HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 1111111110 01123567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.30 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=197.0
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 688999999865432 234567889999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++ ++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 6777777432 345788899999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC---Ccc---
Q 003489 652 DQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN---NVI--- 724 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~--- 724 (816)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+... ............ ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchh
Confidence 12233567899999998865 4578999999999999999999999875433111 111111111000 000
Q ss_pred --cccccc-cc--cccc-H------HHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 --DLVDPL-IS--ESGF-K------MEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 --~l~d~~-l~--~~~~-~------~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
...++. .. .... . .....+.+++..|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 0000 0 01245668888999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=322.39 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=201.6
Q ss_pred hcCcccccccCCCCceeEEEeEe------cCCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEec-C
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER-E 564 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 564 (816)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999973 346789999997543 23346788999999999 689999999988654 4
Q ss_pred cceEEEeeCCCCCccccccCCCC---------------------------------------------------------
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQR--------------------------------------------------------- 587 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 587 (816)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 56899999999999998853210
Q ss_pred -------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccccc
Q 003489 588 -------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660 (816)
Q Consensus 588 -------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 660 (816)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++..+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124688889999999999999999998 9999999999999999999999999998653332222222334
Q ss_pred ccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHH
Q 003489 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKME 739 (816)
Q Consensus 661 gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 739 (816)
++..|+|||.+....++.++||||||+++|||++ |..|++....... +.. ....+..... +. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~~~--~~-------~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTRMRA--PD-------YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCCCCC--CC-------CC
Confidence 5678999999988899999999999999999997 8888764322111 111 1111111000 00 01
Q ss_pred HHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 740 IIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 740 ~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.+.+.+++..|++.+|++||++.||++.|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2457788899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=324.25 Aligned_cols=258 Identities=17% Similarity=0.208 Sum_probs=194.6
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.+|++.++||+|+||.||++.. .+++.||+|... .+.+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 6799999999999999999985 468899999753 235678999999999999999999999999999999998
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 4 788888743 345889999999999999999999998 9999999999999999999999999997542211 1
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh----hhhHHHHHHHhhccCC-------
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF----ELTLLGYAWKLWNDNN------- 722 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~----~~~l~~~~~~~~~~~~------- 722 (816)
.......||+.|+|||++....++.++||||||+++|||++|+.|+....... ................
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 12234579999999999999999999999999999999999998754221100 0011111111000000
Q ss_pred ---ccccc---------cccccc--cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 ---VIDLV---------DPLISE--SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ---~~~l~---------d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..... .+.... .........+.+++.+|++.||++|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 000000 001122356778999999999999999999986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=300.97 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=203.0
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCc-eeeeeeEEEecC------
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRN-LVRLLGCCVERE------ 564 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 564 (816)
..|...++||+|+||+||+|+. .+|+.||+|+++-... .......+|+.++++++|+| ||++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566678999999999999985 4688999999875433 23456789999999999999 999999998877
Q ss_pred cceEEEeeCCCCCccccccCCCCC-CCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
..++|+||+ .-+|..++...... ..++...+..++.||++||+|||+++ |+||||||+|||+++.|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 678999999 66888888653321 34666788999999999999999999 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
|+.+.-+. ......++|..|.|||++.+. .|+...||||+||++.||+++++-|+...+......+-.......+..
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99664222 223446789999999999876 689999999999999999999988877666433322222211112222
Q ss_pred cccc-----cccccccc----cc----HHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 723 VIDL-----VDPLISES----GF----KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 723 ~~~l-----~d~~l~~~----~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+... .+...... .. +.......+++.+|++++|.+|.++..++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 11000000 00 0111467789999999999999999999886
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=306.68 Aligned_cols=254 Identities=33% Similarity=0.481 Sum_probs=203.1
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.++|++.++||+|+||.||++..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788999999999999999998889999999986543 34578999999999999999999999864 56689999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999985432 346889999999999999999999988 99999999999999999999999999987642211
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||++....++.++||||||++++||++ |+.|+....... ..... ........
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~------ 224 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERGYRMPR------ 224 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcCCCCCC------
Confidence 11122345678999999988889999999999999999999 999886433221 11111 11100000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.......+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01123467788889999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.26 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=202.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999865 68999999986532 234567889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999865433
Q ss_pred C---------------------------cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003489 651 Q---------------------------DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703 (816)
Q Consensus 651 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~ 703 (816)
. .........||+.|+|||++....++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012233578999999999999999999999999999999999999987544
Q ss_pred hhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCC-hHHHHHH
Q 003489 704 EEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN-MPTVVSM 767 (816)
Q Consensus 704 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~evl~~ 767 (816)
...... ........... +. .......+.+++..|++ +|.+||+ +.|+++.
T Consensus 235 ~~~~~~------~i~~~~~~~~~--p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYN------KIINWKESLRF--PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHH------HHhccCCcccC--CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 321111 11110000000 00 00123456677888997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.40 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=192.4
Q ss_pred cccCCCCceeEEEeEe----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 501 NKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+.||+|+||.||+++. ..++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357889999986532 22345678899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999998843 345788888999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......|++.|+|||++....++.++||||||+++|||++|+.||........ .. .... ... . +.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~---~~~~-~~~-~-~~---- 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---ID---KILK-GKL-N-LP---- 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HH---HHHc-CCC-C-CC----
Confidence 122335789999999999988899999999999999999999999865433211 11 1111 100 0 11
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
......+.+++.+|++.+|++|| ++.++++
T Consensus 221 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 ----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11234567888899999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.20 Aligned_cols=247 Identities=27% Similarity=0.392 Sum_probs=197.5
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCcc
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 579 (816)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988889999999876543 33457889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccccc
Q 003489 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659 (816)
Q Consensus 580 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 659 (816)
+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 988542 235789999999999999999999998 99999999999999999999999999875432211 111122
Q ss_pred cccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 660 ~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
.++..|+|||++....++.++||||||+++|||++ |..|+......... ... ...... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~~----~~~~~~---------~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQV----EKGYRM---------SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHH----HcCCCC---------CCCCC
Confidence 44678999999998899999999999999999998 88888644332111 111 111000 00112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.37 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=204.6
Q ss_pred cCcccccccCCCCceeEEEeEec--------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE 564 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 564 (816)
.+|++.+.||+|+||.||++... .+..||+|.++... ....+++.+|+.+++++ +|+||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 12368999886532 33457899999999999 7999999999999999
Q ss_pred cceEEEeeCCCCCccccccCCC-------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD 631 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 631 (816)
..++++||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 2335888999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhH
Q 003489 632 DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTL 710 (816)
Q Consensus 632 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l 710 (816)
.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..|+.....+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---
Confidence 999999999999986643222222222344568999999999999999999999999999998 7787754332211
Q ss_pred HHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCC
Q 003489 711 LGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775 (816)
Q Consensus 711 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l 775 (816)
.... ........ .......+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 246 ~~~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 FKLL----KEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHH----HcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111 11111111 0112346778889999999999999999999998885433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.28 Aligned_cols=253 Identities=32% Similarity=0.471 Sum_probs=200.9
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
++|++.+.||+|++|.||++..+.+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999886433 34567899999999999999999998875 456789999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence 99999999643 2345789999999999999999999988 99999999999999999999999999987643221 1
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||......++.++||||||+++|||++ |+.|+....+.. ....... ... +
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~~-----~---- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER----GYR-----M---- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCC-----C----
Confidence 1122345678999999988899999999999999999999 888876433321 1111111 000 0
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.........+.+++.+|++.+|++||++.+|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011223567788889999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.01 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=207.5
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEe-----cCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-----REE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 565 (816)
...|...+.||+|+||.|..+... +|+.||||++.. ......++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 455666789999999999999854 689999999874 334456788899999999999999999999875 245
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.|+|+|+| +.+|...|+ .+..|+...+.-++.||++||+|+|+.+ ++||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 69999999 778999884 3345889999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
...........+..+.|..|.|||++.. ..|+.+.||||.||+|.||++|++-|+..+.-....++-.......++.+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8754423334456788999999998754 579999999999999999999999988776655555544332222221111
Q ss_pred ccc--------ccc--ccccc----cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 725 DLV--------DPL--ISESG----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 725 ~l~--------d~~--l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+- ... ..... .+..-+..+++..+|+..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111 100 00000 11223567788889999999999999999763
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.36 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=197.3
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 46889999988654 334456799999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986543 3678888999999999999999998 999999999999999999999999999765322
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......++..|+|||++....++.++||||||+++|+|++|+.|+....................... .+.+.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 221 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP 221 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC
Confidence 22335788999999999988999999999999999999999999864332111100000000000000 01110
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
. ....+.+.+++.+|++.+|++||+++|+++.
T Consensus 222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 1123456788889999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.77 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=206.8
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7899999988642 2233567899999999999999999999999999999999
Q ss_pred eeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
||+++++|.+++.+. .....+++.+++.++.+|++||+|||+.+ ++||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 22455889999999999999999999998 99999999999999999999999999876533
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... +..... ....+... +
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~~----~ 227 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEKCDYP----P 227 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-hhhcCCCC----C
Confidence 221 122346788999999999888999999999999999999999997533211 111110 00111100 0
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
. ........+.+++.+|++.+|++||++.+|+++|+++
T Consensus 228 ~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 L----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 0112334677888899999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=324.91 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=194.3
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999854 67899999996532 2345678899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 345788889999999999999999998 9999999999999999999999999976431100
Q ss_pred c---------------------------------------------ccccccccccccccChhccccCCCCchhhhHHHH
Q 003489 652 D---------------------------------------------QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFG 686 (816)
Q Consensus 652 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG 686 (816)
. ........||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHH--hhhcCCCCCCChHHH
Q 003489 687 VLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLL--CVQEFVKDRPNMPTV 764 (816)
Q Consensus 687 ~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPt~~ev 764 (816)
|++|||++|+.||.......... ............ +. ......+.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~~~-~~------~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQL------KVINWENTLHIP-PQ------VKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHH------HHHccccccCCC-CC------CCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999987544322111 000000000000 00 0012234445544 667777789999999
Q ss_pred HHH
Q 003489 765 VSM 767 (816)
Q Consensus 765 l~~ 767 (816)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=315.68 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=204.2
Q ss_pred hcCcccccccCCCCceeEEEeEec--------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCceeeeeeEEEec
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER 563 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 563 (816)
.++|.+.+.||+|+||.||+++.. ....+|+|.++... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999742 24568999887532 34456788999999999 699999999999999
Q ss_pred CcceEEEeeCCCCCccccccCCC-------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEE
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL 630 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 630 (816)
+..++++||+++|+|.+++.... ....+++.++++++.||+.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986432 1245889999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhh
Q 003489 631 DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELT 709 (816)
Q Consensus 631 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~ 709 (816)
++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.|+.....+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999986543222221222334567999999998889999999999999999999 8888754332211
Q ss_pred HHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccC
Q 003489 710 LLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 710 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 774 (816)
.... ........ .......+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 246 -~~~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 -FKLL----REGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -HHHH----HcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111 11111110 111233566888899999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.41 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=202.9
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.+|++.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 6889999999999999999985 468899999987665556678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999999842 35789999999999999999999998 99999999999999999999999999876532221
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......+++.|+|||.+....++.++||||||+++|+|++|+.||....+... +... .... ... +.
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~----~~~~-~~~-----~~- 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI----ATNG-TPE-----LQ- 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHH----hcCC-CCC-----CC-
Confidence 12234678899999999988899999999999999999999999864433211 1110 0000 000 00
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........+.+++.+|++.+|++||++.|+++.
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011223456788889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=315.47 Aligned_cols=257 Identities=29% Similarity=0.432 Sum_probs=200.2
Q ss_pred cCcccccccCCCCceeEEEeEec-CCc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ--EIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 569 (816)
++|++.+.||+|+||.||+|..+ ++. .+|+|.+... .....+.+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999864 344 4678877543 234456788999999999 899999999999999999999
Q ss_pred EeeCCCCCccccccCCC-------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCc
Q 003489 570 YEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
+||+++++|.++++... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235889999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHH
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 637 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 715 (816)
||+|||++..... ........++..|+|||++....++.++||||||++++||+| |..|+....... .....
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~- 236 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL- 236 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHH-
Confidence 9999999863211 111111234668999999988889999999999999999998 998875433221 11111
Q ss_pred HhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
....... ........+.+++.+|++.+|++||++.+++++|++++.
T Consensus 237 ---~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 237 ---PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---hcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000000 001123456788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.91 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=208.1
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc-ceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-NMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 570 (816)
++|...+++|+|+||.++..+.+ ++..+|+|.+.-. +....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998865 5778999988543 33445578899999999999999999999999998 89999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
+|++||+|.+.|.+.+ ...+++.++.+++.|++.|+.|||++. |+|||||+.||++++++.++|.|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996644 567899999999999999999999887 999999999999999999999999999988544
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
. ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+-. .++..+.+. .+.|
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~--------~~~P- 225 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRG--------LYSP- 225 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhc--------cCCC-
Confidence 3 2345579999999999999999999999999999999999999987643321 111111110 1111
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+......+..++..|++.+|+.||++.+++.+
T Consensus 226 ----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123345677788889999999999999999875
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.84 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=202.5
Q ss_pred cCcccccccCCCCceeEEEeEec----CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999864 23369999886543 23456889999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 245799999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccc-cccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 650 NQDQAA-TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 650 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
...... .....++..|+|||.+....++.++||||||+++||+++ |+.|+....... ...... +.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~--~~- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGY--RL- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCC--cC-
Confidence 322111 112233568999999998899999999999999999887 998876443321 111111 110 00
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+. .......+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 -~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 111234667888899999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.05 Aligned_cols=248 Identities=28% Similarity=0.371 Sum_probs=206.2
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|-||.||.|+.+ ++-.||+|++.+. ..+-..++.+|+++-+.|+||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 68999999999999999999855 5678999998653 2334568899999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||.++|.|...|.+. ....+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++..||+|||-+..-.
T Consensus 102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999643 4456888899999999999999999988 9999999999999999999999999987532
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.......+||..|.|||...+...+...|+|++|++.||++.|.+||+.....+ ....+.+. ++.+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k~-------~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRKV-------DLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHHc-------cccCC-
Confidence 344556899999999999999999999999999999999999999987544222 22211111 11111
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........+++..|+..+|.+|.+..||+..
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1123456688889999999999999999763
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.27 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=203.2
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|++|.||++..+ +++.|++|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999865 5889999988643 344567889999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2356889999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......+++.|+|||+..+..++.++||||||++++||++|+.|+....+.. ...... .+.... +
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~-----~- 221 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKII----RGVFPP-----V- 221 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCCCC-----C-
Confidence 1233467889999999999999999999999999999999999986544321 111110 110000 0
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.......+.+++.+|++.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11234567888999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.66 Aligned_cols=249 Identities=31% Similarity=0.454 Sum_probs=203.3
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
++|++.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57888999999999999999876 88999999976543 56789999999999999999999999999899999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999985432 236899999999999999999999998 99999999999999999999999999986532211
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
....+..|+|||.+....++.++||||||++++||++ |..|+....... +...... ......
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~~~~------- 220 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEK----GYRMEA------- 220 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhc----CCCCCC-------
Confidence 2334668999999988889999999999999999997 888876443321 1111111 100000
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.......+.+++.+|++.+|++||++.|++++|++
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 --PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11123567788899999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=317.09 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=191.7
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHH---hhcCCCceeeeeeEEEecCcceEE
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVI---SNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
|++.+.||+|+||.||++... +++.||||++++.. ....+.+.+|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999864 68899999996532 23345666676655 567899999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888842 45899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .... .. ...
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i---~~-~~~------ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSI---VN-DEV------ 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-CCC------
Confidence 1 1222346789999999999999999999999999999999999999865433211 1111 00 000
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~ 766 (816)
.. .......+.+++.+|++.||++||+ +.++++
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00 0112345677888999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.29 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=191.9
Q ss_pred cccCCCCceeEEEeEecC---CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 3578999886543 234457889999999999999999999999999999999999999
Q ss_pred CccccccCCC--CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 577 SLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 577 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2234677788899999999999999998 9999999999999999999999999987543222222
Q ss_pred ccccccccccccChhccccC-------CCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
......++..|+|||++... .++.++||||||+++|||++ |+.|+....+.... .... .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHh----hcccCCC
Confidence 22334567889999988542 35789999999999999996 99998654433221 1111 1111122
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.++.+... ....+.+++..|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 1223556777898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.13 Aligned_cols=250 Identities=36% Similarity=0.522 Sum_probs=202.8
Q ss_pred cccCCCCceeEEEeEecC----CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||++.... +..||+|.+...... ..+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998654 788999999765433 367899999999999999999999999998999999999999
Q ss_pred CCccccccCCCC------CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 576 KSLDSFLFDPQR------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 576 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
++|.+++..... ...+++..+++++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965422 367899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
...........++..|+|||.+....++.++||||||++++||++ |..|+....... +..... ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLR----KGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCCCC---
Confidence 432223334567889999999988889999999999999999999 588886543321 111111 111000
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
........+.+++.+|++.+|++||++.|+++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112456778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.27 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=200.8
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999986 46888999998765555566788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++..+....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998843 345889999999999999999999988 9999999999999999999999999998663221
Q ss_pred ccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+....+..... ...... ...+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCC
Confidence 1122346788999999874 3457889999999999999999999875332211100 000000 0001
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.... .......+.+++.+|++.+|++||++.++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 011235677888899999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=323.62 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=196.6
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999865 58899999996532 233456788999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999998765321
Q ss_pred Cccc------------------------------------ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh
Q 003489 651 QDQA------------------------------------ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694 (816)
Q Consensus 651 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt 694 (816)
.... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCC---hHHHHH
Q 003489 695 GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN---MPTVVS 766 (816)
Q Consensus 695 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~evl~ 766 (816)
|..||......... . ............+ .....+.+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~~~---~---~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETY---R---KIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHH---H---HHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99998754432111 1 1111000000000 00112345566667886 8999998 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.46 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=208.8
Q ss_pred cCcccccccCCCCceeEEEeEecC--Cc--EEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD--GQ--EIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~--~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
+.+.+.++||+|.||.|++|.|.. |+ .||||.++..... ....|++|+.+|-+|+|+|+++++|+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 345567899999999999998763 33 5899999766544 56889999999999999999999999888 778899
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
+|.++.|+|.+.|++ .....+-......++.|||.||.||..++ +|||||..+|+||-....+||+||||.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 45567888888999999999999999998 99999999999999999999999999999876
Q ss_pred CCcccc-cccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 650 NQDQAA-TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 650 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
+.+... .....-...|+|||.+....++.++|||+|||+||||+| |..||...... .+.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhc
Confidence 655433 233456789999999999999999999999999999999 55676544332 222333
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
|....-.......+++.+++..||..+|++|||+..|++.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 32222223345677889999999999999999999997544
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.41 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=193.6
Q ss_pred ccCCCCceeEEEeEec---CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCC
Q 003489 502 KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 577 (816)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355699999876533 33567999999999999999999999875 456789999999999
Q ss_pred ccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc-cc
Q 003489 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA-AT 656 (816)
Q Consensus 578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~ 656 (816)
|.+++... ...+++..+++++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++..+....... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998532 346899999999999999999999998 9999999999999999999999999997653322211 11
Q ss_pred ccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 657 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
....++..|+|||.+....++.++||||||+++|||++ |+.|+........ .... ...... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFI----EQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCCCC---------CC
Confidence 12234578999999988889999999999999999996 9988864433211 1111 111100 01
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112245667788899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=318.86 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=195.0
Q ss_pred CcccccccCCCCceeEEEeEe----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcc
Q 003489 496 NFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 566 (816)
+|++.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 357889999986432 23345678899999999 599999999999999999
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 345889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
+..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||............ ......
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~------ 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK------ 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc------
Confidence 533222 222345789999999998765 4788999999999999999999998643321111111 111100
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
.++.+. ......+.+++.+|++.||++|| ++.++++
T Consensus 226 -~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -CDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011111 11224566788899999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.28 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=198.9
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
+|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 68899999986532 2233567889999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888543 2345899999999999999999999998 9999999999999999999999999998753222
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
......|+..|+|||++....++.++||||+|+++|||++|+.||............. .......
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~--------- 221 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKEDQ--------- 221 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhhcc---------
Confidence 1223478999999999998899999999999999999999999987543321111111 0000000
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
..........+.+++..|++.||++|| ++.++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 001112334567888999999999999 7778755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.85 Aligned_cols=203 Identities=25% Similarity=0.362 Sum_probs=174.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||+||++... +++.||+|++++.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999854 58899999996532 233456888999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 356899999999999999999999998 999999999999999999999999998754321
Q ss_pred Ccc---------------------------------cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCC
Q 003489 651 QDQ---------------------------------AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697 (816)
Q Consensus 651 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~ 697 (816)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 003489 698 NTSFYH 703 (816)
Q Consensus 698 p~~~~~ 703 (816)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.74 Aligned_cols=255 Identities=33% Similarity=0.496 Sum_probs=205.2
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.++|++.+.||+|+||.||++..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999998888889999986533 34577999999999999999999999999989999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+.... .
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y 158 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence 999999999653 2345899999999999999999999998 9999999999999999999999999998764321 1
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
........+..|+|||.+.+..++.++||||||++++||++ |+.|+....... .......... ...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~------~~~---- 225 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVERGYR------MPR---- 225 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC------CCC----
Confidence 11112334568999999998889999999999999999999 888875433221 1111111000 000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01113467788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.19 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=212.0
Q ss_pred cccccCCCCceeEEEeEe-cCCc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 499 LANKLGQGGFGPVYKGKL-QDGQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..++||+|+||+||+|.+ .+++ +||+|++... ..+..+++++|+.+|.+++|||+++++|+|.... ..||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 357999999999999985 3443 5899988654 4456789999999999999999999999998776 7899999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
|+.|+|.+|++.++ ..+..+..+.+..|||+||.|||.+. ++||||..+||||.+...+||.|||+++.+.....
T Consensus 779 mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999997643 45888899999999999999999987 99999999999999999999999999999876666
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
........-.+.|||-|.+....++.++|||||||++||++| |..|+.....++..++.. .++.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~geR-------- 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGER-------- 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cccc--------
Confidence 666666667889999999999999999999999999999998 778877555443322221 1111
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCCC
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l~ 776 (816)
-..++-...++..++..||..|+..||+++++...+.+..++.+
T Consensus 919 -LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 919 -LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred -CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 12233455678889999999999999999999999877755543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=340.17 Aligned_cols=265 Identities=20% Similarity=0.304 Sum_probs=205.5
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.++||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 58899999986532 223567899999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCC--------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 571 EYMPNKSLDSFLFDPQ--------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
||+++++|.+++.... .....++..+++++.||++||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234567788999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcc----------------cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh
Q 003489 643 LARIFGGNQDQ----------------AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706 (816)
Q Consensus 643 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~ 706 (816)
+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221110 01122468999999999999999999999999999999999999986422211
Q ss_pred hhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCC-ChHHHHHHHhccccCCC
Q 003489 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP-NMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 707 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~~l~ 776 (816)
... . . .+.++... ....+....+.+++.+|++.||++|| +++++++.|+..++..+
T Consensus 239 ---i~~-~-~--------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 ---ISY-R-D--------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred ---hhh-h-h--------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 000 0 0 00000000 00012234567888999999999995 78888888887765433
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.62 Aligned_cols=250 Identities=29% Similarity=0.422 Sum_probs=194.3
Q ss_pred cccCCCCceeEEEeEecC-Cc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD-GQ--EIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+|+.++ +. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998754 33 4688888653 234556889999999999 799999999999999999999999999
Q ss_pred CCccccccCCC-------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 576 KSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 576 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
++..... .........+..|+|||++....++.++||||||++++||++ |..||....... ..... ...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL----PQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH----hCC
Confidence 9863211 111111234567999999988889999999999999999997 888875432211 11111 111
Q ss_pred CccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
...+. .......+.+++.+|++.+|.+||++.+++++|++++
T Consensus 228 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCC---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00000 0112245778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.14 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=198.0
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCcc
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 579 (816)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccccc
Q 003489 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659 (816)
Q Consensus 580 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 659 (816)
+++... ...+++..++.++.+++.||+|||+++ ++||||+|+||+++.++.++|+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998543 235788999999999999999999998 999999999999999999999999999765322111111122
Q ss_pred cccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 660 ~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..+..|+|||.+....++.++||||||+++|||++ |..|+........... . .... .. .....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~----~~~~--~~-------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---I----ESGY--RM-------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---H----hcCC--CC-------CCCcc
Confidence 34567999999988889999999999999999999 7777754433221111 1 0000 00 00112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
....+.+++.+|++.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2346778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.75 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=212.7
Q ss_pred HhcCcccccccCCCCceeEEEeEecC---Cc--EEEEEEecc-cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQD---GQ--EIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~---~~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 566 (816)
....+...++||.|-||.||+|...+ |+ .||||..+. ......+.|+.|..+|++++||||++++|+|.+ .+.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34566778899999999999998543 33 489998876 456678899999999999999999999999976 467
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++|||.++-|.|.+||... ...|+......++.||..||+|||+.. +|||||..+|||+.....+||+||||++.
T Consensus 466 WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999999999653 345888999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
+.+....... ...-+..|||||.+...+++.++|||-||+.+||++. |.+||...... ++..
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~ 603 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIG 603 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEE
Confidence 8665544333 4566889999999999999999999999999999987 88888643322 2222
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.+..--+-..++...+.+.-++.+||+++|.+||++.|+...|+.++.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 222222223445567788899999999999999999999998877654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.92 Aligned_cols=240 Identities=27% Similarity=0.346 Sum_probs=188.0
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 57889999986532 23344556677777654 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999998843 345889999999999999999999998 9999999999999999999999999997643222 22
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +..... ... ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i~---~~~---~~~~------- 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSIL---NDR---PHFP------- 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---cCC---CCCC-------
Confidence 334578999999999998899999999999999999999999987543321 111110 000 0000
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChH-HHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMP-TVV 765 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl 765 (816)
......+.+++.+|++.+|++||++. +++
T Consensus 217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11123456778899999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=318.95 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=193.0
Q ss_pred cccCCCCceeEEEeEe-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.||+|+||.||++.. .+++.||+|.+.+.. ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999987532 234466788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99988843 3468999999999999999999997 56 9999999999999999999999999987542221 12
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....+..... .. .... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---i~----~~~~------~~p--- 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---IL----MEEI------RFP--- 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---Hh----cCCC------CCC---
Confidence 2335789999999999999999999999999999999999999865433211111 10 0000 000
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVSM 767 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~~ 767 (816)
......+.+++.+|++.||++|| ++.++++.
T Consensus 217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 -RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11234567788899999999996 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.93 Aligned_cols=248 Identities=30% Similarity=0.428 Sum_probs=197.7
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEe-cCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 573 (816)
++|++.+.||+|+||.||++... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888999999999999999875 788999988643 235678999999999999999999998654 45678999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.... ...+++..+++++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986432 335889999999999999999999998 9999999999999999999999999987643221
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.....+..|+|||++....++.++||||||+++|||++ |+.|+...... .+..... .+.... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~-----~- 220 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KGYKMD-----A- 220 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCCCCC-----C-
Confidence 12334568999999998899999999999999999998 88887533221 1111111 110000 0
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.......+.+++.+|++.+|++|||+.++++.|++
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11223566788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.23 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=199.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999865 57888999886542 23446788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++... ..+++..+..++.||++||.|||+. + ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999532 5588999999999999999999974 5 999999999999999999999999998754321
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC---------
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN--------- 722 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 722 (816)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 12335788999999999888899999999999999999999999864332211111100000000000
Q ss_pred --------cccccccccccc----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 723 --------VIDLVDPLISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 723 --------~~~l~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
..+..+...... ........+.+++.+|++.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 000123457789999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.15 Aligned_cols=241 Identities=26% Similarity=0.336 Sum_probs=191.8
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCC-ceeeeeeEEEecCcceEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR-NLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 570 (816)
+|++.+.||+|+||.||+|+.+ +++.||||++... .....+.+..|..++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999865 4678999998653 233456788899999999764 6888999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998843 345789999999999999999999998 999999999999999999999999998753211
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... +..... .... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~----~~~~------~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIM----EHNV------S 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCC------C
Confidence 1 12234578999999999999999999999999999999999999986543321 111111 1100 0
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
. .......+.+++.+|++.+|.+||+.
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 Y----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 01123456788889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.11 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=194.6
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.++||+|+||.||++.. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999985 468899999986532 233467889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999853 345788899999999999999999998 999999999999999999999999999643211
Q ss_pred Ccc-----------c----------------------------------ccccccccccccChhccccCCCCchhhhHHH
Q 003489 651 QDQ-----------A----------------------------------ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSF 685 (816)
Q Consensus 651 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~Sl 685 (816)
... . ......||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCC---CChH
Q 003489 686 GVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDR---PNMP 762 (816)
Q Consensus 686 G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Pt~~ 762 (816)
||++|||++|+.||.......... .. ..........+ .......+.+++.+|++ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~---~i---~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYR---KI---INWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHH---HH---HccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999986544321111 11 00000000000 00112345667778887 66665 5998
Q ss_pred HHHHH
Q 003489 763 TVVSM 767 (816)
Q Consensus 763 evl~~ 767 (816)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.92 Aligned_cols=246 Identities=27% Similarity=0.359 Sum_probs=193.1
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 68899999986532 22335678899999999999999999999999999999999999999
Q ss_pred cccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccc
Q 003489 579 DSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657 (816)
Q Consensus 579 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 657 (816)
..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8887532 23456899999999999999999999998 99999999999999999999999999986643222 223
Q ss_pred cccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccH
Q 003489 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFK 737 (816)
Q Consensus 658 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 737 (816)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ........ .. . ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~-~~--------~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILN-DS--------V--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhcc-cC--------C--CCcc
Confidence 3578999999999999999999999999999999999999986543221110 00000000 00 0 0011
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 738 MEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 738 ~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2234667888899999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.74 Aligned_cols=254 Identities=31% Similarity=0.455 Sum_probs=203.2
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678999999999999999999877888999988643 2345678999999999999999999999887 7789999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 999999999543 2345788999999999999999999988 99999999999999999999999999986643221
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||++....++.++|+||||++++++++ |+.|+....... +.... .......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~~------- 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYRMP------- 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCCCC-------
Confidence 11222345678999999988889999999999999999999 888876433221 11111 1110000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
........+.+++.+|++.+|++||++.++.++|+.
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223467788899999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=320.58 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=198.6
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47889999999999999999864 68899999997542 234566889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999543 246899999999999999999999998 999999999999999999999999999876433
Q ss_pred CcccccccccccccccChhccc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAM------EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......... ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCcc
Confidence 222 223357899999999986 456789999999999999999999998644332111 1111111111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
... ........+.+++..|++ +|++||++.++++
T Consensus 229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 100 001123456677778997 9999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.98 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=203.0
Q ss_pred cCcccccccCCCCceeEEEeEecC-Cc----EEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
.+|++.+.||+|+||.||+|..++ ++ .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568888999999999999998643 33 589998865543 345678999999999999999999999987 78899
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
............++..|+|||.+....++.++||||||+++||+++ |+.|+.....+. +..... ..... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~--~ 231 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLE----KGERL--P 231 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh----CCCCC--C
Confidence 3322222222234568999999988889999999999999999999 999986544322 111111 11000 0
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
.+ ......+.+++.+|+..+|.+||++.++++.|++..+
T Consensus 232 ~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 1122356788889999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.38 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=199.9
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHH--HHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE--EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
|++.+.||+|+||+||+++.. +++.+|+|.+......... ...+|+.++++++|+||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999965 4668999999765433332 3456999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++. ....+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence 9999999995 3456899999999999999999999998 999999999999999999999999999865 1222
Q ss_pred cccccccccccccChhccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||++. ...++.++||||+|+++++|++|+.|+.................. . .... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~----~~~~-~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR---P----LPSS-SQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT---H----HHHH-TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc---c----cccc-cc
Confidence 3344567899999999998 788999999999999999999999998755222221111111100 0 0000 00
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
........+.+++..|++.||++||++.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001267888999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.42 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=188.6
Q ss_pred cccCCCCceeEEEeEecC---CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.||+|+||.||+|.... ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888775433 334567889999999999999999999999999999999999999
Q ss_pred CccccccCCCC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 577 SLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 577 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865332 233567788899999999999999998 9999999999999999999999999987543222222
Q ss_pred ccccccccccccChhcccc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 655 ATKRLVGTYGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+....+.. ...... . ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~---~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVV---R-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHh---h-ccCccC
Confidence 2233455778999998743 356789999999999999999 677776443321 111111 1 111112
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.++.+.. .....+.+++..|+ .+|++||++.||+++|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222211 12234455666787 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.43 Aligned_cols=271 Identities=27% Similarity=0.426 Sum_probs=203.2
Q ss_pred cCcccccccCCCCceeEEEeEec-----CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEe--cCcc
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVE--REEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 566 (816)
+.|++.+.||+|+||.||++++. .++.+|||.+...... ..+.|.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999999854 3678999999765443 56789999999999999999999999887 5578
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999995432 25899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc-cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQDQ-AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
....... .......++..|+|||.+....++.++||||||++++||++|+.|+........ ................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-RMIGIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc-cccccccccccHHHHHH
Confidence 6532221 111123445679999999888999999999999999999999988643222110 00000000000000000
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.+...............+.+++.+|++.+|++||+|.||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000000001112235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.34 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=201.2
Q ss_pred cCcccccccCCCCceeEEEeEe-----cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccc
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 566 (816)
+.|++.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 357789999987543 33456799999999999999999999998875 457
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc-cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh--------hhhHHHHHHHh
Q 003489 647 FGGNQDQ-AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF--------ELTLLGYAWKL 717 (816)
Q Consensus 647 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~--------~~~l~~~~~~~ 717 (816)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 12223456778999999988889999999999999999999876532211000 00000000111
Q ss_pred hccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
...+.... ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111000 0111245788899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.21 Aligned_cols=248 Identities=31% Similarity=0.455 Sum_probs=195.3
Q ss_pred cccCCCCceeEEEeEecC----CcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875543 35567999999999999999999999875 5567999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc-
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA- 654 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 654 (816)
++|.+++... ..+++..++.++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 36899999999999999999999988 9999999999999999999999999998764332211
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|||++ |+.|+...... .+..... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCcCC--------
Confidence 1111233568999999998899999999999999999998 89887644332 1222211 111000
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0111234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.82 Aligned_cols=203 Identities=26% Similarity=0.393 Sum_probs=172.9
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
+|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999854 57889999986532 2334678899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999853 345788889999999999999999998 9999999999999999999999999975331100
Q ss_pred c---------------------------------------------ccccccccccccccChhccccCCCCchhhhHHHH
Q 003489 652 D---------------------------------------------QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFG 686 (816)
Q Consensus 652 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG 686 (816)
. ........||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0011234789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCch
Q 003489 687 VLLLEIVSGRKNTSFYHE 704 (816)
Q Consensus 687 ~vl~elltG~~p~~~~~~ 704 (816)
|+||||++|+.||....+
T Consensus 236 vil~elltG~~Pf~~~~~ 253 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHHhCCCCCCCCCH
Confidence 999999999999875443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.75 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=198.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.++||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999865 57889999986543 23345678899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 975 787777432 345788999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH--------HhhccCCc
Q 003489 653 QAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW--------KLWNDNNV 723 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~~ 723 (816)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||................ +.+.....
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 11223467889999998865 458899999999999999999999987654433322221111 00000000
Q ss_pred ccccc-ccccc----cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 IDLVD-PLISE----SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 ~~l~d-~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+ +.... .........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00000 000112345678889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.01 Aligned_cols=249 Identities=31% Similarity=0.420 Sum_probs=198.7
Q ss_pred cccCCCCceeEEEeEecC--C--cEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD--G--QEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|++|.||+|.+.. + ..||+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3689999977655 566789999999999999999999999988 888999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc-c
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ-A 654 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 654 (816)
++|.+++.+... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999998 999999999999999999999999999876442221 1
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|||++ |+.|+........ ...... ......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCCcCC--------
Confidence 1223456789999999998899999999999999999999 9999754333211 111110 000000
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
........+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112356778889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.69 Aligned_cols=240 Identities=26% Similarity=0.320 Sum_probs=189.3
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.+ +++.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 57899999986532 23445667788887754 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999998843 345889999999999999999999998 999999999999999999999999998743211 112
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....... +..... .. .+.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~----~~------~~~~~~-- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR----VD------TPHYPR-- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCCCC--
Confidence 234678999999999999999999999999999999999999986443321 111111 00 000101
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChH-HHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMP-TVV 765 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl 765 (816)
.....+.+++.+|++.||++||++. +++
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 --WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1123566788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.29 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=192.8
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.+ +++.||+|++++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 58899999997532 23345688899999988 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888843 346899999999999999999999998 999999999999999999999999998743211 122
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh--hhhHHHHHHHhhccCCccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF--ELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+...... ......+........... +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p- 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IP- 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CC-
Confidence 234578999999999999999999999999999999999999986432111 111111221111111110 00
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCC------hHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPN------MPTVVS 766 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt------~~evl~ 766 (816)
......+.+++.+|++.||++||+ +.++++
T Consensus 226 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 ---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112245678888999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=323.80 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=194.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999854 58899999986532 233466889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 345788888999999999999999998 999999999999999999999999997533100
Q ss_pred Cc-----------------------------------------ccccccccccccccChhccccCCCCchhhhHHHHHHH
Q 003489 651 QD-----------------------------------------QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689 (816)
Q Consensus 651 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl 689 (816)
.. ........||+.|+|||++....++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001134799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCC---ChHHHHH
Q 003489 690 LEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP---NMPTVVS 766 (816)
Q Consensus 690 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---t~~evl~ 766 (816)
|||++|+.||....+......+ ......... +. .......+.+++.+|+ .+|++|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i------~~~~~~~~~--~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKV------INWETTLHI--PS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHH------hccCccccC--CC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999998755433211100 000000000 00 0011233445555655 5999999 7888875
Q ss_pred H
Q 003489 767 M 767 (816)
Q Consensus 767 ~ 767 (816)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.69 Aligned_cols=239 Identities=23% Similarity=0.322 Sum_probs=186.9
Q ss_pred ccCCCCceeEEEeEecC-------------------------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeee
Q 003489 502 KLGQGGFGPVYKGKLQD-------------------------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 556 (816)
+||+|+||.||+|.+.. ...||+|.+........+.|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13489998876554555678899999999999999999
Q ss_pred eeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC--
Q 003489 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-- 634 (816)
Q Consensus 557 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-- 634 (816)
++++......++||||+++|+|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988542 345789999999999999999999988 99999999999998654
Q ss_pred -----CceeeccccceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHH-hCCCCCCCCchhhh
Q 003489 635 -----NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIV-SGRKNTSFYHEEFE 707 (816)
Q Consensus 635 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~ell-tG~~p~~~~~~~~~ 707 (816)
.++++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.|+....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988643211 12356788999998865 56899999999999999995 68888764433221
Q ss_pred hhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 708 LTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 708 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.. ..... . .+.. .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~---~~~~~---~--------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER---FYEKK---H--------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---HHHhc---c--------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 11000 0 0000 01235778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.93 Aligned_cols=241 Identities=28% Similarity=0.362 Sum_probs=190.0
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhh-cCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISN-LQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57889999987542 2334556778888876 4899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999999843 345889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... .. .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~----~~------~~~~~~-- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR----MD------NPCYPR-- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCCCc--
Confidence 234578999999999998899999999999999999999999986543321 111111 00 000000
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChH-HHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMP-TVVS 766 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~-evl~ 766 (816)
.....+.+++.+|++.+|++||++. ++.+
T Consensus 218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 --WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1123466788899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.77 Aligned_cols=241 Identities=26% Similarity=0.335 Sum_probs=191.9
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 570 (816)
+|++.+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999865 57789999987532 22344567788888777 5899999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999999754221
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
........||+.|+|||++....++.++|||||||++|||++|+.||....... +..... .... .
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~----~~~~------~ 219 (323)
T cd05616 155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM----EHNV------A 219 (323)
T ss_pred --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCC------C
Confidence 112234578999999999999999999999999999999999999987544321 111111 1100 0
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
........+.+++.+|++.+|++|++.
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011123456788889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.43 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=188.0
Q ss_pred cccCCCCceeEEEeEecC-------------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 501 NKLGQGGFGPVYKGKLQD-------------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2258899887655555668899999999999999999999999999999
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCC-------ceeec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-------PKISD 640 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~D 640 (816)
+||||+++++|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888532 345899999999999999999999988 999999999999987664 89999
Q ss_pred cccceecCCCCcccccccccccccccChhccc-cCCCCchhhhHHHHHHHHHHH-hCCCCCCCCchhhhhhHHHHHHHhh
Q 003489 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIV-SGRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 641 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SlG~vl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ .|..|+.......... ..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH
Confidence 9998654211 2245678899999886 466899999999999999998 4777765332211100 00
Q ss_pred ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 719 NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 719 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
. .. ..... .....+.+++.+||+.||++||++.+|++.|+
T Consensus 223 ~-~~-~~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQ-CMLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cC-ccCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 00110 11245678888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.50 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=192.4
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999986532 23445677888888866 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999988843 345889999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....|++.|+|||++....++.++||||||+++|||++|+.||....+... .... .... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~i---~~~~----~~~p------ 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FESI---LHDD----VLYP------ 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHHH---HcCC----CCCC------
Confidence 2345789999999999998999999999999999999999999875443221 1111 1111 0000
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCC-------ChHHHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRP-------NMPTVVSM 767 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RP-------t~~evl~~ 767 (816)
......+.+++..|++.+|++|| ++.++++.
T Consensus 217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01124567788899999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.22 Aligned_cols=251 Identities=31% Similarity=0.496 Sum_probs=196.7
Q ss_pred cccCCCCceeEEEeEecC-------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 501 NKLGQGGFGPVYKGKLQD-------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999886543 24566889999999999999999999999999999999999
Q ss_pred CCCCCccccccCCC----CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-----Cceeecccc
Q 003489 573 MPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-----NPKISDFGL 643 (816)
Q Consensus 573 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~DfGl 643 (816)
+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996422 2245789999999999999999999988 99999999999999877 899999999
Q ss_pred ceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
++...............++..|+|||++....++.++||||||+++|||++ |+.|+...... ....... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~----~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVT----AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHh----cCC
Confidence 976543322222223345678999999999999999999999999999998 99887643321 1111110 110
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.. .........+.+++.+|++.+|.+||++.+|+++|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0011123466788889999999999999999999853
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.51 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=198.6
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
..++|++.++||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999865 5889999998643 22334567899999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999843 34788888899999999999999998 9999999999999999999999999998654
Q ss_pred CCCcccccccccccccccChhccccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
.... .......||+.|+|||++... .++.++|||||||++|||++|+.||........ .. .........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~i~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS---KIMDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HH---HHHcCCCcC
Confidence 3221 122345789999999998653 378899999999999999999999865433211 11 111111000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCC--CCChHHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKD--RPNMPTVVSM 767 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~~ 767 (816)
... ........+.+++..|++.+|.+ ||++.|+++.
T Consensus 267 ~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 00112345667888999999987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.81 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=196.8
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----cce
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENM 567 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 567 (816)
+|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 46899999998653 2234567889999999999999999999998776 679
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777773 3346899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc-
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID- 725 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~- 725 (816)
..... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+ ...........
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAM 229 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHH
Confidence 33221 122234678899999998764 4789999999999999999999998755443221111 11100000000
Q ss_pred ----------cc-----cccccc--cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 726 ----------LV-----DPLISE--SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 726 ----------l~-----d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+. .+.... .........+.+++.+|++.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000000 0001123567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.13 Aligned_cols=238 Identities=24% Similarity=0.294 Sum_probs=190.7
Q ss_pred cccCCCCceeEEEeEe----cCCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 501 NKLGQGGFGPVYKGKL----QDGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
+.||+|+||.||+++. .+++.+|+|++..... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999975322 234567789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999999843 346899999999999999999999998 9999999999999999999999999987643221 1
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 734 (816)
......|++.|+|||.+....++.++||||||+++|||++|+.|+........ ..... . ... . +.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i~---~-~~~-~-~p------ 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMIL---K-AKL-G-MP------ 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHHH---c-CCC-C-CC------
Confidence 22345789999999999988899999999999999999999999865433211 11111 0 000 0 00
Q ss_pred ccHHHHHHHHHHHHHhhhcCCCCCCChHH
Q 003489 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPT 763 (816)
Q Consensus 735 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e 763 (816)
......+.+++.+|++.||++||++.+
T Consensus 219 --~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 --QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111245667888999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.32 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=197.7
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|++|.||+|+.+ +++.||+|+++... ....+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999865 68899999886432 22346788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
++ ++|.+++........+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888865444467899999999999999999999998 9999999999999999999999999997653321
Q ss_pred ccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC---------C
Q 003489 653 QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN---------N 722 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~ 722 (816)
.......+++.|+|||++.+. .++.++||||||++++||++|+.|+....+...............+. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112224568899999988654 47899999999999999999999886543321111000000000000 0
Q ss_pred ccccccccccc---cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VIDLVDPLISE---SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.....+..... ........++.+++.+|++.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000012345678889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.54 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=199.1
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
++|++.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999985 468899999886432 1233568899999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
|+||+++++|.+++.. ...+++..+.+++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345788999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCcccc-cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAA-TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+........ ... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~~--- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFK----IATQPTNP--- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HHH----HhccCCCC---
Confidence 3211111 1234677899999999998899999999999999999999999753322111 100 00010000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+ .......+.+++.+|++.+|.+|||+.|+++.
T Consensus 227 --~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 --QL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01 11123456778889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.85 Aligned_cols=236 Identities=27% Similarity=0.346 Sum_probs=188.8
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.+ +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5789999998653 223456677888888876 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 999988843 345889999999999999999999998 999999999999999999999999998754221 112
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....||+.|+|||++....++.++||||||+++|||++|+.||........ .... ..... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i----~~~~~---~~~------ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAI----LNDEV---VYP------ 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHH----hcCCC---CCC------
Confidence 2345789999999999988999999999999999999999999875443211 1111 11100 000
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
......+.+++.+|++.||++||++
T Consensus 217 -~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 -TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0122456788889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.88 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=188.8
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.+ +++.||+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5788999998753 223345677898888776 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh--hhhHHHHHHHhhccCCccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF--ELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+.......... . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----C--
Confidence 234578999999999999999999999999999999999999985322111 11111122111111111 0 0
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
+......+.+++.+|++.||++||+.
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11123456688889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=300.38 Aligned_cols=251 Identities=28% Similarity=0.489 Sum_probs=201.2
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
.+|++.+.||+|+||.||++...+++.+|+|.+.... .....|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999998778899999886432 345678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999998542 235789999999999999999999998 999999999999999999999999999865432211
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++.+|+|||.+....++.++||||||+++|||++ |+.|+....... +.... ... .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~--~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI----NAG--FRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----hCC--CCCCCCCC--
Confidence 1112334678999999988889999999999999999998 888875433221 11111 110 01111111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
....+.+++.+|++.+|++||++.|++++|
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 135677889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=307.49 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=202.6
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999985 46899999999765555667789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999843 35788999999999999999999988 99999999999999999999999999976533221
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......+++.|+|||.+....++.++||||||+++|+|++|+.||....+..... . ....+ .+.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~----~~~~~------~~~~- 235 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IATNG------TPEL- 235 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e----eccCC------CCCC-
Confidence 1223467889999999998889999999999999999999999986433211100 0 00000 0000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.........+.+++.+|++.+|++||++.+|++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122345667888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=302.85 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=192.1
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||+|+||.||+++.+ +|+.+|+|.+.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986432 12334566799999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9888543 2335889999999999999999999998 9999999999999999999999999998664322 1223
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..++..|+|||++....++.++||||||+++|||++|+.|+......... ......... .... ... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~-~~~~------~~~---~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE-DEVK------FEH---QN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc-cccc------ccc---cc
Confidence 46889999999999888999999999999999999999998643321111 011111111 0000 000 01
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
....+.+++..|++.||++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 233567888899999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=318.86 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=196.3
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
..++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999865 5788999998642 22334568899999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999843 34788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccChhccccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
... ........||+.|+|||++.... ++.++|||||||++|||++|+.||........ . ..........
T Consensus 194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~---~~i~~~~~~~ 266 (370)
T cd05621 194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---Y---SKIMDHKNSL 266 (370)
T ss_pred cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCCccc
Confidence 222 11223467999999999987543 78899999999999999999999865433211 1 1111111100
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCC--CCChHHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKD--RPNMPTVVSM 767 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~~ 767 (816)
... ........+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 100 01112334556677788755543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.10 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=198.0
Q ss_pred HHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666679999999999999854 57789999987766666778999999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~ 649 (816)
||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999964322212278888899999999999999988 999999999999976 67999999999876532
Q ss_pred CCcccccccccccccccChhccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
... ......++..|+|||++.... ++.++||||||+++|+|++|+.|+......... .+.......
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~------- 229 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKI------- 229 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhcc-------
Confidence 221 122345788999999986543 788999999999999999999997543221110 000000000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+.+ .......+.+++.+|++.+|.+|||+.|+++
T Consensus 230 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011 1112345678888999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.44 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=199.5
Q ss_pred cCcccccccCCCCceeEEEeEec-CCc----EEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
++|+..+.||+|+||.||+|... +++ .||+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778899999999999999853 344 478898865432 3345788999999999999999999998754 4679
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998543 235788999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
............++..|+|||.+....++.++||||||+++|||++ |+.|+........ .... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~~~- 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLL----EKGERLPQ- 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HCCCCCCC-
Confidence 3322222223445678999999998899999999999999999997 8888754332211 1111 11110000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
.......+.+++..|+..+|++||++.+++++|+.+.
T Consensus 233 --------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 233 --------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112346778889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=299.73 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=188.0
Q ss_pred cccCCCCceeEEEeEecCCc-----------EEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 501 NKLGQGGFGPVYKGKLQDGQ-----------EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999976433 4788877554333 6789999999999999999999999988 778999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-------Cceeeccc
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-------NPKISDFG 642 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~DfG 642 (816)
+||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999995432 26889999999999999999999988 99999999999999888 79999999
Q ss_pred cceecCCCCcccccccccccccccChhccccC--CCCchhhhHHHHHHHHHHHhC-CCCCCCCchhhhhhHHHHHHHhhc
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSG-RKNTSFYHEEFELTLLGYAWKLWN 719 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SlG~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 719 (816)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+.......... .. .
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~----~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FY----Q 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HH----h
Confidence 9986532 1223566789999998776 789999999999999999995 55654332211110 00 0
Q ss_pred cCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 720 DNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 720 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
....... .....+.+++.+|++.+|++||++.+|++.|+
T Consensus 221 ~~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRLPM-----------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCCCC-----------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 01157778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=298.80 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=201.6
Q ss_pred cCcccccccCCCCceeEEEeEecC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
++|++.+.||+|+||.||+|+..+ ++.+++|.+..... .+.+.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999764 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998432 356899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....+...... . .. ...+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~----~~-----~~~~~~~- 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---I----PN-----KPPPTLS- 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---h----cc-----CCCCCCC-
Confidence 22234578899999999988999999999999999999999999865433211000 0 00 0000110
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
........+.+++.+|++.+|++||++.||++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112245678888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.90 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=191.5
Q ss_pred cccCCCCceeEEEeEec----CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEe-cCcceEEEeeCC
Q 003489 501 NKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENMLIYEYMP 574 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 574 (816)
+.||+|+||.||+|... +...||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999988543 23445788899999999999999999998764 455789999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc-
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ- 653 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 653 (816)
+++|.+++... ...+++..++.++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234677888999999999999999988 999999999999999999999999999765332111
Q ss_pred -cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCC-CCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 654 -AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR-KNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 654 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
.......++..|+|||.+....++.++||||||+++|||++|. +|+...... .+..... ..... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----~~~~~-----~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----QGRRL-----LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----cCCCC-----CC
Confidence 1112234567899999998889999999999999999999965 454432221 1221111 11000 00
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccc
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 772 (816)
. ......+.+++..|++.+|++||++.||+++|+++.
T Consensus 224 -~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 -P---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -C---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 011245778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.69 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=190.2
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 57889999997542 23345688899999888 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 999988843 346899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......................... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------I---- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC------C----
Confidence 234678999999999999999999999999999999999999986433222211112222211111100 0
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
.......+.+++.+|++.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 01112445678889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.93 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=199.9
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888999999999999999854 6889999998766555566788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.. ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 999999999843 346899999999999999999999998 999999999999999999999999998765322
Q ss_pred ccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
........|+..|+|||++. ...++.++||||||+++|||++|+.|+....+..... .... .... .+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~~~~-----~~~~---~~ 229 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMTK-----SNFQ---PP 229 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--hhhc-----cCCC---CC
Confidence 12223457889999999874 4558899999999999999999999875433221110 0000 0000 00
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..... ......+.+++.+|++.+|++||++.+|++
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01000 011235678888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=304.05 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=202.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888999999999999999854 58889999876543 34467889999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++.. ...+++..+..++.+++.||.|||+. + ++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999998843 34689999999999999999999974 5 999999999999999999999999998654221
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchh-----hhhhHHHHHHHhhccCCcccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE-----FELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~~~~~~l 726 (816)
......++..|+|||.+....++.++||||||+++|+|++|+.|+...... ....+.........+.
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 122357899999999998889999999999999999999999998754332 1111112211111111
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.+.+. ..+....+.+++.+|++.||++||++.||+++.
T Consensus 230 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01110 111234577888899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=301.95 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=201.6
Q ss_pred cCcccccccCCCCceeEEEeEecC----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
++|++.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568888999999999999998643 2468999886554 4456789999999999999999999998875 557899
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999543 235899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
..... .....++..|+|||.+....++.++||||||++++||++ |+.||........ .... .......
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----~~~~~~~--- 228 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----ENGERLP--- 228 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCCcCC---
Confidence 32111 122344568999999988889999999999999999996 9999864433211 1111 1110000
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
. .......+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 229 --~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 --M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 01123467778889999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=299.91 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=196.5
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcc-----eEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN-----MLI 569 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----~lV 569 (816)
.|+..+++|.|+||.||+|++. +++.||||+.-...+ .--+|+++|++++|||||+++-+|...... .||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666789999999999999965 468999998854332 223699999999999999999998754332 489
Q ss_pred EeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-CCceeeccccceec
Q 003489 570 YEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIF 647 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 647 (816)
|||||. +|.+++++. ..+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 788877531 22345777778889999999999999988 9999999999999987 89999999999988
Q ss_pred CCCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc--
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI-- 724 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 724 (816)
..++.. .....+.-|.|||.+.+. .|+.+.||||.|||+.||+-|++-|+..+..+...++-.+......+++.
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 554433 224567889999998765 69999999999999999999999988766554443333222111111111
Q ss_pred -----cccccccccc-----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 -----DLVDPLISES-----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 -----~l~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+...|.+... ......++.++++.++++++|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111222221 22334577889999999999999999999975
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=310.20 Aligned_cols=237 Identities=25% Similarity=0.305 Sum_probs=186.5
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHH-HHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.. +++.||+|++.... ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999865 68999999986532 222344555554 56789999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999998843 346888999999999999999999998 999999999999999999999999998753221 122
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... +.. .... ... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~-~~~------~~~~-- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD---NILN-KPL------RLKP-- 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHH---HHHc-CCC------CCCC--
Confidence 334578999999999999999999999999999999999999986433221 111 1111 000 0111
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMP 762 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 762 (816)
.....+.+++.+|++.+|++||++.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 --NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234567888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=319.95 Aligned_cols=194 Identities=21% Similarity=0.301 Sum_probs=167.4
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..+|.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999865 47889999642 23457899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+ .++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.++|+|||+++.+.....
T Consensus 242 ~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 47888887432 236899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~ 699 (816)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22233457999999999999999999999999999999999988654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.80 Aligned_cols=241 Identities=25% Similarity=0.319 Sum_probs=192.2
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||++... +++.||||++++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 47889999997532 23455677888998888 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999988843 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........ .... ..... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~~i----~~~~~--~~-------- 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQSI----LEDEV--RY-------- 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HHHH----HcCCC--CC--------
Confidence 2335689999999999999999999999999999999999999864433211 1111 01100 00
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCCh-----HHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNM-----PTVVS 766 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~-----~evl~ 766 (816)
.......+.+++.+|++.||.+||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01123456788889999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.36 Aligned_cols=241 Identities=26% Similarity=0.351 Sum_probs=191.2
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 570 (816)
+|+..+.||+|+||.||+++.. +++.||+|++.+.. ....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999864 68899999987532 233456788999988885 577888999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 345899999999999999999999998 999999999999999999999999998754221
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
........||+.|+|||++....++.++||||||+++|||++|+.|+....... +...... ... .
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~~~-~----- 219 (323)
T cd05615 155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIME----HNV-S----- 219 (323)
T ss_pred --CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CCC-C-----
Confidence 112234568999999999998899999999999999999999999986543321 1111110 000 0
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCCh
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNM 761 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 761 (816)
........+.+++.+|++.+|.+|++.
T Consensus 220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 001122456788889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.04 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=200.5
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 6889999988543 3345577889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++... ....++...++.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988532 3345788999999999999999999998 99999999999999999999999999986643221
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||++....++.++|+||||+++|+|++|+.|+....... ..... ..+....+ .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~~~-~----- 221 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKV----CQGSYKPL-P----- 221 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHH----hcCCCCCC-C-----
Confidence 1223568889999999998889999999999999999999999986433211 11111 11111110 0
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
......+.+++.+|++.+|++||++.|++..
T Consensus 222 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 ---SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122356788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.82 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=199.2
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667789999999999999864 57889999886443 33456789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999999883 245889999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||.+....++.++||||||++++||++|+.|+....+... ... .... ..+.+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~~~-----~~~~~~ 222 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IPKN-----SPPTLE 222 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hhcC-----CCCCCC
Confidence 112234678899999999988899999999999999999999998754332211 000 0000 011111
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
......+.+++.+|++.+|++||+|.+|++.
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1233467788899999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.16 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=202.2
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5799999999999999999985 568999999987655555678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998842 35899999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||.+....++.++||||||+++|+|++|+.|+....+...... ... . .... +.
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~---~-~~~~-----~~- 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT---N-GTPE-----LQ- 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---c-CCcc-----cC-
Confidence 12234678899999999988899999999999999999999999865444222111 000 0 0000 00
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
........+.+++.+|++.+|++||++.+++.
T Consensus 237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01112245667888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=300.31 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=199.0
Q ss_pred CcccccccCCCCceeEEEeEecC--CcEEEEEEeccc----------CchhHHHHHHHHHHHhh-cCCCceeeeeeEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQD--GQEIAVKRLSKA----------SGQGQEEFMNEVMVISN-LQHRNLVRLLGCCVE 562 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 562 (816)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 678999987532 12234567788888865 799999999999999
Q ss_pred cCcceEEEeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcCCCCceeec
Q 003489 563 REENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISD 640 (816)
Q Consensus 563 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~D 640 (816)
.+..+++|||+++++|.+++... .....+++..+++++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 233468899999999999999999996 55 99999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 641 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
||++....... ......++..|+|||.+....++.++||||||+++|||++|+.|+........ .... ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~~~----~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---ATKI----VE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HHHH----hh
Confidence 99998754332 23345688899999999988899999999999999999999998753322111 1111 11
Q ss_pred CCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 721 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.... +... ......+.+++.+|++.||++||++.||.++++
T Consensus 228 ~~~~----~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYE----PLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCC----cCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111 1000 112346778888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=301.73 Aligned_cols=256 Identities=30% Similarity=0.399 Sum_probs=201.5
Q ss_pred cCcccccccCCCCceeEEEeEec------CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999864 2467999988654433 4578999999999999999999999999999999
Q ss_pred EEEeeCCCCCccccccCCCCC------CCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecc
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQ------SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 641 (816)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654322 26899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 642 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
|++....... ........++..|+|||.+.....+.++||||||+++++|++ |..|+....... ..... ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~----~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL----QA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH----Hc
Confidence 9987543221 112223456778999999988889999999999999999999 677764322211 11111 11
Q ss_pred CCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 721 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
....... .......+.+++.+|++.+|++||++.|++++|.
T Consensus 234 ~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110000 0112346778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=317.17 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=198.5
Q ss_pred hcCcccccccCCCCceeEEEeEec---CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
..+|++.+.||+|+||.||++... .++.||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999753 3567999988542 34568999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
|++. ++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++..+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 68888882 3456899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc------
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI------ 724 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 724 (816)
..........||+.|+|||++....++.++|||||||++|||++|+.|+...........+....+.+......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333334678999999999999999999999999999999999999985433221111111111111100000
Q ss_pred -cc------cccccccccc-------HHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 725 -DL------VDPLISESGF-------KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 725 -~l------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+ .......... ......+.+++.+|++.+|++||++.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0012356678889999999999999999875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=302.77 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=197.7
Q ss_pred HHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEec------
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER------ 563 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 563 (816)
.+++.|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678899999999999999999864 5788999998644 34456788999999998 699999999998764
Q ss_pred CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3468999999999999998643 2345889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
+....... .......|+..|+|||++. ...++.++||||||+++|||++|+.|+....+...... ..
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~------~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------Hh
Confidence 98653221 1223457889999999986 34578899999999999999999999864333211110 00
Q ss_pred ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 719 NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 719 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. .......+. .....+.+++.+|++.+|++|||+.|+++
T Consensus 230 ~-~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R-NPAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c-CCCCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000111111 11235678888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=324.01 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=190.6
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--------
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-------- 563 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 563 (816)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999864 68899999885432 2345799999999999999999887532
Q ss_pred CcceEEEeeCCCCCccccccC-CCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-Cceeecc
Q 003489 564 EENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDF 641 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Df 641 (816)
...++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 124689999975 67666542 223456899999999999999999999998 99999999999999765 7999999
Q ss_pred ccceecCCCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 642 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
|+++.+.... ......+++.|+|||++.+. .++.++|||||||+||||++|++||........... ....+..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~---i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR---IIQVLGT 289 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCC
Confidence 9998654322 12235678999999988654 689999999999999999999999875443221111 1111110
Q ss_pred CC----------cccccccc-----ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 721 NN----------VIDLVDPL-----ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 721 ~~----------~~~l~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.. ...+.-+. +...........+.+++.+||+.+|.+|||+.|+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 00000000 000001112346788999999999999999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.09 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=188.1
Q ss_pred cccCCCCceeEEEeEecCCc---EEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQDGQ---EIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
++||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754433 45677665433 345678999999999999999999999999999999999999999
Q ss_pred CccccccCCCC-CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 577 SLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 577 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
+|.+++.+... ....++..+..++.||++||+|||+.+ ++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999965322 234667778899999999999999988 99999999999999999999999999864322111112
Q ss_pred cccccccccccChhcccc-------CCCCchhhhHHHHHHHHHHHhC-CCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 656 TKRLVGTYGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVSG-RKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SlG~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....+. ...... . .+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---I-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---H-hhcccccC
Confidence 233567889999998743 2457899999999999999975 5566433221 111111 1 11122233
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
++.+.... ...+.+++..|+ .+|++||+++||+++|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33333222 234556777899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.44 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=201.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..|+..++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999865 58899999886432 34557789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999999842 35788899999999999999999988 99999999999999999999999999976643221
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......++..|+|||++....++.++|+||||+++|||++|+.|+....+....... ... ..+.
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~-----~~~~-- 220 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKN-----NPPT-- 220 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcC-----CCCC--
Confidence 122346788999999998888999999999999999999999997643332111100 000 0011
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........+.+++.+|++.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 --LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112344567789999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=305.74 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=197.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.++||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999865 57889999986432 23345678899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 5888887543 345788999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc---
Q 003489 653 QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD--- 728 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d--- 728 (816)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....................+.....+++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 112224568899999988654 578899999999999999999999875543322111111100000000000000
Q ss_pred ------ccccccc----cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 ------PLISESG----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ------~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+...... .......+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100000 0112345678889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.66 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=201.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999865 58899999986543 34456788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999843 26899999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+.. ...... .. ..+.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~----~~-----~~~~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIP----KN-----NPPSLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhh----hc-----CCCCCc
Confidence 12233567889999999998889999999999999999999999986433211 111110 00 111111
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
... ....+.+++.+|++.+|++||+++++++
T Consensus 220 ~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNK---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 110 2345677888999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.76 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=196.5
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 68899999986532 22345678899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998885432 345899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||....+......... .. .... ...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~-~~~~--~~~----- 224 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RV-LETE--EVY----- 224 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hh-hccc--ccc-----
Confidence 12234689999999999988999999999999999999999999875443222111111 00 0000 000
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~ 766 (816)
.......+.+++..|++.+|++||+ +.++++
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1112235567888999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.45 Aligned_cols=240 Identities=24% Similarity=0.316 Sum_probs=187.7
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHH-HHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.. +++.+|+|++.+.. ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 68899999986532 233345555654 56789999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99988884 3346899999999999999999999998 999999999999999999999999998753211 122
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... +.. ...... . .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~~~~~~-~--~~~~------ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYD---NILHKP-L--VLRP------ 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHH---HHHcCC-c--cCCC------
Confidence 234578999999999999999999999999999999999999986543221 111 111110 0 0111
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVV 765 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl 765 (816)
.....+.+++..|++.+|++||++.+.+
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1234566788899999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.95 Aligned_cols=240 Identities=27% Similarity=0.413 Sum_probs=188.6
Q ss_pred cccCCCCceeEEEeEecC--------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 501 NKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997542 234888888665555567889999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCC--------ceeeccccc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--------PKISDFGLA 644 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~DfGla 644 (816)
+++|+|.+++.... ..+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996432 35789999999999999999999998 999999999999988765 589999988
Q ss_pred eecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCC-CCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR-KNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
..... .....++..|+|||++.. ..++.++||||||+++|||++|. .|+........... . ...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~----~~~- 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---Y----EDR- 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---H----Hcc-
Confidence 65422 122467788999999876 45799999999999999999995 44443222211110 0 000
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
..+ .......+.+++.+|++.+|++|||++++++.|+
T Consensus 222 -~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -HQL---------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -ccC---------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0111245778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.43 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=198.4
Q ss_pred cccccccCCCCceeEEEeEec----CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc-----
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----- 565 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 565 (816)
|++.+.||+|+||.||+|.+. .++.||||.+... .....+++.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999854 3678999988653 23446678999999999999999999998875432
Q ss_pred -ceEEEeeCCCCCccccccCCC---CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecc
Q 003489 566 -NMLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641 (816)
Q Consensus 566 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 641 (816)
.++++||+++|+|.+++.... ....+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 368899999999988874321 2235788899999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 642 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
|+++...............++..|++||.+....++.++||||||+++|||++ |++|+...... .+..+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc---C
Confidence 99986543322222223455678999999988889999999999999999999 78887543322 11111111 0
Q ss_pred CCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 721 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
... .. .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~-~~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL-KQ---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC-CC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 00 012235788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.19 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=198.9
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|+||.||+++.+ +++.||+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999875 6899999988653 333456789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|..++........+++..+..++.||+.||.|||+. + ++|+||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999986543344689999999999999999999974 5 999999999999999999999999998765322
Q ss_pred cccccccccccccccChhccccCC------CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
......++..|+|||.+.... ++.++||||||+++|||++|+.|+............. .. .....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~-~~~~~-- 227 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AI-VDGDP-- 227 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HH-hhcCC--
Confidence 222346788999999885443 5789999999999999999999986433221111110 00 00000
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+.+ .......+.+++.+|++.+|++||++.+++.
T Consensus 228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ---PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 011 1123455678888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.82 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=204.1
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999864 5788999999766555678899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++... ...++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988542 245889999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccccccChhccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+....+...... ... .. ...+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~-----~~---~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISK-----SN---FPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHh-----cc---CCCc
Confidence 112235678899999998776 789999999999999999999999865443221110 000 00 0001
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+. ........+.+++.+|++.+|++||++.+|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 11223456788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.15 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=200.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.+.||+|++|.||+++.+ +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 58899999886432 2234668899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++++.|..++.. ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887643 235899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH--------HhhccCC
Q 003489 652 DQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW--------KLWNDNN 722 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 722 (816)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................ ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457788999999865 557899999999999999999999987544332211111100 0000000
Q ss_pred c-ccccccccccccc-----HHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 V-IDLVDPLISESGF-----KMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~-~~l~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. .....+....... ......+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000011100000 112356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.05 Aligned_cols=192 Identities=26% Similarity=0.383 Sum_probs=164.3
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
...+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4468999999999999999999865 4678999975432 23569999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
++ .++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred cc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 99 4688888743 2346899999999999999999999998 999999999999999999999999999753211
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~ 699 (816)
.......||..|+|||++....++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999999999999999999999999976554
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.01 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=198.1
Q ss_pred CcccccccCCCCceeEEEeEecCCcEEEEEEecccC------chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467889999999999999998789999999886432 12235688999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
+||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999943 245788999999999999999999988 99999999999999999999999999876532
Q ss_pred CC----cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 650 NQ----DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 650 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
.. .........++..|+|||.+....++.++||||||++++||++|+.|+.......... ... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~----~~~~~-- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIG----AHRGL-- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhh----hccCC--
Confidence 11 1111223568889999999998889999999999999999999999986433221110 000 00000
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+.+.. .....+.+++.+|++.+|++||++.|+++
T Consensus 227 --~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 --MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011111 12345677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.03 Aligned_cols=251 Identities=26% Similarity=0.337 Sum_probs=196.9
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999854 68899999886432 2223567889999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999988542 2235889999999999999999999988 9999999999999999999999999987653221
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
......|+..|+|||.+....++.++||||||+++|||++|+.||................... . ...
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-----~----~~~ 224 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----Q----EEY 224 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----h----hhc
Confidence 1223478999999999999999999999999999999999999986533211111111000000 0 000
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~ 766 (816)
.......+.+++..|++.||++||| +.|+++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112245678888999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.33 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=197.3
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999865 4778899998766556677899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|..++.. ....+++..+..++.||++||+|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999988753 2346899999999999999999999998 9999999999999999999999999987653221 12
Q ss_pred cccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 656 TKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.....++..|+|||++. ...++.++||||||+++|||++|++|+....+... ... . .... ......+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~-~---~~~~-~~~~~~~- 231 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK-I---AKSE-PPTLAQP- 231 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH-H---hhcC-CCCCCCc-
Confidence 23356889999999874 34578899999999999999999999764332111 001 0 0000 0001000
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
......+.+++.+|++.+|++||++.++++.
T Consensus 232 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112456788889999999999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.22 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=202.3
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|+..+.||+|+||.||.++. .+++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999884 45888999987643 334556789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.... ...+++.++..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986432 346899999999999999999999988 99999999999999999999999999987643332
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+....... ..... ..+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~~----~~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVVKI----VQGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCCCCC------
Confidence 2233568899999999988889999999999999999999999986433221 11111 01111110
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.......+.+++.+|++.+|++||++.++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011234577888899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.43 Aligned_cols=247 Identities=30% Similarity=0.451 Sum_probs=196.9
Q ss_pred cCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
++|++.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999985 5788999998643 2346789999999999999999999998654 5799999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.... ...+++..+++++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 335789999999999999999999988 999999999999999999999999998764321
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......+..|+|||.+....++.++|+||||+++|||++ |+.|+........ .... ...... ++
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~---~~---- 218 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KECV----EKGYRM---EP---- 218 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH----hCCCCC---CC----
Confidence 112234568999999988899999999999999999998 8888764433211 1111 111000 00
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
.......+.+++.+|++.+|++||++.+|++.|++
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11123466788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.81 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=199.6
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
++|++.++||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67889999999999999999865 48899999997766666788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|..++.+. ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998887432 245899999999999999999999988 9999999999999999999999999987542221
Q ss_pred cccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 654 AATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.......++..|+|||++. ...++.++||||||+++|||++|+.|+........ . ....... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~~~------~ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAKSE------P 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--H----HHHhcCC------C
Confidence 1122346788999999884 34568899999999999999999999764332211 1 0110000 0
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+... ........+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 01112345678888999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.30 Aligned_cols=244 Identities=29% Similarity=0.442 Sum_probs=199.4
Q ss_pred ccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCccc
Q 003489 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 580 (816)
.||+|.||+||.|+.. +...+|||.+........+.+.+|+.+-+.|+|+|||+++|.+.+++..-+.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999954 456799999988777778889999999999999999999999999998899999999999999
Q ss_pred cccCCCCCCCC--ChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCceeeccccceecCCCCcccccc
Q 003489 581 FLFDPQRQSLL--DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGNQDQAATK 657 (816)
Q Consensus 581 ~l~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~ 657 (816)
+|+. +-+++ ++..+-.+..||++||.|||++. |||||||-+|||++. .|.+||+|||-++.+.. -...+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9953 34555 67778889999999999999998 999999999999964 78999999999987632 233455
Q ss_pred cccccccccChhccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 658 RLVGTYGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 658 ~~~gt~~y~aPE~~~~~~--~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
...||..|||||++..+. |..++|||||||++.||.||++||-....... .++.-+-. .+-| .-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy--KvHP----~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY--KVHP----PI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce--ecCC----CC
Confidence 688999999999998654 88999999999999999999999854332111 01111100 0111 12
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+.+...+...++++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3445667788999999999999999999976
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.43 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=197.1
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCch---------hHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ---------GQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 5789999988643221 22568899999999999999999999999999
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 345788899999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCCcc----cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC
Q 003489 646 IFGGNQDQ----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 646 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
........ .......++..|+|||.+....++.++||||||+++|+|++|+.|+........ . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~-- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I----FKIGE-- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H----HHHhc--
Confidence 76432111 111234578899999999988899999999999999999999999864322111 0 00000
Q ss_pred CccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
...+.+. ......+.+++.+|++.+|.+||++.||++
T Consensus 227 ----~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ----NASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111111 112345667888999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=310.88 Aligned_cols=241 Identities=23% Similarity=0.284 Sum_probs=186.8
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHH-HHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEV-MVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 56789999986432 12233444444 456789999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|.+++.. ...+....+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999998843 345778888899999999999999998 999999999999999999999999999754221 122
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .. .. .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~---~~-~~--~~~~------ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNIL---NK-PL--QLKP------ 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHH---hC-Cc--CCCC------
Confidence 334578999999999999999999999999999999999999986443321 111111 00 00 0111
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.....+.+++.+|++.+|.+||++.+.+.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 --NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 12345667888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.34 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=191.8
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhc---CCCceeeeeeEEEec-----C
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNL---QHRNLVRLLGCCVER-----E 564 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 564 (816)
+|++.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 688999998865322 2234566777777665 699999999988653 3
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..++|+||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 48888875432 245899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhh-HHHHHHHhhccCCc
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT-LLGYAWKLWNDNNV 723 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~ 723 (816)
+...... ......++..|+|||++....++.++|||||||++|||++|++||.......... +..... .......
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDW 231 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhhC
Confidence 8653221 1223567899999999998899999999999999999999999986543322111 111100 0000000
Q ss_pred c-------cccccccc---ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 I-------DLVDPLIS---ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 ~-------~l~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. ....+... ....++....+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0011122345678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=314.42 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=197.8
Q ss_pred HHHHHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC
Q 003489 489 ELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE 564 (816)
Q Consensus 489 el~~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 564 (816)
++....++|++.+.||+|+||.||+++.+ +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+..++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999865 5788999998642 2233456789999999999999999999999999
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999843 34788888999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhccccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
+.+..... .......||+.|+|||++.... ++.++|||||||++|||++|+.||........ .......
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~ 262 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH 262 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC
Confidence 87643221 1223457999999999987543 78899999999999999999999865433211 1111111
Q ss_pred CCccccccccccccccHHHHHHHHHHHHHhhhcCCCC--CCChHHHHHH
Q 003489 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKD--RPNMPTVVSM 767 (816)
Q Consensus 721 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~evl~~ 767 (816)
.......+ .......+.+++..|++..+.+ ||++.|+++.
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111111 0112334566777888744433 7889988875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.02 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=204.2
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999854 67889999986432 33567899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965433356899999999999999999999998 99999999999999999999999999977654332
Q ss_pred cc--ccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QA--ATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.. ......++..|+|||.+... .++.++|+||||++++||++|+.|+....... .+.... ... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~----~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL----QND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh----cCC------CC
Confidence 21 22335688999999998877 78999999999999999999999986433221 111111 000 01
Q ss_pred cccccc-cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESG-FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+.... .......+.+++..|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111100 1122356778888999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.94 Aligned_cols=237 Identities=24% Similarity=0.311 Sum_probs=185.4
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHH-HHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEV-MVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||+++.. +++.||+|++.+.. ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57889999986432 22234455555 467889999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999888743 345788889999999999999999988 999999999999999999999999998753221 122
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....|++.|+|||.+....++.++|||||||++|||++|+.||....... +.... ... . .. +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~~-~-~~-----~---- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNI---LHK-P-LQ-----L---- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHH---hcC-C-CC-----C----
Confidence 334578999999999998899999999999999999999999986543211 11111 111 0 00 0
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMP 762 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 762 (816)
.......+.+++.+|++.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111234567888899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.02 Aligned_cols=263 Identities=23% Similarity=0.280 Sum_probs=195.4
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----- 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 564 (816)
..++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 5889999998643 2334567889999999999999999999986543
Q ss_pred -cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 565 -ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 565 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 35899999965 5655552 23788889999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHH------------
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL------------ 711 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~------------ 711 (816)
++..... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9754321 1223357899999999999999999999999999999999999998754332111000
Q ss_pred ----HHHHHhhccCC------ccccccccccc---cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 712 ----GYAWKLWNDNN------VIDLVDPLISE---SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 712 ----~~~~~~~~~~~------~~~l~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........... ..+........ .........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 00000000000 0001123457788999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.81 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=198.4
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-cceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-ENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e 571 (816)
+|++.+.||+|++|.||+++.+ +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999864 57889999986432 334567889999999999999999998876444 5689999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++... ....+++.++..++.+++.||++||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998643 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
. ......+++.|+|||.+....++.++||||||++++||++|+.|+........ .. ... .+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~---~~~-~~~~~~------ 221 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---VY---RII-EGKLPP------ 221 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHH-hcCCCC------
Confidence 1 22335678899999999999999999999999999999999998764332111 11 110 111100
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
........+.+++.+|++.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01123356778899999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=314.75 Aligned_cols=204 Identities=25% Similarity=0.365 Sum_probs=174.8
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 58899999986432 233467888999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 345889999999999999999999998 999999999999999999999999998754221
Q ss_pred Ccc---------------------------------cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCC
Q 003489 651 QDQ---------------------------------AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697 (816)
Q Consensus 651 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~ 697 (816)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00123478999999999999999999999999999999999999
Q ss_pred CCCCCch
Q 003489 698 NTSFYHE 704 (816)
Q Consensus 698 p~~~~~~ 704 (816)
||....+
T Consensus 235 Pf~~~~~ 241 (360)
T cd05627 235 PFCSETP 241 (360)
T ss_pred CCCCCCH
Confidence 9875443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=294.71 Aligned_cols=251 Identities=35% Similarity=0.542 Sum_probs=198.8
Q ss_pred cccccccCCCCceeEEEeEecC-----CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 497 FQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
|++.+.||.|+||.||+++..+ +..||+|.+...... ..+.+.+|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998753 378999999765433 5678999999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854321 12899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
...... ...++..|+|||.+....++.++||||+|++++||++ |..|+...... .+..... .......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~--- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK----KGYRLPK--- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCCCCCC---
Confidence 221111 2346789999999988889999999999999999999 67776542221 1111111 1111000
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.......+.+++.+|++.+|++|||+.|++++|
T Consensus 226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011234677888899999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.04 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=198.2
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCch-----hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-----GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
+|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999864 6889999999754322 345677899999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+ +++|.+++.... ..+++..+++++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999995432 36899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC-------
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN------- 721 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 721 (816)
... ......++..|+|||.+.+ ..++.++||||||++++||++|.+++....+.... ..........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhh
Confidence 221 1222355778999998854 45789999999999999999997776543332111 1111100000
Q ss_pred --Ccccccccccccc-----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 722 --NVIDLVDPLISES-----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 722 --~~~~l~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
............. ........+.+++.+|++.+|++||++.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 011224577889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.42 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=192.6
Q ss_pred cccccCCC--CceeEEEeEe-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 499 LANKLGQG--GFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 499 ~~~~LG~G--~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
+.++||+| +|++||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7789999985 468999999986542 233456788999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++|+|.+++.... ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234889999999999999999999998 999999999999999999999999865443211110
Q ss_pred -----cccccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh----hc---
Q 003489 654 -----AATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL----WN--- 719 (816)
Q Consensus 654 -----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~----~~--- 719 (816)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccc
Confidence 01122356778999999876 4588999999999999999999999864332110 00000000 00
Q ss_pred --cCC-----ccccccc-----------------cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 720 --DNN-----VIDLVDP-----------------LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 720 --~~~-----~~~l~d~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+. .....+. .............+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0000000 0000011122456788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.93 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=198.9
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.++||+|+||.||++..+ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 588999998865322 235678899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|..+... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887643 234899999999999999999999988 9999999999999999999999999998754332
Q ss_pred cccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh--------ccCC
Q 003489 652 DQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW--------NDNN 722 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~~ 722 (816)
.......++..|+|||++.. ..++.++||||||+++|||++|++|++.................+ ....
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 12223457889999998865 447889999999999999999998886433221111111100000 0000
Q ss_pred c-cccccccccccc-----cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 V-IDLVDPLISESG-----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~-~~l~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. .....+...... .......+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000000000 1112456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.84 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=196.0
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----- 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 564 (816)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 5889999998653 2234567889999999999999999999886543
Q ss_pred -cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 565 -ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 565 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
..++||||+++ +|.+.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 45899999965 5666652 23788889999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHH-H----------
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL-G---------- 712 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~-~---------- 712 (816)
++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||............ .
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9864322 1223357899999999999989999999999999999999999998654322111100 0
Q ss_pred -----HHHHhhcc-CCcccccccc------cc--ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 713 -----YAWKLWND-NNVIDLVDPL------IS--ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 713 -----~~~~~~~~-~~~~~l~d~~------l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........ ........+. .. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000000000 00 00011123467789999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=290.60 Aligned_cols=270 Identities=23% Similarity=0.250 Sum_probs=211.7
Q ss_pred cCcccccccCCCCceeEEEeEecC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++++.||+|.-|+||++.+.+ +..+|+|++.+.. .+...+.+.|.+||+.++||.++.++..++..+..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567888999999999999999764 5789999997753 334456778999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
|||+||+|..+++ .+..+.+++..++-++.+|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+......
T Consensus 157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999998774 356678999999999999999999999998 999999999999999999999999997643110
Q ss_pred --------------------------------C-c---------------------ccccccccccccccChhccccCCC
Q 003489 651 --------------------------------Q-D---------------------QAATKRLVGTYGYMSPEYAMEGRF 676 (816)
Q Consensus 651 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 676 (816)
. . .......+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011223589999999999999999
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCC
Q 003489 677 SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVK 756 (816)
Q Consensus 677 s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~ 756 (816)
+.+.|.|+|||+||||+.|+.||.....+.... .++-..+.-...++-...+.+++...+..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999987554432211 11111111112223446677888899999999
Q ss_pred CCCC----hHHHHH--HHhccccCCCCCCCCce
Q 003489 757 DRPN----MPTVVS--MLNSEIKDLPAAKQPAF 783 (816)
Q Consensus 757 ~RPt----~~evl~--~L~~~~~~l~~~~~p~~ 783 (816)
+|-. +.||.+ .++++...|-.-..|++
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 9988 888865 35555433333333333
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.29 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=191.4
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccc
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 566 (816)
.+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 58899999885432 12345688999999999999999999988763 456
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 335788999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCC-cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQ-DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
..... .........++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC----
Confidence 53221 11112234578899999999988899999999999999999999999864322111 11110000
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+.+. ......+..++ +|+..+|++||+++||++
T Consensus 226 -~~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111 11112233343 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.40 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=197.8
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333468999999999999864 5889999998765555667789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ..
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence 999998833 34789999999999999999999998 9999999999999999999999999987653222 11
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....++..|+|||.+....++.++||||||+++|||++|+.|+......... ..... .+.+.+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~---------~~~~~~~~-- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRD---------NLPPRVKD-- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---------cCCCcccc--
Confidence 22356789999999998888999999999999999999999998643332111 11110 01111111
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.......+.+++..|++.+|.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01122356677889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.32 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=196.8
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc----------hhHHHHHHHHHHHhhcCCCceeeeeeEEEecC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG----------QGQEEFMNEVMVISNLQHRNLVRLLGCCVERE 564 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 564 (816)
+|.+.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 688999998753211 11346788999999999999999999999999
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 46888999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
+...............++..|+|||.+.... ++.++|+||||++++|+++|+.|+........ ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhc-cc
Confidence 7654322222233456788999999987654 78999999999999999999999753222111 111111 11
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+++.. ..+....+.+++.+|++.+|++||++.+|++
T Consensus 229 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111111 1122356777888999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.87 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=198.1
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999876 78999999886532 23456789999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999886533
Q ss_pred CCcccccccccccccccChhccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+....+... ........... .+
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~-~~- 223 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKELP-PI- 223 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcccCC-Cc-
Confidence 22 223456788999999987776 89999999999999999999999864332111 11100000000 01
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++||++.++++
T Consensus 224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0112345677888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=310.65 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=196.3
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----- 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 564 (816)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999854 5888999998653 2334567889999999999999999999876433
Q ss_pred -cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 565 -ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 565 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999965 6766662 23788889999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH---------
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA--------- 714 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~--------- 714 (816)
++..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9765322 1223357899999999999999999999999999999999999998755432221111000
Q ss_pred -------HHhhccCC-c-----ccccccccc---ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 715 -------WKLWNDNN-V-----IDLVDPLIS---ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 715 -------~~~~~~~~-~-----~~l~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........ . ..+...... ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0 000000000 00011123467788999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.48 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=194.3
Q ss_pred HHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEec-----
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER----- 563 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 563 (816)
...++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 467899999986532 23345678999999999999999999987643
Q ss_pred -CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 564 -EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 564 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3457899987 788888773 345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH------
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW------ 715 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~------ 715 (816)
+++..... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99865321 223568999999999876 568899999999999999999999986533221111000000
Q ss_pred --HhhccCCccccccc--cccccc----cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 716 --KLWNDNNVIDLVDP--LISESG----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 716 --~~~~~~~~~~l~d~--~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
...........+.. ...... .....+.+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 000000 00012346788899999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.70 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=200.8
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357899999999999999999864 5889999998766666667899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999998542 245899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+........ +. .. .....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~~-~~~~~---- 225 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----KI-LKSEP---- 225 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----HH-hcCCC----
Confidence 1222356788999999875 34567899999999999999999999864432211 10 11 01100
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+.+.. .......+.+++..|++.+|.+||++.+|++.
T Consensus 226 -~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00100 01112356678889999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=301.42 Aligned_cols=197 Identities=25% Similarity=0.444 Sum_probs=159.5
Q ss_pred ccccCCCCceeEEEeEec---CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceEEEeeCC
Q 003489 500 ANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIYEYMP 574 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~ 574 (816)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++... ...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986432 234578899999999999999999998653 44689999985
Q ss_pred CCCccccccCC------CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEE----cCCCCceeeccccc
Q 003489 575 NKSLDSFLFDP------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLA 644 (816)
Q Consensus 575 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DfGla 644 (816)
++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5777766421 12235888999999999999999999998 9999999999999 45678999999999
Q ss_pred eecCCCCc-ccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003489 645 RIFGGNQD-QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFY 702 (816)
Q Consensus 645 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~ 702 (816)
+.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643321 1223346789999999998764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.63 Aligned_cols=202 Identities=25% Similarity=0.350 Sum_probs=172.2
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999865 5889999998642 2234456889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 345888999999999999999999998 999999999999999999999999999765432
Q ss_pred CcccccccccccccccChhcccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003489 651 QDQAATKRLVGTYGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFY 702 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlG~vl~elltG~~p~~~~ 702 (816)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 211 1222468999999999863 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.43 Aligned_cols=265 Identities=21% Similarity=0.324 Sum_probs=201.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.+.||+|++|.||+|..+ +++.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999865 5789999988653 23345788999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++++.+..++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777766532 344889999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh--------hcc-C
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL--------WND-N 721 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~-~ 721 (816)
.. ......++..|+|||++... .++.++||||||+++|+|++|+.|+.................. +.. .
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 22235678899999999888 7899999999999999999999988654332211111111000 000 0
Q ss_pred Cc-----cccccccc-cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 722 NV-----IDLVDPLI-SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 722 ~~-----~~l~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.. ....++.. ...........+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 00011112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=303.88 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=208.3
Q ss_pred HhcCcccccccCCCCceeEEEeEecC-CcEEEEEEecccCch---hHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcce
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENM 567 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 567 (816)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678999999999999999999664 999999999765433 3468999999999998 999999999999999999
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC----CCceeecccc
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD----LNPKISDFGL 643 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DfGl 643 (816)
+|||++.||.|.+.|... .+++..+..++.||+.+++|||+.+ |+||||||+|+|+... +.++++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999654 2899999999999999999999998 9999999999999543 4799999999
Q ss_pred ceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
+..... .......+||+.|+|||++....|+.++||||+|+++|.|++|.+||....+......+. .++.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------RGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------cCCC
Confidence 998754 345566899999999999999999999999999999999999999987555432221111 1111
Q ss_pred cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
..............-+++..|+..||.+|+|+.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122222334556678889999999999999999983
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.98 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=203.0
Q ss_pred CcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-C-----CceeeeeeEEEecCcceE
Q 003489 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H-----RNLVRLLGCCVEREENML 568 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 568 (816)
+|.+.+.||+|+||.|.++. .++++.||||++++.. .-..+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999998 4569999999997543 34456678999999996 4 389999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC--Cceeecccccee
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL--NPKISDFGLARI 646 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DfGla~~ 646 (816)
|+|.+ ..+|.++|+..+ ...++...++.|+.||+.||..||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 789999997653 345899999999999999999999998 99999999999997654 799999999986
Q ss_pred cCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH-----------
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW----------- 715 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~----------- 715 (816)
....-. ...-+.-|.|||++.+.+|+.+.|+||||||+.||++|.+-|+...+.+....+....
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 532221 3455778999999999999999999999999999999988887766655444333221
Q ss_pred ----Hhhcc-CCcc------cc----------------ccccccc--------cccHHHHHHHHHHHHHhhhcCCCCCCC
Q 003489 716 ----KLWND-NNVI------DL----------------VDPLISE--------SGFKMEIIRCVNVGLLCVQEFVKDRPN 760 (816)
Q Consensus 716 ----~~~~~-~~~~------~l----------------~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~~P~~RPt 760 (816)
+.+.. .... .. .+..... .........+++++.+|++.||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 11111 0000 00 0000000 001123467889999999999999999
Q ss_pred hHHHHHH
Q 003489 761 MPTVVSM 767 (816)
Q Consensus 761 ~~evl~~ 767 (816)
..|.++.
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999763
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.88 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=199.7
Q ss_pred HHHHHHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEE----
Q 003489 488 EELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCV---- 561 (816)
Q Consensus 488 ~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 561 (816)
+.+..+.++|++.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 445567789999999999999999999864 57889999886432 3346788999999999 6999999999885
Q ss_pred -ecCcceEEEeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceee
Q 003489 562 -EREENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639 (816)
Q Consensus 562 -~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 639 (816)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 334579999999999999987532 23346788999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhcccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH
Q 003489 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA 714 (816)
Q Consensus 640 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~ 714 (816)
|||+++.+.... .......|+..|+|||++.. ..++.++||||||+++|||++|+.|+....+... +..
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~-- 240 (286)
T cd06638 167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFK-- 240 (286)
T ss_pred cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhh--
Confidence 999998664321 12223468899999998753 4578899999999999999999999864432111 000
Q ss_pred HHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 715 WKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 715 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
. .........++. .....+.+++.+|++.+|++||++.||++.
T Consensus 241 --~-~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 --I-PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --c-cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000111111 012357788889999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=297.26 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=200.6
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 68899999986543 33456799999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+ +++|.+++.... ..+++.+++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999985432 56899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC----------
Q 003489 653 QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN---------- 721 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 721 (816)
.......++..|+|||.+... .++.++||||+|++++||++|.+++....+... ...........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence 122335688899999988654 468999999999999999999777654333211 11111111000
Q ss_pred --Ccccccccccc----ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 722 --NVIDLVDPLIS----ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 722 --~~~~l~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+...+..+... .....+....+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00011223677889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=293.22 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=199.9
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|+||.||+++.. +++.||+|.+... .....+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999854 6889999998643 233456889999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++... ....+++.++++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988542 2235788999999999999999999988 99999999999999999999999999986643221
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
......++..|+|||++.+..++.++|+||||+++++|++|+.|+....... ... .... +.... .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~---~~~~-~~~~~-----~- 221 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LVL---KIIR-GSYPP-----V- 221 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HHH---HHhc-CCCCC-----C-
Confidence 1223457889999999998899999999999999999999999876432221 111 1111 10000 0
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++||+|.+|++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122345778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.69 Aligned_cols=262 Identities=26% Similarity=0.358 Sum_probs=201.9
Q ss_pred cCHHHHHHHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEe
Q 003489 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562 (816)
Q Consensus 485 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 562 (816)
+...++..++++|++.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 33455556788999999999999999999986 468899999986432 3346778899999999 79999999999875
Q ss_pred cC-----cceEEEeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCc
Q 003489 563 RE-----ENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 563 ~~-----~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
.+ ..++|+||+++++|.++++.. .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 478999999999999988532 23356899999999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccChhccccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHH
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711 (816)
Q Consensus 637 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~ 711 (816)
+|+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 9999999876532221 11234678899999987543 368899999999999999999999865433211 11
Q ss_pred HHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 712 GYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 712 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.. .......+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 244 ~~-----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KI-----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH-----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 0011111111 1112345778899999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=297.55 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=195.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999865 688999999865432 2335677899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++ +|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 8988885432 35789999999999999999999998 99999999999999999999999999875422111
Q ss_pred ccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC---Ccccc--
Q 003489 653 QAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN---NVIDL-- 726 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~l-- 726 (816)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .........+... .....
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhh
Confidence 1122346788999998865 457899999999999999999999986443111 1111111111100 00000
Q ss_pred -----------c-ccccccc-ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 727 -----------V-DPLISES-GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 727 -----------~-d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. ...+... ........+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000 00111256678899999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=294.49 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=198.7
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC------chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceE
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 568 (816)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 568899999886432 1234678999999999999999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-Cceeeccccceec
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF 647 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 647 (816)
|+||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 346889999999999999999999998 99999999999998776 5999999999776
Q ss_pred CCCCcc--cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 648 GGNQDQ--AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 648 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
...... .......++..|+|||.+....++.++||||+|+++++|++|+.|+........... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~---- 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASAT---- 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccC----
Confidence 433111 112234678899999999888899999999999999999999999754322111111 11100000
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
............+.+++.+|++.+|++||++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 -----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001111223456778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.55 Aligned_cols=202 Identities=24% Similarity=0.325 Sum_probs=172.8
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 5788999998642 2233456888999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 245788899999999999999999998 999999999999999999999999999876432
Q ss_pred CcccccccccccccccChhcccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003489 651 QDQAATKRLVGTYGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFY 702 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlG~vl~elltG~~p~~~~ 702 (816)
.. .......|++.|+|||++.. ..++.++||||||++||||++|+.||...
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 21 11223578999999999865 46788999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=280.23 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=198.5
Q ss_pred HhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
.++.|++.+.||+|.|+.||+... .+|+.+|+|++.. .+..+.+++.+|+.+-+.|+||||+++.....+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788889999999999999874 4688999998742 3445778999999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC---CCCceeecccccee
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARI 646 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfGla~~ 646 (816)
+|+|.|++|..-|- .+...++..+-..++||++||.|+|.++ |||||+||+|+||-. .-.+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999866552 2245677888899999999999999999 999999999999943 33689999999998
Q ss_pred cCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
+. ........+|||+|||||++...+|+..+|||+-|++||-|+.|.+||...+.. .+.+.+. .+...
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~----~g~yd-- 230 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIK----AGAYD-- 230 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHh----ccccC--
Confidence 75 333445578999999999999999999999999999999999999998643322 2222221 01000
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+++ ..-+...+...+++.+|+..||.+|.|+.|.+.
T Consensus 231 ~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 000 001112234456777999999999999988753
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.49 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=201.9
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6888999999999999999985 467889999986555555678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999843 34788999999999999999999998 99999999999999999999999999876543222
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......+++.|+|||.+....++.++||||||+++|++++|+.||........... ....+. +..
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~------~~~-- 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PEL-- 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC------CCC--
Confidence 22234678899999999888899999999999999999999999864332111000 000000 000
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.........+.+++.+|++.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123456688889999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.16 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=197.2
Q ss_pred cccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCC
Q 003489 499 LANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 577 (816)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3458999999999999864 688999999866555556778999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccc
Q 003489 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657 (816)
Q Consensus 578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 657 (816)
|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..+.... ....
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 9988732 45789999999999999999999998 9999999999999999999999999987553221 1223
Q ss_pred cccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccH
Q 003489 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFK 737 (816)
Q Consensus 658 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 737 (816)
...++..|+|||++....++.++||||||++++||++|+.|+....+..... ... ..... .... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~----~~~~~-----~~~~--~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLR----DSPPP-----KLKN--AH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHh----ccCCC-----Cccc--cC
Confidence 3568899999999998889999999999999999999999986443322111 110 00000 0000 00
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 738 MEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 738 ~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.....+.+++.+|++.+|++||++.++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112346678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=292.10 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=193.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccc
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 566 (816)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 58899999875321 12345788999999999999999999998764 456
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+++|||+++++|.+++.. ...+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 799999999999999843 235788889999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCc-ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQD-QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHhcCC----
Confidence 532211 1122334688899999999888899999999999999999999999864322211 11 000000
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+. ........+..++.+|+. +|++||++.||++
T Consensus 226 -~~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011 112233456677778884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=287.65 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=208.0
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
-|.++++||+|+||.||++.++ .|+.+|||.+... .+.+++..|+.++++++.|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3677899999999999999865 5899999998543 467889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
-|+..+.++. ++++|.+.++..+++..++||+|||... -+|||||..||||+.+|.+||+|||.|..+.+ .-.
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 9999999854 4577999999999999999999999876 89999999999999999999999999976643 223
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 734 (816)
......||+-|||||++..-.|..++||||||++..||..|++|+...++-..... +.....|.++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IPT~PPPTF~-- 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IPTKPPPTFK-- 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------ccCCCCCCCC--
Confidence 44567899999999999999999999999999999999999999886655311000 0011122222
Q ss_pred ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 735 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
...+-..++.+++..|+-.+|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 23344567888999999999999999998865
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.47 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=199.1
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
+|++.++||+|++|.||+|+.. +++.||||.++.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 588999999875433 33567788999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++ +|.+++........+++..+.+++.||+.||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888865444456899999999999999999999988 99999999999999999999999999975532211
Q ss_pred cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc---------
Q 003489 654 AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV--------- 723 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------- 723 (816)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....................+...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 11224568899999988654 5688999999999999999999998654432211111000000000000
Q ss_pred cccccccc---cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 IDLVDPLI---SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 ~~l~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
........ .....+.....+.+++..|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00001122456778899999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=328.15 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=195.7
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccce
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENM 567 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 567 (816)
..++|++.++||+|+||.||+++.. .+..+|+|.+... .......|..|+.+++.|+|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468999999999999999999865 5678899988643 233456789999999999999999999988654 4578
Q ss_pred EEEeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCC----CcEEEeeeCCCcEEEcCC---------
Q 003489 568 LIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSR----LRIIHRDLKASNILLDDD--------- 633 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ivH~Dlkp~NILl~~~--------- 633 (816)
|||||+++++|.++|... .....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998542 223568999999999999999999998542 249999999999999642
Q ss_pred --------CCceeeccccceecCCCCcccccccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003489 634 --------LNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703 (816)
Q Consensus 634 --------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~ 703 (816)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998653221 2233578999999999854 458899999999999999999999986433
Q ss_pred hhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 704 EEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 704 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
... .+.... .... .+.. ......+.+++..||+.+|++||++.|++.
T Consensus 248 ~~~--qli~~l----k~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS--QLISEL----KRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH--HHHHHH----hcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 111111 1110 0000 011345778888999999999999999984
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.89 Aligned_cols=197 Identities=25% Similarity=0.447 Sum_probs=159.0
Q ss_pred ccccCCCCceeEEEeEec---CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEe--cCcceEEEeeCC
Q 003489 500 ANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENMLIYEYMP 574 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 574 (816)
..+||+|+||.||+|+.+ ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999865 35689999886532 23467899999999999999999999864 445689999986
Q ss_pred CCCccccccCC------CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEE----cCCCCceeeccccc
Q 003489 575 NKSLDSFLFDP------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLA 644 (816)
Q Consensus 575 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DfGla 644 (816)
++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4676665321 12335888999999999999999999998 9999999999999 56678999999999
Q ss_pred eecCCCCcc-cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003489 645 RIFGGNQDQ-AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFY 702 (816)
Q Consensus 645 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~ 702 (816)
+.+...... .......+|+.|+|||++.+. .++.++||||||+++|||+||++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876433221 122345789999999998764 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.07 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=204.8
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|++|.||+++.. +++.||+|++..... ...+.+.+|+..+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999876 489999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999543 568999999999999999999999 88 9999999999999999999999999998764322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
.. .....++..|+|||.+....++.++||||||+++|||++|+.|+..........+..... .... +.+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~~ 223 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----PSL 223 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----CCC
Confidence 22 123467889999999998889999999999999999999999986543211111221111 1100 111
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
... .....+.+++.+|++.+|++||++.|+++.
T Consensus 224 ~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAE---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Ccc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 110 033567788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=293.12 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=200.6
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|++|.||++..+ +++.+|+|.+.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999875 58889999987653 34556789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568889999999999999999999 77 9999999999999999999999999987553221
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... .............. .+.+
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~ 224 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRL 224 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCC
Confidence 1 11567889999999998899999999999999999999999986442211 11111111111110 0011
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.. ......+.+++..|++.+|++||++.|++.
T Consensus 225 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred Ch---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 012345778888999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=319.61 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=192.9
Q ss_pred HHHHHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCC------CceeeeeeEEE
Q 003489 489 ELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH------RNLVRLLGCCV 561 (816)
Q Consensus 489 el~~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~ 561 (816)
++....++|++.++||+|+||+||++... .++.||||+++... ...+.+..|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445689999999999999999999864 57889999986432 233456667777777654 45888988887
Q ss_pred ec-CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCC-----
Q 003489 562 ER-EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDL----- 634 (816)
Q Consensus 562 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~----- 634 (816)
.. ...++|||++ +++|.+++.+ ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 65 4567899987 7788888743 34689999999999999999999974 7 99999999999998765
Q ss_pred -----------CceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003489 635 -----------NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703 (816)
Q Consensus 635 -----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~ 703 (816)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875421 12234688999999999999999999999999999999999999997654
Q ss_pred hhhhhhHHHHHHHh----hc----cCCcccc------cccccc---------cc--ccHHHHHHHHHHHHHhhhcCCCCC
Q 003489 704 EEFELTLLGYAWKL----WN----DNNVIDL------VDPLIS---------ES--GFKMEIIRCVNVGLLCVQEFVKDR 758 (816)
Q Consensus 704 ~~~~~~l~~~~~~~----~~----~~~~~~l------~d~~l~---------~~--~~~~~~~~l~~l~~~Cl~~~P~~R 758 (816)
......++...... +. .....++ +++... .. ........+++++..||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 43222222111000 00 0000000 000000 00 001123567799999999999999
Q ss_pred CChHHHHH
Q 003489 759 PNMPTVVS 766 (816)
Q Consensus 759 Pt~~evl~ 766 (816)
||+.|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=294.01 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=198.3
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
-|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 67899999886432 334567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 99999999842 45889999999999999999999988 9999999999999999999999999987653321
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.......++..|+|||.+....++.++|+||||+++|+|++|..|+........ .... ..... +.+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~----~~~~~-----~~~~- 222 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLI----PKNNP-----PTLE- 222 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHH----hcCCC-----CCCC-
Confidence 112234678899999999888899999999999999999999999764332111 1100 00100 1111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 ---GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1123456788889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=292.58 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=199.1
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIY 570 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 570 (816)
+|++.+.||.|+||.||++.. .+++.+|+|.+... .....+.+.+|++++++++|+||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 46788999988643 233456788999999999999999999987643 4568999
Q ss_pred eeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHH-----hcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLH-----RDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 571 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
||+++++|.+++... .....+++..++.++.||+.||+||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998543 22456899999999999999999999 555 999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
......... .....++..|+|||.+....++.++||||||+++++|++|+.|+.....+ .+..... ....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~- 227 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK----EGKF- 227 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh----cCCC-
Confidence 876433221 22346889999999999888999999999999999999999998754321 1111111 1111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+.+ .......+.+++.+|++.+|++||++.+|+++
T Consensus 228 ----~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ----RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011 11234567788899999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.46 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=199.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999865 488999999875432 24567889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998532 3356899999999999999999999998 999999999999999999999999998754321
Q ss_pred Ccc---------------------------cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003489 651 QDQ---------------------------AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703 (816)
Q Consensus 651 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~ 703 (816)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01122467889999999998889999999999999999999999986443
Q ss_pred hhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCC----hHHHHH
Q 003489 704 EEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN----MPTVVS 766 (816)
Q Consensus 704 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----~~evl~ 766 (816)
.... +.. ..... ..-.........+.+++.+|++.+|++||+ +.|++.
T Consensus 237 ~~~~--~~~----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET--FSN----ILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH--HHH----HhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 111 00000 000001113457788889999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=298.66 Aligned_cols=257 Identities=19% Similarity=0.271 Sum_probs=200.5
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999865 57889999886543 233457889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999943 345889999999999999999999988 999999999999999999999999998742111
Q ss_pred Cc-------------ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh
Q 003489 651 QD-------------QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL 717 (816)
Q Consensus 651 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 717 (816)
.. ........++..|+|||.+....++.++|+||||+++|||++|+.|+.....+. +... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~~---~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQ---V 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---H
Confidence 00 001112457889999999988889999999999999999999999986433221 1111 0
Q ss_pred hccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.... ...+... ......+.+++.+|++.+|++||++.++.+.|+..
T Consensus 229 ~~~~----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 229 ISDD----IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred Hhcc----cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 0000 0001100 01234567888899999999999988888888664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.91 Aligned_cols=258 Identities=26% Similarity=0.310 Sum_probs=200.1
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC--cceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--ENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 570 (816)
++|+..+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.... ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 57889999986543 245677999999999999999999999986543 578999
Q ss_pred eeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23455788999999999999999999998 99999999999999999999999999875432
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCch--hhhhhHHHHHHHhhccCCccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE--EFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.. .....++..|+|||.+....++.++||||||+++|+|++|+.|+..... .....+..+... .....+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence 21 1234567899999999989999999999999999999999999865422 111222222111 0111111
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+... ........+.+++.+|++.+|++|||+.||++
T Consensus 230 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1100 00112456788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=293.85 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=199.4
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCc-----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE----- 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----- 565 (816)
.+++|++.+.||+|++|.||+|..+ +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5689999999999999999999975 57889999886543 3457799999999999 69999999999976553
Q ss_pred -ceEEEeeCCCCCccccccCCC-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 566 -NMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 566 -~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
.++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 789999999999999885422 2456899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhcccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
+....... .......++..|+|||.+.. ..++.++||||||+++++|++|+.|+........ +.. .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~- 230 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----I- 230 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----h-
Confidence 87653322 12233568889999998753 3467899999999999999999999864332111 111 0
Q ss_pred ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 719 NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 719 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.... .+.+. ........+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNP-----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccC-----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0110 01111 11123456778888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.12 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=199.6
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 688999999875544 3567899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999854 345788999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccc--cccccccccccChhccccCC---CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 653 QAA--TKRLVGTYGYMSPEYAMEGR---FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 653 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
... .....++..|+|||++.... ++.++||||||++++||++|+.||........ . .+... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~-~~~~~--~-~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I-MFHVG--A-GH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H-HHHHh--c-CC-----
Confidence 111 12356788999999998766 88999999999999999999999864432111 1 11100 0 00
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+.+.. .......+.+++.+|++.+|.+||++.|++.
T Consensus 224 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001100 0111345567888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=304.22 Aligned_cols=270 Identities=21% Similarity=0.314 Sum_probs=199.7
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----cc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----EN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 566 (816)
.++|++.++||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468899999986432 234466888999999999999999999876543 46
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++|+||++ ++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 47777763 345899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCccc-ccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc---C
Q 003489 647 FGGNQDQA-ATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND---N 721 (816)
Q Consensus 647 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~ 721 (816)
........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.|+.......... ........ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCHH
Confidence 54322111 1223567899999998754 568899999999999999999999986433221111 11111111 0
Q ss_pred Ccccccccccc---------c-----cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH--HhccccC
Q 003489 722 NVIDLVDPLIS---------E-----SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSEIKD 774 (816)
Q Consensus 722 ~~~~l~d~~l~---------~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~ 774 (816)
....+.+.... . ...+.....+.+++.+|++.+|++|||+.|+++. |+.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 01101100000 0 0001123567889999999999999999999886 6555433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=303.96 Aligned_cols=202 Identities=24% Similarity=0.327 Sum_probs=171.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.++||+|+||.||+++.+ .++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999865 4778999998642 2223445888999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 245888999999999999999999998 999999999999999999999999999765322
Q ss_pred CcccccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003489 651 QDQAATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFY 702 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~ 702 (816)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 21 1223357899999999986 346789999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.71 Aligned_cols=267 Identities=21% Similarity=0.329 Sum_probs=196.4
Q ss_pred CcccccccCCCCceeEEEeEec---CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccce
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENM 567 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 567 (816)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999865 47899999997632 33446788999999999999999999999988 7789
Q ss_pred EEEeeCCCCCccccccCCC--CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC----CCCceeecc
Q 003489 568 LIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD----DLNPKISDF 641 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Df 641 (816)
+||||+++ +|.+++.... ....++...+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666654322 2236888999999999999999999998 999999999999999 899999999
Q ss_pred ccceecCCCCc-ccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhh------hhHHHH
Q 003489 642 GLARIFGGNQD-QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFE------LTLLGY 713 (816)
Q Consensus 642 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~------~~l~~~ 713 (816)
|++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.....+.. ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122334678899999987664 578999999999999999999999865443220 000111
Q ss_pred HHHhhccC------------Ccccccccc----ccccccH-------HHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 714 AWKLWNDN------------NVIDLVDPL----ISESGFK-------MEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 714 ~~~~~~~~------------~~~~l~d~~----l~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+... ......+.. ....... .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 000000000 0000000 22356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=296.43 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=199.3
Q ss_pred CHHHHHHHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEe-
Q 003489 486 NFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE- 562 (816)
Q Consensus 486 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 562 (816)
+..++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3445555678999999999999999999986 457889999885432 3456788899999998 69999999999863
Q ss_pred -----cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCce
Q 003489 563 -----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637 (816)
Q Consensus 563 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 637 (816)
....+++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 345689999999999999885432 345788888999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCCcccccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHH
Q 003489 638 ISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG 712 (816)
Q Consensus 638 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~ 712 (816)
|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|+.|+....+......
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 99999987543211 1223356888999999875 34578899999999999999999999854332211110
Q ss_pred HHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 713 YAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 713 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. .....+.+.. ......+.+++.+|++.+|.+||++.|+++
T Consensus 238 -~---------~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -I---------PRNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -H---------hhCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000011111 112346778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.46 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=198.6
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-----c---hhHHHHHHHHHHHhhc-CCCceeeeeeEEEe
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----G---QGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-----~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 562 (816)
.-.+|.-.+.||.|..++|.++.++ +|.+.|+|++.... + .-.+.-.+|+.+|+++ .||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777889999999999998754 68889999885321 1 1124456799999998 59999999999999
Q ss_pred cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 563 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
....++|+|.|+.|.|.++|. ..-.++++...+|++|+.+|++|||..+ |+||||||+|||++++.+++|+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999994 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhccc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHH
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAM------EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK 716 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 716 (816)
++..+.. .......+||++|+|||.+. ...|+...|+|+.|+++|-|+.|.+||-...+-. . .+
T Consensus 169 Fa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml------M-LR 238 (411)
T KOG0599|consen 169 FACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML------M-LR 238 (411)
T ss_pred eeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH------H-HH
Confidence 9987643 33455689999999999885 2357889999999999999999999964211111 1 11
Q ss_pred hhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 717 LWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 717 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+..+++.. .....-.+......+++.+|++.||++|-|++|+++
T Consensus 239 ~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11122111 111111223445668888999999999999999875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=285.77 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=203.3
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIY 570 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 570 (816)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 688999999865442 4567899999999999999999999999988 7889999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 27899999999999999999999988 999999999999999999999999999876544
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
..........++..|+|||.+.....+.++||||||+++++|++|+.|+...... ...............+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~---- 225 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGEPPEI---- 225 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCCCcCC----
Confidence 3211233456888999999998888999999999999999999999998654411 1111111111111111
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++||++.|++.
T Consensus 226 -----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 -----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112456778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.40 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=196.8
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 569 (816)
++|++.+.||+|+||.||+|+.+ +++.+|+|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999975 588899999864332 2234577899999999999999999999877 788999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
+||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58888875422 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH--------HHhhcc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA--------WKLWND 720 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~ 720 (816)
.. .......++..|+|||.+.+. .++.++|+||||++++||++|+.|+...........+... +..+.+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234568899999988654 4689999999999999999999998754432221111000 000000
Q ss_pred ------CCccccccccccccccHH-HHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 721 ------NNVIDLVDPLISESGFKM-EIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 721 ------~~~~~l~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..........+....... ....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111111111 2455678888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.74 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=198.2
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|+..+.||+|++|.||++.. .+++.+|+|.+... .....+.+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999985 46888999988653 234456789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-CceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++... ....+++..+.+++.+++++|+|||+++ ++|+||+|+||++++++ .++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999543 2345789999999999999999999998 99999999999998654 58999999998764322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
......++..|+|||.+....++.++||||||+++|+|++|+.|+....... ...... . .....+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~---~-~~~~~~~---- 222 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM---S-GTFAPIS---- 222 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH---h-cCCCCCC----
Confidence 1223467889999999998889999999999999999999999976433221 111111 0 0001111
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
......+.+++.+|++.+|++|||+.|+++
T Consensus 223 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 -----DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112345678888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=294.95 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=191.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHH-HhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMV-ISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.+.||+|+||.||+++.+ +++.||+|+++... ......+..|+.. ++.++|+||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999865 68999999986542 2334556666665 666789999999999999999999999
Q ss_pred eCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 572 YMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 572 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6887777532 2335689999999999999999999986 6 99999999999999999999999999986532
Q ss_pred CCcccccccccccccccChhcccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAME----GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
.. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.|+.......+ .+ ..... .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~----~~~~~-~---- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QL----KQVVE-E---- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HH----HHHHh-c----
Confidence 21 1222467889999998864 4568899999999999999999999753222111 01 00000 0
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+.+.. ......+.+++.+|++.+|++||++.++++
T Consensus 224 -~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011100 012345778888999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.68 Aligned_cols=240 Identities=22% Similarity=0.249 Sum_probs=183.3
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc---CCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL---QHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
||+|+||.||+++.. +++.||||++.+.. ......+..|..++.++ +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 58899999986432 12233455666676655 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988843 345889999999999999999999998 9999999999999999999999999987532221 22
Q ss_pred cccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 734 (816)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||........ .. ....+.. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~----~i~~~~~-~~~~~----- 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YR----NIAFGKV-RFPKN----- 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HH----HHHcCCC-CCCCc-----
Confidence 3345789999999998754 478999999999999999999999864332211 11 0011100 01000
Q ss_pred ccHHHHHHHHHHHHHhhhcCCCCCCC----hHHHHH
Q 003489 735 GFKMEIIRCVNVGLLCVQEFVKDRPN----MPTVVS 766 (816)
Q Consensus 735 ~~~~~~~~l~~l~~~Cl~~~P~~RPt----~~evl~ 766 (816)
.....+.+++.+|++.+|.+||+ +.|+++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11235567888999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.85 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=205.5
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.-|.+.+.||+|.|..|-++++ =+|+.||||++.+.. ......+++|+..|+.++|||||+++.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577778999999999999874 369999999997653 3345678999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEE-EcCCCCceeeccccceecCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL-LDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL-l~~~~~~kl~DfGla~~~~~~ 650 (816)
.-.+|+|.+||.++. ..+.+..+.+++.||+.|+.|+|+.. +|||||||+||. +.+-|-+||+|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996554 34889999999999999999999998 999999999985 577889999999999876443
Q ss_pred CcccccccccccccccChhccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
+ .....+|...|-|||++.+..|+ ++.|||||||+||.|++|++||....+.+... .++|.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence 2 34457999999999999999986 57899999999999999999987554433322 22222
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.- .-+..-..++.+++..|++.||.+|.+.+||+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 11 1123345678899999999999999999999753
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.99 Aligned_cols=247 Identities=25% Similarity=0.413 Sum_probs=197.6
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcC---CCceeeeeeEEEecCcceEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 570 (816)
.|++.+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 46889999998654 3344567889999999996 999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 36889999999999999999999998 999999999999999999999999999876443
Q ss_pred CcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.. ......|+..|+|||.+..+ .++.++||||||+++|+|++|+.|+.......... . ......+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~---------~~~~~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---L---------IPKSKPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---c---------cccCCCC
Confidence 21 12234688899999988654 46899999999999999999999986433211100 0 0000111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+... .....+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 12346778888999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.57 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=197.6
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceEEEe
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIYE 571 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 571 (816)
|++.++||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999865 47899999997653 33446788999999999999999999999988 78899999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++ +|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888875432 46899999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc-----
Q 003489 652 DQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID----- 725 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----- 725 (816)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..........................
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 2 11223456788999997764 4578999999999999999999999865443322111111100000000000
Q ss_pred ---c------ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 ---L------VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 ---l------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. ....+...........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0000000000112467789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.05 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=195.4
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 68899999886432 22345788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6888887543 2345899999999999999999999988 99999999999999999999999999876532211
Q ss_pred ccccccccccccccChhccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC--c------
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN--V------ 723 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~------ 723 (816)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+....+... +..... ...... .
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFR-TLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHH-HhCCCChhhhhhhhH
Confidence 122235678899999887644 68899999999999999999999865433221 111110 000000 0
Q ss_pred --------cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 --------IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 --------~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.. ........+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 00111245678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=295.65 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=193.9
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|+||.||+++.. +|+.+|+|+++... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999865 68899999986432 22335678899999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 5777776432 345899999999999999999999998 99999999999999999999999999986532221
Q ss_pred ccccccccccccccChhccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC------ccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN------VID 725 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 725 (816)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....+.. .............. ...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence 122345688999999887644 6899999999999999999998853322211 11111111110000 000
Q ss_pred ccc----cccccc-----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVD----PLISES-----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d----~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+ +..... ........+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000000 01112356678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=284.42 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=202.7
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
+|++.+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999975 688999999977655567889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 46899999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 734 (816)
.....++..|+|||.+....++.++||||||+++++|++|+.|+........... .. .........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~----~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IA----TNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH----hcCCCCcCc------
Confidence 2345678899999999888899999999999999999999999865432211110 00 010111110
Q ss_pred ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 735 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0101346778888999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.91 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=195.6
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999854 688999999865432 23346789999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+. ++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 6777666432 234778888899999999999999998 999999999999999999999999998754322
Q ss_pred CcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC--------
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN-------- 721 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 721 (816)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.|+....+..+ .....+..+...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence 11 12224568899999998754 578899999999999999999999875443211 111111111000
Q ss_pred ----Ccc-ccc----cccccc-cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 722 ----NVI-DLV----DPLISE-SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 722 ----~~~-~l~----d~~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
... ... .+.+.. .........+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 000 000000 000011345668888999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.19 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=195.3
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
|++.+.||.|++|.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|+|++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 68999999986442 223467889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
+ ++|.+++.... ...+++..+++++.||++||+|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68998885432 235899999999999999999999988 99999999999999999999999999976532211
Q ss_pred cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC-----------
Q 003489 654 AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN----------- 721 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 721 (816)
......++..|+|||++... .++.++||||||+++|||++|+.||....+... +...........
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhch
Confidence 11223567899999987654 578999999999999999999999865443221 111111000000
Q ss_pred Ccccccc---ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 722 NVIDLVD---PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 722 ~~~~l~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....... ..............+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 00000001112256778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.11 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=203.7
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.++.|+..+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+++++.++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999975543 56788999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996432 36899999999999999999999988 9999999999999999999999999987553322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
. ......++..|+|||.+....++.++||||||+++|+|++|+.|+....+..... ... ........+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~---~~~----~~~~~~~~~--- 238 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF---LIT----TKGIPPLKN--- 238 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH----hcCCCCCcc---
Confidence 1 1223457789999999988889999999999999999999999976443321111 100 000000000
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.......+.+++.+|++.+|.+||++.+|++.
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01123456788889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.57 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=197.8
Q ss_pred cccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 497 FQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46889999988655555567789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence 999999844 45889999999999999999999998 9999999999999999999999999887543221 11
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....++..|+|||.+....++.++||||||++++||++|+.|+....+... ...... .. .+....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~----~~-----~~~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRD----NL-----PPKLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHh----cC-----CCCCcc--
Confidence 2234688899999999888899999999999999999999999764332211 111110 00 011110
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0112346778888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.29 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=196.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 58899999986532 234567889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+++++|.+++.. ...++...+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 356889999999999999999999988 999999999999999999999999999875432
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.....+++.|+|||.+.....+.++||||||+++|+|++|+.|+........ .... ..... .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~------~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---YEKI----LEGKV------R 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----hcCCc------c
Confidence 2335688999999999888889999999999999999999999864432111 1100 01100 0
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVV 765 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl 765 (816)
+. ......+.+++.+|++.+|.+|| ++.|++
T Consensus 217 ~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 FP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 00 11134666788899999999998 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=292.99 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=194.4
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCc-----
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREE----- 565 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 565 (816)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999864 68899999876532 223467889999999995 6999999999987665
Q ss_pred ceEEEeeCCCCCccccccCCCC--CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCceeeccc
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFG 642 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG 642 (816)
.++||||+++ +|.+++..... ...+++..++.++.||++||+|||+.+ |+||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7899999985 78888754322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred cceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.|+....+.... ... .......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~-~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHI-FKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH-HHHhCCC
Confidence 9986532211 1122356788999998865 45789999999999999999999988654332111 110 0110000
Q ss_pred C--c----ccccc----ccccc----cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 722 N--V----IDLVD----PLISE----SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 722 ~--~----~~l~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. . ....+ +.... ...+.....+.+++.+|++++|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 00000 00000 001123456778899999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.38 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=192.8
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5566789999999999999864 58899999986533 344567889999999996 99999999999999999999999
Q ss_pred CCCCCccccccC--CCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 573 MPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 573 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
++ ++|.++... ......+++..+.+++.|++.||+|||+. + ++||||||+||+++.++.++|+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 455443211 11235689999999999999999999975 6 99999999999999999999999999976532
Q ss_pred CCcccccccccccccccChhccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
.. ......++..|+|||.+... .++.++||||||+++|||++|+.|+..... ...........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~------ 226 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG------ 226 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC------
Confidence 21 11223678899999998766 689999999999999999999999864331 11111111110
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
..+.+...........+.+++.+|++.+|++|||+.+|++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111112234567788889999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=299.30 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=197.1
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----- 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 564 (816)
..++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999854 6899999998643 2334457788999999999999999999886443
Q ss_pred -cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 565 -ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 565 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
..++||||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999995 578777732 2788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHH-H----------
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL-G---------- 712 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~-~---------- 712 (816)
++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+ .
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98653321 122346788999999999999999999999999999999999998654332111100 0
Q ss_pred -----HHHHhhccC------Ccccccccccc----ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 713 -----YAWKLWNDN------NVIDLVDPLIS----ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 713 -----~~~~~~~~~------~~~~l~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
......... ...++....+. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00011111100 00111234567789999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=288.45 Aligned_cols=247 Identities=24% Similarity=0.269 Sum_probs=199.4
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
+|++.+.||+|+||.||+++.+ +++.||+|.+.+.. ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999875 58899999986532 2346788999999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998432 46889999999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
......++..|+|||.+....++.++|+||||+++|+|++|+.|+..........+. ..... ....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~~~~----- 220 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--ADVL----- 220 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--cccc-----
Confidence 222356788999999998888999999999999999999999998754432111111 11110 0000
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCCh--HHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNM--PTVV 765 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~--~evl 765 (816)
........+.+++.+|++.+|.+||++ +|++
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 ---YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111123577788889999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.85 Aligned_cols=268 Identities=21% Similarity=0.311 Sum_probs=199.1
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----c
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----E 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 565 (816)
.++|++.+.||+|+||.||+++. .+++.||||.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999985 46899999998653 2334456788999999999999999999886542 4
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.++|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999995 688888743 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh------
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW------ 718 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 718 (816)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.|+...................
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 653321 11223467889999998765 468899999999999999999999986543222211111110000
Q ss_pred --ccCCccccc-------cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH--Hhcc
Q 003489 719 --NDNNVIDLV-------DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 719 --~~~~~~~l~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~ 771 (816)
........+ ++.... ........+.+++.+|++.+|++|||+.|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 000000 011234567899999999999999999999876 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=293.05 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=194.8
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc------
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE------ 565 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 565 (816)
++|++.++||+|+||.||+++.. +++.||||.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57999999999999999999865 68899999886432 2223456789999999999999999999876544
Q ss_pred --ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 566 --NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 566 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
.++||||+. ++|.+++... ...+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 389999996 4777777432 235899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcc--cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 644 ARIFGGNQDQ--AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 644 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
+..+...... .......++..|+|||.+... .++.++||||||+++|||++|+.|+....+......+........+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 112234567889999988654 3688999999999999999999988655443332222222111110
Q ss_pred CCc-----cccccccccccc----------cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 721 NNV-----IDLVDPLISESG----------FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 721 ~~~-----~~l~d~~l~~~~----------~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+.. ....+....... .......+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000000000 0001245668999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=288.69 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=192.0
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCceeeeeeEEEec--CcceEEEe
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER--EENMLIYE 571 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 571 (816)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999854 68899999987542 223334567888898885 99999999999987 78899999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 5777777432 246899999999999999999999998 999999999999999 999999999998664322
Q ss_pred cccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh-----------c
Q 003489 652 DQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW-----------N 719 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~ 719 (816)
.. ....++..|+|||.+.. ..++.++||||||+++|||++|+.|+....+... ........ .
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhc
Confidence 21 22457889999997654 5578899999999999999999999865443221 11111110 0
Q ss_pred cCCcccccccccccc----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 720 DNNVIDLVDPLISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 720 ~~~~~~l~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.........+..... ........+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 01123567889999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=295.57 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=199.7
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 570 (816)
...|+++++||+|+.+.||++...+.+.+|+|++.. .+.+...-|++|+.+|.+|+ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457889999999999999999988888899987653 34556678999999999995 999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
|+- ..+|..+|.+.. .....| .+..+..|++.|+.++|+++ |||.||||.|+|+-+ |.+||+|||+|..+...
T Consensus 440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 976 678999985533 233344 67789999999999999999 999999999998854 68999999999988666
Q ss_pred CcccccccccccccccChhccccCC-----------CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGR-----------FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN 719 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 719 (816)
.........+||+.||+||.+.... .+.++||||+||+||+|+.|+.||..... ...
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~a------- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIA------- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHH-------
Confidence 5555566789999999999985332 56789999999999999999999863221 111
Q ss_pred cCCcccccccccccccc-HHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 720 DNNVIDLVDPLISESGF-KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 720 ~~~~~~l~d~~l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
++..+.||.-.-.+. ...-..+++++..|++.||.+||+..|+++.
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122333332111110 0011228899999999999999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=288.96 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=198.9
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
|++.+.||+|++|.||++..+ +++.+++|.+..... .....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999864 688899999865432 24567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
++ +|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 888877542 246899999999999999999999998 9999999999999999999999999998764433
Q ss_pred cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc----
Q 003489 654 AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD---- 728 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d---- 728 (816)
.......++..|+|||.+... .++.++|+||||+++|+|++|+.|++...................+.......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112224577889999998776 789999999999999999999998865544322111111000000000000000
Q ss_pred -------ccc--cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 -------PLI--SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 -------~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
... ...........+.+++.+|++.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00011223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=299.27 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=198.1
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecC--cc
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE--EN 566 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~ 566 (816)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578999999999999999999865 5788999988542 233445678899999999 9999999999986543 57
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 588888843 26789999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCcc---cccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh-----
Q 003489 647 FGGNQDQ---AATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL----- 717 (816)
Q Consensus 647 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~----- 717 (816)
+...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.|+..................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12233568899999998765 45788999999999999999999998654433221111111000
Q ss_pred ---hccCCccccccccccc------cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 718 ---WNDNNVIDLVDPLISE------SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 718 ---~~~~~~~~l~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+.......+++..... .........+.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000111100000 0001124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=292.97 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=195.2
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEec--CcceE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 568 (816)
.++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367999999999999999999864 589999998864322 2234567899999999999999999998765 45789
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
||||++ ++|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4788877532 256899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHH--------hhc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK--------LWN 719 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~ 719 (816)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....+............ .+.
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 3221 1122345778999998865 4578999999999999999999999875443322111111000 000
Q ss_pred cCCccccc--c-ccccc--cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 720 DNNVIDLV--D-PLISE--SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 720 ~~~~~~l~--d-~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
........ . ..... .......+.+.+++..|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 0 00000 0000123556788899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=286.32 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=198.1
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|+||.||+|..+ ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999865 57889999886532 23456788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-CceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998543 2235789999999999999999999998 99999999999999886 46999999997664322
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
. ......|++.|+|||++....++.++|+||||++++||++|+.|+....... ...... .......
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~----- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYFAPI----- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccCCCC-----
Confidence 1 1223467889999999988889999999999999999999999976432211 111111 1111111
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112245778888999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=289.72 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=193.9
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.+.||+|.+|.||+|+.+ +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999865 68899999886532 2334678899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCceeeccccceecCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGN 650 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~ 650 (816)
|++ ++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 5777776432 2233577888899999999999999988 999999999999985 457999999999765322
Q ss_pred CcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccC--Cc----
Q 003489 651 QDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN--NV---- 723 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~---- 723 (816)
. .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.|+....+...... ........ ..
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcccc
Confidence 1 11122456889999998866 4578999999999999999999999875443222111 10000000 00
Q ss_pred ---ccc--cccccccc----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 ---IDL--VDPLISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 ---~~l--~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
... .-+..... ........+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000000 01112345778999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=289.36 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=195.8
Q ss_pred ccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
..+||+|+||.||++..+ +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 358999999999999864 6889999998655555667799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 998732 34789999999999999999999998 9999999999999999999999999987653221 11233
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..++..|+|||.+....++.++|+||||+++|||++|+.|+......... ...... ..+.+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~~---------~~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDN---------LPPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhh---------CCcccCC--ccc
Confidence 56788999999998888999999999999999999999998643332111 111100 0011100 011
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+.+++.+|++.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2335667888999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=302.32 Aligned_cols=269 Identities=25% Similarity=0.344 Sum_probs=202.4
Q ss_pred cccccccCCCCceeEEEeEe-cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC------cceE
Q 003489 497 FQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------ENML 568 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 568 (816)
+...+.||+|+||.||+|+. ..|+.||||.+++.. ....+...+|+++|++++|+|||++++.-.... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457899999999999994 579999999997753 345667889999999999999999999866544 4589
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc--CCC--Cceeeccccc
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD--DDL--NPKISDFGLA 644 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~DfGla 644 (816)
|||||.+|+|...|.++.+..-|++.+.+.++.++..||.|||+++ |+||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999999888888999999999999999999999998 99999999999883 334 5899999999
Q ss_pred eecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
+.+.++. .....+||..|.+||.... +.|+...|.|||||++|+++||..||......-...-..|....-.+..+
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9875443 4556899999999999984 88899999999999999999999998754433111111121111111111
Q ss_pred cccccccccc------------cccHHHHHHHHHHHHHhhhcCCCCCC--ChHHHHHHHhcc
Q 003489 724 IDLVDPLISE------------SGFKMEIIRCVNVGLLCVQEFVKDRP--NMPTVVSMLNSE 771 (816)
Q Consensus 724 ~~l~d~~l~~------------~~~~~~~~~l~~l~~~Cl~~~P~~RP--t~~evl~~L~~~ 771 (816)
.-..++..++ .-+.-...++..+...++..+|++|= ...+.-..+..+
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1111111111 11233455666777777888888886 444444444333
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=285.85 Aligned_cols=236 Identities=26% Similarity=0.347 Sum_probs=189.1
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||.|++|.||+++.. +++.+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999965 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999943 245889999999999999999999988 9999999999999999999999999998764332 2223
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..++..|+|||.+....++.++|+||||+++|+|++|+.|+....++. ..... ....... .......
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~~~~~~---------~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN---DILKGNG---------KLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH---HHhccCC---------CCCCCcc
Confidence 467889999999988889999999999999999999999986544211 11111 1110000 0001111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCC
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPN 760 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt 760 (816)
....+.+++.+|++.+|++||+
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcC
Confidence 1456788899999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=291.07 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=194.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
+.|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++.++||||+++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999864 688999998864322 33457889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5676666322 245899999999999999999999988 999999999999999999999999998764321
Q ss_pred CcccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+......... ... ...+ .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---~~~---~~~~-~---- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI---AQND-S---- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---HHH---hcCC-C----
Confidence 2245778999999874 456889999999999999999999997543322110 000 0000 0
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
+.+. .......+.+++.+||+.+|++||++.+|+...
T Consensus 232 -~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 -PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1110 112334677888899999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-33 Score=301.66 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=190.2
Q ss_pred ccccccCCCCceeEEEeEec-CCcEEEEEE--ecc--cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc--ceEEE
Q 003489 498 QLANKLGQGGFGPVYKGKLQ-DGQEIAVKR--LSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE--NMLIY 570 (816)
Q Consensus 498 ~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~--l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 570 (816)
+....||+|+|-+||+|... +|-+||=-. +++ ..+...++|..|+.+|+.|+|+||++++.++.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34579999999999999864 466676222 222 234455899999999999999999999999987766 56899
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-CCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~ 649 (816)
|.+..|+|..|+++. +.++.....+|++||++||.|||++. +||+|||||.+||+|+.+ |.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999544 45788899999999999999999986 789999999999999765 7999999999987632
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
. . .....|||.|||||... ..|.+..||||||+.++||+|+.-|+..-.. ...+.+....+.-...+
T Consensus 199 s--~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl-- 265 (632)
T KOG0584|consen 199 S--H--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAAL-- 265 (632)
T ss_pred c--c--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHh--
Confidence 2 2 22379999999999776 7899999999999999999999999763221 12222222222111111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..-..+.+.+++..|+.. .++|||+.|++.
T Consensus 266 ------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 ------SKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------hccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 011134566788899999 999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=286.72 Aligned_cols=242 Identities=25% Similarity=0.297 Sum_probs=184.7
Q ss_pred ccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhh---cCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISN---LQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..++.. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 58899999886532 1222334555544443 479999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998843 345899999999999999999999998 9999999999999999999999999987553221
Q ss_pred ccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.....|+..|+|||.+.. ..++.++||||||++++||++|+.||..........+..... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~-- 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TVNVEL-- 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cCCcCC--
Confidence 123468999999998864 558899999999999999999999986433221111111000 000111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVSM 767 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~~ 767 (816)
.......+.+++..|++.||++|| +++|+++.
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111234667788899999999999 59988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=284.24 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=201.2
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|++|.||+++.+ +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788899999999999999754 67889999986532 33456788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCC-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885422 2356889999999999999999999998 999999999999999999999999999876443
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
......++..|+|||.+....++.++|+||||++++||++|+.|+.....+. +.... .......+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~~~----- 221 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKV----QRGKYPPI----- 221 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcCCCCCC-----
Confidence 2223457889999999999889999999999999999999999986543321 11111 11111111
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+.+++.+|++.+|++||++.|+++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1123456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=285.42 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=196.1
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc------
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD------ 652 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~------ 652 (816)
.+++... ..+++..+.+++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998542 36899999999999999999999998 99999999999999999999999999876432211
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
........++..|+|||.......+.++||||||++++||++|+.|+.....+.. .... ..+... . +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~-~--~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNI----LNGKIE-W--P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----hcCCcC-C--C---
Confidence 1122335678899999999888899999999999999999999999865443211 1111 000000 0 0
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
. .......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 222 ~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0 00013566788889999999999999777777754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.95 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=195.9
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----- 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 564 (816)
..++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999975 58899999986532 233456788999999999999999999987655
Q ss_pred -----cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceee
Q 003489 565 -----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639 (816)
Q Consensus 565 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 639 (816)
..++|+||+++ +|..++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 67899999976 666666432 345899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh
Q 003489 640 DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 640 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
|||++..+..... .......++..|+|||.+.. ..++.++||||||++++||++|++|+...........+.......
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999986643221 11122345778999998764 457899999999999999999999886443322221111111000
Q ss_pred ccCCccc--------cccc------cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 719 NDNNVID--------LVDP------LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 719 ~~~~~~~--------l~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+..... ..++ ..... .......+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred Chhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 0000 00000 0011356778889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=280.27 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=199.8
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++.+++|+|++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578899999976543 4557899999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998432 56899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 732 (816)
. .....++..|+|||......++.++|||++|+++++|++|+.|+....+... . + .. ...... .+.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~--~--~~-~~~~~~-~~~---- 220 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L--F--RI-VQDDHP-PLP---- 220 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H--H--HH-hccCCC-CCC----
Confidence 1 2334678899999999888889999999999999999999998764332110 0 0 00 001000 011
Q ss_pred ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 733 ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 733 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
......+.+++.+|++.+|++||++.+++.
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 ----EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111345678888999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=296.65 Aligned_cols=267 Identities=19% Similarity=0.324 Sum_probs=197.6
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEe----cCcc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 566 (816)
.++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999854 68999999986542 2345677889999999999999999998763 3456
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 688888843 345899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCccc--ccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH--------H
Q 003489 647 FGGNQDQA--ATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA--------W 715 (816)
Q Consensus 647 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~--------~ 715 (816)
........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||............... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 54332211 1123478889999998765 45889999999999999999999998654332111111100 0
Q ss_pred HhhccCCcccccccccc-cc-----ccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 716 KLWNDNNVIDLVDPLIS-ES-----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.....+.+.+..+..-. .. ........+.+++.+|++.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000111111100000 00 001224678889999999999999999998773
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=287.17 Aligned_cols=257 Identities=17% Similarity=0.226 Sum_probs=181.9
Q ss_pred hcCcccccccCCCCceeEEEeEecCC----cEEEEEEecccCchhH-----------HHHHHHHHHHhhcCCCceeeeee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKASGQGQ-----------EEFMNEVMVISNLQHRNLVRLLG 558 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 558 (816)
.++|++.++||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999986543 4566665432211110 11223344556678999999999
Q ss_pred EEEecCc----ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC
Q 003489 559 CCVEREE----NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL 634 (816)
Q Consensus 559 ~~~~~~~----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 634 (816)
++..... .++++|++. .++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 8765542 357777663 355555522 223567888999999999999999988 99999999999999999
Q ss_pred CceeeccccceecCCCCcc-----cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhh
Q 003489 635 NPKISDFGLARIFGGNQDQ-----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT 709 (816)
Q Consensus 635 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~ 709 (816)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432211 11223578999999999999999999999999999999999999987553221110
Q ss_pred H---HHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 710 L---LGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 710 l---~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
. .++..+. ..+. +.. ......+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~~~~-~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRL-HEGK--------IKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHh-hhhh--------hcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 1111111 1110 000 111345678888999999999999999999874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=290.79 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=191.7
Q ss_pred cccCCC--CceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQG--GFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G--~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
..||+| +||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 89999999864 78999999986432 23456788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc-
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA- 654 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 654 (816)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886432 234788899999999999999999988 9999999999999999999999998654332111110
Q ss_pred ----ccccccccccccChhccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh-h---------
Q 003489 655 ----ATKRLVGTYGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL-W--------- 718 (816)
Q Consensus 655 ----~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~-~--------- 718 (816)
......++..|+|||++... .++.++||||||+++|||++|+.|+........ +....... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 01112345679999998763 478999999999999999999999865432211 11000000 0
Q ss_pred -------------c----cCC-----ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 719 -------------N----DNN-----VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 719 -------------~----~~~-----~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. +.. ...+.+..+...........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000 00111111222222334567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=296.98 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=200.8
Q ss_pred cCcccccccCCCCceeEEEeEecCCc-EEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
+.+.+...||.|+||.||++..++.. ..|.|.+........+.|+-|+++|..++||+||++++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34566789999999999999876543 35678887777788899999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
.||-++..+... ...|.+.++.-+++|++.||.|||++. |||||||..|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 999999887543 356899999999999999999999998 9999999999999999999999999886532 122
Q ss_pred cccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 654 AATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.....+.||+.|||||+.+ ..+|+.++||||||++|.||.-+.+|.....+. ....+....+ .
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSe------P 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE------P 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcC------C
Confidence 2344579999999999874 567999999999999999999999986533331 1111111111 1
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
|.+.. +..-...+.++...|+..||..||++.++++
T Consensus 253 PTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 PTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111 1223456677888999999999999998864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=308.99 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=186.1
Q ss_pred HhcCcccccccCCCCceeEEEeEecC--CcEEEEEE--------------ec---ccCchhHHHHHHHHHHHhhcCCCce
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQD--GQEIAVKR--------------LS---KASGQGQEEFMNEVMVISNLQHRNL 553 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~--~~~vavK~--------------l~---~~~~~~~~~~~~E~~~l~~l~h~ni 553 (816)
..++|++.++||+|+||+||++..+. +...++|. +. .........+.+|+.+|++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987542 22222221 10 1112234568899999999999999
Q ss_pred eeeeeEEEecCcceEEEeeCCCCCccccccCCC--CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc
Q 003489 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD 631 (816)
Q Consensus 554 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 631 (816)
+++++++...+..++|+|++. ++|.+++.... .........+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999984 56766664321 1122345667789999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCC-CCCchhhhhhH
Q 003489 632 DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT-SFYHEEFELTL 710 (816)
Q Consensus 632 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~-~~~~~~~~~~l 710 (816)
.++.+||+|||+++.+..... .......|+..|+|||++.+..++.++|||||||++|||++|+.++ ..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987643222 1222357899999999999999999999999999999999998543 22211111111
Q ss_pred HHHHHHh--hccC------Ccccc------------ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 711 LGYAWKL--WNDN------NVIDL------------VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 711 ~~~~~~~--~~~~------~~~~l------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
....... ..++ ...+. +.+.+.... ....+.+++.+|++.||.+|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG---LPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcC---CChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 0000 00000 000111000 11345667789999999999999999863
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=281.02 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=190.0
Q ss_pred HHHHHHhcCccccccc--CCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEec
Q 003489 488 EELANATNNFQLANKL--GQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER 563 (816)
Q Consensus 488 ~el~~~~~~f~~~~~L--G~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 563 (816)
.++....++|++.+.+ |+|+||.||++..+ +++.+|+|.+........ |+.....+ +|+||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455777887777 99999999999854 678899998865322111 22222222 699999999999999
Q ss_pred CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-Cceeeccc
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFG 642 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG 642 (816)
+..++||||+++++|.+++... ..+++..+..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999998532 37899999999999999999999998 99999999999999998 99999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
++...... ....++..|+|||++....++.++||||||++++||++|+.|+....++ ......+.... ..
T Consensus 156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~- 225 (267)
T PHA03390 156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QK- 225 (267)
T ss_pred cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cc-
Confidence 98765322 1246788999999999989999999999999999999999998733222 11111221111 00
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCC-hHHHHH
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN-MPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~evl~ 766 (816)
.... .......+.+++.+|++.+|.+||+ ++|+++
T Consensus 226 ~~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KLPF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCCc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 0123356778888999999999996 588764
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=295.25 Aligned_cols=245 Identities=28% Similarity=0.430 Sum_probs=195.4
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCch---hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
+.|+-++.||.|+||.||-++. .+.+.||||++.-...+ .-+.+..|+..|++++|||++.+.|++..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466678999999999999984 46788999999754333 3457889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||| -|+-.++|.- ..+++-+..+..|+.+.+.||+|||+.+ .||||||..||||.+.|.+||+|||.|.+..+
T Consensus 106 EYC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 999 4566666532 2356888889999999999999999998 99999999999999999999999999976532
Q ss_pred CcccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
...++|||.|||||++. .+.|+-|+||||||++-.||.-.++|.-....... ++..+ ..-
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYHIA----------QNe 241 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----------QNE 241 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHHHH----------hcC
Confidence 34479999999999874 57899999999999999999999988643322111 11111 111
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.|.+. ..+-...+.+++..|++.-|.+|||..++++
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 23333 2345566777888999999999999988754
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.91 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=202.6
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|++.+.||.|+||.||++... +++.+|+|++..... ...+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999865 588999999865433 4567789999999999999999999999999999999999
Q ss_pred CCCCCccccccCCC-CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986432 2367899999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
.......+++.|+|||......++.++|+||+|+++++|++|+.|+....... +.... .......+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~~~----- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI----LKGQYPPI----- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH----hcCCCCCC-----
Confidence 12233467889999999988889999999999999999999999976443211 11111 11111111
Q ss_pred cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. ......+.+++.+|++.+|++||++.|+++
T Consensus 224 ~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 P----SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 112345678888999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=284.77 Aligned_cols=241 Identities=27% Similarity=0.350 Sum_probs=187.7
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||+|+||+||++..+ +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 68899999886432 22345677899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999864332 46899999999999999999999998 999999999999999999999999998765321 11223
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+.............. . .... . ......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~-----~~~~-~----~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---R-----TLEM-A----VEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---c-----cccc-c----ccCCcc
Confidence 4677899999999888899999999999999999999999864433111110000 0 0000 0 001111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHH
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPT 763 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~e 763 (816)
....+.+++.+|++.+|++||+.+|
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 2446678888999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=294.44 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=203.5
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----cce
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENM 567 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 567 (816)
+|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999965 48899999987643 345578999999999999999999999998775 679
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
++|||++ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 588888843 237899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc-ccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc-----
Q 003489 648 GGNQD-QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND----- 720 (816)
Q Consensus 648 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 720 (816)
..... ........++..|+|||.+... .++.++||||||+++++|++|+.||...........+........+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 1122334678899999999887 7899999999999999999999998755443222111111000000
Q ss_pred ---CCccccccccccc------cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH--Hhcc
Q 003489 721 ---NNVIDLVDPLISE------SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 721 ---~~~~~l~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~ 771 (816)
......+...... .........+.+++.+||+.+|++||++.++++. +++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000000000 0011124567789999999999999999999874 5444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=280.32 Aligned_cols=244 Identities=21% Similarity=0.240 Sum_probs=188.0
Q ss_pred cccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHH-hhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVI-SNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
+.||+|+||.||++... +++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 588999999865422 2223344555444 455899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 345889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+........ .... ...... ..+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDNI----LSRRIN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HhcccC--CCCcc----
Confidence 2234678899999999888889999999999999999999999864333211 1100 000000 00000
Q ss_pred cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHh
Q 003489 736 FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769 (816)
Q Consensus 736 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~ 769 (816)
.......+.+++.+|++.+|++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0112356778889999999999998887766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=294.74 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=193.6
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC------
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------ 564 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 564 (816)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999854 68999999986432 223456889999999999999999999987553
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..++|+||+. .+|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 3489999985 4666554 134788999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH--------
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW-------- 715 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~-------- 715 (816)
+.... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||................
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 75422 1123466888999999876 458899999999999999999999987543322111111000
Q ss_pred HhhccCCcccccc--ccccccc----cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH--Hhcc
Q 003489 716 KLWNDNNVIDLVD--PLISESG----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 716 ~~~~~~~~~~l~d--~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~--L~~~ 771 (816)
...........++ +...... .+.....+.+++.+|++.||++||++.|++.. ++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000000 0000000 00123457789999999999999999999854 6555
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=275.81 Aligned_cols=266 Identities=25% Similarity=0.337 Sum_probs=215.5
Q ss_pred HHHHHHHhcCcccccccCCCCceeEEEeEec------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCceeeeeeE
Q 003489 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGC 559 (816)
Q Consensus 487 ~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 559 (816)
..++.....+++...++-+|.||.||+|.+. +.+.|-+|.++.. +.-....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3556667788999999999999999999764 3455778877654 33345678899999999999999999999
Q ss_pred EEec-CcceEEEeeCCCCCcccccc-----CCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC
Q 003489 560 CVER-EENMLIYEYMPNKSLDSFLF-----DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD 633 (816)
Q Consensus 560 ~~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~ 633 (816)
+.+. ...+++|.++.-|+|..||. +.+....+...+...++.|++.|++|||..+ +||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9765 45688999999999999997 5666677888899999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhhhhHHH
Q 003489 634 LNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLG 712 (816)
Q Consensus 634 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~~~l~~ 712 (816)
.++||+|=.+++.+.+...+........+..||+||.+.+..|+.++||||||++||||+| |+.|+...++.+-...+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl- 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL- 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-
Confidence 9999999999998776666655555566889999999999999999999999999999998 78888766654322111
Q ss_pred HHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 713 YAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 713 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
.++. ++. .+.....++..++..||...|++||+.+|++.-|.+-
T Consensus 512 ------kdGy-------Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 ------KDGY-------RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------hccc-------eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111 111 1223445677788899999999999999999888653
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=282.23 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=193.1
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhc---CCCceeeeeeEEEecCc-----
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNL---QHRNLVRLLGCCVEREE----- 565 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 565 (816)
|++.+.||+|+||.||+|+.+ +++.+|+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 489999999864322 2234566788777666 59999999999988776
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.+++|||++ ++|.+++.... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 889999996 47888875422 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc-CCc-
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND-NNV- 723 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~- 723 (816)
.+..... .....++..|+|||.+....++.++||||||+++|||++|++|+....+..... ........ ...
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD---KIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH---HHHHHcCCCChHh
Confidence 7643221 122356889999999998899999999999999999999998876544322111 11110000 000
Q ss_pred --------ccccccccc---ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 --------IDLVDPLIS---ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 --------~~l~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
......... .....+....+.+++.+|++.+|.+||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0011123456778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=288.57 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=194.1
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
.|+..+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999854 68899999986432 2334578899999999999999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|++ |+|.+++... ...+++.++..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 996 5777766432 345899999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.....++..|+|||++. .+.++.++||||||+++|||++|+.|+........ +.... ....
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~----~~~~------ 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----QNES------ 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHH----hccC------
Confidence 12346788999999874 45688999999999999999999998754322111 10100 0000
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+... .......+.+++.+|++.+|.+||++.+|++.+--.
T Consensus 242 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0000 111234567888899999999999999999866443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.57 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=194.4
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc-----
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----- 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 565 (816)
.++|++.++||+|+||.||+|+.+ +++.+|+|++..... .....+.+|++++++++|+||+++++++.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 588999998864332 223467889999999999999999998765443
Q ss_pred ---ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 566 ---NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 566 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
.++|+||+.+ +|...+.. ....+++..+..++.||++||+|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 4899999964 66666643 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCccc---------ccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHH
Q 003489 643 LARIFGGNQDQA---------ATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG 712 (816)
Q Consensus 643 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~ 712 (816)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++|+.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998654322111 11224567889999987654 57899999999999999999999986544332222111
Q ss_pred HHHHhhccC--------------CccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 713 YAWKLWNDN--------------NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 713 ~~~~~~~~~--------------~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.......+. .......+.+.. ........+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000000 000001111110 01112256788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=287.10 Aligned_cols=263 Identities=21% Similarity=0.218 Sum_probs=193.3
Q ss_pred ccccccCCCCceeEEEeEecCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCC
Q 003489 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 498 ~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 575 (816)
.+.+.+|.|+++.||+++. +++.||||++... .....+.+.+|+++++.++|+||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666665 5899999998654 344567899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc---
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--- 652 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 652 (816)
++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 234788889999999999999999998 99999999999999999999999999876532211
Q ss_pred --ccccccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHH----hhccC---
Q 003489 653 --QAATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK----LWNDN--- 721 (816)
Q Consensus 653 --~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~----~~~~~--- 721 (816)
........++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+...... .+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 111223456778999999865 358899999999999999999999987543221 11111100 00000
Q ss_pred ----Cccc----cccccc----cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 722 ----NVID----LVDPLI----SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 722 ----~~~~----l~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.... ..++.. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000000 001112223567789999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=279.96 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=193.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--Ccc
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 566 (816)
.+|++.+.||+|+||.||++... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 5889999987432 223446788999999999999999999998764 346
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++++||+++++|.+++.. ...+++..+.+++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 799999999999999843 245788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCc-ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccc
Q 003489 647 FGGNQD-QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 647 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
...... ........++..|+|||.+....++.++|+||||++++||++|+.|+....... ..... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~~~-~~~ 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI----ATQP-TKP 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH----HcCC-CCC
Confidence 532111 111223568889999999988889999999999999999999999986432211 11111 0000 001
Q ss_pred cccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+ .......+.+++.+|++ +|..||+..+++.
T Consensus 229 ~~--------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 ML--------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CC--------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 11123456778889999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=290.30 Aligned_cols=262 Identities=22% Similarity=0.286 Sum_probs=195.0
Q ss_pred cCcc-cccccCCCCceeEEEeEec-CCcEEEEEEecccCchh--------------HHHHHHHHHHHhhcCCCceeeeee
Q 003489 495 NNFQ-LANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQG--------------QEEFMNEVMVISNLQHRNLVRLLG 558 (816)
Q Consensus 495 ~~f~-~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 558 (816)
++|. +.+.||+|+||.||++... +++.||||.++...... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 3577999999999999854 68899999886532211 125778999999999999999999
Q ss_pred EEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCcee
Q 003489 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 559 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
++..++..++||||++ ++|.+++.. ...+++.....++.||+.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 688888843 345889999999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCC------------cccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchh
Q 003489 639 SDFGLARIFGGNQ------------DQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE 705 (816)
Q Consensus 639 ~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~ 705 (816)
+|||++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998764111 01111223467889999998764 4689999999999999999999998755443
Q ss_pred hhhhHHHHHHHhhccCC---cccc------------ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 706 FELTLLGYAWKLWNDNN---VIDL------------VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 706 ~~~~l~~~~~~~~~~~~---~~~l------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
... ........... .... ..+.... ........+.+++..|++.+|++||++.|++..
T Consensus 241 ~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 221 11111111100 0000 0000000 001123567789999999999999999999863
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=284.33 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=200.0
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 569 (816)
++|.+.+.||+|++|.||+++.. +++.||+|.+... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999865 6899999998653 2234567889999999998 99999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
||++++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999943 346899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcc------------------cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHH
Q 003489 650 NQDQ------------------AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711 (816)
Q Consensus 650 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~ 711 (816)
.... .......++..|+|||......++.++||||||++++++++|+.|+........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---F 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---H
Confidence 3211 122334678899999999888899999999999999999999999875432111 1
Q ss_pred HHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCCh----HHHHH
Q 003489 712 GYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNM----PTVVS 766 (816)
Q Consensus 712 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~----~evl~ 766 (816)
.... . . .........+.+.+++.+|++.+|.+||++ .++++
T Consensus 232 ~~~~---~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKIL---K-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHH---h-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1110 0 0 000111124567788899999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=284.12 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=195.4
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
|++.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 478899999865432 23334567999999999 999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988885432 246899999999999999999999998 99999999999999999999999999986533221
Q ss_pred cccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhH-HH---------HHHHhhccCC
Q 003489 654 AATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTL-LG---------YAWKLWNDNN 722 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l-~~---------~~~~~~~~~~ 722 (816)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.|+........... .. |.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123457889999998754 4578999999999999999999988865443221110 00 0000000000
Q ss_pred ccccccccc---cccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 723 VIDLVDPLI---SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+.... ...........+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 00001112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-33 Score=321.89 Aligned_cols=253 Identities=29% Similarity=0.384 Sum_probs=200.2
Q ss_pred HhcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
.+-+++....||.|.||.||.+. .++|+..|+|.++... ........+|+.++..|+|||+|+++|+-.+++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567778899999999999998 5678889999775432 33446788999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
||||++|+|.+.+.. ...+++.....+..|++.|++|||+.| ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999943 344677777788999999999999999 99999999999999999999999999998765
Q ss_pred CCc--ccccccccccccccChhccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 650 NQD--QAATKRLVGTYGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 650 ~~~--~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
+.. ........||+.|||||++.+. ...-++||||+|||+.||+||++||...+.+..... .+.. -+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy--~V~~-gh~---- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY--HVAA-GHK---- 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh--HHhc-cCC----
Confidence 421 1223457899999999999754 356689999999999999999999986665432111 1100 011
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
|.+ +......-.+++..|++.||++|-++.|+++
T Consensus 1460 ----Pq~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ----PQI----PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----CCC----chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111 1123344557788999999999988876655
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=284.31 Aligned_cols=256 Identities=25% Similarity=0.323 Sum_probs=197.8
Q ss_pred CcccccccCCCCceeEEEeEe----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcc
Q 003489 496 NFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 566 (816)
+|++.+.||+|++|.||+++. .+++.||||.+++.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 256889999986432 22345688999999999 599999999999999999
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++||||+++++|.+++.. ...+++..+..++.|++++|+|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345889999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCcccccccccccccccChhccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
+...... ......++..|+|||.+.... .+.++||||||++++||++|..|+........ ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~--- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK--- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC---
Confidence 5433211 122346788999999987655 78899999999999999999999853222111 111111111100
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+.. .......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 229 ----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000 011224566788899999999999999998887554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=293.94 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=193.4
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEec---------
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--------- 563 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 563 (816)
..+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 5889999998766556667889999999999999999999776543
Q ss_pred -----CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCce
Q 003489 564 -----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPK 637 (816)
Q Consensus 564 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~k 637 (816)
...++|+||++ ++|.+++. ...+++..+..++.||++||.|||+.+ ++||||||+||+++. ++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999997 58888773 235889999999999999999999998 999999999999974 55789
Q ss_pred eeccccceecCCCCccc-ccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH
Q 003489 638 ISDFGLARIFGGNQDQA-ATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 638 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~ 715 (816)
|+|||++..+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998653321111 1122357889999998654 557889999999999999999999986544322111110000
Q ss_pred HhhccCC---ccccccccc-----cccc-----cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 716 KLWNDNN---VIDLVDPLI-----SESG-----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 716 ~~~~~~~---~~~l~d~~l-----~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+.. ........+ .... .......+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 000000000 0000 0112346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.79 Aligned_cols=269 Identities=23% Similarity=0.290 Sum_probs=198.0
Q ss_pred CHHHHHHHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEe
Q 003489 486 NFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE 562 (816)
Q Consensus 486 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 562 (816)
...++...+++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667789999999999999999999985 468899999986532 2335678899999999999999999998864
Q ss_pred c------CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCc
Q 003489 563 R------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 563 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
. ...+++++++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 2356777776 7889887732 35899999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH-
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA- 714 (816)
Q Consensus 637 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~- 714 (816)
+|+|||++..... ......++..|+|||.+.. ..++.++||||||+++|||++|+.|+...............
T Consensus 160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999875422 1223467889999998866 56889999999999999999999998654332211111000
Q ss_pred -------HHhhccCCcc---ccccccccccc---cHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 715 -------WKLWNDNNVI---DLVDPLISESG---FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 715 -------~~~~~~~~~~---~l~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.......... ..++....... .......+.+++.+|++.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 00000000000 00123457789999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.11 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=191.2
Q ss_pred cCcccccccCCCCceeEEEeEecC-CcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 571 (816)
++|++.+.||+|++|.||+|..+. ++.||||.++... ......+..|+.++.+.. |+||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 578889999999999999999764 8899999986543 234456677887777665 9999999999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc-CCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
|++ ++|.+++... ...+++..+.+++.||++||+|||+. + |+||||+|+||++++++.++|+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 4666665332 23689999999999999999999974 6 999999999999999999999999998765332
Q ss_pred CcccccccccccccccChhccccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
... ....++..|+|||.+.... ++.++||||||+++|||++|+.|+.....+.+ ... ...... ...
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~---~~~~~~-~~~- 238 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLT---KILQEE-PPS- 238 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHH---HHhcCC-CCC-
Confidence 211 2235678999999987553 78899999999999999999999864322211 111 111111 000
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+... ......+.+++.+|++.+|.+||++.++++.
T Consensus 239 ----~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0123457788889999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=288.10 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=196.8
Q ss_pred HHHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEe-cCcc
Q 003489 491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REEN 566 (816)
Q Consensus 491 ~~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 566 (816)
...+++|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999854 7899999988643 22345678899999999999999999999876 4567
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++++||+ +++|.+++. ...+++..+..++.||++||+|||+.+ ++||||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888873 335788888899999999999999998 99999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH--------HHh
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA--------WKL 717 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~ 717 (816)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............... ...
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 422 1122456788999998766 56899999999999999999999998754432221111100 000
Q ss_pred hccCCcccccccc-ccccccH-----HHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 718 WNDNNVIDLVDPL-ISESGFK-----MEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 718 ~~~~~~~~l~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
...+...+.+... ....... .....+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 0000011 123567788999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.91 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=203.2
Q ss_pred HhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
....|.+...||+|.|++|.++++ .++..||||.+.+..- ...+.+.+|+++|+.|.|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346789999999999999999985 4699999999977532 2335588999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||+.+|.+.+||.+. .......+..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 9999999999999643 33455888899999999999999998 9999999999999999999999999998874
Q ss_pred CCcccccccccccccccChhccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
........+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||+.. .+.++-+
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-------------------~lk~Lr~ 265 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-------------------NLKELRP 265 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-------------------ccccccc
Confidence 3334456799999999999998876 57999999999999999999998631 1222222
Q ss_pred cccccccc--HHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 729 PLISESGF--KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 729 ~~l~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+.+.+..- ..-..++-+++..++..+|.+|+++.++.+.
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22222211 1123456678889999999999999999653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=311.56 Aligned_cols=263 Identities=29% Similarity=0.418 Sum_probs=207.3
Q ss_pred HhcCcccccccCCCCceeEEEeEec--------CCcEEEEEEecccCc-hhHHHHHHHHHHHhhc-CCCceeeeeeEEEe
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 562 (816)
..++..+.+.||+|.||.|++|... ....||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3455566779999999999999743 135699999976533 4567899999999999 59999999999999
Q ss_pred cCcceEEEeeCCCCCccccccCCC------C-----C--CCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEE
Q 003489 563 REENMLIYEYMPNKSLDSFLFDPQ------R-----Q--SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL 629 (816)
Q Consensus 563 ~~~~~lV~e~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 629 (816)
.+..++|.||+..|+|.+||++.+ . . ..+...+.+.++.|||.||+||++.. ++||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997654 0 0 24889999999999999999999987 999999999999
Q ss_pred EcCCCCceeeccccceecCCCCccccc-ccccccccccChhccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCchhhh
Q 003489 630 LDDDLNPKISDFGLARIFGGNQDQAAT-KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFE 707 (816)
Q Consensus 630 l~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt-G~~p~~~~~~~~~ 707 (816)
+.++..+||+|||+++........... ....-+..|||||.+....|+.|+||||||++||||+| |..|++......+
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 999999999999999965444333212 11124667999999999999999999999999999999 6667764221111
Q ss_pred hhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 708 LTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 708 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
+. +.+.++...+. +.....++.+++..||+.+|++||++.|+++.|+..+.
T Consensus 531 --l~----~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 531 --LL----EFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HH----HHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 12223322222 12234567788999999999999999999999988644
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=282.59 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=193.0
Q ss_pred CcccccccCCCCceeEEEeEe----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcc
Q 003489 496 NFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 566 (816)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 368899999986532 22346788899999999 599999999999999889
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++|+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||+|+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999853 345788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCcccccccccccccccChhccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
...... .......++..|+|||.+... .++.++||||||+++|+|++|+.|+....... .............
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--- 228 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC---
Confidence 533221 122235688899999998753 46789999999999999999999986432211 1111111111100
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
+. ........+.+++.+|++.+|++|| ++.+++.
T Consensus 229 ----~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 0111234567888899999999997 5566544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=311.70 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=186.4
Q ss_pred HHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCceeeeeeEEEec------
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------ 563 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 563 (816)
....+|+.++.||+|+||.||+++.+ ||+.+|||++.... ......+.+|+..|++|+|||||+++....+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45578999999999999999999966 79999999986542 33445688999999999999999987532210
Q ss_pred --------------------------------------------------------------------------------
Q 003489 564 -------------------------------------------------------------------------------- 563 (816)
Q Consensus 564 -------------------------------------------------------------------------------- 563 (816)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHH
Q 003489 564 ---------------------------------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610 (816)
Q Consensus 564 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL 610 (816)
...||=||||+...|.+++++..... .....++++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01256678888877777774322111 3566789999999999999
Q ss_pred HhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC---C-------------CCcccccccccccccccChhccccC
Q 003489 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG---G-------------NQDQAATKRLVGTYGYMSPEYAMEG 674 (816)
Q Consensus 611 H~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~~~~ 674 (816)
|+.+ ||||||||.||+++++..+||+|||+|.... . .......+..+||.-|+|||++...
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0 0111123457899999999998654
Q ss_pred ---CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhh
Q 003489 675 ---RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCV 751 (816)
Q Consensus 675 ---~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl 751 (816)
.|+.|+|+|||||||+||+. ||...++- .. +...+..+.+..- ......+.+.=..++.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--AS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHH--HH----HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999985 34332221 11 1111111111111 1122334445567888999
Q ss_pred hcCCCCCCChHHHHH
Q 003489 752 QEFVKDRPNMPTVVS 766 (816)
Q Consensus 752 ~~~P~~RPt~~evl~ 766 (816)
+.||++|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=290.54 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=194.2
Q ss_pred HHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc---
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE--- 565 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 565 (816)
...++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999984 468899999985432 2234568899999999999999999999876543
Q ss_pred ---ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 566 ---NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 566 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
.++||||+ +++|.+++. ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 48999998 778888873 245899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhh-hHHHH-------
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL-TLLGY------- 713 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~-~l~~~------- 713 (816)
++...... .....+++.|+|||.+.. ..++.++|+||||+++++|++|+.|+......... .+...
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99764321 123456889999998876 45889999999999999999999998644321110 00000
Q ss_pred HHHhhccCCcccccc--ccccc----cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 714 AWKLWNDNNVIDLVD--PLISE----SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....+........+. +.... .........+.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 00000 000112345778999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=281.47 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=197.1
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
|+..+.||+|.+|.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456789999999999999965 48999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 653 (816)
+ ++|.+++.... ..+++..+.+++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999985432 45899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhh-HHHHH-------HHhhccCC-c
Q 003489 654 AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT-LLGYA-------WKLWNDNN-V 723 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~-l~~~~-------~~~~~~~~-~ 723 (816)
......++..|+|||.+... .++.++||||||++++||++|+.|+.......... +.... +..+..-. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223456789999998776 78999999999999999999998886543221111 11000 00000000 0
Q ss_pred ccccccc---ccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 724 IDLVDPL---ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 724 ~~l~d~~---l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
....... ......+.....+.+++.+|++.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000001112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.47 Aligned_cols=203 Identities=31% Similarity=0.443 Sum_probs=179.3
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
.+.|+.-+.||+|+||.||-++. .+|+.+|.|.+.+. ..++....++|-.+|.+++.+.||.+-..+...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 36788888999999999999974 46899999988653 234556788999999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
+..|.||+|.-+|.+... ..+++..++-++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999976543 56899999999999999999999998 99999999999999999999999999998754
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYH 703 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~ 703 (816)
.+. ....+||.+|||||++.+..|+...|.||+||+||||+.|+.||....
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 433 233489999999999999999999999999999999999999986443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=288.30 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=190.5
Q ss_pred CcccccccCCCCceeEEEeEec-C--CcEEEEEEecccC--chhHHHHHHHHHHHhhc-CCCceeeeeeEEEec----Cc
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-D--GQEIAVKRLSKAS--GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER----EE 565 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 565 (816)
+|++.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+++++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999865 3 6789999986532 22356788999999999 599999999976533 34
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.++++|++. ++|.+++. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.++|+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 578888885 68888884 3346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCcc--cccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH-------
Q 003489 646 IFGGNQDQ--AATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW------- 715 (816)
Q Consensus 646 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~------- 715 (816)
.+...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+................
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 66432211 11233578899999998765 468999999999999999999999886543221111100000
Q ss_pred -HhhccCCcccccc-------ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 716 -KLWNDNNVIDLVD-------PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 716 -~~~~~~~~~~l~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+.......... ..+. .........+.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 0000 000111346778999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=279.41 Aligned_cols=241 Identities=25% Similarity=0.303 Sum_probs=184.5
Q ss_pred ccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHH---HhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMV---ISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
.||+|+||.||++... +++.||+|.+.+... .....+..|..+ ++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998865321 222334445443 444579999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988843 346899999999999999999999988 9999999999999999999999999987553221
Q ss_pred ccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 655 ATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.....|+..|+|||.+..+ .++.++||||+|+++|||++|+.|+............ .... ..++.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---------~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL---------TMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh---------ccCCCCCC
Confidence 2234688999999998754 5899999999999999999999998654221111110 0000 00111111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCC-----ChHHHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVS 766 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~evl~ 766 (816)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1134677888899999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=283.17 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=192.5
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999864 5788999988642 2233457889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 6777766432 245789999999999999999999988 999999999999999999999999998765321
Q ss_pred CcccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+......... .... ....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~-----~~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA-----QNES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHh-----hcCC----
Confidence 2245788999999874 356788999999999999999999987543221111 0000 0000
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
+.... ......+.+++.+|++.+|++||++.+|++.-
T Consensus 232 -~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CCcCc---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 11111 11234566788899999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=277.29 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=192.7
Q ss_pred CcccccccCCCCceeEEEeEecC-CcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
+|.+.+.||+|+||.||+++... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998643 444566655432 122344677899999999999999999999999999999
Q ss_pred EeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 570 YEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
+||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23456899999999999999999999988 999999999999975 569999999998764
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.... ......++..|+|||.+....++.++|+||||+++|+|++|..|+...... .... ... ... .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~---~~~-~~~-----~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVL---RIV-EGP-----T 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHH-cCC-----C
Confidence 3322 222346788999999998888999999999999999999999987532221 1111 110 010 1
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 1123356778888999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=281.41 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=189.6
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 588999999864322 2345688999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+. ++|.+++... ...+++.+++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 95 5777766432 345899999999999999999999998 9999999999999999999999999886432
Q ss_pred ccccccccccccccChhccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
......++..|+|||++. ...++.++||||||+++|||++|..|+......... .... .. .. +
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~~---~~-~~-----~ 238 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIA---QN-DS-----P 238 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHH---hc-CC-----C
Confidence 112346788999999974 456888999999999999999999987543321111 1110 00 00 0
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.... ......+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQS---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 1112346678889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=291.72 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=195.9
Q ss_pred HhcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc----
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE---- 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 565 (816)
..++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999875 5788999988643 22334667889999999999999999998876654
Q ss_pred --ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 566 --NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 566 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
.++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 78999998 6799888843 45899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH--------
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA-------- 714 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~-------- 714 (816)
+...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.|+...........+...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9765322 223467888999998865 36789999999999999999999998644332111110000
Q ss_pred HHhhccCCcccccccccc---ccc---cHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 715 WKLWNDNNVIDLVDPLIS---ESG---FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 715 ~~~~~~~~~~~l~d~~l~---~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
...+........+..... ... .......+.+++.+|++.+|++|||+.||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000000 000 0012457889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=265.95 Aligned_cols=203 Identities=28% Similarity=0.370 Sum_probs=178.6
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 569 (816)
-++|..+++||+|.||.|-+++-+ .++.+|+|++++... .....-..|-++|+..+||.+..+...|+..+..+.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 368999999999999999999855 688999999987533 3334456788999999999999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
|||..||.|.-+| ++...+++...+-+-..|+.||.|||+++ ||.||||.+|.|||++|++||+||||++.-.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 9999999999888 34566888888889999999999999998 9999999999999999999999999998532
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCch
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~ 704 (816)
.....+...+||+.|+|||++....|..+.|.|.+|+++|||++|+.||...+.
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 234456678999999999999999999999999999999999999999875444
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=261.69 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=192.4
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+.+.+..||.|+.|.|++.+.. .|..+|||.+... +....++++..++++.+-. +|+||+.+|+|......++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3445678999999999999865 5788999998765 3345567777777776654 89999999999999999999998
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
| ...++.+++. ..+++++..+-++...+++||.||.+.. .|+|||+||+|||+|+.|++||+|||++..+.+.
T Consensus 173 M-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 173 M-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred H-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 8 4445555533 2345788888899999999999998765 5999999999999999999999999999876443
Q ss_pred ccccccccccccccChhcccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
...+...|-+.|||||.+.. ..|+.++||||||+.|+||.||..|++.-..+++.- -+.++++ .|
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-----tkvln~e------PP 313 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-----TKVLNEE------PP 313 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-----HHHHhcC------CC
Confidence 33444678899999999864 468899999999999999999999988655443311 1111211 12
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+.+.- .-.+.+++++..|++.|+.+||...++++
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 222211 02456778888999999999999998875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=261.88 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=198.6
Q ss_pred CHHHHHHHhcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCceeeeeeEEEec
Q 003489 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER 563 (816)
Q Consensus 486 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 563 (816)
.++++-..+ .+.||+|+|+.|-.++ +.+|.++|||++.+...+...+..+|++++...+ |+||++++.+|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 355665555 4789999999999987 7889999999999988888899999999999985 99999999999999
Q ss_pred CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC---Cceeec
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISD 640 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~D 640 (816)
...|||||-|.||+|..+|+ +++.+++.++.++..+|+.||.+||..+ |.||||||+|||..+.. -+||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999994 4566899999999999999999999999 99999999999997654 589999
Q ss_pred cccceecCCCC--c---ccccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh----
Q 003489 641 FGLARIFGGNQ--D---QAATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF---- 706 (816)
Q Consensus 641 fGla~~~~~~~--~---~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~---- 706 (816)
|.|..-+..+. + ......++|+..|||||+.. ...|+.+.|.||||+|||-||+|.+||...-.++
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 99875432221 1 12223478999999999863 3457889999999999999999999985432110
Q ss_pred ---h-hhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 707 ---E-LTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 707 ---~-~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
. ..-.....+-..++.. +..|.. -........+++...+..++.+|-++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 0011111111111110 000000 0011233345666777799999998888866
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=269.50 Aligned_cols=236 Identities=27% Similarity=0.335 Sum_probs=190.3
Q ss_pred cCCCCceeEEEeEec-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCc
Q 003489 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 588999999865432 2456789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccc
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 658 (816)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998432 35899999999999999999999988 9999999999999999999999999998754322 12334
Q ss_pred ccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 659 ~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
..++..|+|||.......+.++|+||||+++|||++|+.|+...... ....... . .. . .+ ...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~---~-~~-~-~~--------~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKIL---K-DP-L-RF--------PEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHh---c-CC-C-CC--------CCC
Confidence 56788999999998888999999999999999999999998644331 1111111 0 00 0 00 011
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHH
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPT 763 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~e 763 (816)
....+.+++.+|++.+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1345678888999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=261.67 Aligned_cols=270 Identities=22% Similarity=0.316 Sum_probs=198.8
Q ss_pred cCcccccccCCCCceeEEEeEec---C--CcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCceeeeeeEEEe-cCcc
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ---D--GQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~---~--~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 566 (816)
..|+....||+|.||.||++.-. + ...+|+|+++.... .--....+|+.+++.++|+||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999533 2 23689999865421 223567899999999999999999999987 6778
Q ss_pred eEEEeeCCCCCccccccC--CCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC----CCceeec
Q 003489 567 MLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD----LNPKISD 640 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~D 640 (816)
++++||.+. +|...|+. ......++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999964 67777753 334467899999999999999999999998 9999999999999877 8999999
Q ss_pred cccceecCCCCcc-cccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchh------hhhhHHH
Q 003489 641 FGLARIFGGNQDQ-AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE------FELTLLG 712 (816)
Q Consensus 641 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~------~~~~l~~ 712 (816)
||+++.+...-.. ......+.|..|.|||.+.+. .||.+.|||+.||++.||++-++-|...++. ...+.++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999998654322 244557889999999999875 5899999999999999999988766443222 2223333
Q ss_pred HHHHhhccC---Ccccc---------ccccccccccHH-----------HHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 713 YAWKLWNDN---NVIDL---------VDPLISESGFKM-----------EIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 713 ~~~~~~~~~---~~~~l---------~d~~l~~~~~~~-----------~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.+.+.+.-. ++..+ +...-....... ..+...++...++++||.+|-|+++.++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 333333211 11110 000000000000 012356788899999999999999988754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=301.23 Aligned_cols=145 Identities=28% Similarity=0.443 Sum_probs=130.3
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
++|++.++||+|+||.||+|... +++.||||+++... ....+.+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999865 68899999986532 233467889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
||+++++|.+++.. ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999853 245788899999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=265.30 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=193.4
Q ss_pred cccccccCCCCceeEEEeEec-CCcEEEEEEecccCc-hhHHHHHHHHHHHhh-cCCCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISN-LQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.+.+..||.|+||+|+|-.++ .|+.+|||+++.... ..+++++.|.+...+ -+.||||+++|.+..++..++.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344579999999999999865 689999999976543 667788888876554 47999999999999999999999999
Q ss_pred CCCCccccccC--CCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 574 PNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 574 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
..||+.+.+. ..+...+++...-+|....+.||.||.+.- .|||||+||+||||+..|.+||+|||++..+-
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--- 219 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--- 219 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH---
Confidence 5666655421 123345788877888888999999998753 59999999999999999999999999987652
Q ss_pred cccccccccccccccChhcccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 652 DQAATKRLVGTYGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
+....+...|-..|||||.+.. ..|+.++||||||++|+|+.||+.|+..++...+ ...... .++. |
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-----ql~~Vv-~gdp-----p 288 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-----QLCQVV-IGDP-----P 288 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH-----HHHHHH-cCCC-----C
Confidence 2233344578889999999864 3589999999999999999999999876655322 111111 1111 1
Q ss_pred cccc-cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 730 LISE-SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 730 ~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.+.. ....+....+++++-.|+-.|..+||...++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 1123345677888889999999999999998653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=285.17 Aligned_cols=260 Identities=23% Similarity=0.407 Sum_probs=211.9
Q ss_pred CHHHHHHHhcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEe-
Q 003489 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE- 562 (816)
Q Consensus 486 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 562 (816)
.++.+...++.|++.+.||+|.+|.||+++ .++++.+|+|++... ....+++..|+++++.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344555567889999999999999999998 457888999998654 35567888899999988 59999999999975
Q ss_pred ----cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCcee
Q 003489 563 ----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 563 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
++.++||||||.+|+..++++... ...+.|..+.-|++.++.||.|||.+. ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 456799999999999999998766 667899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcccccccccccccccChhccccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 003489 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGY 713 (816)
Q Consensus 639 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~ 713 (816)
+|||++..+.. .........||+-|||||++... .|+.++|+||||++..||.-|.+|+...++.-.+.+
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~--- 239 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--- 239 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---
Confidence 99999987632 23344557899999999998643 477899999999999999999999887666422111
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+.....|.+. ....-...+.+++..|+..|-++||++.++++
T Consensus 240 ---------IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 ---------IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---------CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111222222 23445678889999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=267.24 Aligned_cols=258 Identities=28% Similarity=0.389 Sum_probs=195.7
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEeccc-Cch------hHHHHHHHHHHHhhcCCCceeeeeeEEEe-cC
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA-SGQ------GQEEFMNEVMVISNLQHRNLVRLLGCCVE-RE 564 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~-~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 564 (816)
.++|-++++||+|+|+.||++. +...+.||||+-... ++. -.+...+|..+-+.|.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4678889999999999999997 566888999975321 111 12456789999999999999999999965 45
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC---CCCceeecc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDF 641 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Df 641 (816)
..+-|+||++|-+|+-||+ ..+.+++.+++.|+.||+.||.||.+.. +||||-||||.||||-. -|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 6789999999999999994 4456899999999999999999999875 78999999999999954 478999999
Q ss_pred ccceecCCCCcc-----cccccccccccccChhccccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHH
Q 003489 642 GLARIFGGNQDQ-----AATKRLVGTYGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG 712 (816)
Q Consensus 642 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~ 712 (816)
||++++.+.... ..+....||..|++||.+.-+ .++.|.||||.||++|+++.|++||...... .+++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh
Confidence 999998765433 234567899999999988543 5788999999999999999999998743322 12221
Q ss_pred HHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 713 YAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 713 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+. ..+....+.--..|.. ..+...++.+|+++--++|-...++..
T Consensus 696 eN-TIlkAtEVqFP~KPvV--------sseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 EN-TILKATEVQFPPKPVV--------SSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hh-chhcceeccCCCCCcc--------CHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 0001111111111111 234456777999999999988776643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=281.26 Aligned_cols=240 Identities=21% Similarity=0.240 Sum_probs=188.9
Q ss_pred HhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 570 (816)
.++.|.+...+|.|+|+.|-.+.. .+++..++|++.+.. .+-.+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 357788888999999999999975 467889999996652 2334677666655 6999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEE-cCCCCceeeccccceecCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL-DDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DfGla~~~~~ 649 (816)
|.+.++-|.+.+.. .......+..|+.+|+.|+.|||+++ ++||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888777733 22233777889999999999999998 9999999999999 5889999999999987643
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
. ....+-|..|.|||++....+++++|+||||++||+||+|+.|+..-..+ ..+. .....+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~~-------- 529 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQMP-------- 529 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcCC--------
Confidence 3 22346688999999999999999999999999999999999998643222 1111 111111
Q ss_pred cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+........+++.+|+|.||++||+|.++..
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111222344557777999999999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=262.37 Aligned_cols=222 Identities=21% Similarity=0.172 Sum_probs=174.0
Q ss_pred CCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCccccccC
Q 003489 506 GGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD 584 (816)
Q Consensus 506 G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 584 (816)
|.+|.||+++.. +++.+|+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999864 68899999986543 233455555666799999999999999999999999999999998843
Q ss_pred CCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccccccccc
Q 003489 585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664 (816)
Q Consensus 585 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 664 (816)
. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||++...... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 2 34899999999999999999999988 999999999999999999999999988655321 112345678
Q ss_pred ccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHH
Q 003489 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCV 744 (816)
Q Consensus 665 y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 744 (816)
|+|||......++.++||||+|+++|||++|+.|+....... ....... +. ......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~~~-----~~----~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTTLN-----IP----EWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccccccC-----Cc----ccCCHHHH
Confidence 999999988889999999999999999999997754211100 0000000 00 11224567
Q ss_pred HHHHHhhhcCCCCCCChHHH
Q 003489 745 NVGLLCVQEFVKDRPNMPTV 764 (816)
Q Consensus 745 ~l~~~Cl~~~P~~RPt~~ev 764 (816)
+++.+|++.||++||++.+.
T Consensus 207 ~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHccCCHHHhcCCCcc
Confidence 78889999999999998443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=258.00 Aligned_cols=238 Identities=27% Similarity=0.361 Sum_probs=191.1
Q ss_pred CceeEEEeEec-CCcEEEEEEecccCchh-HHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCccccccC
Q 003489 507 GFGPVYKGKLQ-DGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD 584 (816)
Q Consensus 507 ~~g~Vy~g~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 584 (816)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997655444 68899999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccccccccccc
Q 003489 585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664 (816)
Q Consensus 585 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 664 (816)
.. .+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2889999999999999999999998 9999999999999999999999999998764322 2334567889
Q ss_pred ccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHH
Q 003489 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCV 744 (816)
Q Consensus 665 y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 744 (816)
|+|||.+....++.++||||||+++++|++|..|+...... ..+..... ....... .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----ccCCCCc-------cccccCCHHHH
Confidence 99999998888999999999999999999999987642211 11111111 1100000 00000234677
Q ss_pred HHHHHhhhcCCCCCCChHHHHH
Q 003489 745 NVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 745 ~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
+++.+|++.+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8899999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=292.03 Aligned_cols=277 Identities=22% Similarity=0.260 Sum_probs=209.4
Q ss_pred HHHHHHHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecc---cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEe
Q 003489 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE 562 (816)
Q Consensus 487 ~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 562 (816)
..+++...++|.+.+.||+|+||.|..++++ +++.+|+|++.+ ........|++|-++|..-..+-|+.+...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455556789999999999999999999975 578899999976 234456679999999999999999999999999
Q ss_pred cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccc
Q 003489 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 563 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 642 (816)
..++|+|||||+||+|-.++.+. ..+++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999999433 36889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhcccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHh
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKL 717 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 717 (816)
.+-.+.... .......+|||.|++||++.. +.|.+.+|.||+||++|||+.|..||.. ..+++-..+.
T Consensus 221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKI 293 (1317)
T ss_pred hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHH
Confidence 987765332 223345799999999999853 5688999999999999999999999852 2233322333
Q ss_pred hccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCC---hHHHHHH--Hhcc----ccCCCCCCCCcee
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN---MPTVVSM--LNSE----IKDLPAAKQPAFT 784 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~evl~~--L~~~----~~~l~~~~~p~~~ 784 (816)
++........+... -.++... ++...+ -+|+.|-. +.++... ++++ +++.++|-.|...
T Consensus 294 m~hk~~l~FP~~~~----VSeeakd---LI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevs 361 (1317)
T KOG0612|consen 294 MNHKESLSFPDETD----VSEEAKD---LIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVS 361 (1317)
T ss_pred hchhhhcCCCcccc----cCHHHHH---HHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCC
Confidence 33333333221111 1223333 333333 45777776 7777543 2222 2555555555543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=261.77 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=200.4
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-C-C----ceeeeeeEEEecCcc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H-R----NLVRLLGCCVEREEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 566 (816)
+++|.+..++|+|.||.|-.+..+ .+..||||+++... .-.+..+-|+++|+++. + | -+|.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 689999999999999999999754 47889999996543 33456678999999993 2 2 278888889999999
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC--------------
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-------------- 632 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-------------- 632 (816)
++|+|.+ |-|+.++|.+. .-.+++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 77999999653 4457899999999999999999999998 999999999999831
Q ss_pred ------CCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh
Q 003489 633 ------DLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706 (816)
Q Consensus 633 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~ 706 (816)
+..++|+|||.|..-. ......+.|..|.|||++.+..++.++||||+||+|.|+.+|..-|..-+.-+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2358999999998642 22355788999999999999999999999999999999999998775443322
Q ss_pred hhhHHHHHH--------------HhhccCCc-----------c---cccccc-ccccccHHHHHHHHHHHHHhhhcCCCC
Q 003489 707 ELTLLGYAW--------------KLWNDNNV-----------I---DLVDPL-ISESGFKMEIIRCVNVGLLCVQEFVKD 757 (816)
Q Consensus 707 ~~~l~~~~~--------------~~~~~~~~-----------~---~l~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~P~~ 757 (816)
...+++.+. +.+..+++ . +..+|. .......++..++.+++..|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 222222221 11111100 0 001110 011234556778999999999999999
Q ss_pred CCChHHHHH
Q 003489 758 RPNMPTVVS 766 (816)
Q Consensus 758 RPt~~evl~ 766 (816)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=251.34 Aligned_cols=247 Identities=21% Similarity=0.235 Sum_probs=192.1
Q ss_pred HhcCcccc-cccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEe----cCc
Q 003489 493 ATNNFQLA-NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE----REE 565 (816)
Q Consensus 493 ~~~~f~~~-~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 565 (816)
.+++|++. ++||-|-.|.|..+..+ +++.+|+|++.. ....++|+++--.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 58999999999999754 688899999843 34567888866555 59999999998864 344
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC---CCCceeeccc
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFG 642 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG 642 (816)
+.+|||.|+||.|.+.|.+. ....+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 57999999999999998553 4567999999999999999999999998 999999999999965 4479999999
Q ss_pred cceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
+|+.-. ........+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||...+...
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---------------- 270 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------------- 270 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------------
Confidence 998643 2344455788999999999999999999999999999999999999986433210
Q ss_pred ccccccccc-ccc--ccHH----HHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 723 VIDLVDPLI-SES--GFKM----EIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 723 ~~~l~d~~l-~~~--~~~~----~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+..-+..++ .+. +..+ -.+...++++..+..+|++|-|+.|++..
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 000001111 111 1111 23455578888999999999999999763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=284.40 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=166.5
Q ss_pred HhcCcccccccCCCCceeEEEeEec-C----CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeE------EE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-D----GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC------CV 561 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 561 (816)
..++|++.++||+|+||.||+|++. + +..||+|++..... .+...+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 68899998854321 1111111 1122222222222221 24
Q ss_pred ecCcceEEEeeCCCCCccccccCCCCC-----------------CCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeC
Q 003489 562 EREENMLIYEYMPNKSLDSFLFDPQRQ-----------------SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK 624 (816)
Q Consensus 562 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 624 (816)
.+...++|+||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999988542210 01123345679999999999999988 9999999
Q ss_pred CCcEEEcC-CCCceeeccccceecCCCCcccccccccccccccChhccccC----------------------CCCchhh
Q 003489 625 ASNILLDD-DLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG----------------------RFSEKSD 681 (816)
Q Consensus 625 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD 681 (816)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986533222 122345789999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccc----cccc--cHHHHHHHHHHHHHhhhcCC
Q 003489 682 VFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI----SESG--FKMEIIRCVNVGLLCVQEFV 755 (816)
Q Consensus 682 V~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l----~~~~--~~~~~~~l~~l~~~Cl~~~P 755 (816)
||||||+||||+++..+.+.........+... ..........+.+.. .... .........+++.+|++.||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN---DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhc---CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999999997765332111100000000 000000000111110 0000 00011234478889999999
Q ss_pred CCCCChHHHHHH
Q 003489 756 KDRPNMPTVVSM 767 (816)
Q Consensus 756 ~~RPt~~evl~~ 767 (816)
++|||+.|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999873
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=275.84 Aligned_cols=262 Identities=20% Similarity=0.283 Sum_probs=177.8
Q ss_pred HhcCcccccccCCCCceeEEEeEe-----------------cCCcEEEEEEecccCchhHHH--------------HHHH
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-----------------QDGQEIAVKRLSKASGQGQEE--------------FMNE 541 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 541 (816)
..++|++.++||+|+||+||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235679999986543322233 3346
Q ss_pred HHHHhhcCCCce-----eeeeeEEEe--------cCcceEEEeeCCCCCccccccCCC---------------------C
Q 003489 542 VMVISNLQHRNL-----VRLLGCCVE--------REENMLIYEYMPNKSLDSFLFDPQ---------------------R 587 (816)
Q Consensus 542 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~---------------------~ 587 (816)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 677787753 345799999999999999886421 1
Q ss_pred CCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccccccccccccC
Q 003489 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667 (816)
Q Consensus 588 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 667 (816)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788999999999999999988 999999999999999999999999999765322111 1112345789999
Q ss_pred hhccccCCC----------------------CchhhhHHHHHHHHHHHhCCC-CCCCCc---hhhh-hhHHHHHHHhhcc
Q 003489 668 PEYAMEGRF----------------------SEKSDVFSFGVLLLEIVSGRK-NTSFYH---EEFE-LTLLGYAWKLWND 720 (816)
Q Consensus 668 PE~~~~~~~----------------------s~ksDV~SlG~vl~elltG~~-p~~~~~---~~~~-~~l~~~~~~~~~~ 720 (816)
||.+..... ..+.||||+||+++||++|.. |+.... .+.. .......|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 134799999999999999885 443211 1100 0000111111111
Q ss_pred CCccccccccccccccHHHHHHHHHHHHHhhhcCC---CCCCChHHHHH
Q 003489 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFV---KDRPNMPTVVS 766 (816)
Q Consensus 721 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPt~~evl~ 766 (816)
.... ++ ..........+++..++..+| .+|+|+.|+++
T Consensus 459 ~~~~--~~------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYD--FS------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCC--cc------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1110 00 011123455667778887655 78999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=266.93 Aligned_cols=242 Identities=26% Similarity=0.377 Sum_probs=186.7
Q ss_pred ccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 500 ANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
.+.||.|-||+||-|++ ++|+.||||++.+. ......++++|+.+|++++||.||.+.-.|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999985 57999999999763 3455678999999999999999999999999999999999999 45
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC---CCceeeccccceecCCCCcc
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~ 653 (816)
+..+.|... ..+.|++..-..++.||+.||.|||..+ |+|+||||+||||... -++||+|||+|++++..
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--- 720 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--- 720 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence 555555332 3345787777788999999999999998 9999999999999654 37999999999998533
Q ss_pred cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......+||+.|+|||++..+.|...-|+||.|+++|--++|..||...++ -.+.++-+.-+.....+.+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~e-------- 790 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSE-------- 790 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhh--------
Confidence 234457999999999999999999999999999999999999988753322 2223332222222222222
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHH
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTV 764 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 764 (816)
.....++++-..+|..-++|-+..+-
T Consensus 791 -----is~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 791 -----ISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred -----cCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 22344555556666666667665543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=268.84 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=204.6
Q ss_pred cCcccccccCCCCceeEEEeEecCCc-EEEEEEeccc---CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQ-EIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
.++++...||-|+||.|=+.+.+... .+|+|++++. ....++.+..|-.+|...+.|.||+++..|.+.+..|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667789999999999999876433 3788888653 3455677889999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
|-|-||.|...|+ .++.++......++..+++|++|||+.+ ||.|||||+|.+|+.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999994 4456888888999999999999999999 999999999999999999999999999987533
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccccc
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
..+-..+||+.|.|||++.++..+..+|.||||+++|||++|++||...++....+++.....+++-+
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--------- 641 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--------- 641 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc---------
Confidence 34456899999999999999999999999999999999999999999887766555554333322111
Q ss_pred ccccccHHHHHHHHHHHHHhhhcCCCCCCC-----hHHHHH
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~evl~ 766 (816)
........+++...+..+|.+|-- +.+|.+
T Consensus 642 ------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 642 ------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 112234456777888899999965 555544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=229.05 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=190.7
Q ss_pred CcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+|...++||+|.||+||+|+. ++++.||+|+++-. ...-.....+|+-+++.++|+|||++++....++...+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355568999999999999985 45788999988643 233346788999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+ ..+|..|... -.+.++...+..++.|+++||.++|+++ +.||||||.|.|++.+|..|++|||+++.++-+-.
T Consensus 83 c-dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9 4566666532 2356888999999999999999999998 99999999999999999999999999998753321
Q ss_pred ccccccccccccccChhccccCC-CCchhhhHHHHHHHHHHHhCCCC-CCCCchhhhhhHHHHHHHhhccCCcc---ccc
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKN-TSFYHEEFELTLLGYAWKLWNDNNVI---DLV 727 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlG~vl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~---~l~ 727 (816)
-.+..+.|..|.+|.++.+.+ |+...|+||-||++.|+..-.+| |+..+-++....+-+......++.+. .+.
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 223356789999999998765 78899999999999999875444 55444433333333333333333222 222
Q ss_pred cccccccc-----cHHHHHH----HHHHHHHhhhcCCCCCCChHHHHH
Q 003489 728 DPLISESG-----FKMEIIR----CVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~-----~~~~~~~----l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
|-..-..+ -...+++ -.++....+.-+|..|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 21111100 0111111 124444566678999999887665
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=257.25 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=191.2
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 568 (816)
..+|..+..||+|+||.|.++..+ +.+.+|||++++.. ..+.+--+.|-++|... +-|.++++..+++.-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999765 46779999997642 23344456677777766 46789999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
||||+.||+|--+|. +-+.+.+..+.-++..||-||-+||+++ |+.||||.+|||||.+|.+||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn- 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN- 500 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc-
Confidence 999999999988773 3455778889999999999999999999 999999999999999999999999999853
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
-.....+...+||+.|+|||++..++|+..+|.||||++||||+.|.+||+..++++- ...+ .+.++
T Consensus 501 -i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~aI----~ehnv----- 567 (683)
T KOG0696|consen 501 -IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQAI----MEHNV----- 567 (683)
T ss_pred -ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HHccC-----
Confidence 1234456678999999999999999999999999999999999999999986555321 1111 11110
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRP 759 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 759 (816)
.++.....+...++...+...|.+|-
T Consensus 568 -----syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 -----SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----cCcccccHHHHHHHHHHhhcCCcccc
Confidence 12223344555666677888888883
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=228.61 Aligned_cols=111 Identities=47% Similarity=0.685 Sum_probs=81.2
Q ss_pred ceEEEecCCCCCCcCC--CceEEEecCCCeEEecCCCcEEEEeeccccccCccceEEEccCCcEEEEecCCcceeecccc
Q 003489 74 KTVVWVANRNKPLIDS--SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQ 151 (816)
Q Consensus 74 ~t~vW~an~~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqsFD 151 (816)
+||||+|||++|+... ..+|.|+.||+|+|+|.+++++|+++.+...+..++.|+|+|+|||||+|. ++.+||||||
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf~ 80 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSFD 80 (114)
T ss_dssp --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEESTT
T ss_pred cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeecC
Confidence 4999999999999653 478999999999999999999999943222221478999999999999996 6778999999
Q ss_pred CCcccccccCcccccccCCcceEEEEeecCCCCC
Q 003489 152 EPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS 185 (816)
Q Consensus 152 ~PTDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps 185 (816)
|||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=278.58 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=186.0
Q ss_pred cccccccCCCCce-eEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceEEEeeCC
Q 003489 497 FQLANKLGQGGFG-PVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 497 f~~~~~LG~G~~g-~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
|.-.+.+|.|+.| .||+|... ++.||||++-. .......+|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445678999998 58999986 89999999843 2344567899999887 5999999999999999999999999
Q ss_pred CCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC---C--CCceeeccccceecC
Q 003489 575 NKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---D--LNPKISDFGLARIFG 648 (816)
Q Consensus 575 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~~kl~DfGla~~~~ 648 (816)
..+|.+++... .......-...+.++.|+++||+|||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999653 11111122455788999999999999988 999999999999976 2 479999999999886
Q ss_pred CCCcc-cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCchhhhhhHHHHHHHhhccCCcccc
Q 003489 649 GNQDQ-AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG-RKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 649 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
..+.. .......||.+|+|||.+....-+.++||||+||++|+.++| +.||...-+... ++ .-....+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI------l~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI------LTGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh------hcCccceeee
Confidence 65443 234557899999999999998888999999999999999997 778764222111 10 0011111111
Q ss_pred ccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHH
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVV 765 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl 765 (816)
. ...+. ...+++.+|++++|..||++.+|+
T Consensus 736 -~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 -E------PLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -c------cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 01111 556788899999999999999995
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=245.37 Aligned_cols=267 Identities=22% Similarity=0.391 Sum_probs=192.7
Q ss_pred cCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEec--------
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-------- 563 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 563 (816)
+.|....+||+|.||.||+++.+ +++.||+|++--. ...-.....+|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555679999999999999854 5778898865332 122234567899999999999999999887532
Q ss_pred CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccc
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGl 643 (816)
...++|+.+++ .+|..+|.+. ...++..++.++..++..||.|+|+.. |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 33689999995 4677777432 245788899999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcc--cccccccccccccChhcccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhcc
Q 003489 644 ARIFGGNQDQ--AATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 644 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
++.+...... ...+..+.|..|.+||.+.+ ..++++.|||.-||++.||+++.+-+....+.....++.........
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9876443322 22334567999999999876 46899999999999999999999876655554444433322111111
Q ss_pred C--------Cccccc--ccccccccc--HHHH------HHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 721 N--------NVIDLV--DPLISESGF--KMEI------IRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 721 ~--------~~~~l~--d~~l~~~~~--~~~~------~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+ .+.+.+ .|.-++... .+.+ ...++++..++..||.+||++.+++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 111111 111111111 1111 255677778999999999999988753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=232.59 Aligned_cols=210 Identities=28% Similarity=0.391 Sum_probs=172.1
Q ss_pred HHHhcCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcce
Q 003489 491 ANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 491 ~~~~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 567 (816)
....++..-...||+|++|.|-+-++ ++|...|+|++... ..+.+++.+.|+++..+. .+|.+|.++|...+....+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33445566678999999999988874 57999999998653 445667788899876655 7999999999999999999
Q ss_pred EEEeeCCCCCccccccC-CCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 568 LIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+.||.| ..||+.|-.+ -++...+++...-+|+..|.+||.|||++- .++|||+||+|||++.+|++|+||||++..
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999 5677776543 234567888888999999999999999974 599999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhcccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCCchhh
Q 003489 647 FGGNQDQAATKRLVGTYGYMSPEYAME----GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706 (816)
Q Consensus 647 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~ 706 (816)
+.+ ....+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++....++
T Consensus 199 L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 199 LVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred ehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 643 222333567889999998753 468999999999999999999999988665543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=255.28 Aligned_cols=204 Identities=26% Similarity=0.403 Sum_probs=173.8
Q ss_pred cCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
.-|..++.||-|+||.|-+++ .++...+|+|.|++.+. ......+.|-+||..-+.+-||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457888999999999999986 55567789999977543 34456789999999999999999999999999999999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC--
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG-- 648 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~-- 648 (816)
+|++||++-.+|- +-+.+++..++.++.++..|+++.|..| +|||||||+|||||.+|.+||+||||+.=+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988883 4466888889999999999999999988 9999999999999999999999999986431
Q ss_pred ------CCCcc--------------------------------cccccccccccccChhccccCCCCchhhhHHHHHHHH
Q 003489 649 ------GNQDQ--------------------------------AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLL 690 (816)
Q Consensus 649 ------~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ 690 (816)
...++ ......+||+.|+|||++....++.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 0011357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCch
Q 003489 691 EIVSGRKNTSFYHE 704 (816)
Q Consensus 691 elltG~~p~~~~~~ 704 (816)
||+.|+.||....+
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999865544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=228.35 Aligned_cols=257 Identities=19% Similarity=0.350 Sum_probs=194.5
Q ss_pred HhcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecC--cceE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE--ENML 568 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 568 (816)
..++|++.+++|+|.++.||.|. ..+.+.++||++++. ..+.+.+|+.+|..|+ ||||+.+++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999997 567889999999754 4567899999999997 999999999987654 4569
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-Cceeeccccceec
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF 647 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 647 (816)
|+||+.+.+...+. +.++-..+.-++.++++||.|+|+.| |.|||+||.|+++|... .++|.|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876655 44777788899999999999999999 99999999999999765 7999999999988
Q ss_pred CCCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc--
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI-- 724 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 724 (816)
....+.+. .+.+.-|.-||.+-.. .|+..-|+|||||+|..|+..+.||-.-++. .+.+..+.+.+..+.+.
T Consensus 184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN--~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC--HHHHHHHHHHhChHHHHHH
Confidence 76655443 3456678899988654 5788899999999999999999997543332 11111121111111100
Q ss_pred -----ccccccccc---------------cccHHH-HHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 -----DLVDPLISE---------------SGFKME-IIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 -----~l~d~~l~~---------------~~~~~~-~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
-.+||.... ..+... .++.++++...+.+|-.+|||++|.+.
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 012222111 111111 266778888899999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=231.52 Aligned_cols=210 Identities=35% Similarity=0.592 Sum_probs=182.1
Q ss_pred cCCCCceeEEEeEecC-CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCccc
Q 003489 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 580 (816)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999999755432 35789999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-CCCceeeccccceecCCCCcccccccc
Q 003489 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGNQDQAATKRL 659 (816)
Q Consensus 581 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 659 (816)
++.... ..+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35889999999999999999999998 999999999999999 89999999999987643321 12234
Q ss_pred cccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHH
Q 003489 660 VGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKM 738 (816)
Q Consensus 660 ~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 738 (816)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999998877 788999999999999999
Q ss_pred HHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 739 EIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 739 ~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356688889999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=235.88 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=193.2
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCceeeeeeEEEecCcceE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 568 (816)
.++|.++..||+|+|..|.+++++ +.+.+|+|++++. ..++.+-.+.|-.+...- +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999865 5777899998764 223344455666666655 69999999999999999999
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
|.||++||+|--++ +++..+++..++.+...|..||.|||++| |+.||||..|||+|.+|.+||+|+|+++.-.
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999986666 55566899999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCch-hhhhhHHHHHHHhhccCCccccc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE-EFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.....++..+||+.|+|||++.+..|....|.|++|++++||+.|+.||+.... ..+.+-.++.....-+..+.
T Consensus 403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--- 477 (593)
T KOG0695|consen 403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--- 477 (593)
T ss_pred --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence 233456678999999999999999999999999999999999999999975432 22222333333332222111
Q ss_pred cccccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRP 759 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 759 (816)
- +.....+...+...-+..||.+|-
T Consensus 478 -----i--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -----I--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----c--cceeehhhHHHHHHhhcCCcHHhc
Confidence 0 111123344556667788888873
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=211.15 Aligned_cols=108 Identities=42% Similarity=0.954 Sum_probs=101.9
Q ss_pred ccCCCCCCcccccccccccccccceeccccCccceEEEEEEeeCCeeE--EEEccCCceEEEEeecCCCceEEEEEecCC
Q 003489 212 WRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTN 289 (816)
Q Consensus 212 w~~g~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~L~~~G~l~~~~w~~~~~~w~~~~~~p~~ 289 (816)
||+|||||..|+|+|+|...+.+.+.|+.++. +.||+|...+.+++ ++||.+|+++++.|++..+.|.+.|.+|.|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~--e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d 78 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNE--EVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKD 78 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCC--eEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEeccc
Confidence 89999999999999999988888899997777 99999999877765 999999999999999999999999999999
Q ss_pred CCccCCCCCCCccccCCCCCcccccCCCccCC
Q 003489 290 DCDVYGKCGAFGSCNSQKIPICSCLLGFEPKN 321 (816)
Q Consensus 290 ~C~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 321 (816)
+||+|+.||+||+|+.+..|.|.||+||+|++
T Consensus 79 ~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 79 QCDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 99999999999999988889999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=235.15 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=190.5
Q ss_pred cccccccCCCCceeEEEeEe-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCceeeeeeEEEecC-----cceE
Q 003489 497 FQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENML 568 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 568 (816)
++-.+.||.|+||.||.... ++|+.||+|++.+.- -..-+.+.+|+.+|..++|.|++..++...-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999985 479999999986532 234567899999999999999999998776443 3578
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
+.|.| ..+|+..|- ....++-..+.-++.||++||+|||+.+ |.||||||.|.|++.+-.+||+|||+++...
T Consensus 135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88888 568888874 3456788888889999999999999998 9999999999999999999999999999765
Q ss_pred CCCcccccccccccccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH--------Hhhc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW--------KLWN 719 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~ 719 (816)
..+....+ ..+.|..|.|||++++. .|+.+.||||.||++.||+-.+.-|....+....+++-... +..-
T Consensus 208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 44433333 34678899999999875 58999999999999999998887665544444333322110 0000
Q ss_pred cCCcccccccc--------cccccc-HHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 720 DNNVIDLVDPL--------ISESGF-KMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 720 ~~~~~~l~d~~--------l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
++.-..++... +-.-.+ ...-...+.+...++..+|++|.+..+.+..+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11000111100 000000 01112334555678899999999988887665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=226.72 Aligned_cols=199 Identities=35% Similarity=0.527 Sum_probs=171.9
Q ss_pred cccccccCCCCceeEEEeEecC-CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999764 889999999765544 67789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999854321 1789999999999999999999997 999999999999999999999999999876543211
Q ss_pred ccccccccccccChhcc-ccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003489 655 ATKRLVGTYGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 701 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SlG~vl~elltG~~p~~~ 701 (816)
......++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335677889999998 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=232.05 Aligned_cols=132 Identities=25% Similarity=0.399 Sum_probs=111.3
Q ss_pred cCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-----C---CceeeeeeEEEec--
Q 003489 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-----H---RNLVRLLGCCVER-- 563 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~-- 563 (816)
.+|.+.++||.|.|++||++. .++.+.||+|+.+. ...-.+..+.|+.+|++++ | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 689999999999999999997 45688899999853 3344567789999999984 3 4699999999754
Q ss_pred --CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc
Q 003489 564 --EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD 631 (816)
Q Consensus 564 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 631 (816)
.+.++|+|++ |.+|..+|..... +-++...+.+|++||+.||.|||+.+ +|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4678999999 7888888865433 34889999999999999999999986 699999999999983
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=199.44 Aligned_cols=115 Identities=44% Similarity=0.690 Sum_probs=100.8
Q ss_pred ccccCCCcEEecCCeEEEeeecCCCCCCceEEEEEEecCCCCCceEEEecCCCCCCcCCCceEEEecCCCeEEecCCCcE
Q 003489 31 QFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQV 110 (816)
Q Consensus 31 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~ 110 (816)
++|.+|++|+|++|.|++|||.+.. +...+.+|||.. .+ .++||.||++.| ....+.|.|+.||+|+|+|.+|.+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~~dgnlv~~~~--~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~ 76 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIM-QSRDYNLILYKG--SS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTV 76 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCC-CCCeEEEEEEeC--CC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcE
Confidence 5788999999999999999999975 334999999998 33 589999999998 566788999999999999999999
Q ss_pred EEEeeccccccCccceEEEccCCcEEEEecCCcceeeccccCC
Q 003489 111 HWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEP 153 (816)
Q Consensus 111 ~wst~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqsFD~P 153 (816)
+|+|++.. .....+|+|+|+|||||++. ++.+||||||||
T Consensus 77 vW~S~~~~--~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P 116 (116)
T cd00028 77 VWSSNTTR--VNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP 116 (116)
T ss_pred EEEecccC--CCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence 99999864 24567899999999999998 466799999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=241.81 Aligned_cols=196 Identities=25% Similarity=0.397 Sum_probs=165.3
Q ss_pred cCcccccccCCCCceeEEEeEecC-CcEEEEEEecccCc--------hhHHHHHHHHHHHhhcC---CCceeeeeeEEEe
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASG--------QGQEEFMNEVMVISNLQ---HRNLVRLLGCCVE 562 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 562 (816)
.+|+..+.+|+|+||.|+.+.++. ..+|+||.+.+... ...-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999999764 56789998865321 11123457999999997 9999999999999
Q ss_pred cCcceEEEeeC-CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecc
Q 003489 563 REENMLIYEYM-PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641 (816)
Q Consensus 563 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 641 (816)
.+..||++|-. ++-+|.++|. ..+.+++.++.-|+.||+.|+++||+++ |+|||||-+||.++.+|-+||.||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999965 5678999983 3456899999999999999999999999 999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhccccCCCC-chhhhHHHHHHHHHHHhCCCCCC
Q 003489 642 GLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGRKNTS 700 (816)
Q Consensus 642 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SlG~vl~elltG~~p~~ 700 (816)
|.+...... .....+||..|.|||++.+.+|- ..-|||++|++||-++....|+.
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765322 23447999999999999988874 55899999999999998877763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=224.33 Aligned_cols=260 Identities=23% Similarity=0.290 Sum_probs=189.7
Q ss_pred cCcccccccCCCCceeEEEeEe-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC------c
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------E 565 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 565 (816)
.+|.-+..+|.|.- .|-.+.. -.+++||+|++... .....++..+|..++..+.|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46666778888887 4544432 24889999987543 2344567789999999999999999999987543 4
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.|+|||+| ..+|...++ ..++-..+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 58999999 678888874 34677888999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhh----------------h
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL----------------T 709 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~----------------~ 709 (816)
.-. ..-..+..+.+.-|.|||++.+..+.+.+||||+||++.||++|+--|...+.-+.. .
T Consensus 167 ~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 532 223445578899999999999988999999999999999999999766533221111 1
Q ss_pred HHHHHHHhhccC-C-----cccc-cccccc--ccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 710 LLGYAWKLWNDN-N-----VIDL-VDPLIS--ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 710 l~~~~~~~~~~~-~-----~~~l-~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
+...++...... + ..++ .|.... ...+........+++.+|+..+|++|-+++++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111111100 0 0011 111111 01112233455678889999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=243.70 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=202.1
Q ss_pred hcCcccccccCCCCceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
.++|+....+|.|+||.|||++. ..++..|+|.++-.......-.++|+-+++..+|+|||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46888899999999999999985 46889999999887777888888999999999999999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+.+|+|.+.-+ -..++++.++...++..++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+.. .
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T 165 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence 99999999874 3467889999999999999999999998 89999999999999999999999999876532 2
Q ss_pred ccccccccccccccChhcc---ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccc
Q 003489 653 QAATKRLVGTYGYMSPEYA---MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
-.......||+.|||||+. ..+.|..++|||+.|+...|+---.+|.-..++.....+ +... ..+|
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTkS----~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTKS----GFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhcc----CCCC
Confidence 3344568999999999987 356789999999999999999877766443333221111 1111 1111
Q ss_pred -cccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHH
Q 003489 730 -LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVV 765 (816)
Q Consensus 730 -~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl 765 (816)
.++. ...-.+.+-+++..|+-.+|.+||+++.++
T Consensus 235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1111 111234556788899999999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=234.69 Aligned_cols=272 Identities=19% Similarity=0.223 Sum_probs=205.0
Q ss_pred ccCHHHHHHHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC------CCceeee
Q 003489 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ------HRNLVRL 556 (816)
Q Consensus 484 ~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 556 (816)
.+.+.|+ ...+|.+....|+|-|++|.+|..+ .|..||||++++. ..-.+.=+.|+++|++|. --|.+++
T Consensus 423 rv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 423 RVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3444443 4578999999999999999999854 4789999999653 223344568999999995 3489999
Q ss_pred eeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-C
Q 003489 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-N 635 (816)
Q Consensus 557 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~ 635 (816)
+..|...++++||+|-+ .-+|.+.|+.......|....+..++.|+.-||..|...+ |+|.||||.|||+++.. .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 99999999999999987 6789999987767777899999999999999999999988 99999999999998765 6
Q ss_pred ceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHH-
Q 003489 636 PKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA- 714 (816)
Q Consensus 636 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~- 714 (816)
+||||||.|.....+. .+....+.-|.|||++.+..|+...|+||.||+||||.||+..|+......-+.+.-..
T Consensus 576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 8999999997653322 22233456799999999999999999999999999999999988765443222221110
Q ss_pred ----HHhhccC-------------------C--------ccccccc------cccc-----cccHHHHHHHHHHHHHhhh
Q 003489 715 ----WKLWNDN-------------------N--------VIDLVDP------LISE-----SGFKMEIIRCVNVGLLCVQ 752 (816)
Q Consensus 715 ----~~~~~~~-------------------~--------~~~l~d~------~l~~-----~~~~~~~~~l~~l~~~Cl~ 752 (816)
.+++..+ . +...+.| .|.+ ......+..+.+|...|+.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 1111110 0 1111222 1111 1123345677788889999
Q ss_pred cCCCCCCChHHHHH
Q 003489 753 EFVKDRPNMPTVVS 766 (816)
Q Consensus 753 ~~P~~RPt~~evl~ 766 (816)
.||++|-|..+.++
T Consensus 732 LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 732 LDPEKRITVNQALK 745 (752)
T ss_pred cChhhcCCHHHHhc
Confidence 99999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-25 Score=214.89 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=186.2
Q ss_pred hcCcccccccCCCCceeEEEeEec-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeE-EEecCcceEEE
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGC-CVEREENMLIY 570 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~ 570 (816)
.+.|.+.+.||+|.||.+-++.++ ..+.+|+|.+... ...+++|.+|...--.| .|.||+.-+.. |+..+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 357889999999999999999865 5778999988543 34567899998766556 48999988765 45566667999
Q ss_pred eeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc-C-CCCceeeccccceecC
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-D-DLNPKISDFGLARIFG 648 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~-~~~~kl~DfGla~~~~ 648 (816)
||+|.|+|.+-+.. ..+.+.-..+++.|+++|+.|+|+.+ +||||||.+||||- . ..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887733 34677778899999999999999998 99999999999993 3 3489999999987643
Q ss_pred CCCcccccccccccccccChhccccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
. .......+..|.|||..... ...+.+|||.||++++.++||+.|+..... .+...|-+..|..+..
T Consensus 175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRKN 246 (378)
T ss_pred c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcccC
Confidence 2 12223345679999987543 235678999999999999999999863221 1222334444444443
Q ss_pred cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
..+.+. ...-.++++++-.+-+.++|++|=-..++.++....
T Consensus 247 ~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 247 PALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 322211 111234555666678889999996667766665433
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=189.54 Aligned_cols=113 Identities=42% Similarity=0.700 Sum_probs=98.4
Q ss_pred ccccCCCcEEecCCeEEEeeecCCCCCCceEEEEEEecCCCCCceEEEecCCCCCCcCCCceEEEecCCCeEEecCCCcE
Q 003489 31 QFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQV 110 (816)
Q Consensus 31 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~ 110 (816)
+.|..|+.|+|++|.|++|||.+.. ...+.+|||+. .+ .++||+||++.|+.+ .+.|.++.||+|+|+|.+|.+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~--q~dgnlV~~~~--~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~ 75 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM--QNDYNLILYKS--SS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRV 75 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC--CCCEEEEEEEC--CC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCE
Confidence 5688899999999999999999965 47899999998 34 589999999999755 478999999999999999999
Q ss_pred EEEeeccccccCccceEEEccCCcEEEEecCCcceeeccccC
Q 003489 111 HWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE 152 (816)
Q Consensus 111 ~wst~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqsFD~ 152 (816)
+|+|++. .+.+..+|+|+|+|||||++. .+.+|||||||
T Consensus 76 vW~S~t~--~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~ 114 (114)
T smart00108 76 VWSSNTT--GANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY 114 (114)
T ss_pred EEEeccc--CCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence 9999985 234567899999999999998 44689999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=263.04 Aligned_cols=196 Identities=19% Similarity=0.250 Sum_probs=139.3
Q ss_pred hcCC-CceeeeeeEE-------EecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcE
Q 003489 547 NLQH-RNLVRLLGCC-------VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618 (816)
Q Consensus 547 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 618 (816)
.++| +||+++++.| .+....++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888877 2334556778887 66999999543 345899999999999999999999998 9
Q ss_pred EEeeeCCCcEEEcC-------------------CCCceeeccccceecCCCCc--------------ccccccccccccc
Q 003489 619 IHRDLKASNILLDD-------------------DLNPKISDFGLARIFGGNQD--------------QAATKRLVGTYGY 665 (816)
Q Consensus 619 vH~Dlkp~NILl~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 665 (816)
+||||||+||||+. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45667777777764321000 0001123578899
Q ss_pred cChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHH
Q 003489 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVN 745 (816)
Q Consensus 666 ~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~ 745 (816)
||||++.+..++.++|||||||+||||++|..|+...... ....... .+++.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~~---------~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRHR---------VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHHh---------hcChhh-----hhcCHHHHH
Confidence 9999999999999999999999999999988775321110 0000000 011110 112334567
Q ss_pred HHHHhhhcCCCCCCChHHHHH
Q 003489 746 VGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 746 l~~~Cl~~~P~~RPt~~evl~ 766 (816)
++.+|++++|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 788999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=219.42 Aligned_cols=201 Identities=26% Similarity=0.473 Sum_probs=167.0
Q ss_pred HHHHhcCcccccccCCCCceeEEEeEec----CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecC
Q 003489 490 LANATNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE 564 (816)
Q Consensus 490 l~~~~~~f~~~~~LG~G~~g~Vy~g~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 564 (816)
+....+.|...++||+|.|++||++.+. ..+.||+|.+... .....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445678999999999999999999753 3678999998654 34456889999999995 999999999999999
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-CCceeecccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGL 643 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfGl 643 (816)
...+|+||+++....+++. .++...+..+++.+++||+++|.+| ||||||||+|+|.+.. +.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999988883 3678899999999999999999999 9999999999999764 5789999999
Q ss_pred ceecCCCC-------------cc-----------------------------cccccccccccccChhccccC-CCCchh
Q 003489 644 ARIFGGNQ-------------DQ-----------------------------AATKRLVGTYGYMSPEYAMEG-RFSEKS 680 (816)
Q Consensus 644 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ks 680 (816)
|......+ .. .......||++|.|||++... ..+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321100 00 000123699999999998754 578999
Q ss_pred hhHHHHHHHHHHHhCCCCCCC
Q 003489 681 DVFSFGVLLLEIVSGRKNTSF 701 (816)
Q Consensus 681 DV~SlG~vl~elltG~~p~~~ 701 (816)
||||-|++++-+++++.||-.
T Consensus 260 Diws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ceeeccceeehhhcccccccc
Confidence 999999999999999999754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=200.14 Aligned_cols=166 Identities=20% Similarity=0.143 Sum_probs=124.0
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccc
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 655 (816)
|+|.+++... ...+++.+++.++.||++||+|||+.+ ||+|||++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6788888532 346999999999999999999999875 999999999999999 99998753321
Q ss_pred cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccc
Q 003489 656 TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESG 735 (816)
Q Consensus 656 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 735 (816)
..|++.|+|||++.+..++.++||||||+++|||++|+.|+....... ..+....... .... +.. ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~~------~~~--~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGM-PADD------PRD--RS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHh-ccCC------ccc--cc
Confidence 267899999999999999999999999999999999999975432211 1111111111 0000 000 00
Q ss_pred cHHHH---HHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 736 FKMEI---IRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 736 ~~~~~---~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
..... ..+.+++.+|++.+|++||++.|+++.+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11111 2588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=213.33 Aligned_cols=167 Identities=20% Similarity=0.236 Sum_probs=130.3
Q ss_pred HHhcCcccccccCCCCceeEEEeEec--CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCceeeeeeEEEecC
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE 564 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 564 (816)
...++|++.+.||+|+||+||+|..+ +++.||||++... .....+.|.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45578999999999999999999864 4777899987532 12235678999999999999999864332 24
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeee-CCCcEEEcCCCCceeecccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL-KASNILLDDDLNPKISDFGL 643 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DfGl 643 (816)
..++||||+++++|.... .. . ...++.+++++|+|||+.+ |+|||| ||+|||++.++.++|+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 679999999999996321 11 1 1467889999999999998 999999 99999999999999999999
Q ss_pred ceecCCCCcccc------cccccccccccChhccccC
Q 003489 644 ARIFGGNQDQAA------TKRLVGTYGYMSPEYAMEG 674 (816)
Q Consensus 644 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 674 (816)
++.+........ .....+++.|+|||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998754322111 1345778899999998654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=208.65 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=193.5
Q ss_pred CcccccccCCCCceeEEEeEecCC--cEEEEEEecccCchhHHHHHHHHHHHhhcCC----CceeeeeeEE-EecCcceE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQDG--QEIAVKRLSKASGQGQEEFMNEVMVISNLQH----RNLVRLLGCC-VEREENML 568 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 568 (816)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999986543 4788888765543333378889999998873 6899999988 47778899
Q ss_pred EEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-----CCceeecccc
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-----LNPKISDFGL 643 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DfGl 643 (816)
||+.+ |.+|.++..... ...++..++++++.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999774433 567899999999999999999999999 9999999999999765 3689999999
Q ss_pred ce--ecCCCCcc----c-c-cccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHH
Q 003489 644 AR--IFGGNQDQ----A-A-TKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 644 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~ 715 (816)
++ .+...... . . .....||..|++++...+...+.+.|+||++.++.|++.|..|+................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 43222111 1 1 223569999999999999999999999999999999999999985443321111111000
Q ss_pred HhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccC
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 774 (816)
....... .....+.+. .++..-+-..+..++|....+...|.+....
T Consensus 254 -------~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 -------RKLLTDR--FGDLKPEEF---AKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -------hhhcccc--ccCCChHHH---HHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0001000 111122333 3333344457889999999999998777544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-22 Score=194.36 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=185.6
Q ss_pred cccccCCCCceeEEEeEecCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCC
Q 003489 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+..+|.+...|..|+|+++ |..+++|++.. .+....+.|.+|.-.|+.+.||||+.++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3458999999999999998 66677787743 23334567999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccccc
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 656 (816)
+|...|++. ..-..+..++.+++.+||+|++|||+..+ -|----|.++.+++|++.+++|+- +-+++.. +.
T Consensus 273 slynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfsf--qe---- 343 (448)
T KOG0195|consen 273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFSF--QE---- 343 (448)
T ss_pred HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceeee--ec----
Confidence 999999764 34467888999999999999999999862 233446899999999999888752 1111110 00
Q ss_pred ccccccccccChhccccCCCC---chhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccc
Q 003489 657 KRLVGTYGYMSPEYAMEGRFS---EKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 657 ~~~~gt~~y~aPE~~~~~~~s---~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
....-.+.||+||.++..+-+ ..+|+|||+++||||.|..-||....+-+- ..+..-++.. -.+
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmkialeglr-v~i------ 410 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKIALEGLR-VHI------ 410 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhhhhcccc-ccC------
Confidence 011235789999999876543 578999999999999999999876555321 1111111111 111
Q ss_pred cccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
++-....+.+++.-|+..||.+||.+..|+-.||+.
T Consensus 411 --ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 411 --PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 122344566777789999999999999999999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=190.54 Aligned_cols=264 Identities=19% Similarity=0.275 Sum_probs=199.3
Q ss_pred cCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEee
Q 003489 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
-+|++.++||+|+||.++.|+ +-+++.||||.-... ...-++..|....+.|. .++|..++.+..++.+..||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999998 557999999976443 23456788998888884 79999999999999999999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-----CCceeeccccceec
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-----LNPKISDFGLARIF 647 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DfGla~~~ 647 (816)
+ |-+|+++..= ....++.+++..+|.|++.-++|+|+.. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 8888887632 2345899999999999999999999998 9999999999999654 35899999999988
Q ss_pred CCCCcc-----cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCC
Q 003489 648 GGNQDQ-----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 648 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
.+.... .......||.+||+-.-..+...+.+.|+-|+|-++++.|-|..||............+.+ .+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI----Ge~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI----GETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh----cccc
Confidence 765432 2344578999999999999999999999999999999999999998654433222211111 1221
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCC
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l 775 (816)
...-++... .+.++++..-++.++. .+-.+-|...-+...+..++..+
T Consensus 256 r~T~i~~Lc--~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 256 RSTPIEVLC--EGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ccCCHHHHH--hcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhc
Confidence 111122122 2356666666666553 34566777776666665554433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=182.17 Aligned_cols=265 Identities=20% Similarity=0.289 Sum_probs=195.8
Q ss_pred hcCcccccccCCCCceeEEEeE-ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC-CceeeeeeEEEecCcceEEEe
Q 003489 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 571 (816)
.++|.+.++||.|+||.+|.|. +.+|++||||.-+... ...++.-|..+.+.|+| ..|..+..+..++....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999998 6789999999865443 34567788999999975 688888999999999999999
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC---CCCceeeccccceecC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFG 648 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfGla~~~~ 648 (816)
.+ |-+|.++..-. ...++..+++-++-|++.-++|+|..+ ++||||||+|+|+.- ...+.++||||++.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 88888877432 234788999999999999999999998 999999999999854 3578999999999875
Q ss_pred CCCcc-----cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc
Q 003489 649 GNQDQ-----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 649 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
+.... .......||.+|.+-....+...+.+.|+-|+|.+|....-|..||..........-.+.+.+. +.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----KM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----hc
Confidence 54322 1223468999999988888888899999999999999999999999765554333322222221 11
Q ss_pred cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhccccCC
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~l 775 (816)
.-.+...-+ +.+.| +...+.-|-+.--++-|...-+.+++.-+...+
T Consensus 242 s~~ie~LC~--G~P~E---F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 242 STPIEVLCK--GFPAE---FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCCHHHHhC--CCcHH---HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 111111111 12222 223333466666677777776666665444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-19 Score=192.71 Aligned_cols=261 Identities=28% Similarity=0.406 Sum_probs=196.7
Q ss_pred cccccccCCCCceeEEEeEecCCcEEEEEEecccCch---hHHHHHHHHHHHhhcCCC-ceeeeeeEEEecCcceEEEee
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQHR-NLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 572 (816)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999876 78899998765433 367899999999999988 799999999777777999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC-CceeeccccceecCCCC
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQ 651 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 651 (816)
+.++++.+++........+.......++.|++.+++|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977643221136888899999999999999999998 99999999999999998 79999999998664433
Q ss_pred ccc----ccccccccccccChhcccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCchh-hhhhHHHHHHHhhccCCc
Q 003489 652 DQA----ATKRLVGTYGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE-FELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 652 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 723 (816)
... ......++..|+|||.+.. ...+...|+||+|++++++++|..|+...... ............... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 3456789999999999987 57889999999999999999999996544321 011111111111110 00
Q ss_pred cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHH
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~ 767 (816)
.....+.. .......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 01223456677888999999999999887663
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=179.41 Aligned_cols=139 Identities=16% Similarity=0.152 Sum_probs=109.1
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCch--h-------HHH-----------------HHHHHHHHhhcCCCce
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--G-------QEE-----------------FMNEVMVISNLQHRNL 553 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 553 (816)
...||+|+||.||+|...+|+.||||+++..... . ... ...|+.++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999654211 1 112 2349999999988877
Q ss_pred eeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHH-HhcCCCcEEEeeeCCCcEEEcC
Q 003489 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL-HRDSRLRIIHRDLKASNILLDD 632 (816)
Q Consensus 554 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivH~Dlkp~NILl~~ 632 (816)
.....+. ....++||||++++++...+. ....++..+..+++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 5443332 233489999999887765432 234688899999999999999999 6877 99999999999998
Q ss_pred CCCceeeccccceec
Q 003489 633 DLNPKISDFGLARIF 647 (816)
Q Consensus 633 ~~~~kl~DfGla~~~ 647 (816)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-20 Score=214.99 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=183.8
Q ss_pred cccccCCCCceeEEEeEe-cCCcEEEEEEeccc--Cchh----HHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEe
Q 003489 499 LANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQG----QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 571 (816)
..+.+|.|++|.|+.... ...+..+.|..+.. .... ...+..|+.+-..++|+|++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999997777653 23333444433210 1111 1225567777788999999888887777776666699
Q ss_pred eCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCC
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 651 (816)
|+++ +|..++... ..+...++..++.|++.|++|||+.| |.|||||++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999998432 35788889999999999999999999 9999999999999999999999999998775554
Q ss_pred cc--cccccccccccccChhccccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcccccc
Q 003489 652 DQ--AATKRLVGTYGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 652 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
+. ......+|...|+|||.+....|.+. .||||.|+++..|++|+.||-....+.... .. .......++..-.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~--~~~~~~~~~~~~~- 550 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT--NNYSDQRNIFEGP- 550 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh--hccccccccccCh-
Confidence 44 44556889999999999999999875 799999999999999998886544332211 00 0000000000000
Q ss_pred ccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..-......+...++.++++.+|.+|-||++|++
T Consensus 551 ----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 ----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0011223456668888999999999999999976
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=183.32 Aligned_cols=171 Identities=13% Similarity=0.172 Sum_probs=134.4
Q ss_pred HhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHH---------HHHHHHHHhhcCCCceeeeeeEEEec
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE---------FMNEVMVISNLQHRNLVRLLGCCVER 563 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 563 (816)
..++|++.+.||.|+||.||+... ++..+|||.+++......+. +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999655 57789999997654333322 67899999999999999999886643
Q ss_pred --------CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCC
Q 003489 564 --------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635 (816)
Q Consensus 564 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 635 (816)
...+|+|||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||++|+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 34689999999999987641 222 34569999999999998 99999999999999988
Q ss_pred ceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHH
Q 003489 636 PKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 693 (816)
Q Consensus 636 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ell 693 (816)
++|+|||........... ..+.....+..++|+|+||+++....
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754211110 11344555667999999999987664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-20 Score=209.77 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=183.3
Q ss_pred CcccccccCCCCceeEEEeEecCCcEEEEEEecccC-chhHHHHHHHHHH--HhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS-GQGQEEFMNEVMV--ISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
++...+.||.+.|=+|.+++.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-.-...+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998777 8899886543 3445556555444 4455899999998887777788899998
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
. ..+|.|.| ..++.+...+...|+.|++.||..+|..+ |+|||||.+||||+.-.-+.|+||...+...-+.+
T Consensus 103 v-khnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 V-KHNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred H-hhhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8 56888887 45567888888999999999999999998 99999999999999999999999998765433322
Q ss_pred ccc-c----ccccccccccChhccccC----------C-CCchhhhHHHHHHHHHHHhC-CCCCCCCchhhhhhHHHHHH
Q 003489 653 QAA-T----KRLVGTYGYMSPEYAMEG----------R-FSEKSDVFSFGVLLLEIVSG-RKNTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 653 ~~~-~----~~~~gt~~y~aPE~~~~~----------~-~s~ksDV~SlG~vl~elltG-~~p~~~~~~~~~~~l~~~~~ 715 (816)
... . .....-..|+|||.+... . .+++-||||+||++.||++- +++|.. ..|..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH--
Confidence 211 1 122334579999987431 1 67889999999999999985 555541 111111
Q ss_pred HhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcc
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 771 (816)
+..+......++ ++ -+...+.++++.|++.||++|-++++.++...+.
T Consensus 248 r~~~~~~~e~~L----e~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 RSGNADDPEQLL----EK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hccCccCHHHHH----Hh----CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111111111111 00 0112566888999999999999999999986555
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=172.97 Aligned_cols=140 Identities=19% Similarity=0.227 Sum_probs=111.5
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCch---------------------h-----HHHHHHHHHHHhhcCCCce
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ---------------------G-----QEEFMNEVMVISNLQHRNL 553 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 553 (816)
...||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1224678999999999988
Q ss_pred eeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcC
Q 003489 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDD 632 (816)
Q Consensus 554 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~ 632 (816)
.....+... ..+|||||++++++..... ....++.....+++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555444333 3589999999886543321 22346778899999999999999999 88 99999999999999
Q ss_pred CCCceeeccccceecC
Q 003489 633 DLNPKISDFGLARIFG 648 (816)
Q Consensus 633 ~~~~kl~DfGla~~~~ 648 (816)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=192.21 Aligned_cols=218 Identities=25% Similarity=0.358 Sum_probs=165.0
Q ss_pred HhhcCCCceeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeC
Q 003489 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK 624 (816)
Q Consensus 545 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 624 (816)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|++||+|||... -.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999965 3345899999999999999999999865 13999999
Q ss_pred CCcEEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccC-------CCCchhhhHHHHHHHHHHHhCCC
Q 003489 625 ASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVSGRK 697 (816)
Q Consensus 625 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SlG~vl~elltG~~ 697 (816)
++|+++|....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876432112222223345679999998653 14678999999999999999999
Q ss_pred CCCCCchhhh-hhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhcccc
Q 003489 698 NTSFYHEEFE-LTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 698 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 773 (816)
||+....... .+++..+.. .-.....|.+.... +..+.++.++..||..+|++||++.+|-..++...+
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9876432221 233333222 11122223222111 233468888999999999999999999998877744
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=171.76 Aligned_cols=233 Identities=20% Similarity=0.208 Sum_probs=149.8
Q ss_pred CcccccccCCCCceeEEEeEec-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCC----------CceeeeeeEEE
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQH----------RNLVRLLGCCV 561 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 561 (816)
.+...+.||.|+++.||.++.. +++++|||++.-. .....+.+++|.-.+..+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556789999999999999976 4899999987432 33456778888766666433 12222222221
Q ss_pred ---------ecC--------cceEEEeeCCCCCcccccc---CC-CCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEE
Q 003489 562 ---------ERE--------ENMLIYEYMPNKSLDSFLF---DP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620 (816)
Q Consensus 562 ---------~~~--------~~~lV~e~~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 620 (816)
... ..+++|+-+ .++|.+++. .. +....+....++.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 225677776 677777753 11 11233455566778899999999999999 999
Q ss_pred eeeCCCcEEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccC--------CCCchhhhHHHHHHHHHH
Q 003489 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG--------RFSEKSDVFSFGVLLLEI 692 (816)
Q Consensus 621 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDV~SlG~vl~el 692 (816)
+||+|+|++++++|.++|+||+.....+.... ....+..|.|||..... .++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998876432111 12445789999977442 478899999999999999
Q ss_pred HhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCC
Q 003489 693 VSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDR 758 (816)
Q Consensus 693 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 758 (816)
++|..|+....++..... .-..+. +-.+.+..++..+++.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999876544322110 112233 445566677789999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=161.85 Aligned_cols=184 Identities=21% Similarity=0.163 Sum_probs=138.6
Q ss_pred cccccCCCCceeEEEeEecCCcEEEEEEecccCchh----HHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEeeC
Q 003489 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG----QEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 57888888776543311 125889999999995 5889999886 4569999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeee-CCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL-KASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
+|.+|...+. . ....++.|++.+|+++|+.+ |+|||| ||.|||+++++.++|+|||++........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998865431 0 12357789999999999999 999999 79999999999999999999986543321
Q ss_pred c----c-------ccccccccccccChhccccC-CCC-chhhhHHHHHHHHHHHhCCCCCC
Q 003489 653 Q----A-------ATKRLVGTYGYMSPEYAMEG-RFS-EKSDVFSFGVLLLEIVSGRKNTS 700 (816)
Q Consensus 653 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~SlG~vl~elltG~~p~~ 700 (816)
. . .......++.|++|+...-. ..+ ...+.++-|.-+|.++|+..+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 01112357788888754322 233 56789999999999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.4e-18 Score=197.20 Aligned_cols=198 Identities=20% Similarity=0.256 Sum_probs=161.1
Q ss_pred HHHhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC---CCceeeeeeEEEecCcce
Q 003489 491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENM 567 (816)
Q Consensus 491 ~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 567 (816)
......|.+.+.||+|+||+||+|...+|+.||+|.-+...... |.--.+++.+|+ -+.|..+..++.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34557899999999999999999998889999999887654321 111122333443 345666666677778889
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-------CCCceeec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-------DLNPKISD 640 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~kl~D 640 (816)
||+||.+.|+|.+++. ..+..+|..++.++.|+++.+++||..+ |||+||||+|.||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999995 5567899999999999999999999998 999999999999943 34689999
Q ss_pred cccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCC
Q 003489 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697 (816)
Q Consensus 641 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~ 697 (816)
||-+-.+..-.+.......++|-.+--+|...+..++.++|.|.|+-+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999876544444455666788899999999999999999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=162.61 Aligned_cols=134 Identities=19% Similarity=0.267 Sum_probs=104.8
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhc-----CCCceeeeeeEEEecC---cce-EEE
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----QHRNLVRLLGCCVERE---ENM-LIY 570 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lV~ 570 (816)
.+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|++.+.. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 56899999999996 433333479988665445667899999999999 5799999999998874 223 789
Q ss_pred ee--CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHH-HHHHhcCCCcEEEeeeCCCcEEEcCC----CCceeecccc
Q 003489 571 EY--MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL-LYLHRDSRLRIIHRDLKASNILLDDD----LNPKISDFGL 643 (816)
Q Consensus 571 e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DfGl 643 (816)
|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 5679999999432 24444 35677888777 9999998 9999999999999743 3799999544
Q ss_pred c
Q 003489 644 A 644 (816)
Q Consensus 644 a 644 (816)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-17 Score=183.61 Aligned_cols=186 Identities=27% Similarity=0.338 Sum_probs=155.3
Q ss_pred ccCCCCceeEEEeE----ecCCcEEEEEEecccCchh--HHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEeeCC
Q 003489 502 KLGQGGFGPVYKGK----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~----~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 574 (816)
.+|+|.||.|++.+ .+.+..+|+|.+++..... ......|..++..++ ||.+|++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999864 2346778888886643211 125567888888887 9999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 654 (816)
+|.|...+. .....+......+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999988773 3445677777888899999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 701 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~ 701 (816)
..+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999987 677889999999999999999999764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=160.47 Aligned_cols=143 Identities=18% Similarity=0.199 Sum_probs=111.8
Q ss_pred cCcccccccCCCCceeEEEeE--ecCCcEEEEEEecccCch------------------------hHHHHHHHHHHHhhc
Q 003489 495 NNFQLANKLGQGGFGPVYKGK--LQDGQEIAVKRLSKASGQ------------------------GQEEFMNEVMVISNL 548 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 548 (816)
..|++.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 458889999999999999998 568999999998643210 112356899999999
Q ss_pred CCCc--eeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCC
Q 003489 549 QHRN--LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKAS 626 (816)
Q Consensus 549 ~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~ 626 (816)
.+.+ +.+++.. ...++||||+++.+|...+.. ...+.......++.||+.+|++||+.+ .++||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 7633 4444442 245899999999888766422 233556667899999999999999886 4999999999
Q ss_pred cEEEcCCCCceeeccccceec
Q 003489 627 NILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 627 NILl~~~~~~kl~DfGla~~~ 647 (816)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=158.64 Aligned_cols=134 Identities=22% Similarity=0.331 Sum_probs=113.9
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCch--------hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--------GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|++++....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5788999976543211 124578899999999999998888888888888999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 12 78899999999999999998 99999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.4e-16 Score=154.73 Aligned_cols=144 Identities=21% Similarity=0.235 Sum_probs=112.7
Q ss_pred HHHHHHhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCc----------------------hhHHHHHHHHHHH
Q 003489 488 EELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG----------------------QGQEEFMNEVMVI 545 (816)
Q Consensus 488 ~el~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l 545 (816)
.++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445788899999999999999988899999998754220 0112367789999
Q ss_pred hhcCCCc--eeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Q 003489 546 SNLQHRN--LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL 623 (816)
Q Consensus 546 ~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dl 623 (816)
..+.|++ ++..++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 345689999999999876542 1345678899999999999988 999999
Q ss_pred CCCcEEEcCCCCceeeccccceec
Q 003489 624 KASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 624 kp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+|+||++++++.++|+|||++...
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=154.14 Aligned_cols=130 Identities=24% Similarity=0.364 Sum_probs=107.7
Q ss_pred ccCCCCceeEEEeEecCCcEEEEEEecccCc--------hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeC
Q 003489 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASG--------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.||+|++|.||+|.+ ++..|++|....... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 478899998643211 12356788999999999988776666677777789999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+|++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873211 078999999999999998 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=177.08 Aligned_cols=137 Identities=22% Similarity=0.331 Sum_probs=112.7
Q ss_pred hcCcccccccCCCCceeEEEeEecCCcEEEEEE-ecccCc-------hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCc
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR-LSKASG-------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 565 (816)
...|...+.||+|+||.||+|.+... .+++|+ +.+... ...+.+.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556678999999999999987644 444443 222111 123568899999999999999998888888888
Q ss_pred ceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998873 45789999999999999998 9999999999999 67899999999997
Q ss_pred e
Q 003489 646 I 646 (816)
Q Consensus 646 ~ 646 (816)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=156.41 Aligned_cols=197 Identities=22% Similarity=0.285 Sum_probs=134.3
Q ss_pred CCCceeeeeeEEEe---------------------------cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHH
Q 003489 549 QHRNLVRLLGCCVE---------------------------REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601 (816)
Q Consensus 549 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 601 (816)
+|||||++.++|.+ ....|+||..+ ..+|.+++. ....+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence 59999999988764 22347888777 457888883 23356667778999
Q ss_pred HHHHHHHHHHhcCCCcEEEeeeCCCcEEE--cCCC--CceeeccccceecCCC--Cc--ccccccccccccccChhcccc
Q 003489 602 GISRGLLYLHRDSRLRIIHRDLKASNILL--DDDL--NPKISDFGLARIFGGN--QD--QAATKRLVGTYGYMSPEYAME 673 (816)
Q Consensus 602 ~ia~aL~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~~kl~DfGla~~~~~~--~~--~~~~~~~~gt~~y~aPE~~~~ 673 (816)
|+++|+.|||+++ |.|||+|++|||+ |+++ .+.|+|||.+-.-... +- ....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999998 4444 5788999987542210 00 011112457788999998864
Q ss_pred CC------CCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHH
Q 003489 674 GR------FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVG 747 (816)
Q Consensus 674 ~~------~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~ 747 (816)
.+ .-.|+|.|+.|-+.||++....||....+. ..+... ..+..+ |.+. ....+.+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qL-----Palp----~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQL-----PALP----SRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhC-----CCCc----ccCChHHHHHH
Confidence 33 235899999999999999999898642221 111110 011111 1111 11234566888
Q ss_pred HHhhhcCCCCCCChHHHHHHH
Q 003489 748 LLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 748 ~~Cl~~~P~~RPt~~evl~~L 768 (816)
...++.||++||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 899999999999877665555
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.9e-16 Score=169.75 Aligned_cols=124 Identities=31% Similarity=0.489 Sum_probs=109.3
Q ss_pred cceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..++.|+++...+|.++|.........++.....++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999776666778899999999999999999 55 999999999999999999999999998
Q ss_pred eecCCCC----cccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHh
Q 003489 645 RIFGGNQ----DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694 (816)
Q Consensus 645 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~ellt 694 (816)
....... .....+...||..||+||.+.+..|+.|+|||+||++|+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7654333 2334556789999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-14 Score=134.80 Aligned_cols=135 Identities=22% Similarity=0.239 Sum_probs=115.1
Q ss_pred cccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC--CceeeeeeEEEecCcceEEEeeCCCC
Q 003489 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH--RNLVRLLGCCVEREENMLIYEYMPNK 576 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 576 (816)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999864 7899998865433 5678999999999976 58999999888888899999999888
Q ss_pred CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566778899999999999987545699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.3e-14 Score=142.03 Aligned_cols=136 Identities=21% Similarity=0.234 Sum_probs=98.6
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCch--hHHH----------------------HHHHHHHHhhcCCCc--e
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--GQEE----------------------FMNEVMVISNLQHRN--L 553 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 553 (816)
.+.||+|+||.||++...+++.||||++...... .... ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 135666666665443 4
Q ss_pred eeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-cCCCcEEEeeeCCCcEEEcC
Q 003489 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDD 632 (816)
Q Consensus 554 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~ 632 (816)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 34689999999965432211100 011 5678899999999999999 77 99999999999999
Q ss_pred CCCceeeccccceec
Q 003489 633 DLNPKISDFGLARIF 647 (816)
Q Consensus 633 ~~~~kl~DfGla~~~ 647 (816)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=167.90 Aligned_cols=227 Identities=19% Similarity=0.221 Sum_probs=145.8
Q ss_pred hcCcccccccCCCCceeEEEeEecC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..+|..+++|..|+||.||..+++. .+.+|+|+-++.. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 4688899999999999999998764 5667885432110 1110 22222233332
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCc
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 652 (816)
|+=...++ ..+.++.. .+.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+.+.......
T Consensus 136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 23233332 22233322 278999999998 99999999999999999999999999875321100
Q ss_pred -------------ccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhc
Q 003489 653 -------------QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN 719 (816)
Q Consensus 653 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 719 (816)
+-.....+||+.|+|||++..+.|....|.|++|+++||.+.|+-||....+++-..........|.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 1112346899999999999999999999999999999999999999876655432211111111111
Q ss_pred cCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCC-ChHHHHHHHhccccCCCC
Q 003489 720 DNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP-NMPTVVSMLNSEIKDLPA 777 (816)
Q Consensus 720 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~~l~~ 777 (816)
++ | ....++..+++.+.++.+|..|- |..+..-+=++.++.+++
T Consensus 279 E~------d--------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 279 EE------D--------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred cc------C--------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 11 1 11223455666688899999994 333333333444455544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=142.14 Aligned_cols=134 Identities=22% Similarity=0.311 Sum_probs=104.4
Q ss_pred cccC-CCCceeEEEeEecCCcEEEEEEecccC-------------chhHHHHHHHHHHHhhcCCCce--eeeeeEEEecC
Q 003489 501 NKLG-QGGFGPVYKGKLQDGQEIAVKRLSKAS-------------GQGQEEFMNEVMVISNLQHRNL--VRLLGCCVERE 564 (816)
Q Consensus 501 ~~LG-~G~~g~Vy~g~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 564 (816)
..|| .|+.|+||+.... +..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 7888889988875 7789999875311 1234568889999999998875 67777654433
Q ss_pred c----ceEEEeeCCC-CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceee
Q 003489 565 E----NMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639 (816)
Q Consensus 565 ~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 639 (816)
. .++|+|++++ .+|.+++.+ ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688888743 233432 3678999999999999 9999999999999999999999
Q ss_pred cccccee
Q 003489 640 DFGLARI 646 (816)
Q Consensus 640 DfGla~~ 646 (816)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-14 Score=167.14 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=186.1
Q ss_pred cCcccccccCCCCceeEEEeEecC--CcEEEEEEecccC--chhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEE
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD--GQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 569 (816)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++.+++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777889999999998886533 3446777665443 223344455777777776 99999999999999999999
Q ss_pred EeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHH-hcCCCcEEEeeeCCCcEEEcCCC-Cceeeccccceec
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH-RDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF 647 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 647 (816)
.+|..++++.+.+.... ....+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999998884221 113455566778999999999999 777 99999999999999999 9999999999988
Q ss_pred CC-CCcccccccccc-cccccChhccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCcc
Q 003489 648 GG-NQDQAATKRLVG-TYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 648 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|. +....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~-----~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWK-----SNKGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeec-----ccccc
Confidence 76 455555556778 9999999998874 4467899999999999999999998765543211 11111 01000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..............++...++..+|+.|.+.+++..
T Consensus 250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000001111223445556777789999998887743
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-13 Score=109.83 Aligned_cols=59 Identities=46% Similarity=1.016 Sum_probs=51.2
Q ss_pred cCCCCeEEeeecCCccccccc---CCchhhHHHhhhccCCcceeecc---CcceeEEeeeccccc
Q 003489 337 GKQDGFFKLETMKVPYFAERS---SANEDKCKDQCSNNCSCKAYAYE---IGVGCMIWTHNLIDI 395 (816)
Q Consensus 337 ~~~~~f~~~~~~~~p~~~~~~---~~~~~~C~~~Cl~nCsC~a~~~~---~~~gc~~~~~~l~~~ 395 (816)
+.+|+|+++++|++|++.... ..+.++|++.|++||||+||+|. ++++|.+|+++|+|+
T Consensus 2 ~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 2 GSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred cCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 457999999999999986544 24559999999999999999998 579999999999884
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.4e-12 Score=144.83 Aligned_cols=141 Identities=23% Similarity=0.271 Sum_probs=101.6
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhH----------------------------------------HHHH
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ----------------------------------------EEFM 539 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~ 539 (816)
.+.||.|++|.||+|++++|+.||||+.++...... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865321110 1245
Q ss_pred HHHHHHhhcC----CCceeeeeeEE-EecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHH-HHHHHHhc
Q 003489 540 NEVMVISNLQ----HRNLVRLLGCC-VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR-GLLYLHRD 613 (816)
Q Consensus 540 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~ 613 (816)
+|+..+.+++ |.+-+.+-..+ ......+|||||++|++|.++...... .. .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666665552 33333333333 334567999999999999887632111 11 34567777766 47888988
Q ss_pred CCCcEEEeeeCCCcEEEcCCCCceeeccccceecC
Q 003489 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 614 ~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 648 (816)
+ ++|+|++|.||++++++.+++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.2e-12 Score=131.34 Aligned_cols=204 Identities=22% Similarity=0.252 Sum_probs=139.6
Q ss_pred HHHHhhcCCCceeeeeeEEEecC-----cceEEEeeCCCCCccccccCCC-CCCCCChhHHHHHHHHHHHHHHHHHhcCC
Q 003489 542 VMVISNLQHRNLVRLLGCCVERE-----ENMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSR 615 (816)
Q Consensus 542 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 615 (816)
..-|-.+.|.|||++..|..+.+ ...++.|||..|+|..+|++.+ .+..+......+++.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34555677999999999876544 3478999999999999997643 3456778888899999999999999975
Q ss_pred CcEEEeeeCCCcEEEcCCCCceeeccccceecCC---CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHH
Q 003489 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGG---NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 692 (816)
Q Consensus 616 ~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~el 692 (816)
++|+|+++..+-|++..++-+|+.- +....... ...........+.++|.|||+-...+.+..+|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 7899999999999999998888742 11111100 0011112234567899999988777888899999999999999
Q ss_pred HhCCCCCCCCc-h-hhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHH
Q 003489 693 VSGRKNTSFYH-E-EFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768 (816)
Q Consensus 693 ltG~~p~~~~~-~-~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L 768 (816)
.-+........ . +.+..+.. -+..+-+++- ...+..|++.+|..||+|++++...
T Consensus 276 ailEiq~tnseS~~~~ee~ia~---------~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIAN---------VIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeehhhhhhh---------heeeccCccc------------cCcCcccccCCCCCCcchhhhhcCc
Confidence 88764311110 0 00000000 0000111111 1345579999999999999886543
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-12 Score=106.33 Aligned_cols=69 Identities=23% Similarity=0.433 Sum_probs=60.6
Q ss_pred cCCCCeEEeeecCCcccccccCCchhhHHHhhhc---cCCcceeecc-CcceeEEeeecc-ccccccCCCCcceeee
Q 003489 337 GKQDGFFKLETMKVPYFAERSSANEDKCKDQCSN---NCSCKAYAYE-IGVGCMIWTHNL-IDIRKLPSGGTNLYIR 408 (816)
Q Consensus 337 ~~~~~f~~~~~~~~p~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~-~~~gc~~~~~~l-~~~~~~~~~~~~lylr 408 (816)
..+.+|+++.+|++|++.. .+.++|+++|++ ||||+||+|. .+.||.+|.+++ ++++.+..++.++|+|
T Consensus 6 ~~~g~fl~~~~~klpd~~~---~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 6 KSAGTTLIKIALKIKTTKA---NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred ecCCeEEEeecccCCcccc---cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 3467899999999998765 456999999999 9999999997 367999999999 9999998888999987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=5e-11 Score=116.88 Aligned_cols=131 Identities=21% Similarity=0.164 Sum_probs=98.4
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCcee-eeeeEEEecCcceEEEeeCCCCCc
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV-RLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL 578 (816)
.+.|+.|.++.||++... ++.+++|....... ....+..|+.+++.+.+.+++ +++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 367899999999999875 78899998754432 233567899999998765554 44443 33456899999999887
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcC--CCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS--RLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
.+.- .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6431 011245678999999999986 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-11 Score=132.63 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=175.8
Q ss_pred cCcccccccCC--CCceeEEEeEe---cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcc
Q 003489 495 NNFQLANKLGQ--GGFGPVYKGKL---QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREEN 566 (816)
Q Consensus 495 ~~f~~~~~LG~--G~~g~Vy~g~~---~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 566 (816)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+....+++ |+|.++........+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667789999 99999999986 35778999974332 2233334456777666774 99999988888899999
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHH----HHHHHHhcCCCcEEEeeeCCCcEEEcCC-CCceeecc
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR----GLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDF 641 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Df 641 (816)
++=.|++ +.+|.++.+.. ...++....+....+... ||.++|... ++|-|+||.||++.++ ...++.||
T Consensus 194 fiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999988 57887777543 233566677777778777 999999998 9999999999999999 89999999
Q ss_pred ccceecCCCCccc---ccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhh
Q 003489 642 GLARIFGGNQDQA---ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW 718 (816)
Q Consensus 642 Gla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 718 (816)
|+...+....... ......+...|++||.. .+.++..+|+|++|.++.+..++.......-.. . |
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~-----W 335 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------S-----W 335 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------C-----c
Confidence 9998876544221 12233677889999965 567788999999999999999987654321000 0 0
Q ss_pred ccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 719 NDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 719 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
.+-+-..+-+....+ ...++...+.++++.+|..|++.+.+..
T Consensus 336 ~~~r~~~ip~e~~~~-----~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEG-----GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccccCchhhhcC-----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000111111111 1122233677899999999998887754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-10 Score=130.69 Aligned_cols=146 Identities=19% Similarity=0.249 Sum_probs=95.4
Q ss_pred cCcccccccCCCCceeEEEeEecC-CcEEEEEEecccCchh----------------------------------HH---
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQG----------------------------------QE--- 536 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~----------------------------------~~--- 536 (816)
..|+. +.||.|++|.||++++++ |+.||||++++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45775 799999999999999987 9999999997542110 11
Q ss_pred ---HHHHHHHHHhhcC----CCceeeeeeEEEe-cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHH-HH
Q 003489 537 ---EFMNEVMVISNLQ----HRNLVRLLGCCVE-REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR-GL 607 (816)
Q Consensus 537 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL 607 (816)
.|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+++.++-.-... ..+ +..++...++ -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d---~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTD---MKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCC---HHHHHHHHHHHHH
Confidence 2344555555442 4444444444433 4567899999999999774210111 111 1122222222 12
Q ss_pred HHHHhcCCCcEEEeeeCCCcEEEcCCC----CceeeccccceecCC
Q 003489 608 LYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFGLARIFGG 649 (816)
Q Consensus 608 ~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DfGla~~~~~ 649 (816)
..++..| ++|+|++|.||+++.++ .+++.|||+...+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344556 99999999999999988 999999999987743
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-09 Score=108.00 Aligned_cols=136 Identities=14% Similarity=0.107 Sum_probs=99.3
Q ss_pred ccccCCCCceeEEEeEecC-------CcEEEEEEecccC----------------------chhHHHHH----HHHHHHh
Q 003489 500 ANKLGQGGFGPVYKGKLQD-------GQEIAVKRLSKAS----------------------GQGQEEFM----NEVMVIS 546 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~-------~~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~ 546 (816)
...||.|-.+.||.|.-.+ +..+|||+.+... ....+.+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 4789999874210 01122333 7999999
Q ss_pred hcCC--CceeeeeeEEEecCcceEEEeeCCCCCccc-cccCCCCCCCCChhHHHHHHHHHHHHHHHH-HhcCCCcEEEee
Q 003489 547 NLQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDS-FLFDPQRQSLLDWPKRFNIIKGISRGLLYL-HRDSRLRIIHRD 622 (816)
Q Consensus 547 ~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivH~D 622 (816)
++.. -++.+++++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|..| |+.+ ++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9864 456666654 56789999997654422 221 12344456677889999999999 7887 99999
Q ss_pred eCCCcEEEcCCCCceeeccccceec
Q 003489 623 LKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 623 lkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 467999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.2e-09 Score=118.83 Aligned_cols=167 Identities=20% Similarity=0.272 Sum_probs=125.8
Q ss_pred ecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhH
Q 003489 516 LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK 595 (816)
Q Consensus 516 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 595 (816)
..++.+|.|...+.......+...+-++.|+.++||||++++......+..|||+|-+ ..|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 4468889888887666544556778889999999999999999999999999999987 355555522 23445
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCC
Q 003489 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR 675 (816)
Q Consensus 596 ~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 675 (816)
..-.+.||+.||.+||..+ .++|++|....|++++.|.-||.+|.++........ .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 5567889999999999765 499999999999999999999999998865432221 111122233566676543322
Q ss_pred CCchhhhHHHHHHHHHHHhCC
Q 003489 676 FSEKSDVFSFGVLLLEIVSGR 696 (816)
Q Consensus 676 ~s~ksDV~SlG~vl~elltG~ 696 (816)
-..|.|-||++++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 2459999999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-09 Score=103.40 Aligned_cols=131 Identities=23% Similarity=0.373 Sum_probs=104.9
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEE-ecccCch-------hHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEEee
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKR-LSKASGQ-------GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 572 (816)
..+++|+-+.+|.+.+. |..+++|. +.+.... ..+.-.+|+.+|.+++--.|.-..=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999775 44566663 3332211 234567899999999877887777788888899999999
Q ss_pred CCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
++|..|.++|... ...++..|-.-+.-||..+ |+|+||.++||++..+. +.+.||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 2567788888899999999 99999999999998765 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-09 Score=109.76 Aligned_cols=142 Identities=18% Similarity=0.287 Sum_probs=111.2
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCC--ceeeeeeEEEecC---cceEEEeeCC
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHR--NLVRLLGCCVERE---ENMLIYEYMP 574 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~ 574 (816)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887678999998754332 2356788999999999764 4577777766543 5689999999
Q ss_pred CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS---------------------------------------- 614 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------- 614 (816)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998876521 34677788888999999999998531
Q ss_pred -------------CCcEEEeeeCCCcEEEcC--CCCceeecccccee
Q 003489 615 -------------RLRIIHRDLKASNILLDD--DLNPKISDFGLARI 646 (816)
Q Consensus 615 -------------~~~ivH~Dlkp~NILl~~--~~~~kl~DfGla~~ 646 (816)
...++|+|+.+.||+++. ++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235899999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.8e-09 Score=102.40 Aligned_cols=143 Identities=22% Similarity=0.333 Sum_probs=109.6
Q ss_pred cccccCCCCceeEEEeEecCCcEEEEE-EecccCc-------hhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcceEEE
Q 003489 499 LANKLGQGGFGPVYKGKLQDGQEIAVK-RLSKASG-------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~~~~~vavK-~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 570 (816)
....|-||+-+.|+++.+. |+...|| ++.+..+ -..++.++|+.+|.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999986 7776666 4433322 22456789999999998777777777788888889999
Q ss_pred eeCCC-CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCC---Cceeecccccee
Q 003489 571 EYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARI 646 (816)
Q Consensus 571 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DfGla~~ 646 (816)
||+++ .++.+++...-.....+ .....++..|-+.+.-||.++ |+|+||..+||+|..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47788875432222222 222678899999999999999 99999999999997665 358999999865
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.8e-10 Score=94.11 Aligned_cols=72 Identities=43% Similarity=0.928 Sum_probs=58.6
Q ss_pred CCCeEEeeecCCcccccc-cCCchhhHHHhhhccCCcceeeccC-cceeEEeeeccccccccCCCCcceeeeee
Q 003489 339 QDGFFKLETMKVPYFAER-SSANEDKCKDQCSNNCSCKAYAYEI-GVGCMIWTHNLIDIRKLPSGGTNLYIRVA 410 (816)
Q Consensus 339 ~~~f~~~~~~~~p~~~~~-~~~~~~~C~~~Cl~nCsC~a~~~~~-~~gc~~~~~~l~~~~~~~~~~~~lylrv~ 410 (816)
.++|..++++++|++... ...+.++|++.|++||+|.||+|.+ +++|.+|...+.+.+.....+..+|+|++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 468999999999987554 3345599999999999999999985 67899999999987765555577898863
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.9e-09 Score=119.80 Aligned_cols=248 Identities=19% Similarity=0.199 Sum_probs=172.0
Q ss_pred HHhcCcccccccCCCCceeEEEeEec--CCcEEEEEEecccCchhHHH--HHHHHHHHhhc-CCCceeeeeeEEEecCcc
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKASGQGQEE--FMNEVMVISNL-QHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~~--~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 566 (816)
..+.+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34568889999999999999998643 57788999886654333322 24566666666 589999988888888888
Q ss_pred eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCC-CCceeeccccce
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLAR 645 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfGla~ 645 (816)
++=-||++++++...+ .....++...++++..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||...
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8889999999887665 23345777888999999999999999887 9999999999999886 788999999886
Q ss_pred ecCCCCccccccccccccccc--ChhccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCc
Q 003489 646 IFGGNQDQAATKRLVGTYGYM--SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
.+.-.. .. ..+.-+++ +|+......+-.++|++|||.-+.|.+++..-.+.... |. .+
T Consensus 416 ~~~~~~----~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~-------~i 475 (524)
T KOG0601|consen 416 RLAFSS----GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL-------TI 475 (524)
T ss_pred ccceec----cc-ccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce-------ee
Confidence 421111 01 11222333 56666667788999999999999999998753221110 00 00
Q ss_pred cccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHHHHhc
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~~L~~ 770 (816)
..-.-+.+. .. ...+..+...++..++..||.+.++..+.+-
T Consensus 476 ~~~~~p~~~--~~---~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDTPNLP--GL---KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ecccccCCC--ch---HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000001111 11 1334445556788999999999888766543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.8e-08 Score=106.10 Aligned_cols=169 Identities=21% Similarity=0.335 Sum_probs=128.2
Q ss_pred ceeEEEeEe-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceeeeeeEEEe----cCcceEEEeeCCC-CCcccc
Q 003489 508 FGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REENMLIYEYMPN-KSLDSF 581 (816)
Q Consensus 508 ~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~ 581 (816)
-.+.|++.. .||..+++|+++....+....-..-++.++++.|.|||++..++.. +...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 347889874 4799999999954433333344456889999999999999998873 3456899999988 677776
Q ss_pred ccCCC------------CCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 582 LFDPQ------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 582 l~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
-+... .....++...+.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 2234678889999999999999999999 88899999999999999999999888766532
Q ss_pred CCcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCC
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 698 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p 698 (816)
+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 220 0011 12367999999999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.8e-08 Score=95.45 Aligned_cols=125 Identities=26% Similarity=0.307 Sum_probs=83.7
Q ss_pred eEEEeEecCCcEEEEEEecccC--------------c------------hhHHHHHHHHHHHhhcCCC--ceeeeeeEEE
Q 003489 510 PVYKGKLQDGQEIAVKRLSKAS--------------G------------QGQEEFMNEVMVISNLQHR--NLVRLLGCCV 561 (816)
Q Consensus 510 ~Vy~g~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 561 (816)
.||.|...+|..+|||+.+... . .......+|++.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998889999999875310 0 0123467899999999866 45666544
Q ss_pred ecCcceEEEeeCC--CCCccccccCCCCCCCCChhHHHHHHHHHHHHHHH-HHhcCCCcEEEeeeCCCcEEEcCCCCcee
Q 003489 562 EREENMLIYEYMP--NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY-LHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 562 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
....|||||++ |..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 35689999998 5555443311 11234556778888886665 56777 9999999999999988 9999
Q ss_pred eccccceec
Q 003489 639 SDFGLARIF 647 (816)
Q Consensus 639 ~DfGla~~~ 647 (816)
.|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-07 Score=99.80 Aligned_cols=134 Identities=19% Similarity=0.133 Sum_probs=97.4
Q ss_pred ceeEEEeEecCCcEEEEEEecccCch-----------hHHHHHHHHHHHhhcCCCce--eeeeeEEEec-----CcceEE
Q 003489 508 FGPVYKGKLQDGQEIAVKRLSKASGQ-----------GQEEFMNEVMVISNLQHRNL--VRLLGCCVER-----EENMLI 569 (816)
Q Consensus 508 ~g~Vy~g~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~-----~~~~lV 569 (816)
...|++..+ +|+.+.||+....... ....+.+|...+.++...+| ++++++.... ...+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334667666 4788999977433211 11247899999998854443 4455565432 246899
Q ss_pred EeeCCCC-CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC-------CCCceeecc
Q 003489 570 YEYMPNK-SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-------DLNPKISDF 641 (816)
Q Consensus 570 ~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~kl~Df 641 (816)
+|++++. +|.+++.+.. ....+...+..++.+++..+..||..| |+|+|++++|||++. +..+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999886 8888874321 233456677789999999999999999 999999999999975 467899999
Q ss_pred cccee
Q 003489 642 GLARI 646 (816)
Q Consensus 642 Gla~~ 646 (816)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5e-07 Score=95.87 Aligned_cols=266 Identities=16% Similarity=0.155 Sum_probs=158.1
Q ss_pred ccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCceeeeeeE------EEecCc-ceEE
Q 003489 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGC------CVEREE-NMLI 569 (816)
Q Consensus 498 ~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~~-~~lV 569 (816)
.....||+|+.+.+|..-- -...+.|++.......+.+...| |... .||-+-.-+.+ .-++.. .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4467899999999995421 12234577655444333333333 2222 45543321111 111222 3467
Q ss_pred EeeCCCC-Ccccccc---CCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 570 YEYMPNK-SLDSFLF---DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 570 ~e~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
|+.+++. ....++. ..+.-...+|.-.++.++.+|.+.+.||..| .+-+|++++|+|+.+++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7777664 2233332 2334456889999999999999999999999 8999999999999999999999865444
Q ss_pred ecCCCCcccccccccccccccChhccc-----cCCCCchhhhHHHHHHHHHHHhC-CCCCCCCchh------hhhhHHHH
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG-RKNTSFYHEE------FELTLLGY 713 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlG~vl~elltG-~~p~~~~~~~------~~~~l~~~ 713 (816)
.. .........+|...|.+||.-. +..-+...|.|.||+++++++.| ++||+..... .+..+...
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 32 2223344568899999999754 23346778999999999999987 7888653211 11111110
Q ss_pred HHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcC--CCCCCChHHHHHHHhccccCCC
Q 003489 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEF--VKDRPNMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 714 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~--P~~RPt~~evl~~L~~~~~~l~ 776 (816)
.. ...++.-. -..+.-..-......+.+..+-.+|+... +.-|||++..+..|..+-++|.
T Consensus 243 ~f-~ya~~~~~-g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RF-AYASDQRR-GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ee-eechhccC-CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00 00000000 00111111111222344455555777543 5689999999998877655544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-08 Score=119.36 Aligned_cols=207 Identities=21% Similarity=0.251 Sum_probs=145.9
Q ss_pred HHhcCcccccccCCCCceeEEEeEec-CCcEEEEEEecc---cCchhHHHHHHHHHHHhhcCCCceeeeeeEEEecCcce
Q 003489 492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 492 ~~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 567 (816)
...+.+.+.+-+-.|.++.++..+-. .|...+.|.... ......+....+-.++-..+||-+++...-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34577888888999999999877532 232223332211 11112222233333333344566666665566677889
Q ss_pred EEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
|+++|+.+++|...|+.. ...+..-....+..+..+++|||... +.|+|++|.|++...++..+++||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999888643 24555556667778899999999876 899999999999999999999999844322
Q ss_pred CCC--------Cc-----------------c----cccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCC
Q 003489 648 GGN--------QD-----------------Q----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 698 (816)
Q Consensus 648 ~~~--------~~-----------------~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p 698 (816)
... .. . .......+|+.|.+||.+.+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0 112235789999999999999999999999999999999999999
Q ss_pred CCCCch
Q 003489 699 TSFYHE 704 (816)
Q Consensus 699 ~~~~~~ 704 (816)
+....+
T Consensus 1035 ~na~tp 1040 (1205)
T KOG0606|consen 1035 FNAETP 1040 (1205)
T ss_pred CCCcch
Confidence 865444
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.8e-07 Score=92.56 Aligned_cols=135 Identities=22% Similarity=0.243 Sum_probs=97.8
Q ss_pred cccccccCCCCceeEEEeEecCCcEEEEEEeccc--------------------Cc--hhHHHHHHHHHHHhhcCCC--c
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--------------------SG--QGQEEFMNEVMVISNLQHR--N 552 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~--------------------~~--~~~~~~~~E~~~l~~l~h~--n 552 (816)
..+.++||-|--+.||.|..+.|.++|||.=+.. +. ......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999954211 00 1123467899999999755 6
Q ss_pred eeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcC
Q 003489 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD 632 (816)
Q Consensus 553 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~ 632 (816)
+.+.++. +...+|||++++-.|...- ++....-.++..|+.-+..+-..| |+|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776654 5668999999987665432 122233344445555554444556 999999999999999
Q ss_pred CCCceeecccccee
Q 003489 633 DLNPKISDFGLARI 646 (816)
Q Consensus 633 ~~~~kl~DfGla~~ 646 (816)
+|.+.+.||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=3e-06 Score=84.26 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=102.9
Q ss_pred cCCCCceeEEEeEecCCcEEEEEEeccc------CchhHHHHHHHHHHHhhcCCC--ceeeeeeEEEecC----cceEEE
Q 003489 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKA------SGQGQEEFMNEVMVISNLQHR--NLVRLLGCCVERE----ENMLIY 570 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~~~~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~ 570 (816)
-|+|+-+.|++-.++ |..+-+|+-... .+.....|.+|+..|.+|... .+.++..+..... ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 456888889988775 456888876421 144678899999999999533 3555552222222 247999
Q ss_pred eeCCC-CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCC--ceeecccccee
Q 003489 571 EYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--PKISDFGLARI 646 (816)
Q Consensus 571 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DfGla~~ 646 (816)
|-+++ .+|.+++.+.. ..+.+...+..++.+|++.+.-||+.+ +.|+|+.+.||+++.++. +++.||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98865 68888874321 234577778899999999999999999 999999999999987676 89999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.5e-06 Score=88.01 Aligned_cols=108 Identities=25% Similarity=0.302 Sum_probs=85.4
Q ss_pred hHHHHHHHHHHHhhcCCC--ceeeeeeEEEecC----cceEEEeeCCC-CCccccccCCCCCCCCChhHHHHHHHHHHHH
Q 003489 534 GQEEFMNEVMVISNLQHR--NLVRLLGCCVERE----ENMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606 (816)
Q Consensus 534 ~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 606 (816)
......+|...+..|... ..++.+++..... ..+||+|++++ .+|.+++.... .++......++.++++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHH
Confidence 345688899988888543 4566677766543 23799999988 47998884321 15566778999999999
Q ss_pred HHHHHhcCCCcEEEeeeCCCcEEEcCCC---Cceeeccccceec
Q 003489 607 LLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARIF 647 (816)
Q Consensus 607 L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 647 (816)
++-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-06 Score=96.73 Aligned_cols=141 Identities=19% Similarity=0.254 Sum_probs=93.9
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCchh----------------------------------------HHHHHH
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG----------------------------------------QEEFMN 540 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~ 540 (816)
+.|+.++-|.||+|++++|+.||||+.++..... +-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999986432110 011344
Q ss_pred HHHHHhhcC----CCceeeeeeEE-EecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHH-HHHHHhcC
Q 003489 541 EVMVISNLQ----HRNLVRLLGCC-VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG-LLYLHRDS 614 (816)
Q Consensus 541 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~ 614 (816)
|...+.+++ +..-+++-.++ .-.+...|+|||++|-.+.+...-.. ...+ +..++..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhcC
Confidence 555555442 22222333333 33567799999999999988742111 2233 23344433333 23333345
Q ss_pred CCcEEEeeeCCCcEEEcCCCCceeeccccceecCC
Q 003489 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 615 ~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 649 (816)
++|.|..|.||+++.++.+.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.7e-07 Score=103.03 Aligned_cols=152 Identities=18% Similarity=0.242 Sum_probs=98.2
Q ss_pred HHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCccc-------ccccccccccccChhcc
Q 003489 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA-------ATKRLVGTYGYMSPEYA 671 (816)
Q Consensus 599 i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~ 671 (816)
=+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+.....+.... ..........|.|||++
T Consensus 104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3445669999999864 69999999999999999999999999887554321111 11112335679999999
Q ss_pred ccCCCCchhhhHHHHHHHHHHHhCCCCC-CCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHh
Q 003489 672 MEGRFSEKSDVFSFGVLLLEIVSGRKNT-SFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLC 750 (816)
Q Consensus 672 ~~~~~s~ksDV~SlG~vl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~C 750 (816)
.....+.++|+||+|+++|.+..|.++. .......... .....+..-..-.+.+...++.+=+...
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHH
Confidence 9988899999999999999999555442 2111100000 0000000000011122233444445578
Q ss_pred hhcCCCCCCChHHHH
Q 003489 751 VQEFVKDRPNMPTVV 765 (816)
Q Consensus 751 l~~~P~~RPt~~evl 765 (816)
+..++.-||++.++.
T Consensus 249 l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLL 263 (700)
T ss_pred hcCCcccCcchhhhh
Confidence 889999999887764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.4e-06 Score=75.34 Aligned_cols=88 Identities=23% Similarity=0.359 Sum_probs=60.5
Q ss_pred EEEecCCCeEEecCC-CcEEEEeeccccccCccceEEEccCCcEEEEecCCcceeeccccCCcccccccCcccccccCCc
Q 003489 93 FTISEDGNLVVLNGK-KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK 171 (816)
Q Consensus 93 l~~~~~g~l~l~~~~-~~~~wst~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqsFD~PTDtlLpg~~l~~~~~tg~ 171 (816)
+.++.||++|+++.. +.++|++++..... ....+.|.++|||||++. ++.++|+| +|
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~-~~~~l~l~~dGnLvl~~~-~g~~vW~S-----~t--------------- 81 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVS-DSCTLTLQSDGNLVLYDG-DGRVVWSS-----NT--------------- 81 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCC-CCEEEEEeCCCCEEEEeC-CCCEEEEe-----cc---------------
Confidence 455688999999765 68999999864332 347899999999999997 45568987 22
Q ss_pred ceEEEEeecCCCCCcceeEeeecCCCCCeEEEEeCCCcccccCC
Q 003489 172 KVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSG 215 (816)
Q Consensus 172 ~~~l~Sw~s~~dps~G~fs~~~d~~~~~~~~~~~~~~~~yw~~g 215 (816)
....|.+.+.++.+|...++- ....+.|.+.
T Consensus 82 -----------~~~~~~~~~~L~ddGnlvl~~--~~~~~~W~Sf 112 (114)
T smart00108 82 -----------TGANGNYVLVLLDDGNLVIYD--SDGNFLWQSF 112 (114)
T ss_pred -----------cCCCCceEEEEeCCCCEEEEC--CCCCEEeCCC
Confidence 012345777788777654432 2335677654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.8e-05 Score=81.21 Aligned_cols=132 Identities=17% Similarity=0.146 Sum_probs=86.5
Q ss_pred cccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCc--eeeeeeEEEecCcceEEEeeCCCCC-
Q 003489 501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--LVRLLGCCVEREENMLIYEYMPNKS- 577 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs- 577 (816)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+.+....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 25567888876432 3455789999999986544 4677777777777789999999863
Q ss_pred ccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh---------------------------------------c-CCCc
Q 003489 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR---------------------------------------D-SRLR 617 (816)
Q Consensus 578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~---------------------------------------~-~~~~ 617 (816)
+...+. .+......++..+++.+.-||+ . ....
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221110 0111111122222222222221 1 1234
Q ss_pred EEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 618 ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
++|+|+.|.||++++++ +.|.||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6e-05 Score=76.12 Aligned_cols=151 Identities=19% Similarity=0.240 Sum_probs=100.4
Q ss_pred cCHHHHHHHhcCccccc---ccCCCCceeEEEeEecCCcEEEEEEecccCchh-------------------HHH-----
Q 003489 485 FNFEELANATNNFQLAN---KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-------------------QEE----- 537 (816)
Q Consensus 485 ~~~~el~~~~~~f~~~~---~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~-------------------~~~----- 537 (816)
.+.+.+.....+..+.+ .|..|--+.||+|...++..+|||+++...... .++
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44556666555555544 455677789999998889999999986432111 111
Q ss_pred HHHHHHHHhhcC--CCceeeeeeEEEecCcceEEEeeCCCCCc-cccccCCCCCCCCChhHHHHHHHHHHHHHHHHHh-c
Q 003489 538 FMNEVMVISNLQ--HRNLVRLLGCCVEREENMLIYEYMPNKSL-DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-D 613 (816)
Q Consensus 538 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~ 613 (816)
...|+..|+++. +-.+.+.+++ ....|||||+....+ .=.|. ...+...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 235777777774 3444555544 345799999965421 11121 1122333566777788888887766 5
Q ss_pred CCCcEEEeeeCCCcEEEcCCCCceeeccccceec
Q 003489 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 614 ~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~ 647 (816)
+ +||+||+.=|||+. ++.+.|+||+.|...
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 5 99999999999999 889999999988754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00012 Score=72.64 Aligned_cols=104 Identities=22% Similarity=0.230 Sum_probs=82.9
Q ss_pred HHHHHHHhhcCC-CceeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCc
Q 003489 539 MNEVMVISNLQH-RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617 (816)
Q Consensus 539 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 617 (816)
.+|..+++.+++ +++++++|+|- .++|.||.+.+++...-.....--..+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 69999999993 4789999987765422100011123689999999999999999999865556
Q ss_pred EEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 618 IIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 618 ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+...|++++|+-+++++++|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.3e-05 Score=76.37 Aligned_cols=138 Identities=15% Similarity=0.229 Sum_probs=93.8
Q ss_pred HhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHH---------HHHHHHhhcCC---CceeeeeeEE
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM---------NEVMVISNLQH---RNLVRLLGCC 560 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~---------~E~~~l~~l~h---~niv~l~~~~ 560 (816)
..++|.+.+.+-......|.+-..+ ++.+++|..++.....++.|+ +++..+.+++. ..+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4578888888888777777777664 788999988765544333332 33444444432 2333333333
Q ss_pred Eec-----CcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCC
Q 003489 561 VER-----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635 (816)
Q Consensus 561 ~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 635 (816)
... ...+++|||++|..|.++.. ++. .++..|++++.-||+.| ++|+|+.|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 322 23468999999988876541 121 25566788899999999 99999999999998655
Q ss_pred ceeecccccee
Q 003489 636 PKISDFGLARI 646 (816)
Q Consensus 636 ~kl~DfGla~~ 646 (816)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.3e-05 Score=68.61 Aligned_cols=100 Identities=23% Similarity=0.422 Sum_probs=67.7
Q ss_pred CcEEecCCeEEEeeecCCCCCCceEEEEEEecCCCCCceEEEec-CCCCCCcCCCceEEEecCCCeEEecCCCcEEEEee
Q 003489 37 ESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVA-NRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSN 115 (816)
Q Consensus 37 ~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~ 115 (816)
+.+.+.+|.+.|-|...|+ |.|.... .+++|.+ +.... ....+.+.|..||||||+|..+.++|++.
T Consensus 12 ~p~~~~s~~~~L~l~~dGn------Lvl~~~~-----~~~iWss~~t~~~-~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf 79 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN------LVLYDSN-----GSVIWSSNNTSGR-GNSGCYLVLQDDGNLVLYDSSGNVLWQSF 79 (114)
T ss_dssp EEEEECETTEEEEEETTSE------EEEEETT-----TEEEEE--S-TTS-S-SSEEEEEETTSEEEEEETTSEEEEEST
T ss_pred cccccccccccceECCCCe------EEEEcCC-----CCEEEEecccCCc-cccCeEEEEeCCCCEEEEeecceEEEeec
Confidence 4555555899999988876 7775332 3679999 43333 11567899999999999999999999995
Q ss_pred ccccccCccceEEEcc--CCcEEEEecCCcceeeccccCCc
Q 003489 116 VSSLANNSNTRAQLLD--SGNLVLHDNISQVSIWDSFQEPT 154 (816)
Q Consensus 116 ~~~~~~~~~~~~~l~d--~gnlvl~~~~~~~~~wqsFD~PT 154 (816)
. ......+..++ .||++ ... ...+.|.|=+.|+
T Consensus 80 ~----~ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps 114 (114)
T PF01453_consen 80 D----YPTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS 114 (114)
T ss_dssp T----SSS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred C----CCccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence 3 22355677777 89998 554 3456898877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.2e-05 Score=78.71 Aligned_cols=144 Identities=24% Similarity=0.256 Sum_probs=84.8
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC--ceeeeeeEEEec---CcceEEEeeCC
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR--NLVRLLGCCVER---EENMLIYEYMP 574 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~~ 574 (816)
.+.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999876 68999987544 4567788899998888533 356666654332 23579999999
Q ss_pred CCCccc----------------cc---cCC-CCCCCCChhHH--HH-------H------------HHHHHH-HHHHHHh
Q 003489 575 NKSLDS----------------FL---FDP-QRQSLLDWPKR--FN-------I------------IKGISR-GLLYLHR 612 (816)
Q Consensus 575 ~gsL~~----------------~l---~~~-~~~~~l~~~~~--~~-------i------------~~~ia~-aL~yLH~ 612 (816)
+..+.. .+ +.. ........... .. . ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 111 01111111000 00 0 011222 2333332
Q ss_pred ----cCCCcEEEeeeCCCcEEEc-CCCCceeecccccee
Q 003489 613 ----DSRLRIIHRDLKASNILLD-DDLNPKISDFGLARI 646 (816)
Q Consensus 613 ----~~~~~ivH~Dlkp~NILl~-~~~~~kl~DfGla~~ 646 (816)
.....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1344599999999999999 556668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.1e-05 Score=77.60 Aligned_cols=140 Identities=14% Similarity=0.163 Sum_probs=85.3
Q ss_pred ccCCCCc-eeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCceeeeeeEEEecCcceEEEeeCCCCCcc
Q 003489 502 KLGQGGF-GPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLD 579 (816)
Q Consensus 502 ~LG~G~~-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 579 (816)
.|..|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 688998764 4678888875432 345678999988884 445667777777666789999999998776
Q ss_pred ccc-------------------cCCCC-CCCCC--hhHHHHHHH--------------------HHHHHHHHHHh----c
Q 003489 580 SFL-------------------FDPQR-QSLLD--WPKRFNIIK--------------------GISRGLLYLHR----D 613 (816)
Q Consensus 580 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~aL~yLH~----~ 613 (816)
... |.... ..+.. ....+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 00110 000000000 01111122211 1
Q ss_pred CCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 614 ~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
..+.++|+|+.|.|||++++..+.|.||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22448999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.89 E-value=2e-05 Score=65.99 Aligned_cols=70 Identities=40% Similarity=0.905 Sum_probs=52.2
Q ss_pred CCCeEEeeecCCcccccc--cCCchhhHHHhhhc-cCCcceeeccC-cceeEEee-eccccccccCCCCcceeee
Q 003489 339 QDGFFKLETMKVPYFAER--SSANEDKCKDQCSN-NCSCKAYAYEI-GVGCMIWT-HNLIDIRKLPSGGTNLYIR 408 (816)
Q Consensus 339 ~~~f~~~~~~~~p~~~~~--~~~~~~~C~~~Cl~-nCsC~a~~~~~-~~gc~~~~-~~l~~~~~~~~~~~~lylr 408 (816)
...|..++++++++.... ...+.++|++.|++ +|+|.||.|.. +.+|.+|. +.+.+.+..+..+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEEe
Confidence 456889999999855432 23455999999999 99999999985 77999999 6767765445445555543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.2e-05 Score=73.20 Aligned_cols=55 Identities=31% Similarity=0.571 Sum_probs=42.7
Q ss_pred EEEec-CCCeEEecCC-CcEEEEeeccccccCccceEEEccCCcEEEEecCCcceeecc
Q 003489 93 FTISE-DGNLVVLNGK-KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149 (816)
Q Consensus 93 l~~~~-~g~l~l~~~~-~~~~wst~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqs 149 (816)
+..+. ||+||+++.. +.++|++|+... ......+.|.++|||||++. ++.++|+|
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~-~g~~vW~S 80 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDG-SGTVVWSS 80 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcC-CCcEEEEe
Confidence 34555 8999999764 589999998643 34567899999999999997 44568885
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=7.2e-05 Score=84.82 Aligned_cols=141 Identities=16% Similarity=0.259 Sum_probs=90.0
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchh-------------------------------------HHHHHHHH
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-------------------------------------QEEFMNEV 542 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~ 542 (816)
.+.||.-+.|.||++++++|+.||||+-++.-... +-.|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36899999999999999999999999876432111 01244555
Q ss_pred HHHhhc----CCCc---eeeeeeEEEe-cCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHH-HHhc
Q 003489 543 MVISNL----QHRN---LVRLLGCCVE-REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY-LHRD 613 (816)
Q Consensus 543 ~~l~~l----~h~n---iv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~ 613 (816)
+...++ +|-+ -|.+-.++.+ ...+.|+||||+|..+.+.-.- ....++... ++..+.++... |-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 544433 3555 1223333333 3467999999999888775321 111233333 33333333221 1223
Q ss_pred CCCcEEEeeeCCCcEEEcC----CCCceeeccccceecC
Q 003489 614 SRLRIIHRDLKASNILLDD----DLNPKISDFGLARIFG 648 (816)
Q Consensus 614 ~~~~ivH~Dlkp~NILl~~----~~~~kl~DfGla~~~~ 648 (816)
| ++|+|-.|.||+++. ++.+.+.|||+...+.
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 4 999999999999984 5689999999987653
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.8e-05 Score=57.58 Aligned_cols=44 Identities=41% Similarity=0.729 Sum_probs=38.5
Q ss_pred cCCCCCCCCceecccCccCCCCCCCcc-cccccccceeeeeecCC
Q 003489 773 KDLPAAKQPAFTVRRGAYDSASSSNQN-QQICSINDVTVTLMEGR 816 (816)
Q Consensus 773 ~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 816 (816)
..||.|++|+|..++...+..++++++ .+.+|.|++|+|+++||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 579999999999999888887776665 46799999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=3.8e-06 Score=93.80 Aligned_cols=189 Identities=17% Similarity=0.148 Sum_probs=135.1
Q ss_pred HhcCcccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCc-eeeeeeEEEecCcceEEEe
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-LVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e 571 (816)
.++-+...+.++++++++++|.+-...+....+.+... ....-++++|.+++||| .++.++-+..++..+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34455556788999999999987443344445554322 45567889999999999 7777777777778889999
Q ss_pred eCCCC-CccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccceecCCC
Q 003489 572 YMPNK-SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 572 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 650 (816)
++..+ +-..-. ......+...+...+.+.-++++++||+.. -+|+| ||+..+ +..+..||+....+.+.
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99776 222111 111222444445556666778899999864 48888 776655 67899999988766433
Q ss_pred CcccccccccccccccChhccccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~elltG~~p~ 699 (816)
. ..+...+++.++|||+.....+..+-|+|++|.--.++--|-+|.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 2 344567899999999999999999999999998777777776664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00037 Score=85.49 Aligned_cols=80 Identities=16% Similarity=0.367 Sum_probs=58.3
Q ss_pred ccccCCCCceeEEEeEecCC---cEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCce--eeeeeEEEec---CcceEE
Q 003489 500 ANKLGQGGFGPVYKGKLQDG---QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNL--VRLLGCCVER---EENMLI 569 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 569 (816)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876553 367777764322 123457889999999995 6665 7778887664 357899
Q ss_pred EeeCCCCCcc
Q 003489 570 YEYMPNKSLD 579 (816)
Q Consensus 570 ~e~~~~gsL~ 579 (816)
|||++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999986543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.001 Score=71.41 Aligned_cols=79 Identities=10% Similarity=0.085 Sum_probs=58.4
Q ss_pred cccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC---CceeeeeeEEEec---CcceEEE
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH---RNLVRLLGCCVER---EENMLIY 570 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lV~ 570 (816)
..-.+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.|.- -.+.++++.+..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33456899999999999876555 466676432 1134588999999998853 3688888887643 5579999
Q ss_pred eeCCCCCc
Q 003489 571 EYMPNKSL 578 (816)
Q Consensus 571 e~~~~gsL 578 (816)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00043 Score=69.13 Aligned_cols=128 Identities=19% Similarity=0.240 Sum_probs=88.8
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccC----------------chhHHHHHHHHHHHhhcC------CCceeeee
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS----------------GQGQEEFMNEVMVISNLQ------HRNLVRLL 557 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 557 (816)
...||+|+.-.||. +.++....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45899999999995 3455667888886554 123456677777666665 88999999
Q ss_pred eEEEecCcceEEEeeCCC------CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc
Q 003489 558 GCCVEREENMLIYEYMPN------KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD 631 (816)
Q Consensus 558 ~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 631 (816)
|+.......-+|+|.+.+ .+|.+++. ...++. ...+.+.+ -.+||-+.. |+.+|++|+||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEEE
Confidence 999999888999998643 35667772 233444 33334433 345555555 99999999999996
Q ss_pred CCC----Cceeec
Q 003489 632 DDL----NPKISD 640 (816)
Q Consensus 632 ~~~----~~kl~D 640 (816)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00045 Score=71.58 Aligned_cols=74 Identities=16% Similarity=0.236 Sum_probs=47.0
Q ss_pred cccCCCCce-eEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC---ceeeeeeEEEecC---cceEEEeeC
Q 003489 501 NKLGQGGFG-PVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR---NLVRLLGCCVERE---ENMLIYEYM 573 (816)
Q Consensus 501 ~~LG~G~~g-~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lV~e~~ 573 (816)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|++++..+... -+.++++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467766666 58875 235777765432 2345788999999888632 3444444433222 347899999
Q ss_pred CCCCccc
Q 003489 574 PNKSLDS 580 (816)
Q Consensus 574 ~~gsL~~ 580 (816)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00052 Score=65.71 Aligned_cols=130 Identities=20% Similarity=0.280 Sum_probs=87.8
Q ss_pred cccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCceee-eeeEEEecCcceEEEeeCCC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR-LLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~ 575 (816)
.+..+.|++|++|.||+|.+. +..+|+|.-+.. .....+..|+++|..+.-.++.+ ++.+.. -++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 345678999999999999987 668899976544 34577889999999998766654 333322 2455999988
Q ss_pred CCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeC-CCcEEEcCCCCceeecccccee
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK-ASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kl~DfGla~~ 646 (816)
-+|.+.-.. .+- +-+..++++---|-..| |-|+.|. |..++|-.+..+.|.||.-|..
T Consensus 97 ~~L~~~~~~------~~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG------GDR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc------ccH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 787664411 112 22334444433344445 8888886 4445555555999999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0024 Score=70.74 Aligned_cols=74 Identities=14% Similarity=0.194 Sum_probs=54.6
Q ss_pred cccCCCCceeEEEeEecCC-cEEEEEEeccc------C-chhHHHHHHHHHHHhhcC---CCceeeeeeEEEecCcceEE
Q 003489 501 NKLGQGGFGPVYKGKLQDG-QEIAVKRLSKA------S-GQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~~-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 569 (816)
+.||.|.+..||+....+| +.|+||.-.+. . ....+++..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5899999999999998776 48999975421 1 234567788888888763 2456777766 44567899
Q ss_pred EeeCCCC
Q 003489 570 YEYMPNK 576 (816)
Q Consensus 570 ~e~~~~g 576 (816)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0015 Score=64.82 Aligned_cols=134 Identities=25% Similarity=0.407 Sum_probs=94.4
Q ss_pred cccccCHHHHHHHhcCcccccccCCCCc-eeEEEeEecCCcEEEEEEecc---cC--------c----------hhHHHH
Q 003489 481 DLLVFNFEELANATNNFQLANKLGQGGF-GPVYKGKLQDGQEIAVKRLSK---AS--------G----------QGQEEF 538 (816)
Q Consensus 481 ~~~~~~~~el~~~~~~f~~~~~LG~G~~-g~Vy~g~~~~~~~vavK~l~~---~~--------~----------~~~~~~ 538 (816)
.+..|+.. +.+|+.++.||.|.- |.||+.++. |+.+|+|.++. .. . .-...|
T Consensus 28 KL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 28 KLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 45556652 278999999999999 999999996 88999999321 00 0 112357
Q ss_pred HHHHHHHhhcC---CCce--eeeeeEEEecC------------------cceEEEeeCCCCCccccccCCCCCCCCChhH
Q 003489 539 MNEVMVISNLQ---HRNL--VRLLGCCVERE------------------ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK 595 (816)
Q Consensus 539 ~~E~~~l~~l~---h~ni--v~l~~~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 595 (816)
..|.+...+|+ +.++ |+.+|+..-.. ...||.||++... ..
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~ 165 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PL 165 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------cc
Confidence 88999888885 4456 89999874321 1136666664322 11
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEcCCCCceeeccccc
Q 003489 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 596 ~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla 644 (816)
..+-+.+|.+-|..+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 2334567788888999998 999999999975 4688999854
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.001 Score=68.86 Aligned_cols=74 Identities=19% Similarity=0.300 Sum_probs=48.9
Q ss_pred cccCCCCceeEEEeEecC--CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCcee-eeeeEEEecCcceEEEeeCCCCC
Q 003489 501 NKLGQGGFGPVYKGKLQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV-RLLGCCVEREENMLIYEYMPNKS 577 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gs 577 (816)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.+++.+...+++ ++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888888999988664 678889977543222 12234788888888544443 4433322 248999999977
Q ss_pred cc
Q 003489 578 LD 579 (816)
Q Consensus 578 L~ 579 (816)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00093 Score=70.17 Aligned_cols=138 Identities=17% Similarity=0.142 Sum_probs=79.3
Q ss_pred ccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCce-eeeeeEEEecCcceEEEeeCCCCCccc
Q 003489 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYMPNKSLDS 580 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL~~ 580 (816)
.+..|-...+|+... +++.+++|..........-...+|..+++.+...++ .+++... ...+|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456688889998874 467788887644322211235778889988864444 3344332 2479999999877653
Q ss_pred c-----------------ccCCCC-CCCCChhHH-HHHHHHH---------HHHHHHHHhc-----CCCcEEEeeeCCCc
Q 003489 581 F-----------------LFDPQR-QSLLDWPKR-FNIIKGI---------SRGLLYLHRD-----SRLRIIHRDLKASN 627 (816)
Q Consensus 581 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~i---------a~aL~yLH~~-----~~~~ivH~Dlkp~N 627 (816)
- ||.... ..+++.... ..+..++ ...+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 111111 111222211 1111111 1112222111 12348999999999
Q ss_pred EEEcCCCCceeeccccce
Q 003489 628 ILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 628 ILl~~~~~~kl~DfGla~ 645 (816)
|++++++ +.|.||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0022 Score=68.91 Aligned_cols=142 Identities=18% Similarity=0.158 Sum_probs=86.5
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCc--eeeeeeE------EEecCcceEEEe
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--LVRLLGC------CVEREENMLIYE 571 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e 571 (816)
.+.|..|....+|+.... +..+++|+... ...+....|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457888888899998765 45788898754 23456777888888885433 4444431 123345689999
Q ss_pred eCCCCCcccc--------------ccCC----CC----CCCCChhHHH----------HHHHHHHHHHHHHHhc----CC
Q 003489 572 YMPNKSLDSF--------------LFDP----QR----QSLLDWPKRF----------NIIKGISRGLLYLHRD----SR 615 (816)
Q Consensus 572 ~~~~gsL~~~--------------l~~~----~~----~~~l~~~~~~----------~i~~~ia~aL~yLH~~----~~ 615 (816)
+++|..+... +|.. .. .....|.... .....+..++.++.+. -+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999776431 0100 00 0111222211 0111233445555431 22
Q ss_pred CcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 616 ~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
..++|+|+.|.||++++++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998778899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0016 Score=78.40 Aligned_cols=196 Identities=21% Similarity=0.202 Sum_probs=132.7
Q ss_pred HHHHHHHHhhcCCCceeeeeeEEEecCcc----eEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhc
Q 003489 538 FMNEVMVISNLQHRNLVRLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613 (816)
Q Consensus 538 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 613 (816)
..-|...+.++.|+|+++++.+..+.... .+..|++..-++...+ +.-..++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34577788889999999999998765433 2445777777777766 3345678888899999999999999998
Q ss_pred CCCcEEEeeeCCC---cEEEcCCCCceee--ccccceecCCCCcccccccccccccccChhccccCCCCc--hhhhHHHH
Q 003489 614 SRLRIIHRDLKAS---NILLDDDLNPKIS--DFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE--KSDVFSFG 686 (816)
Q Consensus 614 ~~~~ivH~Dlkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~SlG 686 (816)
. ..|.-+..+ +-..+.++...++ ||+..+.+...... ....-+..+.|||.......+. ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555554 4455666666766 88888765433221 1123355678888777665554 47999999
Q ss_pred HHHHHHHhCCCCCCCCchhhhhhHHHHHHHhhccCCccccccccccccccHHHHHHHHHHHHHhhhcCCCCCCChHHHHH
Q 003489 687 VLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 687 ~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~evl~ 766 (816)
..+..+..|..+...... ...+++.. ... .+......|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~------------------~~~~l~~~----~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------------------PVSLLDVL----STS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc------------------hhhhhccc----cch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999998765321110 01111111 000 3345556799999999999999987
Q ss_pred HH
Q 003489 767 ML 768 (816)
Q Consensus 767 ~L 768 (816)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 65
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.009 Score=64.91 Aligned_cols=142 Identities=16% Similarity=0.172 Sum_probs=77.7
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCc--eeeeee------EEEecCcceEEEe
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--LVRLLG------CCVEREENMLIYE 571 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~e 571 (816)
.+.|+.|....+|+....+| .+++|++.. ...+....|+.++..|...+ +.+++. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788789999886655 688898752 22334445566666553222 333332 1223455689999
Q ss_pred eCCCCCcccc--------------ccCCCC--------CCCCCh-hHHHHH------------HHH-HHHHHHHHHhc--
Q 003489 572 YMPNKSLDSF--------------LFDPQR--------QSLLDW-PKRFNI------------IKG-ISRGLLYLHRD-- 613 (816)
Q Consensus 572 ~~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~i------------~~~-ia~aL~yLH~~-- 613 (816)
|++|..+... +|.... ...+.| .....- +.+ +...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9998754311 111000 001112 111111 111 11122333211
Q ss_pred --CCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 614 --SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 614 --~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
-+..++|+|+.|.||+++.+...-|.||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12359999999999999976666899999775
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.008 Score=64.98 Aligned_cols=143 Identities=19% Similarity=0.220 Sum_probs=82.7
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCc--eeeeeeE------EEecCcceEEEe
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--LVRLLGC------CVEREENMLIYE 571 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e 571 (816)
.+.++.|....+|+....++ .+++|+..... ..+....|++++..|...+ +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999876544 57788764421 2345566777777774322 3444432 112345679999
Q ss_pred eCCCCCcccc--------------ccCCCCC---------CCCChhHHH------------HHHHHHHHHHHHHHh----
Q 003489 572 YMPNKSLDSF--------------LFDPQRQ---------SLLDWPKRF------------NIIKGISRGLLYLHR---- 612 (816)
Q Consensus 572 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~aL~yLH~---- 612 (816)
|++|..+... +|..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654311 1110000 001121110 001123344555543
Q ss_pred cCCCcEEEeeeCCCcEEEcCCCCceeeccccce
Q 003489 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 613 ~~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~ 645 (816)
.-+..++|+|+.+.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999998877899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.011 Score=63.31 Aligned_cols=137 Identities=18% Similarity=0.235 Sum_probs=86.6
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCC--CceeeeeeEEEecC--cceEEEeeC
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQH--RNLVRLLGCCVERE--ENMLIYEYM 573 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~ 573 (816)
.+.+..|..-.+|..... ++..+++ ... ..........+|+.+|+.+.- --+.+.+++|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344444444445544433 6777887 321 222344556778888887743 34556677777766 568999999
Q ss_pred CCCCccccccCCCCCCCCChhHHHHHHH-HHHHHHHHHHh----------------------------------------
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIK-GISRGLLYLHR---------------------------------------- 612 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~-~ia~aL~yLH~---------------------------------------- 612 (816)
+|..+.+.+... ... .+++. .+++.|+-||+
T Consensus 108 eGe~~~~~~~~~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPE------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcc------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 886554443211 111 12222 55555666664
Q ss_pred ----------c-----CCCcEEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 613 ----------D-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 613 ----------~-----~~~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+ +...++|+|+.+.||+++.+..+-|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1 234699999999999999998899999999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.015 Score=61.76 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=75.2
Q ss_pred cCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC--Cc-eeeeeeEEEecCcceEEEeeCCCCCcc
Q 003489 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH--RN-LVRLLGCCVEREENMLIYEYMPNKSLD 579 (816)
Q Consensus 503 LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~lV~e~~~~gsL~ 579 (816)
.++|....|+.....+|+.+++|.-+. ......+.+|+++|+.+.. +- +.+++. .....++|++++|..+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~----~~~~~~~y~~i~G~p~~ 92 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRV----HTPELIAYPKLPGVPAA 92 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceee----ecCceEEEeccCCCccc
Confidence 344545556655445688888887642 2234567889999998853 21 122221 12335778888776553
Q ss_pred ccccCCCC--CCCCChhHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 003489 580 SFLFDPQR--QSLLDWPKRFNIIKGISRGLLYLHRD-------------------------------------------- 613 (816)
Q Consensus 580 ~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------------- 613 (816)
..-..... ...........++.++++.|.-||+.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~la~~la~~La~LH~i~~~~~~~~g~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 172 (276)
T cd05152 93 TIDPEIGEYVWNFDHKNPPEVFIESLAKALAELHSIPQDEAEAAGIPVETPEEVRQTMADRMDRVKEEFGVSEALWNRWQ 172 (276)
T ss_pred ccCcccccceecccCCCcCHHHHHHHHHHHHHHhCCChhhccccCCCCCCHHHHHHHHHHHHHHHHHhcCCCHHHHHHHH
Confidence 21100000 00000011122344444444444421
Q ss_pred ----------CCCcEEEeeeCCCcEEEcCCCC-ceeecccccee
Q 003489 614 ----------SRLRIIHRDLKASNILLDDDLN-PKISDFGLARI 646 (816)
Q Consensus 614 ----------~~~~ivH~Dlkp~NILl~~~~~-~kl~DfGla~~ 646 (816)
....++|+|+.+.|||+++++. .-|.||+.+..
T Consensus 173 ~~L~~~~~~~~~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 173 AWLDDDSYWPRHTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred HHHhhcCCCCCCCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 1234899999999999997555 46999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0022 Score=67.10 Aligned_cols=146 Identities=17% Similarity=0.235 Sum_probs=98.5
Q ss_pred cCHHHHHHHhc---CcccccccCCCCceeEEEeEecCCcEEEEEEeccc--------------------Cch--hHHHHH
Q 003489 485 FNFEELANATN---NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--------------------SGQ--GQEEFM 539 (816)
Q Consensus 485 ~~~~el~~~~~---~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~--------------------~~~--~~~~~~ 539 (816)
+.+--|....+ =+.+.++||-|--+.||.+-..+|++.++|.-+-. ++. ..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44444444332 46788999999999999999999999999843210 000 012345
Q ss_pred HHHHHHhhcCC--CceeeeeeEEEecCcceEEEeeCCCCCccccccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCc
Q 003489 540 NEVMVISNLQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617 (816)
Q Consensus 540 ~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 617 (816)
+|+..|+.|.. --+.+.+++ +..++|||++.+-+|...-+ ..+..+ +...+..-+--|..+|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---
Confidence 68888888853 234444443 45689999999888865431 123333 3333444445566667
Q ss_pred EEEeeeCCCcEEEcCCCCceeecccccee
Q 003489 618 IIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 618 ivH~Dlkp~NILl~~~~~~kl~DfGla~~ 646 (816)
+||+|..-=||++++++.++++||-....
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999976543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.011 Score=62.91 Aligned_cols=76 Identities=17% Similarity=0.271 Sum_probs=50.2
Q ss_pred cccccccCCCCceeEEEeEecCCcEEEEEEecccCchhHHHHHHHHHHHhhcC---CCceeeeeeEEEecCcceEEEeeC
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~ 573 (816)
.+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+++++++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445688989999999987 567889999875 344567888999888884 456888999888888889999999
Q ss_pred CCC
Q 003489 574 PNK 576 (816)
Q Consensus 574 ~~g 576 (816)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.021 Score=61.48 Aligned_cols=140 Identities=26% Similarity=0.344 Sum_probs=83.1
Q ss_pred cccCCCCceeEEEeEecC-------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCce-eeeeeEEEecCcceEEEee
Q 003489 501 NKLGQGGFGPVYKGKLQD-------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 572 (816)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+...++ .++++++. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456667777899887654 4788999875533 223455778888888854333 34455443 2368999
Q ss_pred CCCCCcccc-----------------ccCCCCCC------CCC--hhHHHH--------------------------HHH
Q 003489 573 MPNKSLDSF-----------------LFDPQRQS------LLD--WPKRFN--------------------------IIK 601 (816)
Q Consensus 573 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 601 (816)
++|..+... +|+..... ..+ +....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776531 11111110 010 101100 111
Q ss_pred HHHHHHHHHHh------cCCCcEEEeeeCCCcEEEcCC----CCceeeccccce
Q 003489 602 GISRGLLYLHR------DSRLRIIHRDLKASNILLDDD----LNPKISDFGLAR 645 (816)
Q Consensus 602 ~ia~aL~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~DfGla~ 645 (816)
.+...+..|.. .....++|+|+.+.|||++++ +.+++.||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 234569999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.019 Score=62.95 Aligned_cols=141 Identities=19% Similarity=0.267 Sum_probs=81.3
Q ss_pred cccCCCCceeEEEeEecC-----CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCcee-eeeeEEEecCcceEEEeeCC
Q 003489 501 NKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV-RLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~ 574 (816)
+.|-.|-.-.+|+....+ ++.+++|+.......... -.+|..+++.+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 355557777899887532 367889987654432222 26788888888654444 445554322 5899998
Q ss_pred CCCcccc-----------------ccCCCC---CCCCChhHHHHHHHHH-----------------HHHHHHH----Hh-
Q 003489 575 NKSLDSF-----------------LFDPQR---QSLLDWPKRFNIIKGI-----------------SRGLLYL----HR- 612 (816)
Q Consensus 575 ~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i-----------------a~aL~yL----H~- 612 (816)
+.+|..- +|.... .....+.+..++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 121110 0011122222332111 1112222 21
Q ss_pred cCCCcEEEeeeCCCcEEEcC-CCCceeecccccee
Q 003489 613 DSRLRIIHRDLKASNILLDD-DLNPKISDFGLARI 646 (816)
Q Consensus 613 ~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfGla~~ 646 (816)
..+..++|+|+++.|||+++ ++.+.+.||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345899999999999986 46899999988753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.1 Score=57.70 Aligned_cols=73 Identities=11% Similarity=0.101 Sum_probs=51.1
Q ss_pred ccccCCCCceeEEEeEecCCcEEEEEEecccC-------chhHHHHHHHHHHHhhcC---CCceeeeeeEEEecCcceEE
Q 003489 500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS-------GQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 569 (816)
.+.||.|....||+.... ++.++||.-.... +....+-..|++.|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 468999999999998764 5678899764211 123444455677776653 247888888877 557889
Q ss_pred EeeCCC
Q 003489 570 YEYMPN 575 (816)
Q Consensus 570 ~e~~~~ 575 (816)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.01 Score=48.94 Aligned_cols=32 Identities=19% Similarity=0.698 Sum_probs=24.9
Q ss_pred CchhhHHHhhhccCCcceeeccCcc-eeEEeee
Q 003489 359 ANEDKCKDQCSNNCSCKAYAYEIGV-GCMIWTH 390 (816)
Q Consensus 359 ~~~~~C~~~Cl~nCsC~a~~~~~~~-gc~~~~~ 390 (816)
.+.++|++.|+.+|+|.||.|..+. .|.++..
T Consensus 25 ~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 25 SSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 3559999999999999999998544 4554444
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.1 Score=56.00 Aligned_cols=140 Identities=19% Similarity=0.240 Sum_probs=95.1
Q ss_pred cccccCCCCceeEEEeEecCCcEEEEEEecccC---------------------chh-HHH----HHHHHHHHhhcCCCc
Q 003489 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS---------------------GQG-QEE----FMNEVMVISNLQHRN 552 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~~~~~vavK~l~~~~---------------------~~~-~~~----~~~E~~~l~~l~h~n 552 (816)
+...|..|--+-||.+.-.+|..+|||+++-.. ... .+. ...|+..|++|....
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445788899999999999899999999874210 001 111 235778888887655
Q ss_pred eeeeeeEEEecCcceEEEeeCCCCCccc-cccCCCCCCCCChhHHHHHHHHHHHHHHHHHhcCCCcEEEeeeCCCcEEEc
Q 003489 553 LVRLLGCCVEREENMLIYEYMPNKSLDS-FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD 631 (816)
Q Consensus 553 iv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 631 (816)
|.-.-.... ....|||+|+....... .| +...++...+..+-.+++.-|.-|-+.+ .+||.||.--|+|+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence 443322222 23579999995422211 12 2334666778888888888888887665 59999999999887
Q ss_pred CCCCceeeccccceec
Q 003489 632 DDLNPKISDFGLARIF 647 (816)
Q Consensus 632 ~~~~~kl~DfGla~~~ 647 (816)
.+|.+.|+|-+.+...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 4567889998877643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.038 Score=56.03 Aligned_cols=31 Identities=39% Similarity=0.548 Sum_probs=21.9
Q ss_pred CcEEEeeeCCCcEEE-cCCCCceeecccccee
Q 003489 616 LRIIHRDLKASNILL-DDDLNPKISDFGLARI 646 (816)
Q Consensus 616 ~~ivH~Dlkp~NILl-~~~~~~kl~DfGla~~ 646 (816)
..++|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 348999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.0038 Score=76.75 Aligned_cols=161 Identities=15% Similarity=0.022 Sum_probs=114.3
Q ss_pred HHHHHHHHHhhcCCCceeeeeeEEE--ecCcceEEEeeCCCCCccccccCC-CCCCCCChhHHHHHHHHHHHHHHHHHhc
Q 003489 537 EFMNEVMVISNLQHRNLVRLLGCCV--EREENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRD 613 (816)
Q Consensus 537 ~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 613 (816)
....|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|-+. .+...++..-+...-.+...+..-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3445555666678998877655443 234557899999999998887543 2333444444443434435555555554
Q ss_pred CC--CcEEEeeeCCCcEEEcCCCCceeeccccceecCCCCcccccccccccccccChhccccCCCCchhhhHHHHHHHHH
Q 003489 614 SR--LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLE 691 (816)
Q Consensus 614 ~~--~~ivH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlG~vl~e 691 (816)
.. ---+|+++|+-|.+|..+.++++.++|+.++.. ..........+++-|++|++...-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 32 237899999999999999999999999998432 22223334567888999999999999999999999999999
Q ss_pred HHhCCCCC
Q 003489 692 IVSGRKNT 699 (816)
Q Consensus 692 lltG~~p~ 699 (816)
..-|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.13 Score=56.09 Aligned_cols=72 Identities=15% Similarity=0.189 Sum_probs=48.2
Q ss_pred ccCCCCceeEEEeEecCC-cEEEEEEecc-------cCchhHHHHHHHHHHHhhcC--CCc-eeeeeeEEEecCcceEEE
Q 003489 502 KLGQGGFGPVYKGKLQDG-QEIAVKRLSK-------ASGQGQEEFMNEVMVISNLQ--HRN-LVRLLGCCVEREENMLIY 570 (816)
Q Consensus 502 ~LG~G~~g~Vy~g~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV~ 570 (816)
.||.|....||++..+++ +.|+||.-.+ .-+...++..-|.+.|+... -|. +++++. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999997654 5899996432 11334556667888886653 343 444443 3555667999
Q ss_pred eeCCC
Q 003489 571 EYMPN 575 (816)
Q Consensus 571 e~~~~ 575 (816)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 816 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-38 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-24 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-24 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-23 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-23 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-21 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-20 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-20 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-20 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-149
Identities = 122/292 (41%), Positives = 174/292 (59%), Gaps = 5/292 (1%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE-EFMNEV 542
F+ EL A++NF N LG+GGFG VYKG+L DG +AVKRL + QG E +F EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIK 601
+IS HRNL+RL G C+ E +L+Y YM N S+ S L + P+ Q LDWPKR I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
G +RGL YLH +IIHRD+KA+NILLD++ + DFGLA++ T + G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFYHEEFELTLLGYAWKLWN 719
T G+++PEY G+ SEK+DVF +GV+LLE+++G++ + + ++ LL + L
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 720 DNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771
+ + LVD + + E+ + + V LLC Q +RP M VV ML +
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-149
Identities = 105/301 (34%), Positives = 160/301 (53%), Gaps = 19/301 (6%)
Query: 481 DLLVFNFEELANATNNF------QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSK----A 530
F+F EL N TNNF NK+G+GGFG VYKG + + +AVK+L+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
+ + +++F E+ V++ QH NLV LLG + ++ L+Y YMPN SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
L W R I +G + G+ +LH + IHRD+K++NILLD+ KISDFGLAR
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTL 710
T R+VGT YM+PE + G + KSD++SFGV+LLEI++G + E L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243
Query: 711 LGYAWKLWNDN-NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769
L ++ ++ + D +D ++++ + +V C+ E RP++ V +L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 770 S 770
Sbjct: 303 E 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-126
Identities = 106/285 (37%), Positives = 163/285 (57%), Gaps = 4/285 (1%)
Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMV 544
+L ATNNF +G G FG VYKG L+DG ++A+KR + S QG EEF E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGI 603
+S +H +LV L+G C ER E +LIY+YM N +L L+ ++ + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
+RGL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723
GY+ PEY ++GR +EKSDV+SFGV+L E++ R + L +A + N+ +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768
+VDP +++ + + + + C+ +DRP+M V+ L
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = 9e-98
Identities = 71/311 (22%), Positives = 126/311 (40%), Gaps = 34/311 (10%)
Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMV 544
E L + QL +G FG V+K +L + +AVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 545 ISNLQHRNLVRLLGCCVE----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
+ ++H N+++ +G + LI + SL FL + +++ W + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 601 KGISRGLLYLHRD-------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
+ ++RGL YLH D + I HRD+K+ N+LL ++L I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 654 AATKRLVGTYGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
T VGT YM+PE + D+++ G++L E+ S +E+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM- 246
Query: 709 TLLGYAWKLWNDNN--------VIDLVDPLISESGFKMEIIRCV-NVGLLCVQEFVKDRP 759
L + ++ + V P++ + K + + C + R
Sbjct: 247 --LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 760 NMPTVVSMLNS 770
+ V +
Sbjct: 305 SAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 5e-84
Identities = 77/337 (22%), Positives = 132/337 (39%), Gaps = 45/337 (13%)
Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--V 542
E + +N +L +G+G +G VYKG L D + +AVK S A+ Q F+NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 543 MVISNLQHRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
+ ++H N+ R + + +L+ EY PN SL +L DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 598 NIIKGISRGLLYLHRD------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN- 650
+ ++RGL YLH + + I HRDL + N+L+ +D ISDFGL+ GN
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 651 -----QDQAATKRLVGTYGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVSGRKN 698
++ A VGT YM+PE ++ D+++ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 699 TSFYHEEFELTLLGYAWKLWNDNNVIDLVD--------PLISESGFKMEIIRCVNVGLL- 749
E + + ++ N D+ P E+ + + +
Sbjct: 235 LFPGESVPEY-QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 750 -CVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTV 785
C + + R + + K + T
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 72/316 (22%), Positives = 120/316 (37%), Gaps = 49/316 (15%)
Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVM 543
F +L LG+G FG K + G+ + +K L + + Q F+ EV
Sbjct: 7 FRPSDL-------IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
V+ L+H N+++ +G + + I EY+ +L + Q W +R + K I
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDI 117
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR----- 658
+ G+ YLH + IIHRDL + N L+ ++ N ++DFGLAR+ + Q R
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 659 -------LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
+VG +M+PE + EK DVFSFG++L EI+
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR---------------- 218
Query: 712 GYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLL-----CVQEFVKDRPNMPTVVS 766
A + + ++ C + RP+ +
Sbjct: 219 VNADPDYLPRTMDFGLN---VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 767 MLNSEIKDLPAAKQPA 782
L + L
Sbjct: 276 WLETLRMHLAGHLPLG 291
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-65
Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 29/290 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
++ +G+G FG V K K + +++A+K++ S ++ F+ E+ +S + H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L G C+ L+ EY SL + L + + S+G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 615 RLRIIHRDLKASNILLDDDLN-PKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
+IHRDLK N+LL KI DFG A + T G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177
Query: 674 GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN--NVIDLVDPLI 731
+SEK DVFS+G++L E+++ RK + +E W + N +I + I
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQP 781
++ C + RP+M +V ++ ++ P A +P
Sbjct: 234 E------SLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-65
Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 38/292 (13%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVM 543
+ +L + K+G G FG V++ + G ++AVK L + EF+ EV
Sbjct: 35 PWCDL-------NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
++ L+H N+V +G + ++ EY+ SL L + LD +R ++ +
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
++G+ YLH I+HR+LK+ N+L+D K+ DFGL+R+ ++K GT
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTP 203
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723
+M+PE + +EKSDV+SFGV+L E+ + + + W + N
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ-------------------QPWGNLNP 244
Query: 724 IDLVDPLISESGFKMEIIRCVNVGLL-----CVQEFVKDRPNMPTVVSMLNS 770
+V + ++EI R +N + C RP+ T++ +L
Sbjct: 245 AQVVA-AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 7e-62
Identities = 72/223 (32%), Positives = 107/223 (47%), Gaps = 28/223 (12%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL----SKASGQGQEEFMNE 541
+F EL L +G GGFG VY+ G E+AVK + Q E E
Sbjct: 5 DFAEL-------TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
+ + L+H N++ L G C++ L+ E+ L+ L + + N
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAV 112
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP--------KISDFGLARIFGGNQDQ 653
I+RG+ YLH ++ + IIHRDLK+SNIL+ + KI+DFGLAR +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHR 168
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
G Y +M+PE FS+ SDV+S+GVLL E+++G
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-61
Identities = 77/316 (24%), Positives = 134/316 (42%), Gaps = 55/316 (17%)
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ 533
+ L E+ + ++G+GGFG V+KG+L D +A+K L +
Sbjct: 6 SEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE 58
Query: 534 GQ-------EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ 586
G+ +EF EV ++SNL H N+V+L G ++ E++P L L D
Sbjct: 59 GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA 116
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-----DDLNPKISDF 641
+ W + ++ I+ G+ Y+ + I+HRDL++ NI L + K++DF
Sbjct: 117 HP--IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 642 GLARIFGGNQDQAATKRLVGTYGYMSPE--YAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 699
GL++ + L+G + +M+PE A E ++EK+D +SF ++L I++G
Sbjct: 174 GLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-- 226
Query: 700 SFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLL-----CVQEF 754
+ E + + I E G + I L C
Sbjct: 227 -PFD---EYSYGKIKFINM------------IREEGLRPTIPEDCPPRLRNVIELCWSGD 270
Query: 755 VKDRPNMPTVVSMLNS 770
K RP+ +V L+
Sbjct: 271 PKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-61
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVM 543
+F++L KL + G ++KG+ Q G +I VK L S + +F E
Sbjct: 8 DFKQL-------NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECP 59
Query: 544 VISNLQHRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
+ H N++ +LG C LI +MP SL + L + ++D +
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFAL 118
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
++RG+ +LH L I L + ++++D+D+ +IS + F + +
Sbjct: 119 DMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMY 170
Query: 662 TYGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGR 696
+++PE A++ + +D++SF VLL E+V+
Sbjct: 171 APAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-60
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 22/217 (10%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVM 543
++ + ++G G FG VYKGK ++AVK L+ + Q + F NEV
Sbjct: 22 PDGQI-------TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 544 VISNLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
V+ +H N++ +G + ++ ++ SL L + + + K +I +
Sbjct: 73 VLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQ 128
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+RG+ YLH IIHRDLK++NI L +D KI DFGLA ++L G+
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 663 YGYMSPE---YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+M+PE +S +SDV++FG++L E+++G+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 78/342 (22%), Positives = 134/342 (39%), Gaps = 57/342 (16%)
Query: 460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
L L A + LQ+ + FE+L ++ +G+G FG VY G+
Sbjct: 6 LSLLSARSFPRKASQTSIFLQEWDI-PFEQL-------EIGELIGKGRFGQVYHGRWH-- 55
Query: 520 QEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577
E+A++ + + + + F EVM +H N+V +G C+ +I ++
Sbjct: 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637
L S + D + LD K I + I +G+ YLH I+H+DLK+ N+ D+
Sbjct: 116 LYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVV 169
Query: 638 ISDFGLARIFGGNQDQAATKRL---VGTYGYMSPE---------YAMEGRFSEKSDVFSF 685
I+DFGL I G Q +L G +++PE + FS+ SDVF+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 686 GVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRC-- 743
G + E+ + +K +I + +G K + +
Sbjct: 230 GTIWYELHAREW----------------PFKTQPAEAIIWQM-----GTGMKPNLSQIGM 268
Query: 744 ----VNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQP 781
++ L C ++RP ++ ML K P
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-56
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVR 555
L +G+G +G V++G Q G+ +AVK S + ++ + E + L+H N++
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILG 66
Query: 556 LLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
+ + + LI Y SL +L + + LD I+ I+ GL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 612 RDSRLR-----IIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQDQAATKRLVGTYG 664
+ I HRDLK+ NIL+ + I+D GLA + NQ VGT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 665 YMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
YM+PE ++ D+++FG++L E+ R ++ E+++
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKP 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 36/299 (12%)
Query: 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVR 555
Q+ ++G+G +G V+ GK + G+++AVK + + E + ++H N++
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILG 95
Query: 556 LLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
+ ++ + LI +Y N SL +L + + LD + GL +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 612 RDSRLR-----IIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQDQAATKRLVGTYG 664
+ I HRDLK+ NIL+ + I+D GLA F N+ VGT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 665 YMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLW 718
YM PE + +D++SFG++L E+ R + EE++L
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDP 270
Query: 719 NDNNVIDLVD-----PLISESGFKMEIIRCVNVGLL--CVQEFVKDRPNMPTVVSMLNS 770
+ ++ ++V P E +R + L+ C R V L
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-54
Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVR 555
L +G+G FG V++GK + G+E+AVK S + + + E + L+H N++
Sbjct: 45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILG 100
Query: 556 LLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
+ + L+ +Y + SL +L + + + + GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 612 RD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQDQAATKRLVGTYG 664
+ + I HRDLK+ NIL+ + I+D GLA + A VGT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 665 YMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFEL 708
YM+PE ++ +++D+++ G++ EI R + HE+++L
Sbjct: 217 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 9e-53
Identities = 68/254 (26%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
+ + +LG+G FG V + G+ +AVK+L ++ + +F E+ ++ +LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
H N+V+ G C LI EY+P SL +L + + +D K I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GY 665
YL R IHRDL NIL++++ KI DFGL ++ +++ + G +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFW 214
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725
+PE E +FS SDV+SFGV+L E+ + + + EF + ++I+
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 726 LVDPLISESGFKME 739
L+ ++ ++
Sbjct: 275 LL-----KNNGRLP 283
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 68/254 (26%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
+ + +LG+G FG V + G+ +AVK+L ++ + +F E+ ++ +LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
H N+V+ G C LI EY+P SL +L + + +D K I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GY 665
YL R IHRDL NIL++++ KI DFGL ++ +++ + G +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPIFW 183
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725
+PE E +FS SDV+SFGV+L E+ + + + EF + ++I+
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 726 LVDPLISESGFKME 739
L+ ++ ++
Sbjct: 244 LL-----KNNGRLP 252
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-52
Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 38/290 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRN 552
+ L ++G+G FG V+ G+L+ D +AVK + +F+ E ++ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+VRL+G C +++ ++ E + +FL + L ++ + G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
IHRDL A N L+ + KISDFG++R A+ + +PE
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 673 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG---YAWKLWNDNNVIDLVDP 729
GR+S +SDV+SFG+LL E S LG Y ++ + V
Sbjct: 289 YGRYSSESDVWSFGILLWETFS----------------LGASPYPN--LSNQQTREFV-- 328
Query: 730 LISESGFKMEI-----IRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774
E G ++ + C RP+ T+ L S K
Sbjct: 329 ---EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-52
Identities = 82/321 (25%), Positives = 141/321 (43%), Gaps = 35/321 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
+ + ++LG+G FG V + G +AVK+L + Q +F E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
+V+ G L+ EY+P+ L FL + ++ LD + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG--- 664
YL R +HRDL A NIL++ + + KI+DFGLA++ ++D V G
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSP 193
Query: 665 --YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDN 721
+ +PE + FS +SDV+SFGV+L E+ + K S L ++G + +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGCERDVPALS 251
Query: 722 NVIDLVDPLISESGFKMEI-----IRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
+++L+ E G ++ + LC +DRP+ + L+
Sbjct: 252 RLLELL-----EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
Query: 777 AAKQPAFT-VRRGAYDSASSS 796
+ AFT G + S S S
Sbjct: 307 GCETHAFTAHPEGKHHSLSFS 327
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 32/259 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL---QDGQEI--AVKRL-SKASGQGQEEFMNEVMVISNL 548
+ LG+G FG V DG AVK L + A Q + + E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 549 QHRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
H ++++ GCC + L+ EY+P SL +L + + + + I G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG-- 664
+ YLH IHRDL A N+LLD+D KI DFGLA+ + V G
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDS 199
Query: 665 ---YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWND 720
+ +PE E +F SDV+SFGV L E+++ + S + EL + ++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTV- 257
Query: 721 NNVIDLVDPLISESGFKME 739
+ +L+ E G ++
Sbjct: 258 LRLTELL-----ERGERLP 271
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-51
Identities = 63/256 (24%), Positives = 121/256 (47%), Gaps = 24/256 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL 548
+ LG+G FG V + G+++AVK L ++ G + E+ ++ NL
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 549 QHRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
H N+V+ G C E N LI E++P+ SL +L P+ ++ ++ ++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--G 664
+ YL + +HRDL A N+L++ + KI DFGL + +++ T +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVF 194
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNV 723
+ +PE M+ +F SDV+SFGV L E+++ ++S ++ + +
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ--MTVTRL 252
Query: 724 IDLVDPLISESGFKME 739
++ + + G ++
Sbjct: 253 VNTL-----KEGKRLP 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
L +LG G FG V GK + ++AVK + K ++EF E + L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+ G C + ++ EY+ N L ++L L+ + + + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY--MSPEYAM 672
+ IHRDL A N L+D DL K+SDFG+ R D + + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 673 EGRFSEKSDVFSFGVLLLEIVS-GRK 697
++S KSDV++FG+L+ E+ S G+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 1e-50
Identities = 80/312 (25%), Positives = 138/312 (44%), Gaps = 59/312 (18%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
+ L +LG+G FG V+ + +D +AVK L + +++F E +++NL
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLLDWPK 595
QH ++V+ G C + + ++++EYM + L+ FL Q + L +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+I I+ G++YL + +HRDL N L+ +L KI DFG++R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDY 188
Query: 656 TKRLVGTYG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTL 710
+ VG + +M PE M +F+ +SDV+SFGV+L EI +
Sbjct: 189 YR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------- 230
Query: 711 LGYA-WKLWNDNNVIDLVDPLISESGFKMEIIRCV-----NVGLLCVQEFVKDRPNMPTV 764
G W ++ VI+ + G +E R +V L C Q + R N+ +
Sbjct: 231 YGKQPWFQLSNTEVIECI-----TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285
Query: 765 VSMLNSEIKDLP 776
+L++ K P
Sbjct: 286 YKILHALGKATP 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ ++G G FG V+ G + ++A+K + + +E+F+ E V+ L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L G C+E+ L+ E+M + L +L ++ L + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYA 671
+IHRDL A N L+ ++ K+SDFG+ R +Q ++T GT + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 177
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS-GRK 697
R+S KSDV+SFGVL+ E+ S G+
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-50
Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 32/280 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
+ + +KLG G +G VY+G + +AVK L K EEF+ E V+ ++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
V+LLG C +I E+M +L +L + RQ + + IS + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL--- 334
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
+ IHR+L A N L+ ++ K++DFGL+R+ G+ A + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 674 GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733
+FS KSDV++FGVLL EI + S Y + + V +L+ E
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT--YGMSPYPG-------------IDLSQVYELL-----E 433
Query: 734 SGFKMEIIR-CV----NVGLLCVQEFVKDRPNMPTVVSML 768
++ME C + C Q DRP+ +
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +LG G FG V GK + ++A+K + K ++EF+ E V+ NL H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L G C ++ +I EYM N L ++L + + + + + K + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL---E 137
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYA 671
+ +HRDL A N L++D K+SDFGL+R ++ ++ G+ + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVL 193
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS 694
M +FS KSD+++FGVL+ EI S
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG-QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
+ + +KLG G +G VY+G + +AVK L K EEF+ E V+ ++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
V+LLG C +I E+M +L +L + RQ + + IS + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL--- 127
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK-----RLVGTYGYMSP 668
+ IHRDL A N L+ ++ K++DFGL+R+ G+ A + + +P
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVS 694
E +FS KSDV++FGVLL EI +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 75/202 (37%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +LG G FG V+ G ++AVK L K + F+ E ++ LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
RL + E +I EYM N SL FL P L K ++ I+ G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---E 126
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY--MSPEYAM 672
IHRDL+A+NIL+ D L+ KI+DFGLAR+ +D T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAIN 183
Query: 673 EGRFSEKSDVFSFGVLLLEIVS 694
G F+ KSDV+SFG+LL EIV+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-50
Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 47/298 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +L KLG G FG V+ ++AVK + K E F+ E V+ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L + E +I E+M SL FL + PK + I+ G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---E 301
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYMSPEYA 671
+ IHRDL+A+NIL+ L KI+DFGLAR+ N+ A G + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAI 357
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730
G F+ KSDV+SFG+LL+EIV+ GR Y ++ VI +
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRI--------------PYPG--MSNPEVIRAL--- 398
Query: 731 ISESGFKMEIIRCV-----NVGLLCVQEFVKDRPNMPTVVSML-------NSEIKDLP 776
E G++M N+ + C + ++RP + S+L S+ +++P
Sbjct: 399 --ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-50
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRL-SKASGQGQEEFMNEVMVISNLQ 549
+ + +G G G V G+L+ +++ A+K L + + + + +F++E ++
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H N++RL G M++ EYM N SLD+FL Q + +++G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG----- 664
L S L +HRDL A N+L+D +L K+SDFGL+R+ + D A T G
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPI 218
Query: 665 -YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
+ +PE FS SDV+SFGV++ E+++ G +
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 63/216 (29%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSK-ASGQGQEEFMNEVMVISNL 548
+ +G G FG VYKG L+ +A+K L + + + +F+ E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
H N++RL G + + M+I EYM N +LD FL + + + +++GI+ G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 161
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG---- 664
YL + + +HRDL A NIL++ +L K+SDFGL+R+ + + T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 665 --YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
+ +PE +F+ SDV+SFG+++ E+++ G +
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 75/312 (24%), Positives = 131/312 (41%), Gaps = 58/312 (18%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRLSKASGQGQEEFMNEVMVISNL 548
+ L +LG+G FG V+ + + +AVK L +AS +++F E +++ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL------------FDPQRQSLLDWPKR 596
QH+++VR G C E ++++EYM + L+ FL + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
+ ++ G++YL + L +HRDL N L+ L KI DFG++R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYY 214
Query: 657 KRLVGTYG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
+ G +M PE + +F+ +SDV+SFGV+L EI +
Sbjct: 215 RV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------------Y 256
Query: 712 GYA-WKLWNDNNVIDLVDPLISESGFKMEI-IRCV----NVGLLCVQEFVKDRPNMPTVV 765
G W ++ ID + G ++E C + C Q + R ++ V
Sbjct: 257 GKQPWYQLSNTEAIDCI-----TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311
Query: 766 SMLNSEIKDLPA 777
+ L + + P
Sbjct: 312 ARLQALAQAPPV 323
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 31/219 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
F+ LG G FG VYKG E +A+K L +A+ +E ++E V++++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ----SLLDWPKRFNIIKGIS 604
+ ++ RLLG C+ LI + MP L ++ + + LL+W I+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G + + + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 665 -----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
+M+ E + ++ +SDV+S+GV + E+++ G K
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 83/307 (27%), Positives = 135/307 (43%), Gaps = 60/307 (19%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
+ + +LG+ FG VYKG L Q +A+K L A G +EEF +E M+ +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLLDWP 594
LQH N+V LLG + + +I+ Y + L FL D +S L+ P
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
+++ I+ G+ YL S ++H+DL N+L+ D LN KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAAD 182
Query: 655 ATKRLVGTYG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT 709
K + +M+PE M G+FS SD++S+GV+L E+ S
Sbjct: 183 YYK--LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--------------- 225
Query: 710 LLGYA-WKLWNDNNVIDLVDPLISESGFKMEI-IRC----VNVGLLCVQEFVKDRPNMPT 763
G + +++ +V++++ + + C + + C EF RP
Sbjct: 226 -YGLQPYCGYSNQDVVEMI-----RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 279
Query: 764 VVSMLNS 770
+ S L +
Sbjct: 280 IHSRLRA 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-49
Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 34/282 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +L KLGQG FG V+ G +A+K L K E F+ E V+ L+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L E E ++ EYM SL FL + L P+ ++ I+ G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYV---E 297
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
R+ +HRDL+A+NIL+ ++L K++DFGLAR+ N+ A + +PE A+ G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 675 RFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733
RF+ KSDV+SFG+LL E+ + GR + + V+D V E
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRV----------------PYPGMVNREVLDQV-----E 395
Query: 734 SGFKMEIIRCV-----NVGLLCVQEFVKDRPNMPTVVSMLNS 770
G++M ++ C ++ ++RP + + L
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-49
Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 34/282 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +L KLGQG FG V+ G +A+K L K E F+ E V+ L+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L E E ++ EYM SL FL + L P+ ++ I+ G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYV---E 380
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
R+ +HRDL+A+NIL+ ++L K++DFGLAR+ N+ A + +PE A+ G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 675 RFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733
RF+ KSDV+SFG+LL E+ + GR + + V+D V E
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRV----------------PYPGMVNREVLDQV-----E 478
Query: 734 SGFKMEIIRCV-----NVGLLCVQEFVKDRPNMPTVVSMLNS 770
G++M ++ C ++ ++RP + + L
Sbjct: 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-49
Identities = 71/212 (33%), Positives = 115/212 (54%), Gaps = 16/212 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQ 549
N + +G G FG V G+L+ +EI A+K L + + + +F+ E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H N++RL G + + M++ EYM N SLDSFL Q + +++GI+ G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKY 162
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT---YGYM 666
L S + +HRDL A NIL++ +L K+SDFGL R+ + + A T R G +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWT 217
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
SPE +F+ SDV+S+G++L E++S G +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-49
Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +G+G FG V G + G ++AVK + + + F+ E V++ L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 77
Query: 555 RLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+LLG VE + ++ EYM SL +L R L + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 133
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG------YMS 667
+HRDL A N+L+ +D K+SDFGL + + ++T + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASST-----QDTGKLPVKWTA 182
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
PE E +FS KSDV+SFG+LL EI S GR
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 498 QLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
+G+G FG VY G+ D + A+K LS+ Q E F+ E +++ L H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 553 LVRLLGCCVEREE-NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
++ L+G + E ++ YM + L F+ PQR + ++RG+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL- 140
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG-----YM 666
+ + +HRDL A N +LD+ K++DFGLAR D+ + +
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWT 195
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ E RF+ KSDV+SFGVLL E+++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-48
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +G+G FG V G + G ++AVK + + + F+ E V++ L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 555 RLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+LLG VE + ++ EYM SL +L R L + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 305
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG-----YMSP 668
+HRDL A N+L+ +D K+SDFGL + + ++T+ G + +P
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQ----DTGKLPVKWTAP 355
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVS 694
E E +FS KSDV+SFG+LL EI S
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQ 549
+ L LG+G FG VY+G G++I AVK K + +E+FM+E +++ NL
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H ++V+L+G E E +I E P L +L + L I + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAY 128
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMS 667
L + +HRD+ NIL+ K+ DFGL+R +D+ K V +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMS 182
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
PE RF+ SDV+ F V + EI+S G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 498 QLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
+G+G FG VY G L D AVK L++ +F+ E +++ + H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 553 LVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
++ LLG C+ E + +++ YM + L +F+ + +++G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL- 144
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYG-----Y 665
+ + +HRDL A N +LD+ K++DFGLAR ++ K T +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----TGAKLPVKW 198
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
M+ E +F+ KSDV+SFGVLL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 88/301 (29%), Positives = 136/301 (45%), Gaps = 46/301 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
N L LG G FG VY+G++ ++AVK L + S Q + +F+ E ++IS
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGI 603
H+N+VR +G ++ ++ E M L SFL P + S L ++ + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR-IFGGNQDQAATKRL 659
+ G YL IHRD+ A N LL KI DFG+AR I+ + + +
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA-WKLW 718
+ +M PE MEG F+ K+D +SFGVLL EI S LGY +
Sbjct: 207 LP-VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------------LGYMPYPSK 249
Query: 719 NDNNVIDLVDPLISESGFKMEIIR-CV----NVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773
++ V++ V SG +M+ + C + C Q +DRPN ++ + +
Sbjct: 250 SNQEVLEFV-----TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
Query: 774 D 774
D
Sbjct: 305 D 305
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKG--KLQDGQEI--AVKRL---SKASGQGQEEFMNEVMVISN 547
+ +L KLG G FG V +G G+ + AVK L + + ++F+ EV + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ----SLLDWPKRFNIIKGI 603
L HRNL+RL G + ++ E P SL L Q +L + +
Sbjct: 78 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQV 130
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT- 662
+ G+ YL R IHRDL A N+LL KI DFGL R N D +
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRK 185
Query: 663 --YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
+ + +PE FS SD + FGV L E+ + G++
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRLSK-ASGQGQEEFMNEVMVISN 547
++ +LGQG FG VY+G + + +A+K +++ AS + + EF+NE V+
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNII 600
++VRLLG + + ++I E M L S+L + + K +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
I+ G+ YL + + +HRDL A N ++ +D KI DFG+ R I+ + + K L
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 660 --VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA-WK 716
V +MSPE +G F+ SDV+SFGV+L EI + L ++
Sbjct: 202 LPVR---WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LAEQPYQ 242
Query: 717 LWNDNNVIDLVDPLISESGFKMEI-----IRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771
++ V+ V G ++ + +C Q K RP+ ++S + E
Sbjct: 243 GLSNEQVLRFV-----MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 772 IKD 774
++
Sbjct: 298 MEP 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQ 549
+L +G+G FG V++G + + A+K S +E+F+ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H ++V+L+G +I E L SFL + LD +S L Y
Sbjct: 75 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 131
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMS 667
L R +HRD+ A N+L+ + K+ DFGL+R +D K G +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMA 185
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
PE RF+ SDV+ FGV + EI+ G K
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
+ LG G FG V+KG E + +K + SG+ + + ++ I +L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ----SLLDWPKRFNIIKGIS 604
H ++VRLLG C L+ +Y+P SL + + LL+W I+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIA 125
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY- 663
+G+ YL ++HR+L A N+LL +++DFG+A + D
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL--PPDDKQLLYSEAKTP 180
Query: 664 -GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
+M+ E G+++ +SDV+S+GV + E+++ G +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVIS 546
+ LGQG F ++KG ++ E+ +K L KA E F ++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 547 NLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
L H++LV G CV +EN+L+ E++ SLD++L + ++ + + K ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAA 125
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNP--------KISDFGLARIFGGNQDQAATKR 658
+ +L +IH ++ A NILL + + K+SD G++
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 659 LVGTYGY-----MSPEYAMEGR-FSEKSDVFSFGVLLLEIVS-GRK 697
+ PE + + +D +SFG L EI S G K
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 74/307 (24%), Positives = 129/307 (42%), Gaps = 54/307 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSK--ASGQGQEEFMNEVMVISNL 548
N L LG+G FG V +G L+ +AVK + +S + EEF++E + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 549 QHRNLVRLLGCCVERE-----ENMLIYEYMPNKSLDSFL---FDPQRQSLLDWPKRFNII 600
H N++RLLG C+E + M+I +M L ++L + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
I+ G+ YL S +HRDL A N +L DD+ ++DFGL++ I+ G+ +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 660 --VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG---YA 714
V +++ E + ++ KSDV++FGV + EI + G Y
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------------RGMTPYP 251
Query: 715 WKLWNDNNVIDLVDPLISESGFKMEI-IRC----VNVGLLCVQEFVKDRPNMPTVVSMLN 769
++ + D + G +++ C + C + DRP + L
Sbjct: 252 G--VQNHEMYDYL-----LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 770 SEIKDLP 776
++ LP
Sbjct: 305 KLLESLP 311
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-47
Identities = 70/223 (31%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE---IAVKRL-SKASGQGQEEFMNEVMVISNL-Q 549
N+ + + +G+G FG V K +++ A+KR+ AS +F E+ V+ L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIK- 601
H N++ LLG C R L EY P+ +L FL DP + +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 602 -----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
++RG+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R +
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 196
Query: 657 KRLVGTYG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
K+ T G +M+ E ++ SDV+S+GVLL EIVS
Sbjct: 197 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-47
Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 46/301 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
N L LG G FG VY+G++ ++AVK L + S Q + +F+ E ++IS
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGI 603
H+N+VR +G ++ ++ E M L SFL P + S L ++ + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR-IFGGNQDQAATKRL 659
+ G YL IHRD+ A N LL KI DFG+AR I+ + +
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA-WKLW 718
+ +M PE MEG F+ K+D +SFGVLL EI S LGY +
Sbjct: 248 LPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------------LGYMPYPSK 290
Query: 719 NDNNVIDLVDPLISESGFKMEIIR-CV----NVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773
++ V++ V SG +M+ + C + C Q +DRPN ++ + +
Sbjct: 291 SNQEVLEFV-----TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
Query: 774 D 774
D
Sbjct: 346 D 346
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
F+ LG G FG VYKG E +A+K L +A+ +E ++E V++++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
+ ++ RLLG C+ LI + MP L ++ + + + N I++G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG---- 664
YL R++HRDL A N+L+ + KI+DFGLA++ G + + + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 665 -YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 697
+M+ E + ++ +SDV+S+GV + E+++ G K
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-47
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 498 QLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
+G+G FG VY G L D AVK L++ +F+ E +++ + H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 553 LVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
++ LLG C+ E + +++ YM + L +F+ + +++G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL- 208
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG-----YM 666
+ + +HRDL A N +LD+ K++DFGLAR + + + T +M
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWM 263
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ E +F+ KSDV+SFGVLL E+++
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 48/295 (16%)
Query: 502 KLGQGGFGPVYKGKLQDGQE---IAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
+LG G FG V +G + ++ +A+K L + EE M E ++ L + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G C + E ML+ E L FL + + + ++ +S G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG------YMSPEYA 671
+HRDL A N+LL + KISDFGL++ G + + + +PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185
Query: 672 MEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730
+FS +SDV+S+GV + E +S G+K +K V+ +
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK----------------PYKKMKGPEVMAFI--- 226
Query: 731 ISESGFKMEI-IRCV----NVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQ 780
E G +ME C + C +DRP+ TV + + L + +
Sbjct: 227 --EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-46
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSK--ASGQGQEEFMNEVMVISNL 548
F L LG+G FG V + +L+ ++AVK L + EEF+ E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 549 QHRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFLFD---PQRQSLLDWPKRFNI 599
H ++ +L+G + M+I +M + L +FL + L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKR 658
+ I+ G+ YL S IHRDL A N +L +D+ ++DFGL+R I+ G+ +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 659 L--VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
V +++ E + ++ SDV++FGV + EI++
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRL-SKASGQGQEEFMNEVMVISN 547
NN + +G+G FG V++ + +AVK L +AS Q +F E +++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------------FDPQ 586
+ N+V+LLG C + L++EYM L+ FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR- 645
L ++ I + ++ G+ YL S + +HRDL N L+ +++ KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 646 IFGGNQDQAATKRLVGTYGY----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
I+ + +A + M PE R++ +SDV+++GV+L EI S
Sbjct: 224 IYSADYYKADGNDAI-----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRL-SKASGQGQEEFMNEVMVISN 547
NN Q LG G FG V + + +AVK L S A +E M+E+ ++S+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDWPK 595
L QH N+V LLG C ++I EY L +FL S
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQA 654
+ +++G+ +L + IHRD+ A N+LL + KI DFGLAR I +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +M+PE + ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 495 NNFQLANK-LGQGGFGPVYKGKLQDG---QEIAVKRLSKA--SGQGQEEFMNEVMVISNL 548
L +K LG G FG V KG Q + +AVK L ++E + E V+ L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
+ +VR++G C E E ML+ E L+ +L Q+ + ++ +S G+
Sbjct: 76 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMK 131
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG---- 664
YL +HRDL A N+LL KISDFGL++ +++ +
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWP 183
Query: 665 --YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDN 721
+ +PE +FS KSDV+SFGVL+ E S G+K ++ +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----------------PYRGMKGS 227
Query: 722 NVIDLVDPLISESGFKMEI-----IRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
V ++ E G +M ++ LC V++RP V L + D+
Sbjct: 228 EVTAML-----EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282
Query: 777 AAKQ 780
Sbjct: 283 NEGH 286
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 37/231 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRL-SKASGQGQEEFMNEVMVISN 547
N L LG+G FG V K +AVK L AS + ++E V+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG--- 602
+ H ++++L G C + +LI EY SL FL + L N
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 603 ----------------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR- 645
IS+G+ YL + ++++HRDL A NIL+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 646 IFGGNQDQAATKRL--VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
++ + ++ V +M+ E + ++ +SDV+SFGVLL EIV+
Sbjct: 200 VYEEDSYVKRSQGRIPV---KWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRL-SKASGQGQEEFMNEVMVI 545
+ L LG+G FG V + +AVK L A+ + + ++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLL 591
+ +H+N++ LLG C + +I EY +L +L + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN 650
+ + ++RG+ YL + + IHRDL A N+L+ ++ KI+DFGLAR I +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 651 QDQAATKRLVGTYGY----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ T + M+PE + ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRL-SKASGQGQEEFMNEVMVI 545
+ L LG+G FG V + +AVK L A+ + + ++E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLL 591
+ +H+N++ LLG C + +I EY +L +L + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN 650
+ + ++RG+ YL + + IHRDL A N+L+ ++ KI+DFGLAR I +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 651 QDQAATKRLVGTYGY----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ T + M+PE + ++ +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRL-SKASGQGQEEFMNEVMVISN 547
N LG G FG V + + +AVK L A +E M+E+ V+S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQSLL 591
L H N+V LLG C ++I EY L +FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN 650
D + +++G+ +L + IHRDL A NILL KI DFGLAR I +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +M+PE ++ +SDV+S+G+ L E+ S
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-45
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
+ +L LG+G FG V + + +AVK L A+ M+E+ ++ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 548 L-QHRNLVRLLGCCVEREE-NMLIYEYMPNKSLDSFL-------------FDPQRQSLLD 592
+ H N+V LLG C + M+I E+ +L ++L + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQ 651
+++G+ +L + + IHRDL A NILL + KI DFGLAR I+
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 652 DQAATKRL--VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ +M+PE + ++ +SDV+SFGVLL EI S
Sbjct: 204 YVRKGDARLPL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-44
Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 44/301 (14%)
Query: 502 KLGQGGFGPVYKGKLQDGQE---IAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
+LG G FG V +G + ++ +A+K L EE M E ++ L + +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
G C + E ML+ E L FL + + + ++ +S G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD----QAATKRLVGTYGYMSPEYAME 673
+HR+L A N+LL + KISDFGL++ G + ++A K + + +PE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPECINF 513
Query: 674 GRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732
+FS +SDV+S+GV + E +S G+K +K V+ +
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQK----------------PYKKMKGPEVMAFI----- 552
Query: 733 ESGFKMEI-IRCV----NVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPAFTVRR 787
E G +ME C + C +DRP+ TV + + L + + +
Sbjct: 553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEV 612
Query: 788 G 788
Sbjct: 613 A 613
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-44
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 32/226 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRL-SKASGQGQEEFMNEVMVI 545
+ L LG+G FG V + ++AVK L S A+ + + ++E+ ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLL 591
+ +H+N++ LLG C + +I EY +L +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN 650
+ ++RG+ YL + + IHRDL A N+L+ +D KI+DFGLAR I +
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 651 QDQAATKRL--VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+ T V +M+PE + ++ +SDV+SFGVLL EI +
Sbjct: 246 YYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 6e-44
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKG--KLQDGQEI--AVKRL-SKASGQGQEEFMNEVMVISNLQ 549
+L +G+G FG V++G + + A+K + S +E+F+ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H ++V+L+G +I E L SFL R+ LD +S L Y
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY--GYMS 667
L R +HRD+ A N+L+ + K+ DFGL+R +D K G +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMA 560
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVS 694
PE RF+ SDV+ FGV + EI+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 9e-44
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
+F+ +G GGFG V+K K DG+ +KR+ + E+ EV ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 554 VRLLGCCVEREENM----------------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
V GC + + + E+ +L+ ++ + +R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
+ + I++G+ Y+H ++I+RDLK SNI L D KI DFGL N +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR- 180
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 697
GT YMSPE + ++ D+++ G++L E++
Sbjct: 181 -SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
+ K+G+G FG K +DG++ +K +S+ S + +EE EV V++N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+V+ E ++ +Y L + + Q+ L + + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+I+HRD+K+ NI L D ++ DFG+AR+ + A +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
++ KSD+++ G +L E+ + +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRL-SKASGQGQEEFMNEVMVISN 547
N + LG G FG V + +AVK L KA +E M+E+ +++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDWPK 595
L H N+V LLG C LI+EY L ++L + + Q L+ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 596 RFNIIKG---------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR- 645
N++ +++G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 646 IFGGNQDQAATKRL--VGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
I + V +M+PE EG ++ KSDV+S+G+LL EI S
Sbjct: 222 IMSDSNYVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRN 552
+F+ LG+GGFG V++ K D A+KR+ +E+ M EV ++ L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 553 LVRLLGCCVEREE---------NMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
+VR +E+ + +Y + ++L ++ + +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR-- 658
I+ + +LH ++HRDLK SNI D K+ DFGL ++++
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 659 --------LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 692
VGT YMSPE +S K D+FS G++L E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
++++ +G G +G K + DG+ + K + ++ ++EV ++ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 552 NLVRLLGCCVEREENML--IYEYMPNKSLDSFL-FDPQRQSLLDWPKRFNIIKGISRGLL 608
N+VR ++R L + EY L S + + + LD ++ ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 609 YLH--RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
H D ++HRDLK +N+ LD N K+ DFGLARI + A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
SPE ++EKSD++S G LL E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 10/207 (4%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL---SKASGQGQEEFMNEVMVISNLQH 550
NF++ K+G+G F VY+ L DG +A+K++ + + + + E+ ++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-FDPQRQSLLDWPKRFNIIKGISRGLLY 609
N+++ +E E ++ E L + +++ L+ + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
+H R++HRD+K +N+ + K+ D GL R F A + LVGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E ++ KSD++S G LL E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
++F+ LGQG FG V K + D + A+K++ + ++EVM++++L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 553 LVRLLGCCVEREENML----------IY---EYMPNKSLDSFLFD--PQRQSLLDWPKRF 597
+VR +ER + ++ EY N +L +D + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT- 656
+ + I L Y+H IIHRDLK NI +D+ N KI DFGLA+ + D
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 657 -----------KRLVGTYGYMSPE-YAMEGRFSEKSDVFSFGVLLLEIVSG 695
+GT Y++ E G ++EK D++S G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNL 553
+ ++G+G F VYKG + E+A + K + ++ F E ++ LQH N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 554 VRLLGCCV---EREENMLIY-EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
VR + ++ +++ E M + +L ++L +R ++ + + I +GL +
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQF 144
Query: 610 LHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
LH IIHRDLK NI + + KI D GLA + + K ++GT +M+P
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 199
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E E + E DV++FG+ +LE+ +
Sbjct: 200 EMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 58/240 (24%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMV 544
F+ ++ + + ++G GG V++ + Q A+K L +A Q + + NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 545 ISNLQHRNL--VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
++ LQ + +RL + + ++ E N L+S+L +++ +D +R + K
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+ + +H+ I+H DLK +N L+ D K+ DFG+A + VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 663 YGYMSPE-----------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
YM PE + + S KSDV+S G +L + G+ T F +++ L
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL 249
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
++ KLG+GGF V + L DG A+KR+ Q +EE E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 555 RLLGCCVEREENM----LIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLY 609
RL+ C+ L+ + +L + + + + L + ++ GI RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV-------GT 662
+H HRDLK +NILL D+ P + D G + + + + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 663 YGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y +PE + + E++DV+S G +L ++ G
Sbjct: 207 ISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE 243
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 25/232 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRN 552
+ + ++G GG V++ + Q A+K ++ A Q + + NE+ ++ LQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 553 L--VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+RL + + ++ E N L+S+L +++ +D +R + K + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE- 669
H+ I+H DLK +N L+ D K+ DFG+A + VGT YM PE
Sbjct: 125 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 670 ----------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
+ + S KSDV+S G +L + G+ T F +++ L
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL 230
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQ 549
+ + + L++ LGQG V++G+ + G A+K + S + M E V+ L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 550 HRNLVRLLGCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
H+N+V+L E E+ P SL + L +P L + +++ + G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 607 LLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+ +L I+HR++K NI+ D K++DFG AR ++ Q + L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178
Query: 663 YGYMSPE--------YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y+ P+ + ++ D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNL-QHR 551
+FQ ++LG G +G V+K +DG+ AVKR + + + EV + QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
VRL E L E SL + L + + ++ L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
++H D+K +NI L K+ DFGL G G YM+PE
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE-L 227
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRK 697
++G + +DVFS G+ +LE+ +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNME 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
+ + ++G GG V++ + Q A+K L +A Q + + NE+ ++ LQ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 553 L--VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+RL + + ++ E N L+S+L +++ +D +R + K + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE- 669
H+ I+H DLK +N L+ D K+ DFG+A + VG YM PE
Sbjct: 172 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 670 ----------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
+ + S KSDV+S G +L + G+ T F +++ L
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL 277
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
LG+G +G VY G+ L + IA+K + + + + E+ + +L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
E + E +P SL + L + K I GL YLH + +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 622 DLKASNILLDDDL-NPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR--FSE 678
D+K N+L++ KISDFG ++ G T GT YM+PE +G + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 679 KSDVFSFGVLLLEIVSGR 696
+D++S G ++E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQ 549
+ + + L++ LGQG V++G+ + G A+K + S + M E V+ L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 550 HRNLVRLLGCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
H+N+V+L E E+ P SL + L +P L + +++ + G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 607 LLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+ +L I+HR++K NI+ D K++DFG AR ++ Q + L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178
Query: 663 YGYMSPE--------YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y+ P+ + ++ D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 489 ELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVI 545
E + ++G+G FG V++ K Q G + AVK RL + E++
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVAC 104
Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
+ L +V L G E + E + SL + ++ L + +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALE 161
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLA-RIFGGNQDQAATKR--LVG 661
GL YLH RI+H D+KA N+LL D + + DFG A + ++ + G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
T +M+PE M K D++S ++L +++G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
K+G+G G V + G+++AVK + Q +E NEV+++ + QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
+ + EE ++ E++ +L D Q L+ + + + + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSPEYAME 673
+IHRD+K+ +ILL D K+SDFG F + KR LVGT +M+PE
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 674 GRFSEKSDVFSFGVLLLEIVSG 695
++ + D++S G++++E+V G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+ K+GQG G VY + GQE+A+++++ +E +NE++V+ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
L + +E ++ EY+ SL D ++ +D + + + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSPEYAME 673
++IHRD+K+ NILL D + K++DFG F +KR +VGT +M+PE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 674 GRFSEKSDVFSFGVLLLEIVSG 695
+ K D++S G++ +E++ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLV 554
+F + LG G G + + D +++AVKR+ EV ++ +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 555 RLLGCCVEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
R C E++ + E +L ++ Q+ + +++ + GL +LH
Sbjct: 82 RYF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH- 135
Query: 613 DSRLRIIHRDLKASNILL-----DDDLNPKISDFGLARIFGGNQD-QAATKRLVGTYGYM 666
L I+HRDLK NIL+ + ISDFGL + + + + GT G++
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 667 SPEY---AMEGRFSEKSDVFSFGVLLLEIVSG 695
+PE + + D+FS G + ++S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNL 553
+++ +LG GGFG V + G+++A+K+ + E + E+ ++ L H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 554 VRLLGCCVEREENM-------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
V + + + L EY L +L + L ++ IS
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 607 LLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
L YLH RIIHRDLK NI+L L KI D G A+ + VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTL 187
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y++PE + +++ D +SFG L E ++G
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 62/266 (23%), Positives = 97/266 (36%), Gaps = 72/266 (27%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRN 552
+F+ +G+GGFG V++ K D A+KR+ +E+ M EV ++ L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 553 LVRLLGCCVEREENMLIYEYMP------------------------NKSLDSFLFDP--- 585
+VR +E E + +D F
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 586 ------------------QRQSLLDWPKRFN------------IIKGISRGLLYLHRDSR 615
++++L DW R I I+ + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK----------RLVGTYGY 665
++HRDLK SNI D K+ DFGL ++++ VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLE 691
MSPE +S K D+FS G++L E
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
F K+G+G FG V+KG + + +A+K + + + E+ E+ V+S +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+ G ++ + +I EY+ S L LD + I++ I +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE- 138
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
+ IHRD+KA+N+LL + K++DFG+A Q + T VGT +M+PE +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 675 RFSEKSDVFSFGVLLLEIVSG 695
+ K+D++S G+ +E+ G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 36/229 (15%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNL-Q 549
T F K+G G FG V+K K DG A+KR A ++ + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 550 HRNLVRLLGCCVEREENMLIY-EYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGL 607
H ++VR E + +MLI EY SL + + R S + +++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNP-------------------KISDFGLARIFG 648
Y+H ++H D+K SNI + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 649 GNQDQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
Q + G +++ E E K+D+F+ + ++
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 54/213 (25%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
+++ +LG G FG VYK K + G A K + S + E+++ E+ +++ H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLY 609
LLG + ++ E+ P ++D+ + L+ + + + + L +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVVCRQMLEALNF 132
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMS 667
LH RIIHRDLKA N+L+ + + +++DFG++ + KR +GT +M+
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMA 185
Query: 668 PE-----YAMEGRFSEKSDVFSFGVLLLEIVSG 695
PE + + K+D++S G+ L+E+
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 11/236 (4%)
Query: 463 GEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQE 521
G+ ++ RL+ L + ++F+ ++LG G G V+K G
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 522 IAVKRLS-KASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
+A K + + + + + E+ V+ +V G E + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
L ++ + + + +GL YL + +I+HRD+K SNIL++ K+ D
Sbjct: 121 VL---KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCD 175
Query: 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
FG++ G + VGT YMSPE +S +SD++S G+ L+E+ GR
Sbjct: 176 FGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 16/224 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQ 549
++++L +G G V +++A+KR++ Q +E + E+ +S
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGI 603
H N+V V ++E L+ + + S+ + + I++ +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKR--LV 660
GL YLH++ IHRD+KA NILL +D + +I+DFG+ A + G R V
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 661 GTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYH 703
GT +M+PE + R + K+D++SFG+ +E+ +G Y
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEE-FMNEVMVISNLQHR 551
+ LG+GGF ++ + A K + K+ Q E E+ + +L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
++V G E + + ++ E +SL + +R++L + R+ ++ I G
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQ 155
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV---GTYGY 665
YLHR R+IHRDLK N+ L++DL KI DFGLA + + +R GT Y
Sbjct: 156 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNY 207
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
++PE + S + DV+S G ++ ++ G+
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEE-FMNEVMVISNLQH 550
+F++ LG+G FG VY + Q +A+K L KA G E EV + S+L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N++RL G + LI EY P ++ L Q+ S D + I ++ L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H R+IHRD+K N+LL KI+DFG + ++ L GT Y+ PE
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEM 178
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT 709
EK D++S GVL E + G+ F ++ T
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET 215
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEE-FMNEVMVISNLQHR 551
+ LG+GGF ++ + A K + K+ Q E E+ + +L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
++V G E + + ++ E +SL + +R++L + R+ ++ I G
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQ 129
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV---GTYGY 665
YLHR R+IHRDLK N+ L++DL KI DFGLA + + +R GT Y
Sbjct: 130 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNY 181
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
++PE + S + DV+S G ++ ++ G+
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 23/223 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNL 553
++ L +GGF VY+ + + G+E A+KRL + + EV + L H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 554 VRLLGCCVEREENM-------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
V+ +E L+ + L FL + + L I R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL------- 659
+ ++HR + IIHRDLK N+LL + K+ DFG A D + + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 660 ---VGTYGYMSPE-YAMEGRF--SEKSDVFSFGVLLLEIVSGR 696
T Y +PE + F EK D+++ G +L + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
F + KLG+G +G VYK + GQ +A+K++ +E + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+ G + + ++ EY S+ + R L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYGYMSPEY 670
R IHRD+KA NILL+ + + K++DFG+A G KR ++GT +M+PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSG 695
E ++ +D++S G+ +E+ G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASGQGQEEFMNEVMVI-SNLQHR 551
++ + +LG+G +G V K + + GQ +AVKR+ + + Q Q+ + ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISR 605
V G + + E M + SLD F + ++D + I I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
L +LH S+L +IHRD+K SN+L++ K+ DFG++ G D A G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPY 175
Query: 666 MSPE----YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
M+PE + +S KSD++S G+ ++E+ R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEE-FMNEVMVISNLQH 550
+F++ N LG+G F VY+ + + G E+A+K + K + G + NEV + L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGI 603
+++ L E + L+ E N + L + K F+ + I
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NR----YLKNRVKPFSENEARHFMHQI 121
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV--- 660
G+LYLH I+HRDL SN+LL ++N KI+DFGLA Q + ++
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLC 173
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
GT Y+SPE A +SDV+S G + ++ GR
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASGQGQEEFMNEVMVI-SNLQHR 551
+ + ++G+G +G V K GQ +AVKR+ S + Q++ + ++ V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISR 605
+V+ G + + E M + S D F + I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
L +L L+IIHRD+K SNILLD N K+ DFG++ G D A R G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPY 191
Query: 666 MSPE----YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
M+PE A + +SDV+S G+ L E+ +GR
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM--------------- 539
N++++ L QG F + + +D + A+K+ K+ + + +F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 540 --NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----FDPQRQSLLD 592
NE+ +I+++++ + G +E +IYEYM N S+ F D +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
IIK + Y+H + I HRD+K SNIL+D + K+SDFG + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK- 206
Query: 653 QAATKRLVGTYGYMSPEYAMEGRFS---EKSDVFSFGVLLLEIVSGR 696
K GTY +M PE S K D++S G+ L +
Sbjct: 207 ---IKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 32/227 (14%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMN 540
+F + + + +Q KLG G +G V + E A+K + K S + +
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN 598
EV V+ L H N+++L ++ L+ E LFD R +FN
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHR-------MKFN 134
Query: 599 ------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGG 649
IIK + G+ YLH + I+HRDLK N+LL + D KI DFGL+ +F
Sbjct: 135 EVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ K +GT Y++PE + ++ EK DV+S GV+L +++G
Sbjct: 192 QK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-32
Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEV 542
N + + LG+G FG V K K QE AVK ++KA + + EV
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN-- 598
++ L H N+++L + ++ E LFD +R KRF+
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKR-------KRFSEH 121
Query: 599 ----IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQ 651
IIK + G+ Y+H + I+HRDLK NILL + D + KI DFGL+ F N
Sbjct: 122 DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
K +GT Y++PE + G + EK DV+S GV+L ++SG
Sbjct: 179 KM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM----NEVMVISNLQHR 551
+++ +KLG GG VY + ++A+K + + +EE + EV S L H+
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+V ++ E + L+ EY+ +L ++ + L N I G+ + H
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+RI+HRD+K NIL+D + KI DFG+A+ T ++GT Y SPE A
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQA 184
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
E +D++S G++L E++ G
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 28/283 (9%), Positives = 63/283 (22%), Gaps = 43/283 (15%)
Query: 449 KAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGF 508
K +E R + + A Q+ L+ +L L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 509 GPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLGCC---- 560
V+ + ++ ++ A+K + S E + L +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 561 ---VEREENM-------------------LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
++ L+ + F +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ + R L ++H N+ + D + D G
Sbjct: 196 LHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TR 247
Query: 656 TKRLVGTYGYMSPEYAM--EGRFSEKSDVFSFGVLLLEIVSGR 696
Y E+ F+ + + G+ + +
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVM 543
N + F KLG G FG V+ + G E +K ++K Q E E+
Sbjct: 13 NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFN---- 598
V+ +L H N++++ + ++ E L + R S K +
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYV 126
Query: 599 --IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQ 653
++K + L Y H ++H+DLK NIL KI DFGLA +F ++
Sbjct: 127 AELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
GT YM+PE + + K D++S GV++
Sbjct: 184 ---TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 72/228 (31%), Positives = 111/228 (48%), Gaps = 33/228 (14%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFM 539
+F A ++ ++ LG+G FG V K GQE AVK +SK +E +
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF 597
EV ++ L H N+++L ++ L+ E L FD R KRF
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISR-------KRF 123
Query: 598 N------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFG 648
+ II+ + G+ Y+H+ +I+HRDLK N+LL D N +I DFGL+ F
Sbjct: 124 SEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
++ K +GT Y++PE + G + EK DV+S GV+L ++SG
Sbjct: 181 ASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-32
Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 49/293 (16%)
Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE 536
+R+ ++ NFE+ + N LG G G V G+ +AVKR+ +
Sbjct: 1 SRIANIP--NFEQ--SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CD 53
Query: 537 EFMNEVMV-ISNLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFL----FDPQRQSL 590
+ E+ + + H N++R C + + + E N +L + + L
Sbjct: 54 IALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKL 111
Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------DDLNPK 637
++++ I+ G+ +LH L+IIHRDLK NIL+ ++L
Sbjct: 112 QKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 638 ISDFGLARIFGGNQD--QAATKRLVGTYGYMSPE-------YAMEGRFSEKSDVFSFGVL 688
ISDFGL + Q + GT G+ +PE + R + D+FS G +
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 689 LLEIVSG---------RKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLIS 732
I+S + ++ F L + DL+ +I
Sbjct: 229 FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 70/219 (31%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNE 541
N + + LG+G FG V K K QE AVK ++KA + + E
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN- 598
V ++ L H N+++L + ++ E LFD +R KRF+
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKR-------KRFSE 120
Query: 599 -----IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGN 650
IIK + G+ Y+H + I+HRDLK NILL + D + KI DFGL+ F N
Sbjct: 121 HDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
K +GT Y++PE + G + EK DV+S GV+L
Sbjct: 178 T---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 42/209 (20%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 497 FQLANKLGQGGFGPVYKGK---LQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRN 552
+++ + GG G +Y + +G+ + +K L + Q M E ++ + H +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 553 LVRLL--GCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
+V++ +R + + Y EY+ +SL L + + I L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPAL 195
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
YLH + +++ DLK NI+L ++ K+ D G + L GT G+ +
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQA 245
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
PE + +D+++ G L +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
F ++G G FG VY + +++ + +A+K++S + Q E++ + EV + L+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRG 606
++ GC + L+ EY + D L K + G +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDL---------LEVHKKPLQEVEIAAVTHGALQG 166
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGTYG 664
L YLH +IHRD+KA NILL + K+ DFG A I VGT
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANSFVGTPY 215
Query: 665 YMSPE---YAMEGRFSEKSDVFSFGVLLLEIVSG 695
+M+PE EG++ K DV+S G+ +E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 20/234 (8%)
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQ 533
+ + + L + L + F+L +G G +G VYKG+ ++ GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 534 GQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM------LIYEYMPNKSLDSFLFDPQ 586
+EE E+ ++ HRN+ G +++ L+ E+ S+ L
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNT 121
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
+ + L I + I RGL +LH+ ++IHRD+K N+LL ++ K+ DFG++
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSE-----KSDVFSFGVLLLEIVSG 695
+ T +GT +M+PE + KSD++S G+ +E+ G
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 54/248 (21%), Positives = 102/248 (41%), Gaps = 28/248 (11%)
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASG 532
+ + L + N+ + ++G G G V+K + + G IAVK++ +
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 533 QGQEEFMNEVMVI-SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL 591
+ + + ++ V+ + +V+ G + + + E M +
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--------K 115
Query: 592 DWPKRFN------IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
+ I + L YL + +IHRD+K SNILLD+ K+ DFG++
Sbjct: 116 RMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS- 172
Query: 646 IFGGNQDQAATKRLVGTYGYMSPE-----YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS 700
G D A R G YM+PE + + ++DV+S G+ L+E+ +G+
Sbjct: 173 --GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
Query: 701 FYHEEFEL 708
+FE+
Sbjct: 231 NCKTDFEV 238
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 45/231 (19%), Positives = 86/231 (37%), Gaps = 16/231 (6%)
Query: 478 RLQDLLVFNFEELANATNNFQLANKLGQG--GFGPVYKGK-LQDGQEIAVKR--LSKASG 532
+++L ++L +G+G V + G+ + V+R L S
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 533 QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLD 592
+ E+ V H N+V + E ++ +M S L ++
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN 126
Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
I++G+ + L Y+H +HR +KAS+IL+ D +S +
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 653 QAAT-----KRLVGTYGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 696
+ K V ++SPE + + KSD++S G+ E+ +G
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEE-FMNEVMVISNLQH 550
++F + LG+G FG VY + Q+ +A+K L K+ +G E E+ + S+L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N++R+ +R+ L+ E+ P L L Q+ D + ++ ++ L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 130
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H ++IHRD+K N+L+ KI+DFG + + + + GT Y+ PE
Sbjct: 131 HE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEM 183
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT 709
EK D++ GVL E + G F T
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM--PPFDSPSHTET 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
+ + L N +G+G +G V A K++ K + + F E+ ++ +L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIK 601
H N++RL + + L+ E LF+ + + F I+K
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHK-------RVFRESDAARIMK 113
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKR 658
+ + Y H +L + HRDLK N L D K+ DFGLA F + +
Sbjct: 114 DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRT 167
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
VGT Y+SP+ +EG + + D +S GV++
Sbjct: 168 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM----NEVMVISNLQHR 551
++L LG GG V+ + L+D +++AVK L +A F E + L H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 552 NLVRLLGCCVEREENMLIY----EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
+V + + EY+ +L + + + + +I + L
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGTYGYM 666
+ H+ IIHRD+K +NI++ K+ DFG+AR I T ++GT Y+
Sbjct: 130 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
SPE A +SDV+S G +L E+++G
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
F LG G F V+ K G+ A+K + K+ NE+ V+ ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKGIS 604
+V L L+ + + L FD +R + +I+ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGV-------YTEKDASLVIQQVL 116
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+ YLH I+HRDLK N+L +++ I+DFGL+++ G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACG 169
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
T GY++PE + +S+ D +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 62/236 (26%), Positives = 111/236 (47%), Gaps = 39/236 (16%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------------ 530
++ ++ ++ KLG G +G V K E A+K + K+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 531 -SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS 589
+ EE NE+ ++ +L H N+++L +++ L+ E+ L F+
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FE----- 135
Query: 590 LLDWPKRFN------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISD 640
+ +F+ I+K I G+ YLH+ I+HRD+K NILL + LN KI D
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
FGL+ F + + +GT Y++PE ++ +++EK DV+S GV++ ++ G
Sbjct: 193 FGLSSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-30
Identities = 31/252 (12%), Positives = 77/252 (30%), Gaps = 27/252 (10%)
Query: 464 EAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK------LQ 517
+Y N + ++ E + + + LG+G F VY+ +
Sbjct: 39 SSYPNTFEWQCKLPAIK-----PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 518 DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577
+ Q+ +K A+ + + ++ + + ++L+ E +
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 578 LDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635
L + + + + ++ + + + +H IIH D+K N +L +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL 210
Query: 636 P-----------KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFS 684
+ D G + T G+ E ++ + D F
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 685 FGVLLLEIVSGR 696
+ ++ G
Sbjct: 271 VAATVYCMLFGT 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 15/204 (7%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
+ + + + +LG G FG V++ G+ K ++ + NE+ +++ L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGL 607
H L+ L ++ E +LI E++ L FD + + N ++ GL
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 608 LYLHRDSRLRIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
++H I+H D+K NI+ + KI DFGLA ++ K T +
Sbjct: 163 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEF 216
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLL 689
+PE +D+++ GVL
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 53/266 (19%), Positives = 88/266 (33%), Gaps = 52/266 (19%)
Query: 480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK-----RLSKASGQ 533
++ L F L + L +GQG +G V Q A+K ++ + + +
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 534 GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM-------------------- 573
E EV ++ L H N+ RL + + L+ E
Sbjct: 71 DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 574 -----------PNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLYLHRDSRL 616
+ + + I++ I L YLH
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---Q 187
Query: 617 RIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQ--DQAATKRLVGTYGYMSPE--Y 670
I HRD+K N L + K+ DFGL++ F + GT +++PE
Sbjct: 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ K D +S GVLL ++ G
Sbjct: 248 TTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQG-QEEFMNEVMVISNLQHRN 552
++L +G+GG G VY+ + + +A+K +S+ +S + E LQ +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 553 LVRL--LGCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
+V + G E + +Y + L + L +RQ L P+ I++ I L
Sbjct: 96 VVPIHDFG-----EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSAL 147
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
H HRD+K NIL+ D + DFG+A + VGT YM+
Sbjct: 148 DAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMA 203
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
PE E + ++D+++ +L E ++G
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH 550
++N+ + +LG+G F V + G E A K ++ S + ++ E + LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
N+VRL E + L+++ + L F+ R+ + + I+ I +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 609 YLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
Y H I+HR+LK N+LL K++DFGLA ++ A GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGY 173
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLL 689
+SPE + +S+ D+++ GV+L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-29
Identities = 32/238 (13%), Positives = 61/238 (25%), Gaps = 53/238 (22%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH-------- 550
LGQ + + G+ V ++ EV+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 551 --------RNLVRLLGCCV--------EREENMLIYEYMPNKSLDSFLF------DPQRQ 588
+LV+ + + P + F
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 589 SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
L R + + R L LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 649 GNQDQAATKRLVGTYGYMSPEY----------AMEGRFSEKSDVFSFGVLLLEIVSGR 696
A+ G+ PE + D ++ G+ + I
Sbjct: 263 ------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQH 550
++L +G+G F V + + GQ+ AVK + + + G E+ E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKG 602
++V LL +++E+M L +R + + ++
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADA---GFVYSEAVASHYMRQ 138
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
I L Y H IIHRD+K +LL ++ K+ FG+A G + A +
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-- 193
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
VGT +M+PE + + DV+ GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG---------QEEFMNEVM 543
N++ LG+G V + +E AVK + G +E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 544 VISNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNII 600
++ + H N+++L L+++ M L FD ++ +L + R I+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETR-KIM 130
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
+ + + LH+ L I+HRDLK NILLDDD+N K++DFG + + + +
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVC 184
Query: 661 GTYGYMSPE------YAMEGRFSEKSDVFSFGVLL 689
GT Y++PE + ++ D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
LG G FG V+K + G ++A K + + +EE NE+ V++ L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+L + + +L+ EY+ L FD L +K I G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 613 DSRLRIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
+ I+H DLK NIL D KI DFGLAR + + K GT +++PE
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEV 259
Query: 671 AMEGRFSEKSDVFSFGVLL 689
S +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH 550
++N+ + +LG+G F V + G E A K ++ S + ++ E + LQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKG 602
N+VRL E + L+++ + LF+ R+ + + I+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTG----GELFEDIVAREF-------YSEADASHCIQQ 136
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
I + Y H I+HR+LK N+LL K++DFGLA ++ A
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGF 190
Query: 660 VGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
GT GY+SPE + +S+ D+++ GV+L
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 30/240 (12%), Positives = 61/240 (25%), Gaps = 56/240 (23%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE------------------------ 537
LGQ + + G+ V
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 538 ----FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF-----LFD-PQR 587
F+ ++ + Q + ++R+ + + P + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
L R + + R L LH ++H L+ +I+LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 648 GGNQDQAATKRLVGTYGYMSPEY-----------AMEGRFSEKSDVFSFGVLLLEIVSGR 696
G A + G+ PE + D ++ G+++ I
Sbjct: 257 G------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 47/230 (20%), Positives = 94/230 (40%), Gaps = 41/230 (17%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG-------- 534
+ ++ + + +G+G V + G E AVK + + +
Sbjct: 83 LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 535 QEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLL 591
+E E ++ + H +++ L+ L+++ M L FD ++
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEK---- 194
Query: 592 DWPKRF------NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
+I++ + + +LH I+HRDLK NILLDD++ ++SDFG +
Sbjct: 195 ---VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 646 IFGGNQDQAATKRLVGTYGYMSPE------YAMEGRFSEKSDVFSFGVLL 689
+ + L GT GY++PE + ++ D+++ GV+L
Sbjct: 249 HLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-28
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 15/201 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
+++ + +LG G FG V++ G A K + +E E+ +S L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYL 610
LV L + E ++IYE+M L F+ + + + ++ + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
H +H DLK NI+ + K+ DFGL Q + K GT + +P
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 669 EYAMEGRFSEKSDVFSFGVLL 689
E A +D++S GVL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE--------FMNEVMV 544
+ + ++ LG G G V + +++A+K +SK E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
+ L H ++++ + E+ ++ E M L FD + L + +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
+ + YLH IIHRDLK N+LL ++D KI+DFG ++I G + + + L
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 176
Query: 660 VGTYGYMSPE---YAMEGRFSEKSDVFSFGVLL 689
GT Y++PE ++ D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------SGQGQEEFMNEVM 543
+ +++++ +LG G F V K + G+E A K + K G +EE EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIK 601
++ ++H N++ L + + +LI E + L FD +++SL + + +K
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTE-DEATQFLK 115
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATK 657
I G+ YLH RI H DLK NI+L + K+ DFG+A K
Sbjct: 116 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFK 169
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
+ GT +++PE ++D++S GV+
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVI 545
++++ F+ KLG G + VYKG G +A+K + EE E+ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLM 57
Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS- 604
L+H N+VRL + L++E+M L ++ D + N++K
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQW 115
Query: 605 ---RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+GL + H + +I+HRDLK N+L++ K+ DFGLAR F G + +V
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV- 170
Query: 662 TYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
T Y +P+ M R S D++S G +L E+++G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS------GQGQEEFMNEVM 543
+ + + +LG G F V K + G E A K + K G +EE EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIK 601
++ + H N++ L R + +LI E + LFD Q++SL + + + IK
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSE-EEATSFIK 122
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATK 657
I G+ YLH +I H DLK NI+L + K+ DFGLA K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFK 176
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
+ GT +++PE ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
+ +A LG+G FG V++ + K + G Q E+ +++ +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
RN++ L EE ++I+E++ + F+ L+ + + + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGTYGYM 666
+LH I H D++ NI+ + KI +FG AR + L Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170
Query: 667 SPEYAMEGRFSEKSDVFSFGVLL 689
+PE S +D++S G L+
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCC 560
LG+G V L QE AVK + K G + EV ++ Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLYLHRDS 614
E + L++E M S+ + + FN +++ ++ L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKR-----RHFNELEASVVVQDVASALDFLHN-- 129
Query: 615 RLRIIHRDLKASNILL---DDDLNPKISDFGLARIF--GGNQDQAATKRL---VGTYGYM 666
I HRDLK NIL + KI DF L G+ +T L G+ YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 667 SPE-----YAMEGRFSEKSDVFSFGVLL 689
+PE + ++ D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 54/235 (22%), Positives = 100/235 (42%), Gaps = 31/235 (13%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE--------FMNEVMV 544
+ + ++ LG G G V + +++A++ +SK E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
+ L H ++++ + E+ ++ E M L FD + L + +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
+ + YLH IIHRDLK N+LL ++D KI+DFG ++I G + + + L
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 301
Query: 660 VGTYGYMSPE---YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
GT Y++PE ++ D +S GV+L +SG F +++L
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY--PPFSEHRTQVSLK 354
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------SGQGQEEFMNEVM 543
+ + + +LG G F V K + G E A K + K G +EE EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIK 601
++ + H N++ L R + +LI E + LFD Q++SL + + + IK
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSE-EEATSFIK 122
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATK 657
I G+ YLH +I H DLK NI+L + K+ DFGLA K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFK 176
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
+ GT +++PE ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------SGQGQEEFMNEVMV 544
N + + +LG G F V K + G + A K + K G +E+ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
+ +QH N++ L + + +LI E + L FD +++SL + + +K
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTE-EEATEFLKQ 122
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATKR 658
I G+ YLH L+I H DLK NI+L KI DFGLA K
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
+ GT +++PE ++D++S GV+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVISNL 548
++ + LG+G F VYK + Q +A+K++ ++ +N E+ ++ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
H N++ LL + L++++M L+ + D K + + +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLE 126
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
YLH+ I+HRDLK +N+LLD++ K++DFGLA+ FG
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE--FMNEVMVISN 547
T +QL +LG+G F V + + GQE A ++ ++ E +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NI 599
L+H N+VRL E + LI++ + LF+ R+ + +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTG----GELFEDIVAREY-------YSEADASHC 115
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAAT 656
I+ I +L+ H+ + ++HR+LK N+LL K++DFGLA G Q
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
GT GY+SPE + + + D+++ GV+L
Sbjct: 173 --FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
++ K+G+G +G V+K K + + +A+KR+ E + E+ ++ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H+N+VRL ++ L++E+ + L + + K F + + +GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGF 116
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
H ++HRDLK N+L++ + K+++FGLAR F G + + +V T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
Query: 670 YAMEGRF-SEKSDVFSFGVLLLEIVSGRK 697
+ S D++S G + E+ + +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQH 550
+Q K+G+G +G VYK K G+ +A+KR+ E + E+ ++ L H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHH 78
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V L+ L++E+M K L L + + K + + + RG+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHC 135
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T +V T Y +P+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDV 190
Query: 671 AMEGRF-SEKSDVFSFGVLLLEIVSGR 696
M + S D++S G + E+++G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQH 550
+ K+G+G +G VYK + G+ A+K++ + E + E+ ++ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V+L ++ +L++E++ + L L + K F + + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYC 116
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H R++HRDLK N+L++ + KI+DFGLAR F G + T +V T Y +P+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDV 171
Query: 671 AMEGRF-SEKSDVFSFGVLLLEIVSGR 696
M + S D++S G + E+V+G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 29/252 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEF-MNEVMVISNLQH 550
+F+ LG+G F V + A+K L K + + + E V+S L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG------IS 604
V+L + E+ Y N L ++ ++ F+ I
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKI------GSFDETCTRFYTAEIV 140
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
L YLH IIHRDLK NILL++D++ +I+DFG A++ QA VGT
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLLG-YAWKLWN 719
Y+SPE E + SD+++ G ++ ++V+G F F+ + Y +
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIFQKIIKLEYDFPEKF 255
Query: 720 DNNVIDLVDPLI 731
DLV+ L+
Sbjct: 256 FPKARDLVEKLL 267
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEF----MNEVMVISN 547
+ ++ K+GQG FG V+K + + GQ++A+K + +E F + E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE----KEGFPITALREIKILQL 72
Query: 548 LQHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
L+H N+V L+ C + L++++ L L + + L KR
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRV-- 129
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA---T 656
++ + GL Y+HR+ +I+HRD+KA+N+L+ D K++DFGLAR F ++ T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 657 KRLVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
R+V T Y PE + E + D++ G ++ E+ +
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 31/232 (13%)
Query: 470 STEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS 528
++ A L + ++ F++ ++LG+G VY+ K + A+K L
Sbjct: 28 ASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK 87
Query: 529 KASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQ 586
K ++ E+ V+ L H N+++L E L+ E + L FD +
Sbjct: 88 KT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVE 141
Query: 587 RQSLLDWPKRF------NIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPK 637
+ + + +K I + YLH I+HRDLK N+L D K
Sbjct: 142 K-------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLK 191
Query: 638 ISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
I+DFGL++I K + GT GY +PE + + D++S G++
Sbjct: 192 IADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 492 NATNNFQLANK-LGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISN 547
N N + L +K LG+G F V + GQE A K L K + E ++E+ V+
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 548 LQHR-NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF------NII 600
+ ++ L E +LI EY + F L + + +I
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS---LCLPELAEMVSENDVIRLI 137
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATK 657
K I G+ YLH+ I+H DLK NILL + KI DFG++R G +
Sbjct: 138 KQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELR 191
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
++GT Y++PE + +D+++ G++
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
T+ +++ +G G + + E AVK + K+ EE E++ + QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEIL-LRYGQHPN 77
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIKGIS 604
++ L + + ++ E M L D ++ K F+ ++ I+
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-------KFFSEREASAVLFTIT 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNP-KISDFGLARIFGGNQDQAATKRLV 660
+ + YLH ++HRDLK SNIL + +I DFG A+ T
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PC 181
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLL 689
T +++PE + D++S GVLL
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVISNL 548
+ +KLG+G + VYKGK +A+K + EE EV ++ +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDL 57
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
+H N+V L + L++EY+ +K L +L D + K F + + RGL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLA 114
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
Y HR +++HRDLK N+L+++ K++DFGLAR + +V T Y P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169
Query: 669 EYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
+ + +S + D++ G + E+ +GR
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEF----MNEVMVIS 546
AT+ ++ ++G G +G VYK + G +A+K + G G + EV ++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 547 NLQ---HRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
L+ H N+VRL+ C + L++E++ ++ L ++L D L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
+++ RGL +LH + I+HRDLK NIL+ K++DFGLARI+ A T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPV 179
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+V T Y +PE ++ ++ D++S G + E+ +
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 51/239 (21%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN------------- 540
N + L +++G+G +G V D A+K LSK Q F
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 541 -------------EVMVISNLQHRNLVRLLGCCVEREENMLIY---EYMPNKSLDSFLFD 584
E+ ++ L H N+V+L+ ++ +Y E + + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127
Query: 585 -PQRQSLLDWPKRF---NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
P + L + RF ++IKGI YLH +IIHRD+K SN+L+ +D + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 641 FGLARIFGGNQDQAATKRLVGTYGYMSPE--YAMEGRFS-EKSDVFSFGVLLLEIVSGR 696
FG++ F G+ + VGT +M+PE FS + DV++ GV L V G+
Sbjct: 181 FGVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMV---ISN 547
N+F + +G+GGFG VY + D ++ A+K L K QG+ +NE ++ +S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISR 605
+V + + + I + M L L + + RF + I
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE-IIL 303
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
GL ++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGY 356
Query: 666 MSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFYHEE 705
M+PE +G + S D FS G +L +++ G + F +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHK 395
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQH 550
+ F LG+GGFG V+ +++ ++ A K+L+K +G + M E +++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 551 RNLVRLLGCCVEREENM-LIYEYMP---------NKSLDSFLFDPQRQSLLDWPKRFNII 600
R +V L E + ++ L+ M N D+ F R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
+ I GL +LH+ II+RDLK N+LLDDD N +ISD GLA Q +
Sbjct: 297 Q-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YA 350
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
GT G+M+PE + + D F+ GV L E+++ R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 70/233 (30%), Positives = 101/233 (43%), Gaps = 31/233 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQH 550
N F+ LG+GGFG V +++ ++ A K+L K +G+ +NE ++ +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSL-------DSFLFDPQRQSLLDWPKRFNIIKGI 603
R +V L ++ L+ M L F R F + I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAE-I 295
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
GL LHR RI++RDLK NILLDD + +ISD GLA Q K VGT
Sbjct: 296 CCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTV 349
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG------RKNTSFYHEEFELTL 710
GYM+PE R++ D ++ G LL E+++G RK E L
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 51/212 (24%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 502 KLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
K+G+G +G VYK K +D ++ A+K++ + +G E+ ++ L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSA-CREIALLRELKHPNVISLQK 85
Query: 559 CCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN--IIKGIS----RGLLYL 610
+ + L+++Y L + + P + ++K + G+ YL
Sbjct: 86 VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFGG-NQDQAATKRLVGTYGY 665
H + ++HRDLK +NIL+ + KI+D G AR+F + A +V T+ Y
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 666 MSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
+PE + R ++ D+++ G + E+++
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQHR 551
++ K+G+G +G V+K + GQ +A+K+ ++ + + E+ ++ L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPN---KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
NLV LL + L++EY + LD Q + +I + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR------YQRGVPEHLVKSITWQTLQAVN 116
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
+ H+ IHRD+K NIL+ K+ DFG AR+
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
+ ++ KLG+G +G VYK + +A+KR+ +E + EV ++ LQ
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN--IIKGIS--- 604
HRN++ L LI+EY ++ L + +D + +IK
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYA-----ENDL-----KKYMDKNPDVSMRVIKSFLYQL 141
Query: 605 -RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIFGGNQDQAATKR 658
G+ + H R +HRDLK N+LL KI DFGLAR F G + T
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHE 197
Query: 659 LVGTYGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 696
++ T Y PE + +S D++S + E++
Sbjct: 198 II-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 32/201 (15%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGC 559
LG+G F K + Q AVK +SK + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 560 CVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIKGISRGLLYLH 611
++ L+ E + L F+ ++ K F+ I++ + + ++H
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKK-------KHFSETEASYIMRKLVSAVSHMH 123
Query: 612 RDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
+ ++HRDLK N+L +D+L KI DFG AR+ + T T Y +P
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFTLHYAAP 178
Query: 669 EYAMEGRFSEKSDVFSFGVLL 689
E + + E D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 34/220 (15%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQH 550
+ + + LG+G +G V + + AVK L K G+ E+ ++ L+H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 551 RNLVRLLGCCVEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN---------- 598
+N+++L+ E+ ++ EY + + D + KRF
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE------KRFPVCQAHGYFCQ 117
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
+I G+ YLH I+H+D+K N+LL KIS G+A +
Sbjct: 118 LIDGLE----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 659 LVGTYGYMSPEYAMEGRFSE--KSDVFSFGVLLLEIVSGR 696
G+ + PE A K D++S GV L I +G
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEF----MNEVMVISN 547
++ +G+G +G V K + G+ +A+K S + M E+ ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD----DKMVKKIAMREIKLLKQ 80
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPN---KSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
L+H NLV LL C +++ L++E++ + L+ + LD+ + I
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL------FPNGLDYQVVQKYLFQII 134
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
G+ + H IIHRD+K NIL+ K+ DFG AR + + T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRW 189
Query: 665 YMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 696
Y +PE + K+ DV++ G L+ E+ G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNL 553
++ L LG+G +G V + +AVK + E E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYLHR 612
V+ G E L EY L + D + F+ ++ G+ YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE--- 669
+ I HRD+K N+LLD+ N KISDFGLA +F N + ++ GT Y++PE
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 670 ---YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ +E DV+S G++L +++G
Sbjct: 181 RREFH-----AEPVDVWSCGIVLTAMLAGE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 28/218 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGK--LQDGQEIAVK--RLSKASGQGQEEF----MNEVMVIS 546
++ ++G+G +G V+K + G+ +A+K R+ G+E + EV V+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLR 66
Query: 547 NLQ---HRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
+L+ H N+VRL C + L++E++ ++ L ++L D + + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKD 124
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
++ + RGL +LH R++HRDLK NIL+ K++DFGLARI+ A T
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSV 179
Query: 659 LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+V T Y +PE ++ ++ D++S G + E+ +
Sbjct: 180 VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN------EVMVISNL 548
+Q+ LG GGFG VY G + D +A+K + K E N EV+++ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 549 QHR--NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGI 603
++RLL ER ++ LI E P D LFD +R +L + R + +
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQV 158
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+ + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 211
Query: 663 YGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 696
Y PE+ R+ + V+S G+LL ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
N++L +G+G F V + + G+E+A+K + K + ++ EV ++ L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYLH 611
+V+L + LI EY + +L R + +F I+ + Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH 131
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+ RI+HRDLKA N+LLD D+N KI+DFG + F G Y +PE
Sbjct: 132 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPE-L 184
Query: 672 MEGRFSE--KSDVFSFGVLLLEIVSGR 696
+G+ + + DV+S GV+L +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 36/204 (17%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
LG G G V + + GQ+ A+K L + QE + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHH-WQASGGPHIVCILDVY 91
Query: 561 VEREENM----LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIKGISRGLL 608
+I E M LF +R + F I++ I +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGE----LFSRIQERGD-----QAFTEREAAEIMRDIGTAIQ 142
Query: 609 YLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
+LH I HRD+K N+L + D K++DFG A+ N + T Y
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYY 195
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLL 689
++PE ++ + D++S GV++
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNL 553
++ L LG+G +G V + +AVK + E E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF---NIIKGISRGLL 608
V+ G E L EY L FD + + + ++ G+
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLH + I HRD+K N+LLD+ N KISDFGLA +F N + ++ GT Y++P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 669 E------YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E + +E DV+S G++L +++G
Sbjct: 177 ELLKRREFH-----AEPVDVWSCGIVLTAMLAGE 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN------EV----MV 544
++L LG+GGFG V+ G L D ++A+K + + G + EV V
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
+ H ++RLL +E ML+ E P + D LFD ++ L + P R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQ 147
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+ + + H ++HRD+K NIL+D K+ DFG + G
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDG 200
Query: 662 TYGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 696
T Y PE+ ++ + V+S G+LL ++V G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG 534
+P ++ +L + + + +G G FG V++ KL + E+A+K++ +
Sbjct: 20 DPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ----- 74
Query: 535 QEEFMN-EVMVISNLQHRNLVRLLGCCVEREENM------LIYEYMP---NKSLDSFLFD 584
+ F N E+ ++ ++H N+V L + L+ EY+P ++ +
Sbjct: 75 DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL 134
Query: 585 PQRQSLLDWPKRFNIIKGIS----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KIS 639
Q +L +IK R L Y+H + I HRD+K N+LLD K+
Sbjct: 135 KQTMPML-------LIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 640 DFGLARIF 647
DFG A+I
Sbjct: 185 DFGSAKIL 192
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 22/213 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--------SGQGQEEFMNEVMVIS 546
+ + LG G FG V+ + +E+ VK + K + E+ ++S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 547 NLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISR 605
++H N++++L E + M LF R LD P I + +
Sbjct: 85 RVEHANIIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
+ YL IIHRD+K NI++ +D K+ DFG A + GT Y
Sbjct: 142 AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEY 195
Query: 666 MSPEYAMEGRFSE--KSDVFSFGVLLLEIVSGR 696
+PE + G + +++S GV L +V
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 43/205 (20%), Positives = 80/205 (39%), Gaps = 37/205 (18%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGC 559
LG G G V + + ++ A+K L + EV + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 560 C---VEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKGISRGL 607
+ + ++ E + L F R + F I+K I +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKSIGEAI 174
Query: 608 LYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
YLH + I HRD+K N+L + K++DFG A+ + + T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLL 689
Y++PE ++ + D++S GV++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHR 551
++ +G G FG VY+ KL D G+ +A+K++ + + F N E+ ++ L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 552 NLVRLLGCCVEREENM------LIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
N+VRL E L+ +Y+P + + Q ++ +K
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-------YVKL 160
Query: 603 IS----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQDQAATK 657
R L Y+H I HRD+K N+LLD D K+ DFG A+ + +
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVS 215
Query: 658 RLVGTYGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 696
+ Y Y +PE + G ++ DV+S G +L E++ G+
Sbjct: 216 YICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+Q +G G G V + +A+K+LS+ F N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 544 VISNLQHRNLVRLLG--CCVEREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
++ + H+N++ LL + E L+ E M D+ L + L +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
+ + + G+ +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMT 221
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + + E D++S G ++ E+V +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 40/206 (19%), Positives = 91/206 (44%), Gaps = 39/206 (18%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+ +++ + +G G +G V + + + +A+K++ + F + E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIA 104
Query: 544 VISNLQHRNLVRLLG-CCVEREENM----LIYEYMP---NKSLDS--FLFDPQRQSLLDW 593
+++ L H ++V++L + E ++ E K + +L + ++LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL-- 162
Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
+N++ G+ Y+H S I+HRDLK +N L++ D + K+ DFGLAR ++
Sbjct: 163 ---YNLL----VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEK 679
+ + M+ + ++
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 38/233 (16%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE--FMN---- 540
EL + + + + G +G V G +G +A+KR+ G+ +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 541 -----EVMVISNLQHRNLVRLLGC-CVEREENM----LIYEYMPN------KSLDSFLFD 584
E+ ++++ H N++ L E M L+ E M +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
Q + ++I+ GL LH ++HRDL NILL D+ + I DF LA
Sbjct: 134 QHIQYFM-----YHIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA 181
Query: 645 RIFGGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
R D T V Y +PE M+ F++ D++S G ++ E+ + +
Sbjct: 182 R--EDTADANKTHY-VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+Q +G G G V + +A+K+LS+ F N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 544 VISNLQHRNLVRLL------GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
++ + H+N++ LL E ++ ++ E M D+ L + L +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
++ + G+ +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMT 184
Query: 658 RLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + + E D++S G ++ E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 50/213 (23%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ- 549
+++QL KLG+G + V++ + + +++ VK L +++ E+ ++ NL+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89
Query: 550 HRNLVRLLGCCVEREENM---LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
N++ L V+ + L++E++ N Q+L D+ RF + I +
Sbjct: 90 GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKA 142
Query: 607 LLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
L Y H S I+HRD+K N+++D + ++ D+GLA + Q R V + +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVR-VASRYF 196
Query: 666 MSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRK 697
PE ++ + + S D++S G +L ++ ++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 51/220 (23%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+ +G G +G V + G+++A+K+LS+ F + E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 544 VISNLQHRNLVRLLGCCV--EREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
++ ++QH N++ LL N L+ +M + L + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
++ + +GL Y+H ++HRDLK N+ +++D KI DFGLAR D T
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH----ADAEMTG 182
Query: 658 RLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + +++ D++S G ++ E+++G+
Sbjct: 183 Y-VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 50/227 (22%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
E + FQ+ GQG FG V GK + G +A+K++ + E +
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQD 72
Query: 545 ISNLQHRNLVRLLGC-CVEREENM------LIYEYMP---NKSLDSFLFDPQRQSLLDWP 594
++ L H N+V+L E + ++ EY+P ++ ++ ++ +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY--YRRQVAPPPIL 130
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
+ + + R + LH S + + HRD+K N+L+++ L K+ DFG A+ ++
Sbjct: 131 IKV-FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSE 186
Query: 652 DQAATKRLVGTYGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 696
A + + Y +PE + G ++ D++S G + E++ G
Sbjct: 187 PNVAY---ICSRYYRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQH 550
++F++ +G+G FG V + D +++ A+K ++K + E E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
LV L + EE+M ++ + + L L Q+ + I + + L
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICE-LVMALD 129
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YL RIIHRD+K NILLD+ + I+DF +A + + + GT YM+P
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAP 183
Query: 669 E--YAMEGRFSEKS-DVFSFGVLLLEIVSGR 696
E + +G + D +S GV E++ GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 66/297 (22%), Positives = 121/297 (40%), Gaps = 42/297 (14%)
Query: 445 FAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLG 504
++++++KE + D + + S + F LG
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQL------------------DQFDRIKTLG 50
Query: 505 QGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
G FG V K ++ A+K L K + E +NE ++ + LV+L
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLRII 619
+ ++ EY+ + S L +R P RF I YLH L +I
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLI 163
Query: 620 HRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEK 679
+RDLK N+L+D +++DFG A+ G T L GT ++PE + +++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKA 218
Query: 680 SDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLLG-YAWKLWNDNNVIDLVDPLI 731
D ++ GVL+ E+ +G F+ ++ +E + G + +++ DL+ L+
Sbjct: 219 VDWWALGVLIYEMAAGY--PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
++ L + LG G FG V G+ G ++AVK L++ S + E+ + +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYL 610
++++L + ++ EY+ L ++ R ++ + F I+ + Y
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YC 127
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE- 669
HR ++HRDLK N+LLD +N KI+DFGL+ + D + G+ Y +PE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAPEV 181
Query: 670 -----YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
YA G + D++S GV+L ++ G
Sbjct: 182 ISGRLYA--GP---EVDIWSCGVILYALLCGT 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
+F++ +G+G FG V KL++ ++ A+K L+K + E F E V+ N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
+ + L + + N+ L+ +Y L + L + + + RF + + + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVI-AIDS 190
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
+H+ L +HRD+K NIL+D + + +++DFG + + VGT Y+SPE
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPE 246
Query: 670 -----YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
+GR+ + D +S GV + E++ G T FY E
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAE 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 53/225 (23%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
+ + LG+G FG V + Q++A+K +S+ E+ + L+H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF---------LFD--PQRQSLLDWPKR--FN 598
++++L Y+ + + D LFD +++ + + R F
Sbjct: 70 HIIKL-------------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ 115
Query: 599 -IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
II I Y HR +I+HRDLK N+LLDD+LN KI+DFGL+ I D K
Sbjct: 116 QIICAIE----YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLK 165
Query: 658 RLVGTYGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
G+ Y +PE YA G + DV+S G++L ++ GR
Sbjct: 166 TSCGSPNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
++F++ +G+G F V K++ ++ A+K ++K + E F E V+ N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
R + +L + E + L+ EY L + L + + RF + + + +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAEIVM-AIDS 177
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
+HR L +HRD+K NILLD + +++DFG + + VGT Y+SPE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPE 233
Query: 670 -------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
G + + D ++ GV E+ G+ T FY +
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYAD 273
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
++++ +G+G FG V + + +++ A+K LSK + + F E +++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+V+L + ++ EYMP L + + + + RF + + L +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVL-ALDAI 184
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE- 669
H + IHRD+K N+LLD + K++DFG VGT Y+SPE
Sbjct: 185 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEV 240
Query: 670 ---YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
+G + + D +S GV L E++ G T FY +
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYAD 276
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 4e-19
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+++G+ +L + + IHRDL A NILL + KI DFGLAR + D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 663 YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 694
+M+PE + ++ +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 19/168 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
+ +L LG+G FG V + + +AVK L A+ M+E+ ++ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 548 L-QHRNLVRLLGCCVER-EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
+ H N+V LLG C + M+I E+ +L ++L KR + ++
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
G + + I DLK + + S F + +++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
++ L + LG G FG V GK G ++AVK L++ S + E+ + +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYL 610
++++L + ++ EY+ L ++ R + + F I+ G+ Y
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YC 132
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE- 669
HR ++HRDLK N+LLD +N KI+DFGL+ + D + G+ Y +PE
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAPEV 186
Query: 670 -----YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
YA G + D++S GV+L ++ G
Sbjct: 187 ISGRLYA--GP---EVDIWSSGVILYALLCGT 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEE-FMNEVMVISNLQH 550
+FQ+ LG G FG V+ + + A+K L K Q E +E +++S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG------IS 604
++R+ G + ++ +I +Y+ L S L ++ +RF +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKS------QRFPNPVAKFYAAEVC 116
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
L YLH II+RDLK NILLD + + KI+DFG A+ T L GT
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 168
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
Y++PE +++ D +SFG+L+ E+++G T FY
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDS 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQH 550
N F+ LG+G FG V K + A+K L K ++E + E V+ N +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLY 609
L L + + EY L F R+ + + RF + +S L Y
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALDY 263
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LH S +++RDLK N++LD D + KI+DFGL + G +D A K GT Y++PE
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPE 319
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
+ + D + GV++ E++ GR FY++
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQ 352
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +G G FG + + +AVK + + + E E++ +L+H N+V
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIV 79
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYLHRD 613
R + +I EY L + + R S + F ++ G+S Y H
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCHS- 134
Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGTYGYMSPE-- 669
++I HRDLK N LLD P KI DFG ++ + K VGT Y++PE
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEVL 189
Query: 670 ----YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y G+ +DV+S GV L ++ G
Sbjct: 190 LRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
++ +G G +G V + G ++A+K+L + F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 544 VISNLQHRNLVRLLGCCV--EREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
++ +++H N++ LL E ++ L+ +M L + + + L + +F
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF 132
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
++ + +GL Y+H IIHRDLK N+ +++D KI DFGLAR D T
Sbjct: 133 -LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTG 184
Query: 658 RLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + R+++ D++S G ++ E+++G+
Sbjct: 185 Y-VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+ + +G+G +G V + +A+K++S F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 544 VISNLQHRNLVRLLGCCV-EREENM----LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
++ +H N++ + E M ++ + M K L + Q L +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-------QHLSNDHI 130
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ + I RGL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ + D
Sbjct: 131 CY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 656 T-KRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + +++ D++S G +L E++S R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 21/206 (10%), Positives = 58/206 (28%), Gaps = 45/206 (21%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD---GQEIAVKRL---SKASGQGQEEFMNEVMVISNLQH 550
++L G ++ D +++A+ + +E ++ + +S +
Sbjct: 33 YRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+ R+L R +++ E++ SL ++ ++
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAA 145
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
HR + S + + D + ++ M
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA- 179
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ + D+ G L ++ R
Sbjct: 180 ------NPQDDIRGIGASLYALLVNR 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQH 550
N+F LG+G FG V + + A+K L K ++E + E V+ N +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
L L + + + + EY L F R+ + + RF + I L
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALE 119
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLH +++RD+K N++LD D + KI+DFGL + G D A K GT Y++P
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAP 174
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E + + D + GV++ E++ GR
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 39/203 (19%), Positives = 81/203 (39%), Gaps = 35/203 (17%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+N+ + + +G+G +G VY + +A+K++++ F + E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77
Query: 544 VISNLQHRNLVRLLGCCV-EREENM----LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
+++ L+ ++RL + + ++ E K + L +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEEHI 131
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
+ I+ + G ++H IIHRDLK +N LL+ D + K+ DFGLAR +D
Sbjct: 132 KT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 656 TKRLVGTYGYMSPEYAMEGRFSE 678
L ++ + +
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTS 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 37/220 (16%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+Q + +G G +G V + G +AVK+LS+ F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 544 VISNLQHRNLVRLLGCCV--EREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
++ +++H N++ LL E L+ M L++ + + Q L D +F
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV---KCQKLTDDHVQF 136
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
+I I RGL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189
Query: 658 RLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + +++ D++S G ++ E+++GR
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 52/234 (22%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+ + LG GG G V+ + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 544 VISNLQHRNLVRLL----------GCCVEREENM----LIYEYMP---NKSLDSFLFDPQ 586
+I L H N+V++ V + ++ EYM L+
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ------ 114
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLAR 645
LL+ R + + RGL Y+H + ++HRDLK +N+ ++ +DL KI DFGLAR
Sbjct: 115 -GPLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 646 IFGGNQDQAA--TKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
I + ++ + T Y SP + +++ D+++ G + E+++G+
Sbjct: 170 IMDPHYSHKGHLSEG-LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
+++FQL + LG+G +G V G+ +A+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 544 VISNLQHRNLVRLLGC-CVEREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
++ + +H N++ + + EN +I E M L + Q L D ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY- 116
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
I R + LH +IHRDLK SN+L++ + + K+ DFGLARI + +
Sbjct: 117 FIYQTLRAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 659 L--------VGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 696
V T Y +PE + ++S DV+S G +L E+ R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 20/218 (9%)
Query: 495 NNFQLANKLGQGGFGPVY---KGKLQDGQEI-AVKRLSKAS--GQGQEEFMNEVMVISNL 548
+ F+L LGQG FG V+ K D +++ A+K L KA+ + + E ++ +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 549 QHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRG 606
H +V+L + E + LI +++ L F ++ + +F + + ++
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--F-TRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYM 666
L +LH L II+RDLK NILLD++ + K++DFGL++ ++ +A + GT YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
+PE ++ +D +SFGVL+ E+++G F +
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQGK 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 8e-17
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNE--VMVISNL 548
+F LG+G FG V + + E+ AVK L K ++ M E V+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
+ L +L C + + EY+ L ++ Q+ P F I+ GL
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF-YAAEIAIGL 455
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
+L II+RDLK N++LD + + KI+DFG+ + + T GT Y++
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIA 510
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
PE + + D ++FGVLL E+++G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 495 NNFQLANKLGQGGFGPVY---KGKLQDGQEI-AVKRLSKAS----GQGQEEFMNEVMVIS 546
F+L LG+GG+G V+ K + +I A+K L KA + E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 547 NLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGIS 604
++H +V L+ + + LI EY+ L +R+ + F + + IS
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAE-IS 131
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
L +LH+ II+RDLK NI+L+ + K++DFGL + + T GT
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIE 186
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
YM+PE M + D +S G L+ ++++G F E
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA--PPFTGE 224
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 38/194 (19%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
++L KLG+G +G V+K + G+ +AVK++ A F N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 544 VISNLQ-HRNLVRLLGCCVEREENM----LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
+++ L H N+V LL V R +N L+++YM + + + L K
Sbjct: 61 ILTELSGHENIVNLLN--VLRADNDRDVYLVFDYMETDLHAVIRA-------NILEPVHK 111
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
++ ++ + + + YLH S ++HRD+K SNILL+ + + K++DFGL+R F +
Sbjct: 112 QY-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 656 TKRLVGTYGYMSPE 669
L + +
Sbjct: 168 NIPLSINENTENFD 181
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVIS-NLQ 549
+NF+ LG+G FG V ++++ ++ AVK L K ++ M E ++S
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
H L +L C + + E++ L +F Q+ D + RF I L+
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-YAAEIISALM 138
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
+LH II+RDLK N+LLD + + K++DFG+ + N AT GT Y++P
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAP 193
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
E E + D ++ GVLL E++ G F E
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH--APFEAE 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMV-ISNLQ 549
+F L +G+G + V +L+ I A+K + K E+ E V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 550 HRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
H LV L C + E + + EY+ L +F QRQ L RF + IS L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 123
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
YLH II+RDLK N+LLD + + K++D+G+ + D +T GT Y++
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
PE + D ++ GVL+ E+++GR
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 50/252 (19%), Positives = 100/252 (39%), Gaps = 63/252 (25%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQ 549
++ + L LG G FG V + + G+ A+K++ + + N E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLD 58
Query: 550 HRNLVRLLGCCVEREENM--------------------------------------LIYE 571
H N+++L+ + +I E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 572 YMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
Y+P +K L SF+ +S+ I + R + ++H L I HRD+K N+
Sbjct: 119 YVPDTLHKVLKSFI--RSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQNL 172
Query: 629 LLD---DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFS 684
L++ + L K+ DFG A+ + + + + Y +PE + ++ D++S
Sbjct: 173 LVNSKDNTL--KLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWS 227
Query: 685 FGVLLLEIVSGR 696
G + E++ G+
Sbjct: 228 IGCVFGELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNE--VMVISNL 548
+F LG+G FG V + + E+ AVK L K ++ M E V+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
+ L +L C + + EY+ L ++ Q+ P F I+ GL
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF-YAAEIAIGL 134
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGTYGY 665
+L II+RDLK N++LD + + KI+DFG+ + I+ G TK GT Y
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDY 187
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
++PE + + D ++FGVLL E+++G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVIS-NLQ 549
+F L LG+G FG V+ + + + A+K L K ++ M E V+S +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
H L + +E + EY+ L ++ Q D + F I GL
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATF-YAAEIILGLQ 132
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
+LH I++RDLK NILLD D + KI+DFG+ + + T GT Y++P
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAP 187
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E + +++ D +SFGVLL E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVIS-NLQ 549
+F L +G+G + V +L+ I A++ + K E+ E V
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
H LV L C + EY+ L +F QRQ L RF + IS L
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 167
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
YLH II+RDLK N+LLD + + K++D+G+ + D +T GT Y++P
Sbjct: 168 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAP 222
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
E + D ++ GVL+ E+++GR
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMV-ISNLQ 549
++F +G+G FG V + + + AVK L K + ++E M+E V + N++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 550 HRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
H LV L + + + + +Y+ L + QR+ P+ RF + I+ L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASAL 152
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
YLH L I++RDLK NILLD + ++DFGL + + +T GT Y++
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLA 207
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
PE + + D + G +L E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 70/241 (29%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ------ 549
+ L KLG G F V+ K + + +A+K + + E +E+ ++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 550 -----HRNLVRLLGCCVEREENMLIYEYMPNKSLDSF------------LFDPQRQSLLD 592
++++LL D F +F+ ++LL
Sbjct: 80 EDSMGANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLA 118
Query: 593 WPKRFN-------IIKGISR----GLLYLHRDSRLRIIHRDLKASNILLDDDLNP----- 636
K++ +K IS+ GL Y+HR R IIH D+K N+L++ +P
Sbjct: 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 637 -KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 695
KI+D G A + + T Y SPE + + +D++S L+ E+++G
Sbjct: 177 IKIADLGNA-CWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231
Query: 696 R 696
Sbjct: 232 D 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 41/205 (20%), Positives = 72/205 (35%), Gaps = 58/205 (28%)
Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGC 559
LG G G V + + ++ A+K L + EV + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 560 C---VEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKGISRGL 607
+ + ++ E + L F R + F I+K I +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKSIGEAI 130
Query: 608 LYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
YLH + I HRD+K N+L + K++DFG A+ Y
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------TGEKYD 176
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLL 689
+ D++S GV++
Sbjct: 177 -------------KSCDMWSLGVIM 188
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 8e-15
Identities = 53/283 (18%), Positives = 95/283 (33%), Gaps = 108/283 (38%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-- 550
+ + KLG G F V+ +Q + +A+K + K++ E ++E+ ++ ++++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 551 -----RNLVRLLGCCVEREENMLIYEYMPNKSLDSF------------LFDPQRQSLLDW 593
R +V L LD F +F+ LL W
Sbjct: 95 PNDPNREMVVQL--------------------LDDFKISGVNGTHICMVFEVLGHHLLKW 134
Query: 594 PKRFN-------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILL------------ 630
+ N +K I + +L YLH ++ RIIH D+K NILL
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAA 192
Query: 631 -------------------------------------DDDLNPKISDFGLARIFGGNQDQ 653
+ L KI+D G A +
Sbjct: 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFT 251
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ T Y S E + ++ +D++S + E+ +G
Sbjct: 252 ----EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 495 NNFQLANKLGQGGFGPVY---KGKLQDGQEI-AVKRLSKAS----GQGQEEFMNEVMVIS 546
NF+L LG G +G V+ K D ++ A+K L KA+ + E E V+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 547 NLQHRN-LVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGI 603
+++ LV L + E + LI +Y+ L + L ++ + + + + I
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGE-I 168
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTY 663
L +LH+ L II+RD+K NILLD + + ++DFGL++ F ++ + GT
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTI 224
Query: 664 GYMSPEYAMEGRFSEKSDV--FSFGVLLLEIVSGR 696
YM+P+ G V +S GVL+ E+++G
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 2e-14
Identities = 35/208 (16%), Positives = 64/208 (30%), Gaps = 47/208 (22%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL--------SKASGQGQ 535
F T Q K+G+G FG V++ D +A+K + + + +
Sbjct: 10 PVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 536 EEFMNEVMVISNLQ---------HRNLVRLLGCCVER----EENMLIYEYM--------- 573
EE + E+++ L + L + + +++
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 574 -PNKSLDSFLF------------DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
P+ D LF + R L +I+ ++ L LR H
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEH 185
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFG 648
RDL N+LL K+ +
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 7e-14
Identities = 25/126 (19%), Positives = 48/126 (38%), Gaps = 21/126 (16%)
Query: 25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
+ +T+ + + +S+ F + D N + Y+ T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEPYHFIMQE---DCNL------VLYDHS-----TSVWASNTGI 47
Query: 85 PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
+ DGN VV + + + W+S+ N N L + GN+V++ +
Sbjct: 48 LGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVR--GNGNYVLVLQEDGNVVIYGS---- 100
Query: 145 SIWDSF 150
IW +
Sbjct: 101 DIWSTG 106
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 34/220 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
N ++L K+G G FG +Y G + G+E+A+K + Q E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
+ + C E + N+++ E + SL+ LF+ ++F++ + ISR
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFC-------SRKFSLKTVLLLADQMISR 117
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK---ISDFGLARIFGGNQDQA-----ATK 657
+ Y+H + IHRD+K N L+ I DFGLA+ + + K
Sbjct: 118 -IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 658 RLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
L GT Y S G S + D+ S G +L+ G
Sbjct: 174 NLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
NF++ K+G G FG + GK L + +A+K S Q E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDG 66
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
+ ++ + N ++ E + SL+ LFD + F++ I+ ISR
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLC-------DRTFSLKTVLMIAIQLISR 117
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK-----ISDFGLARIFGGNQDQA-----A 655
+ Y+H + +I+RD+K N L+ N I DF LA+ + + +
Sbjct: 118 -MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 656 TKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
K L GT YMS G+ S + D+ + G + + + G
Sbjct: 174 HKSLTGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
N F+L K+G G FG +Y G +Q +E+A+K + + Q + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64
Query: 554 V-RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
+ + VE + N+L+ + + SL+ LF+ ++ ++ + I+R
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFC-------SRKLSLKTVLMLADQMINR 115
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK---ISDFGLARIFGGNQDQA-----ATK 657
+ ++H S +HRD+K N L+ I DFGLA+ + K
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 658 RLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
L GT Y S G S + D+ S G +L+ + G
Sbjct: 172 NLTGTARYASV-NTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 45/222 (20%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
++++ ++G+G FG +++G L + Q++A+K + S Q E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
+ + E N+L+ + + SL+ L D ++F++ + ++R
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLC-------GRKFSVKTVAMAAKQMLAR 118
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK-----ISDFGLARIFGGNQDQA-----A 655
+ +H S +++RD+K N L+ + + DFG+ + + +
Sbjct: 119 -VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 656 TKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
K L GT YMS GR S + D+ + G + + + G
Sbjct: 175 KKNLSGTARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-13
Identities = 22/125 (17%), Positives = 45/125 (36%), Gaps = 21/125 (16%)
Query: 25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
++++S + S+ G ++L D NF + Y+ G VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQG-DCNF------VLYDSG-----KPVWASNTGG 48
Query: 85 PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
+GNLV+ + +V W + + + L N+V++
Sbjct: 49 LGSGCRLTLH--NNGNLVIYDQSNRVIWQTKTNG--KEDHYVLVLQQDRNVVIYGP---- 100
Query: 145 SIWDS 149
+W +
Sbjct: 101 VVWAT 105
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 46/226 (20%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK------RLSKASGQGQEEFMNEVMVIS 546
+ +++ + +G+G FG V K + + +A+K + EV ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLE 105
Query: 547 NLQHR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
+ +V L + R L++E + + +L L + + + N+
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGV-----SLNLT 159
Query: 601 KGISR----GLLYLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQA 654
+ ++ LL+L L IIH DLK NILL + KI DFG + G +
Sbjct: 160 RKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR--- 214
Query: 655 ATKRLVGTY----GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ Y Y SPE + + D++S G +L+E+ +G
Sbjct: 215 -----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-11
Identities = 19/135 (14%), Positives = 44/135 (32%), Gaps = 24/135 (17%)
Query: 15 YSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANK 74
+S + +++ + I+ ++ D N + Y+
Sbjct: 5 FSKQPDDNHPQILHATESL----EILFGTHVYRF-IMQTDCNL------VLYDNN----- 48
Query: 75 TVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGN 134
+W N + + DG LVV+ + W S V+ + L N
Sbjct: 49 NPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAG--KAGHYVLVLQPDRN 104
Query: 135 LVLHDNISQVSIWDS 149
+V++ + ++W +
Sbjct: 105 VVIYGD----ALWAT 115
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-11
Identities = 22/125 (17%), Positives = 39/125 (31%), Gaps = 22/125 (17%)
Query: 25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
+ + S Q + S+ + N + Y G +W +N ++
Sbjct: 3 NVLLSGQTLHADHSLQAGAYTLT---IQNKCNL------VKYQNG-----RQIWASNTDR 48
Query: 85 PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
S T+ DGNLV+ + W S +N L G V++
Sbjct: 49 R--GSGCRLTLLSDGNLVIYDHNNNDVWGSACWG--DNGKYALVLQKDGRFVIYGP---- 100
Query: 145 SIWDS 149
+W
Sbjct: 101 VLWSL 105
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 44/239 (18%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI------AVKRLSKASGQ-----------GQEE 537
+++ +GQGGFG +Y + + + VK +G + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 538 FMNEVMVISNLQHRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
+ + + L++ + + G + +I + F Q + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD----------RFGSDLQKIYEA 144
Query: 594 -PKRFNI-------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI--SDFGL 643
KRF+ ++ + L Y+H +H D+KASN+LL+ ++ D+GL
Sbjct: 145 NAKRFSRKTVLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
Query: 644 ARIF---GGNQD--QAATKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
A + G ++ + GT + S + A G S + D+ G +++ ++G
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 39/206 (18%), Positives = 76/206 (36%), Gaps = 47/206 (22%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIA---VKRLSKASGQ-----------GQEEFM 539
N + L K+G GGFG +Y ++ A VK + +G +++ +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 540 NEVMVISNLQHRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK 595
+ + L + + G R ++ E + L Q +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDL---------QKISGQNG 146
Query: 596 RFNI-------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI--SDFGLARI 646
F I+ + L Y+H + +H D+KA+N+LL ++ +D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
Query: 647 F---GGNQD--QAATKRLVGTYGYMS 667
+ G ++ + K GT + S
Sbjct: 203 YCPNGNHKQYQENPRKGHNGTIEFTS 228
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-11
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 22/125 (17%)
Query: 25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
+ + S + + E + + ++ D N + Y+ +W N
Sbjct: 2 NILYSGETLSPGEFLNNG--RYVFIMQE-DCNL------VLYDVD-----KPIWATNTGG 47
Query: 85 PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
D ++ DGNLVV + + W+SN N N L N+V++
Sbjct: 48 L--DRRCHLSMQSDGNLVVYSPRNNPIWASNTGG--ENGNYVCVLQKDRNVVIYGT---- 99
Query: 145 SIWDS 149
+ W +
Sbjct: 100 ARWAT 104
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 52/225 (23%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK------RLSKASGQGQEEFMNEVMVISNLQ 549
+++ +G+G FG V K + Q +A+K R + + E+ ++ +L+
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLR 151
Query: 550 HR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI--IK 601
+ N++ +L R + +E L L++ +++ + F++ ++
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKF---QGFSLPLVR 203
Query: 602 GISR----GLLYLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAA 655
+ L LH+ RIIH DLK NILL K+ DFG + + +
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR---- 255
Query: 656 TKRLVGTY----GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
V TY Y +PE + R+ D++S G +L E+++G
Sbjct: 256 ----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 20/126 (15%)
Query: 24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRN 83
+D + S + S+ + + D N + Y+ VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQN-DCNL------VLYDNN-----RAVWASGTN 46
Query: 84 KPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ 143
S + + DGNLV+ +G + + W+SN + N N L N+V++DN S
Sbjct: 47 GK--ASGCVLKMQNDGNLVIYSGSRAI-WASNTNR--QNGNYYLILQRDRNVVIYDN-SN 100
Query: 144 VSIWDS 149
+IW +
Sbjct: 101 NAIWAT 106
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 19/130 (14%), Positives = 41/130 (31%), Gaps = 23/130 (17%)
Query: 20 TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWV 79
+ + S Q + + + + + D N + Y W
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAKNHQLVMQG---DCNL------VLYGG------KYGWQ 46
Query: 80 ANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHD 139
+N + ++ G L++ + + WSS SS L D G V++
Sbjct: 47 SNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSRSSS--KQGEYVLILQDDGFGVIYG 102
Query: 140 NISQVSIWDS 149
+I+++
Sbjct: 103 P----AIFET 108
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 30/208 (14%), Positives = 65/208 (31%), Gaps = 48/208 (23%)
Query: 495 NNFQLANKLGQGGFGPVYKGK---------LQDGQEIAVKRLSKASGQGQEEFMNEVMVI 545
++L + + G +Y+ Q+ ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 546 SNLQHRNLVRLLGC------------CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
LQ +L + + L+ + +SL S D +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPK----- 153
Query: 594 PKRFNI-------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI--SDFGLA 644
+ + + L +LH + +H ++ A NI +D + ++ + +G A
Sbjct: 154 -HVLSERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 645 RIF---GGNQDQAATKR--LVGTYGYMS 667
+ G + R G ++S
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHEGDLEFIS 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 82/253 (32%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK------RLSKASGQGQEEFMNEVMVIS 546
N F + K+G G FG V + + + + AVK + ++++ E ++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILK 86
Query: 547 NLQHR-----NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLLDW 593
+Q+ N+V+ F+ F+P SL +
Sbjct: 87 KIQNDDINNNNIVKYH---------------------GKFMYYDHMCLIFEPLGPSLYEI 125
Query: 594 PKRFN-------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
R N IK +L YL + + + H DLK NILLDD K
Sbjct: 126 ITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182
Query: 643 LARIFGGNQDQAATKRL----------------VGTY----GYMSPEYAMEGRFSEKSDV 682
G TK G+ Y +PE + + SD+
Sbjct: 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDM 242
Query: 683 FSFGVLLLEIVSG 695
+SFG +L E+ +G
Sbjct: 243 WSFGCVLAELYTG 255
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 9e-09
Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 25/127 (19%)
Query: 23 ATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANR 82
T+ + S Q + + + + D N Y G W + + +
Sbjct: 2 GTNYLLSGQTLDTEGHLKNGDFDLVMQ---DDCNLV-LYNGNWQSNTANNGRDCK----- 52
Query: 83 NKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNIS 142
T+++ G LV+ NG W S S N A + G LV+
Sbjct: 53 ----------LTLTDYGELVIKNGDGSTVWKSGAQS--VKGNYAAVVHPDGRLVVFGP-- 98
Query: 143 QVSIWDS 149
S++
Sbjct: 99 --SVFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-08
Identities = 16/127 (12%), Positives = 37/127 (29%), Gaps = 20/127 (15%)
Query: 23 ATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANR 82
+ + SSQ + D + + D N + +VW +
Sbjct: 5 VRNVLFSSQVMYDNAQLATRDYSLV---MRDDCNL------VLTKGS---KTNIVWESGT 52
Query: 83 NKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNIS 142
+ + G L + + + + SN + L +G V++
Sbjct: 53 SGR--GQHCFMRLGHSGELDITDDRLNTVFVSNTVG--QEGDYVLILQINGQAVVYGP-- 106
Query: 143 QVSIWDS 149
++W +
Sbjct: 107 --AVWST 111
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 44/258 (17%), Positives = 84/258 (32%), Gaps = 96/258 (37%)
Query: 494 TNNFQLANKLGQGGFGPVYKG--KLQDGQEIAVK------RLSKASGQGQEEFMNEVMVI 545
+++ LG+G FG V + + ++A+K + +A+ E+ V+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVL 70
Query: 546 SNLQHR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLL 591
++ + V + D F F+ ++
Sbjct: 71 KKIKEKDKENKFLCVLMS---------------------DWFNFHGHMCIAFELLGKNTF 109
Query: 592 DWPKRFN-------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNP---- 636
++ K N ++ ++ L +LH ++ H DLK NIL +
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN 166
Query: 637 ---------------KISDFGLARIFGGNQDQAATKRLVGTY----GYMSPEYAMEGRFS 677
+++DFG A F T Y PE +E ++
Sbjct: 167 EHKSCEEKSVKNTSIRVADFGSA-TFDHEH--------HTTIVATRHYRPPEVILELGWA 217
Query: 678 EKSDVFSFGVLLLEIVSG 695
+ DV+S G +L E G
Sbjct: 218 QPCDVWSIGCILFEYYRG 235
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 3e-07
Identities = 37/257 (14%), Positives = 73/257 (28%), Gaps = 36/257 (14%)
Query: 20 TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFT--NRYIGIWYNKGGSANKTVV 77
T + + Q + + ++S +FKL DGN + +W
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQ-GDGNLVIQDNGATVWVA--NEQQPFSS 66
Query: 78 WVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS---NTRAQLLDSGN 134
+ RNK + + ++ W ++ S+ +N T L D GN
Sbjct: 67 TIPLRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGN 121
Query: 135 LVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSL-SNPSIGSFSAGL 193
+VL D+++ + + S + L L G+ ++ L
Sbjct: 122 IVLVDSLALWNGTPAIPLVPGAIDSLL-------------LAPGSELVQGVVYGAGASKL 168
Query: 194 DSFTIPEVFIWINGTRPYWRSGPW--NGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTF 251
+ + W +G + D N V N + +
Sbjct: 169 VFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGN-------AVLWHSH 221
Query: 252 AFADNDVFFALTPQGNL 268
L G++
Sbjct: 222 TGGHASAVLRLQANGSI 238
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.5 bits (114), Expect = 4e-06
Identities = 22/115 (19%), Positives = 38/115 (33%), Gaps = 9/115 (7%)
Query: 36 PESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTI 95
+++ GS+ G G + G N W A +
Sbjct: 145 DSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGK---GAVRAVF 201
Query: 96 SEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSF 150
DGNLVV V W S+ +++ +L +G++ + D +W F
Sbjct: 202 QGDGNLVVYGAGNAVLWHSHTG---GHASAVLRLQANGSIAILDE---KPVWARF 250
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.5 bits (101), Expect = 1e-04
Identities = 23/150 (15%), Positives = 38/150 (25%), Gaps = 15/150 (10%)
Query: 11 SSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFF-SPDGNFTNRYIGIWYN-- 67
+ + A D ++ D + S+ + DGN +N
Sbjct: 75 APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGT 134
Query: 68 --------KGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSL 119
S + + DGNLV W++
Sbjct: 135 PAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQ-- 192
Query: 120 ANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149
RA GNLV++ +W S
Sbjct: 193 -GKGAVRAVFQGDGNLVVYGA-GNAVLWHS 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 48/250 (19%), Positives = 86/250 (34%), Gaps = 80/250 (32%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK--LQDGQEIAVK------RLSKASGQGQEEFMNEVMVI 545
+ +++ + LG+G FG V + G+ +AVK R +A+ +E+ V+
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65
Query: 546 SNLQHR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN- 598
+L V++L +++E + S D+ K
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-------------GLSTYDFIKENGF 112
Query: 599 ------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNP------------ 636
I+ ++ + +LH ++ H DLK NIL
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 637 -------KISDFGLARIFGGNQDQAATKRLVGTY----GYMSPEYAMEGRFSEKSDVFSF 685
K+ DFG A + T Y +PE + +S+ DV+S
Sbjct: 170 TLINPDIKVVDFGSA-TYDDEH--------HSTLVSTRHYRAPEVILALGWSQPCDVWSI 220
Query: 686 GVLLLEIVSG 695
G +L+E G
Sbjct: 221 GCILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 56/364 (15%), Positives = 104/364 (28%), Gaps = 133/364 (36%)
Query: 452 KENSKVQRLDLGEA--------YANFSTEKVNPARLQDLLVFNFEELANATNNF------ 497
K+ VQ+ + E + TE+ P+ + + + + L N F
Sbjct: 74 KQEEMVQKF-VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 498 ------QLANKL------------GQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM 539
+L L G G G K + A+ S + Q +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCL--SYKVQCKMD 181
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW----PK 595
++ ++ L C E + + + + + DP S D
Sbjct: 182 FKIFWLN----------LKNCNSPETVLEMLQKL------LYQIDPNWTSRSDHSSNIKL 225
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD-FGL-ARIFGGNQDQ 653
R + I+ RL + + + ++L + N K + F L +I
Sbjct: 226 RIHSIQ---------AELRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKI------- 268
Query: 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGY 713
L+ T RF + +D S I + + +E +LL
Sbjct: 269 -----LLTT------------RFKQVTDFLS-AATTTHISLDHHSMTLTPDE-VKSLLL- 308
Query: 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773
+ D DL P E++ P +S++ I+
Sbjct: 309 ---KYLDCRPQDL--PR--------EVLTT-----------------NPRRLSIIAESIR 338
Query: 774 DLPA 777
D A
Sbjct: 339 DGLA 342
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 8e-06
Identities = 13/77 (16%), Positives = 24/77 (31%), Gaps = 8/77 (10%)
Query: 73 NKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDS 132
VW N + +G + VL + W+S S + L
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSR--SAGRYVFVLQPD 222
Query: 133 GNLVLHDNISQVSIWDS 149
NL ++ ++W +
Sbjct: 223 RNLAIYGG----ALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 2e-05
Identities = 34/172 (19%), Positives = 57/172 (33%), Gaps = 7/172 (4%)
Query: 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
I + G S + + + L SS FT+ D NLV+ + W+SN + +
Sbjct: 3 ILF--GLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV-RVWASNTA---GAT 56
Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
RA L G LV+ + + W S + + Y + T L + +
Sbjct: 57 GCRAVLQSDGLLVILTAQNTI-RWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNK 115
Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
S+ + G + T +S + D N V D
Sbjct: 116 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR 167
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 16/125 (12%), Positives = 36/125 (28%), Gaps = 22/125 (17%)
Query: 26 TITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKP 85
+ + I + + F + D N + YN+ + +N +
Sbjct: 4 VLLTGDVIHTDNQLSYESAAFVMQG---DCNL------VLYNEA------GGFQSNTHGR 48
Query: 86 LIDSSGIFTISEDGNLVVLNGK-KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
++ G L + + W S N A L ++ ++
Sbjct: 49 --GVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP---- 102
Query: 145 SIWDS 149
+IW +
Sbjct: 103 AIWST 107
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 816 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-74 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-26 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 9e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 6e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 3e-74
Identities = 69/285 (24%), Positives = 132/285 (46%), Gaps = 20/285 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ ++G G FG VYKGK + + ++ + Q + F NEV V+ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+G + ++ ++ SL L ++ + K +I + ++G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM-- 672
IIHRDLK++NI L +DL KI DFGLA + ++L G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 673 -EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731
+ +S +SDV++FG++L E+++G+ Y + + + + V
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
++ + C+++ +RP P +++ + + LP
Sbjct: 239 PKA--------MKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 3e-68
Identities = 87/275 (31%), Positives = 129/275 (46%), Gaps = 24/275 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +LG G FG V+ G ++AVK L + S + F+ E ++ LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
RL + E +I EYM N SL FL P L K ++ I+ G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
IHRDL+A+NIL+ D L+ KI+DFGLAR+ N+ A + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP-LISE 733
F+ KSDV+SFG+LL EIV+ + E+ + N +V P E
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRPDNCPE 237
Query: 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768
+ LC +E +DRP + S+L
Sbjct: 238 --------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-67
Identities = 60/285 (21%), Positives = 115/285 (40%), Gaps = 13/285 (4%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQH 550
++F+ ++LG G G V+K G +A K + + + + E+ V+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+V G E + E+M SLD L ++ + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
+ +I+HRD+K SNIL++ K+ DFG++ + VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730
+S +SD++S G+ L+E+ GR + + L + ++ D
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775
+ + + + +++ + P + + E +D
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 3e-67
Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 22/274 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ ++G G FG V+ G + ++A+K + + +E+F+ E V+ L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L G C+E+ L++E+M + L +L ++ L + + G+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLE--- 118
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
+IHRDL A N L+ ++ K+SDFG+ R +Q ++ + SPE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734
R+S KSDV+SFGVL+ E+ S K E+ + + + L P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKP----- 224
Query: 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768
++ + C +E +DRP ++ L
Sbjct: 225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-66
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 22/288 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +L KLGQG FG V+ G +A+K L + E F+ E V+ L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L E ++ EYM SL FL + L P+ ++ I+ G+ Y+ R
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
+ +HRDL+A+NIL+ ++L K++DFGLAR+ N+ A + +PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734
RF+ KSDV+SFG+LL E+ + + + + V+D V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMP 234
Query: 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPA 782
++ C ++ ++RP + + L QP
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-66
Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +LG G FG V GK + ++A+K + + S ++EF+ E V+ NL H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
+L G C ++ +I EYM N L ++L + + + + + K + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
+ +HRDL A N L++D K+SDFGL+R + + ++ + PE M
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734
+FS KSD+++FGVL+ EI S K ++ + ++ + + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 735 GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSML 768
+ + + C E +RP ++S +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 5e-66
Identities = 62/298 (20%), Positives = 112/298 (37%), Gaps = 28/298 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
L +G+G FG V++GK G+E+AVK S + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENIL 60
Query: 555 RLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
+ + L+ +Y + SL +L + + + + GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 611 HRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAATKRLVGTY 663
H + + I HRDLK+ NIL+ + I+D GLA D A VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 664 GYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEE----FELTLLGY 713
YM+PE + +++D+++ G++ EI + + ++L
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 714 AWKLWNDNNVIDLVDPLISESGFKMEIIRCV-NVGLLCVQEFVKDRPNMPTVVSMLNS 770
+ + + P I E +R + + C R + L+
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (555), Expect = 2e-65
Identities = 75/307 (24%), Positives = 135/307 (43%), Gaps = 37/307 (12%)
Query: 485 FNFEELANATNNF---------QLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKA- 530
F FE+ A F ++ +G G FG V G L + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
+ + + +F++E ++ H N++ L G + M+I E+M N SLDSFL Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
+ +++GI+ G+ YL + +HRDL A NIL++ +L K+SDFGL+R +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 651 QDQAATKRLVG---TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFE 707
+G + +PE +F+ SDV+S+G+++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 708 LTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767
+ + +VI+ ++ + L C Q+ RP +V+
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 768 LNSEIKD 774
L+ I++
Sbjct: 287 LDKMIRN 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (551), Expect = 1e-64
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 46/310 (14%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFM 539
L NN + +G+G FG V++ + + +AVK L + AS Q +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL--------- 590
E +++ + N+V+LLG C + L++EYM L+ FL ++
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 591 ------------LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
L ++ I + ++ G+ YL + +HRDL N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 698
+DFGL+R A +M PE R++ +SDV+++GV+L EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 699 TSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDR 758
+ E+ D N++ + E N+ LC + DR
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPLE---------LYNLMRLCWSKLPADR 286
Query: 759 PNMPTVVSML 768
P+ ++ +L
Sbjct: 287 PSFCSIHRIL 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (547), Expect = 2e-64
Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 22/290 (7%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
N+++ + + +KLG G +G VY+G + +AVK L + + + EEF+ E V
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
+ ++H NLV+LLG C +I E+M +L +L + RQ + + IS
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 125
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
+ YL + IHRDL A N L+ ++ K++DFGL+R+ G+ A
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIK 181
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724
+ +PE +FS KSDV++FGVLL EI + + + + + V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVY 226
Query: 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774
+L++ + + + C Q DRP+ + + ++
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-63
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 39/285 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+L +G+G FG V G G ++AVK + + F+ E V++ L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 555 RLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+LLG VE + + ++ EYM SL +L + +S+L + + YL +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAME 673
+HRDL A N+L+ +D K+SDFGL + QD + +PE E
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALRE 174
Query: 674 GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733
+FS KSDV+SFG+LL EI S + + +V+ V E
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR---------------VPYPRIPLKDVVPRV-----E 214
Query: 734 SGFKMEII-----RCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773
G+KM+ V C RP+ + L IK
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE-HIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-63
Identities = 76/307 (24%), Positives = 130/307 (42%), Gaps = 37/307 (12%)
Query: 488 EELANATNNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQ-EEFMNEV 542
++L +N +A+ +LG G FG V +G + ++A+K L + + + EE M E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
++ L + +VRL+G C + E ML+ E L FL + + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ-AATKRLVG 661
+S G+ YL +HRDL A N+LL + KISDFGL++ G + A
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721
+ +PE +FS +SDV+S+GV + E +S + +K
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGP 219
Query: 722 NVIDLVDPLISESGFKMEII-----RCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
V+ + E G +ME + C +DRP+ TV + + L
Sbjct: 220 EVMAFI-----EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 777 AAKQPAF 783
+ +
Sbjct: 275 SKVEGHH 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-61
Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQGQ--EEFMNEVMVISNLQHRNLVR 555
+LG G FG V KG Q + +AVK L + +E + E V+ L + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
++G C E E ML+ E L+ +L + + ++ +S G+ YL
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA-ATKRLVGTYGYMSPEYAMEG 674
+HRDL A N+LL KISDFGL++ +++ A + +PE
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 675 RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISES 734
+FS KSDV+SFGVL+ E S + ++ + V ++ E
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAML-----EK 225
Query: 735 GFKMEII-----RCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775
G +M ++ LC V++RP V L + D+
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-61
Identities = 72/306 (23%), Positives = 121/306 (39%), Gaps = 45/306 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASGQGQ-EEFMNEVMVISN 547
N + LG G FG V ++AVK L + + + E M+E+ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ------------------ 588
L H N+V LLG C LI+EY L ++L + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 589 --SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
++L + +++G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 647 FGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF 706
+ + +M+PE EG ++ KSDV+S+G+LL EI S +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 707 ELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766
+ +KL + +D +E + C + RP+ P + S
Sbjct: 273 DANF----YKLIQNGFKMDQ-PFYATE--------EIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 767 MLNSEI 772
L ++
Sbjct: 320 FLGCQL 325
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-61
Identities = 69/303 (22%), Positives = 109/303 (35%), Gaps = 40/303 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQ-EEFMNEVMVISN 547
N LG G FG V + +AVK L ++ + E M+E+ V+S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL---------------L 591
L H N+V LLG C ++I EY L +FL + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
D + +++G+ +L IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
+ +M+PE ++ +SDV+S+G+ L E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 712 GYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771
+ L ++ C RP +V ++ +
Sbjct: 257 ---FYKMIKEGFRMLSPEHAPA--------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 772 IKD 774
I +
Sbjct: 306 ISE 308
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-61
Identities = 72/313 (23%), Positives = 131/313 (41%), Gaps = 35/313 (11%)
Query: 475 NPARLQDL--LVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLS 528
NP +Q + +V L +F +G+G FG VY G L D AVK L+
Sbjct: 10 NPELVQAVQHVVIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 529 KASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQ 586
+ + G+ +F+ E +++ + H N++ LLG C+ E + +++ YM + L +F+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
+ F + + + + +HRDL A N +LD+ K++DFGLAR
Sbjct: 125 HNPTVKDLIGFGLQVAK-----GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 647 FGGNQDQAATKR--LVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHE 704
+ + + +M+ E +F+ KSDV+SFGVLL E+++ Y +
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPD 237
Query: 705 EFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTV 764
+ L ++ + V L C + RP+ +
Sbjct: 238 VNTFDIT---VYLLQGRRLLQ--PEYCPDP--------LYEVMLKCWHPKAEMRPSFSEL 284
Query: 765 VSMLNSEIKDLPA 777
VS +++
Sbjct: 285 VSRISAIFSTFIG 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-60
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 10/209 (4%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRN 552
++++ +G G +G K + DG+ + K L S ++ ++EV ++ L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 553 LVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQS-LLDWPKRFNIIKGISRGLLY 609
+VR ++R L + EY L S + ++ LD ++ ++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 610 LHR--DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
HR D ++HRDLK +N+ LD N K+ DFGLARI N D + K VGT YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMS 182
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
PE ++EKSD++S G LL E+ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-60
Identities = 71/287 (24%), Positives = 131/287 (45%), Gaps = 27/287 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
+ +G G FG VYKG L+ +A+K L + Q +F+ E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
H N++RL G + + M+I EYM N +LD FL + + + +++GI+ G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT-KRLVGTYGYMS 667
YL + +HRDL A NIL++ +L K+SDFGL+R+ + + T + +
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 668 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727
PE +F+ SDV+SFG+++ E+++ + + +++ V+ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------------LSNHEVMKAI 226
Query: 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774
+ + + C Q+ RP +VS+L+ I+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 23/275 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRN 552
++ L LG+G +G V + +AVK + E E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+ G E L EY L + + + P + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
+ I HRD+K N+LLD+ N KISDFGLA +F N + ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 673 EGRF-SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731
F +E DV+S G++L +++G + + + W + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKI 232
Query: 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766
+ + ++ + E R +P +
Sbjct: 233 DSAP--LALLHK------ILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 2e-59
Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHRN 552
F ++G G FG VY + +++ + +A+K++S + Q E + + EV + L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
++ GC + L+ EY + D + L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
+IHRD+KA NILL + K+ DFG A I A VGT +M+PE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 673 ---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729
EG++ K DV+S G+ +E+ + ++ L ++ P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK---PPLFNMNAMSAL---------YHIAQNESP 232
Query: 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766
+ + V+ C+Q+ +DRP ++
Sbjct: 233 ALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 3e-59
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
N + +++ +LG G FG VYK + + A K + S + E++M E+ ++++ H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V+LL ++ E+ ++D+ + + +R L + + K L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H +IIHRDLKA NIL D + K++DFG++ + + +GT +M+PE
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 671 AM-----EGRFSEKSDVFSFGVLLLEIVSGR 696
M + + K+DV+S G+ L+E+
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 62/278 (22%), Positives = 120/278 (43%), Gaps = 31/278 (11%)
Query: 497 FQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNL 553
+ ++G+G F VYKG + E+A L + ++ F E ++ LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 554 VRLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
VR + +L+ E M + +L ++L +R ++ + + I +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQF 127
Query: 610 LHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSP 668
LH + IIHRDLK NI + + KI D GLA + + K ++GT +M+P
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 182
Query: 669 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728
E E ++ E DV++FG+ +LE+ + S ++ ++ D
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPASFD 235
Query: 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766
+ + C+++ +R ++ +++
Sbjct: 236 KVAIPE--------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-59
Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 49/305 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG---QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
N+ + + +G+G FG V K +++ + A+KR+ + AS +F E+ V+ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLLDWPKR 596
H N++ LLG C R L EY P+ +L FL S L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
+ ++RG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R G +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 657 KRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK 716
+M+ E ++ SDV+S+GVLL EIVS
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------- 226
Query: 717 LWNDNNVIDLVDPLISESGFKMEII-----RCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771
+ +L + L G+++E ++ C +E +RP+ ++ LN
Sbjct: 227 -YCGMTCAELYEKL--PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
Query: 772 IKDLP 776
+++
Sbjct: 284 LEERK 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-59
Identities = 65/291 (22%), Positives = 130/291 (44%), Gaps = 37/291 (12%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQE----IAVKRLSKA-SGQGQEEFMNEVMVISNLQH 550
F+ LG G FG VYKG + +G++ +A+K L +A S + +E ++E V++++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
++ RLLG C+ LI + MP L + + + + N I++G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
R++HRDL A N+L+ + KI+DFGLA++ G + + + +M+ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730
+ ++ +SDV+S+GV + E+++ + + + +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILE-- 227
Query: 731 ISESGFKMEI-----IRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776
G ++ I + + C RP ++ + +D
Sbjct: 228 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 74/303 (24%), Positives = 133/303 (43%), Gaps = 34/303 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
++ +LGQG FG VY+G + +A+K +++ AS + + EF+NE V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-------LDWPKRFNII 600
++VRLLG + + ++I E M L S+L + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
I+ G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720
+MSPE +G F+ SDV+SFGV+L EI + + ++ + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVME 250
Query: 721 NNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQ 780
++D D + +C Q K RP+ ++S + E++ P ++
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFRE 299
Query: 781 PAF 783
+F
Sbjct: 300 VSF 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-58
Identities = 78/287 (27%), Positives = 114/287 (39%), Gaps = 38/287 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSK---ASGQGQEEFMNEVMVISN 547
+ +L KLG G FG V +G+ +AVK L + + ++F+ EV + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
L HRNL+RL G + ++ E P SL L Q LL R ++ G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ-AATKRLVGTYGYM 666
YL R IHRDL A N+LL KI DFGL R N D + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 667 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726
+PE FS SD + FGV L E+ + Y + W N +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT------------------YGQEPWIGLNGSQI 223
Query: 727 VDPLISESGFKMEII-----RCVNVGLLCVQEFVKDRPNMPTVVSML 768
+ I + G ++ NV + C +DRP + L
Sbjct: 224 LH-KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-57
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQH 550
+F++ LG+G FG VY + Q +A+K L KA + + EV + S+L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N++RL G + LI EY P ++ L Q+ S D + I ++ L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H R+IHRD+K N+LL KI+DFG + ++ L GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
EK D++S GVL E + G+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 3e-57
Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 10/206 (4%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
+ + K+GQG G VY + GQE+A+++++ +E +NE++V+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N+V L + +E ++ EY+ SL + + D + + + + L +L
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFL 132
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H ++IHRD+K+ NILL D + K++DFG +Q+ +VGT +M+PE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEV 187
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ K D++S G++ +E++ G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-55
Identities = 72/301 (23%), Positives = 118/301 (39%), Gaps = 39/301 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQG-QEEFMNEVMVIS- 546
+ +L LG+G FG V + K + +AVK L + + M+E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 547 NLQHRNLVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSL-------------LD 592
H N+V LLG C + M+I E+ +L ++L + + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
+++G+ +L + IHRDL A NILL + KI DFGLAR + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLG 712
+M+PE + ++ +SDV+SFGVLL EI S + + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245
Query: 713 YAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772
+ + + D E L C RP +V L + +
Sbjct: 246 -FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
Query: 773 K 773
+
Sbjct: 296 Q 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-53
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 27/285 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
+L +G+G FG V++G +A+K + +E+F+ E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H ++V+L+G E +I E L SF R+ LD +S L Y
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAY 123
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
L R +HRD+ A N+L+ + K+ DFGL+R + A+ + +M+PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPE 179
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729
RF+ SDV+ FGV + EI+ + ++ + + + P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPM-PP 232
Query: 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774
+ ++ C RP + + L++ +++
Sbjct: 233 NCPPT--------LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-53
Identities = 73/298 (24%), Positives = 122/298 (40%), Gaps = 41/298 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL--------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
+ L LG+G FG V + ++AVK L A+ + + ++E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-------------L 591
+ +H+N++ LLG C + +I EY +L +L + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
+ ++RG+ YL + IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL 711
T +M+PE + ++ +SDV+SFGVLL EI + + EL
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 712 GYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLN 769
+KL + + +D +E + C RP +V L+
Sbjct: 247 ---FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-53
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
+F+ LG+G F V + L +E A+K L K E V+S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
V+L + E+ Y N L ++ D I L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
IIHRDLK NILL++D++ +I+DFG A++ QA VGT Y+SPE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
E + SD+++ G ++ ++V+G
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (468), Expect = 2e-52
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
+++ + +LG G FG V++ G A K + +E E+ +S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
V L + E ++IYE+M L + D + + + ++ + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
+H DLK NI+ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
+D++S GVL ++SG
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (456), Expect = 7e-51
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 11/205 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
+ + + +LG G FG V++ G+ K ++ + NE+ +++ L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+ L ++ E +LI E++ L + + + N ++ GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
I+H D+K NI+ + KI DFGLA ++ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
+D+++ GVL ++SG
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-48
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 7/209 (3%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQ 549
+ + + +G+G +G V + +A+K++S Q + + E+ ++ +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H N++ + + Y+ + + L+ + L + I RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT-KRLVGTYGYMSP 668
+H ++HRDLK SN+LL+ + KI DFGLAR+ + D V T Y +P
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 669 EYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
E + + +++ D++S G +L E++S R
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (425), Expect = 2e-47
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 15/212 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQ 549
++ ++L LG GG V+ + L+ +++AVK L + F E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 550 HRNLVRLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
H +V + ++ EY+ +L + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA-TKRLVGTYG 664
L + H+ IIHRD+K +NI++ K+ DFG+AR + + T ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y+SPE A +SDV+S G +L E+++G
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (429), Expect = 6e-47
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVIS---N 547
N+F + +G+GGFG VY + G+ A+K L K QG+ +NE +++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
+V + ++ I + M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 668 PEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
PE +G + +D FS G +L +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 6e-47
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 14/215 (6%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMV 544
+++ + + + + LG G F V + + + +A+K ++K + +G+E NE+ V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
+ ++H N+V L LI + + L + + +I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+ YLH I+HRDLK N+L D+D ISDFGL+++ G
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
T GY++PE + +S+ D +S GV+ ++ G
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 6e-47
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
+FQ+ LG G FG V+ + +G+ A+K L K + E +E +++S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
++R+ G + ++ +I +Y+ L S L QR + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
II+RDLK NILLD + + KI+DFG A+ L GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGRK 697
+++ D +SFG+L+ E+++G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-47
Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 12/204 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
+ +A LG+G FG V++ + K + K G Q E+ +++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
L EE ++I+E++ + + + L+ + + + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH--- 119
Query: 615 RLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
I H D++ NI+ + KI +FG AR + + L Y +PE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQ 176
Query: 673 EGRFSEKSDVFSFGVLLLEIVSGR 696
S +D++S G L+ ++SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 5e-46
Identities = 57/232 (24%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG---------QGQEEFMNEVMVI 545
N++ LG+G V + +E AVK + G + +E + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 546 SNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
+ H N+++L L+++ M L +L + L + I++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
+ LH+ L I+HRDLK NILLDDD+N K++DFG + + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 665 YMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTL 710
Y++PE + ++ D++S GV++ +++G F+H + L L
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQMLML 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMVIS-NLQ 549
+F L LG+G FG V+ + + Q A+K L K ++ M E V+S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
H L + +E + EY+ L + + D + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
LH I++RDLK NILLD D + KI+DFG+ + + T GT Y++PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ +++ D +SFGVLL E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-45
Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 35/293 (11%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK--LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNL 548
A ++ ++G+G +G V+K + G+ +A+KR+ +G+ + EV V+ +L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 549 ---QHRNLVRLLGCCVEREENMLIYEYMPNKSLDS---FLFDPQRQSLLDWPKRFNIIKG 602
+H N+VRL C + + + +D D + + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
+ RGL +LH R++HRDLK NIL+ K++DFGLARI+ +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 663 YGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722
Y +PE ++ ++ D++S G + E+ + L+ ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-------------------PLFRGSS 219
Query: 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775
+D + ++ G E +V L K + V+ ++ KDL
Sbjct: 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (408), Expect = 5e-45
Identities = 43/292 (14%), Positives = 99/292 (33%), Gaps = 27/292 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
++++ ++G+G FG +++G L + Q++A+K + S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+ + + + ++ + SL+ L R K + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE- 119
Query: 614 SRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIF-----GGNQDQAATKRLVGTY 663
+++RD+K N L+ + + DFG+ + + + K L GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 664 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723
YMS + S + D+ + G + + + G K
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------KQKYERIGEK 231
Query: 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775
+GF E + ++ P+ + + + ++ L
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 3e-44
Identities = 53/285 (18%), Positives = 97/285 (34%), Gaps = 25/285 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
N ++L K+G G FG +Y G + G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
+ + C + ++ + SL+ R+ + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS- 121
Query: 614 SRLRIIHRDLKASNIL---LDDDLNPKISDFGLARIFGGNQDQA-----ATKRLVGTYGY 665
IHRD+K N L I DFGLA+ + + K L GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725
S + S + D+ S G +L+ G + + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770
L SE F + C ++ D+P+ + + +
Sbjct: 240 LCKGYPSE--FATYLNFCRSLR-------FDDKPDYSYLRQLFRN 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (397), Expect = 1e-43
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
+ K+G+G +G VYK + G+ A+K RL K + E+ ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+L ++ +L++E++ L+ + + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH- 117
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAM 672
R++HRDLK N+L++ + KI+DFGLAR FG + + + T Y +P+ M
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVLM 173
Query: 673 -EGRFSEKSDVFSFGVLLLEIVSGR 696
++S D++S G + E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-----FMNEVMVISNLQHRNLV 554
+ LG+G F VYK + Q +A+K++ ++ + E+ ++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
LL + L++++M +L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEG 674
I+HRDLK +N+LLD++ K++DFGLA+ FG A V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGA 175
Query: 675 R-FSEKSDVFSFGVLLLEIVSGR 696
R + D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRN 552
NFQ K+G+G +G VYK + G+ +A+K++ + + E+ ++ L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
+V+LL + L++E++ D + + P + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE-YA 671
R++HRDLK N+L++ + K++DFGLAR FG + V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILL 175
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGR 696
+S D++S G + E+V+ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-42
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
++ +G G FG VY+ KL G+ +A+K++ + + E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIV 76
Query: 555 RLLGCCVEREENM------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
RL E L+ +Y+P + + L + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 609 YLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFGGNQDQAATKRLVGTYGYMS 667
Y+H I HRD+K N+LLD D K+ DFG A+ + + + + Y +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 668 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 696
PE ++ DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 6e-42
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS------GQGQEEFMNEVMV 544
N + + +LG G F V K + G + A K + K G +E+ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
+ +QH N++ L + + +LI E + L FL + + L + +K I
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFGGNQDQAATKRLV 660
G+ YLH L+I H DLK NI+L D P KI DFGLA + K +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 661 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
GT +++PE ++D++S GV+ ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-41
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 20/213 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE------FMNEVMVISN 547
+ +Q+ LG GGFG VY G + D +A+K + K E EV+++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 548 LQ--HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
+ ++RLL + +LI E + L + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
+ + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRV 174
Query: 665 YMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 696
Y PE+ R+ + V+S G+LL ++V G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 8e-41
Identities = 49/216 (22%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHR 551
+ ++ K+GQG FG V+K + + GQ++A+K++ + + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 552 NLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
N+V L+ C + L++++ + + + +++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVG 661
L L+ R +I+HRD+KA+N+L+ D K++DFGLAR F ++ + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 662 TYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 696
T Y PE + R + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-41
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQH 550
N+F LG+G FG V + G+ A+K L K ++E + E V+ N +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
L L + + EY L L R+ + + I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H +++RD+K N++LD D + KI+DFGL + G D A K GT Y++PE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ + D + GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 45/206 (21%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
++ K+G+G +G V+K K + + +A+KR+ + E+ ++ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
N+VRL ++ L++E+ F D + + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYA 671
++HRDLK N+L++ + K+++FGLAR FG + + +V +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 672 MEGRFSEKSDVFSFGVLLLEIVSGRK 697
+S D++S G + E+ + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 3e-38
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 15/206 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
+ F LG G FG V K + G A+K L K + E +NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
LV+L + ++ EY+ + S L R P I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H L +I+RDLK N+L+D +++DFG A+ G L GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 671 AMEGRFSEKSDVFSFGVLLLEIVSGR 696
+ +++ D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 45/212 (21%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 495 NNFQLANK-LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHR 551
+++++ ++ LG G G V + + ++ A+K L + EV + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 552 NLVRLLGCC----VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
++VR++ R+ +++ E + L S + D + + I+K I +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAI 124
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNP---KISDFGLARIFGGNQDQAATKRLVGTYG 664
YLH + I HRD+K N+L K++DFG A+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
Y++PE ++ + D++S GV++ ++ G
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHR 551
++ +G G +G V + G ++A+K+L + S + E+ ++ +++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 552 NLVRLLGCCVEREENMLIYE-YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
N++ LL E + Y+ + + L + L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEY 670
H IIHRDLK N+ +++D KI DFGLAR V T Y +PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEV 189
Query: 671 AMEG-RFSEKSDVFSFGVLLLEIVSGR 696
+ R+++ D++S G ++ E+++G+
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (337), Expect = 4e-35
Identities = 56/287 (19%), Positives = 123/287 (42%), Gaps = 29/287 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRN 552
+++QL KLG+G + V++ + + +++ VK L +++ E+ ++ NL+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 553 LVRLLGCCVEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
++ L + L++E++ N Q+L D+ RF + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYC 145
Query: 611 HRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
H + I+HRD+K N+++D + ++ D+GLA + Q+ V + + PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 670 YAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728
++ + + D++S G +L ++ + F+H L K+ ++ D +D
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775
E + I + + + + +++ E D
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQH------LVSPEALDF 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 7e-35
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVIS 546
NF+L LG G +G V+ + G+ A+K L KA+ + E E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 547 NLQHR-NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
+++ LV L + LI +Y+ L + L +R + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
+L L +L II+RD+K NILLD + + ++DFGL++ F ++ + GT Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 666 MSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 696
M+P+ G + D +S GVL+ E+++G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-34
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
+Q +G G G V + +A+K+LS+ + + E++++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 552 NLVRLLGCCV------EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
N++ LL E ++ L+ E M + D + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGY 665
G+ +LH IIHRDLK SNI++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184
Query: 666 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+PE + + E D++S G ++ E+V +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-32
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH 550
+Q + +G G +G V + G +AVK+LS+ S + E+ ++ +++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 551 RNLVRLLGCCVEREENMLI-YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
N++ LL Y+ + + L + + L +I I RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPE 669
+H IIHRDLK SN+ +++D KI DFGLAR D T + +
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEI 189
Query: 670 YAMEGRFSEKSDVFSFGVLLLEIVSGR 696
+++ D++S G ++ E+++GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (299), Expect = 8e-30
Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 18/215 (8%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-- 553
+ L KLG G F V+ K + + +A+K + E +E+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 554 ---------VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKG 602
++LL + N + + ++ L ++ P + I K
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVG 661
+ GL Y+HR R IIH D+K N+L++ D + +A + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 662 TYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 696
T Y SPE + + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 9e-26
Identities = 35/207 (16%), Positives = 71/207 (34%), Gaps = 33/207 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQ--------GQEEFMNEVMVISNL 548
+ +G+G V+ + E VK ++ S + G F + +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 549 QHRNLVRLLGCCVER----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
+ R L +L G V + E N ++ E + K L + + ++ I
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMIL 113
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYG 664
+ + I+H DL N+L+ ++ I DF + G + +R V
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR--- 166
Query: 665 YMSPEYAMEGRFSEKSDVFSFGVLLLE 691
+ + + D+ S +L+
Sbjct: 167 --NIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 78.5 bits (193), Expect = 3e-18
Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 14/115 (12%)
Query: 36 PESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTI 95
+ +G + + + + ++ + T VW +N +
Sbjct: 6 NGEGLYAGQSLDVEPYHF-IMQEDCNLVLYDHS------TSVWASNTGILGKKGCKA-VL 57
Query: 96 SEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSF 150
DGN VV + + + W+S+ N N L + GN+V++ + IW +
Sbjct: 58 QSDGNFVVYDAEGRSLWASHSVR--GNGNYVLVLQEDGNVVIYGS----DIWSTG 106
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.6 bits (165), Expect = 3e-14
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 12/105 (11%)
Query: 54 DGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWS 113
+GN I Y+ N + + L S ++ D NLV+ + +V WS
Sbjct: 8 NGNS------ILYST--QGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRV-WS 58
Query: 114 SNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFY 158
+N + + RA L +G + + N +++W S + Y
Sbjct: 59 TNTAG--KGTGCRAVLQPNGRMDVLTN-QNIAVWTSGNSRSAGRY 100
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.4 bits (159), Expect = 2e-13
Identities = 20/136 (14%), Positives = 45/136 (33%), Gaps = 24/136 (17%)
Query: 14 FYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSAN 73
+S + +++ + I+ ++ + D N + Y+ N
Sbjct: 4 IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQT-DCNL------VLYD-----N 47
Query: 74 KTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSG 133
+W N + DG LVV+ + W S V+ + L
Sbjct: 48 NNPIWATNTGGLGNGC--RAVLQPDGVLVVITNENVTVWQSPVAG--KAGHYVLVLQPDR 103
Query: 134 NLVLHDNISQVSIWDS 149
N+V++ + ++W +
Sbjct: 104 NVVIYGD----ALWAT 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 63.8 bits (155), Expect = 6e-13
Identities = 24/96 (25%), Positives = 38/96 (39%), Gaps = 7/96 (7%)
Query: 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
I + S + + + L SS FT+ D NLV+ + +V W+SN + +
Sbjct: 3 ILFGL--SHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRV-WASNTA---GAT 56
Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYS 159
RA L G LV+ W S + + Y
Sbjct: 57 GCRAVLQSDGLLVILTA-QNTIRWSSGTKGSIGNYV 91
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 63.1 bits (153), Expect = 9e-13
Identities = 24/126 (19%), Positives = 38/126 (30%), Gaps = 22/126 (17%)
Query: 25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
+ + S + + E + F D N +W N
Sbjct: 2 NILYSGETLSTGEFLNYG--SFVFIMQE-DCNLVLYD-----------VDKPIWATNTGG 47
Query: 85 PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
S ++ DGNLVV N + W+SN N N L N+V++
Sbjct: 48 L--SRSCFLSMQTDGNLVVYNPSNKPIWASNTGG--QNGNYVCILQKDRNVVIYGT---- 99
Query: 145 SIWDSF 150
W +
Sbjct: 100 DRWATG 105
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 55.2 bits (132), Expect = 6e-10
Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 20/132 (15%)
Query: 24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRN 83
+D + S + S+ + + D N + Y+ N VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQN-DCNL------VLYD-----NNRAVWASGTN 46
Query: 84 KPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ 143
+ + DGNLV+ +G + + S+ N N L N+V++DN S
Sbjct: 47 GKASGC--VLKMQNDGNLVIYSGSRAIWASNTNRQ---NGNYYLILQRDRNVVIYDN-SN 100
Query: 144 VSIWDSFQEPTD 155
+IW + +
Sbjct: 101 NAIWATHTNVGN 112
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 816 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.84 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.82 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.82 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.62 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.39 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.24 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.77 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.74 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.61 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 82.22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.25 Aligned_cols=265 Identities=27% Similarity=0.443 Sum_probs=210.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 3184211213779855299858628827999981534--73007999999999841499831123469872585359993
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 571 (816)
.++|++.+.||+|+||.||+|+++ ..||||+++.. .....+.|++|+.++++++||||+++++++.+ ...++|+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCC
Q ss_conf 07999943001598999989966799899999999999772599748994208882897389994440344302218987
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 651 (816)
|+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf 58998889998523--578999999999999999988875099---9516147899798189978875002213335567
Q ss_pred CCCCCCCCCCCCCCCCHHCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 6332023345566448100025---9999502368798999998839989998831334319899877412687011224
Q 003489 652 DQAATKRLVGTYGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.........||+.|+|||++.. ..++.++||||||+++|||+||+.||.......... ...............
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~p~~~~~-- 234 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYLSPDLSKV-- 234 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSCCCCGGGS--
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHCCCCCCCCHHC--
T ss_conf 7631256655743179999950568999953151635999999997889989989699999--999658889860003--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 3112455089999999999885312878999968999997101257998
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPA 777 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~l~~ 777 (816)
.......+.+++.+||+.||++||||.||++.|+.+.+++|.
T Consensus 235 -------~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 235 -------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred -------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCC
T ss_conf -------655549999999997588976892999999999999970989
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.39 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=208.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
Q ss_conf 18421121377985529985862882799998153473007999999999841499831123469872585359993079
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 574 (816)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....++|.+|+.++++++||||++++|++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889999999998788-6768999999999996689975653524315993379998369
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCCC
Q ss_conf 99943001598999989966799899999999999772599748994208882897389994440344302218987633
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 654 (816)
+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC-E
T ss_conf 99189975201--347889999999999999877653164---31044315326666887768655321002368873-3
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 20233455664481000259999502368798999998839989-99883133431989987741268701122431124
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......||..|+|||++....++.++||||||+++|||+|+..| +....... +........ ....|
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~~------~~~~p---- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGF------RLYKP---- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHHTC------CCCCC----
T ss_pred EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHHCC------CCCCC----
T ss_conf 50430017666785786079998403321059999999878988877899999---999998068------88995----
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC
Q ss_conf 550899999999998853128789999689999971012
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 772 (816)
......+.+++.+||+.||++||||.||++.|+++.
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ---436799999999976579768919999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.51 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=208.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC-C---CEEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 184211213779855299858628-8---27999981534-730079999999998414998311234698725853599
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 569 (816)
++|++.+.||+|+||.||+|.++. + ..||||.+... .....+.|.+|+.+|++++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCC
Q ss_conf 93079999430015989999899667998999999999997725997489942088828973899944403443022189
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 649 (816)
|||+++|+|.+++... ...+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 9722798530021045--679999999999999999889885279---83576150448988999199888443157567
Q ss_pred CCCCC---CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 87633---2023345566448100025999950236879899999883-9989998831334319899877412687011
Q 003489 650 NQDQA---ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 650 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
..... ......+|+.|+|||.+....++.++||||||+++|||+| |+.||....... +...+.. +...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~----~~~~- 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ----DYRL- 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT----TCCC-
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH---HHHHHHC----CCCC-
T ss_conf 7776536502566688300387888369978612144535789999867999999999999---9999973----7889-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 2243112455089999999999885312878999968999997101257
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 774 (816)
.........+.+++.+||+.||++||||.||++.|+++++.
T Consensus 253 --------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 --------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf --------99742269999999997587976892999999999998418
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=358.12 Aligned_cols=261 Identities=27% Similarity=0.395 Sum_probs=210.7
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 8318421121377985529985862-882799998153473007999999999841499831123469872585359993
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 571 (816)
..++|++.+.||+|+||.||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 579939865982088808999999999969999997776-1039999999999986799988267752745785478763
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCC
Q ss_conf 07999943001598999989966799899999999999772599748994208882897389994440344302218987
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 651 (816)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred CCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 14676067775303-5541579999999999999788898789---3057604576899899928983244546537887
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 63320233455664481000259999502368798999998839989998831334319899877412687011224311
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
. .......|+..|+|||++....++.++||||||+++|||++|+.|+........ +..... .+....
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~----~~~~~~------ 236 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE----KDYRME------ 236 (287)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH----TTCCCC------
T ss_pred C-EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHH----CCCCCC------
T ss_conf 2-210355665466692787279998104302178999999867998877425999--999985----588888------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 2455089999999999885312878999968999997101257
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 774 (816)
........+.+++..||+.||++||||.||++.|+.+.++
T Consensus 237 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ---8743309999999997577976893999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.16 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=208.6
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEECC-C-----CEEEEEEECCC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 83184211213779855299858628-8-----27999981534-730079999999998414-9983112346987258
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQD-G-----QEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE 564 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 564 (816)
..++|++.+.||+|+||.||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred CCEEEEEECCCCCCCCCCCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEC
Q ss_conf 53599930799994300159899--------------------9989966799899999999999772599748994208
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQR--------------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK 624 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 624 (816)
..++||||+++|+|.++|+.... ...+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCC
T ss_conf 5899997279995999998625777510221000012220012577899999999999999999997399---0505270
Q ss_pred CCCEEECCCCCCEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 8828973899944403443022189876332023345566448100025999950236879899999883-998999883
Q 003489 625 ASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYH 703 (816)
Q Consensus 625 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~ 703 (816)
|+|||++.++.+||+|||+|+...............||+.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHC
Q ss_conf 1334319899877412687011224311245508999999999988531287899996899999710
Q 003489 704 EEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNS 770 (816)
Q Consensus 704 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 770 (816)
.... +.... ..+... ..+......+.+++.+||+.||++|||+.||+++|.-
T Consensus 272 ~~~~--~~~~~----~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDAN--FYKLI----QNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHH--HHHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH--HHHHH----HCCCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 8999--99998----569989---------9887678999999999758896689399999999748
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.86 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=205.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
Q ss_conf 1842112137798552998586-288279999815347300799999999984149983112346987258535999307
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 573 (816)
++|++.++||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCC
Q ss_conf 99994300159899998996679989999999999977259974899420888289738999444034430221898763
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 653 (816)
++|+|.+++.+ ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--
T ss_conf 79808988641----59999999999999999999999879---7226776888688789968642515641321366--
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 32023345566448100025999950236879899999883998999883133431989987741268701122431124
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......+||+.|+|||++.+..++.++||||+|+++|||++|+.||........... ... ... .. +
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~---~~~-~~-----~-- 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT---NGT-PE-----L-- 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH---HCS-CC-----C--
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHH---CCC-CC-----C--
T ss_conf 644444447773682664479988012031372999998048899899799999999---985---799-98-----8--
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 550899999999998853128789999689999
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
.........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 885537999999999986699668909999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.73 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=204.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 318421121377985529985862-88279999815347-3007999999999841499831123469872585359993
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 571 (816)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCC
Q ss_conf 07999943001598999989966799899999999999772599748994208882897389994440344302218987
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 651 (816)
|+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 458980899975---3799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 6332023345566448100025999-950236879899999883998999883133431989987741268701122431
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
........+||+.|+|||++....+ +.++||||+|+++|||++|+.||.......... .... .......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~-----~~~~~~~---- 227 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK-----EKKTYLN---- 227 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHH-----TTCTTST----
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHH-----CCCCCCC----
T ss_conf 65311132557474287286189999971016173799999982997888898599999-9986-----3888788----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 124550899999999998853128789999689999
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
........+.+++.+||+.||++|||+.|+++
T Consensus 228 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----64469999999999976799668909999961
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.88 Aligned_cols=258 Identities=32% Similarity=0.453 Sum_probs=206.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
Q ss_conf 31842112137798552998586288279999815347300799999999984149983112346987258535999307
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 573 (816)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCC
Q ss_conf 99994300159899998996679989999999999977259974899420888289738999444034430221898763
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 653 (816)
++|+|.+++.... ...+++..+++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC-
T ss_conf 8982888875147-898878899999999999999997489---54675642251562024404234101477358864-
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 32023345566448100025999950236879899999883998999883133431989987741268701122431124
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.......|++.|+|||++....++.++||||||+++|||+||..|+....... .+...+. .+. .+...
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~i~----~~~-----~~~~p- 232 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLE----RGY-----RMVRP- 232 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH----TTC-----CCCCC-
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----HCC-----CCCCC-
T ss_conf 42035677444458289837999824564525799999996898888888999--9999997----068-----88896-
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 5508999999999988531287899996899999710125
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 773 (816)
......+.+++.+||+.||++||||.||+++|+....
T Consensus 233 ---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 ---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---5571999999999758897689399999998611321
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=342.91 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=206.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
Q ss_conf 318421121377985529985862-8827999981534730079999999998414998311234698725853599930
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 572 (816)
-++|++.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECC--CCCCEEECCCCCEECCCC
Q ss_conf 799994300159899998996679989999999999977259974899420888289738--999444034430221898
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--DLNPKISDFGLARIFGGN 650 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~ 650 (816)
+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 7998899999762--378999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........... +... ......
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~--~~~~~~----- 246 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---VKSC--DWNMDD----- 246 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHT--CCCSCC-----
T ss_pred C---CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHC--CCCCCC-----
T ss_conf 4---32000686242188997589987267655465999999859899899799999999---9847--889894-----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 1245508999999999988531287899996899999
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---2235899999999999756896679089998629
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.19 Aligned_cols=267 Identities=29% Similarity=0.428 Sum_probs=213.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
Q ss_conf 31842112137798552998586288279999815347300799999999984149983112346987258535999307
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 573 (816)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|+|||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEEC
T ss_conf 7997984699307980999999999999999998804-488899999999998666678868999982-39759999944
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCC
Q ss_conf 99994300159899998996679989999999999977259974899420888289738999444034430221898763
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 653 (816)
++|+|..++... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC-
T ss_conf 799435420000-3553059999999999999999875411---43353123079998999299844255542568873-
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 32023345566448100025999950236879899999883998999883133431989987741268701122431124
Q 003489 654 AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
.......|++.|+|||++....++.++||||||+++|||++|+.|+....... .+...+... .... .
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i~~~----~~~~-----~-- 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERG----YRMP-----C-- 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT----CCCC-----C--
T ss_pred EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHHC----CCCC-----C--
T ss_conf 35245455665458089837998917741323589999986899999888899--999999826----8999-----9--
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 5508999999999988531287899996899999710125799899995
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPAAKQPA 782 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~p~ 782 (816)
.......+.+++.+||+.||++||+|.+|+++|+......+++..|.
T Consensus 236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred --CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf --83237999999999756697589199999998766623899999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.39 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=205.9
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEEEC---CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
Q ss_conf 31842112-1377985529985862---88279999815347-3007999999999841499831123469872585359
Q 003489 494 TNNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 494 ~~~f~~~~-~LG~G~~g~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 568 (816)
.+++.+.+ +||+|+||.||+|.+. ++..||||.++... ....+.|.+|++++++++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECC
Q ss_conf 99307999943001598999989966799899999999999772599748994208882897389994440344302218
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 648 (816)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 99807899689975212--569999999999999999878998688---1057676466045468854203313421155
Q ss_pred CCCCC-CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 98763-32023345566448100025999950236879899999883-99899988313343198998774126870112
Q 003489 649 GNQDQ-AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 649 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
..... .......||+.|+|||++....++.++||||||+++|||+| |+.||....... +...+ ..+.....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i----~~~~~~~~ 233 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGKRMEC 233 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH----HTTCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HCCCCCCC
T ss_conf 434321135621137433586887279999541232201789999938999999979999---99999----81899999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 243112455089999999999885312878999968999997101257
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 774 (816)
+......+.+++.+||+.+|++||||.+|++.|+....+
T Consensus 234 ---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ---------976789999999997577976890999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.78 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=204.4
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 8318421121377985529985862-8827999981534-7300799999999984149983112346987258535999
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
..++|++.++||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCC
Q ss_conf 3079999430015989999899667998999999999997725-997489942088828973899944403443022189
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 649 (816)
||+++|+|.+++.+ ...+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 76799868998742---4999999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-HHHH----------
Q ss_conf 87633202334556644810002599995023687989999988399899988313343198998-7741----------
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA-WKLW---------- 718 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~-~~~~---------- 718 (816)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||............... ....
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf ----8621113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred ------------CCCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ------------268701122431124----550899999999998853128789999689999
Q 003489 719 ------------NDNNVIDLVDPLISE----SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 719 ------------~~~~~~~l~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
......+..+..... .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 3221111222354134778876650268766764448999999999986899467908999960
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.39 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=209.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
Q ss_conf 18421121377985529985862882799998153473007999999999841499831123469872585359993079
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP 574 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 574 (816)
++|++.++||+|+||.||+|++++++.||||.++... ...+.|++|+.++++++||||++++|++.+.+..++|+||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475-778999999999996689860158899850781699997048
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCCC
Q ss_conf 99943001598999989966799899999999999772599748994208882897389994440344302218987633
Q 003489 575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654 (816)
Q Consensus 575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 654 (816)
+|+|..++... ...+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC-E
T ss_conf 99388864102--467768999999999999999875468---43466541358876998479886144202357872-2
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 2023345566448100025999950236879899999883-998999883133431989987741268701122431124
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......++..|+|||++....++.++||||||+++|||+| |+.||......... ..+. .+. ....|.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~~i~----~~~--~~~~p~--- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIA----QGL--RLYRPH--- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHH----TTC--CCCCCT---
T ss_pred EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHH---HHHH----HCC--CCCCCC---
T ss_conf 5246578877578078637998852103364324673975599998899999999---9998----079--789965---
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCC
Q ss_conf 55089999999999885312878999968999997101
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 771 (816)
.....+.+++.+||+.||++|||+.++++.|.++
T Consensus 225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf ----4659999999997668976893999999874188
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.68 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=207.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
Q ss_conf 1842112137798552998586288-----279999815347-3007999999999841499831123469872585359
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDG-----QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 568 (816)
+.|+..+.||+|+||.||+|.++.. ..||||++.... ....+.|.+|+.++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECC
Q ss_conf 99307999943001598999989966799899999999999772599748994208882897389994440344302218
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 648 (816)
|+||+.++++.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 99721357402221023--454208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCC-CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 98763-32023345566448100025999950236879899999883998999883133431989987741268701122
Q 003489 649 GNQDQ-AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
..... .......||+.|+|||++....++.++||||||+++|||+++..|+.......+ +...+ ..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i----~~~~~---- 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAI----NDGFR---- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH----HTTCC----
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HCCCC----
T ss_conf 787652674267777343488887049999735563448989999967988655689999--99998----63578----
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 43112455089999999999885312878999968999997101257
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 774 (816)
..........+.+++.+||+.+|++||||.||+++|+++++.
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----998504579999999997767976893999999999998669
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=348.04 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=212.1
Q ss_pred HHHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCCCH-HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
Q ss_conf 998318421121377985529985862------8827999981534730-079999999998414998311234698725
Q 003489 491 ANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVER 563 (816)
Q Consensus 491 ~~~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 563 (816)
+..+++|++.+.||+|+||.||+|+.+ +++.||||+++..... ..+.|.+|+.++++++||||+++++++...
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCC
T ss_conf 38988938867982078839999998887657788299999988210857999999999999966899765524666059
Q ss_pred CCCEEEEEECCCCCCCCCCCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 85359993079999430015989---------------------999899667998999999999997725997489942
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQ---------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRD 622 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~D 622 (816)
...++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEEE
T ss_conf 803899981589929999985275542100001110012103467889899999999999999855413578---68548
Q ss_pred ECCCCEEECCCCCCEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCC
Q ss_conf 088828973899944403443022189876332023345566448100025999950236879899999883998-9998
Q 003489 623 LKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSF 701 (816)
Q Consensus 623 lkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~~ 701 (816)
|||+|||++.++.+||+|||+++.+.............+++.|+|||++....++.++||||||+++|||++|.. |+..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCC
T ss_conf 84011689899928983314421136776411157777676767989972688980563025236299998068999999
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC
Q ss_conf 83133431989987741268701122431124550899999999998853128789999689999971012
Q 003489 702 YHEEFELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 702 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 772 (816)
..+.. +...+ ..+..... ......++.+++..||+.+|++||||.||+++|+++.
T Consensus 246 ~~~~e---~~~~v----~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEE---VIYYV----RDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHH---HHHHH----HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHH---HHHHH----HCCCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 89999---99999----73997888---------7325299999999974889657939999999999842
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=339.70 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=208.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
Q ss_conf 31842112137798552998586-28827999981534730079999999998414998311234698725853599930
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||+++. .+++.||||+++.......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC--CCCCCEEECCCCCEECCCC
Q ss_conf 79999430015989999899667998999999999997725997489942088828973--8999444034430221898
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD--DDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~ 650 (816)
+++|+|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 899808888986--3899899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
. ......|++.|+|||++....++.++||||+||++|||++|+.||......... ...... ....
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~~~--~~~~------- 247 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKRC--DWEF------- 247 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHHC--CCCC-------
T ss_pred C---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHC--CCCC-------
T ss_conf 7---201004764534899974799897633389899999999688998997999999---999847--8898-------
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH--HHCC
Q ss_conf 1245508999999999988531287899996899999--7101
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 771 (816)
...........+.+++.+||+.||++|||+.|+++. +.+.
T Consensus 248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf -930024799999999999756996689189999609734888
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.62 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=203.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
Q ss_conf 18421121377985529985862-88279999815347300799999999984149983112346987258535999307
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM 573 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 573 (816)
+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCC
Q ss_conf 99994300159899998996679989999999999977259974899420888289738999444034430221898763
Q 003489 574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653 (816)
Q Consensus 574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 653 (816)
++|+|.+++.+. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... ..
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TI 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--HH
T ss_pred CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCC--CC
T ss_conf 998188999862--899999999999999999999999889---88714070031487899989971612303577--86
Q ss_pred CCCCCCCCCCCCCCHHCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 3202334556644810002-----59999502368798999998839989998831334319899877412687011224
Q 003489 654 AATKRLVGTYGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 654 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
.......||+.|+|||++. ...++.++||||+||++|||++|+.||....+.... ..... .. .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~~i~~---~~-~----- 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---LKIAK---SE-P----- 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHH---SC-C-----
T ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHC---CC-C-----
T ss_conf 410010256264799998320257888880665787899999982088999998999999---99970---79-9-----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 31124550899999999998853128789999689999
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
+.+. ........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PTLA--QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCS--SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8777--65669999999999976699668919999962
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.33 Aligned_cols=245 Identities=27% Similarity=0.368 Sum_probs=202.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 18421121377985529985862-8827999981534---7300799999999984149983112346987258535999
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.+ +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCC
Q ss_conf 30799994300159899998996679989999999999977259974899420888289738999444034430221898
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 650 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 50479858988750---489999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||.......... ... .... .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i~----~~~~------~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---RIS----RVEF------T 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHH----TTCC------C
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHH----CCCC------C
T ss_conf ----5235578876349999758998931440467599999832999988899999999---997----1899------9
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 124550899999999998853128789999689999
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
+. ......+.+++.+||+.||++|||+.|+++
T Consensus 223 ~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FP----DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 98----668999999999976479768909999971
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.29 Aligned_cols=249 Identities=29% Similarity=0.388 Sum_probs=199.7
Q ss_pred CCCCCCCCEEEEEEEECC---CCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
Q ss_conf 213779855299858628---827999981534--730079999999998414998311234698725853599930799
Q 003489 501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575 (816)
Q Consensus 501 ~~LG~G~~g~Vy~g~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 575 (816)
++||+|+||.||+|.++. ++.||||+++.. .....+.|.+|+.++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCCC-C
Q ss_conf 994300159899998996679989999999999977259974899420888289738999444034430221898763-3
Q 003489 576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ-A 654 (816)
Q Consensus 576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~ 654 (816)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 968999752---257899999999999999976687479---55677761131023567512341345331343234432
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 2023345566448100025999950236879899999883-998999883133431989987741268701122431124
Q 003489 655 ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLISE 733 (816)
Q Consensus 655 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 733 (816)
......||+.|+|||.+....++.++||||||+++|||++ |+.||....... +...+. .+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~----~~~~~~~------- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KGERMGC------- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTCCCCC-------
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----CCCCCCC-------
T ss_conf 24456778420391665379998434430340313289658999999989999---999998----2899999-------
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC
Q ss_conf 550899999999998853128789999689999971012
Q 003489 734 SGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 734 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 772 (816)
+......+.+++.+||+.||++|||+.+|+++|+...
T Consensus 232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf --8656799999999975889768909899999852887
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.24 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=206.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC----EEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
Q ss_conf 18421121377985529985862-882----7999981534-73007999999999841499831123469872585359
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 568 (816)
.+|++.++||+|+||.||+|.+. +++ .||+|+++.. .....+.|.+|+.++++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECC
Q ss_conf 99307999943001598999989966799899999999999772599748994208882897389994440344302218
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 648 (816)
++|++.+|+|.+++.. ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 9984268740101113--3457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9876332023345566448100025999950236879899999883-998999883133431989987741268701122
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
............||+.|+|||++....++.++||||||+++|||+| |++|+.......-.. .... +...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~---~i~~----~~~~--- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEK----GERL--- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH---HHHH----TCCC---
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHC----CCCC---
T ss_conf 44453223651058644670887469998356544079999999977999999999899999---9975----9989---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 43112455089999999999885312878999968999997101257
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 774 (816)
.........+.+++.+||+.||++|||+.||++.|+.+.++
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ------99855689999999984789934691999999999998758
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.90 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=205.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 18421121377985529985862-8827999981534---7300799999999984149983112346987258535999
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCC
Q ss_conf 30799994300159899998996679989999999999977259974899420888289738999444034430221898
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 650 (816)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653---1599999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||....+... ...+. .... . +.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~----~~~~-~-~p-- 230 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKII----KLEY-D-FP-- 230 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----TTCC-C-CC--
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH---HHHHH----CCCC-C-CC--
T ss_conf 764333555677552584400268989666230456999998038899899599999---99997----1899-9-98--
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 124550899999999998853128789999689999
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 231 --~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 --E----KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --T----TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --C----CCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf --5----47999999999985579768919789737
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.61 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=203.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--CCCEE
Q ss_conf 318421121377985529985862-88279999815347--30079999999998414998311234698725--85359
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 568 (816)
.++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEEEEECCCCEEECCCCCCEEECCCCCE
Q ss_conf 99307999943001598-999989966799899999999999772599--748994208882897389994440344302
Q 003489 569 IYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSR--LRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~--~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 645 (816)
||||+++|+|.+++... .....+++..++.++.||+.||.|||+.+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 21898763320233455664481000259999502368798999998839989998831334319899877412687011
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
.+.... .......||+.|+|||++....++.++||||||+++|||++|+.||....... +...+. .+....
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i~----~~~~~~ 233 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIR----EGKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH----HTCCCC
T ss_pred ECCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH---HHHHHH----CCCCCC
T ss_conf 224577--75566778823279999839999938988752789999801889989989999---999997----189988
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 22431124550899999999998853128789999689999
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
+ .. .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-----~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 I-----PY----RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C-----CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----CC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9-----74----35999999999976799557918999972
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=339.22 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=204.0
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 8318421121377985529985862-88279999815347-300799999999984149983112346987258535999
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
..+.|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC---CCCCCEEECCCCCEEC
Q ss_conf 3079999430015989999899667998999999999997725997489942088828973---8999444034430221
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIF 647 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~ 647 (816)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 52689848886530---367887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89876332023345566448100025999950236879899999883998999883133431989987741268701122
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
... ......+||+.|+|||++.+..++.++||||+|+++|||++|+.||....... +...... ... .
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~----~~~-~-- 227 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILK----AEY-E-- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHT----TCC-C--
T ss_pred CCC---CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHC----CCC-C--
T ss_conf 589---70440032842259188737999807873451599999985979999989999---9999861----687-7--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 4311245508999999999988531287899996899999
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
..........+.+.+++..||+.||++|||+.|+++.
T Consensus 228 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---7876666789999999999760897579189998629
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.13 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=211.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 318421121377985529985862------882799998153473-0079999999998414-99831123469872585
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 565 (816)
.++|++.++||+|+||.||+|++. .++.||||+++.... .....+.+|+.++.++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred CEEEEEECCCCCCCCCCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEE
Q ss_conf 359993079999430015989---------------99989966799899999999999772599748994208882897
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQ---------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL 630 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 630 (816)
.++||||+++|+|.++++... ....+++..+..++.||+.||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCCEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHH
Q ss_conf 38999444034430221898763320233455664481000259999502368798999998839989-99883133431
Q 003489 631 DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFYHEEFELT 709 (816)
Q Consensus 631 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~~~~~~~ 709 (816)
+.++.++++|||+++...............|++.|+|||.+....++.++||||||+++|||+++..| +........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH--
T ss_conf 025752102340102336788615862013596876778861799997400102589999998589988778998999--
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 989987741268701122431124550899999999998853128789999689999971012579
Q 003489 710 LLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDL 775 (816)
Q Consensus 710 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~l 775 (816)
+...... +. ...........+.+++.+||+.||++||||.||+++|++.+.+.
T Consensus 257 ~~~~i~~----~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 257 FYKMIKE----GF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHHH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHC----CC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 9999866----89---------88985436599999999975779657929999999998765349
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.18 Aligned_cols=247 Identities=25% Similarity=0.394 Sum_probs=193.7
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC----CCCEEE
Q ss_conf 421121377985529985862-8827999981534--730079999999998414998311234698725----853599
Q 003489 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER----EENMLI 569 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~~lV 569 (816)
|++.++||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC-CCCCCEEECCCCCEECC
Q ss_conf 93079999430015989999899667998999999999997725997489942088828973-89994440344302218
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFG 648 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~ 648 (816)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 957898948999751---355469999999999999999999789-9799687674351166799988980057654236
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 98763320233455664481000259999502368798999998839989998831334319899877412687011224
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVD 728 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 728 (816)
. .......||+.|+|||++.. .++.++||||+|+++|||++|+.||........ +.... ..+...
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i----~~~~~~---- 231 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV----TSGVKP---- 231 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH----TTTCCC----
T ss_pred C----CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HCCCCC----
T ss_conf 8----76677553813008988478-999867110079999999878899987655999--99999----738998----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 31124550899999999998853128789999689999
Q 003489 729 PLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 729 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
+.+... ..+.+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 656755----7899999999976379758929999967
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.18 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=211.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC--------CCEEEEEEECCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEEEC
Q ss_conf 3184211213779855299858628--------82799998153473-0079999999998414-998311234698725
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVER 563 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 563 (816)
.++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +||||+++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEE
Q ss_conf 853599930799994300159899-------------9989966799899999999999772599748994208882897
Q 003489 564 EENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL 630 (816)
Q Consensus 564 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 630 (816)
...++||||+++|+|.++|..... ...+++.+++.++.||+.||+|||+.+ ++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCCEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Q ss_conf 3899944403443022189876332023345566448100025999950236879899999883-998999883133431
Q 003489 631 DDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELT 709 (816)
Q Consensus 631 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~ 709 (816)
+.++.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |.+|+.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH---
T ss_conf 47897676221110113555554314667888466326675179888255547758888874017989899999999---
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9899877412687011224311245508999999999988531287899996899999710125
Q 003489 710 LLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 710 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 773 (816)
+... ...+...... . .....+.+++.+||+.||++|||+.||+++|++++.
T Consensus 246 ~~~~----i~~~~~~~~p-----~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKL----LKEGHRMDKP-----S----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHH----HHTTCCCCCC-----S----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----HHCCCCCCCC-----C----CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999----9728888987-----4----352999999999766797679399999999988860
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.27 Aligned_cols=267 Identities=26% Similarity=0.373 Sum_probs=208.3
Q ss_pred HHHHHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHC-CCCCEEEEEEEE
Q ss_conf 99998318421121377985529985862------88279999815347-30079999999998414-998311234698
Q 003489 489 ELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCC 560 (816)
Q Consensus 489 ~l~~~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 560 (816)
+.+...++|++.++||+|+||.||+|... +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE
T ss_conf 52616799798449841678399999986777555783999999860017178999999999988614998499741154
Q ss_pred EECC-CCEEEEEECCCCCCCCCCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCC
Q ss_conf 7258-5359993079999430015989-------------9998996679989999999999977259974899420888
Q 003489 561 VERE-ENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKAS 626 (816)
Q Consensus 561 ~~~~-~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~ 626 (816)
...+ ..++||||+++|+|.++++... ....+++.+++.++.||+.||.|||+.+ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCC
T ss_conf 04797579999845899299999853666665322202332146899999999999999999887379---717867731
Q ss_pred CEEECCCCCCEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCHH
Q ss_conf 28973899944403443022189876332023345566448100025999950236879899999883998-99988313
Q 003489 627 NILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSFYHEE 705 (816)
Q Consensus 627 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~ 705 (816)
|||+++++.+||+|||+++...............||+.|+|||++....++.++||||||+++|||++|.. |+......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 06577998289845752001135665222475166721020368646889966322136789999986889999899989
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 34319899877412687011224311245508999999999988531287899996899999710125
Q 003489 706 FELTLLGYAWKLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 706 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 773 (816)
.. +.... ..+..... .....+.+.+++.+||+.||++|||+.||+++|+++++
T Consensus 244 ~~--~~~~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EE--FCRRL----KEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HH--HHHHH----HHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH--HHHHH----HCCCCCCC---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99--99999----63898888---------86578999999999767796679199999999979986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=335.85 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=197.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 18421121377985529985862-882799998153473---00799999999984149983112346987258535999
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
+.|+..++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCC
Q ss_conf 30799994300159899998996679989999999999977259974899420888289738999444034430221898
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 650 (816)
||+++|+|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 8069994578997---3799999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 76332023345566448100025---999950236879899999883998999883133431989987741268701122
Q 003489 651 QDQAATKRLVGTYGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.....||+.|+|||++.. ..++.++||||+|+++|||++|+.||......... .... .. ..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---~~i~---~~-~~---- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIA---QN-ES---- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH---HS-CC----
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH---HC-CC----
T ss_conf -----87313476636889983467888672145455899999998788999997999999---9998---28-99----
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 431124550899999999998853128789999689999
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
+.+... .....+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCSCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -988878---88999999999977379657918999971
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.37 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=203.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC------CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
Q ss_conf 318421121377985529985862-88279999815347------30079999999998414998311234698725853
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 566 (816)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCC----CCEEECCC
Q ss_conf 59993079999430015989999899667998999999999997725997489942088828973899----94440344
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFG 642 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfg 642 (816)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 999986778643100103---564215578999999999987666254---22113330127982589866646964334
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 30221898763320233455664481000259999502368798999998839989998831334319899877412687
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNN 722 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 722 (816)
++....... ......|++.|+|||++....++.++||||+|+++|||++|+.||.......... ... ...
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~i~----~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVS----AVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----TTC
T ss_pred HHHHCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHH----HCC
T ss_conf 421057776---3122477774309999818999976652214099999970889988999999999---998----168
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 01122431124550899999999998853128789999689999
Q 003489 723 VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 723 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
. .............+.+++.+||+.||++|||+.|+++
T Consensus 233 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8------8870104788999999999986389668919999961
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.38 Aligned_cols=260 Identities=28% Similarity=0.390 Sum_probs=207.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC--EEEEEEECCC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCCCEEE
Q ss_conf 18421121377985529985862-882--7999981534-730079999999998414-998311234698725853599
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ--EIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 569 (816)
++|++.++||+|+||.||+|.++ ++. .||||+++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCCCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCC
Q ss_conf 9307999943001598-------------999989966799899999999999772599748994208882897389994
Q 003489 570 YEYMPNKSLDSFLFDP-------------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 636 (816)
+||+++|+|.++|+.. .....+++..+++++.||+.||.|||+.+ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCHHHHHHHHHHHH
Q ss_conf 4403443022189876332023345566448100025999950236879899999883998-999883133431989987
Q 003489 637 KISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSFYHEEFELTLLGYAW 715 (816)
Q Consensus 637 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~l~~~~~ 715 (816)
||+|||+++.... ........|+..|+|||.+....++.++||||||+++|||++|.. |+....... +...+.
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP 240 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG
T ss_pred EECCCCCCCCCCC---CCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH
T ss_conf 8743443224442---2345530137755553875269999622153138899999836899999999999---999998
Q ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 7412687011224311245508999999999988531287899996899999710125799
Q 003489 716 KLWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 716 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~l~ 776 (816)
.+.. +.. .......+.+++.+||+.||++||||.||++.|++++++.+
T Consensus 241 ----~~~~-----~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 241 ----QGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ----GTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ----HCCC-----CCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ----2688-----888----76678999999999767896689499999999999986186
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.18 Aligned_cols=248 Identities=23% Similarity=0.282 Sum_probs=203.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 31842112137798552998586-28827999981534---730079999999998414998311234698725853599
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 569 (816)
-++|++.+.||+|+||.||+++. .+++.||+|++++. .....+.+.+|+.+|++++||||+++++++.+....++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCC
Q ss_conf 93079999430015989999899667998999999999997725997489942088828973899944403443022189
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 649 (816)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 003579860555532---567759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 87633202334556644810002599995023687989999988399899988313343198998774126870112243
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..... .... .
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~i~----~~~~-~---- 223 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELIL----MEEI-R---- 223 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCC-C----
T ss_pred CC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHH---HHHHH----CCCC-C----
T ss_conf 78--620551008899666650489888333102230678899878999999699999---99985----2899-8----
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 1124550899999999998853128789999-----689999
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 766 (816)
+ .....+.+.+++.+||+.||++||+ +.|+++
T Consensus 224 -~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -C----CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf -9----866899999999866638934422565234999972
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.08 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=210.5
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 8318421121377985529985862------88279999815347-3007999999999841499831123469872585
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 565 (816)
..++|++.+.||+|+||.||+|.++ ++..||||+++... ......|.+|+.++++++||||+++++++.....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 68991883598207881899999878644778968999998701286899999999999997699988412547842881
Q ss_pred CEEEEEECCCCCCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEE
Q ss_conf 35999307999943001598-------99998996679989999999999977259974899420888289738999444
Q 003489 566 NMLIYEYMPNKSLDSFLFDP-------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
.++|+||+++|+|.+++... .....+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf 06777604899889998750332113444688799999999999999999876479---654328677540359964999
Q ss_pred ECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHHHHHH
Q ss_conf 0344302218987633202334556644810002599995023687989999988399-899988313343198998774
Q 003489 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR-KNTSFYHEEFELTLLGYAWKL 717 (816)
Q Consensus 639 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~ 717 (816)
+|||+++.+.............+++.|+|||.+....++.++||||||+++|||+||. .|+......... ..+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~---~~i--- 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFV--- 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHH---
T ss_pred EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH---HHH---
T ss_conf 42454202357763031340231632378888736998833344437899999996899999998999999---999---
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC
Q ss_conf 1268701122431124550899999999998853128789999689999971012
Q 003489 718 WNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEI 772 (816)
Q Consensus 718 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 772 (816)
..+...... ......+.+++.+||+.+|++||||.+|+++|++.+
T Consensus 249 -~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 -MEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -HTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -HHCCCCCCC---------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf -808888886---------335399999999975779658939999999978761
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.34 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=203.2
Q ss_pred CCCCCCCCCCEEEEEEEECCC----CEEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEEEEE
Q ss_conf 112137798552998586288----27999981534-730079999999998414998311234698725-853599930
Q 003489 499 LANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-EENMLIYEY 572 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~ 572 (816)
..++||+|+||+||+|.+..+ ..||||+++.. .....+.|.+|++++++++||||++++|++.+. ...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898069943899987
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCC
Q ss_conf 79999430015989999899667998999999999997725997489942088828973899944403443022189876
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 652 (816)
+++|+|.+++... ...+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EECCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf 4067414421013--454048999999999887652003367---62577668757677999889910652322556655
Q ss_pred CC--CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33--2023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 653 QA--ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 653 ~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.. ......|+..|+|||.+....++.++||||||+++|||++|+.|+....... ....... .+.. ...|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~~--~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGRR--LLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCC--CCCC-
T ss_pred CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----CCCC--CCCC-
T ss_conf 53100256555645567688743799974574661999999997899998889999--9999998----0898--8996-
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 12455089999999999885312878999968999997101257998
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLPA 777 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~l~~ 777 (816)
......+.+++.+||+.||++||+|.||++.|+++......
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf ------44759999999997688976893999999999999975201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=328.16 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=201.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 18421121377985529985862-8827999981534---7300799999999984149983112346987258535999
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.+ +++.||||++++. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCC
Q ss_conf 30799994300159899998996679989999999999977259974899420888289738999444034430221898
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 650 (816)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432---2221110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
....+||+.|+|||++.+..++.++||||+|+++|||++|+.||.......... .+. ... . ...+
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~---~~~-~--~~p~- 222 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---KIL---NAE-L--RFPP- 222 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHH---HCC-C--CCCT-
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHH---HHH---CCC-C--CCCC-
T ss_conf -----643457634359999838999804304653336899975989999969999999---997---089-8--8997-
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCC-----CHHHHHHH
Q ss_conf 12455089999999999885312878999-----96899999
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRP-----NMPTVVSM 767 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 767 (816)
.....+.+++.+|++.||++|| +++++++.
T Consensus 223 -------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 -------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf -------78999999999995449976664310219999819
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=326.50 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=195.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHH---HHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 18421121377985529985862-88279999815347---3007999999---99984149983112346987258535
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNE---VMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~ 567 (816)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+| +.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEEC
Q ss_conf 99930799994300159899998996679989999999999977259974899420888289738999444034430221
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 647 (816)
+||||+++|+|.++|.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 99991489838999873---255327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 89876332023345566448100025-99995023687989999988399899988313343198998774126870112
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDL 726 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 726 (816)
... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||..........+.... ....
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~----~~~~---- 225 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LTMA---- 225 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS----SSCC----
T ss_pred CCC----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----CCCC----
T ss_conf 788----6433113455421687603899984410467789999998599988889989999999860----4688----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 2431124550899999999998853128789999-----689999
Q 003489 727 VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 727 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 766 (816)
+.+. ....+.+.+++.+||+.||++||| ++|+++
T Consensus 226 --~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 --VELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCC----CCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf --8788----77899999999998566988808874357999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.81 Aligned_cols=250 Identities=29% Similarity=0.407 Sum_probs=203.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEEEEE
Q ss_conf 3184211213779855299858628827999981534730079999999998414998311234698725-853599930
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-EENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||+|+++ ++.||||+++.. ...+.+.+|++++++++||||++++|++.+. +..++|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-909999998857--77999999999998678989854987887238928999963
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCC
Q ss_conf 79999430015989999899667998999999999997725997489942088828973899944403443022189876
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 652 (816)
+++|+|.++|... ....+++..+++++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC--
T ss_conf 6999899998745-7888899999999999985232113376---553666567601468997763245600344787--
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 332023345566448100025999950236879899999883-9989998831334319899877412687011224311
Q 003489 653 QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPLI 731 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 731 (816)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+...... .+...+. .+...+.
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~----~~~~~~~----- 221 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KGYKMDA----- 221 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----TTCCCCC-----
T ss_pred ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----CCCCCCC-----
T ss_conf ---765566646778178727988858877757999999997899999999999---9999998----0899999-----
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCC
Q ss_conf 2455089999999999885312878999968999997101
Q 003489 732 SESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 732 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 771 (816)
.....+.+.+++.+||+.||++||||.+++++|+++
T Consensus 222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----765799999999997566976893999999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.46 Aligned_cols=270 Identities=23% Similarity=0.294 Sum_probs=199.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----CCEEE
Q ss_conf 31842112137798552998586288279999815347300799999999984149983112346987258----53599
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----ENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 569 (816)
.++|.+.+.||+|+||.||+|++. ++.||||+++... ........|+..+..++||||+++++++.+.. ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 868999889820788199999999-9899999987200-46799999999996279986832688998379860489999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEEEEECCCCEEECCCCCCEEECCCCC
Q ss_conf 930799994300159899998996679989999999999977259-----974899420888289738999444034430
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS-----RLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 644 (816)
|||+++|+|.++|+. ..++|..+++++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 964669898999865----8999899999999999999998876652046898661531731357868877688763866
Q ss_pred EECCCCCCCC--CCCCCCCCCCCCCHHCCCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HH----
Q ss_conf 2218987633--202334556644810002599------9950236879899999883998999883133----43----
Q 003489 645 RIFGGNQDQA--ATKRLVGTYGYMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEF----EL---- 708 (816)
Q Consensus 645 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~----~~---- 708 (816)
+......... ......||+.|+|||++.... ++.++||||||+++|||+||..|+....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf 23467776200135525035476782210565454677767501220159999999628998876631124101225564
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 19899877412687011224311245-508999999999988531287899996899999710125
Q 003489 709 TLLGYAWKLWNDNNVIDLVDPLISES-GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 709 ~l~~~~~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 773 (816)
............ ...+|.+... ...+....+.+++.+||+.||++|||+.||+++|+++..
T Consensus 236 ~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHC----CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 309999998750----24688877655776899999999999760698589599999999998888
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.64 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=205.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC----CCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
Q ss_conf 3184211213779855299858628----82799998153473-007999999999841499831123469872585359
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML 568 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 568 (816)
.++|++.+.||+|+||.||+|++.. +..||+|.++.... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECC
Q ss_conf 99307999943001598999989966799899999999999772599748994208882897389994440344302218
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 648 (816)
|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf 9984069807765422--4789999999999999987752302267---4414102655320678967876503421336
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9876332023345566448100025999950236879899999883-998999883133431989987741268701122
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLV 727 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 727 (816)
.... .......||+.|+|||++....++.++||||||+++|||++ |.+|+....... +...+. .+.....
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~----~~~~~~~- 230 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NGERLPM- 230 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTCCCCC-
T ss_pred CCCC-EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----CCCCCCC-
T ss_conf 7762-330540058310326675169988745244424789999826999988899999---999998----1899989-
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 43112455089999999999885312878999968999997101257
Q 003489 728 DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKD 774 (816)
Q Consensus 728 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 774 (816)
.......+.+++.+||+.||++|||+.||++.|+.++++
T Consensus 231 --------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --------877799999999997687976892999999999999778
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=327.79 Aligned_cols=244 Identities=23% Similarity=0.263 Sum_probs=201.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
Q ss_conf 18421121377985529985862-8827999981534---7300799999999984149983112346987258535999
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY 570 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 570 (816)
++|++.+.||+|+||.||+++.+ +++.||||++... .....+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCC
Q ss_conf 30799994300159899998996679989999999999977259974899420888289738999444034430221898
Q 003489 571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650 (816)
Q Consensus 571 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 650 (816)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 23346622666751---589899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+.. .. . .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~---~~-~------~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIVS---GK-V------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH---CC-C------C
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH---HHHHHC---CC-C------C
T ss_conf -----6433676356788997179988533114500789999758899899599999---999861---79-8------8
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCC-----CCHHHHHH
Q ss_conf 1245508999999999988531287899-----99689999
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDR-----PNMPTVVS 766 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Pt~~evl~ 766 (816)
. .......+.+++.+||+.||++| ||+.++++
T Consensus 257 ~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 9----766899999999998340998606553454999971
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.65 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=204.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
Q ss_conf 318421121377985529985862-8827999981534730079999999998414998311234698725853599930
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 572 (816)
.++|++.+.||+|+||.||++... +++.||+|.++... .....+.+|+++|+.++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCC--CCCEEECCCCCEECCCC
Q ss_conf 7999943001598999989966799899999999999772599748994208882897389--99444034430221898
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD--LNPKISDFGLARIFGGN 650 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~Dfgla~~~~~~ 650 (816)
+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..++|+|||++......
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 8998088998753--899999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 76332023345566448100025999950236879899999883998999883133431989987741268701122431
Q 003489 651 QDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDPL 730 (816)
Q Consensus 651 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 730 (816)
. ......+++.|+|||......++.++||||+|+++|+|++|+.||.......... .+... .......
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~---~i~~~--~~~~~~~---- 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NIMNA--EYTFDEE---- 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHHT--CCCCCHH----
T ss_pred C---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHC--CCCCCHH----
T ss_conf 7---5321223322234021048777840113027999999982899999989999999---99838--9998802----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH--HHHCC
Q ss_conf 124550899999999998853128789999689999--97101
Q 003489 731 ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS--MLNSE 771 (816)
Q Consensus 731 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 771 (816)
........+.+++..|++.||++|||+.|+++ .+.+.
T Consensus 226 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf ----236789999999999866996689099999639965667
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.63 Aligned_cols=261 Identities=23% Similarity=0.266 Sum_probs=197.4
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
Q ss_conf 1121377985529985862-8827999981534730-----079999999998414998311234698725853599930
Q 003489 499 LANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-----GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 499 ~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 572 (816)
..++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCC
Q ss_conf 79999430015989999899667998999999999997725997489942088828973899944403443022189876
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 652 (816)
++++++..++ .....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred HCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC-
T ss_conf 3450776554---12667789999999999999998863163---5503577625885377841146576100057875-
Q ss_pred CCCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC---CCC
Q ss_conf 3320233455664481000259-999502368798999998839989998831334319899877412687011---224
Q 003489 653 QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID---LVD 728 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---l~d 728 (816)
......+||+.|+|||++... .++.++||||+||++|||++|+.||....+......+.............. ...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf -5433020473336399972677888056436304289999859699999999999999998518997254521000213
Q ss_pred ----CCCCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf ----311245----508999999999988531287899996899999
Q 003489 729 ----PLISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 729 ----~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
...... ........+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44303478988678565689999999999763894569089999679
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=325.25 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=207.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC----
Q ss_conf 31842112137798552998586-2882799998153473---007999999999841499831123469872585----
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE---- 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 565 (816)
.++|++.+.||+|+||.||+++. .+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCE
Q ss_conf 35999307999943001598999989966799899999999999772599748994208882897389994440344302
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 645 (816)
.++||||+++++|.+++. ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120---3589999999999999999999998579---5276346755665754320100344432
Q ss_pred ECCCCCC-CCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 2189876-332023345566448100025999950236879899999883998999883133431989987741268701
Q 003489 646 IFGGNQD-QAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 646 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
....... ........||+.|+|||++....++.++||||+|+++|||++|+.||....+..... .........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHH------HHHHCCCCC
T ss_conf 21235443333464257624369999839999966320265289999976979989969999999------998469999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CHHHHHHHHHCC
Q ss_conf 12243112455089999999999885312878999-968999997101
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRP-NMPTVVSMLNSE 771 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 771 (816)
+... .......+.+++.+|++.||++|| +++++++.|.++
T Consensus 234 ----~~~~---~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 ----PSAR---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ----GGGT---SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----CCHH---CCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf ----7100---3478999999999986679767773999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.46 Aligned_cols=256 Identities=28% Similarity=0.376 Sum_probs=204.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC--C--CEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
Q ss_conf 184211213779855299858628--8--27999981534---7300799999999984149983112346987258535
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQD--G--QEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM 567 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 567 (816)
++|++.+.||+|+||.||+|++.. + ..||||++... .....+.|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEEC
Q ss_conf 99930799994300159899998996679989999999999977259974899420888289738999444034430221
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 647 (816)
+|+||+++|++.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 146542386125444212--689999999999999999998752178---752056688815655654332561155530
Q ss_pred CCCCCCC-CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 8987633-2023345566448100025999950236879899999883-9989998831334319899877412687011
Q 003489 648 GGNQDQA-ATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 648 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
....... ......++..|+|||.+....++.++||||||+++|||+| |+.||........ ..... ..+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i~---~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKID---KEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH---TSCCCCC
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH---HCCCCCC
T ss_conf 35887526547632573107999983799994215661489999999689999999699999---99998---4799999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCC
Q ss_conf 2243112455089999999999885312878999968999997101
Q 003489 726 LVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSE 771 (816)
Q Consensus 726 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 771 (816)
. .......+.+++.+||+.||++||||.||++.|.+.
T Consensus 236 ~---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 R---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 8---------544539999999997688966792999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=320.67 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=201.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCC---------HHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE
Q ss_conf 31842112137798552998586-2882799998153473---------00799999999984149-9831123469872
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASG---------QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVE 562 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 562 (816)
.++|++.+.||+|+||+||+++. .+++.+|||++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCC
Q ss_conf 58535999307999943001598999989966799899999999999772599748994208882897389994440344
Q 003489 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 563 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 642 (816)
.+..++||||+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 7605999976898668999986---599999999999999999999998759---9432346254898689983871240
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCHHCCCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 3022189876332023345566448100025------9999502368798999998839989998831334319899877
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWK 716 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 716 (816)
+++...... ......||..|+|||++.. ..++.++||||+|+++|||++|+.||....+...... ..
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~---i~- 228 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM---IM- 228 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH-
T ss_pred HEEECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHH---HH-
T ss_conf 316726887---21345246788898886053445678899233185656023103228889889999999999---98-
Q ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 41268701122431124550899999999998853128789999689999
Q 003489 717 LWNDNNVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 717 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
. +... .. ........+.+.+++.+||+.+|++||++.||++
T Consensus 229 --~-~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 --S-GNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --H-TCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --H-CCCC-CC-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --1-8988-89-----8543468999999999976589668919999973
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.82 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=199.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCCCEEE
Q ss_conf 18421121377985529985862-8827999981534---7300799999999984-14998311234698725853599
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVIS-NLQHRNLVRLLGCCVEREENMLI 569 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 569 (816)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCC
Q ss_conf 93079999430015989999899667998999999999997725997489942088828973899944403443022189
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 649 (816)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 750379808998640---478999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 87633202334556644810002599995023687989999988399899988313343198998774126870112243
Q 003489 650 NQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVIDLVDP 729 (816)
Q Consensus 650 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 729 (816)
.. .......||+.|+|||++....++.++||||+||++|||++|+.||......... ..+.. ....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i~~--~~~~------- 221 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---HSIRM--DNPF------- 221 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH--CCCC-------
T ss_pred CC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHC--CCCC-------
T ss_conf 65--3345457877768999982799883232011227898987388999998999999---99971--8998-------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHH-HHHH
Q ss_conf 112455089999999999885312878999968-9999
Q 003489 730 LISESGFKMEIIRCVNVGLLCVQEFVKDRPNMP-TVVS 766 (816)
Q Consensus 730 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 766 (816)
+.. .....+.+++.+||+.||++||++. ++++
T Consensus 222 -~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -YPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCC----CCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf -975----679999999999654489878388999980
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.41 Aligned_cols=253 Identities=19% Similarity=0.202 Sum_probs=195.8
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCCC
Q ss_conf 31842112-137798552998586-28827999981534730079999999998414-99831123469872----5853
Q 003489 494 TNNFQLAN-KLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE----REEN 566 (816)
Q Consensus 494 ~~~f~~~~-~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 566 (816)
.++|++.. .||+|+||.||+++. .+++.||||+++. ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECC---CCCCEEECCCC
Q ss_conf 599930799994300159899998996679989999999999977259974899420888289738---99944403443
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGL 643 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgl 643 (816)
++||||+++|+|.++|... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778998499999862-7877579999999999999999999769---86444100220113555566311354551
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 02218987633202334556644810002599995023687989999988399899988313343198998774126870
Q 003489 644 ARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 644 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
++...... ......|++.|+|||++....++.++||||+||++|+|++|+.||.......... ..........
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~- 233 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ- 233 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred EEECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HHHHHHHCCC-
T ss_conf 23336888---6432267756379277748988888888764516778865889988988778899---9999985388-
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 11224311245508999999999988531287899996899999
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
..+.........+.+.+++.+|++.||++|||+.|+++.
T Consensus 234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----888985434699999999999756996579099999709
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.64 Aligned_cols=270 Identities=22% Similarity=0.313 Sum_probs=202.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 1842112137798552998586-288279999815347--3007999999999841499831123469872585359993
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 571 (816)
++|++.++||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCC
Q ss_conf 07999943001598999989966799899999999999772599748994208882897389994440344302218987
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 651 (816)
|+.++.+ +++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHH-HHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 2377445-55442-02568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC---CCC
Q ss_conf 633202334556644810002599-9950236879899999883998999883133431989987741268701---122
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI---DLV 727 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~l~ 727 (816)
.......|++.|+|||.+.... ++.++||||+|+++|+|++|+.||....................+.... ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf --410010365215411221366577742210333313427966879989889999999999832898333144422242
Q ss_pred C-----CCCCCCC----CHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH--HHCC
Q ss_conf 4-----3112455----08999999999988531287899996899999--7101
Q 003489 728 D-----PLISESG----FKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 728 d-----~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 771 (816)
+ +...... .......+.+++.+|++.||++|||+.|+++. |+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 1243454322220444166789999999999763995579189999678701469
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-45 Score=315.37 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=203.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
Q ss_conf 1842112137798552998586288279999815347--30079999999998414998311234698725853599930
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 572 (816)
++|++.++||+|+||.||+|+.++++.||||+++... ....+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCCC
Q ss_conf 79999430015989999899667998999999999997725997489942088828973899944403443022189876
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 652 (816)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC-
T ss_conf 0045678998---60477514456899999999999860574---8826787750568689978732366430114676-
Q ss_pred CCCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCC---CCC--
Q ss_conf 3320233455664481000259-9995023687989999988399899988313343198998774126870---112--
Q 003489 653 QAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV---IDL-- 726 (816)
Q Consensus 653 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~l-- 726 (816)
.......+++.|+|||.+... .++.++||||+|+++|||++|+.||....+................... ...
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -5410102431101378871788888410021117589999779799898898999999998638997110421233322
Q ss_pred -------CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf -------2431124550899999999998853128789999689999
Q 003489 727 -------VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 727 -------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
..+.............+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 14333335676466651258999999999986689668909999856
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=306.94 Aligned_cols=268 Identities=21% Similarity=0.319 Sum_probs=202.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-------
Q ss_conf 31842112137798552998586-28827999981534--730079999999998414998311234698725-------
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------- 563 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 563 (816)
-++|++.++||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+|++++|+|++++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred -CCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCC
Q ss_conf -8535999307999943001598999989966799899999999999772599748994208882897389994440344
Q 003489 564 -EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642 (816)
Q Consensus 564 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 642 (816)
...++|+|+++++.+..+. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122---20344330899999999999998852299---8856767222036689968763135
Q ss_pred CCEECCCCCCC--CCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 30221898763--320233455664481000259-999502368798999998839989998831334319899877412
Q 003489 643 LARIFGGNQDQ--AATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN 719 (816)
Q Consensus 643 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 719 (816)
++..+...... .......||+.|+|||++... .++.++||||+|+++|||++|+.||....+...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 00223554443211356602497874289970799989178700678646617448799899899999999998418998
Q ss_pred CCCCCCC--------CCCCCC-CCCCHH------HHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 6870112--------243112-455089------99999999988531287899996899999
Q 003489 720 DNNVIDL--------VDPLIS-ESGFKM------EIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 720 ~~~~~~l--------~d~~l~-~~~~~~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
+...... +..... .....+ ..+.+++++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 255344320344433201334455503340444599899999999873896589099999749
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=310.28 Aligned_cols=267 Identities=20% Similarity=0.266 Sum_probs=200.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC----CE
Q ss_conf 31842112137798552998586-288279999815347-3007999999999841499831123469872585----35
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----NM 567 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~ 567 (816)
+.+|++.++||+|+||+||+|.. .+++.||||++.... ....+.+++|+.+|+.++|||++++++++..... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEEC
Q ss_conf 99930799994300159899998996679989999999999977259974899420888289738999444034430221
Q 003489 568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647 (816)
Q Consensus 568 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 647 (816)
++++++.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99996259865664405----89999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCC-CCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 898763-32023345566448100025-9999502368798999998839989998831334319899877412687011
Q 003489 648 GGNQDQ-AATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVID 725 (816)
Q Consensus 648 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 725 (816)
...... ......+|++.|+|||++.. ..++.++||||+|+++|||++|+.||..........................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998765206997566423
Q ss_pred C----------CCCCCCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 2----------24311245----508999999999988531287899996899999
Q 003489 726 L----------VDPLISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 726 l----------~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
. ..+..... ........+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43322220244677557787778378999999999999764895679089998619
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=310.45 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=196.0
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CC-CCEEEEEEECCCCC--HHHHHHHHHHHHHHHC---CCCCEEEEEEEEEEC--
Q ss_conf 831842112137798552998586-28-82799998153473--0079999999998414---998311234698725--
Q 003489 493 ATNNFQLANKLGQGGFGPVYKGKL-QD-GQEIAVKRLSKASG--QGQEEFMNEVMVISNL---QHRNLVRLLGCCVER-- 563 (816)
Q Consensus 493 ~~~~f~~~~~LG~G~~g~Vy~g~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-- 563 (816)
..++|++.++||+|+||.||+++. ++ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred ---CCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEEC
Q ss_conf ---85359993079999430015989999899667998999999999997725997489942088828973899944403
Q 003489 564 ---EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640 (816)
Q Consensus 564 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 640 (816)
...++++|+++++.+...... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECC
T ss_conf 667469999974058714444430--3789998999999999999999997588---98357986278985899754210
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCC
Q ss_conf 44302218987633202334556644810002599995023687989999988399899988313343198998774126
Q 003489 641 FGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND 720 (816)
Q Consensus 641 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 720 (816)
||++..... ........||+.|+|||++....++.++||||+||++|||++|+.||....+......+.........
T Consensus 160 fg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred HHHHHHHCC---CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCH
T ss_conf 001011002---34577765485114831001798881110003289999998787998998989999999984079961
Q ss_pred CCCC---CC-------CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 8701---12-------24311245508999999999988531287899996899999
Q 003489 721 NNVI---DL-------VDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 721 ~~~~---~l-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
.... .. ..+.............+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 105321111033302234564544044589999999999874896679189999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=308.56 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=200.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------
Q ss_conf 318421121377985529985862-8827999981534--7300799999999984149983112346987258------
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------ 564 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 564 (816)
.++|++.++||+|+||+||+|... +++.||||+++.. .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCC
Q ss_conf 53599930799994300159899998996679989999999999977259974899420888289738999444034430
Q 003489 565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644 (816)
Q Consensus 565 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 644 (816)
..++||||+ +.+|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-521899987----402269999999999999999987378---764566851111210012211343102
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHC----
Q ss_conf 221898763320233455664481000259-999502368798999998839989998831334319899877412----
Q 003489 645 RIFGGNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWN---- 719 (816)
Q Consensus 645 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 719 (816)
+..... .....|++.|+|||.+.+. .++.++||||+|+++|||++|+.|+....................
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHH
T ss_conf 206876-----310245533358899817878996501030038999999786998889768999999850378848888
Q ss_pred -CCC----------CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH--HHCC
Q ss_conf -687----------011224311245508999999999988531287899996899999--7101
Q 003489 720 -DNN----------VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 720 -~~~----------~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 771 (816)
... ........+. .......+.+.+++.+|++.||++|||+.|+++. |+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 653000344331157866655667-7556899999999999772995579299999639623758
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=309.42 Aligned_cols=266 Identities=21% Similarity=0.232 Sum_probs=194.7
Q ss_pred CCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------CCEE
Q ss_conf 8421121377985529985862-88279999815347300799999999984149983112346987258------5359
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------ENML 568 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 568 (816)
+|+..++||+|+||+||+++.. +++.||||++..... ...+|+.+|++++|+||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCC-CCEEECCCCCEEC
Q ss_conf 993079999430015989999899667998999999999997725997489942088828973899-9444034430221
Q 003489 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF 647 (816)
Q Consensus 569 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~ 647 (816)
||||++++.+..+.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++..+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH--------HHHH
Q ss_conf 89876332023345566448100025-99995023687989999988399899988313343198998--------7741
Q 003489 648 GGNQDQAATKRLVGTYGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYA--------WKLW 718 (816)
Q Consensus 648 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~ 718 (816)
.... ......|+..|+|||.+.. ..++.++||||+|+++|||++|+.||...........+... +...
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 4776---5320025555568277640468882100024652778550287998987999999999997489817765430
Q ss_pred CCCC----CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH--HHCC
Q ss_conf 2687----011224311245508999999999988531287899996899999--7101
Q 003489 719 NDNN----VIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM--LNSE 771 (816)
Q Consensus 719 ~~~~----~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 771 (816)
.... ..................+.+.+++.+|++.||++|||+.|+++. ++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 62101103554456744443156899999999999765895579299999669845246
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.8e-43 Score=297.43 Aligned_cols=258 Identities=18% Similarity=0.309 Sum_probs=195.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CCCEEE
Q ss_conf 31842112137798552998586-288279999815347300799999999984149-98311234698725--853599
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER--EENMLI 569 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV 569 (816)
.++|++.++||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf 86718978983174819999998899979999998889---999999999999851579987679999981687712688
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCC-CCEEECCCCCEECC
Q ss_conf 93079999430015989999899667998999999999997725997489942088828973899-94440344302218
Q 003489 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFG 648 (816)
Q Consensus 570 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~ 648 (816)
|||+++++|..+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .++|+|||++....
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 8631798589974------68999999999999999998876433---44345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-H----------HHHH
Q ss_conf 98763320233455664481000259-9995023687989999988399899988313343198-9----------9877
Q 003489 649 GNQDQAATKRLVGTYGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLL-G----------YAWK 716 (816)
Q Consensus 649 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~-~----------~~~~ 716 (816)
... ......+|..|+|||.+... .++.++||||+|++++||++|+.|+............ . +...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 887---44432248642476102688888845232335455587604889998876018999999998788415555542
Q ss_pred HHCCC--CCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 41268--701122--------431124550899999999998853128789999689999
Q 003489 717 LWNDN--NVIDLV--------DPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 717 ~~~~~--~~~~l~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
..... ...... .............+.+.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 254447430000033343311211552112448999999999986699568908999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=314.38 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=192.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCC------HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf 318421121377985529985862-882799998153473------00799999999984149--983112346987258
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQ--HRNLVRLLGCCVERE 564 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 564 (816)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCEEEEEECCC-CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCC-CCCEEECCC
Q ss_conf 53599930799-9943001598999989966799899999999999772599748994208882897389-994440344
Q 003489 565 ENMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFG 642 (816)
Q Consensus 565 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfg 642 (816)
..++|+|++.+ +++.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 68999983368622899986---1589999999999999999999998779---75566761114774478848977546
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf 3022189876332023345566448100025999-950236879899999883998999883133431989987741268
Q 003489 643 LARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 643 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
++..... .......||+.|+|||++....+ +.++||||+|+++|||++|+.||....+. . ...
T Consensus 157 ~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---------~---~~~ 220 (273)
T d1xwsa_ 157 SGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------I---RGQ 220 (273)
T ss_dssp TCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------H---HCC
T ss_pred CCEECCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHH---------H---HCC
T ss_conf 5353244----45566565877479999848997886533255403453675688998873677---------6---154
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 7011224311245508999999999988531287899996899999
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
....+. ....+.+++.+|++.||++|||+.|+++.
T Consensus 221 ---~~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ---VFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCCCCC--------CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---477877--------99999999999760897589399998539
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-43 Score=297.90 Aligned_cols=262 Identities=19% Similarity=0.263 Sum_probs=196.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEE-EEEEEECCCCEEEEEE
Q ss_conf 1842112137798552998586-2882799998153473007999999999841499831123-4698725853599930
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL-LGCCVEREENMLIYEY 572 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~e~ 572 (816)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ..+++..|+++++.++|++++.. ..+..+....++|+||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 88999689850788099999998899899999972100--5888999999999703899601799999519877899987
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC---CCCCCEEECCCCCEECCC
Q ss_conf 79999430015989999899667998999999999997725997489942088828973---899944403443022189
Q 003489 573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIFGG 649 (816)
Q Consensus 573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~ 649 (816)
+ +++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..++|+|||+++.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-8713332443--0688768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCC-----CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 8763-----32023345566448100025999950236879899999883998999883133431989987741268701
Q 003489 650 NQDQ-----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNVI 724 (816)
Q Consensus 650 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 724 (816)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 1224311245508999999999988531287899996899999710125
Q 003489 725 DLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIK 773 (816)
Q Consensus 725 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 773 (816)
.+.. .....+.+++..|++.+|++||++.++.+.|+....
T Consensus 239 -----~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 -----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----HHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----HHCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -----7534----788999999999843995579199999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-43 Score=297.50 Aligned_cols=266 Identities=16% Similarity=0.207 Sum_probs=206.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCCCEEEEE
Q ss_conf 318421121377985529985862-882799998153473007999999999841499-831123469872585359993
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 571 (816)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECC-----CCCCEEECCCCCEE
Q ss_conf 0799994300159899998996679989999999999977259974899420888289738-----99944403443022
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-----DLNPKISDFGLARI 646 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~ 646 (816)
|+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.++|+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-88879999752--031106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf 1898763-----32023345566448100025999950236879899999883998999883133431989987741268
Q 003489 647 FGGNQDQ-----AATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDN 721 (816)
Q Consensus 647 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 721 (816)
+...... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 7011224311245508999999999988531287899996899999710125799
Q 003489 722 NVIDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSMLNSEIKDLP 776 (816)
Q Consensus 722 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~l~ 776 (816)
...++. .. ..+.+.+++..|+..+|++||+++.+.+.|+++++...
T Consensus 236 ~~~~l~-----~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PLRELC-----AG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CHHHHT-----TT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHC-----CC----CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 958965-----79----98999999999843993008599999999999999759
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-43 Score=297.10 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=200.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
Q ss_conf 18421121377985529985862-88279999815347--3007999999999841499831123469872585359993
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 571 (816)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+++|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCEECCCCC
Q ss_conf 07999943001598999989966799899999999999772599748994208882897389994440344302218987
Q 003489 572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651 (816)
Q Consensus 572 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 651 (816)
++.+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212---3565403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHHHHHCCCCC---CCC
Q ss_conf 633202334556644810002599-99502368798999998839989998831334-3198998774126870---112
Q 003489 652 DQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFE-LTLLGYAWKLWNDNNV---IDL 726 (816)
Q Consensus 652 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~---~~l 726 (816)
. ......++..|+|||.+.... ++.++||||+|+++|||++|+.|+.......+ ...+........+... ...
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred C--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 5--10010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred CC--------CC-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 24--------31-124550899999999998853128789999689999
Q 003489 727 VD--------PL-ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS 766 (816)
Q Consensus 727 ~d--------~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 766 (816)
.+ .. -...........+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2113344454431043306568999999999986499668909999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-43 Score=297.68 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=198.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CC
Q ss_conf 18421121377985529985862-88279999815347--30079999999998414998311234698725------85
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------EE 565 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 565 (816)
++|++.++||+|+||+||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCE
Q ss_conf 35999307999943001598999989966799899999999999772599748994208882897389994440344302
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 645 (816)
.++|+||+.++.+. .+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHHH-HHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 69998414467787-650-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH----------
Q ss_conf 2189876332023345566448100025999950236879899999883998999883133431989987----------
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAW---------- 715 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~---------- 715 (816)
..... .......+|+.|+|||++.+..++.++||||+|++++||++|+.||...+.......+....
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred CCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 14666---553322146555581331477778774333566257898659899888977889999997205898799987
Q ss_pred ------HHHCCC------CCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf ------741268------70112243112---45508999999999988531287899996899999
Q 003489 716 ------KLWNDN------NVIDLVDPLIS---ESGFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVSM 767 (816)
Q Consensus 716 ------~~~~~~------~~~~l~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 767 (816)
...... ........... ..........+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6566777764175435666421264333543210133379999999999876994579089999669
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=300.11 Aligned_cols=252 Identities=24% Similarity=0.287 Sum_probs=198.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC----CCCEEEEEEECCCC----CHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCC
Q ss_conf 18421121377985529985862----88279999815347----3007999999999841499-831123469872585
Q 003489 495 NNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREE 565 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 565 (816)
++|++.+.||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCE
Q ss_conf 35999307999943001598999989966799899999999999772599748994208882897389994440344302
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 645 (816)
.++++||+.+|+|.+++.. ...+.+..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 0012312341179999873---045437888888999999998851499---8965477320124699988874132022
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 21898763320233455664481000259--9995023687989999988399899988313343198998774126870
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWNDNNV 723 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 723 (816)
.+.... ........|++.|+|||.+... .++.++||||+||+||||++|+.||...........+....... ..
T Consensus 178 ~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~~-- 253 (322)
T d1vzoa_ 178 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EP-- 253 (322)
T ss_dssp ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CC--
T ss_pred HHCCCC-CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC-CC--
T ss_conf 203444-43221222333331068760577688713251777799999976899988887777999999833568-99--
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 1122431124550899999999998853128789999-----689999
Q 003489 724 IDLVDPLISESGFKMEIIRCVNVGLLCVQEFVKDRPN-----MPTVVS 766 (816)
Q Consensus 724 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 766 (816)
.........+.+++.+|+++||++||+ ++|+++
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf ----------88654799999999997445898819997450999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=299.89 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=200.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-----C
Q ss_conf 31842112137798552998586-288279999815347--300799999999984149983112346987258-----5
Q 003489 494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----E 565 (816)
Q Consensus 494 ~~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 565 (816)
.++|++.++||+|+||+||+++. .+++.||||++.... ....+.+.+|+.+++.++|+|++++++++.... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEECCCCCE
Q ss_conf 35999307999943001598999989966799899999999999772599748994208882897389994440344302
Q 003489 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645 (816)
Q Consensus 566 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 645 (816)
.+++++++.+|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 499999625886232002----245309999999999999999997388---7651667763345543220013210001
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCC----
Q ss_conf 218987633202334556644810002599-995023687989999988399899988313343198998774126----
Q 003489 646 IFGGNQDQAATKRLVGTYGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELTLLGYAWKLWND---- 720 (816)
Q Consensus 646 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 720 (816)
... .......|+..|+|||...... ++.++||||+|+++|+|++|+.||...+.......+.........
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred CCC-----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf 257-----544443454355583553377567855124320589999976889978898899999999730799757732
Q ss_pred ----CCCCCCCCC--CCCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH--HHHCC
Q ss_conf ----870112243--11245----50899999999998853128789999689999--97101
Q 003489 721 ----NNVIDLVDP--LISES----GFKMEIIRCVNVGLLCVQEFVKDRPNMPTVVS--MLNSE 771 (816)
Q Consensus 721 ----~~~~~l~d~--~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 771 (816)
......... ..... ........+.+++.+|++.||++|||+.|+++ .+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 001024454443035578755566267899999999999775883459389998559954879
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-38 Score=265.25 Aligned_cols=268 Identities=19% Similarity=0.204 Sum_probs=192.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEE
Q ss_conf 1842112137798552998586-288279999815347300799999999984149-----------9831123469872
Q 003489 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-----------HRNLVRLLGCCVE 562 (816)
Q Consensus 495 ~~f~~~~~LG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 562 (816)
++|++.++||+|+||+||+|+. .+++.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred CC--CCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEEEECCCCEEECCCCC----
Q ss_conf 58--535999307999943001598999989966799899999999999772-59974899420888289738999----
Q 003489 563 RE--ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLN---- 635 (816)
Q Consensus 563 ~~--~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~---- 635 (816)
.. ..++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred --CEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---H
Q ss_conf --44403443022189876332023345566448100025999950236879899999883998999883133431---9
Q 003489 636 --PKISDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFYHEEFELT---L 710 (816)
Q Consensus 636 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~---l 710 (816)
++++|||.+..... ......|++.|+|||++....++.++||||+|+++++|++|+.||.......... .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CEEEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 3056753144212344-----54223665210571321466777643201237899999878899898755432102689
Q ss_pred HHHHHHHHCC------------------CCCCCCCCCC----------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHH
Q ss_conf 8998774126------------------8701122431----------12455089999999999885312878999968
Q 003489 711 LGYAWKLWND------------------NNVIDLVDPL----------ISESGFKMEIIRCVNVGLLCVQEFVKDRPNMP 762 (816)
Q Consensus 711 ~~~~~~~~~~------------------~~~~~l~d~~----------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 762 (816)
.......... ......+... ............+.+++.+|++.||++|||+.
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHHH--HHCC
Q ss_conf 99999--7101
Q 003489 763 TVVSM--LNSE 771 (816)
Q Consensus 763 evl~~--L~~~ 771 (816)
|+++. +.+.
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHHCCCCCCCC
T ss_conf 99669340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.9e-21 Score=156.18 Aligned_cols=171 Identities=17% Similarity=0.158 Sum_probs=120.2
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCC------------------HHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 421121377985529985862882799998153473------------------00799999999984149983112346
Q 003489 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG------------------QGQEEFMNEVMVISNLQHRNLVRLLG 558 (816)
Q Consensus 497 f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g 558 (816)
+.+.++||+|+||.||+|...+|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEE
Q ss_conf 98725853599930799994300159899998996679989999999999977259974899420888289738999444
Q 003489 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638 (816)
Q Consensus 559 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 638 (816)
+. ..+++||++++..+.. ++......++.|++.+++|||+.+ ++||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred EC----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEE
T ss_conf 62----8889999504565420----------015789999999999999982688---8983689036114289-8999
Q ss_pred ECCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 0344302218987633202334556644810002599995023687989999
Q 003489 639 SDFGLARIFGGNQDQAATKRLVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLL 690 (816)
Q Consensus 639 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ 690 (816)
+|||+|.....+....... ..... -.+. ....|+.++|+||..--+.
T Consensus 144 iDFG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCHHHHH---HHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 8778843089987099998---77999-9999-7578998446899999874
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.84 E-value=1.5e-20 Score=150.14 Aligned_cols=112 Identities=24% Similarity=0.434 Sum_probs=94.0
Q ss_pred CCCCCCCCCCCCCCCEEECCCEEEEEEECCCCCCCCEEEEEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEE
Q ss_conf 56435686335999189469958985552899998519999972599999607882179998868985399931787689
Q 003489 24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV 103 (816)
Q Consensus 24 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l 103 (816)
+|||.|||.|.+|++|+| |.|.|.|+.+|+ |.++... ++||.||++.|. ..+.+.++.||+|+|
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN------Lvly~~~------~~vW~s~~~~~~--~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN------LVLYDNN------RAVWASGTNGKA--SGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC------EEEEETT------EEEEECCCTTSC--SSEEEEECTTSCEEE
T ss_pred CCEECCCCEECCCCEEEE--CCEEEEECCCCC------EEEECCC------CEEEECCCCCCC--CCCEEEEECCCCEEE
T ss_conf 989069999559999987--879999817998------8987398------389984673478--885799961534999
Q ss_pred ECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCCCCC
Q ss_conf 6599858998512345457652389936876899826776203112457853
Q 003489 104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTD 155 (816)
Q Consensus 104 ~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~PTD 155 (816)
++.+ ..+|+++++. ..+..+|+|+|+|||||++. ++.++|||+.+|++
T Consensus 65 ~~~~-~~~w~s~t~~--~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSGS-RAIWASNTNR--QNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN 112 (112)
T ss_dssp EETT-EEEEECCCCC--SCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred EECC-CEEEEEEECC--CCCCEEEEECCCCCEEEECC-CCCEEECCCCCCCC
T ss_conf 9348-7499983036--88725999967899999989-99679618885698
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.82 E-value=9.4e-20 Score=144.95 Aligned_cols=108 Identities=19% Similarity=0.291 Sum_probs=92.3
Q ss_pred CCCCCCCCCCCCCCCEEECCCEEEEEEECCCCCCCCEEEEEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEE
Q ss_conf 56435686335999189469958985552899998519999972599999607882179998868985399931787689
Q 003489 24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV 103 (816)
Q Consensus 24 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l 103 (816)
.|+|.+|+.|.+|++|. +|.|.|+|+.+|+ |.++... ++||+||++.|. ...+.|.|+.||+|+|
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn------Lvl~~~~------~~vW~ant~~~~-~~~~~l~l~~dGnLvl 65 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN------LVLYDHS------TSVWASNTGILG-KKGCKAVLQSDGNFVV 65 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC------EEEEETT------EEEEECCCCCTT-CCCCEEEECTTSCEEE
T ss_pred CCCCCCCCEEECCCEEE--ECCEEEEECCCCE------EEEEECC------EEEEEECCCCCC-CEEEEEEECCCCEEEE
T ss_conf 98925999882899898--3788999448986------9998699------899983789987-5107999937960999
Q ss_pred ECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCC
Q ss_conf 6599858998512345457652389936876899826776203112457
Q 003489 104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE 152 (816)
Q Consensus 104 ~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~ 152 (816)
+|+++.++|+|+++.. .+..+|+|+|+|||||++. .+|||+-|
T Consensus 66 ~~~~g~~vW~s~t~~~--~~~~~l~L~ddGNlvly~~----~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEGRSLWASHSVRG--NGNYVLVLQEDGNVVIYGS----DIWSTGTY 108 (109)
T ss_dssp ECSSSCEEEECCCCCC--SSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred EECCCCEEEEEEEECC--CCCEEEEEECCCCEEEECC----CEECCCCC
T ss_conf 9089867999730889--9977999947975999799----87217985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.82 E-value=5.7e-20 Score=146.39 Aligned_cols=107 Identities=21% Similarity=0.309 Sum_probs=92.1
Q ss_pred CCCCCCCCCCCCCCCEEECCCEEEEEEECCCCCCCCEEEEEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEE
Q ss_conf 56435686335999189469958985552899998519999972599999607882179998868985399931787689
Q 003489 24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV 103 (816)
Q Consensus 24 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l 103 (816)
.|+|.+||.|.+|++|. +|.|.|.|+.+|+ |.|+... ++||.||++.| +..+.+.++.+|+|+|
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN------Lvly~~~------~~vW~s~~~~~--~~~~~l~l~~~Gnlvl 64 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN------LVLYDVD------KPIWATNTGGL--SRSCFLSMQTDGNLVV 64 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC------EEEEETT------EEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred CCCCCCCCEECCCCEEE--CCCEEEEECCCCE------EEEEECC------CEEEEECCCCC--CCCCEEEEECCCEEEE
T ss_conf 99956997726999897--2888999878980------9997099------02157078899--8754799812603999
Q ss_pred ECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCC
Q ss_conf 6599858998512345457652389936876899826776203112457
Q 003489 104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE 152 (816)
Q Consensus 104 ~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~ 152 (816)
+++++.++|+|++... ....+|+|+|+|||||++. .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~~--~~~~~l~L~ddGNlVly~~----~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGGQ--NGNYVCILQKDRNVVIYGT----DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCCS--CSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred ECCCCCCEEECCCCCC--CCCEEEEECCCCCEEEECC----CCCCCCCC
T ss_conf 7798551277045588--8767999968889999699----84568888
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=4.8e-15 Score=113.85 Aligned_cols=102 Identities=18% Similarity=0.341 Sum_probs=80.9
Q ss_pred CCCCCCCCE--EECCCEEEEEEECCCCCCCCEEEEEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEECCCC
Q ss_conf 633599918--946995898555289999851999997259999960788217999886898539993178768965998
Q 003489 31 QFIRDPESI--ISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKK 108 (816)
Q Consensus 31 ~~l~~~~~l--~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l~~~~~ 108 (816)
|.|.++|+| .+..|.|.|.|+.+|+ |.++-.. ++||.+|+..+ +....|.++.||+|+|+|+++
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN------LVLy~~~------~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN------LVLYDNN------NPIWATNTGGL--GNGCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC------EEEEETT------EEEEECCCTTS--CSSCEEEECTTSCEEEECTTC
T ss_pred CEEECCCEEEEECCCCEEEEEECCCCC------EEEEECC------EEEEEECCCCC--CCCEEEEEEECCCEEEECCCC
T ss_conf 888289758870478538999889982------9999799------67999467887--741699998377799989998
Q ss_pred CEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCC
Q ss_conf 58998512345457652389936876899826776203112457
Q 003489 109 QVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE 152 (816)
Q Consensus 109 ~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~ 152 (816)
.++|++++.. .....+++|+|+|||||++. .+|||-..
T Consensus 81 ~~vWsS~t~~--~~~~~~l~Lq~DGNlvlYg~----~~W~S~T~ 118 (119)
T d1b2pa_ 81 VTVWQSPVAG--KAGHYVLVLQPDRNVVIYGD----ALWATQTV 118 (119)
T ss_dssp CEEEECSCCC--CSSCEEEEECTTSCEEEEES----EEEECCCC
T ss_pred CEEEECCCCC--CCCCEEEEECCCCCEEEECC----CEECCCCC
T ss_conf 5799788769--98865999969988999799----88416974
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=1.6e-15 Score=117.06 Aligned_cols=109 Identities=21% Similarity=0.359 Sum_probs=85.1
Q ss_pred EEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCC
Q ss_conf 99972599999607882179998868985399931787689659985899851234545765238993687689982677
Q 003489 63 GIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNIS 142 (816)
Q Consensus 63 ~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~ 142 (816)
-|||.+ + +.++++|++|+++|+....-+|.++.||||+|++. +.++|++++.. ....+++.|+++|||||++. +
T Consensus 11 ~il~~~-~-~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~-~ 84 (120)
T d1dlpa2 11 SILYST-Q-GNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTN-Q 84 (120)
T ss_dssp EECCCC----CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCS--SCSSCEEEEETTTEEEEEET-T
T ss_pred EEEECC-C-CCCCCCCEECCCCEEECCCEEEEECCCCCEEEECC-CCEEEEECCCC--CCCCEEEEEECCEEEEEECC-C
T ss_conf 699828-9-88885628839972174887999968983899649-96899975224--77747999907764999929-9
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCEEEEEECCCCCCEEEEEECCCCCCCC
Q ss_conf 62031124578532124573233445796148988404899996205840048998839999489931015
Q 003489 143 QVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWR 213 (816)
Q Consensus 143 ~~~~wqSFd~PTDtlLpg~~l~~~~~~g~~~~l~S~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~yw~ 213 (816)
+.++||||. +.++|.|.+.+++.|...++ . .++|.
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY---~--~~~W~ 119 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY---G--GALWT 119 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE---C--CCCCB
T ss_pred CCEEEEECC-------------------------------CCCCCCEEEEECCCCCEEEE---C--CCCCC
T ss_conf 988998199-------------------------------99998489998889869996---8--97434
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=1.3e-14 Score=110.96 Aligned_cols=87 Identities=22% Similarity=0.355 Sum_probs=46.8
Q ss_pred CCEEEEEEECCCCCCCCEEEEEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEEECCCCCCC
Q ss_conf 99589855528999985199999725999996078821799988689853999317876896599858998512345457
Q 003489 43 GSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANN 122 (816)
Q Consensus 43 ~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~ 122 (816)
+|.|.|.|+.+|+ |.++... ++||.+|... ...+.+.++.||||||+|.++.++|++.+... .
T Consensus 25 ~g~~~l~~q~DGN------LvL~~~~------~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~--~ 87 (115)
T d1dlpa1 25 LSSFRFTMQSDCN------LVLFDSD------VRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGS--I 87 (115)
T ss_dssp STTEEEEECTTSC------EEEEESS------SEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC--S
T ss_pred CCCEEEEECCCCE------EEEECCC------EEEEECCCCC---CCCEEEEEECCCCEEEECCCCCEEEECCCCCC--C
T ss_conf 5988999979983------9998199------0689711689---97568999446789999058978998188899--9
Q ss_pred CCCEEEECCCCCEEEEECCCCCEEECCC
Q ss_conf 6523899368768998267762031124
Q 003489 123 SNTRAQLLDSGNLVLHDNISQVSIWDSF 150 (816)
Q Consensus 123 ~~~~~~l~d~gnlvl~~~~~~~~~wqSF 150 (816)
+..+++|+++|||||++. .+|+|-
T Consensus 88 g~y~l~Lq~DGNlvlY~~----~~Wssg 111 (115)
T d1dlpa1 88 GNYVLVLQPDRTVTIYGP----GLWDSG 111 (115)
T ss_dssp SCCEEEECSSSCEEEECS----EEEECS
T ss_pred CCEEEEECCCCCEEEECC----CEECCC
T ss_conf 978999989986999689----764388
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.39 E-value=4e-13 Score=101.12 Aligned_cols=110 Identities=26% Similarity=0.356 Sum_probs=87.9
Q ss_pred EEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCC
Q ss_conf 99725999996078821799988689853999317876896599858998512345457652389936876899826776
Q 003489 64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ 143 (816)
Q Consensus 64 iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~ 143 (816)
|||.- +...+..|..+.+.++.....+|.++.||||||+++ +.++|++++. +..+.++.|+++|||||++. ++
T Consensus 3 ~~~~~--~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~---~~~~~~l~l~~dGNLvl~d~-~~ 75 (115)
T d1dlpa1 3 ILFGL--SHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTA---GATGCRAVLQSDGLLVILTA-QN 75 (115)
T ss_dssp CCBCS--SSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCC---SCSCCBCCBCSSSCBCCBCT-TT
T ss_pred EEEEC--CCCCCCCCEECCCCCEECCCEEEEECCCCEEEEECC-CEEEEECCCC---CCCCEEEEEECCCCEEEECC-CC
T ss_conf 77864--789988212469981775988999979983999819-9068971168---99756899944678999905-89
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCEEEEEECCCCCCEEEEEECCCCCCCCCCC
Q ss_conf 2031124578532124573233445796148988404899996205840048998839999489931015789
Q 003489 144 VSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP 216 (816)
Q Consensus 144 ~~~wqSFd~PTDtlLpg~~l~~~~~~g~~~~l~S~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~yw~~g~ 216 (816)
.++|||+- +.+.|.|.+.++++|...+ + . .++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvl--Y-~--~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTI--Y-G--PGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEE--E-C--SEEEECSC
T ss_pred CEEEECCC-------------------------------CCCCCCEEEEECCCCCEEE--E-C--CCEECCCC
T ss_conf 78998188-------------------------------8999978999989986999--6-8--97643889
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=2.5e-11 Score=89.25 Aligned_cols=100 Identities=17% Similarity=0.283 Sum_probs=76.0
Q ss_pred CCCCCCCCCCCEEECCCEEEEEEECCCCCCCCEEEEEEEECCCCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEECCC
Q ss_conf 56863359991894699589855528999985199999725999996078821799988689853999317876896599
Q 003489 28 TSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGK 107 (816)
Q Consensus 28 ~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~y~~iw~~~~~~~~~t~vW~an~~~pi~~~~~~l~~~~~g~l~l~~~~ 107 (816)
.+.+.|.+++.| ..|.|.|.|..+|+ |.|+... .+||.+|.. ..+....+.|+.+|||||+|.+
T Consensus 21 ~~~~~l~~~q~l--~~g~y~L~~q~DGN------LvL~~~~------~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 21 NHPQTLHATQSL--QLSPYRLSMETDCN------LVLFDRD------DRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp CCCCEECSSCCC--BCSSCEEEEETTTE------EEEEBTT------BCCSCCCCC--SSCSSCEEEEETTTEEEEEETT
T ss_pred CCCCEECCCCEE--ECCCEEEEECCCCC------EEEECCC------CEEEEECCC--CCCCCEEEEEECCEEEEEECCC
T ss_conf 856288399721--74887999968983------8996499------689997522--4777479999077649999299
Q ss_pred CCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECC
Q ss_conf 858998512345457652389936876899826776203112
Q 003489 108 KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149 (816)
Q Consensus 108 ~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqS 149 (816)
+.++|++++... .+..++.|+++||||||+. .+|.|
T Consensus 85 ~~~lW~S~t~~~--~~~~~l~Lq~DGnlvlY~~----~~W~t 120 (120)
T d1dlpa2 85 NIAVWTSGNSRS--AGRYVFVLQPDRNLAIYGG----ALWTT 120 (120)
T ss_dssp TEEEEECCCCCS--SSCCEEEECSSSCEEEECC----CCCBC
T ss_pred CCEEEEECCCCC--CCCEEEEECCCCCEEEECC----CCCCC
T ss_conf 988998199999--9848999888986999689----74349
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.81 E-value=1.9e-08 Score=70.30 Aligned_cols=85 Identities=25% Similarity=0.445 Sum_probs=62.2
Q ss_pred EEEEECCCCEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 39993178768965998589985123454576523899368768998267762031124578532124573233445796
Q 003489 92 IFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK 171 (816)
Q Consensus 92 ~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~PTDtlLpg~~l~~~~~~g~ 171 (816)
.|.++.||||||+++ +.++|++++... ...+.+.+.++|||||++. ++.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~-~g~~vWsS~t-------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGL--GNGCRAVLQPDGVLVVITN-ENVTVWQSPV-------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTS--CSSCEEEECTTSCEEEECT-TCCEEEECSC--------------------
T ss_pred EEEECCCCCEEEEEC-CEEEEEECCCCC--CCCEEEEEEECCCEEEECC-CCCEEEECCC--------------------
T ss_conf 999889982999979-967999467887--7416999983777999899-9857997887--------------------
Q ss_pred CEEEEEEECCCCCCCCEEEEEECCCCCCEEEEEECCCCCCCCCCC
Q ss_conf 148988404899996205840048998839999489931015789
Q 003489 172 KVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP 216 (816)
Q Consensus 172 ~~~l~S~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~yw~~g~ 216 (816)
.-+.|.|.+.++.+|...++ . .+.|.|+.
T Consensus 89 -----------~~~~~~~~l~Lq~DGNlvlY---g--~~~W~S~T 117 (119)
T d1b2pa_ 89 -----------AGKAGHYVLVLQPDRNVVIY---G--DALWATQT 117 (119)
T ss_dssp -----------CCCSSCEEEEECTTSCEEEE---E--SEEEECCC
T ss_pred -----------CCCCCCEEEEECCCCCEEEE---C--CCEECCCC
T ss_conf -----------69988659999699889997---9--98841697
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=5.5e-08 Score=67.17 Aligned_cols=150 Identities=16% Similarity=0.083 Sum_probs=103.7
Q ss_pred HHHHHHHCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCC
Q ss_conf 99999831842112137798552998586288279999815347300799999999984149-98311234698725853
Q 003489 488 EELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREEN 566 (816)
Q Consensus 488 ~~l~~~~~~f~~~~~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 566 (816)
.++...-..|++.+..+.+....||+... +++.+++|+...........+.+|...+..+. +-.+.+++.+....+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990-89869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------
Q ss_conf 59993079999430015989999899667998999999999997725---------------------------------
Q 003489 567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD--------------------------------- 613 (816)
Q Consensus 567 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------- 613 (816)
++||+++++.++.+... +......++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEECCCCCCCCCCC--------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 99998604334354334--------4026999999899999998556842143576446565557789987765555430
Q ss_pred -----------------------CCCCEEEEEECCCCEEECCCCCCEEECCCCCEE
Q ss_conf -----------------------997489942088828973899944403443022
Q 003489 614 -----------------------SRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 614 -----------------------~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 646 (816)
....++|+|+.+.|||++++....|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 33232005799999999844986781789860047642364996599960231441
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.77 E-value=3.4e-08 Score=68.55 Aligned_cols=87 Identities=26% Similarity=0.460 Sum_probs=62.0
Q ss_pred CCEEEEECCCCEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 85399931787689659985899851234545765238993687689982677620311245785321245732334457
Q 003489 90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRT 169 (816)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~PTDtlLpg~~l~~~~~~ 169 (816)
.-.|.++.||||||++. +.+||++++... .....+.|+++|||||++. ++.++|+| +|
T Consensus 20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~-~g~~vWsS-----~t------------- 77 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYDV-DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP-SNKPIWAS-----NT------------- 77 (108)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTS--CSSCEEEECTTSCEEEECT-TCCEEEEC-----CC-------------
T ss_pred CEEEEECCCCEEEEEEC-CCEEEEECCCCC--CCCCEEEEECCCEEEEECC-CCCCEEEC-----CC-------------
T ss_conf 88999878980999709-902157078899--8754799812603999779-85512770-----45-------------
Q ss_pred CCCEEEEEEECCCCCCCCEEEEEECCCCCCEEEEEECCCCCCCCCCC
Q ss_conf 96148988404899996205840048998839999489931015789
Q 003489 170 GKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP 216 (816)
Q Consensus 170 g~~~~l~S~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~yw~~g~ 216 (816)
....+.|.+.++..|...++ . .+.|.|+.
T Consensus 78 -------------~~~~~~~~l~L~ddGNlVly---~--~~~W~S~t 106 (108)
T d1jpca_ 78 -------------GGQNGNYVCILQKDRNVVIY---G--TDRWATGT 106 (108)
T ss_dssp -------------CCSCSCEEEEECTTSCEEEE---E--CCCCCCCC
T ss_pred -------------CCCCCCEEEEECCCCCEEEE---C--CCCCCCCC
T ss_conf -------------58887679999688899996---9--98456888
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.74 E-value=5.2e-08 Score=67.35 Aligned_cols=89 Identities=26% Similarity=0.454 Sum_probs=63.3
Q ss_pred CCEEEEECCCCEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 85399931787689659985899851234545765238993687689982677620311245785321245732334457
Q 003489 90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRT 169 (816)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~PTDtlLpg~~l~~~~~~ 169 (816)
.-.|.++.||||||+. .+.++|++++... +..+..+.|.++|||||+++ ++.++|+|= |
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~-~~~~~~l~l~~dGnLvl~~~-~g~~vW~s~-----t------------- 78 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGIL-GKKGCKAVLQSDGNFVVYDA-EGRSLWASH-----S------------- 78 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCT-TCCCCEEEECTTSCEEEECS-SSCEEEECC-----C-------------
T ss_pred CEEEEECCCCEEEEEE-CCEEEEEECCCCC-CCEEEEEEECCCCEEEEEEC-CCCEEEEEE-----E-------------
T ss_conf 8899944898699986-9989998378998-75107999937960999908-986799973-----0-------------
Q ss_pred CCCEEEEEEECCCCCCCCEEEEEECCCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 961489884048999962058400489988399994899310157899
Q 003489 170 GKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPW 217 (816)
Q Consensus 170 g~~~~l~S~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~yw~~g~w 217 (816)
..+.|.|.+.++++|...+ + . .+.|.|+.+
T Consensus 79 -------------~~~~~~~~l~L~ddGNlvl--y-~--~~~W~S~t~ 108 (109)
T d1kj1a_ 79 -------------VRGNGNYVLVLQEDGNVVI--Y-G--SDIWSTGTY 108 (109)
T ss_dssp -------------CCCSSCCEEEECTTSCEEE--E-C--CEEEECCCC
T ss_pred -------------ECCCCCEEEEEECCCCEEE--E-C--CCEECCCCC
T ss_conf -------------8899977999947975999--7-9--987217985
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.44 E-value=1.6e-06 Score=57.56 Aligned_cols=89 Identities=25% Similarity=0.429 Sum_probs=61.0
Q ss_pred CCEEEEECCCCEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 85399931787689659985899851234545765238993687689982677620311245785321245732334457
Q 003489 90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRT 169 (816)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~wqSFd~PTDtlLpg~~l~~~~~~ 169 (816)
.-.|.++.||||||++ .+.+||++++... ...+.+.|+.+|||||++. ++ .+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~-~~-~~w~s-------------------- 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG-SR-AIWAS-------------------- 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-TE-EEEEC--------------------
T ss_pred CEEEEECCCCCEEEEC-CCCEEEECCCCCC--CCCCEEEEECCCCEEEEEC-CC-EEEEE--------------------
T ss_conf 7999981799889873-9838998467347--8885799961534999934-87-49998--------------------
Q ss_pred CCCEEEEEEECCCCCCCCEEEEEECCCCCCEEEEEECCCCCCCCCCC
Q ss_conf 96148988404899996205840048998839999489931015789
Q 003489 170 GKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP 216 (816)
Q Consensus 170 g~~~~l~S~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~~yw~~g~ 216 (816)
.+.-..|.+.+.++..|...+ +.....+.|.|+.
T Consensus 75 -----------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -----------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT 108 (112)
T ss_dssp -----------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred -----------EECCCCCCEEEEECCCCCEEE--ECCCCCEEECCCC
T ss_conf -----------303688725999967899999--9899967961888
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=2.1e-05 Score=50.13 Aligned_cols=131 Identities=19% Similarity=0.172 Sum_probs=86.9
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCCCEEEEEECCCCCC
Q ss_conf 1377985-52998586288279999815347300799999999984149--98311234698725853599930799994
Q 003489 502 KLGQGGF-GPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVEREENMLIYEYMPNKSL 578 (816)
Q Consensus 502 ~LG~G~~-g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL 578 (816)
.+..|.. ..||+.....+..+++|...... ...+..|...++.+. .-.+.+++.+..+.+..++|++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q ss_conf 30015989999899667998999999999997725---------------------------------------------
Q 003489 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD--------------------------------------------- 613 (816)
Q Consensus 579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------------- 613 (816)
.+.. ... ...+.++++.|.-||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------268---99999999999987368854488755412468899999987541101134011213799999
Q ss_pred ----------CCCCEEEEEECCCCEEECCCCCCEEECCCCCEE
Q ss_conf ----------997489942088828973899944403443022
Q 003489 614 ----------SRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 614 ----------~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 646 (816)
....++|+|+.+.|||++++..+.|.||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.85 E-value=0.00013 Score=44.90 Aligned_cols=77 Identities=13% Similarity=0.152 Sum_probs=49.7
Q ss_pred CCCCCCCCCEEEEEEEECC-CCEEEEEEECCC-------CCHHHHHHHHHHHHHHHCC-C-C-CEEEEEEEEEECCCCEE
Q ss_conf 1213779855299858628-827999981534-------7300799999999984149-9-8-31123469872585359
Q 003489 500 ANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA-------SGQGQEEFMNEVMVISNLQ-H-R-NLVRLLGCCVEREENML 568 (816)
Q Consensus 500 ~~~LG~G~~g~Vy~g~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H-~-niv~l~g~~~~~~~~~l 568 (816)
.+.||.|....||+....+ ++.+++|.-... ......+...|.+.|..+. + | .+++++. .+....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCCCEE
T ss_conf 9980798527689999579984899961771303467778887789999999999865057988552899--85988779
Q ss_pred EEEECCCCCC
Q ss_conf 9930799994
Q 003489 569 IYEYMPNKSL 578 (816)
Q Consensus 569 V~e~~~~gsL 578 (816)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00046 Score=41.24 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=73.3
Q ss_pred CEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCE--EEEEE-----EEEECCCCEEEEEECCCCCCCC
Q ss_conf 5529985862882799998153473007999999999841499831--12346-----9872585359993079999430
Q 003489 508 FGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL--VRLLG-----CCVEREENMLIYEYMPNKSLDS 580 (816)
Q Consensus 508 ~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL~~ 580 (816)
.-.||+...++|+.+++|..+... ...+++..|...+..|....+ +..+. ........+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 202699983899979999847877-8899999999999999855998787520689805665347999986527768899
Q ss_pred C----C----------C----C--CCCCCCCC-------------------HHHHHHHHHHHHHHHHHHHH----CCCCC
Q ss_conf 0----1----------5----9--89999899-------------------66799899999999999772----59974
Q 003489 581 F----L----------F----D--PQRQSLLD-------------------WPKRFNIIKGISRGLLYLHR----DSRLR 617 (816)
Q Consensus 581 ~----l----------~----~--~~~~~~l~-------------------~~~~~~i~~~ia~aL~yLH~----~~~~~ 617 (816)
. + | . .......+ ...+-.+...+...++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred EEEEEECCCCEEECCCCCCEEECCCCCEE
Q ss_conf 89942088828973899944403443022
Q 003489 618 IIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 618 ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 646 (816)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.29 E-value=0.0026 Score=36.35 Aligned_cols=77 Identities=13% Similarity=0.297 Sum_probs=48.1
Q ss_pred CCCCCCCCCCCCCEEEEEEEECCC--------CEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCC
Q ss_conf 842112137798552998586288--------279999815347300799999999984149-98311234698725853
Q 003489 496 NFQLANKLGQGGFGPVYKGKLQDG--------QEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREEN 566 (816)
Q Consensus 496 ~f~~~~~LG~G~~g~Vy~g~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 566 (816)
.+++ +.|+.|-.-.+|+....++ +.+.+++.-.. .......+|..+++.+. +.-..++++++. -
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~ 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----G 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----T
T ss_pred CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEECC----C
T ss_conf 1699-99178533434899968877544578981799965996--116589999999999975799980899818----9
Q ss_pred EEEEEECCCCCCC
Q ss_conf 5999307999943
Q 003489 567 MLIYEYMPNKSLD 579 (816)
Q Consensus 567 ~lV~e~~~~gsL~ 579 (816)
.+|+||+++.++.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred CEEEEEECCCCCC
T ss_conf 5699973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.61 E-value=0.0055 Score=34.15 Aligned_cols=158 Identities=13% Similarity=0.061 Sum_probs=74.3
Q ss_pred CHHHHHHHHCCCCCCC-----CCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCE-----EE
Q ss_conf 9899999831842112-----1377985529985862882799998153473007999999999841499831-----12
Q 003489 486 NFEELANATNNFQLAN-----KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-----VR 555 (816)
Q Consensus 486 ~~~~l~~~~~~f~~~~-----~LG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~ 555 (816)
+.+++.....+|.+.+ .|..|.--+.|+....+ ..+++|++.... ..+.+..|+..+..+...++ +.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECC-CCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf 99999999986799985685237888526738999789-728999807899--988999999998754302555455641
Q ss_pred EE-E--EEEECCCCEEEEEECCCCCCCCCC--------------C----C--CCCCC------------------CCCHH
Q ss_conf 34-6--987258535999307999943001--------------5----9--89999------------------89966
Q 003489 556 LL-G--CCVEREENMLIYEYMPNKSLDSFL--------------F----D--PQRQS------------------LLDWP 594 (816)
Q Consensus 556 l~-g--~~~~~~~~~lV~e~~~~gsL~~~l--------------~----~--~~~~~------------------~l~~~ 594 (816)
.. | +.........++.+..+....... + . ..... .....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCH
T ss_conf 04897621341255024531146553332046788888998764544432024531011101200245677776531141
Q ss_pred HHHHHHHHHHHHHHHHHHC-CCCCEEEEEECCCCEEECCCCCCEEECCCCCEE
Q ss_conf 7998999999999997725-997489942088828973899944403443022
Q 003489 595 KRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646 (816)
Q Consensus 595 ~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 646 (816)
.....+..+...+...+.. -+..++|+|+.+.||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 27999999987642048554545033378636564020454126742221236
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.22 E-value=0.74 Score=20.07 Aligned_cols=55 Identities=16% Similarity=0.381 Sum_probs=34.8
Q ss_pred CCEEEEEECCCCCCC------CCCCCCHHHHHHHHHC----CCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 983785414776532------3467753339996202----598200001376134886304421
Q 003489 340 DGFFKLETMKVPYFA------ERSSANEDKCKDQCSN----NCSCKAYAYEIGVGCMIWTHNLID 394 (816)
Q Consensus 340 ~~f~~~~~~~~p~~~------~~~~~~~~~C~~~Cl~----nCsC~a~~y~~g~~c~~~~~~l~~ 394 (816)
++|.+..+..+.-.. .....+.++|...|+. +-.|.+|.|....+.|++...-..
T Consensus 5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls~~n~~ 69 (91)
T d2qj2a1 5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSM 69 (91)
T ss_dssp GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEESSCTT
T ss_pred HHHHHCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEECCCCCC
T ss_conf 76642378367646865565632568999999998726798706776898778982787266589
|